Citrus Sinensis ID: 015909
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 398 | 2.2.26 [Sep-21-2011] | |||||||
| P43293 | 389 | Probable serine/threonine | yes | no | 0.969 | 0.992 | 0.689 | 1e-162 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.984 | 0.956 | 0.656 | 1e-160 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.987 | 0.953 | 0.642 | 1e-156 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.889 | 0.896 | 0.650 | 1e-141 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.904 | 0.845 | 0.616 | 1e-133 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.864 | 0.697 | 0.640 | 1e-132 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.904 | 0.734 | 0.621 | 1e-131 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.874 | 0.894 | 0.621 | 1e-131 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.791 | 0.739 | 0.656 | 1e-128 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.806 | 0.782 | 0.623 | 1e-119 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 573 bits (1476), Expect = e-162, Method: Compositional matrix adjust.
Identities = 271/393 (68%), Positives = 329/393 (83%), Gaps = 7/393 (1%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG C SNRIK + S T ++SK+ SRD SS++ SFS PR+EGEILQ++N+K
Sbjct: 1 MGGCFSNRIKTDIASSTWLSSKFLSRDGSKGSSTA----SFSY--MPRTEGEILQNANLK 54
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
NFS S+L++ATRNFRPDSV+GEGGFG VFKGW+DE SLA ++PGTG++IAVKRLNQEGFQ
Sbjct: 55 NFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQ 114
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWL EINYLGQL HPNLVKL+GYCLE++HRLLVYEFM RGS+ENHLFRRG+++QPLS
Sbjct: 115 GHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLS 174
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W+ R+++ALGAA GLAFLH+A+P+VIYRDFKASNILLDSNYNAKLSDFGLARDGP GD S
Sbjct: 175 WNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNS 234
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGT GYAAPEYLATGHL+ KSD+YSFGVVLLE+LSGRRAIDKN+P GEHNLV+W
Sbjct: 235 HVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDW 294
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
A+PYLT+KRR+ RV+DPRL+GQ+SL +A K A LAL C+S++ K RP M+E+VK +E+L
Sbjct: 295 ARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELH 354
Query: 361 ELRNMHKRPQKEHQAKGHVHFKG-RATTYPRPS 392
+ K Q + ++ K +A YPRPS
Sbjct: 355 IQKEASKEQQNPQISIDNIINKSPQAVNYPRPS 387
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 566 bits (1459), Expect = e-160, Method: Compositional matrix adjust.
Identities = 273/416 (65%), Positives = 332/416 (79%), Gaps = 24/416 (5%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG C S ++KAE+ + ++KY ++D SL S KASS S+ +PR+EGEILQS N+K
Sbjct: 1 MGICLSAQVKAES---SGASTKYDAKDIGSLGS---KASSVSVRPSPRTEGEILQSPNLK 54
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+FS+++L++ATRNFRPDSVLGEGGFG VFKGW+DE SL ++RPGTG++IAVK+LNQ+G+Q
Sbjct: 55 SFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQ 114
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWL E+NYLGQ H +LVKL+GYCLED+HRLLVYEFMPRGS+ENHLFRRG YFQPLS
Sbjct: 115 GHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLS 174
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W LR+K+ALGAA GLAFLHS+E +VIYRDFK SNILLDS YNAKLSDFGLA+DGP GDKS
Sbjct: 175 WKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKS 234
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGT+GYAAPEYLATGHLT KSD+YSFGVVLLE+LSGRRA+DKNRP+GE NLVEW
Sbjct: 235 HVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEW 294
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYL +KR+IFRV+D RL+ Q+S+ +A K A+L+L+CL+ E KLRP+M EVV LE +Q
Sbjct: 295 AKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQ 354
Query: 361 ELR-----NMHKRPQKEHQAKGHVHFK-------------GRATTYPRPSASPLRI 398
L NM K ++ + V K YPRPSASPL +
Sbjct: 355 SLNAAIGGNMDKTDRRMRRRSDSVVSKKVNAGFARQTAVGSTVVAYPRPSASPLYV 410
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 552 bits (1422), Expect = e-156, Method: Compositional matrix adjust.
Identities = 268/417 (64%), Positives = 328/417 (78%), Gaps = 24/417 (5%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG C S +IKA +P + KY S +A S +SS S+ PR+EGEILQS N+K
Sbjct: 1 MGICLSAQIKAVSPG---ASPKYMSSEANDSLGSK--SSSVSIRTNPRTEGEILQSPNLK 55
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+F++++L+ ATRNFRPDSVLGEGGFGSVFKGW+DE +L +++PGTG++IAVK+LNQ+G+Q
Sbjct: 56 SFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQ 115
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWL E+NYLGQ HPNLVKL+GYCLED+HRLLVYEFMPRGS+ENHLFRRGSYFQPLS
Sbjct: 116 GHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 175
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W+LR+K+ALGAA GLAFLH+AE VIYRDFK SNILLDS YNAKLSDFGLA+DGPTGDKS
Sbjct: 176 WTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKS 235
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTR+MGTYGYAAPEYLATGHLT KSD+YS+GVVLLE+LSGRRA+DKNRP GE LVEW
Sbjct: 236 HVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEW 295
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
A+P L +KR++FRV+D RL+ Q+S+ +A K A+LAL+CL+ E KLRP+M+EVV LE +Q
Sbjct: 296 ARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQ 355
Query: 361 EL-----RNMHKRPQKEHQAKGHVHFKGR--------------ATTYPRPSASPLRI 398
L RN+ ++ + V + AT YPRPS SPL +
Sbjct: 356 TLNEAGGRNIDMVQRRMRRRSDSVAINQKPNAGFARQTAVGVIATAYPRPSDSPLFV 412
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 502 bits (1292), Expect = e-141, Method: Compositional matrix adjust.
Identities = 235/361 (65%), Positives = 297/361 (82%), Gaps = 7/361 (1%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG+C S+R+KA+ + + Y + SSS+ A+ ++EGEIL S+ +K
Sbjct: 1 MGSCFSSRVKADIFHNGKSSDLYGLSLSSRKSSSTVAAAQ-------KTEGEILSSTPVK 53
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+F++++L+ ATRNFRPDSV+GEGGFG VFKGW+DE +L T+PGTG++IAVK+LNQEGFQ
Sbjct: 54 SFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQ 113
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWLTEINYLGQL HPNLVKL+GYCLED+HRLLVYEFM +GS+ENHLFRRG+YF+PL
Sbjct: 114 GHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLP 173
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W LR+ +AL AA GLAFLHS KVIYRD KASNILLD++YNAKLSDFGLARDGP GD S
Sbjct: 174 WFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLS 233
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
+VSTRVMGTYGYAAPEY+++GHL A+SD+YSFGV+LLEILSG+RA+D NRP E NLV+W
Sbjct: 234 YVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDW 293
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
A+PYLTSKR++ ++D RL+ Q+ +A + AS+A+QCLS EPK RP MD+VV+ L+QLQ
Sbjct: 294 ARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQ 353
Query: 361 E 361
+
Sbjct: 354 D 354
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 476 bits (1226), Expect = e-133, Method: Compositional matrix adjust.
Identities = 230/373 (61%), Positives = 298/373 (79%), Gaps = 13/373 (3%)
Query: 1 MGACCSNRIKAETPSHT----------DVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSE 50
MG C + K ++ SH+ V+SK S S S + +S SLP TPR+E
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLP-TPRTE 59
Query: 51 GEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIA 110
GEIL S N+K F++++L+ ATRNFRPDS+LGEGGFG VFKGW+D +L +++PG+G+++A
Sbjct: 60 GEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVA 119
Query: 111 VKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF 170
VK+L EG+QGHKEWLTE+NYLGQL HPNLVKLVGYC+E ++RLLVYEFMP+GS+ENHLF
Sbjct: 120 VKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF 179
Query: 171 RRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230
RRG+ QPL+W++RMK+A+GAA GL FLH A+ +VIYRDFKA+NILLD+ +N+KLSDFGL
Sbjct: 180 RRGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGL 237
Query: 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNR 290
A+ GPTGDK+HVST+VMGT+GYAAPEY+ATG LTAKSD+YSFGVVLLE+LSGRRA+DK++
Sbjct: 238 AKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSK 297
Query: 291 PTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD 350
E +LV+WA PYL KR++FR++D RL GQ+ A AASLALQCL+ + KLRP M
Sbjct: 298 VGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMS 357
Query: 351 EVVKELEQLQELR 363
EV+ +L+QL+ +
Sbjct: 358 EVLAKLDQLESTK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1216), Expect = e-132, Method: Compositional matrix adjust.
Identities = 223/348 (64%), Positives = 277/348 (79%), Gaps = 4/348 (1%)
Query: 19 VNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDS 78
N K + + +SS++ +++ S TP E+ SS+++ F+++DL+ +TRNFRP+S
Sbjct: 87 ANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPES 146
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
+LGEGGFG VFKGW++E+ A +PGTG+ +AVK LN +G QGHKEWL EIN+LG L HP
Sbjct: 147 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHP 206
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
NLVKLVGYC+EDD RLLVYEFMPRGS+ENHLFRR PL WS+RMKIALGAA GL+FL
Sbjct: 207 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLSFL 263
Query: 199 HSAEPK-VIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEY 257
H K VIYRDFK SNILLD++YNAKLSDFGLA+D P K+HVSTRVMGTYGYAAPEY
Sbjct: 264 HEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEY 323
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDP 317
+ TGHLT+KSD+YSFGVVLLE+L+GRR++DKNRP GEHNLVEWA+P+L KRR +R+LDP
Sbjct: 324 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDP 383
Query: 318 RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365
RLEG FS+ AQK LA QCLS +PK+RP M +VV+ L+ L L++M
Sbjct: 384 RLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDM 431
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1205), Expect = e-131, Method: Compositional matrix adjust.
Identities = 232/373 (62%), Positives = 278/373 (74%), Gaps = 13/373 (3%)
Query: 3 ACCSNRIKAETPSHTDVNSKYSSRDA---------KSLSSSSGKASSFSLPQTPRSEGEI 53
CC++ S T S S+ A +SS++ +++ S TP E+
Sbjct: 56 VCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESSLSTPIISEEL 115
Query: 54 LQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKR 113
S++K FS+ DL+ ATRNFRP+S+LGEGGFG VFKGWV+E+ A +PGTG+ +AVK
Sbjct: 116 NIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT 175
Query: 114 LNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG 173
LN +G QGHKEWL EINYLG L HPNLVKLVGYC+EDD RLLVYEFMPRGS+ENHLFRR
Sbjct: 176 LNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS 235
Query: 174 SYFQPLSWSLRMKIALGAANGLAFLHSAEPK-VIYRDFKASNILLDSNYNAKLSDFGLAR 232
PL WS+RMKIALGAA GL+FLH K VIYRDFK SNILLD YNAKLSDFGLA+
Sbjct: 236 ---LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAK 292
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292
D P K+HVSTRVMGTYGYAAPEY+ TGHLT+KSD+YSFGVVLLE+L+GRR++DKNRP
Sbjct: 293 DAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 352
Query: 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
GEHNLVEWA+P+L KRR +R+LDPRLEG FS+ AQK LA QCLS + K+RP M EV
Sbjct: 353 GEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEV 412
Query: 353 VKELEQLQELRNM 365
V+ L+ L L++M
Sbjct: 413 VEVLKPLPHLKDM 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 467 bits (1201), Expect = e-131, Method: Compositional matrix adjust.
Identities = 225/362 (62%), Positives = 285/362 (78%), Gaps = 14/362 (3%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG+C S+R+ +N S D LSS +S+ ++EGEIL S+ +K
Sbjct: 1 MGSCLSSRV---------LNKSSSGLDDLHLSSCKSSSSA----TAHKTEGEILSSTTVK 47
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+FS+++L+ ATRNFR DSV+GEGGFG VF+GW+DE +L T+ +G++IAVKRLN +GFQ
Sbjct: 48 SFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNPDGFQ 107
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSY-FQPL 179
GH+EWLTEINYLGQL HPNLVKL+GYCLED+ RLLVYEFM +GS+ENHLF G+ F+PL
Sbjct: 108 GHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFKPL 167
Query: 180 SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDK 239
SW LR+K+AL AA GLAFLHS KVIYRD KASNILLDS++NAKLSDFGLARDGP G++
Sbjct: 168 SWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQ 227
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299
S+VSTRVMGT+GYAAPEY++TGHL A+SD+YSFGVVLLE+L GR+A+D NRP E NLV+
Sbjct: 228 SYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNLVD 287
Query: 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
WA+PYLTS+R++ ++D RL Q+ A + AS+A+QCLS EPK RP MD+VV+ L QL
Sbjct: 288 WARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQL 347
Query: 360 QE 361
Q+
Sbjct: 348 QD 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-128, Method: Compositional matrix adjust.
Identities = 208/317 (65%), Positives = 270/317 (85%), Gaps = 2/317 (0%)
Query: 46 TPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGT 105
T R+EGEIL S N+K F++++L+ AT+NFR D++LGEGGFG VFKGW+D+ SL ++RPG+
Sbjct: 58 TLRTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGS 117
Query: 106 GMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSM 165
G+++AVK+L EGFQGHKEWLTE+NYLGQL HPNLV LVGYC E ++RLLVYEFMP+GS+
Sbjct: 118 GIVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSL 177
Query: 166 ENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225
ENHLFRRG+ QPL+W++RMK+A+GAA GL FLH A+ +VIYRDFKA+NILLD+++NAKL
Sbjct: 178 ENHLFRRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKL 235
Query: 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRA 285
SDFGLA+ GPTGD +HVST+V+GT+GYAAPEY+ATG LTAKSD+YSFGVVLLE++SGRRA
Sbjct: 236 SDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRA 295
Query: 286 IDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL 345
+D + E++LV+WA PYL KR++FR++D +L GQ+ A AA+LALQCL+ + KL
Sbjct: 296 MDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKL 355
Query: 346 RPDMDEVVKELEQLQEL 362
RP M EV+ LEQL+ +
Sbjct: 356 RPKMSEVLVTLEQLESV 372
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1097), Expect = e-119, Method: Compositional matrix adjust.
Identities = 205/329 (62%), Positives = 256/329 (77%), Gaps = 8/329 (2%)
Query: 35 SGKASSFSLPQTPRSEGEI---LQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKG 91
S S S P TPR + + + + F+ +L T T++FRPD +LGEGGFG+V+KG
Sbjct: 27 SRSVSDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKG 86
Query: 92 WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151
++D++ + + +AVK LN+EG QGH+EWLTE+N+LGQL HPNLVKL+GYC EDD
Sbjct: 87 YIDDNLRVGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD 143
Query: 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFK 211
HRLLVYEFM RGS+ENHLFR+ + PLSWS RM IALGAA GLAFLH+AE VIYRDFK
Sbjct: 144 HRLLVYEFMLRGSLENHLFRKTT--APLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFK 201
Query: 212 ASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYS 271
SNILLDS+Y AKLSDFGLA+ GP GD++HVSTRVMGTYGYAAPEY+ TGHLTA+SD+YS
Sbjct: 202 TSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYS 261
Query: 272 FGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKA 331
FGVVLLE+L+GR+++DK RP+ E NLV+WA+P L KR++ +++DPRLE Q+S+ AQKA
Sbjct: 262 FGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKA 321
Query: 332 ASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
SLA CLS PK RP M +VV+ LE LQ
Sbjct: 322 CSLAYYCLSQNPKARPLMSDVVETLEPLQ 350
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 398 | ||||||
| 224119448 | 399 | predicted protein [Populus trichocarpa] | 0.994 | 0.992 | 0.785 | 1e-180 | |
| 225440370 | 405 | PREDICTED: protein kinase APK1A, chlorop | 0.994 | 0.977 | 0.755 | 1e-179 | |
| 297746068 | 404 | unnamed protein product [Vitis vinifera] | 0.984 | 0.970 | 0.729 | 1e-174 | |
| 224059486 | 405 | predicted protein [Populus trichocarpa] | 0.977 | 0.960 | 0.709 | 1e-172 | |
| 449450018 | 401 | PREDICTED: protein kinase APK1A, chlorop | 0.992 | 0.985 | 0.720 | 1e-172 | |
| 359807309 | 419 | protein kinase APK1A, chloroplastic-like | 0.992 | 0.942 | 0.698 | 1e-171 | |
| 356506672 | 414 | PREDICTED: protein kinase APK1B, chlorop | 0.992 | 0.954 | 0.710 | 1e-171 | |
| 359807385 | 410 | probable serine/threonine-protein kinase | 0.994 | 0.965 | 0.736 | 1e-171 | |
| 359478936 | 442 | PREDICTED: protein kinase APK1A, chlorop | 0.984 | 0.886 | 0.727 | 1e-171 | |
| 363807636 | 422 | uncharacterized protein LOC100798404 [Gl | 0.994 | 0.938 | 0.692 | 1e-170 |
| >gi|224119448|ref|XP_002331232.1| predicted protein [Populus trichocarpa] gi|222873418|gb|EEF10549.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1639), Expect = e-180, Method: Compositional matrix adjust.
Identities = 312/397 (78%), Positives = 350/397 (88%), Gaps = 1/397 (0%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG C SNRIK+ T S+T ++SK SR+ K+LSSSS K S S+PQTPRSEGEILQSSN+K
Sbjct: 1 MGLCWSNRIKSYTCSNTGLSSKCGSRNGKTLSSSSSKVSIVSVPQTPRSEGEILQSSNLK 60
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
F++ +L+TATRNFRPDSVLGEGGFGSVFKGWVDEHSLA+TRPGTGM+IAVKRLNQEGFQ
Sbjct: 61 IFTFGELKTATRNFRPDSVLGEGGFGSVFKGWVDEHSLAATRPGTGMVIAVKRLNQEGFQ 120
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWL EINYLGQ HPNLVKL+GYCLEDDHRLLVYEFMPRGSMENHLFRRGS+FQPLS
Sbjct: 121 GHREWLAEINYLGQFQHPNLVKLIGYCLEDDHRLLVYEFMPRGSMENHLFRRGSHFQPLS 180
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W++RMK+ALGAA GLAFLHSA+ KVIYRDFK SNILLDSNYNAKLSDFGLARDGPTGD S
Sbjct: 181 WNIRMKVALGAARGLAFLHSADAKVIYRDFKTSNILLDSNYNAKLSDFGLARDGPTGDNS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGT+GYAAPEYLATGHLT KSD+YSFGVVLLE+LSGRRAIDKNRP+G+HNLVEW
Sbjct: 241 HVSTRVMGTHGYAAPEYLATGHLTPKSDVYSFGVVLLEMLSGRRAIDKNRPSGQHNLVEW 300
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYLT+KRR+FRVLD RLEGQ+ +AQK ++LALQCL+VEPK RP+MDEVV LEQLQ
Sbjct: 301 AKPYLTNKRRVFRVLDTRLEGQYVPSRAQKLSNLALQCLAVEPKFRPNMDEVVMVLEQLQ 360
Query: 361 E-LRNMHKRPQKEHQAKGHVHFKGRATTYPRPSASPL 396
E ++++ K KEH K G YPRPSASPL
Sbjct: 361 EQVKDIPKISHKEHNLKVRGGANGGQIAYPRPSASPL 397
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440370|ref|XP_002266032.1| PREDICTED: protein kinase APK1A, chloroplastic [Vitis vinifera] gi|297740368|emb|CBI30550.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1636), Expect = e-179, Method: Compositional matrix adjust.
Identities = 306/405 (75%), Positives = 351/405 (86%), Gaps = 9/405 (2%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MGACCSNRIKAE+P HT +SK S+D LS SS K SS S+PQTPR+EGEILQ+SN+K
Sbjct: 1 MGACCSNRIKAESPVHTGASSKNVSKDENDLSRSSSKFSSTSIPQTPRTEGEILQASNLK 60
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+F +S+LRTATRNFRPDSVLGEGGFGSVFKGW+DE+SL +TRPG GM++AVKRLNQEGFQ
Sbjct: 61 SFGFSELRTATRNFRPDSVLGEGGFGSVFKGWIDENSLMATRPGAGMVVAVKRLNQEGFQ 120
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWL EINYLGQL HPNLVKL+GYCLEDDHRLLVYEFMP+GSMENHLFRRGSYFQPLS
Sbjct: 121 GHREWLAEINYLGQLQHPNLVKLIGYCLEDDHRLLVYEFMPKGSMENHLFRRGSYFQPLS 180
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
WS+RM++A+GAA GLAFLH+AE +VIYRDFK SNILLDSNYNAKLSDFGLARDGPTGDKS
Sbjct: 181 WSVRMEVAIGAARGLAFLHNAETQVIYRDFKTSNILLDSNYNAKLSDFGLARDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGTYGYAAPEYL+TGHLT KSD+YSFGVVLLE+LSGRRA+DKNRP+GEHNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLSTGHLTTKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYLTSKR+IFRV+D RLEGQ+SL +AQKAA LALQCL EP+ RP+MDEVV LEQ+
Sbjct: 301 AKPYLTSKRKIFRVIDTRLEGQYSLDRAQKAAMLALQCLLTEPRARPNMDEVVTALEQIC 360
Query: 361 E----LRNMHKRPQKEHQAKGHVHFK-----GRATTYPRPSASPL 396
E LR+ K HQ++ + + A++YP+PS + L
Sbjct: 361 EPKDKLRSTTKEQHSNHQSRPNDRPRYHRRSADASSYPKPSVAIL 405
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746068|emb|CBI16124.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1593), Expect = e-174, Method: Compositional matrix adjust.
Identities = 296/406 (72%), Positives = 338/406 (83%), Gaps = 14/406 (3%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG C S RIKAE+P HT +SKY S D +S+S K S S+P TPRSEG+ILQS N+K
Sbjct: 1 MGVCLSARIKAESPCHTGGSSKYVSTDGNEQNSTSSKVSVASVPPTPRSEGDILQSPNLK 60
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
NF++S+L+ ATRNFRPDSVLGEGGFGSVFKGW+DE S A+ RPGTGM+IAVKRLN E FQ
Sbjct: 61 NFTFSELKMATRNFRPDSVLGEGGFGSVFKGWIDEQSFAAARPGTGMVIAVKRLNLESFQ 120
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GHKEWL E+NYLGQL+HP+LVKL+G+C ED+HRLLVYEFMPRGS+ENHLFRRGSYFQPLS
Sbjct: 121 GHKEWLAEVNYLGQLYHPHLVKLIGFCSEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W+LR+K+ALGAA GLAFLHSAE KVIYRDFK SNILLDSNYNAKLSDFGLA+DGPTGDKS
Sbjct: 181 WNLRLKVALGAAKGLAFLHSAETKVIYRDFKTSNILLDSNYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLTA+SD+YSFGVVLLE+LSGRRA+DKNRP+GEHNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTARSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYL +KR+IFR+LD RLEGQ+SL A KA++LAL+CLS E K RP M EVV LEQLQ
Sbjct: 301 AKPYLANKRKIFRILDNRLEGQYSLEGAHKASNLALRCLSTEAKFRPTMTEVVTALEQLQ 360
Query: 361 ELRNMHKRPQKEHQAKGHVHFKGR----------ATTYPRPSASPL 396
+ K P+ + G + + R A YPRPSASPL
Sbjct: 361 DC----KEPEITNNRSGGMKHRRRSADDKEKPTTAIAYPRPSASPL 402
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059486|ref|XP_002299870.1| predicted protein [Populus trichocarpa] gi|222847128|gb|EEE84675.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1573), Expect = e-172, Method: Compositional matrix adjust.
Identities = 291/410 (70%), Positives = 339/410 (82%), Gaps = 21/410 (5%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG C S +IKAE+ +T ++SKY S D LSS+ K S S+P TPRSEGEILQS+N+K
Sbjct: 1 MGICLSAQIKAESSCNTGLSSKYVSTDGNDLSSTGSKVLSVSVPPTPRSEGEILQSTNLK 60
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+FS+SDL+ ATR+FRPDSVLGEGGFGSVFKGW+DE S ++ +PGTG++IAVKRLNQ+GFQ
Sbjct: 61 SFSFSDLKMATRSFRPDSVLGEGGFGSVFKGWIDEQSFSAAKPGTGIVIAVKRLNQDGFQ 120
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GHKEWL E+NYLGQ +HP+LVKL+GYCLED+HRLLVYEFMPRGS+ENHLFRRGSYFQPLS
Sbjct: 121 GHKEWLAEVNYLGQFYHPHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W+LR+K+ALGAA GLAFLH AE +VIYRDFK SNILLDS YNAKLSDFGLA+DGPTGDKS
Sbjct: 181 WNLRLKVALGAAKGLAFLHCAETQVIYRDFKTSNILLDSKYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRV+GTYGYAAPEYLATGHLTAKSD+YSFGVVLLE+LSGRRAIDKNRP+GEHNLVEW
Sbjct: 241 HVSTRVIGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAIDKNRPSGEHNLVEW 300
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYL +KR+IFR+LD RLEGQ+S+ A KA++LAL+CLS+E K RP MDEVV +EQLQ
Sbjct: 301 AKPYLANKRKIFRILDNRLEGQYSMDVAFKASTLALRCLSIETKFRPTMDEVVTAMEQLQ 360
Query: 361 ELRNMHKRPQKEHQAKGHVH-------------FKGRAT-TYPRPSASPL 396
+ ++ A GH GR T YPRPS SPL
Sbjct: 361 D-------SKETGSANGHASNAPRIRRRSADDTISGRNTAAYPRPSTSPL 403
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450018|ref|XP_004142761.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Cucumis sativus] gi|449527906|ref|XP_004170949.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 609 bits (1571), Expect = e-172, Method: Compositional matrix adjust.
Identities = 291/404 (72%), Positives = 343/404 (84%), Gaps = 9/404 (2%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG+C S RIKAE+P H ++S+Y+ RD +S+ K SS S P+TPR+EGEILQSSN+K
Sbjct: 1 MGSCLSARIKAESPLHNGLSSRYA-RDGNDKGNSTSK-SSVSTPRTPRTEGEILQSSNLK 58
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
NFSY++L+ ATRNFRPDSVLGEGGFGSVFKGW+DE S A T+PGTG++IAVKRLNQEGFQ
Sbjct: 59 NFSYNELKAATRNFRPDSVLGEGGFGSVFKGWIDEQSFAVTKPGTGLVIAVKRLNQEGFQ 118
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWLTEI+YLGQLHHPNLV+L+G+CLED+HRLLVYEFMPRGS+ENHLFRR S+FQPLS
Sbjct: 119 GHREWLTEIDYLGQLHHPNLVRLIGFCLEDEHRLLVYEFMPRGSLENHLFRRSSHFQPLS 178
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
WSLR+K+ALGAA GLAFLHS E KVIYRDFK+SNILLDS+YNAKLSDFGLA+DGPTGD+S
Sbjct: 179 WSLRLKVALGAAKGLAFLHSDEAKVIYRDFKSSNILLDSDYNAKLSDFGLAKDGPTGDRS 238
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
+VSTRVMGT+GYAAPEY+ TGHLTAKSD+YSFGVVLLEILSGRRAIDKNRP+GEHNLVEW
Sbjct: 239 YVSTRVMGTFGYAAPEYMITGHLTAKSDVYSFGVVLLEILSGRRAIDKNRPSGEHNLVEW 298
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYLTSKRR+ ++LD R+EGQ+S A KAA LA+QC+S EPKLRP+M+ VVK LEQLQ
Sbjct: 299 AKPYLTSKRRVLQMLDARIEGQYSTGGALKAAKLAIQCISTEPKLRPNMNAVVKALEQLQ 358
Query: 361 E------LRNMHKRPQKEHQAKGHVHFKGRATTYPRPSASPLRI 398
+ R P ++G + +YPRPSAS L +
Sbjct: 359 DSSETSGSRGTLSEPLNT-SSQGSGSTNNKPVSYPRPSASVLNL 401
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359807309|ref|NP_001240863.1| protein kinase APK1A, chloroplastic-like [Glycine max] gi|223452444|gb|ACM89549.1| putative protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1569), Expect = e-171, Method: Compositional matrix adjust.
Identities = 292/418 (69%), Positives = 347/418 (83%), Gaps = 23/418 (5%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG C S +IKAE+P +T NSKY S D L S++ K S+ S+PQTPRSEGEILQSSN+K
Sbjct: 1 MGVCLSAQIKAESPFNTVFNSKYVSTDGNDLGSTNDKVSANSVPQTPRSEGEILQSSNLK 60
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+F+ S+L+TATRNFRPDSVLGEGGFGSVFKGW+DE+SL +T+PGTG++IAVKRLNQ+G Q
Sbjct: 61 SFTLSELKTATRNFRPDSVLGEGGFGSVFKGWIDENSLTATKPGTGIVIAVKRLNQDGIQ 120
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWL E+NYLGQL HP+LV+L+G+CLED+HRLLVYEFMPRGS+ENHLFRRGSYFQPLS
Sbjct: 121 GHREWLAEVNYLGQLSHPHLVRLIGFCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
WSLR+K+AL AA GLAFLHSAE KVIYRDFK SN+LLDS YNAKLSDFGLA+DGPTGDKS
Sbjct: 181 WSLRLKVALDAAKGLAFLHSAEAKVIYRDFKTSNVLLDSKYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLTAKSD+YSFGVVLLE+LSG+RA+DKNRP+G+HNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGKRAVDKNRPSGQHNLVEW 300
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKP++ +KR+IFRVLD RL+GQ+S A K A+LAL+CLS+E K RP+MD+VV LEQLQ
Sbjct: 301 AKPFMANKRKIFRVLDTRLQGQYSTDDAYKLATLALRCLSIESKFRPNMDQVVTTLEQLQ 360
Query: 361 ELRNMHKRPQ---------KEHQAKGHVH---FKGRA----------TTYPRPSASPL 396
L N++ P+ + HQ V+ + R+ YPRPSASPL
Sbjct: 361 -LSNVNGGPRVRRRSADVNRGHQNPSSVNGSRVRRRSADDISRLETPNAYPRPSASPL 417
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356506672|ref|XP_003522100.1| PREDICTED: protein kinase APK1B, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 294/414 (71%), Positives = 343/414 (82%), Gaps = 19/414 (4%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MGAC S+RIK+ +PS+T S+ SRD + S+S + SS S+P TPRSEGEILQSSN+K
Sbjct: 1 MGACWSSRIKSVSPSNTGFTSRSVSRDGYDIHSNS-RNSSASIPMTPRSEGEILQSSNLK 59
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
++SY++L+ AT+NF PDSVLGEGGFGSVFKGW+DEHSLA TR GTGM++AVK+LNQE FQ
Sbjct: 60 SYSYNELKMATKNFCPDSVLGEGGFGSVFKGWIDEHSLAVTRAGTGMVVAVKKLNQESFQ 119
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GHKEWL EINYLGQL HPNLVKL+GYCLED HRLLVYE+MP+GS+ENHLFRRGS+FQ LS
Sbjct: 120 GHKEWLAEINYLGQLQHPNLVKLIGYCLEDQHRLLVYEYMPKGSVENHLFRRGSHFQQLS 179
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W+LR+KI+LGAA GLAFLHS E KVIYRDFK SNILLD+NYNAKLSDFGLARDGPTGDKS
Sbjct: 180 WTLRLKISLGAARGLAFLHSTETKVIYRDFKTSNILLDTNYNAKLSDFGLARDGPTGDKS 239
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGT+GYAAPEYLATGHLTAKSD+YSFGVVLLE+LSGRRAIDKNRP+GE LVEW
Sbjct: 240 HVSTRVMGTHGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAIDKNRPSGEQCLVEW 299
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYL++KRR+FRV+D RLEGQ+SL QAQ+AA+LA QCL+VEPK RP+MDEVV+ LEQL+
Sbjct: 300 AKPYLSNKRRVFRVMDSRLEGQYSLTQAQRAATLAFQCLAVEPKYRPNMDEVVRALEQLR 359
Query: 361 E-----LRNMHKRPQKEHQAKGHVHFKG-------------RATTYPRPSASPL 396
E ++N + + G H G + YPRPSAS L
Sbjct: 360 ESNNDQVKNGDHKKRSRVSGSGLGHHNGLPASTSKGSIDAAKKFNYPRPSASLL 413
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359807385|ref|NP_001241128.1| probable serine/threonine-protein kinase NAK-like [Glycine max] gi|223452416|gb|ACM89535.1| protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1564), Expect = e-171, Method: Compositional matrix adjust.
Identities = 302/410 (73%), Positives = 347/410 (84%), Gaps = 14/410 (3%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MGAC SNRIKA +PS+T + S+ SR +SS+S ++SS S+P T RSEGEILQSSN+K
Sbjct: 1 MGACWSNRIKAVSPSNTGITSRSVSRSGHDISSNS-RSSSASIPVTSRSEGEILQSSNLK 59
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+FSY +LR ATRNFRPDSVLGEGGFGSVFKGW+DEHSLA+T+PG G ++AVK+LNQ+G Q
Sbjct: 60 SFSYHELRAATRNFRPDSVLGEGGFGSVFKGWIDEHSLAATKPGIGKIVAVKKLNQDGLQ 119
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWL EINYLGQL HPNLVKL+GYC ED+HRLLVYEFMP+GSMENHLFRRGSYFQP S
Sbjct: 120 GHREWLAEINYLGQLQHPNLVKLIGYCFEDEHRLLVYEFMPKGSMENHLFRRGSYFQPFS 179
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
WSLRMKIALGAA GLAFLHS E KVIYRDFK SNILLD+NYNAKLSDFGLARDGPTGDKS
Sbjct: 180 WSLRMKIALGAAKGLAFLHSTEHKVIYRDFKTSNILLDTNYNAKLSDFGLARDGPTGDKS 239
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGT GYAAPEYLATGHLT KSD+YSFGVVLLE++SGRRAIDKN+PTGEHNLVEW
Sbjct: 240 HVSTRVMGTRGYAAPEYLATGHLTTKSDVYSFGVVLLEMISGRRAIDKNQPTGEHNLVEW 299
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYL++KRR+FRV+DPRLEGQ+S +AQ AA+LA+QC SVEPK RP+MDEVVK LE+LQ
Sbjct: 300 AKPYLSNKRRVFRVMDPRLEGQYSQNRAQAAAALAMQCFSVEPKCRPNMDEVVKALEELQ 359
Query: 361 ELRNMHKR-------------PQKEHQAKGHVHFKGRATTYPRPSASPLR 397
E +NM ++ P + + G +A+ YPRPSAS LR
Sbjct: 360 ESKNMQRKGADHKQHHVRNSGPGRTNGGDGGSDAPRKASAYPRPSASLLR 409
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478936|ref|XP_002283646.2| PREDICTED: protein kinase APK1A, chloroplastic-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1562), Expect = e-171, Method: Compositional matrix adjust.
Identities = 288/396 (72%), Positives = 332/396 (83%), Gaps = 4/396 (1%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG C S RIKAE+P HT +SKY S D +S+S K S S+P TPRSEG+ILQS N+K
Sbjct: 1 MGVCLSARIKAESPCHTGGSSKYVSTDGNEQNSTSSKVSVASVPPTPRSEGDILQSPNLK 60
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
NF++S+L+ ATRNFRPDSVLGEGGFGSVFKGW+DE S A+ RPGTGM+IAVKRLN E FQ
Sbjct: 61 NFTFSELKMATRNFRPDSVLGEGGFGSVFKGWIDEQSFAAARPGTGMVIAVKRLNLESFQ 120
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GHKEWL E+NYLGQL+HP+LVKL+G+C ED+HRLLVYEFMPRGS+ENHLFRRGSYFQPLS
Sbjct: 121 GHKEWLAEVNYLGQLYHPHLVKLIGFCSEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W+LR+K+ALGAA GLAFLHSAE KVIYRDFK SNILLDSNYNAKLSDFGLA+DGPTGDKS
Sbjct: 181 WNLRLKVALGAAKGLAFLHSAETKVIYRDFKTSNILLDSNYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLTA+SD+YSFGVVLLE+LSGRRA+DKNRP+GEHNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTARSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYL +KR+IFR+LD RLEGQ+SL A KA++LAL+CLS E K RP M EVV LEQLQ
Sbjct: 301 AKPYLANKRKIFRILDNRLEGQYSLEGAHKASNLALRCLSTEAKFRPTMTEVVTALEQLQ 360
Query: 361 ELRNMHKRPQKEHQAKGHVHFKGRATTYPRPSASPL 396
+ K P+ + G + + R+ R P+
Sbjct: 361 DC----KEPEITNNRSGGMKHRRRSADDVRNEKPPI 392
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807636|ref|NP_001242670.1| uncharacterized protein LOC100798404 [Glycine max] gi|255647315|gb|ACU24124.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1555), Expect = e-170, Method: Compositional matrix adjust.
Identities = 291/420 (69%), Positives = 341/420 (81%), Gaps = 24/420 (5%)
Query: 1 MGACCSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIK 60
MG C S +IKAE+P +T NSKY S D S++ K S+ S+PQTPRSEGEIL+SSN+K
Sbjct: 1 MGVCLSAQIKAESPYNTGFNSKYVSTDGNDFGSTNDKVSANSIPQTPRSEGEILRSSNLK 60
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+F S+L+TATRNFRPDSVLGEGGFGSVFKGW+DE+SL +T+PGTG++IAVKRLNQ+G Q
Sbjct: 61 SFPLSELKTATRNFRPDSVLGEGGFGSVFKGWIDENSLTATKPGTGIVIAVKRLNQDGIQ 120
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWL E+NYLGQL HP+LV+L+G+CLED+HRLLVYEFMPRGS+ENHLFRRGSYFQPLS
Sbjct: 121 GHREWLAEVNYLGQLSHPHLVRLIGFCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
WSLR+K+AL AA GLAFLHS E KVIYRDFK SNILLDS YNAKLSDFGLA+DGPTGDKS
Sbjct: 181 WSLRLKVALDAAKGLAFLHSTEAKVIYRDFKTSNILLDSKYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLTAKSD+YSFGVVLLE+LSG+RA+DKNRP+G+HNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGKRAVDKNRPSGQHNLVEW 300
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
AKPYL +KR+IFRVLD RLEGQ+S A K A+LAL+CLS+E K RP+MDEVV LEQLQ
Sbjct: 301 AKPYLANKRKIFRVLDTRLEGQYSTDDACKLATLALRCLSIESKFRPNMDEVVTTLEQLQ 360
Query: 361 --ELRNMHKRPQKEHQAKGHVH------------FKGRA----------TTYPRPSASPL 396
+ H+ + + V+ + R+ T YPRPSASPL
Sbjct: 361 VPNVNGGHQNGSRVRRRSADVNRGYQNPSVNGSRVRRRSADDISPMETPTAYPRPSASPL 420
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 398 | ||||||
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.969 | 0.992 | 0.659 | 1.1e-140 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.771 | 0.725 | 0.765 | 2.8e-137 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.871 | 0.878 | 0.646 | 3e-124 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.879 | 0.821 | 0.606 | 1.3e-118 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.768 | 0.620 | 0.690 | 3.8e-117 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.768 | 0.624 | 0.703 | 7.9e-117 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.768 | 0.675 | 0.683 | 5e-115 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.881 | 0.823 | 0.593 | 1.7e-114 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.763 | 0.785 | 0.646 | 4.6e-112 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.766 | 0.740 | 0.651 | 5.9e-112 |
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1376 (489.4 bits), Expect = 1.1e-140, P = 1.1e-140
Identities = 259/393 (65%), Positives = 310/393 (78%)
Query: 1 MGACCSNRIKAETPSHTDVNXXXXXXXXXXXXXXXXXXXXXXLPQTPRSEGEILQSSNIK 60
MG C SNRIK TD+ PR+EGEILQ++N+K
Sbjct: 1 MGGCFSNRIK------TDIASSTWLSSKFLSRDGSKGSSTASFSYMPRTEGEILQNANLK 54
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
NFS S+L++ATRNFRPDSV+GEGGFG VFKGW+DE SLA ++PGTG++IAVKRLNQEGFQ
Sbjct: 55 NFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQ 114
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWL EINYLGQL HPNLVKL+GYCLE++HRLLVYEFM RGS+ENHLFRRG+++QPLS
Sbjct: 115 GHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLS 174
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W+ R+++ALGAA GLAFLH+A+P+VIYRDFKASNILLDSNYNAKLSDFGLARDGP GD S
Sbjct: 175 WNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNS 234
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
HVSTRVMGT GYAAPEYLATGHL+ KSD+YSFGVVLLE+LSGRRAIDKN+P GEHNLV+W
Sbjct: 235 HVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDW 294
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKXXXXXX 360
A+PYLT+KRR+ RV+DPRL+GQ+SL +A K A LAL C+S++ K RP M+E+VK
Sbjct: 295 ARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELH 354
Query: 361 XXRNMHKRPQKEHQAKGHVHFKG-RATTYPRPS 392
+ K Q + ++ K +A YPRPS
Sbjct: 355 IQKEASKEQQNPQISIDNIINKSPQAVNYPRPS 387
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 2.8e-137, Sum P(2) = 2.8e-137
Identities = 235/307 (76%), Positives = 282/307 (91%)
Query: 47 PRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTG 106
PR+EGEILQS N+K+F++++L+ ATRNFRPDSVLGEGGFGSVFKGW+DE +L +++PGTG
Sbjct: 53 PRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTG 112
Query: 107 MLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSME 166
++IAVK+LNQ+G+QGH+EWL E+NYLGQ HPNLVKL+GYCLED+HRLLVYEFMPRGS+E
Sbjct: 113 VVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLE 172
Query: 167 NHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226
NHLFRRGSYFQPLSW+LR+K+ALGAA GLAFLH+AE VIYRDFK SNILLDS YNAKLS
Sbjct: 173 NHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLS 232
Query: 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAI 286
DFGLA+DGPTGDKSHVSTR+MGTYGYAAPEYLATGHLT KSD+YS+GVVLLE+LSGRRA+
Sbjct: 233 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAV 292
Query: 287 DKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR 346
DKNRP GE LVEWA+P L +KR++FRV+D RL+ Q+S+ +A K A+LAL+CL+ E KLR
Sbjct: 293 DKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLR 352
Query: 347 PDMDEVV 353
P+M+EVV
Sbjct: 353 PNMNEVV 359
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1221 (434.9 bits), Expect = 3.0e-124, P = 3.0e-124
Identities = 229/354 (64%), Positives = 283/354 (79%)
Query: 1 MGACCSNRIKAETPSHTDVNXXXXXXXXXXXXXXXXXXXXXXLPQTPRSEGEILQSSNIK 60
MG+C S+R+KA+ H N +T EGEIL S+ +K
Sbjct: 1 MGSCFSSRVKADI-FH---NGKSSDLYGLSLSSRKSSSTVAAAQKT---EGEILSSTPVK 53
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+F++++L+ ATRNFRPDSV+GEGGFG VFKGW+DE +L T+PGTG++IAVK+LNQEGFQ
Sbjct: 54 SFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQ 113
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
GH+EWLTEINYLGQL HPNLVKL+GYCLED+HRLLVYEFM +GS+ENHLFRRG+YF+PL
Sbjct: 114 GHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLP 173
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
W LR+ +AL AA GLAFLHS KVIYRD KASNILLD++YNAKLSDFGLARDGP GD S
Sbjct: 174 WFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLS 233
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
+VSTRVMGTYGYAAPEY+++GHL A+SD+YSFGV+LLEILSG+RA+D NRP E NLV+W
Sbjct: 234 YVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDW 293
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
A+PYLTSKR++ ++D RL+ Q+ +A + AS+A+QCLS EPK RP MD+VV+
Sbjct: 294 ARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVR 347
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1168 (416.2 bits), Expect = 1.3e-118, P = 1.3e-118
Identities = 220/363 (60%), Positives = 282/363 (77%)
Query: 1 MGACCSNRIKAETPSHTD----------VNXXXXXXXXXXXXXXXXXXXXXXLPQTPRSE 50
MG C + K ++ SH+ V+ LP TPR+E
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLP-TPRTE 59
Query: 51 GEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIA 110
GEIL S N+K F++++L+ ATRNFRPDS+LGEGGFG VFKGW+D +L +++PG+G+++A
Sbjct: 60 GEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVA 119
Query: 111 VKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF 170
VK+L EG+QGHKEWLTE+NYLGQL HPNLVKLVGYC+E ++RLLVYEFMP+GS+ENHLF
Sbjct: 120 VKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF 179
Query: 171 RRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230
RRG+ QPL+W++RMK+A+GAA GL FLH A+ +VIYRDFKA+NILLD+ +N+KLSDFGL
Sbjct: 180 RRGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGL 237
Query: 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNR 290
A+ GPTGDK+HVST+VMGT+GYAAPEY+ATG LTAKSD+YSFGVVLLE+LSGRRA+DK++
Sbjct: 238 AKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSK 297
Query: 291 PTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD 350
E +LV+WA PYL KR++FR++D RL GQ+ A AASLALQCL+ + KLRP M
Sbjct: 298 VGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMS 357
Query: 351 EVV 353
EV+
Sbjct: 358 EVL 360
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1154 (411.3 bits), Expect = 3.8e-117, P = 3.8e-117
Identities = 214/310 (69%), Positives = 257/310 (82%)
Query: 46 TPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGT 105
TP E+ SS+++ F+++DL+ +TRNFRP+S+LGEGGFG VFKGW++E+ A +PGT
Sbjct: 114 TPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 173
Query: 106 GMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSM 165
G+ +AVK LN +G QGHKEWL EIN+LG L HPNLVKLVGYC+EDD RLLVYEFMPRGS+
Sbjct: 174 GLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 233
Query: 166 ENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPK-VIYRDFKASNILLDSNYNAK 224
ENHLFRR PL WS+RMKIALGAA GL+FLH K VIYRDFK SNILLD++YNAK
Sbjct: 234 ENHLFRRSL---PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAK 290
Query: 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284
LSDFGLA+D P K+HVSTRVMGTYGYAAPEY+ TGHLT+KSD+YSFGVVLLE+L+GRR
Sbjct: 291 LSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 350
Query: 285 AIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPK 344
++DKNRP GEHNLVEWA+P+L KRR +R+LDPRLEG FS+ AQK LA QCLS +PK
Sbjct: 351 SMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPK 410
Query: 345 LRPDMDEVVK 354
+RP M +VV+
Sbjct: 411 IRPKMSDVVE 420
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1151 (410.2 bits), Expect = 7.9e-117, P = 7.9e-117
Identities = 218/310 (70%), Positives = 252/310 (81%)
Query: 46 TPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGT 105
TP E+ S++K FS+ DL+ ATRNFRP+S+LGEGGFG VFKGWV+E+ A +PGT
Sbjct: 108 TPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 167
Query: 106 GMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSM 165
G+ +AVK LN +G QGHKEWL EINYLG L HPNLVKLVGYC+EDD RLLVYEFMPRGS+
Sbjct: 168 GLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 227
Query: 166 ENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPK-VIYRDFKASNILLDSNYNAK 224
ENHLFRR PL WS+RMKIALGAA GL+FLH K VIYRDFK SNILLD YNAK
Sbjct: 228 ENHLFRRSL---PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAK 284
Query: 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284
LSDFGLA+D P K+HVSTRVMGTYGYAAPEY+ TGHLT+KSD+YSFGVVLLE+L+GRR
Sbjct: 285 LSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
Query: 285 AIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPK 344
++DKNRP GEHNLVEWA+P+L KRR +R+LDPRLEG FS+ AQK LA QCLS + K
Sbjct: 345 SMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSK 404
Query: 345 LRPDMDEVVK 354
+RP M EVV+
Sbjct: 405 IRPKMSEVVE 414
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1134 (404.2 bits), Expect = 5.0e-115, P = 5.0e-115
Identities = 212/310 (68%), Positives = 251/310 (80%)
Query: 46 TPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGT 105
TP GE+ SS ++ F ++DL+ ATRNFRP+S+LGEGGFG VFKGW++E+ A +PGT
Sbjct: 75 TPLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 134
Query: 106 GMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSM 165
G+ +AVK LN +G QGHKEWL EIN+LG L HP+LVKLVGYC+E+D RLLVYEFMPRGS+
Sbjct: 135 GLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSL 194
Query: 166 ENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAK 224
ENHLFRR PL WS+RMKIALGAA GLAFLH AE VIYRDFK SNILLD YNAK
Sbjct: 195 ENHLFRRTL---PLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAK 251
Query: 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284
LSDFGLA+D P KSHVSTRVMGTYGYAAPEY+ TGHLT KSD+YSFGVVLLEIL+GRR
Sbjct: 252 LSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRR 311
Query: 285 AIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPK 344
++DK+RP GE NLVEW +P+L K+R +R+LDPRLEG +S+ AQKA +A QCL+ + K
Sbjct: 312 SVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSK 371
Query: 345 LRPDMDEVVK 354
RP M EVV+
Sbjct: 372 ARPKMSEVVE 381
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 1.7e-114, P = 1.7e-114
Identities = 216/364 (59%), Positives = 282/364 (77%)
Query: 43 LPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTR 102
LP T R+EGEIL S N+K F++++L+ AT+NFR D++LGEGGFG VFKGW+D+ SL ++R
Sbjct: 56 LP-TLRTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASR 114
Query: 103 PGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPR 162
PG+G+++AVK+L EGFQGHKEWLTE+NYLGQL HPNLV LVGYC E ++RLLVYEFMP+
Sbjct: 115 PGSGIVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPK 174
Query: 163 GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222
GS+ENHLFRRG+ QPL+W++RMK+A+GAA GL FLH A+ +VIYRDFKA+NILLD+++N
Sbjct: 175 GSLENHLFRRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFN 232
Query: 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
AKLSDFGLA+ GPTGD +HVST+V+GT+GYAAPEY+ATG LTAKSD+YSFGVVLLE++SG
Sbjct: 233 AKLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISG 292
Query: 283 RRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVE 342
RRA+D + E++LV+WA PYL KR++FR++D +L GQ+ A AA+LALQCL+ +
Sbjct: 293 RRAMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPD 352
Query: 343 PKLRPDMDEVV------KXXXXXXXXRNMHKRPQKEHQA---KGHVHFK-GRATTYPRPS 392
KLRP M EV+ + + P+ H + K V + R + P
Sbjct: 353 AKLRPKMSEVLVTLEQLESVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPG 412
Query: 393 ASPL 396
ASPL
Sbjct: 413 ASPL 416
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1106 (394.4 bits), Expect = 4.6e-112, P = 4.6e-112
Identities = 199/308 (64%), Positives = 261/308 (84%)
Query: 46 TPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGT 105
TPRSEGE+L S +K F++++L+TATRNF+P+S++GEGGFG V+KGW+ E SL+ ++PG+
Sbjct: 56 TPRSEGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGS 115
Query: 106 GMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSM 165
GM++AVK+L EGFQGHKEWLTE++YLG+LHH NLVKL+GYCLE + RLLVYE+MP+GS+
Sbjct: 116 GMVVAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSL 175
Query: 166 ENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225
ENHLFRRG+ +P+ W RMK+A AA GL+FLH A KVIYRDFKASNILLD ++NAKL
Sbjct: 176 ENHLFRRGA--EPIPWKTRMKVAFSAARGLSFLHEA--KVIYRDFKASNILLDVDFNAKL 231
Query: 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRA 285
SDFGLA+ GPTGD++HV+T+V+GT GYAAPEY+ATG LT+KSD+YSFGVVLLE+LSGR
Sbjct: 232 SDFGLAKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPT 291
Query: 286 IDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL 345
+DK++ E NLV+WA PYL +R++FR++D +L GQ+ A AA++AL+CL+ EPKL
Sbjct: 292 LDKSKVGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKL 351
Query: 346 RPDMDEVV 353
RPDM +V+
Sbjct: 352 RPDMADVL 359
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1105 (394.0 bits), Expect = 5.9e-112, P = 5.9e-112
Identities = 202/310 (65%), Positives = 260/310 (83%)
Query: 45 QTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPG 104
QTPRSEGE+L S +K F++++L+TATRNFRPDSV+GEGGFG V+KGW+DE +L+ ++PG
Sbjct: 54 QTPRSEGELLASPTLKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPG 113
Query: 105 TGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH-RLLVYEFMPRG 163
+GM++AVK+L +EGFQGH++WL E++ LG+LHH NLVKL+GYC + DH RLLVYE+MP+G
Sbjct: 114 SGMVVAVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKG 173
Query: 164 SMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223
S+ENHLFRRG+ +P+ W R+K+A+GAA GLAFLH A+ VIYRDFKASNILLDS +NA
Sbjct: 174 SLENHLFRRGA--EPIPWRTRIKVAIGAARGLAFLHEAQ--VIYRDFKASNILLDSEFNA 229
Query: 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
KLSDFGLA+ GPTGD++HVST+VMGT GYAAPEY+ATG +TAKSD+YSFGVVLLE+LSGR
Sbjct: 230 KLSDFGLAKVGPTGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGR 289
Query: 284 RAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEP 343
+DK + E NLV+WA PYL KR++FR++D +L GQ+ A A+ ALQCL+ EP
Sbjct: 290 LTVDKTKVGVERNLVDWAIPYLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEP 349
Query: 344 KLRPDMDEVV 353
KLRP M +V+
Sbjct: 350 KLRPKMSDVL 359
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43293 | NAK_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6895 | 0.9698 | 0.9922 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00021323001 | SubName- Full=Chromosome chr8 scaffold_23, whole genome shotgun sequence; (405 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 398 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-56 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-37 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-26 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-04 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 2e-56
Identities = 96/286 (33%), Positives = 139/286 (48%), Gaps = 35/286 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN--QEGFQGHKEWLTEINY 131
+ LG G FG+V+K GTG ++AVK L E + + EI
Sbjct: 1 YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
L +L HPN+V+L+ + DH LV E+ G + ++L R G PLS KIAL
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQI 107
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
GL +LHS +I+RD K NILLD N K++DFGLA+ S ++T V GT
Sbjct: 108 LRGLEYLHSN--GIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPW 163
Query: 252 YAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
Y APE L G K D++S GV+L E+L+G+ + L +
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQL 210
Query: 311 IFRVLDPRLEG--QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
I R+L P LE +++A L +CL+ +P RP +E+++
Sbjct: 211 IRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-56
Identities = 83/280 (29%), Positives = 122/280 (43%), Gaps = 68/280 (24%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINYLGQLHHP 138
LGEGGFG+V+ TG +A+K + +E E L EI L +L+HP
Sbjct: 1 LGEGGFGTVYLA---------RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+VKL G +++H LV E+ GS+++ L LS ++I L GL +L
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYL 108
Query: 199 HSAEPKVIYRDFKASNILLDS-NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEY 257
HS +I+RD K NILLDS N KL+DFGL++ + ++GT Y APE
Sbjct: 109 HSN--GIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEV 164
Query: 258 L-ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316
L G+ + KSDI+S GV+L E+
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYEL------------------------------------- 187
Query: 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
+ L + L +P+ RP E+++ L
Sbjct: 188 ------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 7e-54
Identities = 92/296 (31%), Positives = 135/296 (45%), Gaps = 52/296 (17%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHH 137
LGEG FG V+KG + G +AVK L ++ + K++L E + +L H
Sbjct: 2 KLGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH 55
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL-----FRRGSYFQPLSWSLRMKIALGAA 192
PN+V+L+G C E++ LV E+M G + ++L LS + A+ A
Sbjct: 56 PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST------RV 246
G+ +L S K ++RD A N L+ + K+SDFGL+RD D T R
Sbjct: 116 KGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306
M APE L G T+KSD++SFGV+L EI + G A PY
Sbjct: 174 M------APESLKDGIFTSKSDVWSFGVLLWEIFTL----------G-------ATPYPG 210
Query: 307 -SKRRIFRVLDPRLEGQFSLPQAQKA----ASLALQCLSVEPKLRPDMDEVVKELE 357
S + L +G LP+ + L L C ++P+ RP E+V+ LE
Sbjct: 211 LSNEEVLEYL---RKGYR-LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-53
Identities = 93/287 (32%), Positives = 135/287 (47%), Gaps = 40/287 (13%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL 135
LGEG FG V+KG + + +AVK L ++ Q +E+L E + +L
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKG-----GKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
HPN+VKL+G C E++ +V E+M G + ++L + LS S + AL A G+
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGM 115
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD-KSHVSTRVMGTYGYAA 254
+L S I+RD A N L+ N K+SDFGL+RD D ++ + A
Sbjct: 116 EYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMA 171
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL-TSKRRIFR 313
PE L G T+KSD++SFGV+L EI + GE +PY S +
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTL----------GE-------QPYPGMSNEEVLE 214
Query: 314 VLDPRLEGQFSLPQAQKA----ASLALQCLSVEPKLRPDMDEVVKEL 356
L G LPQ L LQC + +P+ RP E+V+ L
Sbjct: 215 YLK---NGYR-LPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 5e-53
Identities = 92/285 (32%), Positives = 141/285 (49%), Gaps = 35/285 (12%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL 135
LGEG FG V+KG + G + +AVK L ++ Q +E+L E + +L
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKG-----DGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
HPN+VKL+G C E++ ++V E+MP G + ++L + LS S + AL A G+
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGM 116
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD-KSHVSTRVMGTYGYAA 254
+L S I+RD A N L+ N K+SDFGL+RD D ++ + A
Sbjct: 117 EYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMA 172
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIF 312
PE L G T+KSD++SFGV+L EI + GE +PY +++ +
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTL----------GE-------EPYPGMSNAEVLE 215
Query: 313 RVLDP-RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
+ RL + P + L LQC + +P+ RP E+V+ L
Sbjct: 216 YLKKGYRLPKPPNCP--PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 174 bits (445), Expect = 2e-52
Identities = 92/290 (31%), Positives = 141/290 (48%), Gaps = 49/290 (16%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
LGEG FG V+KG + GT +AVK L + + +E+L E + + +L
Sbjct: 6 KLGEGAFGEVYKGTLKGDGE------GTETKVAVKTLKEGASEEEREEFLEEASIMKKLS 59
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
HPN+V+L+G C + + +V E+MP G + + L + G + L+ +++AL A G+
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGME 116
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST------RVMGTY 250
+L S ++RD A N L+ N K+SDFGL+RD D + M
Sbjct: 117 YLESK--NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM--- 171
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
APE L G T+KSD++SFGV+L EI + GE +PY
Sbjct: 172 ---APESLKDGKFTSKSDVWSFGVLLWEIFTL----------GE-------QPY--PGMS 209
Query: 311 IFRVLDPRLEGQFSLPQAQKA----ASLALQCLSVEPKLRPDMDEVVKEL 356
VL+ LE + LP+ + L LQC + +P+ RP E+V++L
Sbjct: 210 NEEVLE-LLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 2e-51
Identities = 84/283 (29%), Positives = 127/283 (44%), Gaps = 35/283 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINYL 132
+ LGEG FG V+ TG L+A+K + ++ + +E L EI L
Sbjct: 1 YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+L HPN+V+L ++D LV E+ G + + L +RG +
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL--SEDEAR--FYLRQIL 107
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
+ L +LHS +++RD K NILLD + + KL+DFGLAR ++T V GT Y
Sbjct: 108 SALEYLHSK--GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEY 162
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP-TGEHNLVEWAKPYLTSKRRI 311
APE L DI+S GV+L E+L+G+ P G+ L+E K K
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPKPPF 216
Query: 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
P E S +A L + L +P+ R +E ++
Sbjct: 217 -----PPPEWDIS----PEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 9e-37
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLG 133
F +G+GGFG V+K TG +A+K + E + ++ + EI L
Sbjct: 2 FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
+ HPN+VK G L+ D +V EF GS+++ L + S Q L+ S +
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLK--STNQTLTESQIAYVCKELLK 109
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
GL +LHS +I+RD KA+NILL S+ KL DFGL+ + ++GT +
Sbjct: 110 GLEYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWM 164
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGR 283
APE + K+DI+S G+ +E+ G+
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 82/294 (27%), Positives = 126/294 (42%), Gaps = 36/294 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLTEINYLGQLHHP 138
LGEG FG V D TG +AVK LN G + H ++ EI L L H
Sbjct: 12 LGEGHFGKVELCRYD-----PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 139 NLVKLVGYCLEDDHR---LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
N+VK G C E L+ E++P GS+ ++L R ++ + + G+
Sbjct: 67 NIVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGM 122
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST--RVMGTYGYA 253
+L S + I+RD A NIL++S K+SDFGLA+ P + + Y
Sbjct: 123 DYLGSQ--RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL----TSKR 309
APE L T ++ SD++SFGV L E+ + G+ + A+ +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT----------YGDPSQSPPAEFLRMIGIAQGQ 229
Query: 310 RIFRVLDPRLEGQFSLPQAQKAAS----LALQCLSVEPKLRPDMDEVVKELEQL 359
I L L+ LP+ L C EP+ RP +++ +++L
Sbjct: 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 77/281 (27%), Positives = 123/281 (43%), Gaps = 42/281 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEWLTEINYLGQLH 136
+LG G FGSV+ TG L+AVK L+ + + + EI L L
Sbjct: 7 LLGRGSFGSVYLA---------LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 137 HPNLVKLVGYCL--EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
HPN+V+ G E + + E++ GS+ + L + F L + K G
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEG 113
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
LA+LHS +++RD K +NIL+DS+ KL+DFG A+ + + V GT + A
Sbjct: 114 LAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314
PE + +DI+S G ++E+ +G+ P E A ++++
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAA---------LYKI 216
Query: 315 LD----PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDE 351
P + S ++A +CL +PK RP DE
Sbjct: 217 GSSGEPPEIPEHLS----EEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 83/283 (29%), Positives = 132/283 (46%), Gaps = 46/283 (16%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLH 136
++G G FG V+KG ++ TG +A+K+++ E + K + EI+ L L
Sbjct: 7 LIGRGAFGVVYKG-LNLE--------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
HPN+VK +G D ++ E+ GS+ + + G + + L ++ + L GLA
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-AVYVYQVL---QGLA 113
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+LH E VI+RD KA+NIL + KL+DFG+A D S V+GT + APE
Sbjct: 114 YLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPE 169
Query: 257 YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFRV 314
+ + SDI+S G ++E+L+G P PY L +FR+
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTG-------NP-----------PYYDLNPMAALFRI 211
Query: 315 L---DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ P L S +QC +P LRP +++K
Sbjct: 212 VQDDHPPLPEGISPE----LKDFLMQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-31
Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
+ +G+G FG V G G +AVK L + + +L E + + L H
Sbjct: 12 ATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRH 59
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
PNLV+L+G L+ + +V E+M +GS+ ++L RG ++ + ++ AL G+ +
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEY 117
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD---GPTGDKSHVSTRVMGTYGYAA 254
L E ++RD A N+L+ + AK+SDFGLA++ G K V + A
Sbjct: 118 LE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTA 167
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILS-GR 283
PE L + KSD++SFG++L EI S GR
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 80/283 (28%), Positives = 128/283 (45%), Gaps = 40/283 (14%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINYLGQLHHP 138
+G+G FG V+KG + +AVK K +L E L Q HP
Sbjct: 3 IGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHP 52
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+VKL+G C++ +V E +P GS+ L ++ + L+ ++++L AA G+ +L
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYL 109
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL 258
S I+RD A N L+ N K+SDFG++R+ G + + APE L
Sbjct: 110 ESK--NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 259 ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPR 318
G T++SD++S+G++L E S PY + R R
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLG-----------------DTPYPGMSNQQTR---ER 207
Query: 319 LEGQFSLPQAQ----KAASLALQCLSVEPKLRPDMDEVVKELE 357
+E + +P Q + L LQC + +P+ RP E+ EL+
Sbjct: 208 IESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 52/292 (17%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEIN 130
+ +G+G FG V+ R G L +K ++ ++ L E+
Sbjct: 1 KYEIIKQIGKGSFGKVYLV---------RRKSDGKLYVLKEIDLSNMSEKEREDALNEVK 51
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS----WSLRMK 186
L +L+HPN++K E +V E+ G + + ++ +P ++
Sbjct: 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
+ L L +LHS K+++RD K NI L SN KL DFG+++ + T V
Sbjct: 112 LCLA----LKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV 164
Query: 247 MGTYGYAAPE------YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
GT Y +PE Y KSDI+S G VL E+ + + + L
Sbjct: 165 -GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEG---ENLLELA-- 212
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
+I + P + Q+S + +L L +P+ RP + ++
Sbjct: 213 --------LKILKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-30
Identities = 90/298 (30%), Positives = 135/298 (45%), Gaps = 26/298 (8%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEIN 130
R + VLGEG FG V D GTG ++AVK L +E Q + W EIN
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 131 YLGQLHHPNLVKLVGYCLE--DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
L L+H N+VK G C E L+ E++P GS+ ++L + L+ + + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFA 113
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH-VSTRVM 247
G+A+LHS I+RD A N+LLD++ K+ DFGLA+ P G + + V
Sbjct: 114 QQICEGMAYLHSQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
+ A E L + SD++SFGV L E+L+ ++ P ++ + +T
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTV 230
Query: 308 KRRIFRVLDPRLEGQFSLPQ----AQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
R L LE LP Q+ L C E K RP ++ L+++
Sbjct: 231 VR-----LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 83/294 (28%), Positives = 137/294 (46%), Gaps = 48/294 (16%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW--LTEINYLGQ 134
+ V+G G FG V +G + L + + +A+K L + G + LTE + +GQ
Sbjct: 9 EKVIGGGEFGEVCRGRL---KLPGKKE---IDVAIKTL-KAGSSDKQRLDFLTEASIMGQ 61
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
HPN+++L G + +++ E+M GS++ L F + + G A+G
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASG 118
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG--- 251
+ +L +E ++RD A NIL++SN K+SDFGL+R D T T G
Sbjct: 119 MKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGGKI 170
Query: 252 ---YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LT 306
+ APE +A T+ SD++SFG+V+ E++S GE +PY ++
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS----------YGE-------RPYWDMS 213
Query: 307 SKRRIFRVLDP-RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
++ I V D RL P A L L C + RP ++V L+++
Sbjct: 214 NQDVIKAVEDGYRLPPPMDCPSALY--QLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTG-MLIAVKRLNQEGF-QGHKEWLTEINYLGQLH 136
LGEG FG VF G P L+AVK L + K++ E L
Sbjct: 12 ELGEGAFGKVFLG-----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ 66
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF----------QPLSWSLRMK 186
H N+VK G C E D ++V+E+M G + L G L+ S ++
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
IA+ A+G+ +L A ++RD N L+ + K+ DFG++RD T D V
Sbjct: 127 IAVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
M + PE + T +SD++SFGVVL EI +
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 87/294 (29%), Positives = 131/294 (44%), Gaps = 32/294 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
++R LGEG FG V+ + L+A+K L ++ KE L EI
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48
Query: 130 NYLGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
L L H PN+VKL + ++ LV E++ GS+E L ++ PLS S + I
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFIL 107
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN-AKLSDFGLAR----DGPTGDKSHVS 243
+ L +LHS +I+RD K NILLD + KL DFGLA+ G T +
Sbjct: 108 AQILSALEYLHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 244 TRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300
+ +GT GY APE L + ++ SDI+S G+ L E+L+G + GE N
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-----GEKNSSAT 220
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
++ L L ++ A+ L + L+ +PK R +
Sbjct: 221 SQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 88/309 (28%), Positives = 135/309 (43%), Gaps = 45/309 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLTEINY 131
N LGEG FG V K R G +AVK L + ++ L+E N
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFR---LKGRAGY-TTVAVKMLKENASSSELRDLLSEFNL 56
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL---------------FRRGSY- 175
L Q++HP+++KL G C +D LL+ E+ GS+ + L R SY
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 176 FQPLSWSLRMKIALGAA----NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
P +L M + A G+ +L AE K+++RD A N+L+ K+SDFGL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291
RD D ++ + A E L T +SD++SFGV+L EI++
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------- 224
Query: 292 TGEHNLVEWAKPYL-TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD 350
PY + R+F +L + +++ +L L C EP RP
Sbjct: 225 -------LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277
Query: 351 EVVKELEQL 359
++ KELE++
Sbjct: 278 DISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 93/312 (29%), Positives = 150/312 (48%), Gaps = 37/312 (11%)
Query: 50 EGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLI 109
E + S K+ + +D+ ++ + ++V+ G G+ +KG GM
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKE---ENVISRGKKGASYKG---------KSIKNGMQF 718
Query: 110 AVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL 169
VK +N + +EI +G+L HPN+VKL+G C + L++E++ ++ L
Sbjct: 719 VVKEINDV----NSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 170 FRRGSYFQPLSWSLRMKIALGAANGLAFLH-SAEPKVIYRDFKASNILLDSNYNAKLSDF 228
+ LSW R KIA+G A L FLH P V+ + I++D L
Sbjct: 775 -------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826
Query: 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDK 288
L T K +S+ Y APE T +T KSDIY FG++L+E+L+G+ D
Sbjct: 827 SLPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880
Query: 289 NRPTGEH-NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQ--KAASLALQCLSVEPKL 345
G H ++VEWA+ Y S + +DP + G S+ Q + + +LAL C + +P
Sbjct: 881 E--FGVHGSIVEWAR-YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTA 937
Query: 346 RPDMDEVVKELE 357
RP ++V+K LE
Sbjct: 938 RPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 82/291 (28%), Positives = 132/291 (45%), Gaps = 60/291 (20%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-----NQEGFQGHKEWLTEINYLGQ 134
LG G FGSV++G + G AVK + Q G + K+ EI L +
Sbjct: 8 LGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSK 58
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
L HPN+V+ +G E+D+ + E +P GS+ L + GS+ +P+ +I L G
Sbjct: 59 LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----G 114
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM-----GT 249
L +LH ++RD K +NIL+D+N KL+DFG+A+ V G+
Sbjct: 115 LEYLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGS 164
Query: 250 YGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308
+ APE +A G +DI+S G +LE+ +G+ P + V
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVA--------- 209
Query: 309 RRIFRVLDPRLEGQFSLPQ-----AQKAASLALQCLSVEPKLRPDMDEVVK 354
+F++ + LP + +A L+CL +P LRP E+++
Sbjct: 210 -AVFKIGRSK-----ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHP 138
LGEG FG V+KG + +A+K L + + +E+ E + L HP
Sbjct: 13 LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR------------GSYFQPLSWSLRMK 186
N+V L+G C ++ +++E++ G + L R + L S +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
IA+ A G+ +L S ++RD A N L+ K+SDFGL+RD + D V ++
Sbjct: 129 IAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ + PE + G T +SDI+SFGVVL EI S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 85/276 (30%), Positives = 126/276 (45%), Gaps = 50/276 (18%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQLH 136
LG+G FG V L + TG L A+K L ++ KE LTE N L +++
Sbjct: 1 LGKGSFGKVL--------LVRKK-DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRM--KIALGAAN 193
HP +VKL Y + + +L LV E+ P G + +HL + G + + +I L
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRF--SEERARFYAAEIVLA--- 105
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
L +LHS +IYRD K NILLD++ + KL+DFGLA++ + S +T GT Y
Sbjct: 106 -LEYLHSL--GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYL 160
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR-RIF 312
APE L D +S GV+L E+L+G+ P+ R I+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKP------------------PFYAEDRKEIY 202
Query: 313 RVLDPRLEGQFSLPQA--QKAASLALQCLSVEPKLR 346
+ L+ P+ +A L L +P R
Sbjct: 203 EKI---LKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ-EGFQGHKEWLTEINYLGQLHHP 138
LG+G FG V++G + +A+K +N+ + E+L E + + + +
Sbjct: 14 LGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR------GSYFQPLSWSLRMKIALGAA 192
++V+L+G L+V E M +G ++++L R P + +++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-------GPTGDKSHVSTR 245
+G+A+L A K ++RD A N ++ + K+ DFG+ RD G K + R
Sbjct: 130 DGMAYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG-KGLLPVR 186
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
M APE L G T KSD++SFGVVL E+ +
Sbjct: 187 WM------APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 81/279 (29%), Positives = 133/279 (47%), Gaps = 37/279 (13%)
Query: 80 LGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
+G G FG V+ G W+++ +A+K + +EG ++++ E + +L HP
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-----------VAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHL-FRRGSYFQPLSWSLRMKIALGAANGLAF 197
LV+L G C E LV+EFM G + ++L +RG S + + L G+A+
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAY 115
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEY 257
L S+ VI+RD A N L+ N K+SDFG+ R D+ ST +++PE
Sbjct: 116 LESS--NVIHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEV 172
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDP 317
+ ++KSD++SFGV++ E+ S + +NR E +VE + FR+ P
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE-------TINAGFRLYKP 223
Query: 318 RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
RL +Q L C P+ RP ++ +L
Sbjct: 224 RL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 25/229 (10%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
VLG G FG+V+KG W+ E + +A+K L +E + +KE L E + +
Sbjct: 14 VLGSGAFGTVYKGVWIPEGE------KVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSM----ENHLFRRGSYFQPLSWSLRMKIALGAA 192
HP++V+L+G CL L+ + MP G + NH GS L+W +++ A
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQ-YLLNWCVQI------A 119
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+++L E ++++RD A N+L+ + + K++DFGLA+ +K + + +
Sbjct: 120 KGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGE-HNLVE 299
A E + T KSD++S+GV + E+++ G + + P E +L+E
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 74 FRPDSVLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
F + LG G FG V++G W + +A+K L + +++ E+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKN------RVR-----VAIKILKSDDLLKQQDFQKEVQAL 56
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+L H +L+ L C + ++ E M +GS+ F R Q L + + +A A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVA 114
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+A+L E I+RD A NIL+ + K++DFGLAR + ++S+ Y +
Sbjct: 115 EGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKW 170
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILS 281
APE + G + KSD++SFG++L E+ +
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 87/294 (29%), Positives = 133/294 (45%), Gaps = 57/294 (19%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-----NQEGFQGHKEWL-TEINYL 132
VLG+G +G+V+ G + G LIAVK++ N + E L E++ L
Sbjct: 7 VLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
L H N+V+ +G CL+D+ + EF+P GS+ + L R G +P+ +I
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----L 112
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD----GPTGDKSHVSTRVMG 248
+G+A+LH V++RD K +N++L N KL DFG AR G G S++ + G
Sbjct: 113 DGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308
T + APE + KSDI+S G + E+ +G KP L S
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG-------------------KPPLASM 211
Query: 309 RRI--------FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
R+ R L PRL FS A CL+ + RP ++++
Sbjct: 212 DRLAAMFYIGAHRGLMPRLPDSFS----AAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 72/272 (26%), Positives = 123/272 (45%), Gaps = 36/272 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQLHH 137
+G+G FG VFK R + A+K+++ +E + E L +L
Sbjct: 8 IGKGSFGVVFK---------VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL-FRRGSYFQPLSWSLRMKIALGAANGLA 196
+++ L+ +V E+ G + L +RG +PL + + GLA
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLA 115
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
LHS K+++RD K+ N+ LD+ N K+ D G+A+ D ++ + ++GT Y +PE
Sbjct: 116 HLHSK--KILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPE 171
Query: 257 YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316
KSD+++ GVVL E +G+ D N + L+ +I R +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI----------LKIIRGVF 218
Query: 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPD 348
P + +S Q+ A L QCL+ + + RPD
Sbjct: 219 PPVSQMYS----QQLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 44/287 (15%)
Query: 80 LGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQLHH 137
LG+G FG V +G W ST G + +AVK L + ++L E + L H
Sbjct: 3 LGDGSFGVVRRGEW-------STSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS--WSLRMKIALGAANGL 195
NL++L G L ++V E P GS+ + L + +S ++IA NG+
Sbjct: 56 ENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGM 110
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST---RVMGTYGY 252
+L S + I+RD A NILL S+ K+ DFGL R P + +V +V + +
Sbjct: 111 RYLESK--RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAW 166
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL-TSKRRI 311
APE L T + SD++ FGV L E+ + GE +P+ S +I
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT----------YGE-------EPWAGLSGSQI 209
Query: 312 FRVLDPRLEGQFSLPQA--QKAASLALQCLSVEPKLRPDMDEVVKEL 356
+ +D E + P+A Q ++ LQC + P RP + + L
Sbjct: 210 LKKIDKEGE-RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 89/284 (31%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
++GEG FG+V +G E+ TG +AVK + + + +L E + +LHH
Sbjct: 12 EIIGEGEFGAVLQG---EY--------TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHH 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
NLV+L+G L + +V E M +G++ N L RG + L+ +L A G+ +
Sbjct: 59 KNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF--SLDVAEGMEY 115
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTG-DKSHVSTRVMGTYGYAAPE 256
L S K+++RD A NIL+ + AK+SDFGLAR G G D S + + + APE
Sbjct: 116 LESK--KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPE 167
Query: 257 YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316
L ++KSD++S+GV+L E+ S RA P + +L E + R ++
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRA-----PYPKMSLKEVKECVEKGYR-----ME 217
Query: 317 PRLEGQFSLPQAQKAA--SLALQCLSVEPKLRPDMDEVVKELEQ 358
P P+ A L C EPK RP ++ ++LE+
Sbjct: 218 P--------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 76/283 (26%), Positives = 123/283 (43%), Gaps = 44/283 (15%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
+GEG G V+K T TG +A+K++ Q + + EI + H
Sbjct: 25 EKIGEGASGEVYKA---------TDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKH 74
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
PN+V L D +V E+M GS+ + + + F ++ + GL +
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVLQGLEY 131
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEY 257
LHS VI+RD K+ NILL + + KL+DFG A T +KS ++ V GT + APE
Sbjct: 132 LHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSVV-GTPYWMAPE- 186
Query: 258 LATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK--RRIFRV 314
+ K DI+S G++ +E+ G P PYL R +F +
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEG-------EP-----------PYLREPPLRALFLI 228
Query: 315 LD---PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
P L+ + + +CL +P+ RP +E+++
Sbjct: 229 TTKGIPPLKNPEKW--SPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 86/292 (29%), Positives = 132/292 (45%), Gaps = 45/292 (15%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQ-EGFQGHKEWLTEINYLGQLH 136
V+G+G FG V+ G +D G + AVK LN+ + +++L E +
Sbjct: 2 VIGKGHFGCVYHGTLIDSD-------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 137 HPNLVKLVGYCLEDDHR-LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
HPN++ L+G CL + L+V +M G + N F R P L + L A G+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDL-IGFGLQVAKGM 111
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS----TRVMGTYG 251
+L A K ++RD A N +LD ++ K++DFGLARD DK + S T
Sbjct: 112 EYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARD--IYDKEYYSVHNHTGAKLPVK 167
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311
+ A E L T T KSD++SFGV+L E+++ R ++ YL RR
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITV----YLLQGRR- 220
Query: 312 FRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
L Q + + L C +P++RP E+V +EQ+
Sbjct: 221 -------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 33/296 (11%)
Query: 80 LGEGGFGSVFKGWVDE-HSLAS------TRPGTGMLIAVKRLNQEGFQGHK-EWLTEINY 131
LGEG FG V V L + R G +L+AVK L + + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR--------GSYFQP----- 178
L +L PN+++L+G C+++D ++ E+M G + L G+ P
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 179 --LSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236
+S+S + +AL A+G+ +L S ++RD N L+ N K++DFG++R+
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL--NFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296
GD + R + + A E + G T SD+++FGV L EIL + T E
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV 250
Query: 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
+ + + R+++ P P Q L LQC S + + RP ++
Sbjct: 251 IENAGEFFRDQGRQVYLFRPP--------PCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 82/295 (27%), Positives = 118/295 (40%), Gaps = 61/295 (20%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYL 132
LG G G V K RP TG ++AVK + E K+ L E++ L
Sbjct: 3 LEYLGELGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDIL 53
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+ + P +V G + + E+M GS++ L + + KIA+
Sbjct: 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVL 110
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM----- 247
GL +LH K+I+RD K SNIL++S KL DFG VS +++
Sbjct: 111 KGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAK 157
Query: 248 ---GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
GT Y APE + + KSDI+S G+ L+E+ +GR P
Sbjct: 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPP 206
Query: 305 LTSKRRIFRVLD-------PRL-EGQFSLPQAQKAASLALQCLSVEPKLRPDMDE 351
IF +L PRL G+FS CL +P+ RP E
Sbjct: 207 DG----IFELLQYIVNEPPPRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 49/223 (21%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN----QEGFQGHKEWLT---EINYL 132
+GEG +G V+K TG L+A+K++ +EGF +T EI L
Sbjct: 7 IGEGTYGQVYKA---------RNKKTGELVALKKIRMENEKEGFP-----ITAIREIKLL 52
Query: 133 GQLHHPNLVKLVGYCLEDDHR--LLVYEFMP---RGSMENHLFRRG-----SYFQPLSWS 182
+L HPN+V+L +V+E+M G +++ + Y + L
Sbjct: 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL--- 109
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
GL +LHS +++RD K SNIL++++ KL+DFGLAR T S
Sbjct: 110 ---------LEGLQYLHSN--GILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSAD 157
Query: 243 STRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
T + T Y PE L AT + D++S G +L E+ G+
Sbjct: 158 YTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 25/221 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHP 138
+G+G FG VF+ L P T ++AVK L +E ++ E + + HP
Sbjct: 13 IGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQ------------------PLS 180
N+VKL+G C L++E+M G + L R Q PLS
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
+ ++ IA A G+A+L +E K ++RD N L+ N K++DFGL+R+ + D
Sbjct: 129 CTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
S + PE + T +SD++++GVVL EI S
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 87/291 (29%), Positives = 133/291 (45%), Gaps = 38/291 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGML-IAVKRLNQEGF-QGHKEWLTEINYLGQLHH 137
LG G FG V++G + PG+G + +AVK L + Q KE+L E + + +H
Sbjct: 3 LGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFR-RGSYFQP--LSWSLRMKIALGAANG 194
PN+VKL+G CL ++ + ++ E M G + ++L R F P L+ + I L A G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 195 LAFLHSAEPKVIYRDFKASNILL-----DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
+L + I+RD A N L+ D++ K+ DFGLARD D +
Sbjct: 119 CVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
+ APE L G T +SD++SFGV++ EIL+ +P N E
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL-----GQQPYPALNNQE---------- 221
Query: 310 RIFRVLD-PRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVKELE 357
VL G+ P+ K L C + +P RP D + + L+
Sbjct: 222 ----VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 70/209 (33%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 80 LGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
LG G FG V+ G W +T+ +AVK L + G + +L E + +L H
Sbjct: 14 LGAGQFGEVWMGTW-----NGTTK------VAVKTL-KPGTMSPEAFLQEAQIMKKLRHD 61
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
LV+L C E++ +V E+M +GS+ + L L + M A A G+A+L
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYL 119
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT---YGYAAP 255
S I+RD A NIL+ N K++DFGLAR + + R G + AP
Sbjct: 120 ESR--NYIHRDLAARNILVGENLVCKIADFGLAR---LIEDDEYTAR-EGAKFPIKWTAP 173
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILS-GR 283
E G T KSD++SFG++L EI++ GR
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 57/243 (23%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGH----K 123
+F+ ++GEG F +V T A+K +L +E + K
Sbjct: 2 DFKFGKIIGEGSFSTVVLA---------KEKETNKEYAIKILDKRQLIKEKKVKYVKIEK 52
Query: 124 EWLTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWS 182
E LT +N HP ++KL Y +D+ L V E+ P G + ++ + GS
Sbjct: 53 EVLTRLN-----GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS-------- 98
Query: 183 LRMKIA-LGAAN---GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD 238
L K AA L +LHS +I+RD K NILLD + + K++DFG A+
Sbjct: 99 LDEKCTRFYAAEILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156
Query: 239 KSHVSTRVM------------------GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEIL 280
+ GT Y +PE L SD+++ G ++ ++L
Sbjct: 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216
Query: 281 SGR 283
+G+
Sbjct: 217 TGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 91/284 (32%), Positives = 133/284 (46%), Gaps = 47/284 (16%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHP 138
LG G FGSV KG + G + +AVK L QE G KE+L E + + QL HP
Sbjct: 3 LGHGNFGSVVKGVY------LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
+V+L+G C + +LV E P G + +L +R + S ++A A G+A+L
Sbjct: 57 CIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRRE----IPVSDLKELAHQVAMGMAYL 111
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG-----YA 253
S ++RD A N+LL + + AK+SDFG++R G + +T T G +
Sbjct: 112 ESK--HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWY 165
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK-RRI 311
APE + G ++KSD++S+GV L E S G AKPY K +
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYG------------------AKPYGEMKGAEV 207
Query: 312 FRVLDP--RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVV 353
+L+ RL PQ S+ L C P+ RP E+
Sbjct: 208 IAMLESGERLPRPEECPQE--IYSIMLSCWKYRPEDRPTFSELE 249
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 74/294 (25%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH--KEWLTEINYLGQLH 136
+LGEG FGSV +G + S G+ + +AVK + + +E+L+E +
Sbjct: 6 ILGEGEFGSVMEGQL------SQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 137 HPNLVKLVGYCLEDDHR------LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM--KIA 188
HPN++KL+G C E +++ FM G + + L P L+ K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD---KSHVSTR 245
+ A G+ +L + I+RD A N +L + ++DFGL++ +GD + ++
Sbjct: 120 VDIALGMEYLSNR--NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
+ + A E LA T+KSD+++FGV + EI + R H + + YL
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYD----YL 228
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
R+ + D E + C +PK RP ++ + LE +
Sbjct: 229 RHGNRLKQPEDCLDELYDLM----------YSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 32/219 (14%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQ--EGFQGHKEWLTEI 129
+ LGEG +G V+K D+ TG ++A+K RL+ EG L EI
Sbjct: 1 YEKLEKLGEGTYGVVYKAR-DKK--------TGEIVALKKIRLDNEEEGIP--STALREI 49
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWSLRMK 186
+ L +L HPN+VKL+ + LV+E+ + ++ PLS +L
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR-------PGPLSPNLIKS 102
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
I GLA+ HS ++++RD K NIL++ + KL+DFGLAR +++ + V
Sbjct: 103 IMYQLLRGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEV 159
Query: 247 MGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
+ T Y APE L + + TA DI+S G + E+++G+
Sbjct: 160 V-TLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 91/319 (28%), Positives = 134/319 (42%), Gaps = 59/319 (18%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ----EGFQGHKEWLTEINYLGQL 135
+GEG +G V+K TG ++A+K++ EG K L EI L +L
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIP--KTALREIKLLKEL 55
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMEN--HLFRRGSYFQPLSWSLRMKIALGAAN 193
+HPN++KL+ LV+EFM + L + L SL
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQR--GLPESLIKSYLYQLLQ 109
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGPTGDKSH-VSTRVMGTY 250
GLAF HS +++RD K N+L+++ KL+DFGLAR P +H V TR
Sbjct: 110 GLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR----- 162
Query: 251 GYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRP--TGEHNLVEWAKPYLTS 307
Y APE L + DI+S G + E+LS RP G+ + + K
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-------RPLFPGKSEIDQLFK----- 210
Query: 308 KRRIFRVL-DPRLEGQFSLPQAQKAASLAL-QCLSVE-PKLRPDMDEVVKELEQLQELRN 364
IFR L P E + + + + PKL P+ + L+ L ++ +
Sbjct: 211 ---IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASP--QALDLLSQMLH 265
Query: 365 M--HKRPQKEHQAKGHVHF 381
HKR QA H +F
Sbjct: 266 YDPHKRITA-EQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 17/217 (7%)
Query: 80 LGEGGFGSV-------FKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINY 131
LGEG FG V + + ++ + +L+AVK L + +++L E+
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR-------GSYFQPLSWSLR 184
L +L PN+ +L+G C D ++ E+M G + L + + LS+S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST 244
+ +A A+G+ +L ++RD N L+ NY K++DFG++R+ + D V
Sbjct: 133 LYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
R + A E + G T KSD+++FGV L EIL+
Sbjct: 191 RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 68/213 (31%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPG--TGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL 135
LG G FG V++G L R G + +AVK L + Q ++L E + +
Sbjct: 13 ALGHGAFGEVYEG------LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK----IALGA 191
+H N+V+L+G E R ++ E M G +++ L R SL MK A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDV 125
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
A G +L I+RD A N LL AK++DFG+ARD R M
Sbjct: 126 AKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ PE G T+K+D++SFGV+L EI S
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 7e-24
Identities = 76/302 (25%), Positives = 113/302 (37%), Gaps = 55/302 (18%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL--NQEGFQGHKEWLTEINYLGQL 135
V+GEG +G V K TG ++A+K+ +++ K L E+ L QL
Sbjct: 7 GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMEN-HLFRRG---SYFQPLSWSLRMKIALGA 191
H N+V L LV+E++ R +E G + W L
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL-------- 109
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
+A+ HS +I+RD K NIL+ + KL DFG AR S ++ V T
Sbjct: 110 LQAIAYCHSH--NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRW 166
Query: 252 YAAPEYLATGHLTAKS-DIYSFGVVLLEILSGR----------------RAIDKNRPTGE 294
Y APE L K D+++ G ++ E+L G + + P
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP--S 224
Query: 295 HNLVEWAKPYLTSKRRIFRVLDP-----RLEGQFSLPQAQKAASLALQCLSVEPKLRPDM 349
H + + P P R G+ S P A CL ++PK R
Sbjct: 225 HQELFSSNPRFAGVA-FPEPSQPESLERRYPGKVSSP----ALDFLKACLRMDPKERLTC 279
Query: 350 DE 351
DE
Sbjct: 280 DE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
LGEG FG VF + ++L+ T+ ML+AVK L K++ E L L H +
Sbjct: 13 LGEGAFGKVF--LAECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF------QP------LSWSLRMKI 187
+VK G C + D ++V+E+M G + L G QP L S + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
A A+G+ +L A ++RD N L+ +N K+ DFG++RD + D V M
Sbjct: 129 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ PE + T +SD++SFGV+L EI +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-23
Identities = 80/290 (27%), Positives = 141/290 (48%), Gaps = 43/290 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTG-MLIAVKRLNQEGF--QGHKEWLTEINYLGQL 135
V+G G FG VF+G + PG + +A+K L + G+ + +++L+E + +GQ
Sbjct: 12 VIGAGEFGEVFRGIL-------KMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQF 63
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
H N+++L G + +++ E+M G+++ +L F ++ G A G+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGM 120
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR---DGPTGDKSHVSTRVMGTYGY 252
+L ++ ++RD A NIL++SN K+SDFGL+R D P G + ++ +
Sbjct: 121 KYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRW 176
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL-TSKRRI 311
APE +A T+ SD++SFG+V+ E++S GE +PY S +
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMS----------FGE-------RPYWDMSNHEV 219
Query: 312 FRVLDP--RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
+ ++ RL P A L LQC + RP ++V L++L
Sbjct: 220 MKAINDGFRLPAPMDCPSA--VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 81/286 (28%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN-QEGFQGHKEWLTEINYLGQLH 136
S LGEG GSV K + TGM+ A+K + K+ L E+
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK 57
Query: 137 HPNLVKLVGYCLEDDHRLL--VYEFMPRGSMENHLFRRGSYFQPLSWSLRM------KIA 188
P +VK G L++ + E+ GS+++ Y + R+ KIA
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS------IYKKVKKRGGRIGEKVLGKIA 111
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
GL++LHS K+I+RD K SNILL KL DFG++ G + S T G
Sbjct: 112 ESVLKGLSYLHSR--KIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVN-SLAGTFT-G 165
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAI--DKNRPTGEHNLVEWAKPYLT 306
T Y APE + + SD++S G+ LLE+ R + P G L+ +
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY------ 219
Query: 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLAL-----QCLSVEPKLRP 347
I + +P L+ + P S QCL +P RP
Sbjct: 220 ----IVNMPNPELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 70/204 (34%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINYLGQLHH 137
+LG+G FG VFKG +L P +AVK ++ Q K ++L+E L Q H
Sbjct: 2 LLGKGNFGEVFKG-----TLKDKTP-----VAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
PN+VKL+G C + +V E +P G + L ++ L +K AL AA G+A+
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAY 108
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEY 257
L S I+RD A N L+ N K+SDFG++R G S + + + APE
Sbjct: 109 LESK--NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEA 165
Query: 258 LATGHLTAKSDIYSFGVVLLEILS 281
L G +++SD++S+G++L E S
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLTEINYLGQLH 136
VLG+G G V+K +P TG + A+K+++ +G + K+ L E+ L
Sbjct: 7 KVLGQGSSGVVYK--------VRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
P +VK G + + +V E+M GS+ + L + G + + IA GL
Sbjct: 58 SPYVVKCYG-AFYKEGEISIVLEYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGL 112
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAP 255
+LH+ + +I+RD K SN+L++S K++DFG+++ +T V GT Y +P
Sbjct: 113 DYLHT-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYMSP 169
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILSGR 283
E + + +DI+S G+ LLE G+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 62/218 (28%), Positives = 111/218 (50%), Gaps = 27/218 (12%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKR--LNQEGFQGHKEWL--------TE 128
++G+G +G V+ L T TG ++AVK+ L H +E
Sbjct: 8 LIGKGTYGRVYLA------LNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
I L L H N+V+ +G+ +++ + E++P GS+ + L G + + L ++
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
GLA+LHS +++RD KA N+L+D++ K+SDFG+++ + + + G
Sbjct: 119 ----EGLAYLHSK--GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 249 TYGYAAPEYLATGH--LTAKSDIYSFGVVLLEILSGRR 284
+ + APE + + +AK DI+S G V+LE+ +GRR
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-23
Identities = 80/284 (28%), Positives = 126/284 (44%), Gaps = 39/284 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
LG G +G V++G ++SL +AVK L ++ + E+L E + ++ HPN
Sbjct: 14 LGGGQYGEVYEGVWKKYSLT---------VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPN 63
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH 199
LV+L+G C + ++ EFM G++ ++L L M A ++ + +L
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM--ATQISSAMEYLE 121
Query: 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA 259
I+RD A N L+ N+ K++DFGL+R TGD + APE LA
Sbjct: 122 KKN--FIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 178
Query: 260 TGHLTAKSDIYSFGVVLLEI----LSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315
+ KSD+++FGV+L EI +S ID + + L+E K Y
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLE--KGY----------- 222
Query: 316 DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
R+E P K L C P RP E+ + E +
Sbjct: 223 --RMERPEGCP--PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-23
Identities = 81/294 (27%), Positives = 144/294 (48%), Gaps = 45/294 (15%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTG-MLIAVKRLNQEGFQGH--KEWLTEINYLG 133
+ V+G G FG V +G + PG + +A+K L + G+ +++L+E + +G
Sbjct: 9 EEVIGAGEFGEVCRGRLKL-------PGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMG 60
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
Q HPN++ L G + +++ EFM G++++ L + F + + + G A
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAA 117
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGPTGDKSHVSTRVMG--- 248
G+ +L +E ++RD A NIL++SN K+SDFGL+R + T D ++ S+ +G
Sbjct: 118 GMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKI 173
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL-TS 307
+ APE +A T+ SD++S+G+V+ E++S GE +PY S
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS----------YGE-------RPYWDMS 216
Query: 308 KRRIFRVL--DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
+ + + D RL P A L L C + RP ++V L+++
Sbjct: 217 NQDVINAIEQDYRLPPPMDCPTALH--QLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLG 133
F LGEG +GSV+K TG ++A+K + E +E + EI+ L
Sbjct: 5 FDILEKLGEGSYGSVYKA---------IHKETGQVVAIKVVPVEE--DLQEIIKEISILK 53
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
Q P +VK G ++ +V E+ GS+ + + L+ I
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLK 110
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPTGDKSHVSTRVMGTYGY 252
GL +LHS K I+RD KA NILL+ AKL+DFG++ T K + V+GT +
Sbjct: 111 GLEYLHSN--KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFW 165
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
APE + K+DI+S G+ +E+ G+
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-23
Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 16/216 (7%)
Query: 80 LGEGGFGSVF----KGWVDEHSLASTR-PGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLG 133
LGEG FG V +G + + G +L+AVK L + + ++L EI +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQ--------PLSWSLRM 185
+L +PN+++L+G C+ DD ++ E+M G + L +R +S + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
+A+ A+G+ +L A ++RD N L+ ++Y K++DFG++R+ +GD + R
Sbjct: 133 YMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ + A E + G T SD+++FGV L E+ +
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-22
Identities = 75/295 (25%), Positives = 139/295 (47%), Gaps = 55/295 (18%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-----NQEGFQGHKEWLT----E 128
+++G G FGSV+ G ++ +G L+AVK++ + + L E
Sbjct: 6 ALIGSGSFGSVYLGM---NAS------SGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
I L +L H N+V+ +G L+ DH + E++P GS+ L G++ + L + +I
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI- 115
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR----DGPTGDKSHVST 244
GL +LH+ +I+RD K +NIL+D+ K+SDFG+++ + + +
Sbjct: 116 ---LKGLNYLHNR--GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
+ G+ + APE + T K+DI+S G +++E+L TG+H P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML-----------TGKHPF-----PD 214
Query: 305 LTSKRRIFRVLDPRLEGQFSLPQ-----AQKAASLALQCLSVEPKLRPDMDEVVK 354
T + IF++ G+ + P+ + +A + ++ RP E++K
Sbjct: 215 CTQLQAIFKI------GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 35/222 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGW-VDEHSLASTRPGTGMLIAVKRLNQEGFQGH-----KEWL 126
N+R +LG+G FG V+ + VD TG +AVK++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD----------TGRELAVKQVPFDPDSPETKKEVNALE 52
Query: 127 TEINYLGQLHHPNLVKLVGYCLEDDHRLLVY-EFMPRGSMENHLFRRGSYFQPLSWSLRM 185
EI L L H +V+ G CL DD L ++ E+MP GS+++ L G L+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTR 107
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA------RDGPTGDK 239
K G+ +LHS +++RD K +NIL DS N KL DFG + TG K
Sbjct: 108 KYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
S V GT + +PE ++ K+D++S G ++E+L+
Sbjct: 166 S-----VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 80 LGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
LG G FG V G W + +A+K + EG +++ E + +L HP
Sbjct: 12 LGSGQFGVVHLGKWRGKID-----------VAIKMIR-EGAMSEDDFIEEAKVMMKLSHP 59
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
NLV+L G C + +V E+M G + N+L R W L M + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG-TEWLLDM--CSDVCEAMEYL 116
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR---DGPTGDKSHVSTRVMGTYGYAAP 255
S I+RD A N L+ + K+SDFGLAR D D+ S +A P
Sbjct: 117 ESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKWAPP 170
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILSG 282
E ++KSD++SFGV++ E+ S
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 79/295 (26%), Positives = 144/295 (48%), Gaps = 41/295 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEIN 130
+ + V+G G FG V G + L R + +A+K L + G+ + +++L+E +
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRL---KLPGKRE---IPVAIKTL-KAGYTEKQRRDFLSEAS 57
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
+GQ HPN++ L G + ++V E+M GS++ L + F + ++ G
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---G 114
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR---DGPTGDKSHVSTRVM 247
A+G+ +L ++ ++RD A NIL++SN K+SDFGL+R D P + ++ +
Sbjct: 115 IASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EAAYTTRGGK 170
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL-T 306
+ APE +A T+ SD++S+G+V+ E++S GE +PY
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS----------YGE-------RPYWEM 213
Query: 307 SKRRIFRVLDP--RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
S + + + ++ RL P A L L C + RP +++V L++L
Sbjct: 214 SNQDVIKAIEEGYRLPAPMDCPAALH--QLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-22
Identities = 77/285 (27%), Positives = 134/285 (47%), Gaps = 47/285 (16%)
Query: 80 LGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
LG G FG V G W ++ +A+K + +EG E++ E + +L H
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMKLSHE 59
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
LV+L G C + +V E+M G + N+L G FQP S +++ G+A+L
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYL 116
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT---YGYAAP 255
S + I+RD A N L+D K+SDFGL+R D + S+ +G+ ++ P
Sbjct: 117 ESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPP 170
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDK--NRPTGEHNLVEWAKPYLTSKRRIF 312
E L ++KSD+++FGV++ E+ S G+ ++ N T E ++ R++
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK---------VSQGLRLY 221
Query: 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357
R P L ++K ++ C + + RP +++ +E
Sbjct: 222 R---PHL-------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 4e-22
Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 80 LGEGGFGSV-------FKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINY 131
LGEG FG V + ++D+ +L+AVK L ++ + + ++L EI
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQP-------LSWSLR 184
+ +L PN+++L+ C+ D ++ E+M G + L R +S+S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST 244
+ +A A+G+ +L S ++RD N L+ NY K++DFG++R+ +GD +
Sbjct: 133 IFMATQIASGMKYLSSL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
R + + + E + G T SD+++FGV L EIL+
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 69/219 (31%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTE 128
+F LG G FG V L + +G A+K L++ K+ L E
Sbjct: 1 DDFEFIKTLGTGSFGRVM--------LVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNE 51
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
L + HP LV L G +DD L LV E++P G + +HL + G + +P++ ++
Sbjct: 52 KRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
L L +LHS + ++YRD K N+LLDS+ K++DFG A+ V R
Sbjct: 111 VLA----LEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTY 156
Query: 248 ---GTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSG 282
GT Y APE L+ G+ A D ++ G+++ E+L+G
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 4e-22
Identities = 80/299 (26%), Positives = 136/299 (45%), Gaps = 28/299 (9%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
R+ + LG+G FGSV D + TG ++AVK+L + +++ EI
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58
Query: 132 LGQLHHPNLVKLVGYCLEDDHR--LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L L H N+VK G C R LV E++P GS+ ++L + + L + A
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYAS 115
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG- 248
G+ +L + ++RD NIL++S K+ DFGL + P DK + R G
Sbjct: 116 QICKGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGE 172
Query: 249 --TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNR-PTGEHNLVEWAKPYL 305
+ Y APE L + SD++SFGVVL E+ + DK+ P E +
Sbjct: 173 SPIFWY-APESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAE--FMRMMGNDK 226
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQ----KAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
+ ++ +++ L+ LP + ++ +C + +P RP E+ ++E ++
Sbjct: 227 QGQMIVYHLIE-LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 5e-22
Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
LGEG FG VF + ML+AVK L + +++ E L L H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDK----MLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFR------------RGSYFQPLSWSLRMKI 187
+V+ G C E L+V+E+M G + N R L+ + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
A A+G+ +L S ++RD N L+ K+ DFG++RD + D V R M
Sbjct: 128 ASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ PE + T +SDI+SFGVVL EI +
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 9e-22
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLH 136
LG+GGFG V A TG + A K+L+++ +G + L E L ++
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 137 HPNLVKLVGYCLED-DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI-ALGAANG 194
+V L Y E D LV M G ++ H++ G P + R A G
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA---RAIFYAAQIICG 107
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
L LH + +++YRD K N+LLD + N ++SD GLA + G K GT GY A
Sbjct: 108 LEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMA 162
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGR 283
PE L D ++ G L E+++GR
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-21
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 49/294 (16%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
+ + +G+G FG V G ++ G +AVK + + + +L E +
Sbjct: 6 KELKLLQTIGKGEFGDVMLG---DYR--------GNKVAVKCIKNDATA--QAFLAEASV 52
Query: 132 LGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
+ QL H NLV+L+G +E+ L +V E+M +GS+ ++L RG L +K +L
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLD 110
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPTGDKSHVSTRVMGT 249
+ +L + ++RD A N+L+ + AK+SDFGL ++ T D + +
Sbjct: 111 VCEAMEYLEAN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---- 164
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
+ APE L + KSD++SFG++L EI S R PY R
Sbjct: 165 --WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PY---PR 202
Query: 310 RIFRVLDPRLEGQFSL--PQAQKAA--SLALQCLSVEPKLRPDMDEVVKELEQL 359
+ + PR+E + + P + QC ++ RP ++ ++LE +
Sbjct: 203 IPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
LGEG FG VF + ++L + +L+AVK L K++ E L L H +
Sbjct: 13 LGEGAFGKVF--LAECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHL---------FRRGSYFQPLSWSLRMKIALG 190
+VK G C+E D ++V+E+M G + L G+ L+ S + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
A G+ +L A ++RD N L+ N K+ DFG++RD + D V M
Sbjct: 129 IAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ PE + T +SD++S GVVL EI +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN----QEGFQGHKEWLTEINYLGQL 135
+GEG G VFK E TG +A+K++ + G + L EI L
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
HP +VKL+ +LV E+MP E +PL + G+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSE----VLRDEERPLPEAQVKSYMRMLLKGV 112
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAP 255
A++H+ +++RD K +N+L+ ++ K++DFGLAR + S +V T Y AP
Sbjct: 113 AYMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAP 169
Query: 256 EYL-ATGHLTAKSDIYSFGVVLLEILSGR 283
E L D+++ G + E+L+G
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 46/222 (20%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW-----LTEINYL 132
LG+G FGSV+ TG L+A+K++ ++ W L E+ L
Sbjct: 5 KQLGDGTFGSVYLA--RNKE-------TGELVAIKKMKKK----FYSWEECMNLREVKSL 51
Query: 133 GQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF-----RRGSYFQPLSWSLRMK 186
+L HPN+VKL E+D V+E+M E +L+ R+G F +R
Sbjct: 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESV--IR-S 103
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD----GPTGDKSHV 242
I GLA +H +RD K N+L+ K++DFGLAR+ P D +V
Sbjct: 104 IIYQILQGLAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YV 159
Query: 243 STRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGR 283
STR Y APE L + ++ DI++ G ++ E+ + R
Sbjct: 160 STR-----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 33/213 (15%)
Query: 80 LGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
LG G FG V++G W + T P +AVK L + G K++L E + +L HP
Sbjct: 14 LGAGQFGEVWEGLWNN------TTP-----VAVKTL-KPGTMDPKDFLAEAQIMKKLRHP 61
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
L++L C ++ +V E M GS+ +L + L + +A A+G+A+L
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYL 119
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR-------DGPTGDKSHVSTRVMGTYG 251
+ I+RD A N+L+ N K++DFGLAR + G K +
Sbjct: 120 EAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK-------- 169
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILS-GR 283
+ APE + KSD++SFG++L EI++ GR
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 71/289 (24%), Positives = 132/289 (45%), Gaps = 45/289 (15%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ------EGFQGHKEWLTEINYL 132
LG G F S + + TG L+AVK++ E + + EI +
Sbjct: 7 QLGTGAFSSCY---------QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLM 57
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+L+HP++++++G ED H L E+M GS+ + L S + ++ +
Sbjct: 58 ARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLL 113
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSN-YNAKLSDFG----LARDGPTGDKSHVSTRVM 247
GL++LH E ++I+RD K +N+L+DS +++DFG LA G + +++
Sbjct: 114 RGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLL 169
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
GT + APE L D++S G V++E+ + + + + + L
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---------- 219
Query: 308 KRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
IF++ S+P+ + + L+CL ++P+ RP E++K
Sbjct: 220 ---IFKIASA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 62/288 (21%)
Query: 80 LGEGGFGSVFKGW-VDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEWLTEINYLGQLH 136
+G G FG V+ +D TG L+AVK R+ + KE E+ L L
Sbjct: 8 IGGGTFGKVYTAVNLD----------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK 57
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
HPNLVK G + + + E+ G++E L G + L GLA
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEH---VIRVYTLQLLEGLA 113
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG----- 251
+LHS +++RD K +NI LD N KL DFG A K +T MG
Sbjct: 114 YLHSH--GIVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQSLAG 165
Query: 252 ---YAAPEYL----ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
Y APE + GH A +DI+S G V+LE+ +G+ RP E + E+ +
Sbjct: 166 TPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGK------RPWSELD-NEFQIMF 217
Query: 305 -LTSKRRIFRVLDPRLEGQFSLPQAQKAASLAL----QCLSVEPKLRP 347
+ + + P +P + + + +CL +PK RP
Sbjct: 218 HVGAGHK------P------PIPDSLQLSPEGKDFLDRCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 30/221 (13%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQL 135
+ V+GEG FG V + + + G M A+K L + + H+++ E+ L +L
Sbjct: 7 EDVIGEGNFGQVIRAMI-------KKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 136 -HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL------------FRRGSYFQPLSWS 182
HHPN++ L+G C + + E+ P G++ + L + L+
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
++ A A G+ +L +E + I+RD A N+L+ N +K++DFGL+R G++ +V
Sbjct: 120 QLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV 173
Query: 243 STRVMGTYG--YAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ MG + A E L T KSD++SFGV+L EI+S
Sbjct: 174 K-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLTEINYLGQLHH 137
V+G G V+ A P +A+KR++ E Q E E+ + Q +H
Sbjct: 8 VIGVGATAVVYA--------AICLPN-NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
PN+VK + D LV ++ GS+ + + L ++ + GL +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFG----LARDGPTGDKSHVSTRVMGTYGYA 253
LHS I+RD KA NILL + + K++DFG LA G V +GT +
Sbjct: 118 LHSN--GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG--DRTRKVRKTFVGTPCWM 173
Query: 254 APEYLATGH-LTAKSDIYSFGVVLLEILSGR 283
APE + H K+DI+SFG+ +E+ +G
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-21
Identities = 77/309 (24%), Positives = 129/309 (41%), Gaps = 47/309 (15%)
Query: 62 FSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG 121
F S+L+ T LG G FG VF G L+ VK L + +
Sbjct: 2 FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTKDEN 50
Query: 122 -HKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF-----RRGSY 175
E+ E++ +L H N+V+L+G C E + ++ E+ G ++ L
Sbjct: 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLK 110
Query: 176 FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235
PLS ++ + A G+ L +A + ++RD A N L+ S K+S L++D
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSLSKD-V 167
Query: 236 TGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295
+ + + + APE + + KSD++SFGV++ E+ + GE
Sbjct: 168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGE- 216
Query: 296 NLVEWAKPY--LTSKRRIFRVLDPRLEGQFSLPQAQKAAS----LALQCLSVEPKLRPDM 349
P+ L+ + VL+ G+ LP + S L +C +V PK RP
Sbjct: 217 ------LPFYGLSDE----EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSF 266
Query: 350 DEVVKELEQ 358
E+V L +
Sbjct: 267 SELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 9e-21
Identities = 82/276 (29%), Positives = 124/276 (44%), Gaps = 36/276 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT-EINYLGQLHHP 138
+G+G FG VFKG +D T ++A+K ++ E + E + EI L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNR--------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
+ K G L+D ++ E++ GS + L G PL + I GL +L
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG----PLDETQIATILREILKGLDYL 117
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL 258
HS K I+RD KA+N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 118 HSE--KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 259 ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPR 318
+K+DI+S G+ +E+ G + P L+ P P
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PT 220
Query: 319 LEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
LEG +S P + + CL+ EP RP E++K
Sbjct: 221 LEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 84/290 (28%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAV-KRLNQEGFQGHKEWLTEINYLGQLHHP 138
LGEG FGSV +G +++ M IA+ R E F L+E + + HP
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDF------LSEAVCMKEFDHP 60
Query: 139 NLVKLVGYCLEDDHR------LLVYEFMPRGSMENHLF--RRGSYFQPLSWSLRMKIALG 190
N+++L+G CL+ +++ FM G + + L R G Q L + +K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
A+G+ +L S I+RD A N +L+ N N ++DFGL++ GD
Sbjct: 121 IASGMEYLSSK--SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK--PYLTSK 308
+ A E LA T KSD++SFGV + EI + R + VE ++ YL
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIAT--------RGQTPYPGVENSEIYDYLRQG 230
Query: 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358
R+ + D L+G + SL C + PK RP + + ELE+
Sbjct: 231 NRLKQPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEI 129
+F+ LG+G +GSV+K R A+K ++ G KE + EI
Sbjct: 1 DFKVLKKLGKGSYGSVYK---------VKRLSDNQFYALKEVDL-GSMSQKEREDAVNEI 50
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L ++HPN++ L+ + +V E+ P G + + +R + + +I +
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
GL LH K+++RD K++NILL +N K+ D G++ K +++ +GT
Sbjct: 111 QLLRGLQALHEQ--KILHRDLKSANILLVANDLVKIGDLGIS----KVLKKNMAKTQIGT 164
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
Y APE + KSDI+S G +L E+ + + A+ +
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQDLRY 211
Query: 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
++ R P + +S Q + L V+PKLRP+ D++
Sbjct: 212 KVQRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQL-H 136
V+GEG FG V K + + G M A+KR+ + + H+++ E+ L +L H
Sbjct: 2 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL------------FRRGSYFQPLSWSLR 184
HPN++ L+G C + L E+ P G++ + L S LS
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST 244
+ A A G+ +L ++ + I+RD A NIL+ NY AK++DFGL+R G + +V
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 167
Query: 245 RVMGTYG--YAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ MG + A E L T SD++S+GV+L EI+S
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 75/298 (25%), Positives = 120/298 (40%), Gaps = 53/298 (17%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLT-EINYLGQLH 136
+G+G FG+V K R G ++ K ++ K+ L E+N L +L
Sbjct: 7 TIGKGSFGTVRK---------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 137 HPNLVKLVGYC----LEDDHRL-LVYEFMPRG---SMENHLFRRGSYF-QPLSWSLRMKI 187
HPN+V+ Y + L +V E+ G + + Y + W + ++
Sbjct: 58 HPNIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD---KSHVST 244
L A V++RD K +NI LD+N N KL DFGLA+ K++V
Sbjct: 115 LL-ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-- 171
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
GT Y +PE L KSDI+S G ++ E+ + P A+
Sbjct: 172 ---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL-------SPPFT------ARNQ 215
Query: 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362
L +I R+ ++S + + L+V+P RP +EL QL +
Sbjct: 216 LQLASKIKEGKFRRIPYRYS-SELNEVIKS---MLNVDPDKRPS----TEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW--LTEIN 130
+ V+G G FG V R L+ +K++ E + E
Sbjct: 1 KYEKIRVVGRGAFGIVH---------LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQ 51
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQP----LSWSLRMK 186
L L HPN+++ LED ++V E+ P G++ ++ +R + L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA-KLSDFGLARDGPTGDKSHVSTR 245
+AL H +++RD K NILLD + K+ DFG+++ KS T
Sbjct: 112 LALH--------HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT- 160
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
V+GT Y +PE KSDI++ G VL E+ S +RA + NL P L
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------ANL-----PAL 209
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVV 353
K I + ++S P ++ L L L+++P RP + +++
Sbjct: 210 VLK--IMSGTFAPISDRYS-PDLRQ---LILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 38/293 (12%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH--KEWLTEINYLGQLH 136
+LG+G FGSV + + G+ +AVK L + F +E+L E + +
Sbjct: 6 MLGKGEFGSV------REAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 137 HPNLVKLVGYCLEDDHR------LLVYEFMPRGSMENHLFRRGSYFQPLSWSLR--MKIA 188
HPN++KL+G L + +++ FM G + L +P + L+ ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
+ A+G+ +L S I+RD A N +L+ N ++DFGL++ +GD
Sbjct: 120 IDIASGMEYLSSK--NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK--PYLT 306
+ A E LA T SD+++FGV + EI++ R + VE ++ YL
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RGQTPYAGVENSEIYNYLI 229
Query: 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
R+ + D + L QC S EPK RP + +LE +
Sbjct: 230 KGNRLKQPPDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 30/219 (13%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQL-H 136
V+GEG FG V K + + G M A+KR+ + + H+++ E+ L +L H
Sbjct: 14 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR------------GSYFQPLSWSLR 184
HPN++ L+G C + L E+ P G++ + L + S LS
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST 244
+ A A G+ +L ++ + I+RD A NIL+ NY AK++DFGL+R G + +V
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179
Query: 245 RVMGTYG--YAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ MG + A E L T SD++S+GV+L EI+S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 85/305 (27%), Positives = 145/305 (47%), Gaps = 36/305 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQLH 136
+G G FG+V+ +T T ++AVK+++ G Q +++W + E+ +L QL
Sbjct: 29 IGHGSFGAVY---------FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
HPN ++ G L++ LV E+ GS + L + +PL I GA GLA
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLA 135
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+LHS +I+RD KA NILL KL+DFG A KS + +GT + APE
Sbjct: 136 YLHSH--NMIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPE 187
Query: 257 YLAT---GHLTAKSDIYSFGVVLLEILSGRRAI-DKNRPTGEHNLVEWAKPYLTSKR--- 309
+ G K D++S G+ +E+ + + + N + +++ + P L S
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD 247
Query: 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSV--EPKLRPDMDEVVKELEQLQELRNMHK 367
+D L+ +PQ + A++ L+ V + R +D + + + ++EL N+
Sbjct: 248 SFRGFVDYCLQ---KIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNLQY 304
Query: 368 RPQKE 372
R K+
Sbjct: 305 RKMKK 309
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGT--GMLIAVKRLNQ-EGFQGHKEWLTEINYLGQLH 136
LGE FG ++KG + PG L+A+K L Q E+ E + + +LH
Sbjct: 13 LGECAFGKIYKGHL-------YLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH 65
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR-------------GSYFQPLSWSL 183
HPN+V L+G ++ +++E++ +G + L R G+ L
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS 243
+ IA+ A G+ +L S +++D A NIL+ + K+SD GL+R+ + D V
Sbjct: 126 FLHIAIQIAAGMEYLSSH--FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ + + PE + G ++ SDI+SFGVVL EI S
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-----WLT 127
+ LGEG + V+K E TG ++A+K++ + K+ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALR 51
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSY-FQPL---SWSL 183
EI L +L HPN++ L+ + LV+EFM +E + + S P S+ L
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYML 109
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS 243
GL +LHS +++RD K +N+L+ S+ KL+DFGLAR + ++
Sbjct: 110 MT------LRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMT 160
Query: 244 TRVMGTYGYAAPEYLATGHLTAKS-----DIYSFGVVLLEILSGR 283
+V+ T Y APE L A+ D++S G + E+L
Sbjct: 161 HQVV-TRWYRAPELL----FGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 7e-20
Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 39/291 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINYLGQLHHP 138
LG+G FG V++G + P T +A+K +N+ + E+L E + + + +
Sbjct: 14 LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHL------FRRGSYFQPLSWSLRMKIALGAA 192
++V+L+G + L++ E M RG ++++L P S +++A A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
+G+A+L++ K ++RD A N ++ ++ K+ DFG+ RD D + + +
Sbjct: 130 DGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL-TSKRRI 311
+PE L G T SD++SFGVVL EI + L E +PY S ++
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGMSNEQV 230
Query: 312 FRVLDPRLEGQFSLPQAQKAASLALQ----CLSVEPKLRPDMDEVVKELEQ 358
R + +EG L + + + C PK+RP E++ +++
Sbjct: 231 LRFV---MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 54/299 (18%)
Query: 76 PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINYLGQ 134
+GEG FG V++G + +AVK +E +L E + Q
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI----ALG 190
HP++VKL+G ++ +V E P G + SY Q +SL + +
Sbjct: 64 FDHPHIVKLIGVI-TENPVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQ 115
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV-STRVMGT 249
+ LA+L S + ++RD A N+L+ S KL DFGL+R D+S+ +++
Sbjct: 116 LSTALAYLESK--RFVHRDIAARNVLVSSPDCVKLGDFGLSR--YLEDESYYKASKGKLP 171
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPY--LT 306
+ APE + T+ SD++ FGV + EIL G KP+ +
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGV------------------KPFQGVK 213
Query: 307 SKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQE 361
+ I R+E LP SL +C + +P RP E+ +L + +
Sbjct: 214 NNDVIG-----RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTE----INYLGQ 134
LG G FG V V+ + ++ M +AVK L +E L +++LG
Sbjct: 42 TLGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
H N+V L+G C L++ E+ G + N L R+ F L+ + + A G
Sbjct: 98 --HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKG 153
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV---STRVMGTYG 251
+AFL A I+RD A N+LL K+ DFGLARD D ++V + R+
Sbjct: 154 MAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVK 208
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ APE + T +SD++S+G++L EI S
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 76/298 (25%), Positives = 135/298 (45%), Gaps = 44/298 (14%)
Query: 71 TRNFRPDSVLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEWLTE 128
R +LG G FG+V KG W+ E + +A+K + ++ G Q +E
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGD------SIKIPVAIKTIQDRSGRQTFQEITDH 59
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQP---LSWSLRM 185
+ +G L H +V+L+G C +L V + P GS+ +H+ + P L+W +++
Sbjct: 60 MLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
A G+ +L E ++++R+ A NILL S+ +++DFG+A DK + +
Sbjct: 119 ------AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
+ A E + G T +SD++S+GV + E++S A+PY
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS-----------------YGAEPY- 212
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQ----KAASLALQCLSVEPKLRPDMDEVVKELEQL 359
+ R V D LE L Q Q + ++C ++ +RP E+ E ++
Sbjct: 213 -AGMRPHEVPD-LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 72/210 (34%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEW-LTEINYLGQL 135
VLG+G FG V LA GT L AVK L ++ E +TE L
Sbjct: 2 VLGKGSFGKVL--------LAE-LKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 136 -HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
HP L +L D V E++ G + H+ R G + +P + +I LG
Sbjct: 53 GKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG---- 108
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM-GTYGYA 253
L FLH E +IYRD K N+LLDS + K++DFG+ ++G G V+T GT Y
Sbjct: 109 LQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDYI 163
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGR 283
APE L+ D ++ GV+L E+L+G+
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 22/207 (10%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
LG G FG V+ G+ + H+ +A+K L ++G + +L E N + QL HP
Sbjct: 14 LGAGQFGEVWMGYYNGHTK----------VAIKSL-KQGSMSPEAFLAEANLMKQLQHPR 62
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH 199
LV+L ++ ++ E+M GS+ + L + L+ + + +A A G+AF+
Sbjct: 63 LVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY--GYAAPEY 257
I+RD +A+NIL+ K++DFGLAR + + + R + + APE
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEA 174
Query: 258 LATGHLTAKSDIYSFGVVLLEILS-GR 283
+ G T KSD++SFG++L EI++ GR
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 72/288 (25%), Positives = 133/288 (46%), Gaps = 47/288 (16%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN----------QEGFQGHKEWLTEI 129
LG G FG V+K V + + L+A+K +N +E + + ++E+
Sbjct: 8 LGSGAFGCVYK--VRKKN------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 130 NYLG-QLHHPNLVKLVGYCLEDDHRLLVYEFM---PRGSMENHLFRRGSYF-QPLSWSLR 184
+ QL HPN+V+ LE+D +V + + P G N L + F + W++
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST 244
+++ L L +LH E ++++RD +NI+L + ++DFGLA+ K T
Sbjct: 120 VQMVLA----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LT 171
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
V+GT Y+ PE + K+D+++FG +L ++ + P N++ A
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKI 225
Query: 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
+ + V +P EG +S + + CL+ + + RPD+ +V
Sbjct: 226 VEA------VYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 78/276 (28%), Positives = 124/276 (44%), Gaps = 36/276 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT-EINYLGQLHHP 138
+G+G FG V+KG +D T ++A+K ++ E + E + EI L Q P
Sbjct: 12 IGKGSFGEVYKG-IDNR--------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
+ + G L+ ++ E++ GS + L + G PL + I GL +L
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG----PLEETYIATILREILKGLDYL 117
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL 258
HS + I+RD KA+N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 118 HSE--RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 259 ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPR 318
K+DI+S G+ +E+ G P L+ P P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PT 220
Query: 319 LEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
LEGQ+S P + + CL+ +P+ RP E++K
Sbjct: 221 LEGQYSKPFKEFVEA----CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 83 GGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEINYLGQLHHPN 139
G +G VF LA + TG + A+K + + + LTE + L Q P
Sbjct: 4 GAYGRVF--------LA-KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 140 LVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
+VKL Y + L LV E++P G + L + R+ IA L +L
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSL-DEDVA-RIYIA-EIVLALEYL 109
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS------TRVMGTYGY 252
HS +I+RD K NIL+DSN + KL+DFGL++ G + +++ R++GT Y
Sbjct: 110 HSN--GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 253 AAPE-YLATGHLTAKSDIYSFGVVLLEILSG 282
APE L GH + D +S G +L E L G
Sbjct: 168 IAPEVILGQGH-SKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEI 129
+F V+G+G FG V + + T + A+K +N++ + L E
Sbjct: 1 HFELLRVIGKGAFGKV---CIVQKR------DTKKMFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRM-KI 187
L +L+HP LV L Y +D+ + LV + + G + HL ++ F + +I
Sbjct: 52 RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEI 109
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
L L +LHS +I+RD K NILLD + ++DF +A +T
Sbjct: 110 VLA----LEYLHSK--GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTS 160
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292
GT GY APE L + D +S GV E L G+R + T
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 80/290 (27%), Positives = 136/290 (46%), Gaps = 37/290 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHP 138
LG+G FG V++G + + T +AVK +N+ + E+L E + +
Sbjct: 14 LGQGSFGMVYEGNARD--IIKGEAET--RVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHL--FRRGSYFQP--LSWSLRMKIALGA--A 192
++V+L+G + L+V E M G ++++L R + P +L+ I + A A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
+G+A+L++ K ++RD A N ++ ++ K+ DFG+ RD D + + +
Sbjct: 130 DGMAYLNAK--KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LTSKRR 310
APE L G T SD++SFGVVL EI S L E +PY L++++
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAE--QPYQGLSNEQV 230
Query: 311 IFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358
+ V+D G P ++ L C PK+RP E+V L+
Sbjct: 231 LKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 5e-19
Identities = 63/209 (30%), Positives = 112/209 (53%), Gaps = 22/209 (10%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
VLG G FG+V+KG WV E + +A+K LN+ G + + E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVK------IPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR----GSYFQPLSWSLRMKIALGAA 192
HP+LV+L+G CL +L V + MP G + +++ GS L+W +++ A
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLL-LNWCVQI------A 119
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+ +L E ++++RD A N+L+ S + K++DFGLAR +K + + +
Sbjct: 120 KGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILS 281
A E + T +SD++S+GV + E+++
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 70/210 (33%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRP---GTGMLIAVKRLNQEGFQGHKEWL-TEINYLGQL 135
LGEG FG V L P TG +AVK L E H L EI L L
Sbjct: 12 LGEGHFGKV--------ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 63
Query: 136 HHPNLVKLVGYCLEDDHR--LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
+H N+VK G C ED L+ EF+P GS++ +L R + ++ ++K A+
Sbjct: 64 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICK 120
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR--VMGTYG 251
G+ +L S + ++RD A N+L++S + K+ DFGL + T DK + + + +
Sbjct: 121 GMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDLDSPVF 177
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ APE L SD++SFGV L E+L+
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-19
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HH 137
LGEG FG V K ++ P +AVK L + + + ++E+ + + H
Sbjct: 20 LGEGAFGQVVKA----EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR---GSYF---------QPLSWSLRM 185
N++ L+G C ++ +V E+ G++ + L R G Y + L+ +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
A A G+ FL A K I+RD A N+L+ ++ K++DFGLARD D +T
Sbjct: 136 SFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ APE L T +SD++SFGV+L EI +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 69/240 (28%), Positives = 102/240 (42%), Gaps = 45/240 (18%)
Query: 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ----EGFQGHKE 124
+ R++ LGEG FG V+K + TG ++A+K++ +GF
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGF--PIT 53
Query: 125 WLTEINYLGQLHHPNLVKLVGYCLE--DDH---RLLVYEFMP------RGSMENHLFRRG 173
L EI L +L HPN+V L+ +E D R VY P G +EN +
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-- 111
Query: 174 SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR- 232
M L G+ +LH +++RD KA+NIL+D+ K++DFGLAR
Sbjct: 112 --LTESQIKCYMLQLL---EGINYLHEN--HILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 233 --------DGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGR 283
G G + T ++ T Y PE L T DI+ G V E+ + R
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQLHHP 138
LG G GSV S P TG ++A K ++ K+ L E+ + + P
Sbjct: 13 LGAGNGGSV--------SKVKHIP-TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSP 63
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
+V G L +++ + EFM GS++ ++++G P+ + KIA+ GL +L
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGG---PIPVEILGKIAVAVVEGLTYL 119
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDK-SHVSTRVMGTYGYAAPEY 257
++ ++++RD K SNIL++S KL DFG+ +G+ + ++ +GT Y +PE
Sbjct: 120 YN-VHRIMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPER 173
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGR 283
+ G T KSD++S G+ ++E+ G+
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 66/304 (21%), Positives = 131/304 (43%), Gaps = 50/304 (16%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-----GHKEW 125
NF+ + +G+G F V+K G ++A+K++ + F+ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---------ICLLDGRVVALKKV--QIFEMMDAKARQDC 49
Query: 126 LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGS---MENHLFRRGSYF-QPLSW 181
L EI+ L QL HPN++K + +E++ +V E G M H ++ + W
Sbjct: 50 LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109
Query: 182 SLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH 241
+++ + L +HS ++++RD K +N+ + + KL D GL R K+
Sbjct: 110 KYFVQL----CSALEHMHSK--RIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTT 161
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301
+ ++GT Y +PE + KSDI+S G +L E +
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQ 203
Query: 302 KPYLTSKRRIFRVLDPRLEGQFS-LPQAQKAA---SLALQCLSVEPKLRPDMDEVVKELE 357
P+ K ++ + + + LP + L +C++ +P+ RPD+ V++ +
Sbjct: 204 SPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263
Query: 358 QLQE 361
++
Sbjct: 264 EMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 76/281 (27%), Positives = 115/281 (40%), Gaps = 37/281 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINYLGQLHHP 138
+G G FG VF G + +AVK + K ++L E L Q HP
Sbjct: 3 IGRGNFGEVFSGRLR---------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+V+L+G C + +V E + G L G L +++ AA G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYL 110
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL 258
S I+RD A N L+ K+SDFG++R+ G + + APE L
Sbjct: 111 ESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 259 ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LTSKR-RIFRVL 315
G +++SD++SFG++L E S A PY L++++ R
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS-----------------LGAVPYANLSNQQTREAIEQ 211
Query: 316 DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
RL P A L +C +P RP V +EL
Sbjct: 212 GVRLPCPELCPDA--VYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLH 136
LG+GGFG V A TG + A K+L+++ + G K L E L +++
Sbjct: 1 LGKGGFGEV---------CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 137 HPNLVKLVGYCLEDD-HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
P +V L Y E H LV M G ++ H++ G + I A
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGE----RGLEMERVIHYSAQITC 106
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAP 255
LH ++YRD K N+LLD N +LSD GLA + G T+ GT GY AP
Sbjct: 107 GILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAP 163
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILSGR 283
E L + D ++ G + E+++GR
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 79/288 (27%), Positives = 125/288 (43%), Gaps = 43/288 (14%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN--QEGFQGHKEWLTEINY 131
++ ++G G +G+V++G H TG ++A+K +N E+
Sbjct: 3 YQRLELIGRGAYGAVYRGK---HVP------TGRVVALKIINLDTPDDDVSDIQ-REVAL 52
Query: 132 LGQLHH---PNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
L QL PN+ K G RL ++ E+ GS+ L + G + S+ ++
Sbjct: 53 LSQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYI-SVIIRE 109
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
L A L ++H VI+RD KA+NIL+ + N KL DFG+A S ST V
Sbjct: 110 VLVA---LKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-SSKRSTFV- 162
Query: 248 GTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306
GT + APE + G K+DI+S G+ + E+ +G L+ +KP
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--- 219
Query: 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
PRLE ++ + CL EPK R +E++K
Sbjct: 220 ----------PRLEDNGYSKLLREFVAA---CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN-----QEGFQGHKEWLTEINYLGQ 134
LG GGFG V L + A+K + + G Q H +E L +
Sbjct: 1 LGVGGFGRV--------ELVKVKS-KNRTFALKCVKKRHIVETGQQEHI--FSEKEILEE 49
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
+HP +VKL + + ++ E+ G + L RG + + + R IA
Sbjct: 50 CNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA---RFYIA-CVVLA 105
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
+LH+ +IYRD K N+LLDSN KL DFG A+ +G K+ GT Y A
Sbjct: 106 FEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVA 160
Query: 255 PEY-LATGHLTAKSDIYSFGVVLLEILSGR 283
PE L G+ + D +S G++L E+L+GR
Sbjct: 161 PEIILNKGYDFS-VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 69/233 (29%), Positives = 102/233 (43%), Gaps = 36/233 (15%)
Query: 67 LRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL 126
L T F V+GEG +G V+K + TG L+A+K ++ +E
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIK 50
Query: 127 TEINYLGQL-HHPNLVKLVGYCLEDDHRL------LVYEFMPRGS---MENHLFRRGSYF 176
E N L + +HPN+ G ++ + LV E GS + L ++G
Sbjct: 51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG--- 107
Query: 177 QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236
+ L I GLA+LH E KVI+RD K NILL N KL DFG++
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-- 163
Query: 237 GDKSHVSTR--VMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSG 282
S + R +GT + APE +A A+SD++S G+ +E+ G
Sbjct: 164 --DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
LG+G FG V+K A + TG+ A K + E + ++++ EI+ L + HPN
Sbjct: 13 LGDGAFGKVYK--------AQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH 199
+V L ++ ++ EF G++++ + + L+ + L FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLH 120
Query: 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA 259
S KVI+RD KA NILL + + KL+DFG++ + + + +GT + APE +A
Sbjct: 121 SH--KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVA 176
Query: 260 TGHLT-----AKSDIYSFGVVLLEILSGR 283
K+DI+S G+ L+E+
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 71/228 (31%), Positives = 109/228 (47%), Gaps = 42/228 (18%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEWLTEIN 130
NF+ +GEG +G V+K A + TG ++A+K RL+ E + EI+
Sbjct: 1 NFQKVEKIGEGTYGVVYK--------ARNKL-TGEVVALKKIRLDTETEGVPSTAIREIS 51
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFM-----------PRGSMENHLFRRGSYFQPL 179
L +L+HPN+VKL+ ++ LV+EF+ P + L + SY L
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQL 109
Query: 180 SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDK 239
GLAF HS +V++RD K N+L+++ KL+DFGLAR G
Sbjct: 110 ------------LQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVP 153
Query: 240 SHVSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGRRAI 286
T + T Y APE L + + DI+S G + E+++ RRA+
Sbjct: 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQ 134
VLG+G FG V + + R GT L A+K L ++ + + E L
Sbjct: 6 MVLGKGSFGKV---------MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 135 LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
P + + C + RL V E++ G + H+ + G + +P + +IA+G
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG--- 113
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM-GTYGY 252
L FLHS +IYRD K N++LD+ + K++DFG+ ++ G K +TR GT Y
Sbjct: 114 -LFFLHSK--GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDY 167
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287
APE +A D ++FGV+L E+L+G+ D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-18
Identities = 79/294 (26%), Positives = 134/294 (45%), Gaps = 51/294 (17%)
Query: 73 NFRPDSVLGEGGFGSVFKG-W--VDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEI 129
+ R + LG+G FG V+ G W ++ + +PGT ++ E F L E
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--------MSPEAF------LQEA 52
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+ +L H LV+L + ++ +V E+M +GS+ + F +G + L + +A
Sbjct: 53 QVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAA 109
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
A+G+A++ ++RD +A+NIL+ N K++DFGLAR + + + R
Sbjct: 110 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAK 164
Query: 250 Y--GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
+ + APE G T KSD++SFG++L E+ + R PY
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGM 207
Query: 308 KRRIFRVLDPRLEGQFSLPQAQKAAS----LALQCLSVEPKLRPDMDEVVKELE 357
R VLD ++E + +P + L QC EP+ RP + + LE
Sbjct: 208 VNR--EVLD-QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 9e-18
Identities = 79/276 (28%), Positives = 121/276 (43%), Gaps = 36/276 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT-EINYLGQLHHP 138
+G+G FG VFKG +D T ++A+K ++ E + E + EI L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNR--------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
+ K G L+ ++ E++ GS + L R F + +K L GL +L
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEIL---KGLDYL 117
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL 258
HS K I+RD KA+N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 118 HSE--KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 259 ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPR 318
+K+DI+S G+ +E+ G P L+ P P
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PT 220
Query: 319 LEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
L G+FS + CL+ +P RP E++K
Sbjct: 221 LTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 80/298 (26%), Positives = 124/298 (41%), Gaps = 67/298 (22%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT-EINYL 132
F +G+G FG V+K +D+ T ++A+K ++ E + E + EI +L
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKR--------TNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
Q P + K G L+ ++ E+ GS L + G L + I
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG----KLDETYIAFILREVL 108
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR---VMGT 249
GL +LH E I+RD KA+NILL + KL+DFG++ G + ++ +GT
Sbjct: 109 LGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGT 161
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR---------RA---IDKNRPTGEHNL 297
+ APE + K+DI+S G+ +E+ G R I KN P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------ 215
Query: 298 VEWAKPYLTSKRRIFRVLDPRLEG-QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
P LEG +FS + S CL+ +PK RP E++K
Sbjct: 216 -------------------PSLEGNKFS-KPFKDFVS---LCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEI 129
+F VLG+G FG V + + R GT L A+K L ++ + + E
Sbjct: 1 DFNFLMVLGKGSFGKV---------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
L P + + C + RL V E++ G + H+ + G + +P + +I+
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM- 247
+G L FLH +IYRD K N++LDS + K++DFG+ ++ V+TR
Sbjct: 112 VG----LFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFC 162
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287
GT Y APE +A D +++GV+L E+L+G+ D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 43/282 (15%)
Query: 80 LGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
LG G FG V G W + +A+K +N EG ++++ E + +L HP
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-----------VAIKAIN-EGAMSEEDFIEEAKVMMKLSHP 59
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
LV+L G C + +V EFM G + N+L +R + + + G+ +L
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYL 116
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR---DGPTGDKSHVSTRVMGTYGYAAP 255
I+RD A N L+ S K+SDFG+ R D D+ S+ ++ P
Sbjct: 117 ERN--SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD----DEYTSSSGAKFPVKWSPP 170
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314
E ++KSD++SFGV++ E+ + G+ +K + N + R FR+
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-----KSNY-----EVVEMISRGFRL 220
Query: 315 LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
P+L + + C +P+ RP E+++ +
Sbjct: 221 YRPKL-------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 82/306 (26%), Positives = 128/306 (41%), Gaps = 45/306 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINY 131
+F LG G G V K RP +G+++A K ++ E + + E+
Sbjct: 2 DFEKLGELGAGNGGVVTK--------VLHRP-SGLIMARKLIHLEIKPAIRNQIIRELKV 52
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
L + + P +V G D + E M GS++ L + G + ++ KI++
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAV 108
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
GL +L + K+++RD K SNIL++S KL DFG++ G D S ++ V GT
Sbjct: 109 LRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID-SMANSFV-GTRS 163
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAI-------------DKNRPTGEHNLV 298
Y +PE L H T +SDI+S G+ L+E+ GR I
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223
Query: 299 EWAKPYLTSKRR---IFRVLD-------PRLEGQFSLPQAQKAASLALQCLSVEPKLRPD 348
+ R IF +LD P+L + Q +CL PK R D
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVD---KCLKKNPKERAD 280
Query: 349 MDEVVK 354
+ E+ K
Sbjct: 281 LKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 74/229 (32%), Positives = 110/229 (48%), Gaps = 42/229 (18%)
Query: 64 YSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK 123
++DLR +G G FG+V+ + T ++A+K+++ G Q ++
Sbjct: 17 FTDLRE----------IGHGSFGAVY---------FARDVRTNEVVAIKKMSYSGKQSNE 57
Query: 124 EW---LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
+W + E+ +L QL HPN ++ G L + LV E+ GS + L + +PL
Sbjct: 58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDIL---EVHKKPLQ 113
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
I GA GLA+LHS E I+RD KA NILL KL+DFG A S
Sbjct: 114 EVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSA--------S 163
Query: 241 HVS--TRVMGTYGYAAPEY-LAT--GHLTAKSDIYSFGVVLLEILSGRR 284
VS +GT + APE LA G K D++S G+ +E L+ R+
Sbjct: 164 LVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 73/284 (25%), Positives = 124/284 (43%), Gaps = 34/284 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEIN 130
++ P VLG+G FG + R L+ K +N + ++ L EI
Sbjct: 1 HYIPIRVLGKGAFGE---------ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIV 51
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
L L HPN++ + ++D+ L+ E+ G++ + + R+ L +
Sbjct: 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
+A ++++H A +++RD K NI L KL DFG+++ + + S T V+GT
Sbjct: 112 SA--VSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAET-VVGTP 165
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
Y +PE KSDI++ G VL E+L+ +R D P NLV +
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV----------K 212
Query: 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
I + + +S + SL L +P+ RP DEV+
Sbjct: 213 IVQGNYTPVVSVYS----SELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 80 LGEGGFGSVFKGWVDEHSLAS-TRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHH 137
+G G FG V G H S R + VK L +L E+ +L+H
Sbjct: 3 IGNGWFGKVLLGEA--HRGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNH 54
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFR-RGSYFQPLSWSLRMKIALGAANGLA 196
PN+++ +G C+E LLV EF P G ++N+L RG Q + ++A A+GL
Sbjct: 55 PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG------PTGDKSHVSTRVMGTY 250
+LH A+ I+ D N L ++ + K+ D+GLA + T D V R
Sbjct: 115 WLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----- 167
Query: 251 GYAAPEY-------LATGHLTAKSDIYSFGVVLLEI 279
+ APE L T KS+I+S GV + E+
Sbjct: 168 -WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 42/217 (19%)
Query: 82 EGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLT---EINYLGQ 134
EG +G V++ D+ TG ++A+K+L +EGF +T EIN L +
Sbjct: 15 EGTYGVVYRA-RDKK--------TGEIVALKKLKMEKEKEGFP-----ITSLREINILLK 60
Query: 135 LHHPNLVKL----VGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWSLRMKI 187
L HPN+V + VG L D +V E++ + ME QP S +
Sbjct: 61 LQHPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMK-------QPFLQSEVKCL 111
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
L +G+A LH + +++RD K SN+LL++ K+ DFGLAR G T+++
Sbjct: 112 MLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLV 167
Query: 248 GTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGR 283
T Y APE L + D++S G + E+L+ +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 75/291 (25%), Positives = 134/291 (46%), Gaps = 46/291 (15%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
VLG G FG+V+KG W+ + + +A+K L + + +KE L E + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGE------NVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF----RRGSYFQPLSWSLRMKIALGAA 192
P + +L+G CL +L V + MP G + +++ R GS L+W +++ A
Sbjct: 68 SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQI------A 119
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+++L E ++++RD A N+L+ S + K++DFGLAR + + + +
Sbjct: 120 KGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312
A E + T +SD++S+GV + E+++ AKPY R
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFG-----------------AKPYDGIPAREI 220
Query: 313 RVLDPRLEGQFSLPQ----AQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
L LE LPQ + ++C ++ + RP E+V E ++
Sbjct: 221 PDL---LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 4e-17
Identities = 69/236 (29%), Positives = 103/236 (43%), Gaps = 59/236 (25%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN---QEGFQGHKEWLTEIN 130
+ +G G +G V VD+ TG +A+K+++ + K L EI
Sbjct: 2 YELLKPIGSGAYGVVCSA-VDKR--------TGRKVAIKKISNVFDDLIDA-KRILREIK 51
Query: 131 YLGQLHHPNLVKL-------VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWS- 182
L L H N++ L D + +V E M + + + + QPL+
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVY--IVTELME--TDLHKVIKSP---QPLTDDH 104
Query: 183 --------LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR-D 233
LR GL +LHSA VI+RD K SNIL++SN + K+ DFGLAR
Sbjct: 105 IQYFLYQILR---------GLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
Query: 234 GPTGDKS-----HVSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGR 283
P D+ +V TR Y APE L++ T DI+S G + E+L+ +
Sbjct: 154 DPDEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEWLTEINYLGQLHH 137
+GEG +G V+KG + TG ++A+K RL E + EI+ L +L H
Sbjct: 8 IGEGTYGVVYKG---RNKK------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSME--NHL--FRRGSYFQP-LSWSLRMKIALGAA 192
PN+V L +++ L++EF+ SM+ +L +G Y L S +I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQIL---- 111
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+ F HS +V++RD K N+L+D+ KL+DFGLAR G V T + T Y
Sbjct: 112 QGILFCHSR--RVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 253 AAPEYL-ATGHLTAKSDIYSFGVVLLEILSGR 283
APE L + + DI+S G + E+ + +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 69/247 (27%), Positives = 99/247 (40%), Gaps = 59/247 (23%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN-----QEGFQGHKEWLT 127
+F V+G G FG V+ L TG + A+K L + H
Sbjct: 2 DFEVIKVIGRGAFGEVW--------LV-RDKDTGQVYAMKVLRKSDMIKRNQIAH--VRA 50
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWS---- 182
E + L P +VKL Y +D+ L LV E+MP G + N L R+ + P +
Sbjct: 51 ERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF--PEETARFYI 107
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS-- 240
+ +AL + + L F+H RD K NIL+D++ + KL+DFGL +
Sbjct: 108 AELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159
Query: 241 --------------------HVSTRVM-----GTYGYAAPEYLATGHLTAKSDIYSFGVV 275
H RV GT Y APE L + D +S GV+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219
Query: 276 LLEILSG 282
L E+L G
Sbjct: 220 LYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 72/229 (31%), Positives = 109/229 (47%), Gaps = 58/229 (25%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-----N----QEGFQGHKEWLTEIN 130
LG+G +G V+K +D T ++A+K++ N Q F+ EI
Sbjct: 15 LGKGAYGIVWKA-IDRR--------TKEVVALKKIFDAFRNATDAQRTFR-------EIM 58
Query: 131 YLGQL-HHPNLVKLVG-YCLEDDHRL-LVYEFMP--------RGSMEN-HLFRRGSYFQP 178
+L +L HPN+VKL+ E+D + LV+E+M +E+ H +R +Q
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--KRYIMYQL 116
Query: 179 LSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR---DGP 235
L L ++HS VI+RD K SNILL+S+ KL+DFGLAR +
Sbjct: 117 L-------------KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 236 TGDKSHVSTRVMGTYGYAAPEYLATGHLTAKS-DIYSFGVVLLEILSGR 283
++ V T + T Y APE L K D++S G +L E+L G+
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 86/314 (27%), Positives = 137/314 (43%), Gaps = 64/314 (20%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-------NQEGFQGHKEWLTEIN 130
VLG+GG+G VF+ T TG + A+K L NQ+ K E N
Sbjct: 2 KVLGKGGYGKVFQ------VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK---AERN 52
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L + HP +V L+ Y + +L L+ E++ G + HL R G + + + +I+L
Sbjct: 53 ILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL 111
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
L LH +IYRD K NILLD+ + KL+DFGL ++ V+ GT
Sbjct: 112 A----LEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGT 163
Query: 250 YGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308
Y APE L +GH A D +S G ++ ++L+G A P+
Sbjct: 164 IEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTG------------------APPFTAEN 204
Query: 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKR 368
R+ + +D L+G+ +LP P L P+ +++K+L + +
Sbjct: 205 RK--KTIDKILKGKLNLP----------------PYLTPEARDLLKKLLKRNPSSRLGAG 246
Query: 369 PQKEHQAKGHVHFK 382
P + + H F+
Sbjct: 247 PGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-17
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
LG G FG V+ G+ + ST+ +AVK L + G + +L E N + L H
Sbjct: 14 LGAGQFGEVWMGYYNN----STK------VAVKTL-KPGTMSVQAFLEEANLMKTLQHDK 62
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHL-FRRGSYFQ-PLSWSLRMKIALGAANGLAF 197
LV+L +++ ++ E+M +GS+ + L G P +IA G+A+
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA----EGMAY 118
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY--GYAAP 255
+ I+RD +A+N+L+ + K++DFGLAR + + + R + + AP
Sbjct: 119 IE--RKNYIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAP 173
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILS 281
E + G T KSD++SFG++L EI++
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 44/216 (20%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
+GEG G V +T TG +AVK+++ Q + E+ + HPN
Sbjct: 27 IGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM---KIA------LG 190
+V++ L D +V EF+ G++ + + RM +IA L
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIATVCLAVLK 126
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG----LARDGPTGDKSHVSTRV 246
A L+FLH+ VI+RD K+ +ILL S+ KLSDFG ++++ P KS V
Sbjct: 127 A---LSFLHAQ--GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLV---- 176
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
GT + APE ++ + DI+S G++++E++ G
Sbjct: 177 -GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 45/290 (15%)
Query: 73 NFRPDSVLGEGGFGSVF--KGWVD-EHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEI 129
+ +GEG FG ++ K D EH + T M + K +++ E+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK----------EV 50
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFR-RGSYF---QPLSWSLRM 185
L ++ HPN+V E+ +V E+ G + + R RG F Q LSW +
Sbjct: 51 ILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV-- 108
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-YNAKLSDFGLARDGPTGDKSHVST 244
+I+LG H + K+++RD K+ NI L N AKL DFG+AR D ++
Sbjct: 109 QISLG------LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAY 160
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
+GT Y +PE K+DI+S G VL E+ + + + N H LV
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN---NLHQLV------ 211
Query: 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
L + F + P ++ SL Q V P+ RP + ++K
Sbjct: 212 LKICQGYFAPISPNF--------SRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 47/225 (20%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEINYLGQ 134
S +GEG +G V A+ +P TG+ +A+K++ F+ + L EI L +
Sbjct: 11 SYIGEGAYGMVC--------SATHKP-TGVKVAIKKI--SPFEHQTFCQRTLREIKILRR 59
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMP-----RGSMENHLFRRGSYFQPLSWS------- 182
H N++ ++ D R +E + ME L++ Q LS
Sbjct: 60 FKHENIIGIL-----DIIRPPSFESFNDVYIVQELMETDLYKL-IKTQHLSNDHIQYFLY 113
Query: 183 --LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR-DGPTGDK 239
LR GL ++HSA V++RD K SN+LL++N + K+ DFGLAR P D
Sbjct: 114 QILR---------GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKS-DIYSFGVVLLEILSGR 283
+ T + T Y APE + K+ DI+S G +L E+LS R
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 86/305 (28%), Positives = 131/305 (42%), Gaps = 50/305 (16%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEIN 130
FR VLG+GGFG V A TG + A KRL ++ + G L E
Sbjct: 2 FRQYRVLGKGGFGEV---------CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSY-FQPLSWSLRMKIAL 189
L +++ +V L D LV M G ++ H++ G+ F+ +
Sbjct: 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE------EERALF 106
Query: 190 GAAN---GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
AA GL LH +YRD K NILLD + ++SD GLA P G+ + RV
Sbjct: 107 YAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV 162
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306
GT GY APE L T D + G ++ E++ G+ P+
Sbjct: 163 -GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ------------------SPFRG 203
Query: 307 SKRRIFR-VLDPRL---EGQFSLPQAQKAASLALQCLSVEPKLRPD-MDEVVKELEQLQE 361
K ++ R +D R+ E +S +++A S+ L+ +PK R +E E+++
Sbjct: 204 RKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263
Query: 362 LRNMH 366
RNM+
Sbjct: 264 FRNMN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 87/300 (29%), Positives = 140/300 (46%), Gaps = 60/300 (20%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL--NQEGFQGHKE---WLT 127
N+R +LG+G FG V+ + + TG +AVK++ + E + KE
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 128 EINYLGQLHHPNLVKLVGYCLED--DHRLLVY-EFMPRGSMENHLFRRGSYFQPLSWSLR 184
EI L L H +V+ G CL D + L ++ E MP GS+++ L G+ L+ ++
Sbjct: 54 EIQLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGA----LTENVT 108
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD------GPTGD 238
K G+++LHS +++RD K +NIL DS N KL DFG ++ TG
Sbjct: 109 RKYTRQILEGVSYLHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 239 KSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298
KS V GT + +PE ++ K+DI+S G ++E+L+ +P
Sbjct: 167 KS-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT-------EKPP------ 208
Query: 299 EWAKPYLTSKRRIFRV----LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
WA+ + IF++ +P L P L+ + VE KLRP DE+++
Sbjct: 209 -WAE--FEAMAAIFKIATQPTNPVLP-----PHVSDHCRDFLKRIFVEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 50/223 (22%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEWLTEINYLGQLHH 137
+GEG +G V++ T +G ++A+K R++ E L EI L L H
Sbjct: 15 IGEGTYGIVYRA-------RDTT--SGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 138 PNLVKL---------------VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWS 182
PN+V+L + YC +D LL + MP P S S
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT---------------PFSES 108
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
+ L GL +LH E +I+RD K SN+LL K++DFGLAR G +
Sbjct: 109 QVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKP 164
Query: 243 STRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
T + T Y APE L T + TA D+++ G +L E+L+ +
Sbjct: 165 MTPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 39/244 (15%)
Query: 105 TGMLIAVKRLNQEGFQGHKE---WLTEINYLGQLHHPNLVKLV--GYCLEDDHRLLVYEF 159
TG +A+K L + + + + E +L+HPN+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 160 MPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL-- 217
+P ++ L G L ++ L + LA H+ +++RD K NI++
Sbjct: 61 VPGRTLREVLAADG----ALPAGETGRLMLQVLDALACAHNQ--GIVHRDLKPQNIMVSQ 114
Query: 218 -DSNYNAKLSDFGLARDGP-TGDKSHV----STRVMGTYGYAAPEYLATGHLTAKSDIYS 271
+AK+ DFG+ P D +T V+GT Y APE L +T SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 272 FGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKA 331
+G++ LE L+G+R + G + +++ L P SLP
Sbjct: 175 WGLIFLECLTGQRVV-----QGA-----------SVAEILYQQLSPV---DVSLPPWIAG 215
Query: 332 ASLA 335
L
Sbjct: 216 HPLG 219
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 68/215 (31%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEIN 130
FR +VLG G FG V LA + TG L A+K L + E + E
Sbjct: 1 FRCLAVLGRGHFGKVL--------LAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 131 YL---GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
HP LV L +DH V E+ G + H+ + +P + +
Sbjct: 52 IFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACV 110
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
LG L +LH E K++YRD K N+LLD+ K++DFGL ++G G ST
Sbjct: 111 VLG----LQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FC 162
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
GT + APE L T D + GV++ E+L G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 18/216 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLTEINYLGQL-HH 137
LGEG FG V + + +P + +AVK L + + + ++E+ + + H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG------SY------FQPLSWSLRM 185
N++ L+G C +D ++ E+ +G++ +L R SY + +++ +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
A G+ +L A K I+RD A N+L+ N K++DFGLARD D +T
Sbjct: 141 SCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ APE L T +SD++SFGV++ EI +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINYLGQL 135
+ +LG G FG + +G + L S R + +A+ L + +L E LGQ
Sbjct: 10 ERILGTGRFGELCRGCL---KLPSKRE---LPVAIHTLRAGCSDKQRRGFLAEALTLGQF 63
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
H N+V+L G + ++V E+M G++++ L + L M + G A+G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGM 120
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG---Y 252
+L +E +++ A +L++S+ K+S F ++ DKS M +
Sbjct: 121 KYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE----DKSEAIYTTMSGKSPVLW 174
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILS-GRR 284
AAPE + H ++ SD++SFG+V+ E++S G R
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLH 136
LG+GGFG V A TG L A K+LN++ +G++ + E L ++H
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH 51
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLF----RRGSYFQPLSWSLRMKIALGA 191
+V L Y + L LV M G + H++ + +P + +I G
Sbjct: 52 SRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG- 109
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA---RDGPTGDKSHVSTRVMG 248
L LH + ++IYRD K N+LLD++ N ++SD GLA +DG + K + G
Sbjct: 110 ---LEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----G 159
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
T G+ APE L D ++ GV L E+++ R
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 72 RNFRPDSV------LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW 125
R+ P+ V LG+G FG V+K E TG L A K + + + +++
Sbjct: 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDY 56
Query: 126 LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
+ EI L +HP +VKL+G D ++ EF P G+++ + +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL-ARDGPTGDKSHVST 244
+ L A L +LHS K+I+RD KA N+LL + + KL+DFG+ A++ T +
Sbjct: 117 RQMLEA---LQYLHSM--KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RD 168
Query: 245 RVMGTYGYAAPEYLATGHLTA-----KSDIYSFGVVLLEI 279
+GT + APE + + K+DI+S G+ L+E+
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 71/224 (31%), Positives = 97/224 (43%), Gaps = 56/224 (25%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL--NQEGFQGHKEWLTEINYLGQLHH 137
+GEG +G VFK E TG ++A+K+ +++ K L EI L QL H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 138 PNLVKLV-------------GYCLEDDHRLL-VYEFMPRGSMENHLFRRGSYFQPLSWSL 183
PNLV L+ YC DH +L E PRG + HL ++ + W
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRG-VPEHLIKK------IIWQT 109
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGPTGDKS- 240
+ F H I+RD K NIL+ KL DFG AR GP D +
Sbjct: 110 --------LQAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKS--DIYSFGVVLLEILSG 282
+V+TR Y APE L G D+++ G V E+L+G
Sbjct: 160 YVATR-----WYRAPELL-VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 72/297 (24%), Positives = 136/297 (45%), Gaps = 48/297 (16%)
Query: 74 FRPDSVLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINY 131
F+ VLG G FG+V+KG W+ E + +A+K L + + +KE L E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSM----ENHLFRRGSYFQPLSWSLRMKI 187
+ + +P++ +L+G CL +L + + MP G + H GS + L+W +++
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQI-- 118
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
A G+ +L E ++++RD A N+L+ + + K++DFGLA+ +K + +
Sbjct: 119 ----AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306
+ A E + T +SD++S+GV + E+++ G + D P E + +
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI-------- 223
Query: 307 SKRRIFRVLDPRLEGQFSLPQAQ----KAASLALQCLSVEPKLRPDMDEVVKELEQL 359
LE LPQ + ++C ++ RP E++ E ++
Sbjct: 224 ------------LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQ- 134
V+G+G FG V L + G AVK L ++ KE + E N L +
Sbjct: 2 VIGKGSFGKV---------LLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN 52
Query: 135 LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
+ HP LV L Y + +L V +++ G + HL R S+ +P + +IA +
Sbjct: 53 VKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIA----S 107
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
L +LHS +IYRD K NILLDS + L+DFGL ++G K+ ++ GT Y
Sbjct: 108 ALGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYL 163
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSG 282
APE L D + G VL E+L G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 74/214 (34%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT--EINYLGQLH 136
VLG+G FG VF T P G L A+K L + + T E + L +++
Sbjct: 3 VLGQGSFGKVFL------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLR-----MKIALG 190
HP +VKL Y + + +L L+ +F+ R G F LS + +K L
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFL----------RGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 191 A-ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
A L LHS +IYRD K NILLD + KL+DFGL+++ +K S GT
Sbjct: 106 ELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 161
Query: 250 YGYAAPEYL-ATGHLTAKSDIYSFGVVLLEILSG 282
Y APE + GH T +D +SFGV++ E+L+G
Sbjct: 162 VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 80/283 (28%), Positives = 120/283 (42%), Gaps = 47/283 (16%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEIN 130
FR VLG+GGFG V A TG + A K+L ++ + G L E
Sbjct: 2 FRQYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ 52
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
L +++ +V L D LV M G ++ H++ G +
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFY 107
Query: 191 AAN---GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
AA GL LH + +++YRD K NILLD + + ++SD GLA P G + RV
Sbjct: 108 AAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV- 162
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
GT GY APE + T D ++ G +L E+++G+ P+
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ------------------SPFQQR 204
Query: 308 KRRIFRVLDPRL----EGQFSLPQAQKAASLALQCLSVEPKLR 346
K++I R RL + ++S + A SL L +PK R
Sbjct: 205 KKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQLHH 137
LG G FG+V KG T +AVK L + E L E N + QL +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKT-------VAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
P +V+++G C E + +LV E G + L + + L ++++G + +
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKY 110
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY--GYAAP 255
L E ++RD A N+LL + + AK+SDFGL++ D+++ + G + + AP
Sbjct: 111 LE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAP 167
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILS 281
E + ++KSD++SFGV++ E S
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 27/217 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKG-W--VDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEI 129
+ R D LG+G FG V+ G W + ++ + +PGT + E F L E
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--------MMPEAF------LQEA 52
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+ +L H LV L + ++ +V EFM +GS+ + L + L + M A
Sbjct: 53 QIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM--AA 109
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
A+G+A++ I+RD +A+NIL+ N K++DFGLAR + + + R
Sbjct: 110 QIADGMAYIERM--NYIHRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAK 164
Query: 250 Y--GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284
+ + APE G T KSD++SFG++L E+++ R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 84/292 (28%), Positives = 139/292 (47%), Gaps = 44/292 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGW-VDEHSLASTRPGTGMLIAVKRL--NQEGFQGHKEWLT-- 127
N+R +LG+G FG V+ + VD TG +A K++ + E + KE
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD----------TGRELAAKQVQFDPESPETSKEVSALE 52
Query: 128 -EINYLGQLHHPNLVKLVGYCLED--DHRLLVY-EFMPRGSMENHLFRRGSYFQPLSWSL 183
EI L L H +V+ G CL D + L ++ E+MP GS+++ L G+ L+ S+
Sbjct: 53 CEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESV 107
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS 243
K G+++LHS +++RD K +NIL DS N KL DFG ++ T S
Sbjct: 108 TRKYTRQILEGMSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 244 TR-VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302
R V GT + +PE ++ K+D++S G ++E+L+ +P WA+
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-------EKPP-------WAE 211
Query: 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ IF++ Q ++ A L C+ VE + RP +E+++
Sbjct: 212 --YEAMAAIFKIATQPTNPQLPSHISEHARDF-LGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 67/209 (32%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQL 135
+LG+G FG V V E + TG A+K L +E E LTE L
Sbjct: 2 LLGKGTFGKVI--LVREKA-------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
HP L L Y + RL V E+ G + HL R + + + +I
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA---- 107
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
L +LHS + V+YRD K N++LD + + K++DFGL ++G + D + + T GT Y A
Sbjct: 108 LGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLA 163
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGR 283
PE L D + GVV+ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-16
Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 30/229 (13%)
Query: 83 GGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE----WLTEINYLGQLHHP 138
G FGSV+ LA R TG A+K L + + + Q P
Sbjct: 7 GAFGSVY--------LAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP 57
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
+ KL D+ LV E++ G + + G P W+ + G+ L
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL--PEDWA--KQYIAEVVLGVEDL 113
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL 258
H + +I+RD K N+L+D + KL+DFGL+R+G + + +GT Y APE +
Sbjct: 114 H--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETI 165
Query: 259 ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG-----EHNLVEWAK 302
SD +S G V+ E L G P + W +
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLTEINYLGQL-HH 137
LGEG FG V + L +P +AVK L + + + ++E+ + + H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG------SY------FQPLSWSLRM 185
N++ L+G C +D ++ E+ +G++ +L R Y + LS+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
A A G+ +L A K I+RD A N+L+ + K++DFGLARD D +T
Sbjct: 144 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ APE L T +SD++SFGV+L EI +
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-16
Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 43/286 (15%)
Query: 77 DSVLGEGGFGSVFKGWVDEHS---LASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLG 133
+ LG G FG V+ ++H+ + + +PG+ ++ E F L E N +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--------MSVEAF------LAEANVMK 56
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
L H LVKL + + ++ EFM +GS+ + L QPL + + A
Sbjct: 57 TLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AE 113
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR-VMGTYGY 252
G+AF+ + I+RD +A+NIL+ ++ K++DFGLAR D + + +
Sbjct: 114 GMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKW 169
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL-TSKRRI 311
APE + G T KSD++SFG++L+EI++ R PY S +
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-----------------PYPGMSNPEV 212
Query: 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357
R L+ ++ ++ ++C P+ RP + + L+
Sbjct: 213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 71/209 (33%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEIN-YLGQ 134
V+G+G FG V L + R G AVK L ++ KE + E N L
Sbjct: 2 VIGKGSFGKV---------LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 135 LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
+ HP LV L Y + +L V +F+ G + HL R S+ +P + R A A+
Sbjct: 53 VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA---RFYAA-EIAS 107
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
L +LHS ++YRD K NILLDS + L+DFGL ++G +S +T GT Y
Sbjct: 108 ALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYL 163
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSG 282
APE + D + G VL E+L G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 76/277 (27%), Positives = 110/277 (39%), Gaps = 86/277 (31%)
Query: 81 GEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT--------EINYL 132
G G +G V+K G A+K F+G KE T EI L
Sbjct: 9 GRGTYGRVYKAKRKN-------GKDGKEYAIK-----KFKGDKEQYTGISQSACREIALL 56
Query: 133 GQLHHPNLVKLVGYCLEDDHRL--LVYEFMPRGSMENHLFR--------RGSYFQP---- 178
+L H N+V LV LE + L++++ E+ L++ + P
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 179 -LSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA----KLSDFGLAR- 232
L W + NG+ +LHS V++RD K +NIL+ K+ D GLAR
Sbjct: 112 SLLWQI--------LNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
Query: 233 -DGP-----TGDKSHVSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILS---- 281
+ P D V+ T Y APE L H T DI++ G + E+L+
Sbjct: 162 FNAPLKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215
Query: 282 --GRRA-IDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315
GR A I K+ P + + +E RIF VL
Sbjct: 216 FKGREAKIKKSNPF-QRDQLE----------RIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HH 137
LGEG FG V + + +P + +AVK L + + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR---GSYF---------QPLSWSLRM 185
N++ L+G C +D ++ E+ +G++ +L R G + + L++ +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
A A G+ +L A K I+RD A N+L+ + K++DFGLARD D +T
Sbjct: 138 SCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ APE L T +SD++SFGV+L EI +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 79/305 (25%), Positives = 139/305 (45%), Gaps = 36/305 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQLH 136
+G G FG+V+ + ++A+K+++ G Q +++W + E+ +L +L
Sbjct: 23 IGHGSFGAVY---------FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
HPN ++ G L + LV E+ GS + L + +PL + GA GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAVTHGALQGLA 129
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+LHS +I+RD KA NILL KL DFG A + +GT + APE
Sbjct: 130 YLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPE 181
Query: 257 YLAT---GHLTAKSDIYSFGVVLLEILSGRRAI-DKNRPTGEHNLVEWAKPYLTSKR--R 310
+ G K D++S G+ +E+ + + + N + +++ + P L S
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 311 IFR-VLDPRLEGQFSLPQAQKAASLAL--QCLSVEPKLRPDMDEVVKELEQLQELRNMHK 367
FR +D L+ +PQ + + + L + + E MD + + + ++EL N+
Sbjct: 242 YFRNFVDSCLQ---KIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 298
Query: 368 RPQKE 372
R K+
Sbjct: 299 RKMKK 303
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 37/213 (17%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQLH 136
+G+GG+G VF LA + TG ++A+KR+ + E LTE + L
Sbjct: 9 VGQGGYGQVF--------LAKKK-DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLS------WSLRMKIAL 189
LVKL+ Y +DD L L E++P G L G LS + M A+
Sbjct: 60 SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAV 114
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
A + L ++H RD K N L+D++ + KL+DFGL++ T S V+G+
Sbjct: 115 DALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGS 161
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
Y APE L D +S G +L E L G
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 79/307 (25%), Positives = 135/307 (43%), Gaps = 59/307 (19%)
Query: 64 YSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK 123
++DLR +G G FG+V+ + T ++A+K+++ G Q ++
Sbjct: 27 FTDLRE----------IGHGSFGAVY---------FARDVRTNEVVAIKKMSYSGKQSNE 67
Query: 124 EW---LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
+W + E+ +L ++ HPN ++ G L + LV E+ GS + L + +PL
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQ 123
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
I GA GLA+LHS +I+RD KA NILL KL+DFG A +
Sbjct: 124 EVEIAAITHGALQGLAYLHSH--NMIHRDIKAGNILLTEPGQVKLADFGSA------SIA 175
Query: 241 HVSTRVMGTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAI-DKNRPTGEHN 296
+ +GT + APE + G K D++S G+ +E+ + + + N + ++
Sbjct: 176 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 235
Query: 297 LVEWAKPYLTSKR--RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ + P L S FR + CL P+ RP +E++K
Sbjct: 236 IAQNESPTLQSNEWSDYFR-------------------NFVDSCLQKIPQDRPTSEELLK 276
Query: 355 ELEQLQE 361
+ L+E
Sbjct: 277 HMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQL 135
VLG+G FG V + + R GT L A+K L ++ + + E L
Sbjct: 7 VLGKGSFGKV---------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
P + + C + RL V E++ G + + + G + +P + +IA+G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG---- 113
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR----DGPTGDKSHVSTRVM-GT 249
L FLHS +IYRD K N++LDS + K++DFG+ + DG V+T+ GT
Sbjct: 114 LFFLHSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-------VTTKTFCGT 164
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287
Y APE +A D ++FGV+L E+L+G+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HH 137
LGEG FG V + + + + +RP + +AVK L + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR------------GSYFQPLSWSLRM 185
N++ L+G C ++ ++ E+ +G++ L R + LS+ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
A A G+ +L S + I+RD A N+L+ + K++DFGLAR D ++
Sbjct: 138 SCAYQVARGMEYLESR--RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ APE L T +SD++SFG+++ EI +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 75/254 (29%), Positives = 115/254 (45%), Gaps = 62/254 (24%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLTEINYLGQL 135
+GEG +G+VFK + T ++A+KR+ + EG L EI L +L
Sbjct: 8 IGEGTYGTVFKA-KNRE--------THEIVALKRVRLDDDDEGVPSSA--LREICLLKEL 56
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMP----------RGSMENHLFRRGSY-FQPLSWSL 183
H N+V+L L D +L LV+E+ G ++ + + S+ FQ L
Sbjct: 57 KHKNIVRLYD-VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK--SFMFQLL---- 109
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS 243
GLAF HS V++RD K N+L++ N KL+DFGLAR + + S
Sbjct: 110 ---------KGLAFCHSH--NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-S 157
Query: 244 TRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301
V+ T Y P+ L A + T+ D++S G + E+ + RP N V+
Sbjct: 158 AEVV-TLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAEL------ANAGRPLFPGNDVD-- 207
Query: 302 KPYLTSKRRIFRVL 315
+RIFR+L
Sbjct: 208 ----DQLKRIFRLL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
LG+G FG V+K E TG+L A K ++ + + ++++ EI+ L HPN
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH 199
+VKL+ +++ ++ EF G+++ + +PL+ + L +LH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLH 120
Query: 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA 259
E K+I+RD KA NIL + + KL+DFG++ + S +GT + APE +
Sbjct: 121 --ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 176
Query: 260 TGH-----LTAKSDIYSFGVVLLEI 279
K+D++S G+ L+E+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEWLTEINYLGQLHH 137
+GEG +G V+K TG ++A+K RL E + EI+ L +L+H
Sbjct: 7 IGEGTYGVVYKA----RDKL-----TGEIVALKKIRLETEDEGVPSTAIREISLLKELNH 57
Query: 138 PNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
PN+V+L+ + +++L LV+EF+ ++ + S L L G+A
Sbjct: 58 PNIVRLLD-VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+ HS +V++RD K N+L+D KL+DFGLAR G T + T Y APE
Sbjct: 114 YCHSH--RVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPE 169
Query: 257 -YLATGHLTAKSDIYSFGVVLLEILSGR 283
L + + DI+S G + E+++ R
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPG-TGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHH 137
LGE FG V+KG L T PG +A+K L + +E+ E +L H
Sbjct: 13 LGEDRFGKVYKG-----HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG---------------SYFQPLSWS 182
PN+V L+G ++ +++ + + L R S +P +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF- 126
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
+ I A G+ FL S V+++D N+L+ N K+SD GL R+ D +
Sbjct: 127 --VHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ + +PE + G + SDI+S+GVVL E+ S
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQL 135
VLG+G FG V + E +G L AVK L ++ + +TE L
Sbjct: 2 VLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52
Query: 136 H-HPNLVKLVGYCLEDDHRLL-VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
HP L +L C + RL V EF+ G + H+ + + + + +I +
Sbjct: 53 RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----S 107
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
L FLH + +IYRD K N+LLD + KL+DFG+ ++G K+ ++ GT Y
Sbjct: 108 ALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYI 163
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSG 282
APE L D ++ GV+L E+L G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 73 NFRPDSVLGEGGFGSVF--KGWVDEHSLASTRPGTGMLIA-VKRLNQ-EGFQGHKEWLTE 128
+ +G G FG V + + EH A M I V RL Q + K L E
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKV----MAIPEVIRLKQEQHVHNEKRVLKE 57
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLL--VYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186
++ HP +++L + E D R L + E++P G + ++L G + S S +
Sbjct: 58 VS------HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRF----SNSTGLF 105
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
A L +LHS E ++YRD K NILLD + KL+DFG A+ K T
Sbjct: 106 YASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWT 157
Query: 247 M-GTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSG 282
+ GT Y APE + GH A D ++ G+++ E+L G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 73/267 (27%), Positives = 115/267 (43%), Gaps = 59/267 (22%)
Query: 28 AKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGS 87
+ S SSSS AS + S S+L R +G G G+
Sbjct: 52 SSSSSSSSSSASGSAPSAAK---------------SLSELERVNR-------IGSGAGGT 89
Query: 88 VFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT-----EINYLGQLHHPNLVK 142
V+K RP TG L A+K + + H++ + EI L ++HPN+VK
Sbjct: 90 VYK--------VIHRP-TGRLYALKVI----YGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE 202
+ ++ EFM GS+E + ++ + +G+A+LH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI--------LSGIAYLHRR- 187
Query: 203 PKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPTGDKSHVSTRVMGTYGYAAPEYLATG 261
+++RD K SN+L++S N K++DFG++R T D + S +GT Y +PE + T
Sbjct: 188 -HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTD 243
Query: 262 HLTAK-----SDIYSFGVVLLEILSGR 283
DI+S GV +LE GR
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 25/215 (11%)
Query: 136 HHPNLVKLVGYCLEDDHRLL-VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
+HP LV L C + + RL V E++ G + H+ R+ + + +I+L
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA---- 108
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG-PTGDKSHVSTRVMGTYGYA 253
L +LH E +IYRD K N+LLDS + KL+D+G+ ++G GD ++ GT Y
Sbjct: 109 LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 163
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313
APE L D ++ GV++ E+++GR D G + P ++ +F+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI---VGSSD-----NPDQNTEDYLFQ 215
Query: 314 VLDPRLEGQFSLPQAQ--KAASLALQCLSVEPKLR 346
V+ LE Q +P++ KAAS+ L+ +PK R
Sbjct: 216 VI---LEKQIRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
+G G +G V+K A TG L+A+K + E + EI+ L + H
Sbjct: 9 QRIGSGTYGDVYK--------ARDIA-TGELVAIKVIKLEPGDDFEIIQQEISMLKECRH 59
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMEN--HLFRRGSYFQPLSWSLRMKIALGAANGL 195
PN+V G L D +V E+ GS+++ + R PLS + GL
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGL 114
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR--VMGTYGYA 253
A+LH I+RD K +NILL + + KL+DFG++ + ++ R +GT +
Sbjct: 115 AYLHET--GKIHRDIKGANILLTEDGDVKLADFGVS----AQLTATIAKRKSFIGTPYWM 168
Query: 254 APEYLA---TGHLTAKSDIYSFGVVLLE 278
APE A G K DI++ G+ +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 7e-15
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQLHHP 138
LG G FG V KG + + + + +A+K L E + E + E + QL +P
Sbjct: 3 LGSGNFGCVKKG---VYKMRKKQ----IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
+V+++G C E + +LV E G + L ++ S +++ + G+ +L
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY--GYAAPE 256
++RD A N+LL + + AK+SDFGL++ D S+ R G + + APE
Sbjct: 112 E--GKNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPE 168
Query: 257 YLATGHLTAKSDIYSFGVVLLEILS 281
+ +++SD++S+G+ + E S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW-LTEINY 131
NF+ LGEG + +V+KG TG ++A+K ++ + +G + EI+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWSLRMKIA 188
+ +L H N+V+L ++ +LV+E+M + M+ H R L +
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRG-----ALDPNTVKSFT 106
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG--PTGDKSHVSTRV 246
G+AF H E +V++RD K N+L++ KL+DFGLAR P + S V
Sbjct: 107 YQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEV 161
Query: 247 MGTYGYAAPEYLATGHLTAKS-DIYSFGVVLLEILSGR 283
+ T Y AP+ L + S DI+S G ++ E+++GR
Sbjct: 162 V-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-15
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLG-Q 134
+LG+G FG VF LA + GT A+K L ++ + + E L
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 135 LHHPNLVKLVGYCL--EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
HP L L YC ++ V E++ G + H+ + P + +I G
Sbjct: 53 WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG-- 108
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
L FLHS ++YRD K NILLD++ + K++DFG+ ++ GD + GT Y
Sbjct: 109 --LQFLHSK--GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
APE L D +SFGV+L E+L G+
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 77/287 (26%), Positives = 129/287 (44%), Gaps = 51/287 (17%)
Query: 80 LGEGGFGSVFKG-WVDEHSLA--STRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH 136
LG G FG V+ G W +A + +PGT ++ E F L E + +L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT--------MSPESF------LEEAQIMKKLR 59
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
H LV+L + ++ +V E+M +GS+ + F + + L + +A A G+A
Sbjct: 60 HDKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY--GYAA 254
++ I+RD +++NIL+ K++DFGLAR + + + R + + A
Sbjct: 117 YIERM--NYIHRDLRSANILVGDGLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTA 171
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314
PE G T KSD++SFG++L E+++ R PY R V
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRV-----------------PYPGMNNR--EV 212
Query: 315 LDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELE 357
L+ ++E + +P Q L LQC +P+ RP + + LE
Sbjct: 213 LE-QVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-15
Identities = 78/280 (27%), Positives = 122/280 (43%), Gaps = 41/280 (14%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEIN 130
FR VLG+GGFG V A TG + A K+L ++ + G L E
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 131 YLGQLHHPNLVKLVGYCLE-DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L +++ +V L Y E D LV M G ++ H++ G+ +
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----EERAVF 106
Query: 190 GAAN---GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
AA GL LH +++YRD K NILLD + ++SD GLA + P G+ + RV
Sbjct: 107 YAAEITCGLEDLHRE--RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV 162
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306
GT GY APE + T D + G ++ E++ G+ + + + VE
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE------- 214
Query: 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR 346
RR+ + ++S ++ A S+ Q L+ +P R
Sbjct: 215 --RRVKED-----QEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINY 131
+F S LG G G VFK S +P +G+++A K ++ E + + E+
Sbjct: 6 DFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQIIRELQV 56
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
L + + P +V G D + E M GS++ L + G + + K+++
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAV 112
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
GL +L K+++RD K SNIL++S KL DFG++ G D ++ +GT
Sbjct: 113 IKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRS 167
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAI 286
Y +PE L H + +SDI+S G+ L+E+ GR I
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 9e-15
Identities = 66/247 (26%), Positives = 106/247 (42%), Gaps = 55/247 (22%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLTEINYLG 133
+GEG +G V+K D+ TG L+A+K++ +EGF + EI L
Sbjct: 13 GQIGEGTYGQVYKA-RDKD--------TGELVALKKVRLDNEKEGFP--ITAIREIKILR 61
Query: 134 QLHHPNLVKLVGYCLEDDHRL----------LVYEFMPRGSM-----------ENHLFRR 172
QL+H N+V L + L LV+E+M M E+H+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI--- 118
Query: 173 GSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232
S+ + L GL + H + ++RD K SNILL++ KL+DFGLAR
Sbjct: 119 KSFMKQL------------LEGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291
+ + + +V+ T Y PE L D++S G +L E+ + + N+
Sbjct: 165 LYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
Query: 292 TGEHNLV 298
+ L+
Sbjct: 224 LAQLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 78/307 (25%), Positives = 118/307 (38%), Gaps = 77/307 (25%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL--NQEGFQGHKEWLTEINYLGQLH 136
++GEG +G V K E TG ++A+K+ +++ K + EI L QL
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMEN-HLFRRGSYFQPLSWSLRMKIALGAANGL 195
H NLV L+ LV+EF+ +++ + G L S K G+
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGI 113
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGPTGDKSHVSTRVMGTYGYA 253
F HS +I+RD K NIL+ + KL DFG AR P V T + T Y
Sbjct: 114 EFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP----GEVYTDYVATRWYR 167
Query: 254 APEYLATGHLTAKS-DIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR--- 309
APE L ++ DI++ G ++ E+L+G +P
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTG-------------------EPLFPGDSDID 208
Query: 310 ------RIFRVLDPRLEGQFS---------LPQAQK--------------AASLALQCLS 340
+ L PR + F LP+ ++ LA QCL
Sbjct: 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLR 268
Query: 341 VEPKLRP 347
++P RP
Sbjct: 269 IDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 35/223 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-----NQEGFQGHKEWLT 127
N+R +LG G FG V+ + + TG +AVK++ +QE +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 128 EINYLGQLHHPNLVKLVGYCLED--DHRLLVY-EFMPRGSMENHLFRRGSYFQPLSWSLR 184
EI L L H +V+ G CL D + +L ++ E+MP GS+++ L G+ + ++
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT 112
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD------GPTGD 238
+I G+++LHS +++RD K +NIL DS N KL DFG ++ TG
Sbjct: 113 RQIL----QGVSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 239 KSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
KS V GT + +PE ++ K+D++S ++E+L+
Sbjct: 167 KS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLG-Q 134
VLG+G FG V LA + GT A+K L ++ + + E L
Sbjct: 2 VLGKGSFGKVM--------LAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA 52
Query: 135 LHHPNLVKLVGYCL--EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
HP L L +C +H V E++ G + H+ G + + + +I
Sbjct: 53 WEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIIC--- 107
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
GL FLH +IYRD K N+LLD + + K++DFG+ ++ G+ ++ GT Y
Sbjct: 108 -GLQFLHKK--GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
APE L D +SFGV+L E+L G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 72/280 (25%), Positives = 131/280 (46%), Gaps = 41/280 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHH 137
+LG G G+V+K + T ++AVK + + + K+ ++E+ L +
Sbjct: 8 ILGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
P ++ G ++ + EFM GS++ ++R+ + + +IA+ GL +
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLD--VYRK------IPEHVLGRIAVAVVKGLTY 110
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEY 257
L S K+++RD K SN+L+++ KL DFG++ T + ++ +GT Y APE
Sbjct: 111 LWSL--KILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPER 164
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGR---RAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314
++ SD++S G+ +E+ GR I KN+ + L+ L + I
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS----LMP-----LQLLQCIVDE 215
Query: 315 LDPRL-EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVV 353
P L GQFS +K QC+ +PK RP + ++
Sbjct: 216 DPPVLPVGQFS----EKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 69/296 (23%), Positives = 128/296 (43%), Gaps = 40/296 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKG--WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEIN 130
NF+ + +G G F V++ +D +A L V+ + ++ + EI+
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVA--------LKKVQIFEMMDAKARQDCVKEID 54
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL--FRRGSYFQPLSWSLRMKIA 188
L QL+HPN++K + +ED+ +V E G + + F++ P + +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
L +A + +HS +V++RD K +N+ + + KL D GL R + K+ + ++G
Sbjct: 115 LCSA--VEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVG 168
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308
T Y +PE + KSDI+S G +L E + P+ K
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDK 210
Query: 309 RRIFRVLDPRLEGQF-SLPQ---AQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
+F + + + LP ++K L C+ +P RPD+ V + +Q+
Sbjct: 211 MNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
VLG+G +G V+ A+ T + IA+K + + + + EI L H
Sbjct: 15 VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA--NGLA 196
N+V+ +G E+ + E +P GS+ L R S + PL + + I GL
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLR--SKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNA--KLSDFG----LARDGPTGDKSHVSTRVMGTY 250
+LH + ++++RD K N+L+++ Y+ K+SDFG LA P + GT
Sbjct: 123 YLH--DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTL 173
Query: 251 GYAAPEYLATGH--LTAKSDIYSFGVVLLEILSGR 283
Y APE + G A +DI+S G ++E+ +G+
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 81/289 (28%), Positives = 123/289 (42%), Gaps = 51/289 (17%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN-QEGFQGHKEWLTEINY-LGQLHH 137
LG G +G V K TG ++AVKR+ Q K L +++ + +
Sbjct: 9 LGRGAYGVVDK---------MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 138 PNLVKLVGYCL-EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM------KIALG 190
P V G E D V+ M M+ L + Y + L + KIA+
Sbjct: 60 PYTVTFYGALFREGD----VWICME--VMDTSLDK--FYKKVYDKGLTIPEDILGKIAVS 111
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
L +LHS + VI+RD K SN+L++ N KL DFG++ G D S T G
Sbjct: 112 IVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVD-SVAKTIDAGCK 167
Query: 251 GYAAPEY----LATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306
Y APE L KSD++S G+ ++E+ +GR D W P+
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTPFQQ 216
Query: 307 SKRRIFRVLDPRL-EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
K ++ P+L +FS P+ Q + +CL K RP+ E+++
Sbjct: 217 LK-QVVEEPSPQLPAEKFS-PEFQDFVN---KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 81/324 (25%), Positives = 132/324 (40%), Gaps = 65/324 (20%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL------NQEGFQGHKEWL 126
NF VLG G +G VF T TG L A+K L + H
Sbjct: 1 NFELLKVLGTGAYGKVFL------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 127 TEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
TE N L + + + Y + + +L L+ +++ G M HL++R ++ + +
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-----EV 107
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
+ G LA H + ++YRD K NILLDS + L+DFGL+++ + +K +
Sbjct: 108 RFYSGEII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS- 165
Query: 246 VMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303
GT Y APE + GH A D +S G+++ E+L+G A P
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTG------------------ASP 206
Query: 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363
+ LEG + + ++ + L +P + ++L +
Sbjct: 207 F-------------TLEG-----ERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRK 248
Query: 364 NMHKR----PQKEHQAKGHVHFKG 383
+ KR PQ + K H FKG
Sbjct: 249 DPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW-LTEINYLGQLH 136
+L EG FG +F G +DE +PG + VK + + L E L L
Sbjct: 13 LLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 137 HPNLVKLVGYCLED-DHRLLVYEFMPRGSMENHL--FRRGSYFQPLSWSLR--MKIALGA 191
H N++ ++ C+ED + ++Y +M G+++ L R G P + S + + +A+
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPT-----GDKSHVSTR 245
A G+++LH VI++D A N ++D K++D L+RD P GD + +
Sbjct: 127 ACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
M A E L ++ SD++SFGV+L E+++
Sbjct: 185 WM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 69/235 (29%), Positives = 101/235 (42%), Gaps = 49/235 (20%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
+ P +G G +G V ++ T +A+K++ F K L
Sbjct: 4 DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLR 53
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHR------LLVYEFMPRGSMENHLFRRGSYFQPLSW 181
EI L L H N++ + + HR +VYE M + H R S Q LS
Sbjct: 54 EIKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSS--QTLSD 107
Query: 182 S---------LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232
LR GL ++HSA V++RD K SN+LL++N + K+ DFGLAR
Sbjct: 108 DHCQYFLYQLLR---------GLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLAR 156
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGRRAI 286
T +K T + T Y APE L T D++S G + E+L GR+ +
Sbjct: 157 --TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 79/281 (28%), Positives = 120/281 (42%), Gaps = 43/281 (15%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEIN 130
FR VLG+GGFG V A TG + A K+L ++ + G L E
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKR 52
Query: 131 YLGQLHHPNLVKLVGYCLE-DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L +++ +V L Y E D LV M G ++ H++ G+ + A
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAA 109
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
GL L +++YRD K NILLD + ++SD GLA P G+ V RV GT
Sbjct: 110 ELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GT 164
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
GY APE + T D + G ++ E++ G+ P+ K
Sbjct: 165 VGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ------------------SPFRKRKE 206
Query: 310 RIFR-VLDPRL---EGQFSLPQAQKAASLALQCLSVEPKLR 346
R+ R +D R+ + ++S ++ A S+ L+ PK R
Sbjct: 207 RVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 40/218 (18%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEWLTEINYLGQLHH 137
+GEG +G V+K D T IA+K RL QE + EI+ L ++ H
Sbjct: 10 IGEGTYGVVYKA-RDRV--------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMP---RGSME-------NHLFRRGSYFQPLSWSLRMKI 187
N+V+L + LV+E++ + M+ N + +Q L
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILR------- 113
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA-KLSDFGLARDGPTGDKSHVSTRV 246
G+A+ HS +V++RD K N+L+D NA KL+DFGLAR G T
Sbjct: 114 ------GIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHE 163
Query: 247 MGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGR 283
+ T Y APE L + H + DI+S G + E+++ +
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEIN-YLGQ 134
V+G+G FG V L + R G AVK L ++ KE + E N L
Sbjct: 2 VIGKGSFGKV---------LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 135 LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI-ALGAA 192
L HP LV L Y + +L V +++ G + HL R + +P R + A A
Sbjct: 53 LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVA 106
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
+ + +LHS +IYRD K NILLDS + L+DFGL ++G + ++ GT Y
Sbjct: 107 SAIGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEY 162
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
APE L D + G VL E+L G
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 65/211 (30%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLG-Q 134
VLG+G FG V L + G G AVK L ++ + + E L
Sbjct: 2 VLGKGSFGKV---------LLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA-- 192
+P L L +H V EF+ G + H+ +G + L A
Sbjct: 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF------DLYRATFYAAEIV 106
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
GL FLHS +IYRD K N++LD + + K++DFG+ ++ GD ++ GT Y
Sbjct: 107 CGLQFLHSK--GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
APE L T D +SFGV+L E+L G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPG--TGMLIAVKRLNQEGF-QGHK---EWL 126
NF VLG G +G VF L G G L A+K L + Q K
Sbjct: 1 NFELLRVLGTGAYGKVF--------LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR 52
Query: 127 TEINYLGQLHH-PNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLR 184
TE L + P LV L Y + D +L L+ +++ G + HL++R + + +R
Sbjct: 53 TERQVLEAVRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVR 108
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD--GPTGDKSHV 242
+ IA LA H + +IYRD K NILLDS + L+DFGL+++ ++++
Sbjct: 109 VYIAEIV---LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY- 164
Query: 243 STRVMGTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSG 282
GT Y APE + GH A D +S GV+ E+L+G
Sbjct: 165 --SFCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLG-Q 134
VLG+G FG V + + GT + A+K L ++ + +TE L
Sbjct: 2 VLGKGSFGKV---------MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52
Query: 135 LHHPNLVKLVGYCLEDDHRLL-VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
HP L L C + RL V E++ G + + R + +P S ++ L
Sbjct: 53 AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--- 108
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
L FLH VIYRD K NILLD+ + KL+DFG+ ++G +T GT Y
Sbjct: 109 -LMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYI 163
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGR 283
APE L D ++ GV++ E+++G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQL 135
+LG+G FG V + +G A+K L +E E LTE L
Sbjct: 2 LLGKGTFGKV---------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
HP L L Y + RL V E++ G + HL R + + + +I +
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV----SA 107
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
L +LHS K++YRD K N++LD + + K++DFGL ++G T D + + T GT Y A
Sbjct: 108 LDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKT-FCGTPEYLA 163
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGR 283
PE L D + GVV+ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 34/211 (16%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL-TEINYLGQLHHP 138
+G+G G+V+ + TG +A+K++N + Q KE + EI + + HP
Sbjct: 27 IGQGASGTVY---------TAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHP 76
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA------ 192
N+V + L D +V E++ GS+ + + M AA
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECL 125
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL-ARDGPTGDKSHVSTRVMGTYG 251
L FLHS + VI+RD K+ NILL + + KL+DFG A+ P ++S ST V GT
Sbjct: 126 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPY 180
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
+ APE + K DI+S G++ +E++ G
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQL 135
+LG+G FG V V E + TG A+K L +E E +TE L
Sbjct: 2 LLGKGTFGKVI--LVREKA-------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
HP L L Y + RL V E+ G + HL R + + + +I +
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV----SA 107
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
L +LHS + V+YRD K N++LD + + K++DFGL ++G + D + + T GT Y A
Sbjct: 108 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLA 163
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGR 283
PE L D + GVV+ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--H-KEWLTEIN 130
++ S +G G +G V A TG +A+K+L++ FQ H K E+
Sbjct: 17 YQNLSPVGSGAYGQVCS--------AFDT-KTGRKVAIKKLSRP-FQSAIHAKRTYRELR 66
Query: 131 YLGQLHHPNLVKLVGYCLEDDHR------LLVYEFMPRGSMENHLFRRGSYFQPLSWSLR 184
L + H N++ L+ LV M G+ N++ + Q LS
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKC----QKLSDDHI 120
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR---DGPTGDKSH 241
+ GL ++HSA +I+RD K SNI ++ + K+ DFGLAR D TG +
Sbjct: 121 QFLVYQILRGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG---Y 175
Query: 242 VSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGR 283
V+TR Y APE L H DI+S G ++ E+L+G+
Sbjct: 176 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 62/197 (31%), Positives = 90/197 (45%), Gaps = 39/197 (19%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLTEINYLGQL 135
+G+G FG VFK A + T ++A+K++ +EGF L EI L L
Sbjct: 20 IGQGTFGEVFK--------ARHKK-TKQIVALKKVLMENEKEGFPITA--LREIKILQLL 68
Query: 136 HHPNLVKLVGYC-----LEDDHR---LLVYEFMPRGSMENHLFRRGSY----FQPLSWSL 183
H N+V L+ C + ++ LV+EF E+ L S F
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKK 123
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGPTGDKSH 241
MK+ L NGL ++H K+++RD KA+NIL+ + KL+DFGLAR K +
Sbjct: 124 VMKMLL---NGLYYIHRN--KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178
Query: 242 VSTRVMGTYGYAAPEYL 258
T + T Y PE L
Sbjct: 179 RYTNRVVTLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 26/226 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTE---INYL 132
++G GGFG V+ + TG + A+K L+++ QG L E ++ +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
P +V + D + + M G + HL + G + + +I LG
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG-- 109
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
L +H+ V+YRD K +NILLD + + ++SD GLA D + K H S +GT+GY
Sbjct: 110 --LEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGY 161
Query: 253 AAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297
APE L G + +D +S G +L ++L G +++ +H +
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
HP LV L C + + RL V EF+ G + H+ R+ + + +I+L L
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 109
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG-PTGDKSHVSTRVMGTYGYAA 254
FLH E +IYRD K N+LLD+ + KL+D+G+ ++G GD ++ GT Y A
Sbjct: 110 NFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIA 164
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAID--KNRPTGEHNLVEWAKPYLTSKRRIF 312
PE L D ++ GV++ E+++GR D + N + YL F
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN----TEDYL------F 214
Query: 313 RVLDPRLEGQFSLPQAQ--KAASLALQCLSVEPKLR 346
+V+ LE Q +P++ KA+S+ L+ +PK R
Sbjct: 215 QVI---LEKQIRIPRSLSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 67/287 (23%), Positives = 127/287 (44%), Gaps = 41/287 (14%)
Query: 80 LGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
LG+G F +++KG + L PG + + +K L + + + + + QL H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHK 61
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
+LVKL G C+ D++ ++V E++ G ++ L R + +S ++ +A A+ L +L
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYL 117
Query: 199 HSAEPKVIYRDFKASNILL-----DSNYN--AKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
+ K+++ + NIL+ + Y KLSD G+ + R+
Sbjct: 118 E--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 252 YAAPEYLATGH--LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
+ APE + G LT +D +SFG LLEI S + L++
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICS------------------NGEEPLSTLS 211
Query: 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
+ + + + +P + A+L QC + +P RP ++++L
Sbjct: 212 SSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 66/287 (22%), Positives = 124/287 (43%), Gaps = 38/287 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
NFR + +G G F V++ + + + L V+ + + + + EI+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVA-------LKKVQIFDLMDAKARADCIKEIDL 55
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL--FRRGSYFQPLSWSLRMKIAL 189
L QL+HPN++K +ED+ +V E G + + F++ P + + L
Sbjct: 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
+A L +HS +V++RD K +N+ + + KL D GL R + K+ + ++GT
Sbjct: 116 CSA--LEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 169
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
Y +PE + KSDI+S G +L E + P+ K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKM 211
Query: 310 RIFRVLDPRLEGQF-SLPQ---AQKAASLALQCLSVEPKLRPDMDEV 352
++ + + + LP +++ L C++ +P+ RPD+ V
Sbjct: 212 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 47/273 (17%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQLH 136
LG G FG V +A + GTG A+K L + K+ E + L +L
Sbjct: 26 LGTGSFGRV--------RIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
HP +V ++ +++ + EF+ G + HL + G + ++ ++ L
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FE 132
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+LHS + +IYRD K N+LLD+ + K++DFG A+ P D++ + GT Y APE
Sbjct: 133 YLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAPE 185
Query: 257 YLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315
+ + GH A D ++ GV+L E ++G + P FR+
Sbjct: 186 VIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTP--------------------FRIY 224
Query: 316 DPRLEGQFSLPQ--AQKAASLALQCLSVEPKLR 346
+ L G+ P +A L L + R
Sbjct: 225 EKILAGRLKFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 2e-13
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
+G+G G+VF + TG +A+K++N + + + EI + +L +PN
Sbjct: 27 IGQGASGTVF---------TAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH 199
+V + L D +V E++ GS+ + + + + + L FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLH 132
Query: 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA 259
+ + VI+RD K+ N+LL + + KL+DFG T ++S ST V GT + APE +
Sbjct: 133 ANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 260 TGHLTAKSDIYSFGVVLLEILSG 282
K DI+S G++ +E++ G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 88/335 (26%), Positives = 131/335 (39%), Gaps = 87/335 (25%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKR----LNQEGFQGHKEWLTEINYLGQL 135
+GEG +G+V+K TG +A+K+ L++EG L EI L QL
Sbjct: 7 IGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQL 55
Query: 136 ---HHPNLVKLVGYCL--EDDHRL---LVYEFM-----------PRGSMENHLFRRGSYF 176
HPN+V+L+ C D L LV+E + P+ + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD---- 111
Query: 177 QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236
L L G+ FLHS ++++RD K NIL+ S+ K++DFGLAR
Sbjct: 112 --LMRQL--------LRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLAR---I 156
Query: 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296
T V+ T Y APE L D++S G + E L RR + R T E +
Sbjct: 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE-LFRRRPL--FRGTSEAD 213
Query: 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQ---KAASLALQCLSVEPKLRPDMDEVV 353
++ +IF V+ LP + + SL V
Sbjct: 214 QLD----------KIFDVI--------GLPSEEEWPRNVSLPRSSFP--SYTPRSFKSFV 253
Query: 354 KELEQ--LQELRNM-----HKRPQKEHQAKGHVHF 381
E+ + L L+ M HKR +A H +F
Sbjct: 254 PEICEEGLDLLKKMLTFNPHKRISAF-EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 58/186 (31%), Positives = 85/186 (45%), Gaps = 23/186 (12%)
Query: 105 TGMLIAVKRLNQEGFQG---HKEWLTEINYLGQLHHPNLVKLVGYC---LEDDHRLLVYE 158
TG +A+K++ + F K E+ L L H N++ L LED + V E
Sbjct: 34 TGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY--FVTE 90
Query: 159 FMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218
+ G+ + L PL GL ++HSA V++RD K SNIL++
Sbjct: 91 LL--GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA--GVVHRDLKPSNILIN 142
Query: 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH-LTAKSDIYSFGVVLL 277
N + K+ DFGLAR +VSTR Y APE + T + DI+S G +
Sbjct: 143 ENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFA 197
Query: 278 EILSGR 283
E+L G+
Sbjct: 198 EMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 40/107 (37%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
GL +LHSA +++RD K N+L++SN K+ DFGLAR + H++ V+ Y Y
Sbjct: 115 GLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 254 APEYLATG--HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298
APE L G H T+ DI+S G + E+L R P + +L+
Sbjct: 172 APEIL-MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 67/254 (26%), Positives = 112/254 (44%), Gaps = 37/254 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL 135
++G GGFG V+ + TG + A+K L+++ QG L E L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 136 HHPN--LVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+ + + Y +L + + M G + HL + G + + +I LG
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG-- 109
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
L +H+ V+YRD K +NILLD + + ++SD GLA D + K H S +GT+GY
Sbjct: 110 --LEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGY 161
Query: 253 AAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311
APE L G + +D +S G +L ++L G +++ +H + R+
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------DRM 210
Query: 312 FRVLDPRLEGQFSL 325
+ L FS
Sbjct: 211 TLTMAVELPDSFSP 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL---NQEGFQGHKEWLTEINYLGQLH 136
+G G FG+V K +G ++AVKR+ E Q K L +++ + +
Sbjct: 12 IGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQ--KRLLMDLDVVMRSS 60
Query: 137 H-PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR--GSYFQPLSWSLRMKIALGAAN 193
P +VK G + + E M S++ ++ + + KIA+
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDI-SLDK-FYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
L +L E K+I+RD K SNILLD N N KL DFG++ G D S TR G Y
Sbjct: 119 ALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVD-SIAKTRDAGCRPYM 174
Query: 254 APEYLATGHLTA---KSDIYSFGVVLLEILSGR 283
APE + +SD++S G+ L E+ +G+
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQL 135
+LG+G FG V + TG A+K L +E E LTE L
Sbjct: 2 LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
HP L L Y + RL V E+ G + HL R + + + +I +
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----SA 107
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
L +LH +E V+YRD K N++LD + + K++DFGL ++G D + + T GT Y A
Sbjct: 108 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLA 164
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGR 283
PE L D + GVV+ E++ GR
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
+P LV L C + RL LV E++ G + H+ R+ + + +I + L
Sbjct: 55 NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----L 109
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG-PTGDKSHVSTRVMGTYGYAA 254
FLH E +IYRD K N+LLD++ + KL+D+G+ ++G GD ++ GT Y A
Sbjct: 110 NFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIA 164
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314
PE L D ++ GV++ E+++GR D + P + ++ +F+V
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD----------IITDNPDMNTEDYLFQV 214
Query: 315 LDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLR 346
+ LE +P+ + KA+ + L+ +PK R
Sbjct: 215 I---LEKPIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 94/370 (25%), Positives = 141/370 (38%), Gaps = 108/370 (29%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ--EGFQGHKEWLTEINY 131
++ V+G+G +G V +D H TG +A+K++N E L EI
Sbjct: 2 YKIQEVIGKGSYGVVCSA-IDTH--------TGEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 132 LGQLHHPNLVKLVGYCLEDDHR-----LLVYEFMPRG-----------SMENHLFRRGSY 175
L L HP++V++ L R +V+E M + E+H F
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF---FL 109
Query: 176 FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--- 232
+Q L L ++H+A V +RD K NIL +++ K+ DFGLAR
Sbjct: 110 YQLL-------------RALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAF 154
Query: 233 -DGPTGD--KSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGRRAID 287
D PT +V+TR Y APE + T DI+S G + E+L+G+
Sbjct: 155 NDTPTAIFWTDYVATR-----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209
Query: 288 KNRPTGEHNLV-----------------EWAKPYLTSKRRIFRVLDPRLEGQFS--LPQA 328
+ +L+ E A+ YL+S R + FS P A
Sbjct: 210 GKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMR-------KKQPVPFSQKFPNA 262
Query: 329 QKAASLALQ-CLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQKEHQAKGHVHFKGRATT 387
A L+ L+ +PK RP +E A +FKG A
Sbjct: 263 DPLALRLLERLLAFDPKDRPTAEE-----------------------ALADPYFKGLAKV 299
Query: 388 YPRPSASPLR 397
PSA P+
Sbjct: 300 EREPSAQPIT 309
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINY 131
+F S LG G G V K +P +G+++A K ++ E + + E+
Sbjct: 6 DFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQIIRELQV 56
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
L + + P +V G D + E M GS++ L + + + K+++
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAV 112
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
GLA+L ++++RD K SNIL++S KL DFG++ G D ++ +GT
Sbjct: 113 LRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRS 167
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAI 286
Y +PE L H + +SDI+S G+ L+E+ GR I
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 51/255 (20%)
Query: 53 ILQSSNIKNF---------SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRP 103
+ ++ NI NF + LR +F V+G G FG V + H +
Sbjct: 15 LRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHKSSKQ-- 69
Query: 104 GTGMLIAVKRLNQEGFQGHKE------WLTEINYLGQLHHPNLVKLVGYCLEDDHRL-LV 156
+ A+K L++ F+ K W E + + + +V+L Y +DD L +V
Sbjct: 70 ----VYAMKLLSK--FEMIKRSDSAFFW-EERDIMAHANSEWIVQLH-YAFQDDKYLYMV 121
Query: 157 YEFMPRGSMENHLFRRGSYFQPLSWS----LRMKIALGAANGLAFLHSAEPKVIYRDFKA 212
E+MP G + N + +Y P W+ + +AL A + + F+H RD K
Sbjct: 122 MEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKP 170
Query: 213 SNILLDSNYNAKLSDFGLA-RDGPTGDKSHVSTRVMGTYGYAAPEYLAT----GHLTAKS 267
N+LLD + + KL+DFG + G T V GT Y +PE L + G+ +
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228
Query: 268 DIYSFGVVLLEILSG 282
D +S GV L E+L G
Sbjct: 229 DWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 43/247 (17%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
+GEG G V +T TG +AVK+++ Q + E+ + HH N
Sbjct: 30 IGEGSTGIV---------CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH 199
+V + L D +V EF+ G++ + + + ++ + L L++LH
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH 135
Query: 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV------MGTYGYA 253
+ VI+RD K+ +ILL S+ KLSDFG + VS V +GT +
Sbjct: 136 NQ--GVIHRDIKSDSILLTSDGRIKLSDFGFC--------AQVSKEVPKRKSLVGTPYWM 185
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313
APE ++ + DI+S G++++E++ G + +P L + RRI
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY-------------FNEPPLQAMRRIRD 232
Query: 314 VLDPRLE 320
L PR++
Sbjct: 233 NLPPRVK 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 76/289 (26%), Positives = 121/289 (41%), Gaps = 62/289 (21%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKR----LNQEGFQGHKEWLTEINYLGQL 135
LG+G +GSV+K RP TG+ +A+K L++ F + E++ L +
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLELDESKFNQ---IIMELDILHKA 56
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
P +V G + + E+M GS++ L+ G + + + +I GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHVSTRVMGTYGYA 253
FL E +I+RD K +N+L++ N KL DFG+ +G+ S T + G Y
Sbjct: 116 KFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNI-GCQSYM 168
Query: 254 APEYLATGHLTA------KSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY-LT 306
APE + +G +SD++S G+ +LE+ GR PY
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY------------------PYPPE 210
Query: 307 SKRRIFRVLD-------PRLEGQFSLPQAQKAASLALQCLSVEPKLRPD 348
+ IF L P L +S AQ + CL+ P RP
Sbjct: 211 TYANIFAQLSAIVDGDPPTLPSGYS-DDAQDFVAK---CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPG--TGMLIAVKRLNQ----EGFQGHKEWL 126
NF VLG G +G VF L G +G L A+K L + + + +
Sbjct: 1 NFELLKVLGTGAYGKVF--------LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR 52
Query: 127 TEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
TE L + + + Y + D +L L+ +++ G + HL +R + + +
Sbjct: 53 TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EV 107
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
+I G LA H + +IYRD K NILLDSN + L+DFGL+++ D+ +
Sbjct: 108 QIYSGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYS 165
Query: 246 VMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSG 282
GT Y AP+ + GH A D +S GV++ E+L+G
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 59/238 (24%), Positives = 94/238 (39%), Gaps = 56/238 (23%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEI 129
++P +G G +G V + +G +A+K++ F K L E+
Sbjct: 6 RYKPIENIGSGAYGVVCS---------AIDTRSGKKVAIKKIPH-AFDVPTLAKRTLREL 55
Query: 130 NYLGQLHHPNLVKLVGYCLED---------DHRLLVYEFM---------PRGSMENHLFR 171
L H N++ + D +V + M + R
Sbjct: 56 KILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIR 110
Query: 172 RGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
YF L LR GL ++HSA VI+RD K SN+L++ + ++ DFG+A
Sbjct: 111 ---YF--LYQLLR---------GLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMA 154
Query: 232 RDGPTGDKSH--VSTRVMGTYGYAAPEYLATGH-LTAKSDIYSFGVVLLEILSGRRAI 286
R + H T + T Y APE L + T D++S G + E+L GRR +
Sbjct: 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHH- 137
+G G G V+K TG ++AVK++ + G + +K L +++ + + H
Sbjct: 23 IGSGTCGQVYK---------MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDC 73
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
P +VK GY + D + E M + + L +R P+ + K+ + L +
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM--STCLDKLLKR--IQGPIPEDILGKMTVAIVKALHY 129
Query: 198 L---HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
L H VI+RD K SNILLD++ N KL DFG++ G D S TR G Y A
Sbjct: 130 LKEKHG----VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMA 182
Query: 255 PEYL----ATGHLTAKSDIYSFGVVLLEILSGR 283
PE + ++D++S G+ L+E+ +G+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 81/318 (25%), Positives = 124/318 (38%), Gaps = 55/318 (17%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLT 127
+ + + +GEG +G VFK A G +A+KR+ +EG +
Sbjct: 1 QQYECVAEIGEGAYGKVFK--------ARDLKNGGRFVALKRVRVQTGEEGMP--LSTIR 50
Query: 128 EINYLGQLH---HPNLVKLVGYCL-----EDDHRLLVYEFMPRGSMENHLFRRGSYFQPL 179
E+ L L HPN+V+L C + LV+E + + + +L + P
Sbjct: 51 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 109
Query: 180 SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDK 239
M L GL FLHS +V++RD K NIL+ S+ KL+DFGLAR
Sbjct: 110 ETIKDMMFQL--LRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSF 162
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299
T V+ T Y APE L D++S G + E+ + + +
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--- 219
Query: 300 WAKPYLTSKRRIFRVLD-PRLE---GQFSLPQAQKAASLALQCLSVEP--KLRPDMDEVV 353
+I V+ P E +LP+ + A +P K D+DE+
Sbjct: 220 ----------KILDVIGLPGEEDWPRDVALPRQAFHSKSA------QPIEKFVTDIDELG 263
Query: 354 KELEQLQELRNMHKRPQK 371
K+L N KR
Sbjct: 264 KDLLLKCLTFNPAKRISA 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 64/210 (30%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEIN-YLGQ 134
V+G+G FG V L + AVK L ++ KE ++E N L
Sbjct: 2 VIGKGSFGKV---------LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 52
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
+ HP LV L D V +++ G + HL R + +P + +IA +
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SA 108
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG--PTGDKSHVSTRVMGTYGY 252
L +LHS ++YRD K NILLDS + L+DFGL ++ G ++ GT Y
Sbjct: 109 LGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEY 162
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
APE L D + G VL E+L G
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-12
Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 32/230 (13%)
Query: 67 LRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL 126
LR F ++G G +G V+KG TG L A+K ++ G + +E
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTGDE-EEEIK 50
Query: 127 TEINYLGQL-HHPNLVKLVGYCLE------DDHRLLVYEFMPRGSMENHLFRRGSYFQPL 179
EIN L + HH N+ G ++ DD LV EF GS+ + + + + L
Sbjct: 51 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTL 108
Query: 180 SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGPTG 237
I GL+ LH + KVI+RD K N+LL N KL DFG++ D G
Sbjct: 109 KEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 166
Query: 238 DKSHVSTRVMGTYGYAAPEYLATGH-----LTAKSDIYSFGVVLLEILSG 282
++ +GT + APE +A KSD++S G+ +E+ G
Sbjct: 167 RRN----TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQLHH 137
+GEG FG L ++ G +K +N +E E+ L + H
Sbjct: 8 IGEGSFGKAI--------LVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL-FRRGSYF---QPLSWSLRMKIALGAAN 193
PN+V+ E+ + +V ++ G + + +RG F Q L W +++ +AL
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--- 115
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
H + K+++RD K+ NI L + KL DFG+AR ++ +GT Y
Sbjct: 116 -----HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYL 168
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287
+PE KSDI++ G VL E+ + + A +
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 8e-12
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
+G+G G+V+ + TG +A+K++N + + + EI + + +PN
Sbjct: 27 IGQGASGTVY---------TAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH 199
+V + L D +V E++ GS+ + + ++ R + L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLH 132
Query: 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA 259
S + VI+RD K+ NILL + + KL+DFG T ++S ST V GT + APE +
Sbjct: 133 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 260 TGHLTAKSDIYSFGVVLLEILSG 282
K DI+S G++ +E++ G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 21/217 (9%)
Query: 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW 125
D RT NF +GEG G V +A+ + +G L+AVK+++ Q +
Sbjct: 17 DPRTYLDNFIK---IGEGSTGIV--------CIATVK-SSGKLVAVKKMDLRKQQRRELL 64
Query: 126 LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
E+ + H N+V++ L D +V EF+ G++ + + + ++
Sbjct: 65 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----- 119
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
+ L L+ LH+ VI+RD K+ +ILL + KLSDFG +
Sbjct: 120 AVCLAVLKALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKS 175
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
++GT + APE ++ + DI+S G++++E++ G
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 71/233 (30%), Positives = 104/233 (44%), Gaps = 34/233 (14%)
Query: 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE 124
S LR F V+G G +G V+KG TG L A+K ++ + +E
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTEDE-EEE 58
Query: 125 WLTEINYLGQL-HHPNLVKLVGYCLE------DDHRLLVYEFMPRGSMENHLFR-RGSYF 176
EIN L + HH N+ G ++ DD LV EF GS+ + + +G+
Sbjct: 59 IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118
Query: 177 QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DG 234
+ W I GLA LH+ KVI+RD K N+LL N KL DFG++ D
Sbjct: 119 KE-DWI--AYICREILRGLAHLHAH--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173
Query: 235 PTGDKSHVSTRVMGTYGYAAPEYLATGH-----LTAKSDIYSFGVVLLEILSG 282
G ++ +GT + APE +A +SDI+S G+ +E+ G
Sbjct: 174 TVGRRN----TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN-QEGFQGHKEWLTEINYLGQLHH 137
V+GEG FG + + +H + + A+K + + ++ E L ++ H
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQK------YAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGS-MENHLFRRGSYFQP---LSWSLRMKIALGAAN 193
PN+V D H +V E+ G M+ +RG F L W ++M
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM-------- 109
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
L H E +V++RD K+ NI L N KL DFG AR T ++ T V GT Y
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV-GTPYYV 167
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289
PE KSDI+S G +L E+ + + N
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 95/360 (26%), Positives = 136/360 (37%), Gaps = 115/360 (31%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQL- 135
LG G FG V ++ + + T +AVK L +EG H E ++E+ L +
Sbjct: 15 LGRGAFGQV----IEADAFGIDKTATCRTVAVKML-KEG-ATHSEHRALMSELKILIHIG 68
Query: 136 HHPNLVKLVGYCLEDDHRLLV-YEFMPRGSMENHL----------------FRRGS---- 174
HH N+V L+G C + L+V EF G++ N+L FR+G
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYG 128
Query: 175 -------------------------------------------YFQPLSWSLRMKIALGA 191
Y + L+ + +
Sbjct: 129 DISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQV 188
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV---STRVMG 248
A G+ FL A K I+RD A NILL N K+ DFGLARD D +V R+
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARL-- 243
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308
+ APE + T +SD++SFGV+L EI S A PY K
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------------LGASPYPGVK 286
Query: 309 ------RRI---FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
RR+ R+ P ++ P+ + L C EP RP E+V+ L L
Sbjct: 287 IDEEFCRRLKEGTRMRAP----DYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQLH 136
LG G FG V LA+ + +A+KR + K+ +E L ++
Sbjct: 38 LGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
HP V L G ++ + LV EF+ G L R + + +I L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL------I 143
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR---VMGTYGYA 253
F + ++YRD K N+LLD + K++DFG A+ V TR + GT Y
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYI 195
Query: 254 APE-YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291
APE L GH A +D ++ G+ + EIL G N P
Sbjct: 196 APEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-11
Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
+G+G G+V+ + TG +A++++N + + + EI + + +PN
Sbjct: 28 IGQGASGTVY---------TAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH 199
+V + L D +V E++ GS+ + + ++ R + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLH 133
Query: 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGL-ARDGPTGDKSHVSTRVMGTYGYAAPEYL 258
S + VI+RD K+ NILL + + KL+DFG A+ P K + ++GT + APE +
Sbjct: 134 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVV 188
Query: 259 ATGHLTAKSDIYSFGVVLLEILSG 282
K DI+S G++ +E++ G
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINYLGQLHHP 138
LGEG + +VFKG T L+A+K + E +G + E++ L L H
Sbjct: 14 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+V L D LV+E++ + ++ ++ G+ + + + L GLA+
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYC 120
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE-Y 257
H KV++RD K N+L++ KL+DFGLAR K++ + V T Y P+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGR 283
L + + + D++ G + E+ SGR
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG------SYFQPLSW 181
EI L ++ N++K+ G+ ++ + + +PR S+ RG + LS+
Sbjct: 68 EIKNLRRIDSNNILKIYGFIID------IVDDLPRLSLILEYCTRGYLREVLDKEKDLSF 121
Query: 182 SLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH 241
++ +A+ GL L+ K Y++ + + L+ NY K+ GL + + +
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180
Query: 242 VSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGR 283
V+ V Y + + L T K DIYS GVVL EI +G+
Sbjct: 181 VNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 29/232 (12%)
Query: 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE 124
DL + + RP LG G G VF VD +AVK++ Q K
Sbjct: 1 FDLGSRYMDLRP---LGCGSNGLVFSA-VDSDC--------DKRVAVKKIVLTDPQSVKH 48
Query: 125 WLTEINYLGQLHHPNLVKLV------GYCLEDDHRLLVY---EFMPRGSMENHLFRRGSY 175
L EI + +L H N+VK+ G L +D L ++ + ME L
Sbjct: 49 ALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDL-ANVLE 107
Query: 176 FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLSDFGLAR-- 232
PLS GL ++HSA V++RD K +N+ +++ + K+ DFGLAR
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGR 283
D K ++S ++ + Y +P L+ + T D+++ G + E+L+G+
Sbjct: 166 DPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 72/257 (28%), Positives = 110/257 (42%), Gaps = 70/257 (27%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ----EGFQ-GHKEWLT 127
+F V+G G FG V L + TG + A+K+L + E Q H
Sbjct: 2 DFESIKVIGRGAFGEV--------RLVQKK-DTGHIYAMKKLRKSEMLEKEQVAHVR--A 50
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186
E + L + +P +VKL Y +D++ L L+ E++P G M L ++ ++ + + R
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---RFY 106
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTG-DKSHVST- 244
IA + +H I+RD K N+LLD+ + KLSDFGL TG KSH +
Sbjct: 107 IA-ETILAIDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGLC----TGLKKSHRTEF 159
Query: 245 ---------------------------------RVM-----GTYGYAAPE-YLATGHLTA 265
R + GT Y APE +L TG+
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NK 218
Query: 266 KSDIYSFGVVLLEILSG 282
+ D +S GV++ E+L G
Sbjct: 219 ECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHP 138
+G+G +G V+K T G L AVK L+ +E E N L L +HP
Sbjct: 30 IGKGTYGKVYK---------VTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHP 79
Query: 139 NLVKLVGYCLEDDHRL-----LVYEFMPRGSME---NHLFRRGSYFQPLSWSLRMKIALG 190
N+VK G + D + LV E GS+ L G Q L ++ I G
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG---QRLDEAMISYILYG 136
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
A GL LH+ ++I+RD K +NILL + KL DFG++ T + +T V GT
Sbjct: 137 ALLGLQHLHNN--RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ-LTSTRLRRNTSV-GTP 192
Query: 251 GYAAPEYLATGH-----LTAKSDIYSFGVVLLEILSG 282
+ APE +A A+ D++S G+ +E+ G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINYLGQLHHP 138
LGEG + +VFKG T L+A+K + E +G + E++ L L H
Sbjct: 13 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+V L + LV+E++ ++ +L G+ + + M L GL++
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYC 119
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE-Y 257
H + K+++RD K N+L++ KL+DFGLAR K++ + V T Y P+
Sbjct: 120 H--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 175
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGR 283
L + + D++ G +L E+ +GR
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 32/283 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN-QEGFQGHKEWLTEINYLGQLHHP 138
+G G FG V G V+ + + VK L Q ++L E L H
Sbjct: 3 IGNGWFGKVILGEVNS-GYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHL--FRRGSYFQPLSWSLRMKIALGAANGLA 196
NL++ +G C E LLV EF P G ++ +L R+ P +L+ ++A A GL
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLL 114
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
LH + I+ D N LL ++ K+ D+GL+ + D ++ + APE
Sbjct: 115 HLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
Query: 257 YLATGH-------LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
+ H T +S+++S GV + E+ ++P + + T +
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL-----GSQPYRHLSDEQVLT--YTVRE 225
Query: 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
+ ++ PRL+ LP + + + +Q ++P+ RP +EV
Sbjct: 226 QQLKLPKPRLK----LPLSDRWYEV-MQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 69/249 (27%), Positives = 105/249 (42%), Gaps = 43/249 (17%)
Query: 55 QSSNIKNF---------SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGT 105
++ NI NF DLR ++ V+G G FG V + H
Sbjct: 17 KNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEV---QLVRHKSTRKVYAM 73
Query: 106 GMLIA---VKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMP 161
+L +KR + F ++ + N P +V+L Y +DD L +V E+MP
Sbjct: 74 KLLSKFEMIKRSDSAFFWEERDIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMP 126
Query: 162 RGSMENHLFRRGSYFQPLSW----SLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217
G + N + +Y P W + + +AL A + + F+H RD K N+LL
Sbjct: 127 GGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLL 175
Query: 218 DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT----GHLTAKSDIYSFG 273
D + + KL+DFG T V GT Y +PE L + G+ + D +S G
Sbjct: 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 274 VVLLEILSG 282
V L E+L G
Sbjct: 235 VFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 48/156 (30%), Positives = 71/156 (45%), Gaps = 23/156 (14%)
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
LA H +I+RD K++NILL SN KL DFG ++ V GT Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314
PE + K+D++S GV+L E+L+ +R D GE+ + V
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GEN---------------MEEV 253
Query: 315 LDPRLEGQFS-LPQ--AQKAASLALQCLSVEPKLRP 347
+ L G++ LP + + + LS +PK RP
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 65/214 (30%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW--LTEINYLGQL-H 136
+GEG F V K S + TG A+K + + F+ ++ L EI L +L
Sbjct: 7 IGEGTFSEVLKA-------QSRK--TGKYYAIKCMKKH-FKSLEQVNNLREIQALRRLSP 56
Query: 137 HPNLVKLVGYCLEDDH-RL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
HPN+++L+ + RL LV+E M ++ + R M L
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLL---KS 112
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH------VSTRVMG 248
L +H + +RD K NIL+ + KL+DFG R G S +STR
Sbjct: 113 LDHMHRN--GIFHRDIKPENILIK-DDILKLADFGSCR----GIYSKPPYTEYISTR--- 162
Query: 249 TYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILS 281
Y APE L T G+ K DI++ G V EILS
Sbjct: 163 --WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQ-GHKEWLTE 128
+ P + +G G +G+V+K + P +G +A+K + N++G +
Sbjct: 2 YEPVAEIGVGAYGTVYK---------ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL 52
Query: 129 INYLGQLHHPNLVKLVGYC--LEDDHRL---LVYEFMPRGSMENHLFRRGSYFQPLSWSL 183
+ L HPN+V+L+ C D LV+E + + + +L + P ++
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE-TI 110
Query: 184 R--MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH 241
+ M+ L GL FLH+ +++RD K NIL+ S KL+DFGLAR
Sbjct: 111 KDLMRQFL---RGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQM 162
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEIL 280
T V+ T Y APE L D++S G + E+
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 50/291 (17%)
Query: 80 LGEGGFGSVFKG----WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL 135
LG+G F +FKG D L T +L R E F + + QL
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESF------FEAASMMSQL 56
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
H +LV G C+ D ++V E++ GS++ +L + + +SW L + L A L
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLI-NISWKLEVAKQLAWA--L 113
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNA--------KLSDFGLARDGPTG-DKSHVSTRV 246
FL + + + + A N+LL + KLSD G++ T K + R+
Sbjct: 114 HFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS---ITVLPKEILLERI 168
Query: 247 MGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
+ PE + +L+ +D +SFG L EI SG ++P L
Sbjct: 169 ----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLSA----------L 209
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
S++++ + + R Q P+ + A+L QC+ EP RP ++++L
Sbjct: 210 DSQKKL-QFYEDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN-QEGFQGHKEWLTEINYLGQLHHP 138
LG+G FG+V+ D+ ++A R I V LN E Q ++E L +L HP
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHP 62
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSME---NHLFRRGSYF---QPLSWSLRMKIALGAA 192
+VK LE D ++ E+ ++ L G Q W +++ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+ ++H + ++++RD KA NI L +N K+ DFG++R ++T GT Y
Sbjct: 118 -GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLATTFTGTPYY 171
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEI 279
+PE L +KSDI+S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT 127
R +F +G G +G V+K + TG L A+K + E +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYK---------ARNVNTGELAAIKVIKLEPGEDFAVVQQ 55
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
EI + H N+V G L D + EF GS+++ G PLS S +
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYV 111
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
+ GL +LHS ++RD K +NILL N + KL+DFG++ S +
Sbjct: 112 SRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FI 167
Query: 248 GTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEI 279
GT + APE A G DI++ G+ +E+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 74/268 (27%), Positives = 106/268 (39%), Gaps = 75/268 (27%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQL- 135
VLG G FG V V+ + + + +AVK L +EG HK ++E+ L +
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKML-KEGATASEHKALMSELKILIHIG 68
Query: 136 HHPNLVKLVGYCLEDDHRLLV-YEF----------------------------------- 159
+H N+V L+G C + + L+V EF
Sbjct: 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMV 128
Query: 160 -------MPRGSMENHLFRRGS----------------YFQPLSWSLRMKIALGAANGLA 196
+ LF R + PL+ + + A G+
Sbjct: 129 EQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGME 188
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV---STRVMGTYGYA 253
FL A K I+RD A NILL N K+ DFGLARD D +V S R+ +
Sbjct: 189 FL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGSARL--PLKWM 243
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILS 281
APE + T +SD++SFGV+L EI S
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTEINYLGQ 134
S +G G +GSV A+ TG+ +AVK+L++ FQ K E+ L
Sbjct: 23 SPVGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 72
Query: 135 LHHPNLVKLV-----GYCLED-DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
+ H N++ L+ LE+ + LV M G+ N++ + Q L+ +
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK----CQKLTDDHVQFLI 126
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
GL ++HSA+ +I+RD K SN+ ++ + K+ DFGLAR +V+TR
Sbjct: 127 YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 181
Query: 249 TYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGR 283
Y APE + H DI+S G ++ E+L+GR
Sbjct: 182 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 62/248 (25%), Positives = 104/248 (41%), Gaps = 52/248 (20%)
Query: 68 RTATRNFRP-DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEW 125
+ + + + LGEG +G V K + T TG ++A+K++ E +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAY-------DTL--TGKIVAIKKVKIIEISNDVTKD 54
Query: 126 -------------LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHL 169
L E+ + ++ H N++ LV +E D LV + M + ++ +
Sbjct: 55 RQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI 114
Query: 170 FRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229
L+ S I L NGL LH ++RD +NI ++S K++DFG
Sbjct: 115 R--------LTESQVKCILLQILNGLNVLHKW--YFMHRDLSPANIFINSKGICKIADFG 164
Query: 230 LAR--------DGPTGDKSHVSTRVMG----TYGYAAPEYL--ATGHLTAKSDIYSFGVV 275
LAR D + D++ M T Y APE L A + A D++S G +
Sbjct: 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCI 223
Query: 276 LLEILSGR 283
E+L+G+
Sbjct: 224 FAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 57/197 (28%), Positives = 82/197 (41%), Gaps = 33/197 (16%)
Query: 105 TGMLIAVKRLNQEGFQGHKEWLT----EINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEF 159
T L+AVK++N + KE L EI QL HPN++ V D L +V
Sbjct: 24 TNTLVAVKKINLD--SCSKEDLKLLQQEIITSRQLQHPNILPYV-TSFIVDSELYVVSPL 80
Query: 160 MPRGS----MENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215
M GS ++ H F G L+ + +K L N L ++HS I+R KAS+I
Sbjct: 81 MAYGSCEDLLKTH-FPEG--LPELAIAFILKDVL---NALDYIHSKG--FIHRSVKASHI 132
Query: 216 LLDSNYNAKLSDFGLARDGPTGDKSHV--------STRVMGTYGYAAPEYLATGHL--TA 265
LL + LS + K S + + + +PE L
Sbjct: 133 LLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQQNLQGYNE 189
Query: 266 KSDIYSFGVVLLEILSG 282
KSDIYS G+ E+ +G
Sbjct: 190 KSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQLH 136
+G+G FG V++ + T + A+K L+++ KE + E N L +
Sbjct: 1 IGKGTFGQVYQ---------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51
Query: 137 HPNLVKLVG--YCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
+VG + + D L LV ++M G + HL + G + + R K + A
Sbjct: 52 LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----RAKFYI-AEL 105
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
LA H + ++YRD K NILLD+ + L DFGL++ T +K+ + GT Y
Sbjct: 106 VLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 254 APEYL--ATGHLTAKSDIYSFGVVLLEILSG 282
APE L G+ T D +S GV++ E+ G
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 68/246 (27%), Positives = 100/246 (40%), Gaps = 51/246 (20%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTE 128
++F+ +LG+G G VF L + GTG L A+K L+++ + LTE
Sbjct: 1 KHFKKIKLLGKGDVGRVF--------LVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTE 51
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR--GSYFQPLSWSLRMK 186
L L HP L L + + LV ++ P G + L +R G R
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLS--EEVARFY 108
Query: 187 IA-LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL--------------A 231
A + A L +LH ++YRD K NILL + + LSDF L
Sbjct: 109 AAEVLLA--LEYLHLL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164
Query: 232 RDGPTGDKSH----------VSTRVM---GTYGYAAPEYLA-TGHLTAKSDIYSFGVVLL 277
R G + S R GT Y APE ++ GH + D ++ G++L
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLY 223
Query: 278 EILSGR 283
E+L G
Sbjct: 224 EMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 36/122 (29%), Positives = 60/122 (49%), Gaps = 8/122 (6%)
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
GL +LH+ ++I+RD K NI ++ + D G A+ P + + + GT
Sbjct: 169 GLRYLHAQ--RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVETN 223
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313
APE LA +K+DI+S G+VL E+L+ I ++ P+ E+ K + +I
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE---EYVKSCHSHLLKIIS 280
Query: 314 VL 315
L
Sbjct: 281 TL 282
|
Length = 357 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 39/109 (35%), Positives = 56/109 (51%), Gaps = 10/109 (9%)
Query: 177 QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236
PL ++ + A G+ FL A I+RD A N+LL AK+ DFGLARD
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD-IM 263
Query: 237 GDKSHVSTRVMGT----YGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
D ++V V G + APE + T +SD++S+G++L EI S
Sbjct: 264 NDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 40/93 (43%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV---STRVMG 248
A G+ FL A K I+RD A NILL N K+ DFGLARD D +V R+
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARL-- 237
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ APE + T +SD++SFGV+L EI S
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 51/180 (28%), Positives = 72/180 (40%), Gaps = 24/180 (13%)
Query: 127 TEINYLGQLHHPNLVKLVGYCLEDDHRL--LVYEFMPRGSMENHLFRRGSYFQPLSWSLR 184
EI+ L + H ++ L+ +R V MP+ + LF PL
Sbjct: 135 REIDILKTISHRAIINLI-----HAYRWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQA 187
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST 244
+ I LA+LH +I+RD K NI LD NA L DFG A K
Sbjct: 188 ITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAAC------KLDAHP 239
Query: 245 RVMGTYGYA------APEYLATGHLTAKSDIYSFGVVLLEILSGRRAI-DKNRPTGEHNL 297
YG++ +PE LA AK+DI+S G+VL E+ + K + L
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 20/153 (13%)
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSW----SLRMKIALGAAN 193
P +V+L +D + +V E+MP G + N + +Y P W + + +AL A +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVVLALDAIH 159
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
+ +H RD K N+LLD + + KL+DFG T V GT Y
Sbjct: 160 SMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYI 210
Query: 254 APEYLAT----GHLTAKSDIYSFGVVLLEILSG 282
+PE L + G+ + D +S GV L E+L G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 18/159 (11%)
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL--FRRGSYFQPLSWSLRMKIALGAANGL 195
PN+V L Y + +D LV + G + +H+ F W+ M +AL A
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPTGDKSHVSTRVMGTYGYAA 254
LH ++ RD +NILLD + +L+ F + + D V Y A
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293
PE T D +S G +L E+L+G + + + P+G
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 8/101 (7%)
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR---DGPTGDKSHVSTRVMGTY 250
GL ++HSA V++RD K N+L++++ K+ DFGLAR + P + + T + T
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR 173
Query: 251 GYAAPEYLATGHLTAKS-DIYSFGVVLLEILSGRRAIDKNR 290
Y APE + + K+ D++S G +L E+L GR+ + K +
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 51/160 (31%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 126 LTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSY--FQPLSWS 182
L E L Q++ P +V L + + +L LV F+ G + +HL R G + + ++
Sbjct: 41 LAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT 99
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
+ AL LH VIYRD K NILLD + L DFGL +
Sbjct: 100 AELLCALEN------LHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDK 149
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
+ GT Y APE L T D ++ GV+L E+L+G
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINYLGQLHHP 138
LGEG + +V+KG T L+A+K + E +G + E++ L L H
Sbjct: 14 LGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+V L + LV+E++ + ++ +L G+ + L + L GL +
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYC 120
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE-Y 257
H KV++RD K N+L++ KL+DFGLAR K++ + V T Y P+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGR 283
L + + + D++ G + E+ +GR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHK-EWLTEINYLGQL 135
LGEG + +V+KG + TG L+A+K RL E +G + E + L L
Sbjct: 12 KLGEGSYATVYKG-RSKL--------TGQLVALKEIRLEHE--EGAPFTAIREASLLKDL 60
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRG---SMENHLFRRGSYFQPLSWSLRMKIALGAA 192
H N+V L LV+E++ M++ G + L + L
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC----GGGLSMHNVRLFLFQLL--- 113
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
GLA+ H +V++RD K N+L+ KL+DFGLAR K++ + V T Y
Sbjct: 114 RGLAYCHQR--RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWY 169
Query: 253 AAPEYL-ATGHLTAKSDIYSFGVVLLEILSGR 283
P+ L + + D++ G + E+ +GR
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 19/239 (7%)
Query: 105 TGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGS 164
+G +AVK ++ Q + E+ + H N+V++ L + ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 165 MENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224
+ + + + L+ + L +LHS VI+RD K+ +ILL + K
Sbjct: 105 LTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ--GVIHRDIKSDSILLTLDGRVK 157
Query: 225 LSDFG----LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEIL 280
LSDFG +++D P ++GT + APE ++ + DI+S G++++E++
Sbjct: 158 LSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
Query: 281 SGRRAIDKNRP-TGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSL-PQAQKAASLALQ 337
G + P L + P L + +I VL LE + PQ + A L
Sbjct: 212 DGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 39/234 (16%)
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
L HPN+++ +G C+E LLV+E+ G ++++L + + + L ++A A G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP---------TGDKSHVSTR 245
+ +H + ++ D N L S+ K+ D+G+ GP T D V R
Sbjct: 112 VTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVPLR 166
Query: 246 VMGTYGYAAPEYLATGH---LTAK----SDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298
+ APE + H +TA+ S++++ GV L E+ +N +L
Sbjct: 167 ------WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLS 213
Query: 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
+ K + ++ P+LE LP +++ + LQ + P+ R +EV
Sbjct: 214 DREVLNHVIKDQQVKLFKPQLE----LPYSERWYEV-LQFCWLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 17/167 (10%)
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
A G++FL A I+RD A NILL K+ DFGLARD V
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311
+ APE + T +SD++S+G++L EI S + P +K Y K
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKMIKEG- 333
Query: 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358
+R+L P + + + + C +P RP ++V+ +EQ
Sbjct: 334 YRMLSP----ECAPSEMYD---IMKSCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEINYLGQLH 136
+G G +G+V S R TG +A+K+L + FQ K E+ L +
Sbjct: 23 VGSGAYGTVC-------SALDRR--TGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMK 72
Query: 137 HPNLVKLVGY-----CLEDDHRL-LVYEFMPR--GSMENHLFRRGSYFQPLSWSLRMKIA 188
H N++ L+ L+ H LV FM G + H Q L + +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM----- 127
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
GL ++H+A +I+RD K N+ ++ + K+ DFGLAR + +V TR
Sbjct: 128 ---LKGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR--- 179
Query: 249 TYGYAAPEY-LATGHLTAKSDIYSFGVVLLEILSGR 283
Y APE L H T DI+S G ++ E+L+G+
Sbjct: 180 --WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 50/271 (18%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKR------LNQEGFQGHKEW 125
++F S++G G FG V V E + TG + A+K L QE +E
Sbjct: 1 KDFDVKSLVGRGHFGEV--QVVREKA-------TGDIYAMKVMKKSVLLAQETVSFFEE- 50
Query: 126 LTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSL- 183
E + L + P + +L Y +D L LV E+ P G + + L R Y +
Sbjct: 51 --ERDILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDMA 104
Query: 184 -----RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD 238
+ +A+ + + + ++H RD K N+L+D + KL+DFG A T +
Sbjct: 105 QFYLAELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSAA-RLTAN 155
Query: 239 KSHVSTRVMGTYGYAAPEYLATGHLTAKS------DIYSFGVVLLEILSGRRAIDKNRPT 292
K S +GT Y APE L T + K D +S GV+ E++ GR P
Sbjct: 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR------SPF 209
Query: 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQF 323
E + + +R + DP++ F
Sbjct: 210 HEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 78/291 (26%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINYLGQLHHP 138
LGEG + +V+KG G L+A+K ++ + +G + E + L L H
Sbjct: 13 LGEGSYATVYKG---------ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+V L + V+E+M + ++ + P + L M L GLA++
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLL---RGLAYI 119
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL 258
H +++RD K N+L+ KL+DFGLAR +++ S V T Y P+ L
Sbjct: 120 HGQ--HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
Query: 259 --ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA--------------- 301
AT + +A DI+ G + +E+L G+ A E W
Sbjct: 176 LGATDYSSA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234
Query: 302 ----KP--YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR 346
KP +L K + RV+ RL + KA LA Q L + PK R
Sbjct: 235 LPNYKPEWFLPCKPQQLRVVWKRLS------RPPKAEDLASQMLMMFPKDR 279
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 73/318 (22%), Positives = 120/318 (37%), Gaps = 77/318 (24%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ---EGFQGHKEWLTEINYLGQLH 136
+G+GG G V+ + P +A+K++ + E K +L E L
Sbjct: 10 IGKGGMGEVYLAY---------DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMP--RGSMENHLFRRGSYFQPLSWSLRMKIALGA--- 191
HP +V + C + D VY MP G L + + LS L K ++GA
Sbjct: 61 HPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 192 -----ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD------------- 233
+ ++HS V++RD K NILL + D+G A
Sbjct: 118 IFHKICATIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 234 GPTGDKSHVST---RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS--------- 281
T +++GT Y APE L + +DIY+ GV+L ++L+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
Query: 282 GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSV 341
GR+ ++ PY R I L + +A++ L+V
Sbjct: 236 GRKISYRDVILSP----IEVAPY----REIPPFL----------------SQIAMKALAV 271
Query: 342 EPKLR-PDMDEVVKELEQ 358
+P R + E+ ++LE
Sbjct: 272 DPAERYSSVQELKQDLEP 289
|
Length = 932 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 59/239 (24%), Positives = 113/239 (47%), Gaps = 39/239 (16%)
Query: 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT 127
R+ ++++ +++G G FG V++ + T +A+K++ Q+ ++E L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDPQYKNRELLI 112
Query: 128 EINYLGQLHHPNLVKLVGY----CLEDDHRLL----VYEFMPRGSMENHLFRRGSYFQPL 179
N L+H N++ L Y C + + + + V EF+P+ ++ ++ L
Sbjct: 113 MKN----LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167
Query: 180 SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-YNAKLSDFGLARDGPTGD 238
L + LA++HS + +RD K N+L+D N + KL DFG A++ G
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
Query: 239 K--SHVSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLE------ILSGRRAIDK 288
+ S++ +R Y APE L + T D++S G ++ E I SG+ ++D+
Sbjct: 226 RSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279
|
Length = 440 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 20/203 (9%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
+G G +G V+K + TG L AVK + E EI + + H N
Sbjct: 17 VGSGTYGDVYK---------ARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH 199
+V G L + + E+ GS+++ G PLS + GLA+LH
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLH 123
Query: 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA 259
S ++RD K +NILL N + KL+DFG+A S +GT + APE A
Sbjct: 124 SKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAA 179
Query: 260 ---TGHLTAKSDIYSFGVVLLEI 279
G DI++ G+ +E+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 34/214 (15%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEINYLGQLH 136
+G G +GSV +D+ TG +A+K+L++ FQ K E+ L +
Sbjct: 23 VGSGAYGSVCSA-IDKR--------TGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHMQ 72
Query: 137 HPNLVKLV-----GYCLEDDHRLLVYEFMPRGSMENHLFR-RGSYFQPLSWSLRMKIALG 190
H N++ L+ ++ Y MP M+ L + G PLS +
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDF--YLVMP--YMQTDLQKIMG---HPLSEDKVQYLVYQ 125
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
GL ++HSA +I+RD K N+ ++ + K+ DFGLAR +V TR
Sbjct: 126 MLCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----- 178
Query: 251 GYAAPEY-LATGHLTAKSDIYSFGVVLLEILSGR 283
Y APE L H DI+S G ++ E+L+G+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTE 128
+N P +G G +GSV + TR +AVK+L++ FQ + E
Sbjct: 18 QNLTP---VGSGAYGSVCSAY-------DTR--LRQKVAVKKLSRP-FQSLIHARRTYRE 64
Query: 129 INYLGQLHHPNLVKLV-----GYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWS 182
+ L + H N++ L+ +E+ + + LV M G+ N++ + Q LS
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVK----CQKLSDE 118
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
+ GL ++HSA +I+RD K SN+ ++ + ++ DFGLAR +V
Sbjct: 119 HVQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV 176
Query: 243 STRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGR 283
+TR Y APE L H DI+S G ++ E+L G+
Sbjct: 177 ATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 70/283 (24%), Positives = 107/283 (37%), Gaps = 78/283 (27%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL--------NQEGFQGHKEW 125
F +G G FG V L + T L A+K L NQ H +
Sbjct: 3 FVKIKTIGIGAFGEV--------CLVR-KVDTNALYAMKTLRKADVLMRNQ---AAHVK- 49
Query: 126 LTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLS--WS 182
E + L + + +VKL Y +D L V +++P G M + L R G + + L+ +
Sbjct: 50 -AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYI 107
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR---------- 232
+ A+ + + + F+H RD K NIL+D + + KL+DFGL
Sbjct: 108 AELTCAIESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 233 ----DGPTGDKSHVSTRV---------------------------MGTYGYAAPEYLA-T 260
D D S +GT Y APE L T
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 261 GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG-EHNLVEWAK 302
G+ T D +S GV+L E+L G+ + P + ++ W
Sbjct: 220 GY-TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 45/285 (15%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN--QEGFQGHKEWLTEINYLGQLH 136
V+G+G +G V SL R G +K+LN + K E L QL
Sbjct: 7 VVGKGSYGEV--------SLVRHRT-DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57
Query: 137 HPNLVKLV-GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQP----LSWSLRMKIALGA 191
HPN+V + ED +V F G + + L + P + W +++ +AL
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL-- 115
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
+LH E +++RD K N+ L K+ D G+AR ++ +++ ++GT
Sbjct: 116 ----QYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLIGTPY 167
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID-KNRPTGEHNLVEWAKPYLTSKRR 310
Y +PE + KSD+++ G + E+ + + A + K+ + + ++E P +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKD-- 225
Query: 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355
P L L LS P+ RP + ++++
Sbjct: 226 ----YSPEL------------GELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKR----LNQEGFQGHKEWLTEINYLGQL 135
+GEG +G V+K + TG L+A+K+ +++EG L EI+ L L
Sbjct: 9 IGEGTYGKVYK---------ARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57
Query: 136 HH-PNLVKL--VGYCLEDDHRL---LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+V+L V + E + + LV+E++ + +PL
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA-KLSDFGLARDGPTGDKSHVSTRVMG 248
G+A H V++RD K N+L+D K++D GL R KS+ T +
Sbjct: 118 QLLKGVAHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIV 173
Query: 249 TYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSG 282
T Y APE L + H + DI+S G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 39/126 (30%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216
Y+ ++N L G + L+ + A G+ FL A ++RD A N+L
Sbjct: 214 YKGSNDSEVKNLLSDDG--SEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVL 269
Query: 217 LDSNYNAKLSDFGLARDGPTGDKSHVST-RVMGTYGYAAPEYLATGHLTAKSDIYSFGVV 275
L K+ DFGLARD D ++VS + APE + T SD++S+G++
Sbjct: 270 LAQGKIVKICDFGLARD-IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 276 LLEILS 281
L EI S
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
G+ LHSA +I+RD K SNI++ S+ K+ DFGLAR T S + T + T Y
Sbjct: 130 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 254 APEY-LATGHLTAKSDIYSFGVVLLEILSGR 283
APE L G+ DI+S G ++ E++ G
Sbjct: 185 APEVILGMGY-KENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 9e-08
Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 45/235 (19%)
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
Q+ H ++V L G C+ D ++V EF+ G ++ + R+ L+ + K+A A+
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLAS 116
Query: 194 GLAFLHSAEPKVIYRDFKASNILL-----DSNYNA--KLSDFGLARDGPTGDKSHVSTR- 245
L++L + +++ + NILL D KLSD G+ P V +R
Sbjct: 117 ALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PIT----VLSRQ 166
Query: 246 -VMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303
+ + APE + + +L+ +D +SFG L EI + P + L E
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI-----CYNGEIPLKDKTLAE---- 217
Query: 304 YLTSKRRIFRVLDPRLEGQFSL--PQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
K R + EGQ L P ++ A L C++ +P RP +++++
Sbjct: 218 ----KERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HP 138
+G+G +G VFK + ++ +L + +++E E N L L HP
Sbjct: 26 IGKGTYGKVFKV---LNKKNGSKAAVKILDPIHDIDEE-------IEAEYNILKALSDHP 75
Query: 139 NLVKLVG-YCLED----DHRLLVYEFMPRGSMEN---HLFRRGSYFQPLSWSLRMKIALG 190
N+VK G Y +D D LV E GS+ + +RG + + + AL
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL- 134
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
GL LH K I+RD K +NILL + KL DFG++ T + +T V GT
Sbjct: 135 --MGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ-LTSTRLRRNTSV-GTP 188
Query: 251 GYAAPEYLATGH-----LTAKSDIYSFGVVLLEILSG 282
+ APE +A A+ D++S G+ +E+ G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEW-LTEINYLGQLH 136
V+GEG +G V K E T ++A+K+ + E + KE L E+ L L
Sbjct: 8 VVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
N+V+L LV+E++ + +E L P +R I +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-KVRSYI-YQLIKAIH 114
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+ H + +++RD K N+L+ N KL DFG AR+ G ++ T + T Y +PE
Sbjct: 115 WCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPE 171
Query: 257 YLATGHLTAKSDIYSFGVVLLEILSGR 283
L D++S G +L E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 33/89 (37%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
G+ LHSA +I+RD K SNI++ S+ K+ DFGLAR T + + T + T Y
Sbjct: 135 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSG 282
APE + DI+S G ++ E++ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 10/162 (6%)
Query: 127 TEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWS---- 182
+E++ L H +VK DD LL+ E+ G + + +R P
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
L +I L L +HS K+++RD K++NI L KL DFG ++ V
Sbjct: 174 LFYQIVLA----LDEVHSR--KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284
++ GT Y APE + K+D++S GV+L E+L+ R
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
G+ LHSA +I+RD K SNI++ S+ K+ DFGLAR T S + T + T Y
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGR 283
APE + DI+S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 29/185 (15%)
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
G+ LHSA +I+RD K SNI++ S+ K+ DFGLAR T S + T + T Y
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILS------GRRAIDK-NR---------PTGEHNL 297
APE + DI+S G ++ E++ GR ID+ N+ P L
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLP--------QAQKAASLALQCLSVEPKLRPDM 349
+ Y+ ++ + + P+L P +A +A L + L ++P R +
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 350 DEVVK 354
DE ++
Sbjct: 306 DEALQ 310
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 65/251 (25%), Positives = 103/251 (41%), Gaps = 61/251 (24%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEI--- 129
+F V+G G FG V + TG + A+K L + KE + I
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAE 51
Query: 130 -NYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLS--WSLRM 185
+ L + +VK+ Y +D L L+ EF+P G M L ++ + + + +
Sbjct: 52 RDILVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAET 110
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA-------------- 231
+A+ A + L F+H RD K N+LLD+ + KLSDFGL
Sbjct: 111 VLAIDAIHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162
Query: 232 -----------------RDGPTGDKS--HVSTRVMGTYGYAAPE-YLATGHLTAKSDIYS 271
R T K+ ++ +GT Y APE ++ TG+ D +S
Sbjct: 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWS 221
Query: 272 FGVVLLEILSG 282
GV++ E+L G
Sbjct: 222 LGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST-RVMGTY 250
ANG+ FL A ++RD A N+L+ K+ DFGLARD D +++S
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARD-IMRDSNYISKGSTFLPL 305
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+ APE + T SD++SFG++L EI +
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 5e-07
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINYLGQLHHP 138
LGEG + +V+KG G L+A+K + + +G + E + L L H
Sbjct: 13 LGEGSYATVYKG---------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+V L + LV+E++ + ++ + P + L + L GL+++
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYI 119
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE-Y 257
H + +++RD K N+L+ KL+DFGLAR SH + + T Y P+
Sbjct: 120 H--QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPDVL 175
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGRRA 285
L + + D++ G + +E++ G A
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 41/235 (17%)
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
+ Q+ H +L + G C+ ++V EF+ G ++ R+ P++W ++ +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV-CLRKEKGRVPVAW--KITVAQQL 126
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILL-------DSNYNAKLSDFGLARDGPTGDKSHVST 244
A+ L++L + +++ + A NILL ++ KLSD G++ + ++
Sbjct: 127 ASALSYLE--DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE----- 179
Query: 245 RVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303
RV + APE + G L+ +D +SFG LLEI K R E
Sbjct: 180 RV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--------- 229
Query: 304 YLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVKEL 356
K R + E + LP+ ++ A+L QCL+ EP RP ++++L
Sbjct: 230 ----KERFY-------EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 54/199 (27%), Positives = 84/199 (42%), Gaps = 39/199 (19%)
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
G +W+T ++Y Q + NL ++ Y + D L+ +F R + F
Sbjct: 58 GDNQWITTLHYAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF---------- 106
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG----LARDGPT 236
+ M IA+ + + L ++H RD K NIL+D N + +L+DFG L DG
Sbjct: 107 YLAEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158
Query: 237 GDKSHVSTRVMGTYGYAAPEYL-----ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291
S+ +GT Y +PE L G + D +S GV + E+L G P
Sbjct: 159 Q-----SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TP 207
Query: 292 TGEHNLVEWAKPYLTSKRR 310
+LVE + K R
Sbjct: 208 FYAESLVETYGKIMNHKER 226
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 74 FRPDSVLGEGGFGSVF----KGWVDE-------HSLASTRPGTGMLIAVKRLNQEGFQGH 122
FR L G FG +F + +E +S +P LIA KR+ + G +
Sbjct: 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIA-KRV-KAGSRAA 207
Query: 123 KEWLTEINYLGQLHHPNLVKL--------VGYCLEDDHRLLVYEFMPRGSMENHLFRRGS 174
+ EI LG+L+H N++K+ Y + + +Y FM + +
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK------ 261
Query: 175 YFQPLSWSLR--MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232
+PL R MK L A + ++H K+I+RD K NI L+ + L DFG A
Sbjct: 262 -DRPLLKQTRAIMKQLLCA---VEYIHDK--KLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 233 DGPTGDKSHVSTRV--MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
+K + +GT +PE LA +DI+S G++LL++LS
Sbjct: 316 ---PFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 64/264 (24%), Positives = 104/264 (39%), Gaps = 69/264 (26%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL---TEINYLGQLH 136
LG G FG V + + T L A+K L ++ + E + L +
Sbjct: 9 LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59
Query: 137 HPNLVKLVGYCLED-DHRLLVYEFMPRGSMENHLFRRGSYFQPLS--WSLRMKIALGAAN 193
+ +VKL Y +D D+ V +++P G M + L R + + L+ + + +A+ + +
Sbjct: 60 NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL----------------------- 230
+ F+H RD K NIL+D + + KL+DFGL
Sbjct: 119 KMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170
Query: 231 ---------ARDGPTGD----------KSH---VSTRVMGTYGYAAPEYLATGHLTAKSD 268
+ GD K H ++ ++GT Y APE L T D
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 269 IYSFGVVLLEILSGRRAIDKNRPT 292
+S GV+L E+L G+ PT
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPT 254
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 28/167 (16%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEWLT---- 127
+F V+G+G FG V L + TG + A+K L E F+ K+ L
Sbjct: 2 DFHTVKVIGKGAFGEV--------RLVQ-KKDTGKIYAMKTLLKSEMFK--KDQLAHVKA 50
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLS--WSLR 184
E + L + P +V L Y +D L L+ EF+P G + L + ++ + ++ +
Sbjct: 51 ERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAE 109
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
+A+ A + L F+H RD K NIL+D + KLSDFGL+
Sbjct: 110 CVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 61/255 (23%), Positives = 98/255 (38%), Gaps = 69/255 (27%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---------QGHK 123
+F V+G G FG V + TG + A+K L + + +
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAER 52
Query: 124 EWLTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLS-- 180
+ L E + L +VK+ Y +D L L+ EF+P G M L ++ + + +
Sbjct: 53 DILVEADSLW------VVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF 105
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA--------- 231
+ +A+ + + L F+H RD K N+LLDS + KLSDFGL
Sbjct: 106 YIAETVLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157
Query: 232 ----------------------RDGPT--GDKSHVSTRVMGTYGYAAPEYLATGHLTAKS 267
R T ++ ++ +GT Y APE
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC 217
Query: 268 DIYSFGVVLLEILSG 282
D +S GV++ E+L G
Sbjct: 218 DWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 69/255 (27%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL---TEINYLGQLH 136
LG G FG V + + T L A+K L ++ + E + L +
Sbjct: 9 LGIGAFGEV---------CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD 59
Query: 137 HPNLVKLVGYCLED-DHRLLVYEFMPRGSMENHLFRRGSYFQPLS--WSLRMKIALGAAN 193
+ +V+L Y +D D+ V +++P G M + L R G + + L+ + + A+ + +
Sbjct: 60 NEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH 118
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL--------------ARDGPTGDK 239
+ F+H RD K NIL+D + + KL+DFGL + D D
Sbjct: 119 KMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 240 SHVSTR-------------------------------VMGTYGYAAPEYLATGHLTAKSD 268
S ++GT Y APE L T D
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230
Query: 269 IYSFGVVLLEILSGR 283
+S GV+L E+L G+
Sbjct: 231 WWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 8/160 (5%)
Query: 127 TEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186
TE + L ++HP++++L G + L+ +PR + + + + L ++
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
++ A + +LH E ++I+RD KA NI ++ + L DFG A P ++
Sbjct: 189 RSVLRA--IQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAAC-FPVDINANKYYGW 243
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAI 286
GT APE LA DI+S G+VL E+ + ++
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 47/178 (26%)
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSM-------ENHLFRRG 173
G + W+T ++Y Q ++++ LV ++ G + E+ L
Sbjct: 58 GDRRWITNLHYAFQ--------------DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM 103
Query: 174 SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG---- 229
+ F + M +A+ + + L ++H RD K N+LLD N + +L+DFG
Sbjct: 104 ARF----YLAEMVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLR 151
Query: 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYL-----ATGHLTAKSDIYSFGVVLLEILSG 282
L DG +S+V+ +GT Y +PE L G + D +S GV + E+L G
Sbjct: 152 LLADGTV--QSNVA---VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 80 LGEGGFGSVFKG----WVDEHSLASTR-PGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQ 134
+G G +G V+K DE A + GTG+ ++ R EI L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 135 LHHPNLVKLVGYCLEDDHR--LLVYEFMPRGSMENHLFRRGSYF--QPLSWSLRMKIAL- 189
L HPN++ L L R L++++ F R S +P+ M +L
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL 114
Query: 190 -GAANGLAFLHSAEPKVIYRDFKASNILL----DSNYNAKLSDFGLAR--DGPTGDKSHV 242
+G+ +LH+ V++RD K +NIL+ K++D G AR + P + +
Sbjct: 115 YQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 243 STRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILS 281
V+ T+ Y APE L H T DI++ G + E+L+
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 29/187 (15%)
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRLL--VYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
E+N + +L H N+V+ + L ++ L + EF G + ++ + F + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 186 KIALGAANGLAFLHSAE-----PKVIYRDFKASNILLDS-------------NYN----A 223
I + LA+ H+ + +V++RD K NI L + N N A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILS 281
K+ DFGL+++ +H +GT Y +PE L T KSD+++ G ++ E+ S
Sbjct: 182 KIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238
Query: 282 GRRAIDK 288
G+ K
Sbjct: 239 GKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 80 LGEGGFGSVFK-----GWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQ 134
+G G +G V+K G D GTG+ ++ R EI L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 135 LHHPNLVKLVGYCLEDDHR--LLVYEFMPRGSMENHLFRRGSYF--QPLSWSLRMKIAL- 189
L HPN++ L L R L++++ F R S +P+ M +L
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 190 -GAANGLAFLHSAEPKVIYRDFKASNILL----DSNYNAKLSDFGLAR--DGPTGDKSHV 242
+G+ +LH+ V++RD K +NIL+ K++D G AR + P + +
Sbjct: 115 YQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 243 STRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILS 281
V+ T+ Y APE L H T DI++ G + E+L+
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 14/86 (16%)
Query: 206 IYRDFKASNILLDSNYNAKLSDFG----LARDGPTGDKSHVSTRVMGTYGYAAPEYL--- 258
++RD K N+LLD N + +L+DFG + +DG S+ +GT Y +PE L
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-----SSVAVGTPDYISPEILQAM 178
Query: 259 --ATGHLTAKSDIYSFGVVLLEILSG 282
G + D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 15/101 (14%)
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG-------------PTGDKSH 241
L +LH+ +++RD K N+L+ S + KL+DFGL++ G +
Sbjct: 114 LEYLHNY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
+ +V GT Y APE + D ++ G++L E L G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 21/159 (13%)
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF-QPLSWSLRMKIALGAANGL 195
HPN++ ++ FM GS N L + +YF + +S +L I GA GL
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGS-ANSLLK--TYFPEGMSEALIGNILFGALRGL 114
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSD----FGLARDGPTG----DKSHVSTRVM 247
+LH + I+R+ KAS+IL+ + LS + L R+G D ST V+
Sbjct: 115 NYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL 172
Query: 248 GTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGR 283
+ +PE L G+ KSDIYS G+ E+ +GR
Sbjct: 173 P---WLSPELLRQDLYGY-NVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 15/149 (10%)
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
+PN +KL +L+ +++ G + + L + G LS + KI L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEAL 122
Query: 196 AFLHSAEPKVIYRDFKASNILLD-SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
LH +I+ D K N+L D + L D+GL + G S GT Y +
Sbjct: 123 NDLHKH--NIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSCYD----GTLDYFS 174
Query: 255 PEYLATGHLTAKS-DIYSFGVVLLEILSG 282
PE + GH S D ++ GV+ E+L+G
Sbjct: 175 PEKIK-GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 10/102 (9%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTE----INYLGQ 134
LG G FG V V+ + + M +AVK L +E L ++YLG
Sbjct: 42 TLGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG- 96
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF 176
+H N+V L+G C L++ E+ G + N L R+ F
Sbjct: 97 -NHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 25/74 (33%), Positives = 36/74 (48%)
Query: 205 VIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLT 264
+I+RD K N+L++ + L DFG A + + GT APE LA T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 265 AKSDIYSFGVVLLE 278
DI+S G+V+ E
Sbjct: 341 PSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 30/203 (14%)
Query: 97 SLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL-GQLH------HPNLVKLVGYCLE 149
+LA +P TG + V+R+N E + +L G+LH HPN+V +
Sbjct: 17 NLARYKP-TGEYVTVRRINLEACTNEM-----VTFLQGELHVSKLFNHPNIVPYRATFIA 70
Query: 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRD 209
D+ +V FM GS ++ + + +S I G L ++H ++R
Sbjct: 71 DNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM--GYVHRS 126
Query: 210 FKASNILLDSNYNAKLS----DFGLARDGPTGDKSH----VSTRVMGTYGYAAPEYLATG 261
KAS+IL+ + LS + + G H S +V+ + +PE L
Sbjct: 127 VKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP---WLSPEVLQQN 183
Query: 262 --HLTAKSDIYSFGVVLLEILSG 282
AKSDIYS G+ E+ +G
Sbjct: 184 LQGYDAKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 398 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.88 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.82 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.44 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.39 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.26 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.18 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.11 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.03 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.98 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.94 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.82 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.67 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.64 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.63 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.58 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.55 | |
| PLN02236 | 344 | choline kinase | 97.4 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.24 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.07 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.99 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.91 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.85 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.73 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.72 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.66 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.62 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.59 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.39 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.23 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.15 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.08 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.08 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.22 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.2 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.87 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.29 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.05 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=372.66 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=209.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+.+.++.||+|..|+||++.++. +++.+|+|++... .....+++.+|+++++..+|||||++|+.|..+.
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~---------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKP---------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcC---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 34456789999999999997654 8999999999533 2244678999999999999999999999999998
Q ss_pred c-eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 152 H-RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 152 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
. ..++||||++|+|++++...+ .+++.....++.+|+.||.|||. ++ ||||||||+||||+..|.|||||||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEecccc
Confidence 5 999999999999999998764 48999999999999999999995 66 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
.+..+... ...+++||..|||||.+.+..|+.++||||||++++||.+|+.||....+.. .+..+.+.
T Consensus 225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~Ll~------- 292 (364)
T KOG0581|consen 225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFELLC------- 292 (364)
T ss_pred ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHHHHH-------
Confidence 99876443 4567899999999999999999999999999999999999999997641111 11111111
Q ss_pred cccccccccccCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSL-PQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.+.+.. ....+. ..++++++|+..||++||.+||++.++++|=
T Consensus 293 ---~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 293 ---AIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred ---HHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 111111 112222 3678999999999999999999999999883
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-52 Score=388.81 Aligned_cols=249 Identities=29% Similarity=0.463 Sum_probs=214.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.+|...++||+|||++||.+++.. +|+.||+|++.+... ...+.+.+|++|.++|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 579999999999999999997754 899999999976433 34677899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+++|+|+|+|..++|..++.++ +++++..++.++.||+.||.|||+++ |+|||||..|+|++++.+|||+||
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEeccc
Confidence 999999999999999999999865 56999999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|........ ...+.+|||.|.|||++....++..+||||+||++|-||.|++||+...-. ..+..
T Consensus 163 GLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----------ety~~- 229 (592)
T KOG0575|consen 163 GLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----------ETYNK- 229 (592)
T ss_pred ceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----------HHHHH-
Confidence 99998764422 244589999999999999999999999999999999999999999743110 00110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+ . .-...+|...+.++++||.++|+.||.+|||+++++.+
T Consensus 230 --I---k--~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 230 --I---K--LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --H---H--hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0 01223445667889999999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=357.91 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=210.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceee-EEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVG-YCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~-~~~ 148 (398)
.+|++.++||+|.||+||++.+.. +|..+|.|.+.-... .....+..|+.+|++|+||||+++++ .+.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~---------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLL---------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeecc---------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 457788999999999999986654 899999999975433 33566889999999999999999998 455
Q ss_pred eCCc-eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--ceecCCCCCCEEEcCCCCEEE
Q 015909 149 EDDH-RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPK--VIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 149 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~--ivH~Dlkp~Nilv~~~~~~kl 225 (398)
.+.. ++||||+|..|+|...+...+...+-+++..+|.++.|++.||.++|+.-++ |+||||||.||+++.+|.|||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5555 7999999999999999988777778899999999999999999999994333 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+|||+++.+.... ......+|||.||+||.+.+.+|++++||||+||++|||+.-++||.+. ++.
T Consensus 170 GDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~------- 234 (375)
T KOG0591|consen 170 GDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL------- 234 (375)
T ss_pred ccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-------
Confidence 9999999865433 2345689999999999999999999999999999999999999999764 222
Q ss_pred hccccccccccccccCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFS-LPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
....++.+.- ..+.+ ...+.++..+|..|+..||+.||+.-.++..+
T Consensus 235 ~L~~KI~qgd----~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 235 SLCKKIEQGD----YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHHHHHcCC----CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 2222222111 11123 55688999999999999999999854444443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=370.24 Aligned_cols=255 Identities=28% Similarity=0.397 Sum_probs=208.3
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-------chHHHHHHHHHHcCCCCCcccc
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-------GHKEWLTEINYLGQLHHPNLVK 142 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~~I~~ 142 (398)
..+.|.+.+.||+|+||.|-+|..+. +++.||||++++.... ....+.+|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 45678899999999999999996554 8999999999764322 1233579999999999999999
Q ss_pred eeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC--
Q 015909 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-- 220 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~-- 220 (398)
++++|...+..|+||||++||+|.+.+..++. +.+..-..++.|++.|+.|||+.| |+||||||+|||+..+
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAE 314 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCc
Confidence 99999999999999999999999999988754 677777889999999999999999 9999999999999765
Q ss_pred -CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCC---CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 015909 221 -YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL---TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296 (398)
Q Consensus 221 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~ 296 (398)
..+||+|||+|+.... ...+.++|||+.|.|||++.+..+ ..++|+|||||+||-+|+|.+||........
T Consensus 315 ~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-- 389 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-- 389 (475)
T ss_pred ceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--
Confidence 7899999999998643 335778999999999999977543 3468999999999999999999976432210
Q ss_pred hhhhhhhhhhcccccccccccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 297 LVEWAKPYLTSKRRIFRVLDPRLE--GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
+. .++...... .......++++.+||.+||..||++|||+.|+|++=.
T Consensus 390 l~-------------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 390 LK-------------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred HH-------------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 10 011111111 1123456889999999999999999999999998743
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=363.86 Aligned_cols=243 Identities=29% Similarity=0.421 Sum_probs=204.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.++||+|+||+||.++.++ +++.||+|++++... .+.+....|..+|..++||+||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 4578999999999999999986553 899999999987544 2345678999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
++.+.+|+|+||+.||.|...+++.+. +++..+..++..|+.||.|||+++ ||||||||+|||++.+|+++|+|
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEec
Confidence 999999999999999999999998864 899999999999999999999999 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||+++..... .....+++||+.|||||++.+..|+.++|+||||+++|||++|.+||...+.. .+.......
T Consensus 169 FgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~ 240 (357)
T KOG0598|consen 169 FGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKG 240 (357)
T ss_pred cccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcC
Confidence 9999864332 22345589999999999999999999999999999999999999999764321 111111111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 347 (398)
+ ....+...+.++++++.++|..||++|.
T Consensus 241 k-----------~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 241 K-----------LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred c-----------CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1 1112223567899999999999999995
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=363.58 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=206.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..+|.+.+.||.|+||+||+|+++. ++..||||.+.... ....+.+..|+.+|+.|+|||||.+++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 3578888899999999999998765 67999999998764 344566789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC------CC
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN------YN 222 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~------~~ 222 (398)
.++.+|+|||||.||+|.+++.+++ .+++..+..++.||+.||++||+++ ||||||||+|||++.. ..
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCce
Confidence 9999999999999999999999886 4999999999999999999999999 9999999999999754 56
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+||+|||+|+.+.++. ...+.+|++.|||||++....|+.++|+||+|+++|+|++|++||+.....+ +..
T Consensus 154 LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e---L~~--- 224 (429)
T KOG0595|consen 154 LKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE---LLL--- 224 (429)
T ss_pred EEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH---HHH---
Confidence 8999999999876543 3456899999999999999999999999999999999999999997533211 110
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+......+. ...+...+..+.+++...|+.+|.+|-++.+-+.+
T Consensus 225 -~~~k~~~~~--------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 225 -YIKKGNEIV--------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred -HHhcccccc--------CchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 111111111 11222334456688888888888888777665544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=368.19 Aligned_cols=290 Identities=56% Similarity=1.007 Sum_probs=249.1
Q ss_pred CCCCCCHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCC
Q 015909 58 NIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137 (398)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 137 (398)
....|++.++..++++|....+||+|+||.||+|...+ +..||||.+.........+|.+|+.+|.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 56679999999999999999999999999999998753 58899998876543314559999999999999
Q ss_pred CcccceeeEEEeCC-ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCceecCCCCCCE
Q 015909 138 PNLVKLVGYCLEDD-HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE-PKVIYRDFKASNI 215 (398)
Q Consensus 138 ~~I~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~ivH~Dlkp~Ni 215 (398)
||+++++|+|.+.+ ..+||+||++.|+|.+.+...... +++|..+++|+.++|.||+|||... ++|+|||||++||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 99999999999988 599999999999999999876532 7899999999999999999999864 3799999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCccccccc-ccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRV-MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE 294 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~ 294 (398)
|+|++...||+|||+|+..... ... .... .||..|+|||.+..+..+.++||||||+++.||++|+.+.+...+...
T Consensus 209 LLD~~~~aKlsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~ 286 (361)
T KOG1187|consen 209 LLDEDFNAKLSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE 286 (361)
T ss_pred eECCCCCEEccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc
Confidence 9999999999999999765431 111 1112 799999999999989999999999999999999999999887666666
Q ss_pred cchhhhhhhhhhcccccccccccccc-CCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLE-GQFSL-PQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
..+..|+.+.+... .+.+++|+.+. ..++. ..-..+..+..+|++.+|++||++.++++.|+.+...
T Consensus 287 ~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 67899998777665 78899999987 56654 5667789999999999999999999998888555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=348.44 Aligned_cols=267 Identities=26% Similarity=0.344 Sum_probs=209.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
+.|+.+.++|+|+||+||+|++++ +|+.||||++.... ....+-.++|+++|++|+|+|+|.++++|.-
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 457788899999999999997665 89999999986432 2334567999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
...+++|+|||+. ++.+.+++.. ..++...+..++.|++.|+.|+|+++ ++||||||+||||+.+|.+||||||
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccch
Confidence 9999999999955 6666666654 46899999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh------
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK------ 302 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~------ 302 (398)
+|+.+.. .....+.++.|.+|.|||++.| ..|+..+||||+||++.||++|.+.|.+.++.+....+...-
T Consensus 147 FAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr 224 (396)
T KOG0593|consen 147 FARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR 224 (396)
T ss_pred hhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence 9998763 2234566788999999999988 689999999999999999999999997765543322221110
Q ss_pred --hhhhccccccccccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 --PYLTSKRRIFRVLDPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 --~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..+........+.-+..+..-+ +..+.-+.+|+.+||..||.+|++.++++.+
T Consensus 225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111111111111111 1234578899999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=367.61 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=215.2
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCC-CCCcccce
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL-HHPNLVKL 143 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~I~~~ 143 (398)
.....+|.+++.||.|+|++|++|+... ++..||||++.+... ...+.+..|-.+|.+| .||.|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 4455789999999999999999997654 899999999976543 2234567888899999 79999999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
+..|.++..+|+|+||+++|+|.++|.+.+. +++...+.++.+|+.||+|||++| ||||||||+|||+++++++
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhi 213 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHI 213 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcE
Confidence 9999999999999999999999999999864 899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCc---------cc--ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 015909 224 KLSDFGLARDGPTGDKS---------HV--STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~ 292 (398)
+|+|||.|+.+...... .. ...++||..|.+||++..+..++.+|+|+|||+||+|+.|.+||.+..+.
T Consensus 214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 99999999876543222 11 14589999999999999999999999999999999999999999764321
Q ss_pred CCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
. - ++.++. +...++...++.+.+||.++|..||.+|+++.+|.+|.
T Consensus 294 l-----i-FqkI~~------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 L-----I-FQKIQA------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred H-----H-HHHHHH------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1 0 111111 22344555568899999999999999999999988763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=363.82 Aligned_cols=258 Identities=36% Similarity=0.583 Sum_probs=211.0
Q ss_pred CCCceecccCCceEEEEEecCCcccccCCCCCcE-EEEEEcccCCccc--hHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 75 RPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGML-IAVKRLNQEGFQG--HKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.+.+.||.|+||+||+|.+. |.. ||+|.+....... .+.|.+|+.+|.+++||||++++|++....
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred hhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34456999999999999985 444 9999997643322 568999999999999999999999998877
Q ss_pred -ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-CEEEeecc
Q 015909 152 -HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKLSDFG 229 (398)
Q Consensus 152 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-~~kl~Dfg 229 (398)
..++||||+++|+|..++... ....+++..++.++.+|+.||.|||++++ ||||||||+||||+.++ ++||+|||
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCc
Confidence 799999999999999999884 12569999999999999999999999875 89999999999999997 99999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLA--TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+++...... .......||+.|||||++. ...|+.++||||||+++|||+||+.||.+.... ..
T Consensus 190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~------------ 254 (362)
T KOG0192|consen 190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QV------------ 254 (362)
T ss_pred cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HH------------
Confidence 998644321 2233367999999999999 569999999999999999999999999865431 10
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
...+.........+..++..+..++.+||..||..||++.+++..|+.+...-.
T Consensus 255 ---~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 255 ---ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ---HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 001111111222333467789999999999999999999999999998876433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=350.24 Aligned_cols=263 Identities=30% Similarity=0.458 Sum_probs=210.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.+|...+.||+|+||.||++.+.+ +|...|||.+........+.+.+|+.+|++|+|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 457778899999999999997754 58899999997654333677899999999999999999999754444
Q ss_pred --ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-CCCEEEeec
Q 015909 152 --HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLSDF 228 (398)
Q Consensus 152 --~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-~~~~kl~Df 228 (398)
.+++.|||+++|+|.+++.+.+. .+++..+..+..||++||.|||+++ |+||||||+||||+. ++.+||+||
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDF 162 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADF 162 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccC
Confidence 58899999999999999998763 5999999999999999999999999 999999999999999 799999999
Q ss_pred cCCcCCCC-CCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 229 GLARDGPT-GDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 229 g~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|++..... ...........||+.|||||++..+ ....++|||||||++.||+||++||.... ....+
T Consensus 163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~------ 231 (313)
T KOG0198|consen 163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEA------ 231 (313)
T ss_pred ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHH------
Confidence 99987543 1222223457899999999999853 34458999999999999999999997530 00000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
+..+........++...+.++++|+.+|+..||++|||++++|++.--.++..
T Consensus 232 ----~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 232 ----LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ----HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 01111111112445557789999999999999999999999999976555444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=355.00 Aligned_cols=263 Identities=28% Similarity=0.409 Sum_probs=210.8
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHH--HHHHHHHHcCCC-CCcccceeeE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE--WLTEINYLGQLH-HPNLVKLVGY 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~~I~~~~~~ 146 (398)
..++|.+.+.||.|+||.||+|...+ ++..||||.++..... .++ -++|+..|++|+ ||||+++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 45789999999999999999996654 7889999999765433 333 378999999998 9999999999
Q ss_pred EEeCC-ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 147 CLEDD-HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 147 ~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
+.+.+ .+|+||||+ ..+|+.++..++ ..+++..+..|+.||++||+|+|.+| +.|||+||+||||.....+||
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKi 151 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKI 151 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEe
Confidence 99988 999999999 679999998874 68999999999999999999999999 999999999999998899999
Q ss_pred eeccCCcCCCCCCCccccccccccccccccccc-ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL-ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
+|||+|+...... ..+.++.|.+|+|||++ +.+.|+.+.|+||+||+++|+.+-++.|.+..+.++...+. ..
T Consensus 152 aDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc---~V 225 (538)
T KOG0661|consen 152 ADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC---EV 225 (538)
T ss_pred cccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH---HH
Confidence 9999999764433 35567889999999987 45778999999999999999999999998755432211100 00
Q ss_pred hhc--------ccccccccccc--------ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTS--------KRRIFRVLDPR--------LEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~--------~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+.. ...+...+.-. +..-++ ..+.++.++|.+||++||++|||+.+++++
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 00111111111 111122 257889999999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=359.21 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=215.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
..|.....||+|+.|.||.|... .+++.||+|.+........+-+++|+.+|+..+|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~---------~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKI---------STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhcchhhhccccccceeeeeec---------cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 56788889999999999998544 478889999998877777788999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
.+|+||||++||+|.+.+.... +++.++..|+..++.||+|||.++ |+|||||.+|||++.+|.+||+|||+|
T Consensus 344 eLWVVMEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred eeEEEEeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeee
Confidence 9999999999999999998753 899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
..+..... ...+.+||++|||||++....|++++||||||++++||+.|++||-...+....-+ +
T Consensus 417 aqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------------I 481 (550)
T KOG0578|consen 417 AQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------I 481 (550)
T ss_pred eccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------------H
Confidence 88655432 34567999999999999999999999999999999999999999965433221110 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ........+...+..+++|+.+||+.|+++|+++.|||+|
T Consensus 482 a~--ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 482 AT--NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred hh--cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 00 1112223455668899999999999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=332.07 Aligned_cols=237 Identities=28% Similarity=0.426 Sum_probs=204.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.+|++.+.||.|+||+|.+++.+. +|..||+|++.+... ...+...+|..+|+.+.||+++++++.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred hhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 467888999999999999987665 799999999987543 34556789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+.+|+||||.+||.|..++.+.++ +++..++.++.||+.||+|||+++ |++|||||+|||+|.+|.+||+||
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEec
Confidence 99999999999999999999998764 899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|+..... ..+.|||+.|+|||++...+|+.++|+||||+++|||+.|.+||....+.. ...
T Consensus 189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY~------ 251 (355)
T KOG0616|consen 189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IYE------ 251 (355)
T ss_pred cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HHH------
Confidence 999875432 456899999999999999999999999999999999999999997654411 011
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCC
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR 346 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 346 (398)
.++.. .-.+|...+.++++|+.++|+.|-.+|
T Consensus 252 ----KI~~~--~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 252 ----KILEG--KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----HHHhC--cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11111 123556667889999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=322.43 Aligned_cols=266 Identities=27% Similarity=0.394 Sum_probs=210.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc--hHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.+|...+.||+|.||.||+|++.+ +|+.||||+++.....+ ....++|++.|+.++|+||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 467788999999999999997765 89999999998654332 3567899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+.+.+|+||++ .+|+..+.... ..++...+..++.+++.||+|||++. |+||||||.|+||+.+|.+||+|||
T Consensus 73 ~~~l~lVfEfm~-tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 73 KSNLSLVFEFMP-TDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred CCceEEEEEecc-ccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeeccc
Confidence 999999999995 59999997765 56899999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh---------
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE--------- 299 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~--------- 299 (398)
+++.+...+.... ..+-|.+|.|||++.|. .|+..+|+||.||++.||+.|.+.|.+..+.+....+-
T Consensus 147 LAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 147 LARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD 224 (318)
T ss_pred chhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence 9998766544332 23779999999998764 68999999999999999999998887654432221111
Q ss_pred -hhh-hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 -WAK-PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 -~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
|-. ..+.+...+.....+.+.. .-...+.++.+|+.+||..||.+|++++|++++
T Consensus 225 ~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 225 QWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 100 0000111111111111222 223446677999999999999999999999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=352.42 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=208.6
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC----Cc-cchHHHHHHHHHHcCCC-CCcccc
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE----GF-QGHKEWLTEINYLGQLH-HPNLVK 142 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~~I~~ 142 (398)
...+.|.+.+.||+|+||+|+.|+... ++..||+|++... .. ...+.+.+|+.+++.+. ||||++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~ 84 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIR 84 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeE
Confidence 345689999999999999999997654 7899999987654 22 23456678999999999 999999
Q ss_pred eeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC-C
Q 015909 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-Y 221 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~-~ 221 (398)
+++++.....+++||||+.+|+|.+++...+ .+.+.....++.|++.|++|||+++ |+||||||+|||++.+ +
T Consensus 85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~ 158 (370)
T KOG0583|consen 85 LLEVFATPTKIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEG 158 (370)
T ss_pred EEEEEecCCeEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCC
Confidence 9999999999999999999999999999854 5888999999999999999999999 9999999999999999 9
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH-LT-AKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
++||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||++.... .
T Consensus 159 ~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~ 230 (370)
T KOG0583|consen 159 NLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------N 230 (370)
T ss_pred CEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------H
Confidence 99999999998763 2223456689999999999999877 76 6799999999999999999999862211 1
Q ss_pred hhhhhhhccccccccccccccCCCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQ-AQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... . ...++... +.++++|+.+||..||.+|+++.+++++
T Consensus 231 l~~ki~~----------~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 231 LYRKIRK----------G--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred HHHHHhc----------C--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 1111111 1 11122223 7789999999999999999999999954
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=337.39 Aligned_cols=257 Identities=27% Similarity=0.354 Sum_probs=211.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccch---HHHHHHHHHHcCCCCCcccceeeE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
..+.|++++.||+|.-|+||++.... ++..+|+|++.+.....+ .++..|-+||..+.||.++.+|..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~ 145 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS 145 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe
Confidence 34567788999999999999998765 679999999987655443 445679999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
|..++..|++||||+||+|..+.+++.. +.+++..++.++..|+.||+|||-.| ||+|||||+||||.++|++.|+
T Consensus 146 fet~~~~cl~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLs 221 (459)
T KOG0610|consen 146 FETDKYSCLVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLS 221 (459)
T ss_pred eeccceeEEEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEee
Confidence 9999999999999999999999987654 67999999999999999999999999 9999999999999999999999
Q ss_pred eccCCcCCCC---------------------------------CCCc---------------------cccccccccccc
Q 015909 227 DFGLARDGPT---------------------------------GDKS---------------------HVSTRVMGTYGY 252 (398)
Q Consensus 227 Dfg~a~~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y 252 (398)
||.++..... .... .....++||-.|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 9998753211 0000 011236899999
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHH
Q 015909 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAA 332 (398)
Q Consensus 253 ~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 332 (398)
+|||++.|...+.++|+|+|||++||||.|..||.+.... ..+..++...+.-......+..++
T Consensus 302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~ak 365 (459)
T KOG0610|consen 302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAK 365 (459)
T ss_pred ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHH
Confidence 9999999999999999999999999999999999874321 222333333333333336678899
Q ss_pred HHHHHhccCCCCCCCC----HHHHHHH
Q 015909 333 SLALQCLSVEPKLRPD----MDEVVKE 355 (398)
Q Consensus 333 ~li~~~l~~dP~~Rps----~~ell~~ 355 (398)
+||+++|.+||.+|.. +.||.+|
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcC
Confidence 9999999999999987 7777654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=348.20 Aligned_cols=269 Identities=25% Similarity=0.328 Sum_probs=208.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.+.|+.++.||+|+||.||+|++.. +|+.||+|+++.+.. .......+||.||++|.||||+++.+...
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~---------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLE---------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecc---------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 3567788899999999999997655 899999999987653 33456689999999999999999999988
Q ss_pred eC--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 149 ED--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+. ..+|+|+|||+. +|..++...+ -.+++.++..++.||+.||+|||+++ |+|||||.+|||||.+|.+||+
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEec
Confidence 76 689999999955 8888887654 35899999999999999999999999 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh-hh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK-PY 304 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~ 304 (398)
|||+|+.+...... ..+..+-|.+|.|||++.|. .|+.++|+||+||||.||+.|++.|.+..+......+...- ..
T Consensus 261 DFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 261 DFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred cccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 99999976554332 35566789999999999874 79999999999999999999999998866543322221100 00
Q ss_pred hhc---ccccc--ccccccccCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTS---KRRIF--RVLDPRLEGQ-----FSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~---~~~~~--~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ...+. ..+.+..... .-...+..+.+|+..+|..||.+|.|+.+.|+.
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000 00000 1111100000 011225678899999999999999999998864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=354.33 Aligned_cols=258 Identities=29% Similarity=0.451 Sum_probs=212.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+.+++.+.||+|.||.||.|+++. ...||+|.++... ...+.|.+|+.+|++|+|++||++++++..++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~----------~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG----------STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC----------CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 344566789999999999999964 3478999987653 44577889999999999999999999999988
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
.++|||||++.|+|.+++..... ..+.....+.++.||++||+||++++ +|||||..+||||++++.+||+|||+|
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccc
Confidence 99999999999999999987332 56888999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+...+..+. ......-...|.|||.+..+.++.++||||||++||||+| |+.||.+.... .
T Consensus 351 r~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----------------e 412 (468)
T KOG0197|consen 351 RLIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----------------E 412 (468)
T ss_pred cccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----------------H
Confidence 954333222 2222223567999999999999999999999999999999 99998653211 1
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
+.+.++....-+-|..+|.++.+++..||+.+|++|||++.+...|+++...
T Consensus 413 v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 413 VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 1122222333344566889999999999999999999999999999887653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=339.34 Aligned_cols=265 Identities=25% Similarity=0.335 Sum_probs=211.8
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc-hHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
....|++.++||.|..++||+|++.. +++.||||+++.+.+.. .+.+.+|+..|+.++||||++++..|.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 34679999999999999999998764 67999999998776644 478899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.+..+|+||+|+.+|++.+++...-. ..+++..+..|++++++||.|||.+| .||||||+.||||+++|.|+|+||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCc
Confidence 99999999999999999999986544 45999999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCC-ccc-cccccccccccccccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 229 GLARDGPTGDK-SHV-STRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 229 g~a~~~~~~~~-~~~-~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|.+-....... ... ...++||++|||||++.. ..|+.++||||||++.+||.+|+.||....+..-.-
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-------- 242 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-------- 242 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--------
Confidence 98765433221 111 256789999999999643 579999999999999999999999997644321100
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+.............+..+.....+..+++++..||+.||.+|||+++++++
T Consensus 243 ~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 243 LTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 000000000000011111122335689999999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.98 Aligned_cols=273 Identities=22% Similarity=0.396 Sum_probs=218.5
Q ss_pred HHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCccc
Q 015909 64 YSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLV 141 (398)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~ 141 (398)
..+..+..+...+...||+|.||+||+|.|.. .||||+++.+.. +..+.|.+|+.+|++-+|.||+
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIl 451 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENIL 451 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhe
Confidence 34555556677888999999999999998854 599999986644 3567899999999999999999
Q ss_pred ceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 142 KLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
-++|++..+.. .||+.+|+|.+|+.++.... ..+.....+.|+.||++||.|||.++ |||||||..|||+.+++
T Consensus 452 LFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~ 525 (678)
T KOG0193|consen 452 LFMGACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDL 525 (678)
T ss_pred eeehhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCC
Confidence 99999988777 99999999999999998765 45888999999999999999999999 99999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCccccccccccccccccccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~ 298 (398)
+|||+|||++................|...|||||+++. .+|++.+||||||+++|||++|..||.... .++.+.
T Consensus 526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dqIif 603 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQIIF 603 (678)
T ss_pred cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhheEE
Confidence 999999999876544443334445568889999999965 478999999999999999999999997321 111111
Q ss_pred hhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH-HhhccC
Q 015909 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE-LRNMHK 367 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~-~~~~~~ 367 (398)
...+. .+- .........+++++++|+..||..++++||.+.+|+..|+.+.. +.+..+
T Consensus 604 mVGrG----------~l~-pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R 662 (678)
T KOG0193|consen 604 MVGRG----------YLM-PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR 662 (678)
T ss_pred Eeccc----------ccC-ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence 00000 000 01112233457899999999999999999999999998887766 444444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=351.25 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=211.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|.+.+.||+|+||+||+|+-+ .+.+.||+|.+.+... .+.+.+.+|++|++.|+||||+.++++|..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK---------~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK---------YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeecccc---------cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 57889999999999999999544 4899999999976543 446678999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
..++|+|.||+.| +|..++...+ .++++.+..++.+++.||.|||+++ |+|||+||.|||++..+.+|+||||
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg 145 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFG 145 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhh
Confidence 9999999999965 9999998775 4999999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+|+.... .........||+.|||||++.+.+|+..+|+|||||++|||+.|++||... .+....+.+..+
T Consensus 146 ~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d-- 215 (808)
T KOG0597|consen 146 LARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD-- 215 (808)
T ss_pred hhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC--
Confidence 9997654 333456678999999999999999999999999999999999999999421 111111111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.-..+...+..+..|+..+|.+||.+|.+..+++.|
T Consensus 216 ----------~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 216 ----------PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----------CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 112334567889999999999999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=346.17 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=206.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|.++++||+|+||.||+|+-+. +|..+|+|++++... ...+.++.|-.+|....+|.||+++..|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred cccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 3789999999999999999996554 899999999987654 3355678899999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+++||||||++||++..++.+.+ .|++..+..++.+++.|+.-||+.| +|||||||+|+|||..|++||+|
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeecc
Confidence 99999999999999999999999875 5999999999999999999999999 99999999999999999999999
Q ss_pred ccCCcCCCC----------------------CCCcc------c-----------------ccccccccccccccccccCC
Q 015909 228 FGLARDGPT----------------------GDKSH------V-----------------STRVMGTYGYAAPEYLATGH 262 (398)
Q Consensus 228 fg~a~~~~~----------------------~~~~~------~-----------------~~~~~gt~~y~aPE~~~~~~ 262 (398)
||+|.-... .+... . ....+|||.|+|||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999852211 00000 0 01258999999999999999
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC-cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccC
Q 015909 263 LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE-HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSV 341 (398)
Q Consensus 263 ~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 341 (398)
|+..+|+||||||+||||.|.+||....+... ..+..|... +..+.....+.++.+||.+||.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPEEVDLSDEAKDLITRLLC- 428 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCCcCcccHHHHHHHHHHhc-
Confidence 99999999999999999999999987654422 111222111 1111222335789999999999
Q ss_pred CCCCCCC---HHHHHHH
Q 015909 342 EPKLRPD---MDEVVKE 355 (398)
Q Consensus 342 dP~~Rps---~~ell~~ 355 (398)
||++|.- +.||.+|
T Consensus 429 d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKH 445 (550)
T ss_pred CHHHhcCcccHHHHhcC
Confidence 9999964 5555543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=328.72 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=209.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc--hHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
+.|+.+..|++|+||.||+|+++. +++.||+|+++.+.... .-..++||.+|.+++|||||.+.++...
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~---------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKK---------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCC---------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 457778889999999999996654 89999999998653211 2245899999999999999999998765
Q ss_pred --CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 150 --DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 150 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
-+.+|+|||||+. +|..++...+ +++....+..++.|++.|++|||.+. |+||||||+|+|++..|.+||+|
T Consensus 147 ~~~d~iy~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaD 220 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIAD 220 (419)
T ss_pred cccceeeeeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecc
Confidence 4679999999955 9999999887 67899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh---
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP--- 303 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~--- 303 (398)
||+|+.+.... ...+..+-|.+|.|||++.+. .|+.+.|+||+|||+.||+++++.|.+..+....+.+-..-.
T Consensus 221 FGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 221 FGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred cchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence 99999875543 235567889999999999874 699999999999999999999999988765443332211000
Q ss_pred -----hhhc-----cccccccccccccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 -----YLTS-----KRRIFRVLDPRLEGQFSLP-QAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 -----~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
-+.. ...........+...+... .++..++|+..+|..||.+|.|+++.|++
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000 0001111111122222222 45788999999999999999999999987
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=344.13 Aligned_cols=250 Identities=28% Similarity=0.410 Sum_probs=212.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..|+..+.||+|.||.||+|.+.. +++.||+|++..+.. ...+.+..|+.+|.+++++||.++|+.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 457777899999999999997765 899999999986544 4467788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
..++++||||.||++.+++.... .+.+..+..++++++.|+.|||+++ .+|||||+.|||+..+|.+||+|||.
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecce
Confidence 99999999999999999997654 3477888889999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ...+++||+.|||||++.+..|+.++||||||++++||.+|.+|+.+..+..... .
T Consensus 158 a~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------l 222 (467)
T KOG0201|consen 158 AGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------L 222 (467)
T ss_pred eeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------e
Confidence 987654433 2367899999999999999999999999999999999999999998755422111 1
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+.+...|.+.+ ..+..+++|+..||..||+.||++.++|++
T Consensus 223 Ipk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 223 IPKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11222233333 456779999999999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=347.61 Aligned_cols=270 Identities=28% Similarity=0.412 Sum_probs=208.3
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
..++|++.++||+|+||.||+|.+.. .....++..||+|.+..... .....+.+|+.++..+ +||||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFG----IDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEec----cCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 34679999999999999999997532 11223567899999875432 2345688999999999 899999999988
Q ss_pred EeC-CceEEEEeecCCCCHHHHHhhcCCC---------------------------------------------------
Q 015909 148 LED-DHRLLVYEFMPRGSMENHLFRRGSY--------------------------------------------------- 175 (398)
Q Consensus 148 ~~~-~~~~lv~e~~~~~~L~~~~~~~~~~--------------------------------------------------- 175 (398)
... ...++||||+++|+|.+++......
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4578999999999999999754211
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccccccccc
Q 015909 176 -------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248 (398)
Q Consensus 176 -------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 248 (398)
..++++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++...............+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 235788889999999999999999998 99999999999999999999999999986533222212223346
Q ss_pred ccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHH
Q 015909 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ 327 (398)
Q Consensus 249 t~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (398)
+..|+|||++.+..++.++||||||+++|||++ |..||....... .+ .. .+.... ....+...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~---~~-~~~~~~----------~~~~~~~~ 302 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF---CQ-RLKDGT----------RMRAPENA 302 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH---HH-HHhcCC----------CCCCCCCC
Confidence 778999999998999999999999999999997 999997532211 00 00 011000 01112234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 328 AQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 328 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
+.++.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=352.99 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=207.2
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCC-CCcccce
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLH-HPNLVKL 143 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~I~~~ 143 (398)
.....+|++.++||+|+||+|+++..+. +++.||||.++++.. ++.+..+.|.+|+.... ||.++.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence 4456789999999999999999997765 788999999988654 44566788888888875 9999999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
+..|...+++|+||||+.||++..+... ..+++..+..++..|+.||.|||+++ |||||||.+|||+|.+|++
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~ 507 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHV 507 (694)
T ss_pred ccccccCCeEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcE
Confidence 9999999999999999999995444332 35899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
||+|||+++.... ......+++||+.|||||++.+..|+.++|+|||||+|||||.|..||.+.++.+..+ .
T Consensus 508 kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd------s 579 (694)
T KOG0694|consen 508 KIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD------S 579 (694)
T ss_pred EecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------H
Confidence 9999999987432 2235677999999999999999999999999999999999999999998754432111 1
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM 349 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 349 (398)
++. ....+|...+.++.++++++|..+|++|.-.
T Consensus 580 I~~------------d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVN------------DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred Hhc------------CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 1224566678899999999999999999654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=351.25 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=210.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-c--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-F--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.-|++++-||.|+-|.|-+|++.+ ||+..|||++.... . .....+.+|+-+|+.|.||||+.+|++|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~---------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE---------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhhhccc---------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 358889999999999999986554 99999999997652 1 22345789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+..++|+|+||+++|.|.+++.+++ ++++....+++.||+.|+.|+|..+ |+||||||+|+|++..+++||+||
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeecc
Confidence 9999999999999999999999886 5899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLT-AKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|+|..-..+. ...+.||.+.|.+||++.|.+|. .++||||.|+|||.||+|+.||++.. +... .+.-
T Consensus 157 GMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~L---LlKV 224 (786)
T KOG0588|consen 157 GMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVL---LLKV 224 (786)
T ss_pred ceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHH---HHHH
Confidence 9998643333 34567999999999999999885 67999999999999999999997421 1111 1111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.+.. .++|...+.++++||.+||..||+.|.|+++|++|--
T Consensus 225 ~~G~---------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 225 QRGV---------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HcCc---------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 1111 2334556789999999999999999999999999854
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=311.88 Aligned_cols=270 Identities=27% Similarity=0.362 Sum_probs=219.5
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
....++|++.+.||+|||+.||++. ...++..||+|++.....++.+..++|++..++++|||+++++++.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~---------~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVK---------GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeec---------ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 4456799999999999999999974 3448899999999877777888999999999999999999998876
Q ss_pred EeC-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 148 LED-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 148 ~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
..+ ...|++++|+..|+|.+.+.........+++..++.++.+|+.||++||+..+++.||||||.|||+.+.+.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence 543 348999999999999999998877777899999999999999999999999888999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCccc-------ccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 015909 223 AKLSDFGLARDGPTGDKSHV-------STRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~ 292 (398)
++|.|||.+....-.-.... ......|..|.|||++. +...+.++|||||||+||.|+.|..||+..-..
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 99999999876432211110 11234688999999985 456789999999999999999999999743221
Q ss_pred CCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
++ ..-..+.......+-....++.+.++|++||+.||.+||++.+++..++.+.
T Consensus 248 Gg--------------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 GG--------------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CC--------------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 1111222222333333346889999999999999999999999999998763
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=331.46 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=210.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc---hHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..+|++.+.||+|.||+|-+|+... .|..||||.++++...+ .-.+.+|++||..|+||||+.++++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~---------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHK---------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhcc---------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 4578888999999999999986543 79999999998765544 34568999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+.+.|||||..+|.|++|+.+++ .+++.....++.||..|+.|+|.++ ++|||||.+|||+|.++++||+|
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIAD 196 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIAD 196 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeec
Confidence 99999999999999999999999886 4999999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||++-.+... ....+++|++.|.+||++.|.+| ++.+|-||||++||-|+.|..||++.+-. ..++
T Consensus 197 FGLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvr---- 263 (668)
T KOG0611|consen 197 FGLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVR---- 263 (668)
T ss_pred cchhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHH----
Confidence 9999765433 24567899999999999999988 46799999999999999999999864211 1111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
++-.... ..+..+.++.-||++||..||++|.|+.++..|-.
T Consensus 264 ------QIs~GaY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 264 ------QISRGAY---REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ------Hhhcccc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1111000 11123456789999999999999999999988754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.19 Aligned_cols=297 Identities=25% Similarity=0.376 Sum_probs=246.4
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEccc-CCccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ-EGFQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
......+.++||.|-||.||+|.+...+ .+..-.||||..+. ...+..+.|+.|+.+|+.+.||||++++|++.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3344566788999999999999987632 34566799999976 44566888999999999999999999999986
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+ ...|+|||.++.|.|..+++.+. ..++......++.||+.||.|||+.. +|||||..+||||...-.|||+||
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeeccc
Confidence 4 57899999999999999999876 46888999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|+++........... ...-...|||||.+.-..++.++|||.||+++||++. |..||.+-.-
T Consensus 536 GLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN---------------- 598 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN---------------- 598 (974)
T ss_pred chhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------
Confidence 999998766554433 2334668999999999999999999999999999987 9999975211
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhccCCchhh-hhcccccccCCCCC
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQKE-HQAKGHVHFKGRAT 386 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 386 (398)
..+...++..-..+.|..++..+..|+.+||+.||.+||.+.++...|.++...++...+.+.+ ++..+....++..+
T Consensus 599 -sDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r~~R~~a~~~~~~~~~ 677 (974)
T KOG4257|consen 599 -SDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLRRQRKVASMIWQNSDD 677 (974)
T ss_pred -cceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHHhhhcccceeeccCCc
Confidence 1112233333344667788899999999999999999999999999999999988887776644 44577778888888
Q ss_pred cCCCCCCCC
Q 015909 387 TYPRPSASP 395 (398)
Q Consensus 387 ~~~~~~~~~ 395 (398)
..+||+||.
T Consensus 678 ~e~PPKPSR 686 (974)
T KOG4257|consen 678 IEIPPKPSR 686 (974)
T ss_pred cCCCCCccc
Confidence 888887774
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=328.37 Aligned_cols=266 Identities=28% Similarity=0.385 Sum_probs=209.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEccc--CCccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ--EGFQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
...+|...+.||+|+||.|..|.+.. +|+.||+|++.. ......+..++|+++|+.++|+||+.+++++
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~ 90 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIF 90 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeec
Confidence 44567778999999999999997765 789999999973 3445567889999999999999999999988
Q ss_pred Ee-----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 148 LE-----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 148 ~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
.. -+.+|+|+|++ +.+|...+... +.++...+..++.||+.||.|+|+.+ |+||||||.|+|++.+..
T Consensus 91 ~p~~~~~f~DvYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~ 163 (359)
T KOG0660|consen 91 RPPSRDKFNDVYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCD 163 (359)
T ss_pred ccccccccceeEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCC
Confidence 65 35679999999 66888888765 35999999999999999999999999 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh-
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW- 300 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~- 300 (398)
+||+|||+|+...........+..+-|.+|.|||++. ...|+.+.||||+|||+.||++|++.|.+.+......++..
T Consensus 164 lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 164 LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 9999999999875443333446678899999999874 46899999999999999999999999987654322222111
Q ss_pred ----------------hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 ----------------AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+++++.... ......+...++ ..+..+.+|+.+||..||.+|+|++|.|+|
T Consensus 244 lGtP~~e~l~~i~s~~ar~yi~slp---~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 244 LGTPSEEDLQKIRSEKARPYIKSLP---QIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred cCCCCHHHHHHhccHHHHHHHHhCC---CCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111100 000001111112 336788999999999999999999999987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=329.58 Aligned_cols=269 Identities=26% Similarity=0.327 Sum_probs=210.9
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--------------cchHHHHHHHHH
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--------------QGHKEWLTEINY 131 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~ 131 (398)
+-....++|++.+.||+|.||.|-+|++.. +++.||||++.+... ...+...+||.+
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIai 161 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAI 161 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHH
Confidence 334556899999999999999999997654 799999999964311 123578899999
Q ss_pred HcCCCCCcccceeeEEEe--CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecC
Q 015909 132 LGQLHHPNLVKLVGYCLE--DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRD 209 (398)
Q Consensus 132 l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~D 209 (398)
|++|.|||||+++++..+ .+.+|||+|||..|.+...- .....+++.+.++++.+++.||+|||.++ |+|||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRD 235 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRD 235 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence 999999999999999876 46889999999888764321 11123899999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcCCCCC---CCcccccccccccccccccccccCC----CCCchhHHHHHHHHHHHHhC
Q 015909 210 FKASNILLDSNYNAKLSDFGLARDGPTG---DKSHVSTRVMGTYGYAAPEYLATGH----LTAKSDIYSFGVVLLEILSG 282 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g 282 (398)
|||+|+||+++|+|||+|||.+.....+ +.........||+.|+|||.+.++. .+.+.||||+|++||.|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 9999999999999999999998765332 1122233478999999999987632 35678999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 283 RRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
+.||-+..... . ...+.+..+..+.......++++||.+||.+||++|.++.++..|....+..
T Consensus 316 ~~PF~~~~~~~------l----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 316 QLPFFDDFELE------L----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred cCCcccchHHH------H----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 99996432110 0 1122333333333345678899999999999999999999999998776654
Q ss_pred hhc
Q 015909 363 RNM 365 (398)
Q Consensus 363 ~~~ 365 (398)
.-.
T Consensus 380 ~~~ 382 (576)
T KOG0585|consen 380 DSP 382 (576)
T ss_pred CCC
Confidence 433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=356.39 Aligned_cols=269 Identities=30% Similarity=0.466 Sum_probs=226.0
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
...+.+..+.||+|+||+||+|..... ........||||.++..... ...+|.+|+++|..|+|||||+++|+|.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 344566778899999999999987541 22346789999999877655 6788999999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC------C----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS------Y----FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~------~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
+++..++|+||+..|+|.+++..+.. . ..+++..+.+.|+.||+.||.||-++. +|||||..+|+||.
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG 637 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec
Confidence 99999999999999999999975432 1 233889999999999999999999998 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNL 297 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~ 297 (398)
++..|||+|||+++.....++........-...|||||.+..+.|+.++|||||||+|||+++ |+.||.+.... ..
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---EV 714 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---EV 714 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---HH
Confidence 999999999999999888777665545555779999999999999999999999999999999 99999763221 11
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
+ +.+.......-+..+|.++++|+..||+.+|++||+++||-..|..+-+
T Consensus 715 I--------------e~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 I--------------ECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred H--------------HHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 1 1111112244566788999999999999999999999999999987754
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=350.79 Aligned_cols=266 Identities=24% Similarity=0.309 Sum_probs=217.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeE-E
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGY-C 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~-~ 147 (398)
...++++.++|.+|||+.||+|.+.. .+..||+|++-..+....+.+.+|+.+|++|. |+|||.+++. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 44578889999999999999997654 45899999987666677788899999999997 9999999993 2
Q ss_pred Ee------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 148 LE------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 148 ~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
.. .-+++|+||||.+|.|.+++..+.. ..|++.++++|+.++++|+.+||...++|||||||-+||||+.+|
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG 183 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence 21 1356799999999999999987665 349999999999999999999999999999999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCcccc-------ccccccccccccccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015909 222 NAKLSDFGLARDGPTGDKSHVS-------TRVMGTYGYAAPEYL---ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~ 291 (398)
..||||||.+............ -...-|+.|+|||.+ .+.++++++|||+|||+||-||....||+....
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 9999999998754332211100 012458999999987 678899999999999999999999999975321
Q ss_pred CCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcc
Q 015909 292 TGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMH 366 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 366 (398)
..+++.....+.....+..+.+||..||+.||++||++.++++.+..|..-..-.
T Consensus 264 --------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 264 --------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred --------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 2344444444444578899999999999999999999999999999887544433
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=330.69 Aligned_cols=275 Identities=28% Similarity=0.453 Sum_probs=208.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcc-------cccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSL-------ASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVK 142 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-------~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~ 142 (398)
.++|++.+.||+|+||.||+|.+..... ......++..||+|.+..... .....+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4679999999999999999998654210 011234566899999875432 23456889999999999999999
Q ss_pred eeeEEEeCCceEEEEeecCCCCHHHHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015909 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGS---------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIY 207 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH 207 (398)
+++++...+..++||||+++++|.+++..... ....+++..+..++.||+.||.|||+++ |+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH 161 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVH 161 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 99999999999999999999999999865321 1134678889999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh--CCCC
Q 015909 208 RDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS--GRRA 285 (398)
Q Consensus 208 ~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p 285 (398)
|||||+|||++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986544333222333456788999999988899999999999999999987 5567
Q ss_pred CCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 286 IDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
|..... ................ ......+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGR-------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhccc-------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 754321 1111111111111100 0001112234578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=337.13 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=216.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|..++++|+|+||.++.++.+ ..+..|++|.+...... .......|+.++++++||||+.+.+.|..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk---------~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK---------SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc---------cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 57889999999999999987544 46779999999765443 34467899999999999999999999999
Q ss_pred CCc-eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 150 DDH-RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 150 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
++. .+|||+||+||+|.+.+.+.+. .-++++.++.++.|++.|+.|||++. |+|||||+.|||++.++.|+|+||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecch
Confidence 988 8999999999999999987763 56899999999999999999999887 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|+...... ....+..||+.||+||++.+.+|+.++|||||||++|||++-+++|...+... ..
T Consensus 151 GlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li------- 215 (426)
T KOG0589|consen 151 GLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LI------- 215 (426)
T ss_pred hhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HH-------
Confidence 9999876544 23456789999999999999999999999999999999999999997543211 00
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
. ++. .....+.+...+.+++.++..||..+|+.||++.++|..---+
T Consensus 216 ~---ki~-~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 216 L---KIN-RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred H---HHh-hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 0 111 1112345667788999999999999999999999999984333
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=340.80 Aligned_cols=266 Identities=26% Similarity=0.377 Sum_probs=206.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. .....++..||+|+++... ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~----~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYG----LFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEec----cccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4578999999999999999997532 1223467789999987442 23345688999999999 8999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCC-----------------------------------------------------
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSY----------------------------------------------------- 175 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~----------------------------------------------------- 175 (398)
..+..++||||+++|+|.+++......
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999999999998753210
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCC
Q 015909 176 ------------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTG 237 (398)
Q Consensus 176 ------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~ 237 (398)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788889999999999999999998 999999999999999999999999999765433
Q ss_pred CCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 238 DKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
..........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..... +...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~-------- 333 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEG-------- 333 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhC--------
Confidence 22212222345667999999999999999999999999999998 888986432110 11111 1100
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
.....+...+.++.+|+.+||+.||++||++.++++.|++
T Consensus 334 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 --YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0001111235689999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=304.94 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=211.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|.+++.||+|.||.||.|+.+. ++-.||+|++.+... ....++.+|++|...|+||||+++|++|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred hhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 3568899999999999999998765 788999999975432 3456789999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+....|+++||.+.|.|...+..... ..+++.....+..|++.|+.|+|..+ |+||||||+|+|++..+.+||+|
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccC
Confidence 999999999999999999999984332 45788888999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||.+..... ....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||+..... .. +.
T Consensus 168 fGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---et-------Yk- 232 (281)
T KOG0580|consen 168 FGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ET-------YK- 232 (281)
T ss_pred CCceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HH-------HH-
Confidence 999876432 2345689999999999999999999999999999999999999999754311 00 00
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
++ . .....++...+.+++++|.+||..+|.+|.+..+++.+=
T Consensus 233 --rI---~--k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 233 --RI---R--KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred --HH---H--HccccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 00 0 011223456678899999999999999999999998874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=336.67 Aligned_cols=240 Identities=29% Similarity=0.462 Sum_probs=207.2
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
++-||.|+.|.||+|++ .++.||||+++.-. ..+|+.|++|+||||+.+.|+|...-.++||
T Consensus 129 LeWlGSGaQGAVF~Grl-----------~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-----------HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred hhhhccCcccceeeeec-----------cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 45599999999999987 46889999886432 3678999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
||||..|.|...+.... +++......+..+|+.||.|||.+. |||||||.-||||+.+..|||+|||.++....
T Consensus 191 MEfCa~GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eeccccccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999999998764 5888899999999999999999998 99999999999999999999999999886543
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
. ...-.+.||..|||||++++.+.++++|||||||+|||||||..||.+-+. ...+..+-.
T Consensus 265 ~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----------------sAIIwGVGs 325 (904)
T KOG4721|consen 265 K---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----------------SAIIWGVGS 325 (904)
T ss_pred h---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----------------heeEEeccC
Confidence 3 223347899999999999999999999999999999999999999975321 222334444
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
..+....+..+++-+.-|+++||+..|..||++++++.||+-.
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 4555667777889999999999999999999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=328.35 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=203.5
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.|+..+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++|+||+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 37788999999999999997654 788999999865432 223457889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg 147 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLG 147 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999988865432 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||............ .. ...
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--~~-~~~--- 218 (285)
T cd05631 148 LAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV--DR-RVK--- 218 (285)
T ss_pred CcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH--HH-Hhh---
Confidence 997643222 123356899999999999999999999999999999999999999764332111000 00 000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
.....++...+.++.+|+.+||+.||.+||+ +++++++
T Consensus 219 --------~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 --------EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --------cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0011223344678899999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=336.81 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=205.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|.+.. ++..||+|++.... ......+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 368999999999999999997754 68899999987542 233456788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Df 145 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDF 145 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999997653 4889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ . ......
T Consensus 146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~---~~i~~~- 213 (333)
T cd05600 146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---W---ENLKYW- 213 (333)
T ss_pred cCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---H---HHHHhc-
Confidence 99976433 22345799999999999999999999999999999999999999975332110 0 000000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...+............+.++.+++.+||..+|.+||++.+++++
T Consensus 214 ---~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 214 ---KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00011111111112346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=339.94 Aligned_cols=267 Identities=25% Similarity=0.381 Sum_probs=207.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|++... ....++..||+|.+..... ...+.+.+|+.+++.+ +|+||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 45788999999999999999976431 1223556899999975432 3345688999999999 8999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC------------------------------------------------------
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS------------------------------------------------------ 174 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------------ 174 (398)
..+..++||||+++|+|.+++.....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999864321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccc
Q 015909 175 ------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242 (398)
Q Consensus 175 ------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~ 242 (398)
....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++..........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 1124788889999999999999999998 99999999999999999999999999876533322212
Q ss_pred ccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccC
Q 015909 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEG 321 (398)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (398)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ...... . .....
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~----~----------~~~~~ 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMV----K----------RGYQM 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHH----H----------cccCc
Confidence 222335667999999988899999999999999999997 999996532211 110000 0 00011
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 322 QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 322 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
..+...+.++.+++.+||+.||.+||++.++++.|+++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11112356899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=349.74 Aligned_cols=256 Identities=22% Similarity=0.277 Sum_probs=206.8
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCc
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~ 152 (398)
.|.+.+.||+|+||.||+|.... ..+..|++|.+..........+.+|+.+|+.++||||+++++++...+.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~--------~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGS--------DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcC--------CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 48899999999999999996543 1267888998765544444567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
.++||||+++++|.+++........++++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 99999999999999988754433456899999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccc
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~------ 285 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLY------ 285 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh------
Confidence 754433222334567999999999999999999999999999999999999999643211 11111000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ....+...+.++.++|.+||+.||++||++.+++.+
T Consensus 286 ----~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 286 ----GK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----CC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00 011223345689999999999999999999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=334.48 Aligned_cols=243 Identities=30% Similarity=0.406 Sum_probs=198.6
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL 154 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~ 154 (398)
++||+|+||.||+|.... ++..||+|++..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 469999999999997654 789999999875422 23356778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
+||||+++++|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++..
T Consensus 72 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 72 FVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9999999999999987653 5889999999999999999999998 999999999999999999999999998753
Q ss_pred CCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccc
Q 015909 235 PTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314 (398)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~------- 210 (323)
T cd05571 146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME------- 210 (323)
T ss_pred ccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHcC-------
Confidence 2211 1223457999999999999999999999999999999999999999643211 000000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 315 LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
...++...+.++.+||.+||+.||++|| ++.+++++
T Consensus 211 -----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 211 -----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0122334567899999999999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=324.61 Aligned_cols=246 Identities=20% Similarity=0.323 Sum_probs=199.9
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc---hHHHHHHHHHHcCCCCCcccceeeEEEe----C
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTEINYLGQLHHPNLVKLVGYCLE----D 150 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~I~~~~~~~~~----~ 150 (398)
..||+|++|.||+|.+ +|..||+|.+....... .+.+.+|+.+|++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 5799999999999976 47889999997654333 4567799999999999999999999876 3
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
...++||||+++|+|.+++.... .+++.....++.+++.||.|||+. + ++||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg 168 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHG 168 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccc
Confidence 46789999999999999997653 578899999999999999999984 6 8899999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
++....... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .. .......
T Consensus 169 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~---~~~i~~~ 237 (283)
T PHA02988 169 LEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EI---YDLIINK 237 (283)
T ss_pred hHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHHhc
Confidence 987643221 23467899999999976 68999999999999999999999999753211 11 1110000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
......+...+..+.+++.+||+.||++|||++++++.|+.++.
T Consensus 238 ----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 238 ----------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ----------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 01112233456789999999999999999999999999998864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=332.19 Aligned_cols=247 Identities=25% Similarity=0.338 Sum_probs=203.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 368899999999999999997654 688999999864322 23456788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Df 145 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDF 145 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEec
Confidence 9999999999999999999997654 4888999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .........
T Consensus 146 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~- 213 (291)
T cd05612 146 GFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAG- 213 (291)
T ss_pred CcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-
Confidence 998765322 12356899999999999989999999999999999999999999653211 111111100
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKEL 356 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~L 356 (398)
...++...+..+.+|+.+||+.||.+||+ +++++++-
T Consensus 214 -----------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 214 -----------KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred -----------CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 01122233567899999999999999995 88888773
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.34 Aligned_cols=267 Identities=25% Similarity=0.346 Sum_probs=201.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||.|+||+||+|.... ++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 568999999999999999997654 788999999865432 2345678999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||++ ++|.+++...+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 76 RCLTLVFEYLD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred CeEEEEEeCCC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999999996 58998887654 34788999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh--------
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA-------- 301 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~-------- 301 (398)
+........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||...............
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 150 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred eeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 875432221 1233568999999999865 56899999999999999999999999754322111100000
Q ss_pred hhhhhccccccccccccccCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQ----FSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+.............+..... .....+.++.+||.+||+.||.+|||++|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000111111110000 011235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=326.76 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=202.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||+||+|++.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 468999999999999999997754 688999999865422 234567899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++..++||||++++.+..+.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg 145 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFG 145 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeecc
Confidence 99999999999887665544322 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh-hh-----
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA-KP----- 303 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~-~~----- 303 (398)
++......... ......|++.|+|||++.+..++.++|||||||++|+|++|++||............... .+
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07848 146 FARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ 224 (287)
T ss_pred Ccccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence 99875332211 123356899999999999888999999999999999999999999754321110000000 00
Q ss_pred --hhhcccccccccccccc------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 --YLTSKRRIFRVLDPRLE------GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 --~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.............+... .......+.++.+|+.+||+.||++|||++++++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000000 01111245679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=335.49 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=203.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 468889999999999999997654 688999999865322 33456889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997653 4788999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .......
T Consensus 163 g~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~--- 228 (329)
T PTZ00263 163 GFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKIL--- 228 (329)
T ss_pred cCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHh---
Confidence 9997653321 2357899999999999999999999999999999999999999653211 0001000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
... ..++...+..+.+||.+||+.||.+|++ +++++++
T Consensus 229 -------~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 229 -------AGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -------cCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 000 1122224567899999999999999986 7888877
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=331.22 Aligned_cols=266 Identities=24% Similarity=0.346 Sum_probs=206.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4689999999999999999997654 788999999875422 234568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.++|+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCc
Confidence 999999999999999999997653 4889999999999999999999852 39999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh-hhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK-PYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 308 (398)
++....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||....... +..... +.....
T Consensus 150 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~ 222 (331)
T cd06649 150 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGE 222 (331)
T ss_pred ccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccc
Confidence 987653321 233568999999999999999999999999999999999999996432110 000000 000000
Q ss_pred cc-------------------------------ccc-cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 309 RR-------------------------------IFR-VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 309 ~~-------------------------------~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.. ... +.............+.++++||.+||+.||++|||+.+++++-
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00 000 0000000001112467899999999999999999999999985
Q ss_pred H
Q 015909 357 E 357 (398)
Q Consensus 357 ~ 357 (398)
-
T Consensus 303 ~ 303 (331)
T cd06649 303 F 303 (331)
T ss_pred H
Confidence 3
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=315.38 Aligned_cols=266 Identities=26% Similarity=0.340 Sum_probs=204.7
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCc-ccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPN-LVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~-I~~~~~~~~~ 149 (398)
.|...+.||+|+||+||+|+... +|..||+|+++..... ......+|+.+|+.|+|+| |+.+++++..
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 45556779999999999997765 7899999999765332 3456789999999999999 9999999988
Q ss_pred CC------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 150 DD------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 150 ~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
.+ .+++|+||+ ..+|..++.........++...+..++.||+.||+|||+++ |+||||||+||||++.|.+
T Consensus 83 ~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~l 159 (323)
T KOG0594|consen 83 SNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVL 159 (323)
T ss_pred cccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcE
Confidence 77 789999999 66999999887643245777899999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
||+|||+|+....... .....++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+..+.... ....+
T Consensus 160 KlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql--~~If~ 235 (323)
T KOG0594|consen 160 KLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL--FRIFR 235 (323)
T ss_pred eeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH--HHHHH
Confidence 9999999986543222 24556789999999999887 7999999999999999999999999876542111 00000
Q ss_pred hhhhc--cccccccc--------ccccc--CCCCHHH---HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTS--KRRIFRVL--------DPRLE--GQFSLPQ---AQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~--~~~~~~~~--------~~~~~--~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+.. ...+.... .+... ....... ..+..+++.+||+.+|.+|.|++.+++|
T Consensus 236 -~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 236 -LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred -HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000 00000000 00000 0001111 2478899999999999999999999997
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=328.84 Aligned_cols=243 Identities=29% Similarity=0.394 Sum_probs=197.7
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL 154 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~ 154 (398)
+.||+|+||.||+|.... ++..||+|.+..... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 469999999999997654 789999999875422 23455678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
+||||+++++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 72 lv~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 72 FVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9999999999998887653 5889999999999999999999998 999999999999999999999999998753
Q ss_pred CCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccc
Q 015909 235 PTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314 (398)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........
T Consensus 146 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~------- 210 (323)
T cd05595 146 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILME------- 210 (323)
T ss_pred cCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcC-------
Confidence 22211 2234579999999999999999999999999999999999999996432110 00000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 315 LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
...++...+.++.++|.+||+.||++|+ ++.+++++
T Consensus 211 -----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 211 -----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0112233467889999999999999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=321.78 Aligned_cols=264 Identities=28% Similarity=0.471 Sum_probs=209.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+|++.+.||+|+||.||+|..... ........|++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGP----NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecC----CCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4688899999999999999976541 1122457899999875432 2345688999999999999999999999998
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSY------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
...+++|||+++++|.+++...... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 9999999999999999999764321 145788899999999999999999998 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNL 297 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~ 297 (398)
+++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... +.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV 235 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence 999999999999976544333222334456888999999988899999999999999999998 99998653221 11
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
... +........+...+.++.+|+.+||+.||.+||++.+++++|+.
T Consensus 236 ~~~--------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEM--------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHH--------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 110 00011112234456889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=321.12 Aligned_cols=268 Identities=29% Similarity=0.452 Sum_probs=211.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|.+.+.||+|+||.||++.+... ....++..+++|.+........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45788999999999999999975331 12235677999998765444556789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGS---------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
+..++||||+++++|.+++...+. ....+++..++.++.|++.||+|||+++ ++||||||+||++++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 999999999999999999975431 2234899999999999999999999998 99999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~ 300 (398)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ....
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~- 233 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE- 233 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-
Confidence 999999999986543322222223445778999999998899999999999999999998 99998643211 0100
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.. .... . ...+...+.++.+++.+||+.||.+|||+.+++..|+++.+
T Consensus 234 --~i-~~~~------~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 --CI-TQGR------V----LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --HH-HcCC------c----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 00 0000 0 01111234678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=333.50 Aligned_cols=262 Identities=19% Similarity=0.225 Sum_probs=198.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|++.+.||+|+||.||+|.+.. ++..||+|.... ..+.+|+.+|+.|+||||+++++++...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 3679999999999999999997654 788999997542 3467899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++|+|++ .++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~ 228 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGA 228 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCc
Confidence 9999999999 568888886543 4789999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc-chhhhhhhhhhc--
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH-NLVEWAKPYLTS-- 307 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~-- 307 (398)
+........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... +...........
T Consensus 229 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g 307 (391)
T PHA03212 229 ACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG 307 (391)
T ss_pred ccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhc
Confidence 875322211 1223457999999999999999999999999999999999999887543221110 000000000000
Q ss_pred ----------ccccc----cccc--ccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 ----------KRRIF----RVLD--PRLEGQF-----SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ----------~~~~~----~~~~--~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...+. .... ....... ....+.++.+||.+||+.||++|||++|++++
T Consensus 308 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred CChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0000 0000000 11246689999999999999999999999965
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=334.43 Aligned_cols=269 Identities=25% Similarity=0.357 Sum_probs=209.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCC-CCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLH-HPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~I~~~~~~~ 147 (398)
..++|++.++||+|+||.||+|.+.. ......+..||+|.+..... ...+.+.+|+.+|+.+. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYG----LSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcc----cCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 35689999999999999999997643 12223456899999975432 23457889999999996 99999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCC-----------------------------------------------------
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGS----------------------------------------------------- 174 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------------------- 174 (398)
......++|||||++|+|.+++.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999998865321
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 175 ---------------------------------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 175 ---------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
....+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhE
Confidence 0134778888999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGE 294 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~ 294 (398)
|++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~- 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS- 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence 999999999999999876533322222233456788999999988899999999999999999997 999986432110
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.+.. ..... .....+...+.++.+++.+||+.||++||++.++.+.|+++.
T Consensus 348 -~~~~----~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 -TFYN----KIKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHH----HHhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0000 00000 011122344678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=324.08 Aligned_cols=266 Identities=22% Similarity=0.309 Sum_probs=199.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.... ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 4679999999999999999997654 688999999875432 223457789999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....++||||++ ++|.+++.... ..++...+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg 148 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFG 148 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCC
Confidence 999999999994 68888776543 35788999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .............
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 224 (303)
T cd07869 149 LARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTP 224 (303)
T ss_pred cceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCC
Confidence 987532221 12233568999999999865 458889999999999999999999997532210 0000000000000
Q ss_pred --c------ccccccccccc--CCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 --R------RIFRVLDPRLE--GQFS-------LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 --~------~~~~~~~~~~~--~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ........... .... ...+.++.+|+.+||+.||++|||+.++++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 225 NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 00000000000 0000 0123568899999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.12 Aligned_cols=260 Identities=22% Similarity=0.384 Sum_probs=206.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|++.. ....+..||+|.++.... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKL------PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEec------CCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 3568899999999999999997643 123577999999976432 223568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.++++|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCc
Confidence 999999999999999999987643 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
.+........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... ...
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~- 223 (266)
T cd05064 153 RLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VED- 223 (266)
T ss_pred ccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHC-
Confidence 8765322111 11112335678999999999999999999999999999775 99999653221 11110 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
. .....+...+..+.+++.+||+.+|.+||++++|++.|.++
T Consensus 224 -----~----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 -----G----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----C----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 01112233567889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=345.93 Aligned_cols=260 Identities=24% Similarity=0.306 Sum_probs=209.1
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceee
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
....++|++.+.||+|+||+||+|.... ++..||+|.+..... .....+.+|+.++..++|+||+++++
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~ 98 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeec
Confidence 3345789999999999999999997654 688999999875433 23456788999999999999999988
Q ss_pred EEEeCC--------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE
Q 015909 146 YCLEDD--------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217 (398)
Q Consensus 146 ~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv 217 (398)
.+...+ ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 99 ~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl 176 (496)
T PTZ00283 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL 176 (496)
T ss_pred ceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE
Confidence 765432 367999999999999999866554567899999999999999999999998 9999999999999
Q ss_pred cCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 218 DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 218 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
+.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------ 250 (496)
T PTZ00283 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------ 250 (496)
T ss_pred eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------
Confidence 99999999999999865443333333456799999999999999999999999999999999999999964321
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......... .....+...+.++.+++.+||+.||.+||++.+++++
T Consensus 251 ~~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EEVMHKTLAG-----------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHhcC-----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111100 0111233456789999999999999999999999875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=319.73 Aligned_cols=263 Identities=29% Similarity=0.456 Sum_probs=208.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|.+.+.||+|+||.||+|.+... ....++..|++|.+...... ..+.+.+|+++|+.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 4688889999999999999976431 11235688999998765433 356789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGS----------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
...++||||+++++|.+++...+. ....+++..+..++.|++.|+.|||+++ ++||||||+||+++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 999999999999999999976532 2244788899999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhh
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~ 299 (398)
+.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~ 235 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIE 235 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH
Confidence 9999999999876433322222223446788999999999999999999999999999998 99998643221 1111
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.. .. ......+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 236 ~~----~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CI----TQ----------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH----Hc----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 00 0011112234578899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=319.99 Aligned_cols=267 Identities=29% Similarity=0.458 Sum_probs=212.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|.+.+.||+|+||.||+|.+... ....++..+++|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4688889999999999999975431 122356779999987665555677899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~ 219 (398)
..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence 99999999999999999976432 1234789999999999999999999998 999999999999999
Q ss_pred CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchh
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLV 298 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~ 298 (398)
++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~ 235 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVI 235 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH
Confidence 99999999999976544332222233456788999999999999999999999999999998 99998643211 011
Q ss_pred hhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.. .... .....+...+..+.+++.+||+.||.+||++.++++.|+++.+
T Consensus 236 ~~----~~~~----------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 EC----ITQG----------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HH----HhCC----------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 10 0000 0001122245678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=326.95 Aligned_cols=269 Identities=28% Similarity=0.394 Sum_probs=207.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++.++||+|+||.||+|.... .....++..||+|++..... ...+.+..|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~----~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFG----IEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccc----cccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 4579999999999999999996533 12223568999999875432 2345678899999999 7999999999876
Q ss_pred e-CCceEEEEeecCCCCHHHHHhhcCCC----------------------------------------------------
Q 015909 149 E-DDHRLLVYEFMPRGSMENHLFRRGSY---------------------------------------------------- 175 (398)
Q Consensus 149 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~---------------------------------------------------- 175 (398)
. +..++++|||+++++|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 5 45678999999999999998653211
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccccccccccc
Q 015909 176 -----FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250 (398)
Q Consensus 176 -----~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 250 (398)
...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++................++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 125789999999999999999999998 9999999999999999999999999998754332222223345677
Q ss_pred ccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHH
Q 015909 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQ 329 (398)
Q Consensus 251 ~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (398)
.|+|||.+.+..++.++|||||||++|+|++ |..||....... .+. ..+.... ....+...+.
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~----------~~~~~~~~~~ 303 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGT----------RMRAPEYATP 303 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccC----------CCCCCccCCH
Confidence 8999999999999999999999999999998 999996532111 110 0011000 0011223356
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 330 KAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 330 ~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
++.+++.+||+.+|++||++.+++++|+++-+
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 78999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=327.86 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=213.8
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCC-CCcccceee
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLH-HPNLVKLVG 145 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~~I~~~~~ 145 (398)
....|.+.+.||.|.||.||+|..+. +|..+|+|.+.+.... ..+.+.+|+.+|+++. ||||+.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~---------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS---------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC---------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 45678899999999999999996654 7999999999876543 3468899999999998 999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC----CC
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS----NY 221 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~----~~ 221 (398)
+|.+.+..++|||+|.||.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+.. ++
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCC
Confidence 999999999999999999999999876 2899999999999999999999998 999999999999953 35
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
.++++|||++..... .......+||+.|+|||++....|+..+|+||+|+++|.|++|.+||.+.........+.
T Consensus 177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-- 251 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-- 251 (382)
T ss_pred cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH--
Confidence 799999999998655 334566899999999999999999999999999999999999999998754332211000
Q ss_pred hhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. .+..+....-...+..+.+++..||..||.+|+++.++|+|
T Consensus 252 ----~--------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 ----R--------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----c--------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 0 00122233334557889999999999999999999999996
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=328.60 Aligned_cols=243 Identities=28% Similarity=0.394 Sum_probs=198.6
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL 154 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~ 154 (398)
++||+|+||.||+|.... ++..||+|++..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 469999999999997654 789999999975422 23456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
+||||+++++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...
T Consensus 72 lv~Ey~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 72 FVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred EEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 9999999999998887653 5889999999999999999999998 999999999999999999999999998753
Q ss_pred CCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccc
Q 015909 235 PTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314 (398)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~-------- 209 (328)
T cd05593 146 ITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILM-------- 209 (328)
T ss_pred CCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhcc--------
Confidence 2211 1223457999999999999999999999999999999999999999643211 11110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 315 LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
....++...+.++.++|.+||+.||++|+ ++.+++++
T Consensus 210 ----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 210 ----EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 01122334467889999999999999997 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=306.89 Aligned_cols=253 Identities=27% Similarity=0.380 Sum_probs=205.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.+.|.+.++||+|.|+.||++. +..+|+.+++|+++...+ ...+.+.+|+.|.+.|+||||+++.+.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~---------~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCV---------HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred chhhhHHHHHccCchHHHHHHH---------hccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 4567888999999999999974 444899999998864322 35678899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc---CCCCEEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD---SNYNAKL 225 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~---~~~~~kl 225 (398)
.....|+|+|++.|++|..-|..+ ...++..+..++.||++||.|+|.++ |||||+||+|+++. ...-+||
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceee
Confidence 999999999999999998777655 24788889999999999999999999 99999999999995 4456999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+|||++.....+ .......|||.|||||+++..+|+..+|||+.|++||-||.|.+||.+.+... +. ..+.
T Consensus 155 ~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---ly---e~I~ 225 (355)
T KOG0033|consen 155 ADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LY---EQIK 225 (355)
T ss_pred cccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---HH---HHHh
Confidence 999999887622 23445789999999999999999999999999999999999999998643211 10 0000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. -. ....+.-...++++++|+++||..||.+|.|+.|.|+|
T Consensus 226 ~g---~y-----d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 226 AG---AY-----DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cc---cc-----CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 00 00 01111223456789999999999999999999998865
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=317.20 Aligned_cols=269 Identities=25% Similarity=0.334 Sum_probs=203.4
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC-
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD- 151 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~- 151 (398)
.|+..+++|.|+||.||+|...+ +++.||||.+-.+.. .--+|+.+|+.+.||||+++..+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 46677999999999999998876 689999999865432 1237999999999999999998886532
Q ss_pred ----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-CCCEEEe
Q 015909 152 ----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLS 226 (398)
Q Consensus 152 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-~~~~kl~ 226 (398)
...+||||++ .+|...+.........++...+.-+..||+.||.|||+.+ |+||||||.|+|||. .|.+|||
T Consensus 92 ~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEec
Confidence 3358999995 4999999865444466888888999999999999999988 999999999999995 4999999
Q ss_pred eccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|||.|+....+... .....|..|+|||++.| ..|+.+.||||.||++.||+.|++.|.+.+.... +....+-+-
T Consensus 169 DFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG 243 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLG 243 (364)
T ss_pred cCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhC
Confidence 99999987665543 34567899999999876 5799999999999999999999999987543221 111111000
Q ss_pred hcc-c------------cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHHHH
Q 015909 306 TSK-R------------RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE--LEQLQEL 362 (398)
Q Consensus 306 ~~~-~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l~~~ 362 (398)
... + ...++.......-+....+.++.+|+.++|..+|.+|.++.+++.+ ++.+++-
T Consensus 244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000 0 0011111111111333457889999999999999999999999965 5555544
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=329.08 Aligned_cols=267 Identities=25% Similarity=0.384 Sum_probs=197.8
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 58889999999999999997654 78899999986432 23345678999999999999999999987643
Q ss_pred -----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 151 -----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 151 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
...++||||+ +++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL 144 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKI 144 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEE
Confidence 2479999999 568988887553 4899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCc-cccccccccccccccccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh---
Q 015909 226 SDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE--- 299 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~--- 299 (398)
+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.............
T Consensus 145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 224 (338)
T cd07859 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224 (338)
T ss_pred ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 999999764322211 11234578999999999865 678999999999999999999999996543211000000
Q ss_pred ------hhhhhhh-ccccccccccccccCCCC---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 ------WAKPYLT-SKRRIFRVLDPRLEGQFS---LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ------~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... ........+......... ...+..+.+++.+||+.||++||++++++++
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 000000000000000000 1124578899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=327.67 Aligned_cols=249 Identities=25% Similarity=0.345 Sum_probs=194.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+|+..+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+++.++|+||+++++++...
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 456677899999999999997654 688999999864422 2345688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|... ....+..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 145 ~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred CeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999998642 22466778899999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccccccccccccccccccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+........ ......||..|+|||++.. ...+.++|||||||++|||++|+.||....... .........
T Consensus 215 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~ 289 (353)
T PLN00034 215 SRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAIC 289 (353)
T ss_pred ceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHh
Confidence 876532211 1233578999999998743 334568999999999999999999997322111 110000000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ......+...+.++.+||.+||+.||++||++.|++++
T Consensus 290 ~-----------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 M-----------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred c-----------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00111223446789999999999999999999999986
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=326.52 Aligned_cols=263 Identities=27% Similarity=0.399 Sum_probs=202.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+.. ++..+++|.+..... .....+.+|+++++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 4689999999999999999997654 688899998865422 234568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
++..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.++|+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Df 148 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 148 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeC
Confidence 999999999999999999997653 478899999999999999999974 5 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh--
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT-- 306 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-- 306 (398)
|++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... +.........
T Consensus 149 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~ 221 (333)
T cd06650 149 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE---LELMFGCPVEGD 221 (333)
T ss_pred Ccchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH---HHHHhcCcccCC
Confidence 998754322 1223568999999999998899999999999999999999999996532210 0000000000
Q ss_pred ----------------------ccc---ccccccccccc---CCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 ----------------------SKR---RIFRVLDPRLE---GQF-SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ----------------------~~~---~~~~~~~~~~~---~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..+ ........... ... ....+.++.+|+.+||+.||++||++.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 222 PAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000 00000000000 000 01135678999999999999999999999887
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=317.79 Aligned_cols=265 Identities=24% Similarity=0.407 Sum_probs=206.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..++|++.+.||+|+||.||+|.+... ....++..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456799999999999999999986531 223356789999986432 233456889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSY------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
.....++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence 999999999999999999998754321 124677889999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~ 301 (398)
++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~- 233 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRF- 233 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH-
Confidence 99999999876543322222222345778999999998899999999999999999999 78888643211 11100
Q ss_pred hhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.... . ....+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 234 --~~~~--~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 --VMEG--G---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --HHcC--C---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0000 0 00112233567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=326.30 Aligned_cols=241 Identities=29% Similarity=0.363 Sum_probs=196.3
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999997654 68899999986432 23345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++....
T Consensus 72 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 72 LAFINGGELFHHLQREG----RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred EcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 99999999999997653 4889999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..........
T Consensus 146 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~--------- 208 (312)
T cd05585 146 DD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQE--------- 208 (312)
T ss_pred CC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcC---------
Confidence 21 123345799999999999999999999999999999999999999964321 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPD---MDEVVKE 355 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 355 (398)
...++...+.++.+++.+||+.||.+||+ +.+++++
T Consensus 209 ---~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 209 ---PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 11223345678899999999999999975 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=330.60 Aligned_cols=247 Identities=26% Similarity=0.307 Sum_probs=202.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|.+.. ..+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKN--------EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEEC--------CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 468889999999999999997643 134689999986432 233456788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecC
Confidence 9999999999999999999997654 4889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .......
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~-- 242 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILE-- 242 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhc--
Confidence 999764321 224579999999999998889999999999999999999999997532210 0000000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
. ...++...+..+.+++.+||+.||.+|+ ++++++++
T Consensus 243 --------~--~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 243 --------G--IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --------C--CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 0112233456789999999999999995 89998876
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=312.36 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=209.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|+... ++..|++|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 578999999999999999997654 688999998764322 23346788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++++||+++++|.+++.........+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999988754433356889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...+... ..
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-~~-- 221 (267)
T cd08228 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-IE-- 221 (267)
T ss_pred ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-Hh--
Confidence 99876533221 122346888999999998888999999999999999999999998643211 1111110 00
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
... .........+..+.+++.+||+.+|++||++.++++.|++++
T Consensus 222 ----~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 222 ----QCD---YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----cCC---CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 011112244578999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=331.56 Aligned_cols=254 Identities=26% Similarity=0.338 Sum_probs=199.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.... ++..||+|++..... .....+..|+.++..++|+||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 468899999999999999997654 788999999975322 22356778999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+....++||||+++|+|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DF 145 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDF 145 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeec
Confidence 9999999999999999999998653 5899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc---------------------------------ccccccccccccccccccccCCCCCchhHHHHHHH
Q 015909 229 GLARDGPTGDKS---------------------------------HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVV 275 (398)
Q Consensus 229 g~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 275 (398)
|+++........ ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 225 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence 998754321100 00123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCC---CCCCHHHH
Q 015909 276 LLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPK---LRPDMDEV 352 (398)
Q Consensus 276 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rps~~el 352 (398)
+|||++|+.||....... ........... +........+.++.++|.+|+. +|. .||+++++
T Consensus 226 l~ell~G~~Pf~~~~~~~------~~~~i~~~~~~--------~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei 290 (363)
T cd05628 226 MYEMLIGYPPFCSETPQE------TYKKVMNWKET--------LIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEI 290 (363)
T ss_pred HHHHHhCCCCCCCCCHHH------HHHHHHcCcCc--------ccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 999999999997533211 00000000000 0001111245678899988764 444 45899999
Q ss_pred HHH
Q 015909 353 VKE 355 (398)
Q Consensus 353 l~~ 355 (398)
+++
T Consensus 291 ~~h 293 (363)
T cd05628 291 KTN 293 (363)
T ss_pred hCC
Confidence 997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=333.84 Aligned_cols=254 Identities=27% Similarity=0.361 Sum_probs=205.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.+.. ++..||+|++..... .....+..|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 468999999999999999997654 789999999875322 33456788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecC
Confidence 999999999999999999999876 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCC---------------------------CcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh
Q 015909 229 GLARDGPTGD---------------------------KSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281 (398)
Q Consensus 229 g~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~ 281 (398)
|++....... .........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 9997654332 0011233568999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 015909 282 GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-MDEVVKE 355 (398)
Q Consensus 282 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~ 355 (398)
|+.||....... ......... ...........+.++.++|.+||. ||.+||+ +++++++
T Consensus 226 g~~Pf~~~~~~~------~~~~i~~~~--------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 226 GFPPFYSDTLQE------TYNKIINWK--------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCCHHH------HHHHHhccC--------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 999997543110 000000000 000111111146789999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=321.89 Aligned_cols=262 Identities=22% Similarity=0.391 Sum_probs=204.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+|++.+.||+|+||.||+|.+..+ ....+..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 35689999999999999999976431 111244699999875422 335678899999999999999999998876
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
. ..++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccc
Confidence 4 5789999999999999988654 35788899999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+.... .+.. .....
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~----~~~~~ 227 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKG 227 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHhCC
Confidence 9987544332222222334678999999999999999999999999999997 99998653211 0100 01100
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.....+...+.++.+++.+||+.||.+||++.+++..|..+.
T Consensus 228 ----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 ----------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011112223467889999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.98 Aligned_cols=267 Identities=22% Similarity=0.254 Sum_probs=203.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
...+|++.+.||+|+||.||+|.... ...+..|++|.+... ....+|+.+|+.++||||+++++++..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~-------~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHG-------DEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcC-------CccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 45679999999999999999986532 235778999988643 235689999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....++|||++ .++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 158 ~~~~~lv~e~~-~~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 158 KSTVCMVMPKY-KCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred CCEEEEEehhc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCc
Confidence 99999999999 56888888543 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++................||..|+|||++.+..++.++|||||||++|||++|+.||.+................+....
T Consensus 231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 99765444333333346799999999999999999999999999999999999999976433221111100000000000
Q ss_pred -cc-----------cccccccccCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 -RI-----------FRVLDPRLEGQFS-------LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 -~~-----------~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ...........+. ...+.++.++|.+||..||++||++.+++.+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000000 1124578899999999999999999999987
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=333.68 Aligned_cols=254 Identities=25% Similarity=0.297 Sum_probs=199.2
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.|++++.||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 58889999999999999997654 788999999975432 234567899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.++|+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCc
Confidence 999999999999999999987653 4888999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCC---------------------------------------------cccccccccccccccccccccCCCC
Q 015909 230 LARDGPTGDK---------------------------------------------SHVSTRVMGTYGYAAPEYLATGHLT 264 (398)
Q Consensus 230 ~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 264 (398)
++........ .......+||+.|+|||++.+..++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 9753211000 0001235799999999999988999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhc--cCC
Q 015909 265 AKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCL--SVE 342 (398)
Q Consensus 265 ~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~d 342 (398)
.++|||||||++|||++|..||......... ...... ............+.++.+||.+|+ ..+
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~------~~i~~~--------~~~~~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAPTPTETQ------LKVINW--------ENTLHIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCCCHHHHH------HHHHcc--------ccccCCCCCCCCCHHHHHHHHHHccCccc
Confidence 9999999999999999999999754321100 000000 000111111234578889999855 455
Q ss_pred CCCCCCHHHHHHH
Q 015909 343 PKLRPDMDEVVKE 355 (398)
Q Consensus 343 P~~Rps~~ell~~ 355 (398)
+..|+++.+++++
T Consensus 293 ~~~R~~~~~~l~h 305 (381)
T cd05626 293 RLGRNGADDIKAH 305 (381)
T ss_pred ccCCCCHHHHhcC
Confidence 5569999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=333.06 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=201.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 468999999999999999997654 688999999975321 23455778999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeec
Confidence 9999999999999999999987653 4899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcc------------------------------------cccccccccccccccccccCCCCCchhHHHH
Q 015909 229 GLARDGPTGDKSH------------------------------------VSTRVMGTYGYAAPEYLATGHLTAKSDIYSF 272 (398)
Q Consensus 229 g~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 272 (398)
|++.......... .....+||+.|+|||++.+..++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 9987542211100 0112469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC---H
Q 015909 273 GVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD---M 349 (398)
Q Consensus 273 G~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~ 349 (398)
||++|+|++|..||....... ......... ..+........+.++.++|.+||. +|.+|++ +
T Consensus 226 G~il~el~~G~~Pf~~~~~~~------~~~~i~~~~--------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 226 GVIMYEMLVGYPPFCSDNPQE------TYRKIINWK--------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred hhHHHHhhcCCCCCCCCCHHH------HHHHHHcCC--------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 999999999999997543211 001000000 000111111345688999999997 9999997 9
Q ss_pred HHHHHH
Q 015909 350 DEVVKE 355 (398)
Q Consensus 350 ~ell~~ 355 (398)
.+++++
T Consensus 291 ~~ll~h 296 (364)
T cd05599 291 NEIKSH 296 (364)
T ss_pred HHHhcC
Confidence 999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.91 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=196.4
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHH---cCCCCCcccceeeEE
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYL---GQLHHPNLVKLVGYC 147 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~~I~~~~~~~ 147 (398)
|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.++ +.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 6788999999999999997654 78899999997432 12334566666554 567899999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..|+||||+++++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~D 144 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIAD 144 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCc
Confidence 999999999999999999888754 34899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .........
T Consensus 145 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~ 216 (324)
T cd05589 145 FGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVND 216 (324)
T ss_pred ccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC
Confidence 99987532221 1223467999999999999999999999999999999999999999753211 011111000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
....+...+.++.++|.+||+.||.+|| ++.+++++
T Consensus 217 ------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 ------------EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0112223467788999999999999999 67888775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=311.55 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=207.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||+|+||.||+|.+... ..+...|++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLP------GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccC------CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 5688999999999999999987531 12456899999875432 2345688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+||++++++.++|+|||+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccch
Confidence 99999999999999999997654 35889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~----~~~~- 224 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKA----VEDG- 224 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHH----HHcC-
Confidence 987642222212222344678999999998899999999999999999998 99998543211 11100 0000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.....+...+..+.+++.+||+.+|++||++.+++++|+++
T Consensus 225 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 ---------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=316.51 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=198.7
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
||+|+||+||+|.+.. ++..||+|.+...... ..+.+..|+.+++.++|+||+++.+++......++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 7999999999997654 7889999998654322 234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 9999999999888654444456899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ..... ....
T Consensus 150 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~----------~~~~ 215 (280)
T cd05608 150 GQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQ----------RILN 215 (280)
T ss_pred CCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHH----------hhcc
Confidence 222 123357899999999999999999999999999999999999999653221110 00000 0011
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
. ....+...+..+.+++.+||+.||++|| ++++++++
T Consensus 216 ~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 216 D--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred c--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0 0122334567889999999999999999 67778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=317.82 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=196.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCC---CCCcccceeeE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQL---HHPNLVKLVGY 146 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~I~~~~~~ 146 (398)
.+|++.+.||+|+||+||+|.+.. .++..||+|.+..... .....+.+|+.+++.+ .||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC--------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 379999999999999999997632 2467899998864322 2234456777776665 69999999998
Q ss_pred EEe-----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 147 CLE-----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 147 ~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
+.. ....++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSG 147 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCC
Confidence 753 456899999995 689998876432 45889999999999999999999998 99999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
.++|+|||++...... .......||..|+|||++.+..++.++|||||||++|+|++|++||.+...... ....
T Consensus 148 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i 221 (290)
T cd07862 148 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKI 221 (290)
T ss_pred CEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHH
Confidence 9999999999764332 122345689999999999888999999999999999999999999976432111 0000
Q ss_pred hhhhh--ccccc-------ccccccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLT--SKRRI-------FRVLDPRLE---GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~--~~~~~-------~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ..... ...+..... .......+..+.+++.+||+.||++|||+.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000 00000 000000000 00111235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=324.78 Aligned_cols=256 Identities=28% Similarity=0.369 Sum_probs=202.0
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC----ccchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG----FQGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
+|++.+.||+|+||+||+++... ...++..||+|++.... ....+.+..|+.+++.+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVT------GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcc------cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 48889999999999999987532 23468899999986432 12345577899999999 599999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEee
Confidence 99999999999999999999987653 4889999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||+++........ ......||..|+|||++.+. .++.++|||||||++|+|++|+.||.......... ........
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~ 225 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK 225 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc
Confidence 9998764332221 12345799999999999765 47889999999999999999999996432221111 11110000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
. ....+...+..+.+++.+||+.||++|| ++++++++
T Consensus 226 --------~----~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 --------C----DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --------C----CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0 1112223456789999999999999999 78899876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=309.17 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=197.1
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+++++.++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 469999999999997654 688999998864432 3346688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++...+ ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 72 MELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEED 146 (252)
T ss_pred EeeccCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCccccc
Confidence 99999999999987543 35789999999999999999999998 99999999999999999999999999876432
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . .....
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~----~~~~~--------- 210 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---T----REAIE--------- 210 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---H----HHHHH---------
Confidence 211111111123456999999998889999999999999999998 888886432110 0 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 316 DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 211 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 211 -QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 00111222334668899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=311.48 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=206.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.+|.+.+.||.|+||.||+|.+.. ++..|++|.+.... .....+.+|+.+++.++|+||+++++++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 457888999999999999997754 67889999987543 33567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccc
Confidence 99999999999999999876432 45889999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ......
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~------ 218 (263)
T cd05052 152 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELL------ 218 (263)
T ss_pred cccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH------
Confidence 765432211 1112234567999999998999999999999999999998 99998643211 111100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
........+...+.++.+++.+||+.||++||++.++++.|+.+
T Consensus 219 -----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 -----EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00011122333467899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.29 Aligned_cols=265 Identities=23% Similarity=0.346 Sum_probs=196.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
...+|++.++||+|+||+||+|.+.. ++..||+|.+.... ....+|+.+|+.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 34679999999999999999997654 68899999885432 234579999999999999999988753
Q ss_pred C--------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 150 D--------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 150 ~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
. ..+++||||++ ++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT 207 (440)
T ss_pred cccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCC
Confidence 2 23568999996 5787777654333467899999999999999999999998 99999999999998654
Q ss_pred -CEEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 222 -NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 222 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...... +..
T Consensus 208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~ 282 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVR 282 (440)
T ss_pred CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH
Confidence 799999999986543222 223568999999999866 4689999999999999999999999976432111 110
Q ss_pred hhhhh----hh----ccccc-----cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPY----LT----SKRRI-----FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~----~~----~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... .. ..... .......+...++...+.++.+||.+||+.||.+|||+.+++++
T Consensus 283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000 00 00000 00000001111222345789999999999999999999999976
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=331.69 Aligned_cols=200 Identities=27% Similarity=0.389 Sum_probs=174.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-C-----Ccccceee
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-H-----PNLVKLVG 145 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~I~~~~~ 145 (398)
-+|.+.++||+|+||.|.+|++.. +++.||||+++... .-..+...|+.+|..|+ | -|||++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 478899999999999999998765 89999999997652 22355678999999997 4 38999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC--CCCE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS--NYNA 223 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~--~~~~ 223 (398)
+|...++.|||+|.+ ..+|.+++..+.. ..++...+..++.||+.||.+||+.+ |||+||||+|||+.+ ...|
T Consensus 256 ~F~fr~HlciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred ccccccceeeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCce
Confidence 999999999999999 6799999987654 67999999999999999999999998 999999999999963 3479
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~ 291 (398)
||+|||.|........ ..+-+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+.++
T Consensus 331 KVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred eEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9999999987433222 45678899999999999999999999999999999999999987654
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=313.18 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=209.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|++.+.||.|+||.||+|.+. .+..+++|.+..........+..|+.+++.++|+||+++++++...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~----------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWK----------NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEec----------CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 356888999999999999999764 2678999999876555567789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccc
Confidence 999999999999999999976432 45889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...... .
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~---~---- 218 (261)
T cd05148 151 ARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQI---T---- 218 (261)
T ss_pred hhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH---H----
Confidence 976533221 1123345778999999988899999999999999999998 89999653211 111100 0
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.......+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 219 -------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 219 -------AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -------hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0111122334467889999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=315.68 Aligned_cols=263 Identities=27% Similarity=0.436 Sum_probs=206.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+|++.+.||+|+||+||+|.+.. .....+..|++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYL-----PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEec-----CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 457888999999999999997532 1223578899999975332 2345688899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGS-------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv 217 (398)
+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+++ ++|+||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 999999999999999999864321 1234788899999999999999999998 9999999999999
Q ss_pred cCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 015909 218 DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHN 296 (398)
Q Consensus 218 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~ 296 (398)
+.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~ 234 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---E 234 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999986544332222333446778999999988889999999999999999998 99898643210 1
Q ss_pred hhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
..... ... .....+...+..+.+++.+||+.||.+||++.++++.|..
T Consensus 235 ~~~~~----~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMV----RKR----------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH----HcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11100 000 0011122345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=327.36 Aligned_cols=243 Identities=30% Similarity=0.393 Sum_probs=196.8
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL 154 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~ 154 (398)
+.||+|+||.||+|.... ++..||+|.+..... .....+..|+.+++.++||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 469999999999997654 789999999875422 23455678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
+||||+++++|..++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.++|+|||++..
T Consensus 72 lv~E~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 72 FVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 9999999999998887653 58999999999999999999997 67 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .........
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~------ 211 (325)
T cd05594 146 GIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME------ 211 (325)
T ss_pred cCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcC------
Confidence 322211 123457999999999999999999999999999999999999999643211 000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
...++...+.++.+++.+||+.||++|+ ++.+++++
T Consensus 212 ------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 212 ------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0112223456789999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.09 Aligned_cols=255 Identities=23% Similarity=0.296 Sum_probs=199.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.... ++..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 468899999999999999997654 788999999864321 23456788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..|+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999998765 35889999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCc------------c---------------------------------cccccccccccccccccccCCC
Q 015909 229 GLARDGPTGDKS------------H---------------------------------VSTRVMGTYGYAAPEYLATGHL 263 (398)
Q Consensus 229 g~a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~ 263 (398)
|+++........ . .....+||+.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 998632211000 0 0012469999999999999999
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCC
Q 015909 264 TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEP 343 (398)
Q Consensus 264 ~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 343 (398)
+.++|||||||++|||++|..||....... .......... .+........+.++.+||.+||. +|
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~--------~~~~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSENSHE------TYRKIINWRE--------TLYFPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCCCHHH------HHHHHHccCC--------ccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence 999999999999999999999996533211 0000000000 00001111245678999999998 67
Q ss_pred CCC---CCHHHHHHHH
Q 015909 344 KLR---PDMDEVVKEL 356 (398)
Q Consensus 344 ~~R---ps~~ell~~L 356 (398)
.+| +++.+++++-
T Consensus 291 ~~r~~r~~~~~~l~hp 306 (377)
T cd05629 291 ENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhcCCCCCHHHHhcCC
Confidence 765 5999999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=298.54 Aligned_cols=258 Identities=27% Similarity=0.376 Sum_probs=207.3
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc----cc----hHHHHHHHHHHcCC-CCC
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----QG----HKEWLTEINYLGQL-HHP 138 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~h~ 138 (398)
...-..|...+.||.|..++|-++..+ .++..+|+|++..... +. .+.-..|+.||+++ .||
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k---------~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP 83 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHK---------ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHP 83 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhc---------ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCC
Confidence 344567888899999999999987544 3788899998853211 11 23346799999998 599
Q ss_pred cccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 139 ~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
+|+++.++|..+..+++|+|.++.|.|.|++.... .++++....|+.|+++|++|||..+ ||||||||+|||++
T Consensus 84 ~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld 157 (411)
T KOG0599|consen 84 YIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD 157 (411)
T ss_pred cEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec
Confidence 99999999999999999999999999999998764 5999999999999999999999999 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT------GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~ 292 (398)
++.+++|+|||++..+..+.. ....+||++|+|||.+.. ..|+..+|+|++|+++|.||.|.+||....+
T Consensus 158 dn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ- 233 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ- 233 (411)
T ss_pred cccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-
Confidence 999999999999998877654 456899999999999843 4688889999999999999999999964211
Q ss_pred CCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
+..-+.+.+.-. .+..+--.+.+...++||.+||+.||.+|.|++|+|.|=-
T Consensus 234 ------------mlMLR~ImeGky-qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 234 ------------MLMLRMIMEGKY-QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred ------------HHHHHHHHhccc-ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 111111111000 0111112345778999999999999999999999998743
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=307.91 Aligned_cols=248 Identities=28% Similarity=0.406 Sum_probs=212.6
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCce
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
|.+++.||+|+||.||+|.+++ +|..+|+|.+..+ .+.+++..|+.+|+++..|++|++|+.|.....+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~E---------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRE---------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhc---------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 4456789999999999986655 8999999999765 5568899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
|+|||||..|+..+.+..+. +++++..+..++...++||+|||... -+|||||..|||++.+|..||+|||.+..
T Consensus 104 WIVMEYCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred EeehhhcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccch
Confidence 99999999999999998765 68999999999999999999999887 99999999999999999999999999977
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
+.+. ....++..||+-|||||++..-.|+.++||||||++..||..|++||.+-.+... ++-
T Consensus 179 LTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFM 240 (502)
T KOG0574|consen 179 LTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFM 240 (502)
T ss_pred hhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEe
Confidence 5432 2234567899999999999999999999999999999999999999976443321 211
Q ss_pred cc-cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 314 VL-DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 314 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+. .+...-..+...+.++-+++++||-+.|++|-|+.++++|
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11 1222234456678999999999999999999999998876
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=314.00 Aligned_cols=264 Identities=28% Similarity=0.431 Sum_probs=208.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.++||+|+||.||+|.... .....++..+++|.+..........+.+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHN----LLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEec----CCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3568889999999999999997542 123345778999988765555567789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSY-----------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~ 219 (398)
...+++|||+++++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 9999999999999999999765321 134788999999999999999999998 999999999999999
Q ss_pred CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchh
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLV 298 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~ 298 (398)
++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||....... ..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~ 234 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI 234 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH
Confidence 99999999999875433222112223345678999999999999999999999999999998 999985432111 00
Q ss_pred hhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.. ... ......+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 235 ~~----~~~----------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 EC----ITQ----------GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HH----HHc----------CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 000 0001112234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.35 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=198.5
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
+|++.++||+|+||+||+|.... ++..||+|.+..... .....+.+|+.+++.++||||+++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 58889999999999999997654 788999999875422 234567889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECC
Confidence 999999999999999999987653 4788999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCC---------------------------------------------cccccccccccccccccccccCCCC
Q 015909 230 LARDGPTGDK---------------------------------------------SHVSTRVMGTYGYAAPEYLATGHLT 264 (398)
Q Consensus 230 ~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 264 (398)
++........ .......+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 9753210000 0001234699999999999999999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCC
Q 015909 265 AKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPK 344 (398)
Q Consensus 265 ~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 344 (398)
.++|||||||++|||++|++||....+... ....... ............+.++.++|.+|+ .+|.
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~--------~~~~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLET------QMKVINW--------QTSLHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCCHHHH------HHHHHcc--------CCCcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 999999999999999999999975432110 0000000 000111111234567889998876 5999
Q ss_pred CCCC---HHHHHHH
Q 015909 345 LRPD---MDEVVKE 355 (398)
Q Consensus 345 ~Rps---~~ell~~ 355 (398)
+|++ +.++++|
T Consensus 292 ~R~~~~~~~ei~~h 305 (382)
T cd05625 292 DRLGKNGADEIKAH 305 (382)
T ss_pred HcCCCCCHHHHhcC
Confidence 9987 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=336.18 Aligned_cols=267 Identities=21% Similarity=0.368 Sum_probs=192.6
Q ss_pred HHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC------CCcc
Q 015909 67 LRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH------HPNL 140 (398)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~I 140 (398)
+....++|++.++||+|+||+||+|++.. ++..||||+++... .....+..|+.+++.++ |.++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i 193 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPL 193 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcce
Confidence 34456789999999999999999997654 68899999986432 12234455666666654 4568
Q ss_pred cceeeEEEeC-CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEc
Q 015909 141 VKLVGYCLED-DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLD 218 (398)
Q Consensus 141 ~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~ 218 (398)
+++++++... ...++|||++ +++|.+++.+.+ .+++..+..++.||+.||.|||+ .+ |+||||||+|||++
T Consensus 194 ~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~ 266 (467)
T PTZ00284 194 MKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILME 266 (467)
T ss_pred eeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEe
Confidence 8888888764 5688999988 778998887653 58999999999999999999997 47 99999999999998
Q ss_pred CCC----------------CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhC
Q 015909 219 SNY----------------NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282 (398)
Q Consensus 219 ~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g 282 (398)
.++ .+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence 655 499999998764221 12346799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhh---------hhh--------hhhhcccccccccccc-----cc-CCC-CHHHHHHHHHHHHHh
Q 015909 283 RRAIDKNRPTGEHNLVE---------WAK--------PYLTSKRRIFRVLDPR-----LE-GQF-SLPQAQKAASLALQC 338 (398)
Q Consensus 283 ~~p~~~~~~~~~~~~~~---------~~~--------~~~~~~~~~~~~~~~~-----~~-~~~-~~~~~~~l~~li~~~ 338 (398)
++||............. |.. .+......+.....+. .. ... .......+.+||.+|
T Consensus 342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence 99997643211111100 000 0000000000000000 00 000 001245678999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 015909 339 LSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 339 l~~dP~~Rps~~ell~~ 355 (398)
|+.||++|||++|+++|
T Consensus 422 L~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 422 LHYDRQKRLNARQMTTH 438 (467)
T ss_pred CCcChhhCCCHHHHhcC
Confidence 99999999999999986
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=322.45 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=197.4
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCC-CCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||.||+|.+.. ++..||+|++..... .....+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 469999999999997654 688999999975422 2345577899999888 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 99999999999998887653 5899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC--Ccchhhhhhhhhhccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG--EHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 311 (398)
..... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||....... ......+.......
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---- 219 (329)
T cd05588 146 GIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---- 219 (329)
T ss_pred cccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc----
Confidence 32211 12234679999999999999999999999999999999999999996422111 11111111111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD------MDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~ell~~ 355 (398)
. ....+...+.++.++|.+||+.||.+|++ +++++++
T Consensus 220 -----~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 220 -----K--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -----C--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0 01122234567899999999999999987 6787765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.46 Aligned_cols=265 Identities=29% Similarity=0.417 Sum_probs=206.5
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+|++.+.||+|+||.||+|..... ........+++|.+..... .....+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 478889999999999999976431 1122346788888865432 23456889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGS--------------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFK 211 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlk 211 (398)
..++++||+.+++|.+++..... ....+++..++.++.|++.||.|||+++ ++|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 99999999999999999875321 1135788999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015909 212 ASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNR 290 (398)
Q Consensus 212 p~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~ 290 (398)
|+||++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999876533322111222345678999999988889999999999999999998 999996532
Q ss_pred CCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 291 PTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
+. .+..... .......+...+.++.+++.+||+.+|++||++.++++.|+++-
T Consensus 235 ~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 235 PE---RLFNLLK--------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HH---HHHHHHh--------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11 1111110 00111112234568999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=319.45 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=194.6
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
....+|++.+.||+|+||.||+|.... ++..||+|..... ....|+.+++.++|+||+++++++.
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~ 127 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV 127 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE
Confidence 344679999999999999999997654 6788999975432 2356999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.....++|||++ .++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 128 ~~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 128 SGAITCMVLPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred eCCeeEEEEEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecC
Confidence 999999999999 568888886543 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh----hhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW----AKPY 304 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~----~~~~ 304 (398)
|++....... ......||..|+|||++.+..++.++|||||||++|||+++..++....+......... ....
T Consensus 202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~ 278 (357)
T PHA03209 202 GAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278 (357)
T ss_pred ccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence 9987532211 12235689999999999999999999999999999999985554422221111100000 0000
Q ss_pred hhc----ccccc---------ccccc--cccCC-------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTS----KRRIF---------RVLDP--RLEGQ-------FSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~----~~~~~---------~~~~~--~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ..... ..... ..... .....+.++.+||.+||+.||.+|||+.|+++|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000 00000 00000 00000 001224567789999999999999999999986
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=332.47 Aligned_cols=254 Identities=25% Similarity=0.310 Sum_probs=200.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.+|++.+.||+|+||.||+|.... ++..||+|++..... .....+.+|+.+|+.++|+||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 368999999999999999997654 689999999864322 23456788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DF 145 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDF 145 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999997653 4788999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCC-----------------------------------------cccccccccccccccccccccCCCCCch
Q 015909 229 GLARDGPTGDK-----------------------------------------SHVSTRVMGTYGYAAPEYLATGHLTAKS 267 (398)
Q Consensus 229 g~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 267 (398)
|++..+..... .......+||+.|+|||++.+..++.++
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 225 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence 99753210000 0001134799999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 015909 268 DIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347 (398)
Q Consensus 268 DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 347 (398)
|||||||++|+|++|+.||........ ........ ...........+.++.++|.+|+ .+|.+|+
T Consensus 226 DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~--------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 226 DWWSVGVILYEMLVGQPPFLADTPAET------QLKVINWE--------TTLHIPSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred eeeeccceeeehhhCCCCCCCCCHHHH------HHHHhccC--------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 999999999999999999975432110 00000000 00011111224567888999976 5999999
Q ss_pred ---CHHHHHHH
Q 015909 348 ---DMDEVVKE 355 (398)
Q Consensus 348 ---s~~ell~~ 355 (398)
++.+++++
T Consensus 291 ~~~t~~ell~h 301 (376)
T cd05598 291 GKNGADEIKAH 301 (376)
T ss_pred CCCCHHHHhCC
Confidence 99999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.22 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=205.8
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC--CccchHHHHHHHHHHcCCC-CCccccee
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE--GFQGHKEWLTEINYLGQLH-HPNLVKLV 144 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~I~~~~ 144 (398)
...++.|++++.||+||.+.||++..- ....||+|.+... +.+...-+.+|+..|.+|+ |.+|+.++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s----------~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~ 426 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNS----------DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLY 426 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecC----------CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence 345678999999999999999998543 3466777776533 3345677899999999995 99999999
Q ss_pred eEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 145 GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
+|-..++.+|+|||+- ..+|..++..... .++...++.+..|++.|+.++|.+| |||.||||.|+|+- .|.+|
T Consensus 427 DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LK 499 (677)
T KOG0596|consen 427 DYEVTDGYLYMVMECG-DIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLK 499 (677)
T ss_pred eeeccCceEEEEeecc-cccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEE
Confidence 9999999999999975 6799999988764 2333478899999999999999999 99999999999984 57999
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccC-----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-----------HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
|+|||+|.........-.....+||..||+||.+... ..+.++||||||||||+|+.|++||..
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~----- 574 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ----- 574 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-----
Confidence 9999999988776666666778999999999998532 256789999999999999999999963
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ-AQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+......+..+.++.-..+++... ..++.++++.||+.||++||++.++|++
T Consensus 575 ----------~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 575 ----------IINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----------HHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122223344555554444444322 2339999999999999999999999976
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=322.63 Aligned_cols=246 Identities=28% Similarity=0.390 Sum_probs=197.8
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc----cchHHHHHHHHHHcCCCCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
+.||+|+||.||+++... ...++..||+|.+..... .....+..|+.+|+.++||||+++++++..++..
T Consensus 2 ~~lg~G~~g~V~~~~~~~------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVT------GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcc------cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 679999999999997532 123688999999865321 2234567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|.+++...+ .+.+..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999999999987654 4788889999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~------- 214 (323)
T cd05584 150 SIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILK------- 214 (323)
T ss_pred cccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHc-------
Confidence 322221 123357899999999999888999999999999999999999999653211 11111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
. ....+...+.++.++|.+||+.||++|| ++.+++++
T Consensus 215 ---~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 215 ---G--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ---C--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0 0112223456789999999999999999 89998885
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=328.46 Aligned_cols=254 Identities=23% Similarity=0.276 Sum_probs=203.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|.+.+.||+|+||+||+|.... ++..||+|.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 468899999999999999997654 788999999975422 23456788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Df 146 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADF 146 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccC
Confidence 9999999999999999999998753 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccc------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLA------TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
|++......... ......||+.|+|||++. +..++.++|||||||++|+|++|..||....... ...
T Consensus 147 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~ 219 (330)
T cd05601 147 GSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYN 219 (330)
T ss_pred CCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHH
Confidence 999765433221 223346899999999986 4567889999999999999999999996532211 111
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... ..........+.++.+|+.+||+ +|.+||++.+++++
T Consensus 220 ~i~~~~~--------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 220 NIMNFQR--------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHcCCC--------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1111000 00111112346778999999998 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=320.76 Aligned_cols=243 Identities=29% Similarity=0.388 Sum_probs=191.9
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHH-HHcCCCCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEIN-YLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||+||+|.+.. ++..||+|++..... .....+..|.. +++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 469999999999997654 789999999865322 22234445544 56789999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred EEEEcCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 99999999999999887653 5889999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .........
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~------- 210 (323)
T cd05575 146 GIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILN------- 210 (323)
T ss_pred cccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHc-------
Confidence 32221 123345799999999999999999999999999999999999999965321 111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH----HHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD----EVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~----ell~~ 355 (398)
.. ...+...+..+.++|.+||+.||.+||++. +++++
T Consensus 211 ---~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 211 ---KP--LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred ---CC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 00 011223367789999999999999999884 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.83 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=208.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
..++|.+.+.||+|+||.||+|.+.. .....++..||+|.+..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYG----LSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEec----CCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34578999999999999999997532 12233567899999875432 2345688999999999 799999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECC
Confidence 999999999999999999999975432 33799999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .+.. ...
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~ 258 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIK 258 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHH
Confidence 999986543322112223346788999999998899999999999999999998 999986432211 0000 000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
. ......+...+.++.+++.+||..+|++||++.++++.|+++
T Consensus 259 ~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 E----------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred c----------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 000111222356899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=329.36 Aligned_cols=256 Identities=23% Similarity=0.258 Sum_probs=202.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
..++|++.+.||+|+||.||+|.... ++..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34679999999999999999997654 78899999986432 1233457789999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+.+.+..++||||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~ 184 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLA 184 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEE
Confidence 99999999999999999999988653 3788889999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG----HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ....
T Consensus 185 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~ 257 (370)
T cd05596 185 DFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYS 257 (370)
T ss_pred eccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHH
Confidence 9999876433221 112345799999999998653 4788999999999999999999999753221 0011
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL--RPDMDEVVKEL 356 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~L 356 (398)
....... .+........+.++.+||.+||+.+|.+ |+++.+++++-
T Consensus 258 ~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 258 KIMDHKN--------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHHcCCC--------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 1110000 0111111234678999999999999988 99999999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=315.27 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=202.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.|++.++||+|+||+||++.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 47888999999999999997654 688999999865322 223456789999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999988865432 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++........ .....|+..|+|||++.+..++.++||||||+++|+|++|..||.+....... ......
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~~~~~------ 216 (285)
T cd05605 148 LAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EEVERR------ 216 (285)
T ss_pred CceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HHHHHH------
Confidence 9876432221 22346899999999999889999999999999999999999999753221100 000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
+. .....++...+..+.+|+.+||+.||++|| ++.+++++
T Consensus 217 -~~-----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 -VK-----EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -hh-----hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00 001122334567889999999999999999 78888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=327.80 Aligned_cols=266 Identities=29% Similarity=0.446 Sum_probs=212.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++..+.++||+|+||.||+|.+... .......||+|...... .....++.+|+++|++++||||+++||+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~-----~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLK-----NGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEec-----CCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4455678999999999999987641 11012238999988532 355678999999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
....+++|||+|+||+|.+++.+.+. .++......++.+.+.||+|||+++ ++||||-.+|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999998763 5899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|+++....-... .....-...|+|||.+....|++++|||||||++||+++ |..||.+.... ....
T Consensus 307 GLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~-------- 373 (474)
T KOG0194|consen 307 GLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKA-------- 373 (474)
T ss_pred ccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHH--------
Confidence 999875311111 101124568999999999999999999999999999999 88898764321 0000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
.+......-..+...+.++..++.+||..||++||++.++.+.|+.+......
T Consensus 374 -----kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 374 -----KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -----HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11111122233445678899999999999999999999999999998766553
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=317.29 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=213.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc--hHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..-|.+.+-||+|.|+.|-+|++ --+|+.||||++.+...+. ...+..|++.|+.++|||||++|++..
T Consensus 17 AGLYDLekTlG~GHFAVVKLArH---------VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARH---------VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhh---------hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 45578888999999999998754 3489999999998765543 456889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc-CCCCEEEee
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD-SNYNAKLSD 227 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-~~~~~kl~D 227 (398)
....+|||+|+-++|+|+++|.++. ..+.+....+++.||+.|+.|+|+.. +|||||||+||++. .-|-|||+|
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeee
Confidence 9999999999999999999999876 46899999999999999999999998 99999999998775 678999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLT-AKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||++-.+.++.. ..+.+|...|.|||++.|..|+ +++||||||+|||-|++|++||+...+.+
T Consensus 163 FGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------------- 226 (864)
T KOG4717|consen 163 FGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------------- 226 (864)
T ss_pred ccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------
Confidence 999987766654 4557899999999999999987 46899999999999999999997543221
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+..+++. ....|..++.++++||..||..||++|.+.++|...
T Consensus 227 ---TLTmImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 227 ---TLTMIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---hhhhhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22233333 234577889999999999999999999999998754
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=320.69 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=198.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCC-cccceeeEEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHP-NLVKLVGYCL 148 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-~I~~~~~~~~ 148 (398)
+|++.+.||+|+||.||+|.... ++..||+|++.... ....+.+..|+.++..+.|+ +|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 48889999999999999997654 68899999987532 13345677899999999764 6888999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeec
Confidence 9999999999999999999987653 4788999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .. ......
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~---~~~i~~-- 215 (324)
T cd05587 146 GMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---EL---FQSIME-- 215 (324)
T ss_pred CcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHHc--
Confidence 99865322111 223457999999999999999999999999999999999999999653211 01 110000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM-----DEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 355 (398)
....++...+.++.+++.+||..||.+|++. .+++++
T Consensus 216 ----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 216 ----------HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111223345688999999999999999976 666655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=310.68 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=202.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+|++.+.||+|+||+||+|.+... .......+++|.+..... .....+..|+.+++.+.||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPE-----GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCC-----CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 4688899999999999999987431 011123588888754322 22356778888999999999999999875 4
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++++||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCcc
Confidence 56789999999999999997654 35899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..... ... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~ 228 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPD----LLEKGE 228 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCC
Confidence 986544333222334456778999999988899999999999999999998 999996542211 000 011110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.. ..+...+.++.+++.+||..||++|||+.++++.|..+.
T Consensus 229 ~~----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 229 RL----------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred cC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00 011123456789999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=321.61 Aligned_cols=242 Identities=27% Similarity=0.426 Sum_probs=192.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcC-CCCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQ-LHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||.||+|.+.. ++..||+|.+..... ...+.+..|..++.. ++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999997654 788999999875321 223445567777765 4899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~e~~~gg~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 99999999999999887653 4889999999999999999999998 99999999999999999999999999975
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ........
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~------- 210 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILN------- 210 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc-------
Confidence 43222 1233457999999999999989999999999999999999999999753211 11111000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD-EVVK 354 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 354 (398)
....++...+.++.+++.+||+.||.+||++. ++++
T Consensus 211 -----~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 211 -----DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 01112233466789999999999999999875 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=311.86 Aligned_cols=273 Identities=30% Similarity=0.446 Sum_probs=205.0
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC--
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED-- 150 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~-- 150 (398)
|++.+.||+|+||+||++.+.. ....++..||+|.+..... .....+.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4889999999999999876542 2334678999999875432 2356778999999999999999999987653
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...+++|||+++++|.+++... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccc
Confidence 4578999999999999998753 3899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccc-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHV-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ +......... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~ 231 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVV 231 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chh
Confidence 886543222111 1122356679999999888899999999999999999999999864322110 0000000000 000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.+............+...+.++.+++.+||+.||++|||++++++.|+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000111111111223344678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=314.63 Aligned_cols=255 Identities=36% Similarity=0.574 Sum_probs=197.5
Q ss_pred CCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceE
Q 015909 76 PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL 154 (398)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~ 154 (398)
+.+.||.|.||.||+|.+.. .....+..|+||.++.... ...+.+.+|++.+++++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 45789999999999998863 2334678999999965432 33678999999999999999999999999888899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
+|+||+++|+|.+++..... ..+++..+..++.||+.||.|||+++ ++|+||+++||+++.++.+||+|||++...
T Consensus 78 lv~e~~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccc--cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence 99999999999999988722 46899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 235 PTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
.............+...|+|||.+.+..++.++||||||+++|||++ |+.||..... .++. ... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~---~~~-~~~~---- 222 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEII---EKL-KQGQ---- 222 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHH---HHH-HTTE----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc---ccc-cccc----
Confidence 33322222333456778999999999889999999999999999999 7888854311 1111 111 1110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
....+...+..+.+++.+||+.||++||++.++++.|
T Consensus 223 ------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 ------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112223466789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=320.93 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=196.1
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCC-CCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||.||+|.+.. ++..||+|.+..... .....+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 469999999999997654 788999999975422 2344567888888776 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||+++.
T Consensus 72 ~lv~E~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 99999999999998887653 5899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC--Ccchhhhhhhhhhccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG--EHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 311 (398)
...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||....... ......+......
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~----- 218 (329)
T cd05618 146 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----- 218 (329)
T ss_pred ccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-----
Confidence 322111 2234578999999999999999999999999999999999999996422111 1111111111000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD------MDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps------~~ell~~ 355 (398)
.. ...++...+..+.+++.+||+.||++||+ +.+++++
T Consensus 219 ----~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 219 ----EK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ----cC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 00 11223344667889999999999999998 4676665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=316.11 Aligned_cols=272 Identities=26% Similarity=0.374 Sum_probs=210.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|.+.+.||+|+||.||+|.+.... .....+...+|+|.+.... ......+..|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLD--KEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccC--CcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 357999999999999999999764311 0111234679999997542 23345688899999999 7999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSY------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
..+..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+++ ++||||||+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil 172 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL 172 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheE
Confidence 999999999999999999999765321 134888999999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEH 295 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~ 295 (398)
++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 99999999999999876533221111112234568999999988889999999999999999998 8888854221
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
...... ... ......+...+.++.+++.+||..+|.+||++.++++.|+++....
T Consensus 249 --~~~~~~-~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 249 --EELFKL-LKE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred --HHHHHH-HHc----------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111110 000 0011122334678899999999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=316.05 Aligned_cols=267 Identities=27% Similarity=0.403 Sum_probs=208.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|..... ........+++|.+..... .....+.+|+.+++.+ +|+||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~----~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGL----DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecC----CCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345788899999999999999976531 1123457899999875422 2345678999999999 799999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRG------------SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
...+..+++|||+++++|..++.... .....+++..++.++.|++.||.|||+++ |+||||||+||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Ni 163 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNV 163 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeE
Confidence 99999999999999999999997532 22356889999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGE 294 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~ 294 (398)
+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 999999999999999986544322222222335678999999988899999999999999999997 999986432110
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.. . ... .......+...+..+.+|+.+||..||++|||+.++++.|+.+
T Consensus 243 --~~---~-~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 --LF---K-LLK----------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --HH---H-HHH----------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 00 0 000 0001112233456889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=321.57 Aligned_cols=243 Identities=28% Similarity=0.428 Sum_probs=195.2
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCC-CCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||+||+|++.. ++..||+|++.... ....+.+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 469999999999997654 68899999987532 13345567888888876 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred EEEEcCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 99999999999999887653 4889999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .........
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~------ 211 (320)
T cd05590 146 GIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILND------ 211 (320)
T ss_pred cCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcC------
Confidence 32221 1233457999999999999999999999999999999999999999753211 111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM------DEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 355 (398)
....+...+.++.+++.+||+.||++||++ ++++++
T Consensus 212 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 212 ------EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 011222346788999999999999999998 566554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=309.56 Aligned_cols=261 Identities=26% Similarity=0.445 Sum_probs=203.7
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
|++.+.||+|+||.||+|.... ...++..||+|.+..... .....+.+|+..++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQ------DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEec------CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5778999999999999997643 122467899999875432 23457889999999999999999999886654
Q ss_pred c------eEEEEeecCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 152 H------RLLVYEFMPRGSMENHLFRRG--SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 152 ~------~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
. .+++|||+++++|..++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeE
Confidence 4 789999999999999986542 12245889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....+.
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~- 228 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL- 228 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-
Confidence 9999999986543332222222335678999999988899999999999999999999 88988643211 111110
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
... .....+...+.++.+++.+||+.||++||++.++++.|+++
T Consensus 229 ---~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 ---RHG----------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---HcC----------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 01112234466899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=314.53 Aligned_cols=274 Identities=25% Similarity=0.379 Sum_probs=212.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
...+|.+.+.||+|+||.||+|.+.... ......+..|++|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccC--CCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 3567889999999999999999753210 0112345689999987542 23456788999999999 799999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
......++||||+++++|.+++..... ....+++..+..++.||+.||.|||+++ ++||||||+||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Ni 168 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNV 168 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceE
Confidence 999999999999999999999976432 1235788889999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGE 294 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~ 294 (398)
+++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 999999999999999986543332222223345678999999988889999999999999999998 7888854321
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
...... +... .....+...+..+.+++.+||+.+|.+||++.++++.|.++..+..
T Consensus 246 ---~~~~~~-~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 246 ---EELFKL-LKEG----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred ---HHHHHH-HHcC----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 111111 0000 0011122446789999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.26 Aligned_cols=267 Identities=24% Similarity=0.359 Sum_probs=207.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCC-CCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLH-HPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~~I~~~~~~~~ 148 (398)
.++|.+.+.||+|+||.||+|++... ....++..||+|++...... ..+.+.+|+.+|..+. ||||+++++++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGL----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCC----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34678889999999999999987531 12235678999999754322 2346889999999997 999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC------------------------------------------------------
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS------------------------------------------------------ 174 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------------ 174 (398)
..+..++||||+++|+|.+++...+.
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975431
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCC
Q 015909 175 ----------------------------------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASN 214 (398)
Q Consensus 175 ----------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~N 214 (398)
....+++..+..++.||+.||.|||+.+ ++||||||+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~N 269 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARN 269 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcce
Confidence 1124677788899999999999999988 9999999999
Q ss_pred EEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 015909 215 ILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTG 293 (398)
Q Consensus 215 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~ 293 (398)
||+++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999976433222111223456788999999988889999999999999999998 888985432110
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
. ....... ......+...+.++.+++.+||+.+|.+||++++|++.|+++
T Consensus 350 ---~---~~~~~~~----------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 ---Q---FYNAIKR----------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---H---HHHHHHc----------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 0000000 001112223467899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=307.60 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=203.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-----cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-----QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
+.|.+.+.||+|++|.||+|.... ++..|++|.+..... .....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 468899999999999999997654 688999998864322 123467889999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+...+..++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~ 146 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLG 146 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEe
Confidence 999999999999999999999987653 4788999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCccc-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHV-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|||++........... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~---- 217 (263)
T cd06625 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIF---- 217 (263)
T ss_pred ecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHH----
Confidence 9999876433221111 12346788999999999988999999999999999999999999643211 0000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...........+...+.++.+++.+||..+|.+||++.+++++
T Consensus 218 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 -------KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0000111122333456788999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=311.85 Aligned_cols=268 Identities=23% Similarity=0.374 Sum_probs=210.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..++|++.++||+|+||.||+|.+... ...++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~-----~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDE-----KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecC-----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 457899999999999999999987541 12346889999886432 233566789999999999999999999876
Q ss_pred e-CCceEEEEeecCCCCHHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 149 E-DDHRLLVYEFMPRGSMENHLFRRGSY----FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 149 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
. ....+++++|+++++|.+++...... ...+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQV 156 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcE
Confidence 6 56788999999999999998765322 145899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |+.||....+. .+..+.
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~- 232 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYL- 232 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHH-
Confidence 9999999986544332222233456778999999988889999999999999999998 99999653221 111110
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
... .....+...+.++.+++.+||..||++|||+.++++.|+.+.+
T Consensus 233 ---~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 ---KDG----------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---HcC----------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000 0111122345678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=309.69 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=204.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||.||+|.+. .+..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~----------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN----------NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec----------CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 457899999999999999999754 35679999886543 2356788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCcc
Confidence 999999999999999999876432 45788899999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...... .
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~--- 218 (261)
T cd05072 150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL----Q--- 218 (261)
T ss_pred ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH----H---
Confidence 9865332211 1122345678999999988889999999999999999998 99999643211 111100 0
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
... ........+.++.+++.+||..+|++||+++++++.|+++
T Consensus 219 ---~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 219 ---RGY----RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---cCC----CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000 0011123456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.56 Aligned_cols=256 Identities=27% Similarity=0.357 Sum_probs=203.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||.||+|.... ++..|++|++..........+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 3579999999999999999997654 6889999998755444456678899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCcc
Confidence 99999999999999999887543 5789999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+........ ......|+..|+|||.+. ...++.++|+||||+++|+|++|+.||....+...... . .
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~------~ 222 (267)
T cd06646 153 AAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--M------S 222 (267)
T ss_pred ceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--e------e
Confidence 876532211 122346888999999884 34578899999999999999999999864322111000 0 0
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.. ....+.. ......+..+.+++.+||+.||++||++++++++|
T Consensus 223 ~~---~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 223 KS---NFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cC---CCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 0000000 11123456889999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=328.24 Aligned_cols=255 Identities=23% Similarity=0.280 Sum_probs=201.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34689999999999999999997654 78899999986421 1233457789999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+.+++..++||||+++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999998653 3788999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG----HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ...
T Consensus 185 DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~ 257 (370)
T cd05621 185 DFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYS 257 (370)
T ss_pred ecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHH
Confidence 9999986533221 112345799999999999654 37889999999999999999999997532210 011
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL--RPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 355 (398)
....... .+........+..+.+++.+||..++.+ |+++.+++++
T Consensus 258 ~i~~~~~--------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 KIMDHKN--------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHhCCc--------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111000 0111112234678899999999865544 8999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=314.29 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=205.4
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+|++.+.||+|+||.||+|.+... .....+..||+|.+...... ....+..|+.++..++||||+++++++....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 467788999999999999976531 11224678999999754322 2356788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~ 219 (398)
..++++||+++++|.+++..... ....+++..+..++.|++.||.|||+++ |+||||||+||++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~ 159 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFD 159 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecC
Confidence 99999999999999999864321 1234788889999999999999999998 999999999999999
Q ss_pred CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchh
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLV 298 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~ 298 (398)
++.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.... ..
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~- 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV- 235 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH-
Confidence 99999999999886544332222233456788999999988889999999999999999998 88888643211 11
Q ss_pred hhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
....... .....+...+..+.+++.+||+.+|++||++++++..|+.
T Consensus 236 --~~~i~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 --IEMIRNR-----------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHHcC-----------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1110000 0111233456778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=312.40 Aligned_cols=275 Identities=26% Similarity=0.404 Sum_probs=210.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCccc-------ccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLA-------STRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVK 142 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~ 142 (398)
..+|++.+.||+|+||.||+|.+...... ......+..|++|.+..... ...+.+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 45799999999999999999987542211 12333457899999875432 33567889999999999999999
Q ss_pred eeeEEEeCCceEEEEeecCCCCHHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGS-------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
+++++..++..+++||++++++|.+++..... ....+++..++.++.|++.||.|||+++ |+|+||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhce
Confidence 99999999999999999999999999976541 1125899999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS--GRRAIDKNRPTG 293 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p~~~~~~~~ 293 (398)
+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ +..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 999999999999999876544333223334456788999999988889999999999999999998 6677753221
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
............. .........+...+.++.+++.+||+.||.+||++.++++.|.
T Consensus 240 -~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 -QQVIENAGHFFRD-------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -HHHHHHHHhcccc-------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111110000 0011111122234578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=305.86 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=210.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|.+.. ++..|++|.++... ....+.+.+|++++++++|+||+++++.+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 578999999999999999997654 68899999886422 223567889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++.........+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEecc
Confidence 999999999999999999998765443456899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .........
T Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~--- 221 (267)
T cd08224 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE--- 221 (267)
T ss_pred ceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhh---
Confidence 99876433221 122346888999999998888999999999999999999999998643211 111110000
Q ss_pred ccccccccccccCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSL-PQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.......+. ..+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 222 --------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 --------KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000111122 44668899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=311.54 Aligned_cols=267 Identities=25% Similarity=0.387 Sum_probs=206.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..++|++.+.||+|+||.||+|..++. .....+..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 356899999999999999999976531 1222456899999865432 22345788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSY------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
..+..++||||+++++|.+++...... ...++...+..++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 999999999999999999999764321 234567788999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~ 301 (398)
++|+|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||...... +..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~--- 231 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVL--- 231 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---
Confidence 99999999876543332222222345678999999998899999999999999999998 78888643211 111
Q ss_pred hhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.... ... ....+...+..+.+++.+||+.||++|||+.++++.|.+.
T Consensus 232 ~~~~-~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 232 KFVM-DGG----------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHH-cCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1000 000 0011222356899999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=320.24 Aligned_cols=242 Identities=27% Similarity=0.410 Sum_probs=192.9
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcC-CCCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQ-LHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||.||+|.+.. ++..||+|.+..... .....+..|..++.. ++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 469999999999997654 788999999875321 234456678888775 4899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++.
T Consensus 72 ~lv~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred EEEECCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 99999999999999887653 4788999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .. ......
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~---~~~~~~------- 210 (316)
T cd05620 146 NVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---EL---FESIRV------- 210 (316)
T ss_pred cccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHHh-------
Confidence 32221 1233467999999999999999999999999999999999999999653211 11 100000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD-EVVK 354 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 354 (398)
. ....+...+.++.+++.+||+.||++||++. ++++
T Consensus 211 -~----~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 211 -D----TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred -C----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0 0111223456789999999999999999984 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=320.97 Aligned_cols=243 Identities=26% Similarity=0.398 Sum_probs=196.1
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCC-CCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||.||+|.+.. ++..||+|++..... .....+..|.+++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 469999999999997654 688999999875322 2344567888888865 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeeccccee
Confidence 99999999999999887653 4888999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .........
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~------ 211 (321)
T cd05591 146 GILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHD------ 211 (321)
T ss_pred cccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcC------
Confidence 332221 223457899999999999999999999999999999999999999753211 111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-------DMDEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~ell~~ 355 (398)
....+...+.++.+++.+||+.||++|| ++.+++++
T Consensus 212 ------~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 212 ------DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0111223456889999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=306.36 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=199.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||+|+||.||+|.+.. +..+++|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 457888999999999999997642 4579999886443 33467889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||.+
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCc
Confidence 9999999999999999987543 34789999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... ...... ....
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i----~~~~- 218 (256)
T cd05114 148 RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMI----SRGF- 218 (256)
T ss_pred cccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HCCC-
Confidence 764332211 1112234568999999988899999999999999999999 89999653211 111110 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.. ..+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 219 --~~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 --RL-------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CC-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00 01112346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=329.53 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=208.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+.|.++..||-|+||.||+|..++ ++...|.|++........+.++-||+||..+.||+|+++++.|+..+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 346677789999999999996654 67777888887776677888999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
.+|+++|||.||....++...+ .+|.+..+..++.|++.||.|||+++ |||||||..|||++-+|.++|+|||.+
T Consensus 103 kLwiliEFC~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVS 177 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVS 177 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeeccccc
Confidence 9999999999999999888776 57999999999999999999999999 999999999999999999999999987
Q ss_pred cCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
-.... .......+.||++|||||++. ..+|+.++||||||++|+||..+.+|-....+.. ..+.
T Consensus 178 AKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---------VllK 246 (1187)
T KOG0579|consen 178 AKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---------VLLK 246 (1187)
T ss_pred ccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---------HHHH
Confidence 54221 112244689999999999874 5689999999999999999999999976433211 1111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+...-.+.+ --|..++..+.+|+.+||.+||+.||++.+|++|
T Consensus 247 ----iaKSePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 247 ----IAKSEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----HhhcCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 001111111 2245667889999999999999999999999875
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=307.20 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=209.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||.|+||.||+|.+.. ++..+++|.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 468888999999999999997654 688999998764322 23456789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..+++|||+++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999998754443456899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... .......
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~----- 219 (267)
T cd08229 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK----- 219 (267)
T ss_pred hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh-----
Confidence 99876533221 122346889999999998888999999999999999999999999643211 1111110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
+.....+ .......+..+.+++.+||+.||++|||+.++++.+.++
T Consensus 220 --~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 220 --IEQCDYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --hhcCCCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0000011 111123567899999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=311.39 Aligned_cols=264 Identities=25% Similarity=0.424 Sum_probs=207.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+... ....++..|++|.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGV----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEecc----CCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 45788999999999999999987541 112356789999986543 2334567899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSY------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
....++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCE
Confidence 99999999999999999999754321 234788899999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~-- 233 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKF-- 233 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHH--
Confidence 9999999876543332222233456788999999988889999999999999999998 99998643221 11110
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.... .....+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 234 --~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 --VIDG----------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --HhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000 001112233678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=318.95 Aligned_cols=269 Identities=28% Similarity=0.388 Sum_probs=205.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||+||+|.+.. .....++..||+|.++.... .....+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeecc----CCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4579999999999999999997542 12234678999999975432 2345678999999999 6899999999876
Q ss_pred eC-CceEEEEeecCCCCHHHHHhhcCCC----------------------------------------------------
Q 015909 149 ED-DHRLLVYEFMPRGSMENHLFRRGSY---------------------------------------------------- 175 (398)
Q Consensus 149 ~~-~~~~lv~e~~~~~~L~~~~~~~~~~---------------------------------------------------- 175 (398)
.. ...+++|||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 4678999999999999998753210
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccccc
Q 015909 176 -----------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST 244 (398)
Q Consensus 176 -----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 244 (398)
...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 123677888999999999999999998 9999999999999999999999999987653322211122
Q ss_pred ccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCC
Q 015909 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQF 323 (398)
Q Consensus 245 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (398)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... . ...... ....
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~---~-~~~~~~----------~~~~ 303 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC---R-RLKEGT----------RMRA 303 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH---H-HHhccC----------CCCC
Confidence 2345678999999988899999999999999999997 999986432110 000 0 000000 0011
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 324 SLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 324 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
+...+.++.+++.+||+.||++||++.+++++|+.+.+
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=325.90 Aligned_cols=245 Identities=29% Similarity=0.431 Sum_probs=205.3
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
|.-++.||.|+||.||-|++.. +.+.||||++.-.+- ..+..++.|+..|++|+|||++.+.+.|..+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre 98 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE 98 (948)
T ss_pred HHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence 3345669999999999997654 789999999975443 4467789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...||||||| -|+-.|++.... +++-+..+..|..+.+.||.|||+++ .||||||..|||+++.|.|||+|||.
T Consensus 99 ~TaWLVMEYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 99 HTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred chHHHHHHHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccc
Confidence 9999999999 779999998876 67999999999999999999999999 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+....+ .+.++|||+|||||++. .+.|+.++||||||++.+||...++|+-+...
T Consensus 173 Asi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---------------- 230 (948)
T KOG0577|consen 173 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------- 230 (948)
T ss_pred hhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----------------
Confidence 876433 44689999999999984 47899999999999999999999999754221
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...++.+.......-....++..++.|+..||++-|.+|||.++++.+
T Consensus 231 MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 231 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111111211111222256778999999999999999999999998876
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=315.42 Aligned_cols=267 Identities=25% Similarity=0.346 Sum_probs=200.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||+|+||.||+|++.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 568999999999999999997654 678999999875432 2334677899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||++ ++|.+++...+ ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcccc
Confidence 99999999996 48888876554 35788999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh--------
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA-------- 301 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~-------- 301 (398)
+........ ......++..|+|||++.+ ..++.++||||||+++|+|++|++||...............
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 151 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228 (309)
T ss_pred ceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 875432221 1223467899999998865 46889999999999999999999999754332111110000
Q ss_pred hhhhhcccccccccccccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLE----GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+.............+... .......+.++.+||.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000000000000 00111245678999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=306.79 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=204.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|++|.||+|.+. .+..|++|.+.... ...+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN----------NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec----------CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 457899999999999999999753 35679999987543 3356788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcce
Confidence 99999999999999999997653 245889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+......... .......+..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... .....
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~- 220 (261)
T cd05068 150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ----QVDQG- 220 (261)
T ss_pred EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcC-
Confidence 8865422111 1111223457999999998899999999999999999999 99999643211 0000 00000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 221 ---------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 221 ---------YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00112223457899999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=318.53 Aligned_cols=242 Identities=26% Similarity=0.426 Sum_probs=193.0
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcC-CCCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQ-LHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~~I~~~~~~~~~~~~~ 153 (398)
+.||+|+||+||+|.+.. ++..||+|.+..... .....+..|..++.. ++||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 469999999999997654 688999999875421 233456677778776 4899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 99999999999999987643 4788999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
...... ......||..|+|||++.+..++.++|||||||++|+|++|..||...... .... .. .
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~---~i-~------- 209 (316)
T cd05619 146 NMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQ---SI-R------- 209 (316)
T ss_pred CCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHH---HH-H-------
Confidence 322211 223457899999999999989999999999999999999999999653211 1110 00 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD-EVVK 354 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 354 (398)
... ..++...+.++.+++.+||+.||++||++. ++++
T Consensus 210 ~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 210 MDN----PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred hCC----CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 000 111223456789999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=307.72 Aligned_cols=260 Identities=28% Similarity=0.445 Sum_probs=198.8
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEeC-
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED- 150 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~- 150 (398)
|.+.+.||+|+||.||+|.+... .....+|+|.+.... ....+.+..|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD-------DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccC-------CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 35678999999999999976541 122468999886542 23356688899999999999999999976432
Q ss_pred -----CceEEEEeecCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 151 -----DHRLLVYEFMPRGSMENHLFRRG--SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 151 -----~~~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
...+++|||+++++|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCE
Confidence 24689999999999998875332 12245889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||++................++..|++||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~--- 225 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYD--- 225 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---
Confidence 9999999987543322111222345678999999998899999999999999999999 88898643211 1111
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
....... ...+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 226 -~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 -YLRQGNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -HHHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111000 011223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=321.37 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=198.3
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 45789999999999999999997654 78899999986432 23345678999999999999999999988
Q ss_pred EeCC------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 148 LEDD------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 148 ~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
...+ ..++||||+++ +|...+.. .++...+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~ 160 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 160 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCC
Confidence 6543 46899999954 66666532 3788889999999999999999998 99999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc------
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH------ 295 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~------ 295 (398)
.++|+|||++....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 161 ~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 237 (359)
T cd07876 161 TLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237 (359)
T ss_pred CEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999997543221 123356899999999999999999999999999999999999999754321100
Q ss_pred ------chhhh----hhhhhhccccccccc----cccc----cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 296 ------NLVEW----AKPYLTSKRRIFRVL----DPRL----EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 296 ------~~~~~----~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.+... ...+........... .+.. ........+.++++||.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000 000000000000000 0000 0001112356789999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=318.39 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=197.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCC-CCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||+||+|.... ++..||+|++..... ...+.+.+|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 469999999999997654 688999999975422 2345577899999888 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEecccccee
Confidence 99999999999998887653 4899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............+......
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------- 216 (327)
T cd05617 146 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL------- 216 (327)
T ss_pred ccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-------
Confidence 32211 122346799999999999999999999999999999999999999965332222111111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM------DEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 355 (398)
.. ....+...+..+.+++.+||+.||++|+++ .+++++
T Consensus 217 --~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 217 --EK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred --hC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 00 111233345678899999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=311.69 Aligned_cols=275 Identities=25% Similarity=0.438 Sum_probs=205.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcc-----cccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCccccee
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSL-----ASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLV 144 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~ 144 (398)
.++|++.+.||+|+||.||+|++..... ..........||+|.+..... .....+.+|+++++.++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999987643210 011122345699999875422 2345688999999999999999999
Q ss_pred eEEEeCCceEEEEeecCCCCHHHHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 145 GYCLEDDHRLLVYEFMPRGSMENHLFRRGS--------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||||+||+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCL 161 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEE
Confidence 999999999999999999999999865321 1124688899999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCCCC
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS--GRRAIDKNRPTGE 294 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p~~~~~~~~~ 294 (398)
++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ +..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 99999999999999876543332222223345778999999988899999999999999999988 56677542211
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
............... ......+...+..+.+|+.+||+.||++||+++++++.|.
T Consensus 240 -~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -QVIENTGEFFRNQGR-------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHhhhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111110100000 0001112224568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=309.35 Aligned_cols=262 Identities=23% Similarity=0.385 Sum_probs=202.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+|++.+.||+|+||+||+|.+... .......||+|.+..... .....+.+|+.+++.+.|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPD-----GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecC-----CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 45788899999999999999976531 011233689999865432 234567899999999999999999998865
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
...++++||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+++++.++|+|||
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG 154 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFG 154 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCC
Confidence 45789999999999999987643 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~ 227 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL----LEKG 227 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCC
Confidence 9986543322211222335678999999988899999999999999999998 89998643211 11111 0000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.....+...+.++.+++.+||+.||++||++.++++.|.++.
T Consensus 228 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 228 ----------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ----------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 001112234567899999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=311.17 Aligned_cols=275 Identities=25% Similarity=0.428 Sum_probs=206.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCccc-------ccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLA-------STRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVK 142 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~ 142 (398)
.++|++.+.||+|+||.||++.+...... .....++..+|+|.+..... .....+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 35799999999999999999865431100 01223456799999875432 23467889999999999999999
Q ss_pred eeeEEEeCCceEEEEeecCCCCHHHHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSY-------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
+++++...+..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheE
Confidence 999999999999999999999999999764321 124778889999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS--GRRAIDKNRPTG 293 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p~~~~~~~~ 293 (398)
+++.++.++|+|||++................++..|++||...+..++.++|+|||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999876543322222222344678999999888889999999999999999998 77888543221
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
........+...... ......+..++..+.+|+.+||+.||.+||++.++++.|+
T Consensus 241 --~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 --QVIENTGEFFRDQGR-------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred --HHHHHHHHHHhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111111110000 0001112234578899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=309.41 Aligned_cols=264 Identities=26% Similarity=0.386 Sum_probs=204.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|.+.+.||+|+||.||+|.+... ....++..|++|.+..... .....+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGR----DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecC----CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45688999999999999999977531 1112567899998865432 224568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC---CE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSY---FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY---NA 223 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~---~~ 223 (398)
.+..++||||+++++|.+++...+.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcce
Confidence 99999999999999999999765421 124889999999999999999999998 99999999999998654 59
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||...... ....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~--- 232 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME--- 232 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---
Confidence 9999999986532222111112234567999999998899999999999999999997 99999653221 1110
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
. ... ......+...+..+.+++.+||+.+|++||++.+++++|.
T Consensus 233 ~-~~~----------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 F-VTG----------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H-HHc----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 000 0011122334568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=319.86 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=198.3
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
+|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+..|..++..+ .|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 47889999999999999997654 688999999875422 2234566788888777 5899999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~Df 145 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccC
Confidence 9999999999999999999987654 4888999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .. ......
T Consensus 146 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~---~~~i~~-- 215 (323)
T cd05616 146 GMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL---FQSIME-- 215 (323)
T ss_pred CCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HH---HHHHHh--
Confidence 99875322111 223457999999999999999999999999999999999999999753211 11 111110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM-----DEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 355 (398)
. ...++...+.++.+++.+||+.||.+|++. .+++++
T Consensus 216 --------~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 216 --------H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --------C--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0 111233446788999999999999999985 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=318.84 Aligned_cols=243 Identities=29% Similarity=0.433 Sum_probs=196.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCC-CCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||+||+|.+.. ++..||+|.+.... ......+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999997654 68899999987532 23345567888898887 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred EEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCee
Confidence 99999999999999887653 4899999999999999999999998 99999999999999999999999999865
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
...... ......||..|+|||++.+..++.++|+|||||++|+|++|+.||...... .........
T Consensus 146 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~~------ 211 (318)
T cd05570 146 GILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILED------ 211 (318)
T ss_pred cCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcC------
Confidence 322211 123356899999999999999999999999999999999999999643211 111110000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM-----DEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 355 (398)
...++...+.++.+||.+||+.||.+||++ .+++++
T Consensus 212 ------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 ------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 011222346788999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.75 Aligned_cols=267 Identities=26% Similarity=0.371 Sum_probs=199.5
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 47889999999999999997643 68899999986432 23346788999999999999999999999877
Q ss_pred C-----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 151 D-----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 151 ~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
+ ..++||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL 144 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKI 144 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEe
Confidence 6 7899999995 6888877554 35899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh----
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW---- 300 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~---- 300 (398)
+|||++........ .......++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+..
T Consensus 145 ~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~ 223 (372)
T cd07853 145 CDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT 223 (372)
T ss_pred ccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999976433221 122334678999999998774 478999999999999999999999976443211111000
Q ss_pred ------hhhhhhcccccccc-ccc-ccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 301 ------AKPYLTSKRRIFRV-LDP-RLE--GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 301 ------~~~~~~~~~~~~~~-~~~-~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
..........+... ..+ ... .......+.++.+||.+||+.||++|||+.+++++-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 00000000000000 000 000 011122356789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=310.07 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=194.9
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
||+|+||.||++.... ++..||+|.+...... ....+..|+++++.++||||+++++++......++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 7999999999997654 7899999998643221 233456799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred EecCCCCCHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 999999999988865443 45888999999999999999999998 99999999999999999999999999876533
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ....... ...
T Consensus 148 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~----------~~~ 212 (277)
T cd05607 148 GK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRR----------TLE 212 (277)
T ss_pred Cc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHH----------hhc
Confidence 22 12234689999999999988899999999999999999999999965322111 0010010 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
..... .....+.++.+++.+||+.||++||+++|+++.+
T Consensus 213 ~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 213 DEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 00000 0112456789999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=320.61 Aligned_cols=246 Identities=29% Similarity=0.390 Sum_probs=196.7
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLL 155 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~l 155 (398)
+.||+|+||.||+++.. ....++..||+|++..... .....+..|+.+|++++||||+++++++...+..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 57999999999998653 2234688999999975432 233456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCC
Q 015909 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235 (398)
Q Consensus 156 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~ 235 (398)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 76 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 99999999999998765 35899999999999999999999998 9999999999999999999999999987643
Q ss_pred CCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccc
Q 015909 236 TGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315 (398)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 150 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~--------- 212 (318)
T cd05582 150 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILK--------- 212 (318)
T ss_pred CCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHc---------
Confidence 3211 223457899999999999888999999999999999999999999653211 00000000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 316 DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
. ....+...+.++.+++.+||+.||++||+ +.+++++
T Consensus 213 -~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 213 -A--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred -C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 0 01122334568899999999999999999 4556543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=325.38 Aligned_cols=264 Identities=20% Similarity=0.237 Sum_probs=197.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
...|.+.+.||+|+||.||+|.+.. ++..|++|.... ..+.+|+.+|++|+|+||+++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4579999999999999999997654 678999996432 2356899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++|||++ .++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.++|+|||+
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGl 306 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGA 306 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCC
Confidence 9999999999 568888886543 36899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-CCCCc----chhhhhhhhh
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNR-PTGEH----NLVEWAKPYL 305 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~-~~~~~----~~~~~~~~~~ 305 (398)
++...............||..|+|||++.+..++.++|||||||++|||++|..++.... ..... .+........
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~ 386 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ 386 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence 976543322222234579999999999999999999999999999999999876653321 11111 1111111000
Q ss_pred hcccccccc----------------ccccccCC-C--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRV----------------LDPRLEGQ-F--SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~----------------~~~~~~~~-~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......... ..+..... + -...+.++.+||.+||+.||++|||+.|+|++
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 00000000 0 01224578899999999999999999999986
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=310.16 Aligned_cols=263 Identities=28% Similarity=0.423 Sum_probs=203.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCC-CCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQL-HHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~ 149 (398)
++|++.++||+|+||.||+|++... +....+++|.+.... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKD-------GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCC-------CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 5789999999999999999976541 123457888876422 23345688999999999 79999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv 217 (398)
.+..+++|||+++++|.+++..... ....+++..+..++.|++.||+|||+++ |+||||||+||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE
Confidence 9999999999999999999975431 1135888999999999999999999998 9999999999999
Q ss_pred cCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 015909 218 DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHN 296 (398)
Q Consensus 218 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~ 296 (398)
+.++.++|+|||++........ ......+..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---- 225 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---- 225 (297)
T ss_pred CCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 9999999999999864221110 111123457999999988889999999999999999997 99999653221
Q ss_pred hhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
...... ........+...+..+.+|+.+||+.+|.+||+++++++.|..+....
T Consensus 226 --~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 226 --ELYEKL-----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred --HHHHHH-----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 001100 000111122234567899999999999999999999999998877555
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=309.30 Aligned_cols=274 Identities=25% Similarity=0.376 Sum_probs=204.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe--
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE-- 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~-- 149 (398)
.+|++.+.||+|+||.||+|.+.. ....++..|++|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 478899999999999999997532 2334688999999876655556778899999999999999999997654
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCc
Confidence 346789999999999999997643 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCccc-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh--
Q 015909 230 LARDGPTGDKSHV-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT-- 306 (398)
Q Consensus 230 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-- 306 (398)
++........... .....++..|+|||.+.+..++.++||||||+++|||++|..++...... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~ 229 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQ 229 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccc
Confidence 9986543322111 11122345699999999889999999999999999999987765432110 0000000000
Q ss_pred -ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 307 -SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 307 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
....+............+...+.++.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000000111111223456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=312.39 Aligned_cols=264 Identities=29% Similarity=0.448 Sum_probs=203.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCC-CCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQL-HHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||.||+|.+..+ +....+++|.+.... ......+.+|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccC-------CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 5688899999999999999976431 122456777765432 22345678899999999 89999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv 217 (398)
.+..++||||+++++|.+++...+. ....+++..++.++.||+.||+|||+++ ++||||||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili 157 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV 157 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe
Confidence 9999999999999999999976532 1235789999999999999999999998 9999999999999
Q ss_pred cCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 015909 218 DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHN 296 (398)
Q Consensus 218 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~ 296 (398)
+.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 231 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E 231 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---H
Confidence 999999999999986421111 1111224567999999988889999999999999999998 99999643221 1
Q ss_pred hhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
.. ... . .......+...+.++.+++.+||+.+|++||++.+++..|..+..-++
T Consensus 232 ~~---~~~-~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 LY---EKL-P----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HH---HHH-h----------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11 000 0 000111122345678999999999999999999999999988755554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.14 Aligned_cols=269 Identities=30% Similarity=0.444 Sum_probs=216.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
...++.+.||+|+||.||.|.+.+.. .......||+|.+... ..+....|++|..+|+.++||||++++|++...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~----~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVP----GSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCC----CCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 34566788999999999999876521 1112456999999754 446678899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGS---YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...++++|||.+|+|..++...+. ....++....+.++.+|++|+.||+++. +|||||..+|+|++....|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999987621 1245889999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||+|+.....++........-...|||||.+..+.|+.++|||||||++||+++ |..||...+... +. ..++.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~---~~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VL---LDVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HH---HHHHh
Confidence 999996655554433333233468999999999999999999999999999999 999996532211 11 11111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
.. .-+.+..+++.+.+++..||+.+|++||++..|++.+..+-.-.
T Consensus 920 gg-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 920 GG-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CC-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11 22345667889999999999999999999999999777765443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=304.63 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=200.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.+|++.+.||+|+||+||+|.+.. +..+|+|.+.... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468888999999999999997642 3459999887543 23467889999999999999999999999888
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccc
Confidence 9999999999999999987643 25889999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .... .. ....
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~-~~~~- 218 (256)
T cd05113 148 RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---KV-SQGL- 218 (256)
T ss_pred eecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---HH-hcCC-
Confidence 764332211 1112335678999999988889999999999999999998 99998643211 0100 00 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
....+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 219 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 ---------RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00011123568899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=312.34 Aligned_cols=272 Identities=24% Similarity=0.381 Sum_probs=208.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
..+|.+.+.||+|+||.||+|...... .........+++|.+..... .....+..|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGID--KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccC--CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 357889999999999999999753210 11223466799999875322 3345678899999999 6999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
..+..+++|||+++++|.+++..... ....+++..+..++.||+.||.|||+++ ++||||||+||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil 166 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVL 166 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEE
Confidence 88999999999999999999976432 1245888999999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEH 295 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~ 295 (398)
++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999986543222111122234567999999988899999999999999999999 88888543211
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
..... .... .....+...+.++.+++.+||+.||++||++.++++.|.++....
T Consensus 244 ~~~~~----~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 ELFKL----LREG----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHH----HHcC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11110 0000 001122334567889999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.61 Aligned_cols=261 Identities=24% Similarity=0.280 Sum_probs=203.4
Q ss_pred HHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCccc
Q 015909 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLV 141 (398)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~ 141 (398)
.++....++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv 106 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence 3444556899999999999999999997654 788999999864221 2234577899999999999999
Q ss_pred ceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 142 KLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
++++.+...+..++||||+++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSG 179 (371)
T ss_pred eEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCC
Confidence 9999999999999999999999999998653 3788889999999999999999998 99999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG----HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
.++|+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 180 ~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----- 253 (371)
T cd05622 180 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----- 253 (371)
T ss_pred CEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----
Confidence 999999999976533221 122345799999999998654 3788999999999999999999999753221
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL--RPDMDEVVKEL 356 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~L 356 (398)
........... .+........+..+.++|.+||..++.+ |+++.+++++.
T Consensus 254 -~~~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 254 -GTYSKIMNHKN--------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -HHHHHHHcCCC--------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111111000 0111112234678899999999844443 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.11 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=202.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|++.+.||+|+||.||+|.+.. ...|++|.+..... ..+.+.+|+.+++.++||||+++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 4579999999999999999997643 34599999975432 3467889999999999999999998764 4
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~ 148 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL 148 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCc
Confidence 568999999999999999976432 35788999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... .. ...
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~---~~-~~~-- 218 (262)
T cd05071 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL---DQ-VER-- 218 (262)
T ss_pred eeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH---HH-Hhc--
Confidence 9765432221 1122345678999999988899999999999999999999 88888643211 000 00 000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
......+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 219 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 --------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 001112334567889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=309.84 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=205.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|++.+.||+|+||.||+|.... ++..|++|.+........+.+.+|+.+++.+.|+||+++++.+...
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 3579999999999999999997644 6889999999766555567788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~ 162 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF 162 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECcccc
Confidence 9999999999999999998643 3788999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .... ..
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~----~~---- 230 (296)
T cd06654 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLI----AT---- 230 (296)
T ss_pred chhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHH----hc----
Confidence 876433221 12234688999999999888899999999999999999999999965432110 0000 00
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........+...+..+.+++.+||..||++||++.+++++
T Consensus 231 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 231 -----NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -----CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0000111223445678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=303.02 Aligned_cols=255 Identities=32% Similarity=0.497 Sum_probs=205.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc-hHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
+.||+|+||.||+|.+... ...+..|++|.+....... ...+.+|+.+++.++|+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGK------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecC------CCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 4699999999999987541 0247889999997654333 67788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 157 YEFMPRGSMENHLFRRGSY-----FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
|||+++++|.+++...... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccc
Confidence 9999999999999875211 256899999999999999999999998 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
................++..|+|||.+....++.++||||||+++|+|++ |..||...... ... .. ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~-~~~--- 222 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVL---EY-LRK--- 222 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHH---HH-HHc---
Confidence 87654432222334567889999999988889999999999999999999 69999754211 111 10 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
......+...+.++.+++.+||..+|++|||+.+++++|+
T Consensus 223 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111223334678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=303.61 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=200.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.+|++.+.||+|+||.||+|.+. ++..+++|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----------GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----------CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 35788999999999999999653 35578999886433 23456888999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccc
Confidence 9999999999999999987654 35889999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ... . ...
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~-~~~--- 216 (256)
T cd05059 148 RYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---S-VSA--- 216 (256)
T ss_pred eeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---H-HHc---
Confidence 764322111 1111223457999999998899999999999999999999 899986532211 100 0 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
. .....+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 217 ---~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 ---G----YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---C----CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 01111223467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=325.31 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=199.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.... ++..||+|++.... ......+..|+.++..++|++|+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 368889999999999999997654 78899999986432 223456788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~Df 145 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDF 145 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997653 4889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc---------------------------------ccccccccccccccccccccCCCCCchhHHHHHHH
Q 015909 229 GLARDGPTGDKS---------------------------------HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVV 275 (398)
Q Consensus 229 g~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 275 (398)
|++......... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 225 (360)
T cd05627 146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (360)
T ss_pred cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence 998754221100 00113479999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHH
Q 015909 276 LLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD---MDEV 352 (398)
Q Consensus 276 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~el 352 (398)
+|||++|+.||........ ......... .+........+.++.++|.+|+. ||.+|++ +.++
T Consensus 226 lyel~tG~~Pf~~~~~~~~------~~~i~~~~~--------~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei 290 (360)
T cd05627 226 MYEMLIGYPPFCSETPQET------YRKVMNWKE--------TLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEI 290 (360)
T ss_pred eeecccCCCCCCCCCHHHH------HHHHHcCCC--------ceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHH
Confidence 9999999999975432110 000000000 00001111245678899999774 9999984 7788
Q ss_pred HHH
Q 015909 353 VKE 355 (398)
Q Consensus 353 l~~ 355 (398)
++|
T Consensus 291 ~~h 293 (360)
T cd05627 291 KSH 293 (360)
T ss_pred hcC
Confidence 777
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=309.97 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=202.1
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.|+..++||+|+||.||+|.+.. ++..||+|.+...... ....+..|+.+++.++|++|+++++.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 36778999999999999997764 7889999998654322 23456789999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++...+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLG 147 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999998865443 45889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++........ .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||............ ......
T Consensus 148 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~-- 219 (285)
T cd05630 148 LAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE-- 219 (285)
T ss_pred ceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh--
Confidence 9875432221 12346899999999999999999999999999999999999999753221110000 000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
.....+...+.++.+|+.+||+.||++||| +.+++++
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 ---------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 001122234567899999999999999999 8898885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=304.46 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=203.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.++||+|+||.||+|... ++..|++|.+.... .....+.+|+.+++.++|+||+++++++ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 71 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-T 71 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-c
Confidence 4567999999999999999999653 46789999987544 3346788999999999999999999886 4
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..+++|||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCc
Confidence 5678999999999999999875432 45888999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ..... +..
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~- 218 (260)
T cd05067 148 LARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQN----LER- 218 (260)
T ss_pred ceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHH----HHc-
Confidence 98765422211 1122345678999999988889999999999999999998 99999653211 11100 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
. .....+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 219 -----~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 219 -----G----YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----C----CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 0011122345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=325.17 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=206.5
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEEe
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYE 158 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 158 (398)
+||+|.||+||.|++.. +...+|||.+........+-+.+|+.+-++|+|.|||+++|.+.+++.+-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 59999999999997765 788999999987766666778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc-CCCCEEEeeccCCcCCC
Q 015909 159 FMPRGSMENHLFRRGSYFQPL--SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD-SNYNAKLSDFGLARDGP 235 (398)
Q Consensus 159 ~~~~~~L~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-~~~~~kl~Dfg~a~~~~ 235 (398)
-++||+|.+++.... .++ .+.++-.+.+||++||.|||.+. |||||||-+||||+ -.|.+||+|||.++.+.
T Consensus 653 qVPGGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred cCCCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhc
Confidence 999999999998654 456 78889999999999999999998 99999999999997 57899999999998753
Q ss_pred CCCCcccccccccccccccccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 236 TGDKSHVSTRVMGTYGYAAPEYLATG--HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
. -.....++.||..|||||++..+ .|+.++|||||||++.||.||++||....... ..+++
T Consensus 728 g--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------------AAMFk 790 (1226)
T KOG4279|consen 728 G--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------------AAMFK 790 (1226)
T ss_pred c--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------------Hhhhh
Confidence 2 22345568899999999999664 58889999999999999999999996422111 01111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+---....+.|...+.+++.+|.+|+..||.+||+++++|+.
T Consensus 791 VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 791 VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 111122345677788999999999999999999999999874
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=302.51 Aligned_cols=250 Identities=28% Similarity=0.506 Sum_probs=204.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||.|+||.||+|.. .+..|++|.+..... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-----------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 45788999999999999999865 467899999976543 457789999999999999999999999989
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccc
Confidence 999999999999999999976542 35899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+........ ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ++... ...
T Consensus 149 ~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~-- 214 (256)
T cd05039 149 AKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPH----VEK-- 214 (256)
T ss_pred ccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----Hhc--
Confidence 987532211 2234567999999988889999999999999999997 99998643211 11100 000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
......+...+..+.+++.+||..+|++||++.++++.|++
T Consensus 215 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 215 --------GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --------CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00111122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=320.31 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=198.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 45789999999999999999996543 688999999875422 2345678899999999999999999988
Q ss_pred EeC------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 148 LED------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 148 ~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
... ...++||||+++ +|...+.. .++...+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~ 156 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 156 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCC
Confidence 653 346899999954 67666643 3788889999999999999999998 99999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc-----
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN----- 296 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~----- 296 (398)
.++|+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+........
T Consensus 157 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (355)
T cd07874 157 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_pred CEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999997643221 2233578999999999999999999999999999999999999997543211000
Q ss_pred -------hhh----hhhhhhhccccccccccccc--------cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 297 -------LVE----WAKPYLTSKRRIFRVLDPRL--------EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 297 -------~~~----~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ....+............+.. ........+.++.+||.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 00000000000000000000 001111235678999999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.77 Aligned_cols=254 Identities=33% Similarity=0.539 Sum_probs=201.0
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchH--HHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK--EWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
|++.+.||+|+||+||+|.... +++.||+|.+......... ...+|+.++++++||||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 6788999999999999997665 7889999999876443322 3356999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++|||++++++|.+++... ..+++..+..++.||+.||.+||+++ ++|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccccccccccccc----cccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence 999999999998999999844 35899999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
... ...........++..|+|||++. +..++.++||||||+++|+|++|..||..... .+............
T Consensus 146 ~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~~-- 218 (260)
T PF00069_consen 146 VKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKRP-- 218 (260)
T ss_dssp EES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHTH--
T ss_pred ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhccccc--
Confidence 753 11222334467899999999998 88899999999999999999999999975410 01111111000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ...........+.+++.+||+.||++||++.+++++
T Consensus 219 ----~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 219 ----LPS--SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ----HHH--HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ----ccc--cccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000113789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.89 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||.||+|.+. .+..+++|.+..... ..+.+.+|+.+++.++|+||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN----------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec----------CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 357899999999999999999654 356799999876433 3467889999999999999999999874 5
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...+++|||+++++|.+++..... ..+++..++.++.+++.||.|||+++ ++|+||||+||++++++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCcee
Confidence 668999999999999999875432 45889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +... . ...
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~-~~~-- 218 (260)
T cd05070 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLE---Q-VER-- 218 (260)
T ss_pred eeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---H-HHc--
Confidence 9765332211 1112335667999999988889999999999999999999 89999643211 1111 0 000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
......+...+..+.+++.+||..+|++|||+.++++.|++
T Consensus 219 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 --------GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --------CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00111223345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=303.35 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=202.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+|++.+.||.|+||.||++.+.. ++..|++|.++... ....+.+.+|+.+++.++|+||+++++.+...+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 47889999999999999997654 68899999986432 234567788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcc
Confidence 99999999999999998865432 45789999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~----- 214 (255)
T cd08219 148 RLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVCQ----- 214 (255)
T ss_pred eeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHhc-----
Confidence 76533221 123356889999999998888999999999999999999999999643211 00000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......+...+..+.+++.+||+.||++||++.+++..
T Consensus 215 ------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 ------GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00111223345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.14 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=196.8
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
.||+|+||.||+|.+.. ..++..+++|++..... ...+.+.+|+.+++.+.||||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM-------KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEec-------CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 58999999999997532 23678899999865432 23467889999999999999999999875 5577899
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||.||+++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 74 MELAELGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 99999999999987643 4889999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCccc-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccccccc
Q 015909 237 GDKSHV-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314 (398)
Q Consensus 237 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
...... .....++..|+|||.+....++.++|+||||+++|||++ |..||...... ...... .
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i----~-------- 212 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMI----E-------- 212 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----H--------
Confidence 322111 112234578999999988889999999999999999998 99999653221 111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 315 LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.......+...+.++.++|.+||+.||++||++.+|.+.|++.
T Consensus 213 --~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 213 --SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0001112234567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=301.97 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=204.2
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|.+.+.||+|++|.||+|.+.. ++..|++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 47788999999999999997754 68899999986432 23456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~ 147 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGV 147 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEccccc
Confidence 999999999999999999976522 46889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......|+..|+|||.+.+..++.++|+||||+++++|++|+.||...... ... .....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~---- 215 (256)
T cd08529 148 AKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI---LKIIR---- 215 (256)
T ss_pred ceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHc----
Confidence 876543221 123346889999999999989999999999999999999999999643210 000 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ....+...+.++.+++.+||+.+|++||++.+++++
T Consensus 216 --~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 --GV-----FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CC-----CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 111222446789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.57 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=204.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.++||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 579999999999999999997654 688999999875422 22456889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS-------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
+.+..++||||+++++|.+++..... ....++...++.++.||+.||.|||+++ |+||||||+||+++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCC
Confidence 99999999999999999999875311 1133566778899999999999999998 99999999999999999
Q ss_pred CEEEeeccCCcCCCCCCC----------------cccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCC
Q 015909 222 NAKLSDFGLARDGPTGDK----------------SHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRA 285 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p 285 (398)
.++|+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999976521110 0011235699999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 015909 286 IDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-DMDEVVKELEQLQE 361 (398)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~l~~ 361 (398)
|........ . . .. ....+ .........+..+.+++.+||+.||++|+ +++++++.|+.+.+
T Consensus 231 F~~~~~~ki---~-~-~~---------~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 231 YRRKKGRKI---S-Y-RD---------VILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCcchhhh---h-h-hh---------hccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 965321100 0 0 00 00000 00000123456788999999999999995 67777777776543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.05 Aligned_cols=267 Identities=26% Similarity=0.359 Sum_probs=203.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||+|+||.||+|.+.. ++..+++|.+..... .....+.+|++++++++||||+++++.+..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 368899999999999999997654 678899998865422 2345688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg 145 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 145 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCC
Confidence 9999999999999999999765 348899999999999999999997 46 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++....... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......................
T Consensus 146 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
T cd06615 146 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221 (308)
T ss_pred Ccccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccC
Confidence 987543221 2335688999999999888899999999999999999999999864332111000000000000000
Q ss_pred ----------------cccc----cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 310 ----------------RIFR----VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 310 ----------------~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.... ..............+.++.+++.+||..||++||++.+++++.-
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000 00000000000124567999999999999999999999999844
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=306.63 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=198.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.++||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 367889999999999999997654 78899999986542 23345688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~ 141 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGV 141 (279)
T ss_pred CEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 9999999999999986542 3678889999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc-hhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN-LVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 309 (398)
+....... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ........
T Consensus 142 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 212 (279)
T cd06619 142 STQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI----- 212 (279)
T ss_pred ceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-----
Confidence 87643221 233578999999999999899999999999999999999999996532211110 00000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.............+.++.+++.+||+.||++||++++++++
T Consensus 213 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 213 -----VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -----hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000000111234678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=305.18 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=203.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+|++.+.||+|+||.||+|.+... ...+..|++|.+.... ......+..|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecC------CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 4578899999999999999976541 1124579999987542 23356789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCcc
Confidence 99999999999999999987653 35789999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccc-cc--cccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 231 ARDGPTGDKSHVSTR-VM--GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 231 a~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
+.............. .. .+..|+|||.+.+..++.++||||||+++|||++ |..||...... +...+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~---- 225 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE---- 225 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----
Confidence 876533222111111 11 2457999999998899999999999999999886 99998643211 1111110
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
. . .....+...+..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 226 ~------~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 Q------D----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c------C----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 01111223456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=309.16 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=194.9
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCC---CCCcccceeeEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQL---HHPNLVKLVGYC 147 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~~I~~~~~~~ 147 (398)
+|++.+.||+|+||+||+|.+.. ++..||+|.+...... ....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 58889999999999999997654 7889999998753221 223455677777665 699999999987
Q ss_pred Ee-----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 148 LE-----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 148 ~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
.. ....+++||+++ ++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~ 146 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQ 146 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCC
Confidence 64 245789999996 588888876432 45899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
++|+|||++....... ......||..|+|||++.+..++.++|||||||++|+|++|++||........ +.....
T Consensus 147 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~ 221 (288)
T cd07863 147 VKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFD 221 (288)
T ss_pred EEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHH
Confidence 9999999987653222 12234689999999999988999999999999999999999999965322111 000000
Q ss_pred hhhhc--ccccc-------ccccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTS--KRRIF-------RVLDPRL---EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~--~~~~~-------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.... ..... ..+.+.. ........+..+.+++.+||+.||++|||+.+++.+
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 222 -LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred -HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00000 0000000 001112345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=326.06 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=198.9
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC----ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG----FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.+...+||+|+|-+||+|.+.. +|..||--.++... ....+.|..|+.+|+.|+||||+++|++|.+
T Consensus 42 ~k~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred eehhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 4566789999999999997754 77777765554322 2335789999999999999999999999988
Q ss_pred CCc--eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc-CCCCEEEe
Q 015909 150 DDH--RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD-SNYNAKLS 226 (398)
Q Consensus 150 ~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-~~~~~kl~ 226 (398)
... +.+|+|.+..|+|..|+.+.+. ++.+.+..|++||++||.|||++.++|+|||||.+||||+ ..|.|||+
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence 665 7799999999999999998864 8889999999999999999999999999999999999998 45899999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|+|+|....... .....|||.|||||++. ..|+..+||||||++++||+|+..||....-. .+..+.
T Consensus 189 DLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIYKK--- 255 (632)
T KOG0584|consen 189 DLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIYKK--- 255 (632)
T ss_pred chhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHHHH---
Confidence 999998754332 23368999999999996 89999999999999999999999999643211 000010
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+........+..-...++++||.+||.. ..+|||+.|||++
T Consensus 256 -------V~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 256 -------VTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -------HHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 0000011111111256899999999999 9999999999975
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=300.74 Aligned_cols=255 Identities=27% Similarity=0.375 Sum_probs=206.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||.|+||.||+|.... ++..+++|.+........+.+.+|+.+++.++||||+++++.+...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 578899999999999999997654 67889999997665556678899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccc
Confidence 9999999999999999887653 35889999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATG---HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ ... ...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~------~~~ 218 (262)
T cd06613 149 AQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL------ISK 218 (262)
T ss_pred hhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH------HHh
Confidence 76433211 12235688899999999776 888999999999999999999999965332111 000 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. .+.. .........+.++.+++.+||..+|.+||++.+++++
T Consensus 219 ~----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 219 S----NFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c----cCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 0111233456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=317.82 Aligned_cols=240 Identities=28% Similarity=0.356 Sum_probs=189.4
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHH-HHHcCCCCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEI-NYLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
+.||+|+||+||+|++.. ++..||+|++..... .....+..|. .+++.++||||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 469999999999997654 678999999864321 1223344444 456889999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 72 YFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 99999999999999987653 4778888999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~------- 210 (325)
T cd05602 146 NIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILN------- 210 (325)
T ss_pred cccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHh-------
Confidence 32221 1233457999999999999999999999999999999999999999643211 11111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 352 (398)
. ....+...+..+.+++.+||+.||.+|+++.+.
T Consensus 211 ---~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 211 ---K--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred ---C--CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 0 011222345688999999999999999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=319.81 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=198.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 35689999999999999999997654 68889999987532 23345678999999999999999999987
Q ss_pred EeC------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 148 LED------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 148 ~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
... ...++||||++ ++|...+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 163 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 163 (364)
T ss_pred cccccccccCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCC
Confidence 543 35799999995 577777643 3788889999999999999999998 99999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh---
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV--- 298 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~--- 298 (398)
.++|+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+........
T Consensus 164 ~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 164 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred cEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999997643221 123356899999999999999999999999999999999999999754321110000
Q ss_pred ---------hhh----hhhhhccccccc-----cccc---cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 299 ---------EWA----KPYLTSKRRIFR-----VLDP---RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 299 ---------~~~----~~~~~~~~~~~~-----~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ..+......... .... ..........+.++++||.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000000000000 0000 00001111224578999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.71 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=206.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|++.+.||.|+||.||+|.... ++..|++|.+........+.+.+|+.+++.++|+||+++++++...
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3689999999999999999997654 6889999999765555567788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~ 161 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF 161 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999999998653 4788999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+......
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------------- 226 (297)
T cd06656 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------------- 226 (297)
T ss_pred ceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------------
Confidence 876433221 12234688899999999988899999999999999999999999965432111000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ..........+...+..+.+++.+||..||++||++.+++++
T Consensus 227 ~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 227 I--ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred e--ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000111223345678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=314.88 Aligned_cols=242 Identities=26% Similarity=0.384 Sum_probs=194.1
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCC-CCcccceeeEEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLH-HPNLVKLVGYCL 148 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~ 148 (398)
+|++.++||+|+||+||+|.... ++..||+|++..... ...+.+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 46778999999999999997654 788999999875321 23455678888888885 577888999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEecc
Confidence 9999999999999999999987653 4899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~-- 215 (323)
T cd05615 146 GMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIME-- 215 (323)
T ss_pred ccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh--
Confidence 99875322211 123456899999999999999999999999999999999999999753211 00111110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM 349 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 349 (398)
. ...++...+.++.+++.+||+.||.+|++.
T Consensus 216 --------~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 --------H--NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --------C--CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 011223345678999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=314.96 Aligned_cols=256 Identities=21% Similarity=0.258 Sum_probs=198.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|+... ++..||+|++.... ....+.+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 478999999999999999997654 68899999986421 123455788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++.+.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Df 146 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADF 146 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999999999997643 35889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
|++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 147 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~ 219 (331)
T cd05597 147 GSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGK 219 (331)
T ss_pred CceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHH
Confidence 998764332211 1223468999999999863 45788999999999999999999999653211 11111
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL--RPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 355 (398)
...... ... +. ......+.++.+++.+||..++++ |+++.+++++
T Consensus 220 i~~~~~-~~~-----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 220 IMNHKE-HFQ-----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHcCCC-ccc-----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111000 000 00 011124678899999988764443 7899999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=302.76 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=203.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|+..+.||+|+||.||+|..... ......+++|.+.... ......+..|+++++.++|+||+++.+++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMP------GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 4678889999999999999976431 1124579999986542 23346688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcc
Confidence 99999999999999999987643 35889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccc-cccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 231 ARDGPTGDKSHVS-TRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 231 a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+............ .....+..|+|||.+.+..++.++||||||+++|+|++ |..||...... .. .... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~---~~~i-~~- 225 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EV---MKAI-ND- 225 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH---HHHH-hc-
Confidence 8765432221111 11223457999999988889999999999999999997 99999643211 11 1100 00
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
......+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ---------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 ---------GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001111223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.36 Aligned_cols=201 Identities=25% Similarity=0.358 Sum_probs=162.1
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe--CCceE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE--DDHRL 154 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~--~~~~~ 154 (398)
.+.||+|+||+||+|.... ..++..||+|.+.... ....+.+|+.+|+.++||||+++++++.. +...+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~-------~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD-------GKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEcc-------CCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 4679999999999997643 1257889999986543 23457789999999999999999998854 45678
Q ss_pred EEEeecCCCCHHHHHhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE----cCCCCEEE
Q 015909 155 LVYEFMPRGSMENHLFRRGS-----YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL----DSNYNAKL 225 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv----~~~~~~kl 225 (398)
++|||+ +++|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +..+.+||
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEE
Confidence 999998 5688888764321 1235889999999999999999999998 9999999999999 45678999
Q ss_pred eeccCCcCCCCCCCc-cccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015909 226 SDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~ 289 (398)
+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999999765332211 12234578999999999876 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.64 Aligned_cols=273 Identities=25% Similarity=0.378 Sum_probs=209.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
..+|++.+.||+|+||.||+|.+.... ......+..|++|.+..... .....+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGID--KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccC--CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 346899999999999999999764310 01112345789998875422 3356788999999999 7999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
..+..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+++ ++||||||+||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 166 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVL 166 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEE
Confidence 99999999999999999999976431 1234788899999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEH 295 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~ 295 (398)
++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 242 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 242 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 99999999999999876543222111222334567999999999999999999999999999998 8888854321
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
....... .. ......+...+.++.+++.+||+.+|.+||++.++++.|..+.....
T Consensus 243 --~~~~~~~-~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 --EELFKLL-KE----------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred --HHHHHHH-Hc----------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1111110 00 00111222345678999999999999999999999999988875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=311.07 Aligned_cols=266 Identities=27% Similarity=0.437 Sum_probs=219.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc-hHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
......+.+.||+|-||.|.+|... .+..||+|.++...... .+.|.+|+++|.+|+||||+.++++|.
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve----------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE----------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec----------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 4456788999999999999999764 26899999998765544 488999999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.++.+++|+||++.|+|..++..+.. +.+.......|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+||
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCc
Confidence 99999999999999999999998754 22455666779999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS--GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|+++.+..++........+-...|||+|.+..+.++.++|+|+||+++||+++ ...||...... ..++-...++.
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~ 758 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFR 758 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcC
Confidence 99999888888777777777889999999999999999999999999999865 67788643211 11111111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
..........|..++..+.+++.+||..|-++||+++++..+|.+.
T Consensus 759 -------~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 759 -------DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -------CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111112234556788999999999999999999999999998764
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.99 Aligned_cols=251 Identities=27% Similarity=0.450 Sum_probs=201.9
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc---------hHHHHHHHHHHcCCCCCcccce
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---------HKEWLTEINYLGQLHHPNLVKL 143 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~~I~~~ 143 (398)
+|.+.+.||.|+||.||+|.+.. ++..|++|.+....... .+.+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 47888999999999999997643 67889999886543221 2457789999999999999999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
++++...+..+++|||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~ 145 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGI 145 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCE
Confidence 999999999999999999999999997653 4788899999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCc----ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 224 KLSDFGLARDGPTGDKS----HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
+|+|||.++........ .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~ 220 (267)
T cd06628 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QA 220 (267)
T ss_pred EecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HH
Confidence 99999998865422111 1112345888999999999888999999999999999999999999643211 00
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ..... ....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 221 ----~~~----~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 221 ----IFK----IGENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----HHH----HhccC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 000 00011 112233456788999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=304.94 Aligned_cols=254 Identities=27% Similarity=0.380 Sum_probs=201.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||+|+||.||+|.... ++..|++|.+..........+.+|+.+++.++||||+++++.+...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 467888899999999999997654 68899999987654444556788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceee
Confidence 9999999999999999987653 5899999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
....... .......|+..|+|||.+. ...++.++|+|||||++|+|++|..||....+... ... ...
T Consensus 154 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~------~~~ 223 (267)
T cd06645 154 AQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL------MTK 223 (267)
T ss_pred eEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHh------hhc
Confidence 7543221 1223457899999999874 45688899999999999999999999864322111 000 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ....+... .....+..+.+++.+||+.+|++||++++++++
T Consensus 224 ~---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 224 S---NFQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c---CCCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 00000000 011234578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.32 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=199.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEE-eC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCL-ED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~-~~ 150 (398)
.+|++.+.||+|+||.||+|.. .+..|++|.+... ...+.+.+|+.+++.++|+||+++++++. ..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----------~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----------cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 4788999999999999999865 3667899988654 23467889999999999999999999764 45
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCcc
Confidence 678999999999999999876543 35788999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+....... ....++..|+|||++.+..++.++||||||+++|+|++ |+.||..... ...... ...
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~-~~~-- 214 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPR-VEK-- 214 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-Hhc--
Confidence 87543221 12234567999999998899999999999999999997 9999864211 111110 000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
......+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 215 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 --------GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 001112223456889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.87 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=200.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||.|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 578999999999999999997654 688999999864432 2334677899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||++ ++|..++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999999996 58988887653 35789999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh----
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL---- 305 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---- 305 (398)
+........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||........ .......+
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~ 225 (301)
T cd07873 151 ARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPT 225 (301)
T ss_pred hhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence 875432221 1223457889999998865 4578899999999999999999999975432110 00000000
Q ss_pred -------hccccccccccccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 -------TSKRRIFRVLDPRLEG----QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 -------~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...........+.... ......+..+.+||.+||+.||.+|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 226 EETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000000000 0111235678999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=305.28 Aligned_cols=267 Identities=28% Similarity=0.403 Sum_probs=205.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+.|++.+.||+|+||.||+|.+.. ....++..|++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 357889999999999999997642 233468899999987543 23346788999999999999999999988775
Q ss_pred --CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 151 --DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 151 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
...++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCC
Confidence 56789999999999999987543 35889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC---------CCcchh
Q 015909 229 GLARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT---------GEHNLV 298 (398)
Q Consensus 229 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~---------~~~~~~ 298 (398)
|++......... .......++..|+|||.+.+..++.++||||||+++|+|++++.|+...... ......
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT 233 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence 999865433221 1122345677899999998888999999999999999999987765321110 000000
Q ss_pred hhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
... ..... ......+...+..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 234 ~~~-~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 234 RLV-RVLEE----------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHH-HHHHc----------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 00000 001111223467899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.64 Aligned_cols=253 Identities=30% Similarity=0.454 Sum_probs=200.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.|+..++||+|+||+||+|.+.. ++..||+|.+...... ....+.+|+.+++.++|+||+.+.+.+..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec
Confidence 36778899999999999997654 6889999998654322 23456789999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++..++||||+++++|.+++...+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg 147 (285)
T cd05632 72 KDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred CCEEEEEEEeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCC
Confidence 9999999999999999988876542 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++........ .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......... .....
T Consensus 148 ~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~------- 215 (285)
T cd05632 148 LAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDR------- 215 (285)
T ss_pred cceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHH-------
Confidence 9876432211 22346899999999999889999999999999999999999999753221100 00000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
.+... ...++...+.++.+|+.+||+.||++||+ +.+++++
T Consensus 216 ~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 216 RVLET-----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred hhhcc-----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00000 01122234567889999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=316.07 Aligned_cols=238 Identities=28% Similarity=0.388 Sum_probs=188.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHH-HHcCCCCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEIN-YLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||.||+|++.. ++..||+|++..... .....+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 469999999999997654 688999999864322 22234445544 67889999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|...+... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999999999999888764 34788899999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. .........
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~------- 210 (321)
T cd05603 146 GVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILH------- 210 (321)
T ss_pred CCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhc-------
Confidence 32221 123345789999999999998999999999999999999999999965321 111111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD 350 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 350 (398)
. ....+...+..+.+++.+||+.||.+||++.
T Consensus 211 ---~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 211 ---K--PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---C--CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 0112223456789999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.77 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=201.1
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCce
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
|++.+.||.|+||.||+|.+.. ++..+++|.+........+.+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 6778899999999999997654 6788999998765545566788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++|+||+++++|..++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999988876533 46899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
..... .......++..|+|||++. +..++.++|+|||||++|+|++|.+||....... .... ...
T Consensus 153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~----~~~-- 222 (282)
T cd06643 153 NTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLK----IAK-- 222 (282)
T ss_pred ccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHH----Hhh--
Confidence 43221 1223356899999999983 4557889999999999999999999986432110 0000 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
...+ ....+...+.++.+++.+||+.||.+||++.+++++-
T Consensus 223 -----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 223 -----SEPP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -----cCCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0000 0011223457899999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=302.04 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=204.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+|++.+.||+|+||.||+|.+... ...+..+++|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLP------GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecC------CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 5788999999999999999976421 11345799999865432 2345788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCc
Confidence 99999999999999999997654 35788999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccc-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 231 ARDGPTGDKSHV-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 231 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+........... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ..... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~- 224 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EE- 224 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hC-
Confidence 986543321111 111223567999999998889999999999999999886 999986532211 11100 00
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
. .....+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 225 -----~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 -----G----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----C----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00111223456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=316.20 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=196.9
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceee
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
....++|++.+.||.|+||+||+|.+.. ++..||+|.+..... .....+.+|+.+|+.++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhh
Confidence 3456789999999999999999997654 688999999875422 23455778999999999999999998
Q ss_pred EEEeC------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC
Q 015909 146 YCLED------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219 (398)
Q Consensus 146 ~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~ 219 (398)
++... ...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~ 153 (343)
T cd07878 82 VFTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNE 153 (343)
T ss_pred hhcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECC
Confidence 87543 3568999988 7899887753 34899999999999999999999998 999999999999999
Q ss_pred CCCEEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~ 298 (398)
++.++|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.
T Consensus 154 ~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~ 226 (343)
T cd07878 154 DCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLK 226 (343)
T ss_pred CCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHH
Confidence 999999999999864322 223568999999999876 568899999999999999999999996532210 000
Q ss_pred hhhhhhhhcc------------ccccccccccccC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 299 EWAKPYLTSK------------RRIFRVLDPRLEG---QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 299 ~~~~~~~~~~------------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......... ......+...... ......+..+.+|+.+||..||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 227 RIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0000000000000 0000123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=301.21 Aligned_cols=256 Identities=29% Similarity=0.431 Sum_probs=205.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.+.||+|+||.||+|.+. .+..|++|.+.... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~----------~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN----------GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc----------CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 4568999999999999999999754 34679999987543 345678999999999999999999999998
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....++||||+++++|.+++..... ..+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccc
Confidence 8999999999999999999976432 45889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... ..... ..
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~---~~--- 218 (261)
T cd05034 149 LARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQ---VE--- 218 (261)
T ss_pred cceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HH---
Confidence 9876543211 11112234568999999998889999999999999999998 99999643211 11110 00
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
.. .....+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 219 ----~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 ----RG----YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----cC----CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 0111122235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=305.45 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=203.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+.|++.+.||.|+||.||+|.... ++..|++|.+........+.+.+|+.+++.++|+||+++++.+..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 3678999999999999999997654 6889999999766555567788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||+++++|..++.... ..+++..+..++.|++.+|.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~ 156 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGV 156 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999988876543 35889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+....... .......++..|+|||.+. ...++.++|+||||+++|+|++|..||...... .......
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~ 228 (292)
T cd06644 157 SAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA 228 (292)
T ss_pred ceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHh
Confidence 86532221 1123356888999999984 345788899999999999999999998643211 0000000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....+ ....+...+.++.+++.+||..||++||++.+++++
T Consensus 229 -------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 -------KSEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------cCCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 011122345678899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=302.78 Aligned_cols=263 Identities=23% Similarity=0.397 Sum_probs=205.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+|++.+.||+|+||.||+|.+..+ .......+++|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPE-----GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecC-----CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 35788999999999999999976531 111234789998875533 334678899999999999999999999876
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
...++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCc
Confidence 78899999999999999987654 34899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++................++..|+|||.+....++.++|+||||+++||+++ |..||...... ++ ... +...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~---~~~-~~~~ 227 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EI---PDL-LEKG 227 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HH---HHH-HhCC
Confidence 9987543332221222234568999999988889999999999999999998 99999653211 11 110 0000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.....+...+..+.+++.+||..||.+||++.++++.|.++.+
T Consensus 228 ----------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ----------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122234578899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=299.06 Aligned_cols=250 Identities=23% Similarity=0.392 Sum_probs=195.7
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEEe
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYE 158 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 158 (398)
||+|+||.||+|.+.. ...+..||+|.+..... ...+.+.+|+.+++.++||||+++++++. ....++|||
T Consensus 3 ig~G~~g~v~~~~~~~-------~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 3 LGSGNFGCVKKGVYKM-------RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred cCCCCcccEEEEEEec-------CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEE
Confidence 8999999999997642 12466799999875432 23456889999999999999999999875 457899999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCC
Q 015909 159 FMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD 238 (398)
Q Consensus 159 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~ 238 (398)
|+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 75 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 75 MASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred eCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 999999999987543 45899999999999999999999998 9999999999999999999999999987543332
Q ss_pred Cccc-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 239 KSHV-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 239 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .... .....
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~-------- 214 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMS----FIEQG-------- 214 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCC--------
Confidence 2111 111223568999999988889999999999999999996 99999653211 1100 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.....+...+.++.+++.+||..||++||++.++++.|+.+
T Consensus 215 --~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 215 --KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11122234467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=305.54 Aligned_cols=264 Identities=27% Similarity=0.383 Sum_probs=204.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+... ....++..|++|.+..... .....+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 45789999999999999999976421 1123577899999875432 234568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCC
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGS------------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFK 211 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlk 211 (398)
.+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~ 157 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLA 157 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccccc
Confidence 9999999999999999999975321 1134778889999999999999999998 9999999
Q ss_pred CCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015909 212 ASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNR 290 (398)
Q Consensus 212 p~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~ 290 (398)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999875433222111222334667999999988899999999999999999997 888885432
Q ss_pred CCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 291 PTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.. ..... .... . . ...+...+.++.+++.+||+.||.+||++.|+++.|+
T Consensus 238 ~~------~~~~~-~~~~-~--------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 238 HE------EVIYY-VRDG-N--------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HH------HHHHH-HhcC-C--------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11 11110 0000 0 0 0112234568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.23 Aligned_cols=254 Identities=29% Similarity=0.407 Sum_probs=199.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
..+.|++.+.||+|+||.||+|.... ++..||+|.+.... .....+..|+.+++.+ +|+||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 45678888999999999999997654 68899999986543 3346778899999998 6999999999987
Q ss_pred eC------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 ED------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
.. ...+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~ 149 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAE 149 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCC
Confidence 53 457899999999999999876432 45889999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
++|+|||++....... .......|+..|+|||++. +..++.++|+|||||++|+|++|..||........
T Consensus 150 ~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~--- 224 (272)
T cd06637 150 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--- 224 (272)
T ss_pred EEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---
Confidence 9999999987643221 1223456899999999985 34578899999999999999999999964322110
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ... . ...........+.++.+|+.+||..||.+||++.+++++
T Consensus 225 --~~---~~~-~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 225 --LF---LIP-R-------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --HH---HHh-c-------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 000 0 000111112345678999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=306.57 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=205.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.+|++.+.||.|+||.||+|.+.. ++..|++|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 468999999999999999997544 78899999987655555677889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++|+||+++++|..++... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999999988643 4789999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ . .......
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~----~~~~~~~--- 231 (296)
T cd06655 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L----YLIATNG--- 231 (296)
T ss_pred hhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHhcC---
Confidence 76543322 12234688899999999888899999999999999999999999965432110 0 0000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+ ....+...+..+.++|.+||..||.+||++.+++.+
T Consensus 232 ----~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 232 ----TP--ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ----Cc--ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 011122345678899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=340.93 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=201.8
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceee
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
....++|++.+.||+|+||+||+|.+.. ++..|++|.+..... .....+..|+.+|+.|+||||+++++
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d 79 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence 3445789999999999999999997654 688999999875433 23456889999999999999999999
Q ss_pred EEEeC--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCceecCCCCCCEEEc
Q 015909 146 YCLED--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE-----PKVIYRDFKASNILLD 218 (398)
Q Consensus 146 ~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~ivH~Dlkp~Nilv~ 218 (398)
+|... ..+||||||+++++|.+++.........+++..++.|+.||+.||.|||+.+ .+|+||||||+||||+
T Consensus 80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 88653 5689999999999999999865443456999999999999999999999843 3499999999999995
Q ss_pred C-----------------CCCEEEeeccCCcCCCCCCCccccccccccccccccccccc--CCCCCchhHHHHHHHHHHH
Q 015909 219 S-----------------NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEI 279 (398)
Q Consensus 219 ~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el 279 (398)
. .+.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 4 3458999999997653322 1234578999999999854 4588999999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 280 LSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 280 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
++|..||..... ....... +.. . +.+. ....+.++.+||..||+.+|.+||++.++|.+
T Consensus 237 LTGk~PF~~~~~-----~~qli~~-lk~------~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 237 CSGKTPFHKANN-----FSQLISE-LKR------G--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHCCCCCCcCCc-----HHHHHHH-Hhc------C--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 999999964321 1111111 000 0 0000 01235678999999999999999999999964
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=299.84 Aligned_cols=253 Identities=32% Similarity=0.483 Sum_probs=199.0
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
+.||+|+||.||+|.+.. ..+++..+++|.+..... ...+.+.+|+.+++.+.|+||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeec------cCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 469999999999997643 122457899999876543 24467889999999999999999999765 5568999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++.... .+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 74 MELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred EEeCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 99999999999998654 5889999999999999999999998 99999999999999999999999999886543
Q ss_pred CCCccc-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccccccc
Q 015909 237 GDKSHV-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314 (398)
Q Consensus 237 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+..+.. ...
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~----- 215 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGE----- 215 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCC-----
Confidence 322111 111223467999999998899999999999999999998 9999964321 11111110 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 315 LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
....+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 216 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 -----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01122234568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=315.09 Aligned_cols=238 Identities=29% Similarity=0.367 Sum_probs=188.8
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHH-HHcCCCCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEIN-YLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
++||+|+||+||+|.... ++..||+|++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 469999999999997654 788999999865321 22334455554 57789999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 9999999999999888765 35899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~------- 210 (325)
T cd05604 146 GIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH------- 210 (325)
T ss_pred CCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc-------
Confidence 32221 1223457999999999999999999999999999999999999999653211 11111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD 350 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 350 (398)
.. ...+...+..+.+++.+||+.||.+||++.
T Consensus 211 ---~~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 211 ---KP--LVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred ---CC--ccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 00 011123456788999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=298.69 Aligned_cols=253 Identities=28% Similarity=0.418 Sum_probs=201.4
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
++||+|++|.||+|.+... .+....|++|.+..... ...+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS------GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecC------CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 4689999999999977431 12345799999987665 556788999999999999999999999888 889999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred EEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999999999987543 45899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCCcc-cccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccccccc
Q 015909 237 GDKSH-VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314 (398)
Q Consensus 237 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +. ........
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~---~~~~~~~~------ 217 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QI---LKKIDKEG------ 217 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHHhcC------
Confidence 32211 1112456788999999998899999999999999999998 99998643211 11 11000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 315 LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ----ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011112234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=302.58 Aligned_cols=263 Identities=26% Similarity=0.399 Sum_probs=206.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+|++.+.||.|+||.||+|..... ........|++|.+...... ....+.+|+.++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccC----CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 5688899999999999999987542 22345678999988654332 346788999999999999999999999998
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYF-----QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
+..++||||+++++|.+++....... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEE
Confidence 99999999999999999997654211 25899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ......
T Consensus 159 ~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~--- 231 (275)
T cd05046 159 SLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL--- 231 (275)
T ss_pred cccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH---
Confidence 99999875432221 11223356778999999988889999999999999999998 88888542211 111100
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.........+...+..+.+++.+||+.+|.+||++.+++..|.
T Consensus 232 ----------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 ----------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0001111122234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=304.19 Aligned_cols=276 Identities=28% Similarity=0.374 Sum_probs=207.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEe-
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLE- 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~- 149 (398)
++|++.+.||+|+||.||+|.+.. ....++..||+|.+...... ....+.+|+.+++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDP-----LGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecC-----CCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 467888999999999999997653 12346889999999765433 45678999999999999999999998877
Q ss_pred -CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 150 -DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 150 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
....+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~df 153 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDF 153 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccc
Confidence 557899999999999999997654 25899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCccc-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHV-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|++........... .....++..|++||.+.+..++.++||||||+++|+|++|..|+............. . .....
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~ 231 (284)
T cd05038 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMI 231 (284)
T ss_pred ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-ccccc
Confidence 99987643222111 112234567999999988889999999999999999999999985432111000000 0 00000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
...+...+........+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000000001111111223457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=298.18 Aligned_cols=253 Identities=28% Similarity=0.411 Sum_probs=200.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||+|++|.||+|.+.. +..+++|.+.... ...+.+.+|+.+++.++|+||+++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 568899999999999999997643 3468999886543 23466889999999999999999998874 56
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccc
Confidence 68999999999999999976432 45788999999999999999999998 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ..... ..
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~---- 217 (260)
T cd05069 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ----VE---- 217 (260)
T ss_pred eEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HH----
Confidence 765332211 1122345678999999988889999999999999999999 99999653211 11000 00
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
.. .....+...+..+.+++.+||+.||++||+++++++.|++
T Consensus 218 --~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 --RG----YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --cC----CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00 0111223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=301.46 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=206.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+|.+.+.||+|+||.||+|.+... ......|++|...... ....+.+.+|+.+++.+.||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSP------ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecC------CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 35688899999999999999976431 1234578999886543 3445678899999999999999999998765
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
...++||||+++++|.+++.... ..+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCc
Confidence 56789999999999999997643 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... +...
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~ 224 (270)
T cd05056 153 LSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGR----IENG 224 (270)
T ss_pred eeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH----HHcC
Confidence 9876533321 11122234567999999988889999999999999999986 999996542211 1000 0000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
. ....+...+..+.+++.+||..+|.+|||+.++++.|+.+...+
T Consensus 225 ~----------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 225 E----------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred C----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 00112234568999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=312.23 Aligned_cols=256 Identities=21% Similarity=0.258 Sum_probs=198.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||++++.. ++..||+|.+.... ......+.+|+.++..+.|++|+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 478999999999999999997654 68899999986421 122345778999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEec
Confidence 9999999999999999999998643 35889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
|++........ .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .....
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~ 219 (331)
T cd05624 147 GSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGK 219 (331)
T ss_pred cceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHH
Confidence 99876533221 11223569999999999865 46788999999999999999999999643211 11111
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL--RPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 355 (398)
........ .+. ......+.++.+++.+||..++++ |+++++++++
T Consensus 220 i~~~~~~~------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 220 IMNHEERF------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHcCCCcc------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11000000 000 001123578999999999876655 4689998877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=303.46 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=199.0
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||+|++|.||+|.... ++..|++|.+..... ...+.+.+|+.+++.++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 47888999999999999997654 688999999865422 2345678999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||++ ++|.+++..... ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999996 688888765432 245899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh-----
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY----- 304 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~----- 304 (398)
+....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|++||........ ........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~ 223 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTE 223 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence 87543221 11223457889999998865 4578899999999999999999999975422110 00000000
Q ss_pred --------hhccc-cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 --------LTSKR-RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 --------~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ......... ........+.++.++|.+||+.||.+|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 224 DVWPGVTSLPDYKNTFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhhcchhhHHHHhhccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 000000000 000111246778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=304.74 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=204.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||.|+||.||+|.+.. ++..|++|.+........+.+..|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 3568889999999999999997654 6889999998765545566788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||+++++|.+++...+ ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~ 149 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGV 149 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCcc
Confidence 99999999999999999987654 35899999999999999999999998 99999999999999999999999998
Q ss_pred CcCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+........ ......|+..|+|||.+. ...++.++|+||||+++|+|++|+.||....... . .....
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~ 221 (280)
T cd06611 150 SAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--V----LLKIL 221 (280)
T ss_pred chhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--H----HHHHh
Confidence 875433221 123356899999999874 3457788999999999999999999996532210 0 00000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....+. ...+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 222 -------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 222 -------KSEPPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------cCCCCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000000 01122345678999999999999999999999887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=297.24 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=205.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||.|+||.||+|.... ++..|++|.+..... .+.+.+|+.+++.++|+||+++++.+....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 578899999999999999997654 578999999875432 578899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++++||+++++|.+++...+ ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999999999999987544 46899999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... ....
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---------~~~~--- 212 (256)
T cd06612 147 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---------FMIP--- 212 (256)
T ss_pred hhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---------hhhc---
Confidence 87543321 122345788999999999889999999999999999999999999753222110 0000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ......+...+.++.+++.+||+.||++||++.+++++
T Consensus 213 -~~~--~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 213 -NKP--PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -cCC--CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 000 00111223345688999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=299.23 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=193.2
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
+.||+|+||.||+|.+.. ..++..+++|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-------GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcC-------CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 359999999999997642 22467799998875432 2334688899999999999999999999998999999
Q ss_pred EeecCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCC
Q 015909 157 YEFMPRGSMENHLFRRGS-YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~ 235 (398)
|||+++++|.+++..... .....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999975432 1234567788889999999999999998 9999999999999999999999999987543
Q ss_pred CCCCcccccccccccccccccccccC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 236 TGDKSHVSTRVMGTYGYAAPEYLATG-------HLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
............++..|+|||++.+. .++.++|+||||+++|||++ |..||....... ...+. .
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~----~- 223 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT----V- 223 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----h-
Confidence 32222222234578889999998542 35789999999999999996 999996432211 10000 0
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.........+. .....+..+.+++..|| .+|++|||+++|+..|+
T Consensus 224 ~~~~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 REQQLKLPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hcccCCCCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000111111 11223456889999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=312.79 Aligned_cols=256 Identities=20% Similarity=0.259 Sum_probs=199.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||++.+.. ++..||+|.+..... .....+.+|+.++..++|++|+++++.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 468899999999999999997654 678999999864221 22344778999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~Df 146 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADF 146 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997643 35889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
|++........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~ 219 (332)
T cd05623 147 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGK 219 (332)
T ss_pred chheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHH
Confidence 99875432221 1223357999999999986 346888999999999999999999999653211 11111
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL--RPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 355 (398)
........ ... ......+.++.+|+.+||..++++ |+++.+++++
T Consensus 220 i~~~~~~~------~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 220 IMNHKERF------QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HhCCCccc------cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11100000 000 011234678899999999765554 6899999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=301.97 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=203.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||.|++|.||+|.+.. ++..|++|.+.... ......+.+|+.+++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 368889999999999999997654 68899999987543 23345678999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999998754 5899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....+.. .. . .
T Consensus 145 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~---~-------~ 209 (274)
T cd06609 145 SGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VL---F-------L 209 (274)
T ss_pred ceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HH---H-------H
Confidence 87754332 12233568889999999998889999999999999999999999996533110 00 0 0
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+.....+.+.. ...+.++.+++.+||..||++||++++++++
T Consensus 210 ~~~~~~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 210 IPKNNPPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hhhcCCCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00001111111 1145678999999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=307.55 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=203.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.... ++..|++|.+...... ..+.+..|+.+++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 368889999999999999997654 6889999999765433 3456889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.....++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~df 147 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDF 147 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeec
Confidence 99999999999999999999875432 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc---------------------------ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh
Q 015909 229 GLARDGPTGDKS---------------------------HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281 (398)
Q Consensus 229 g~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~ 281 (398)
|++......... .......|+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence 998754322110 01123468899999999998889999999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHHH
Q 015909 282 GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD----MDEVVKE 355 (398)
Q Consensus 282 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 355 (398)
|..||....... .+ ................+.++.+++.+||+.||++||+ +.+++++
T Consensus 228 g~~pf~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 228 GTTPFKGSNRDE--TF--------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCCCchHH--HH--------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 999996533210 00 0001111111111125678999999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=298.48 Aligned_cols=250 Identities=21% Similarity=0.379 Sum_probs=192.4
Q ss_pred ceecccCCceEEEEEecCCccc---ccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLA---STRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL 154 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~ 154 (398)
+.||+|+||.||+|+....... .........+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986431100 0111245578999887654445567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC-------EEEee
Q 015909 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN-------AKLSD 227 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~-------~kl~D 227 (398)
+||||+++++|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999988886543 35899999999999999999999998 999999999999986654 89999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccc-cCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEIL-SGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell-~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
||++...... ....++..|+|||.+. +..++.++||||||+++|+|+ .|..||........ ..+.
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence 9998654321 2245788899999886 467889999999999999998 58888754321100 0000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.. .. ....+.+.++.+|+.+||+.||.+||++.+|++.|+
T Consensus 223 ~~----------~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EG----------QC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hc----------Cc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 00 011123467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=301.33 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=200.2
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
+.||+|+||.||+|.+.... .....+..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 36999999999999775411 112234689999886542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-----CEEEeec
Q 015909 157 YEFMPRGSMENHLFRRGS---YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-----NAKLSDF 228 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-----~~kl~Df 228 (398)
|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCc
Confidence 999999999999975432 1234788999999999999999999998 99999999999999877 8999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ...
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~ 228 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH----VTA 228 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH----Hhc
Confidence 99876543332222223345788999999999999999999999999999998 99998643211 11110 000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
......+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus 229 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 ----------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0011122344678899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=308.69 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=195.7
Q ss_pred CCceeccc--CCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 76 PDSVLGEG--GFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 76 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+.++||+| +|++||++.... ++..||+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 46789999 688999987654 799999999975432 22355778999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++||+..
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchh
Confidence 99999999999999999975432 35889999999999999999999998 999999999999999999999999865
Q ss_pred cCCCCCCCc-----cccccccccccccccccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh--
Q 015909 232 RDGPTGDKS-----HVSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK-- 302 (398)
Q Consensus 232 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-- 302 (398)
......... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~ 226 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGT 226 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCC
Confidence 432211110 01122356778999999976 4688999999999999999999999964321100 000000
Q ss_pred -hhhhc-----ccc-------------cc---------ccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 015909 303 -PYLTS-----KRR-------------IF---------RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354 (398)
Q Consensus 303 -~~~~~-----~~~-------------~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 354 (398)
+.... ... .. ...............+..+.+|+.+||+.||++|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000 000 00 000000001112234568899999999999999999999998
Q ss_pred H
Q 015909 355 E 355 (398)
Q Consensus 355 ~ 355 (398)
+
T Consensus 307 ~ 307 (327)
T cd08227 307 H 307 (327)
T ss_pred C
Confidence 5
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=297.75 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=201.1
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe-
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE- 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~- 149 (398)
+|++.+.||+|++|.||++.+.. ++..|++|.+..... ...+.+.+|+.+++.++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 48899999999999999997654 678899999865432 334567889999999999999999988764
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+...+++|||+++++|.+++..... ..+++..+..++.+++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~ 147 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLG 147 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEeccc
Confidence 4457899999999999999876432 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++....... .......+++.|+|||++.+..++.++|+||||+++++|++|+.||..... .........
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~--- 216 (257)
T cd08223 148 IARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIE--- 216 (257)
T ss_pred ceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh---
Confidence 987653322 122345688999999999999999999999999999999999999864321 111111000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ....+...+..+.+++.+||+.||++||++.+++++
T Consensus 217 ---~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 ---GK-----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---cC-----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 011233456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=295.34 Aligned_cols=248 Identities=30% Similarity=0.477 Sum_probs=197.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
++||.|+||.||+|.+. .+..|++|.+...... ....+.+|+.+++++.|+||+++++++......++|
T Consensus 1 ~~lg~g~~g~v~~~~~~----------~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEe----------CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 46999999999999653 2788999998765433 456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++.... ..+++..+..++.+++.+|.|||+++ ++||||+|+||+++.++.++|+|||++.....
T Consensus 71 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 145 (251)
T cd05041 71 MELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEG 145 (251)
T ss_pred EEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence 99999999999987643 35788999999999999999999998 99999999999999999999999999876432
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .... ..
T Consensus 146 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~----~~--------- 209 (251)
T cd05041 146 GIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER----IE--------- 209 (251)
T ss_pred CcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH----Hh---------
Confidence 221111112234567999999988899999999999999999998 888886532211 0000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 316 DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.......+...+..+.+++.+||..+|++||++.++++.|+
T Consensus 210 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 210 -SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00011122234568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=303.29 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=197.2
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||+|+||.||+|.+.. +|..|++|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 48888999999999999997754 688999999865322 2234577899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++|+||++ ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~ 145 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGL 145 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccch
Confidence 99999999995 58888776543 35899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..|+........ .............
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~ 221 (284)
T cd07839 146 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPT 221 (284)
T ss_pred hhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCC
Confidence 876433221 12234578899999998764 478899999999999999999888643221110 0000000000000
Q ss_pred -----ccccccc----ccccC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 -----RIFRVLD----PRLEG-----QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 -----~~~~~~~----~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+....+ +.... ......+.++.++|.+||+.||.+|||+++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 00000 1112246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=296.78 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=204.8
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.++||.|+||.||.+.... ++..+++|.+.... ......+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 58889999999999999986554 68889999886543 23456688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..+++|||+++++|.+++..... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~ 147 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGI 147 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcc
Confidence 999999999999999999976532 45889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~---- 215 (256)
T cd08221 148 SKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQ---- 215 (256)
T ss_pred eEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc----
Confidence 876533321 223456899999999998888899999999999999999999999643211 11111000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
... .......+.++.+++.+||+.+|++||++.++++++
T Consensus 216 ------~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 216 ------GNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ------CCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 000 011123456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=304.50 Aligned_cols=264 Identities=24% Similarity=0.418 Sum_probs=202.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+|+..+.||+|+||.||+|.+.... ......+++|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEG-----ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCC-----CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 356788899999999999999765410 01123678998865432 223467889999999999999999998865
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
...++++||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccc
Confidence 45679999999999999987654 35788999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+.... ....+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~ 227 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDL----LEKG 227 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCC
Confidence 9986543322222222345778999999998899999999999999999997 89998643211 11111 1110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.. ...+...+..+.+++.+||..+|++||+++++++.|..+.+-
T Consensus 228 ~~----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 ER----------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 011112345788999999999999999999999999987433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=296.06 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=193.9
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCCCCCcccceeeEEE-eCCceEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHHPNLVKLVGYCL-EDDHRLL 155 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~-~~~~~~l 155 (398)
+.||+|+||.||+|.+.. ....+..+|+|.+... .....+.+.+|+.+++.++||||+++++++. .+...++
T Consensus 1 ~~lg~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLID------SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEec------CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 468999999999997643 1124568999988543 2234567889999999999999999999765 4556789
Q ss_pred EEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCC
Q 015909 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235 (398)
Q Consensus 156 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~ 235 (398)
+|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 75 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 75 VLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999997643 34677788899999999999999998 9999999999999999999999999987543
Q ss_pred CCCCcc--cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCCCcchhhhhhhhhhcccccc
Q 015909 236 TGDKSH--VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG-RRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312 (398)
Q Consensus 236 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
...... ......++..|+|||.+.+..++.++||||||+++|||++| .+||...... .. ... ....
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~---~~~-~~~~---- 218 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DI---TVY-LLQG---- 218 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHH-HhcC----
Confidence 321110 11123457789999999888999999999999999999994 5666432110 11 110 0000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
. ....+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 219 --~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 --R----RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --C----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 00111223567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=298.29 Aligned_cols=253 Identities=30% Similarity=0.455 Sum_probs=195.3
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCC-CCCcccceeeEEEeCCceEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHRLL 155 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~~~~~l 155 (398)
++||+|+||.||+|.+.+. +....+++|.+.... ....+.+.+|+.++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCC-------CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 4699999999999976541 122457888886432 23345788999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 156 VYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 156 v~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
||||+++++|.+++..... ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeE
Confidence 9999999999999976431 1234788999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||...... .. ..
T Consensus 152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~---~~ 222 (270)
T cd05047 152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL---YE 222 (270)
T ss_pred EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HH---HH
Confidence 999999986321110 1111223567999999988889999999999999999997 99999643211 00 00
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.. . .......+...+.++.+++.+||+.||.+|||+.+++..|.++
T Consensus 223 ~~-~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 223 KL-P----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HH-h----------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 0 0001111223456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=296.89 Aligned_cols=250 Identities=29% Similarity=0.405 Sum_probs=206.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccch---HHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|..+++||+|.||+|.+++-+ .+++.||+|+++++..-.. ..-+.|-++|+..+||.+..+.-.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEK---------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREK---------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeec---------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 356778899999999999998544 4899999999987654332 3346799999999999999999899
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+.+|+||||..||.|.-.+.+.. .+++.....+...|+.||.|||+++ ||+||||.+|+|+|.+|++||+|
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeee
Confidence 99999999999999999998888764 5888889999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||+++... .......+++||+.|+|||++....|+.++|+|.+|+++|||++|+.||...+..
T Consensus 312 FGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--------------- 374 (516)
T KOG0690|consen 312 FGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--------------- 374 (516)
T ss_pred cccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---------------
Confidence 99998632 2333566789999999999999999999999999999999999999999753221
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
.+++.+-. -...+|...+++++.|+..+|.+||.+|. ++.|+.++
T Consensus 375 --kLFeLIl~-ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 375 --KLFELILM-EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred --HHHHHHHh-hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11111100 12245666778999999999999999994 45555443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=281.52 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=198.3
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCCC-CCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~ 150 (398)
+.+++..||.|+.|.|+++.+.. +|..+|||.+... +.++.+.++..+.++..-+ +|+||+++|+|..+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 34556779999999999998776 8999999999754 3344566777777666554 89999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++.||.+ ...+..++.+.. +++++..+-++...++.||.||..+. +|+|||+||+|||+|+.|++||||||+
T Consensus 164 ~dV~IcMelM-s~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 164 TDVFICMELM-STCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred chHHHHHHHH-HHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccc
Confidence 9999999998 556677766654 67999999999999999999997653 599999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+.+..+.. ..+...|-+.|||||.+. ...|+.++||||||++++||.||+.||.+.... .+. ....+.
T Consensus 239 sGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~---ltkvln- 309 (391)
T KOG0983|consen 239 SGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEV---LTKVLN- 309 (391)
T ss_pred cceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHH---HHHHHh-
Confidence 98764433 334457899999999984 457899999999999999999999999864321 111 111111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
-..+.+.... ..+.++.+|+..||.+|+.+||...+++++
T Consensus 310 ------~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 ------EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ------cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1112222211 256789999999999999999999999876
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=303.59 Aligned_cols=264 Identities=26% Similarity=0.356 Sum_probs=203.6
Q ss_pred HHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccc
Q 015909 64 YSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVK 142 (398)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~ 142 (398)
++.+....++|++.+.||+|+||.||+|.... ++..+++|.+.... .....+.+|+.+++.+ +||||++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~ 79 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVK 79 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeee
Confidence 34555567889999999999999999997654 67899999876432 2235677899999999 6999999
Q ss_pred eeeEEE-----eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE
Q 015909 143 LVGYCL-----EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217 (398)
Q Consensus 143 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv 217 (398)
+++++. .+...++||||+++++|.+++.........+++..+..++.|++.||.|||+++ ++||||||+||++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili 157 (286)
T cd06638 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILL 157 (286)
T ss_pred eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEE
Confidence 999874 345689999999999999988654333356889999999999999999999998 9999999999999
Q ss_pred cCCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 015909 218 DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292 (398)
Q Consensus 218 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~ 292 (398)
+.++.++|+|||++........ ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred CCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 9999999999999876533221 1223468999999998853 45788999999999999999999999653221
Q ss_pred CCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.. .. . ......+. ...+...+.++.+++.+||+.||++||++.++++++
T Consensus 236 ~~--~~-------~----~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 RA--LF-------K----IPRNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HH--Hh-------h----ccccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 10 00 0 00000000 011112345789999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=315.55 Aligned_cols=242 Identities=26% Similarity=0.364 Sum_probs=188.2
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCC---CCCcccceeeEEEeCCce
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL---HHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~~I~~~~~~~~~~~~~ 153 (398)
||+|+||+||+|++.. ++..||+|++..... ........|..++..+ .||||+++++++...+..
T Consensus 1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999997654 788999999864322 1223345566666654 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred EEEEcCCCCChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 99999999999999887653 4899999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
...... ......||..|+|||++.+. .++.++|||||||++|+|++|..||...... ...........
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~--- 214 (330)
T cd05586 146 NLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFGKV--- 214 (330)
T ss_pred CCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcCCC---
Confidence 332221 22345799999999998754 4889999999999999999999999653211 11111000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC----CHHHHHHH
Q 015909 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP----DMDEVVKE 355 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~ell~~ 355 (398)
.+. ....+.++.+++.+||+.||.+|| ++.+++++
T Consensus 215 -----~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 215 -----RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred -----CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 000 112356788999999999999998 67777774
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=297.54 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=197.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-----cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-----QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
.+|++.++||+|+||.||+|.... ++..|++|.+..... .....+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 468899999999999999996644 688999998864321 223457889999999999999999998
Q ss_pred EEe--CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 147 CLE--DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 147 ~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
+.. ....++++||+++++|.+++.... .+++...+.++.|++.||.|||+.+ |+|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEE
Confidence 875 356789999999999999997653 4788999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 225 LSDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... . .
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~-~-- 218 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----A-I-- 218 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----H-H--
Confidence 9999998754322111 11123457889999999998889999999999999999999999996432110 0 0
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
............+...+..+.+++ +||..+|++||++++++++
T Consensus 219 --------~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 219 --------FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --------HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 000000111223334566778888 6777899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=297.35 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=199.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-----cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-----QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
.+|++.+.||+|+||.||+|.+.. ++..|++|.+..... ...+.+.+|+.+++.+.||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 468899999999999999997654 688999998853211 223567889999999999999999998
Q ss_pred EEeC--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 147 CLED--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 147 ~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
+.+. ...+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEE
Confidence 8763 46789999999999999987653 4788889999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 225 LSDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
|+|||++......... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... . .
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~-- 218 (265)
T cd06652 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-I-- 218 (265)
T ss_pred ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-H--
Confidence 9999998764322111 11223468889999999988889999999999999999999999996421110 0 0
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
............+...+..+.+++.+||. +|++||++++++++
T Consensus 219 --------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 --------FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --------HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00011111122344566788999999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=302.44 Aligned_cols=261 Identities=29% Similarity=0.384 Sum_probs=202.7
Q ss_pred CHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCccc
Q 015909 63 SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLV 141 (398)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~ 141 (398)
+..++....+.|++.+.||.|+||.||+|.+.. ++..+++|.+.... .....+..|+.+++.+ +|+||+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~ 76 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIA 76 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEE
Confidence 344555566789999999999999999997654 67899999986542 2345678899999998 699999
Q ss_pred ceeeEEEe------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 142 KLVGYCLE------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 142 ~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
++++++.. ....+++|||+++++|.+++..... ..+++..+..++.||+.||.|||+++ |+|+||+|+||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~ni 152 (282)
T cd06636 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNV 152 (282)
T ss_pred EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHE
Confidence 99998853 4577999999999999999876442 45788889999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNR 290 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~ 290 (398)
+++.++.++|+|||++........ ......|+..|+|||.+. ...++.++|+||||+++|+|++|..||....
T Consensus 153 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 153 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred EECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 999999999999999875432211 123356899999999885 3467889999999999999999999996432
Q ss_pred CCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 291 PTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+..... ...............+.++.++|.+||+.||.+||++.+++++
T Consensus 231 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 231 PMRALF----------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred HHhhhh----------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 211100 0000000011112345689999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=305.63 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=189.7
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe--CCceE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE--DDHRL 154 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~--~~~~~ 154 (398)
...||+|+||+||+|.... ..++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~-------~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKD-------GKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred ceEeccCCCeeEEEEEecC-------CCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 3579999999999997643 2256789999986543 23457789999999999999999998854 45778
Q ss_pred EEEeecCCCCHHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE----cCCCCEEE
Q 015909 155 LVYEFMPRGSMENHLFRRG-----SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL----DSNYNAKL 225 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv----~~~~~~kl 225 (398)
+||||++ ++|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.++|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEE
Confidence 9999985 58887775321 11235888999999999999999999998 9999999999999 46678999
Q ss_pred eeccCCcCCCCCCCc-cccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc-------c
Q 015909 226 SDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH-------N 296 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-------~ 296 (398)
+|||+++........ .......||..|+|||++.+ ..++.++|||||||++|+|++|++||......... .
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 999999865432211 11233568999999999876 45789999999999999999999999753321110 0
Q ss_pred hhhhhhhhh-------hc---c---cccccccc------ccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 015909 297 LVEWAKPYL-------TS---K---RRIFRVLD------PRL---EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354 (398)
Q Consensus 297 ~~~~~~~~~-------~~---~---~~~~~~~~------~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 354 (398)
+........ .. . ........ ..+ ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000 00 0 00000000 000 00011122456889999999999999999999987
Q ss_pred H
Q 015909 355 E 355 (398)
Q Consensus 355 ~ 355 (398)
+
T Consensus 314 h 314 (317)
T cd07867 314 D 314 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=297.05 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=202.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
...+|++.+.||+|+||.||+|.+. .+..+++|.+.... .....+.+|+.+++.++|+||+++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~----------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec----------CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 3568999999999999999999654 34569999887542 234678899999999999999999998877
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
...+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 73 -EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCc
Confidence 778999999999999999976432 45788889999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... ..... ....
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~ 219 (260)
T cd05073 148 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERG 219 (260)
T ss_pred ceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhCC
Confidence 98765332211 1122345677999999988889999999999999999998 99999643211 11110 0000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
.....+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 ----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=293.54 Aligned_cols=247 Identities=31% Similarity=0.465 Sum_probs=195.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
++||.|+||.||+|... ++..+++|.+...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 46999999999999643 4678999998755322 234678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++.... ..+++..+..++.+++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 71 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 71 MELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred EECCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccc
Confidence 99999999999886543 35789999999999999999999998 99999999999999999999999999875332
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. .. ... .
T Consensus 146 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~---~~-~~~------~- 210 (250)
T cd05085 146 GIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR---EQ-VEK------G- 210 (250)
T ss_pred cccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH---HH-HHc------C-
Confidence 2111 1112234567999999988889999999999999999998 999996432110 00 00 000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 316 DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 211 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 211 ---YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 011122234578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=297.83 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=199.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+.+.....||+|+||.||+|.+.. ++..|++|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 334445689999999999997654 67899999987665555678899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-CCCEEEeec
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPL--SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLSDF 228 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-~~~~kl~Df 228 (398)
..++|+||+++++|.+++.... ..+ +...+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecc
Confidence 9999999999999999997643 234 77888899999999999999998 999999999999975 679999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH--LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|++........ ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ..+....
T Consensus 154 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~-- 226 (268)
T cd06624 154 GTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGM-- 226 (268)
T ss_pred hhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhh--
Confidence 99876432221 122345789999999986543 78899999999999999999999864321100 0000000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 227 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 ----------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 001112233456789999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=297.95 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=204.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..|+..+.||.|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.+.|+||+++++.+.+.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 357778899999999999997654 67899999986442 23456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~ 147 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEccccc
Confidence 999999999999999998864 24788899999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------------- 211 (277)
T cd06640 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------------- 211 (277)
T ss_pred ceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------------
Confidence 876533221 1223467889999999988889999999999999999999999996532211000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
..............+..+.+++.+||+.+|++||++.+++.+--
T Consensus 212 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 212 ---LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred ---hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 00000111233456778999999999999999999999998843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=301.09 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=200.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.|+..+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+...+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 46667889999999999997654 67899999987443 233456889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++++|.+++.. ..+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999999998854 34788999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....+... ... .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~------ 213 (277)
T cd06642 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----I------ 213 (277)
T ss_pred ccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----h------
Confidence 76543221 12234678899999999988999999999999999999999999864322110 000 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
............+.++.+++.+||+.+|++||++.+++++
T Consensus 214 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 214 ----PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000111222345678999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=299.19 Aligned_cols=249 Identities=23% Similarity=0.406 Sum_probs=190.8
Q ss_pred eecccCCceEEEEEecCCcc---------------cccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccce
Q 015909 79 VLGEGGFGSVFKGWVDEHSL---------------ASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKL 143 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~---------------~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~ 143 (398)
.||+|+||.||+|.+..... ..........|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997542110 011223345789999875544445678889999999999999999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC--
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-- 221 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-- 221 (398)
++++......++||||+++++|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999998886543 35788999999999999999999998 99999999999997543
Q ss_pred -----CEEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCCCCCC
Q 015909 222 -----NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEIL-SGRRAIDKNRPTGE 294 (398)
Q Consensus 222 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell-~g~~p~~~~~~~~~ 294 (398)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 4899999987643221 12356788999998865 56889999999999999995 69999865432111
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.. ..... ...+.....++.+++.+||+.+|++||++.++++.|.
T Consensus 231 ---~~----~~~~~------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ---ER----FYEKK------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HH----HHHhc------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 00000 0011122346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.40 Aligned_cols=255 Identities=25% Similarity=0.461 Sum_probs=203.3
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc------cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF------QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
+|+..+.||+|++|.||+|.... ++..|++|.+..... ...+.+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 47888999999999999997644 688999999864321 124568899999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-CEEE
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKL 225 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-~~kl 225 (398)
+.+.+..++||||+++++|.+++...+ ++++..+..++.||+.||.|||+++ ++|+||+|+||+++.++ .++|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l 145 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRI 145 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999999999987653 5889999999999999999999998 99999999999998765 5999
Q ss_pred eeccCCcCCCCCCCc--ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 226 SDFGLARDGPTGDKS--HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
+|||.+......... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------ 219 (268)
T cd06630 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL------ 219 (268)
T ss_pred cccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH------
Confidence 999998765432111 112234678899999999888899999999999999999999999964322111000
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.............+...+.++.+++.+||..+|.+||++.+++++
T Consensus 220 -------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 220 -------IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 000001111223344567789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.20 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=203.9
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe-
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE- 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~- 149 (398)
+|++.+.||.|+||.||+|.+.. ++..+++|.+..... ...+.+..|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 47888999999999999997654 678999999865432 234567889999999999999999998764
Q ss_pred -CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCceecCCCCCCEEEcCCCCE
Q 015909 150 -DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH-----SAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 150 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
....+++|||+++++|.+++.........+++..++.++.||+.||.||| +.+ ++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~ 149 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNV 149 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCE
Confidence 45678999999999999999875444467899999999999999999999 777 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
+|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..+. ..
T Consensus 150 kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~---~~ 221 (265)
T cd08217 150 KLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA---SK 221 (265)
T ss_pred EEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH---HH
Confidence 9999999887543322 12234689999999999888899999999999999999999999975321 1111 10
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ........+...+.++.+++.+||+.+|++||++.+++++
T Consensus 222 -~----------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 -I----------KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -H----------hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0011112333456789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.18 Aligned_cols=256 Identities=32% Similarity=0.483 Sum_probs=202.9
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeCCc
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~ 152 (398)
+++.+.||.|+||.||+|.+... ...++..|++|.+...... ..+.+..|+.+++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGL-----SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCC-----CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 35678999999999999987541 1123588999999765433 46788899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
.+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCce
Confidence 9999999999999999876542 22899999999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
........... ...++..|+|||.+.+..++.++|+||||+++|+|++ |.+||..... .... ..... ..
T Consensus 152 ~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~---~~~~~-~~-- 221 (258)
T smart00219 152 DLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVL---EYLKK-GY-- 221 (258)
T ss_pred ecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH---HHHhc-CC--
Confidence 75443222111 2336789999999988889999999999999999998 8888864211 0111 10000 00
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
....+...+.++.+++.+||..||++|||+.++++.|
T Consensus 222 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 --------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111222567899999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=297.29 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=199.9
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---c-------chHHHHHHHHHHcCCCCCcccc
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---Q-------GHKEWLTEINYLGQLHHPNLVK 142 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~~I~~ 142 (398)
+|.+.+.||.|+||.||+|.... ++..|++|.+..... . ..+.+..|+.+++.++|+||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 57888999999999999996543 688999998753211 0 1245778999999999999999
Q ss_pred eeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
+++++...+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~ 146 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGI 146 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCe
Confidence 9999999999999999999999999987653 5888999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH--LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
++|+|||++................|+..|+|||.+.... ++.++|+||||+++|+|++|..||...... ...
T Consensus 147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~ 221 (272)
T cd06629 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAM 221 (272)
T ss_pred EEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHH
Confidence 9999999987643322222223356888999999987654 788999999999999999999998532211 000
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. .. .. ..............+.++.+++.+||+.+|.+||++.+++++
T Consensus 222 ~~-~~--~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 222 FK-LG--NK----RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HH-hh--cc----ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 00 00 000111111222346789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.75 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=191.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVY 157 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 157 (398)
+.||.|+||.||+|....... ........|++|.+........+.+.+|+.+++.+.||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999997643110 001134568888886554444567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC--------EEEeecc
Q 015909 158 EFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN--------AKLSDFG 229 (398)
Q Consensus 158 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~--------~kl~Dfg 229 (398)
||+++++|..++...+ ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999987654 35788999999999999999999998 999999999999986654 6999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCC-CCCCCCCCCCCcchhhhhhhhhhc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGR-RAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
++...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|. .||........ . .....
T Consensus 154 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~------~-~~~~~ 220 (258)
T cd05078 154 ISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK------L-QFYED 220 (258)
T ss_pred cccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH------H-HHHHc
Confidence 88654321 22457889999999976 45789999999999999999984 55543221100 0 00000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
....+.....++.+++.+||+.||++|||++++++.|+
T Consensus 221 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122223467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=298.93 Aligned_cols=257 Identities=28% Similarity=0.392 Sum_probs=201.8
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
..++|++.+.||.|++|.||+|.+.. ++..+++|.+..... ....+.+|+.+++++ .|+||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 45789999999999999999997654 678999999875432 346788999999999 6999999999987
Q ss_pred eCC------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 EDD------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
... ..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAE 151 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCe
Confidence 644 489999999999999998765433356899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCccccccccccccccccccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
++|+|||++....... .......|+..|+|||.+.. ..++.++||||||+++|+|++|..||....... ..
T Consensus 152 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 227 (275)
T cd06608 152 VKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--AL 227 (275)
T ss_pred EEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HH
Confidence 9999999987543221 12233568899999998753 346788999999999999999999996432110 00
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ... ....+ ....+...+.++.+++.+||..||++|||+.+++++
T Consensus 228 ~-------~~~----~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 228 F-------KIP----RNPPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred H-------Hhh----ccCCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 000 00000 111122346789999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=296.14 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=190.3
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEE
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVY 157 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 157 (398)
.||+|+||.||+|.... ......+++|.+..... .....+.+|+.+++.++|+||+++++.+......++||
T Consensus 2 ~lg~G~fg~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHR-------GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEec-------CCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 59999999999996532 12456789998764432 22456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 158 EFMPRGSMENHLFRRGSY-FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 158 e~~~~~~L~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
||+++++|.+++...... ....++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYP 152 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEecccccccccc
Confidence 999999999999765421 233567788899999999999999998 99999999999999999999999999865433
Q ss_pred CCCccccccccccccccccccccc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLAT-------GHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
...........++..|+|||++.. ..++.++|||||||++|+|++ |..||...... +.. ......
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~---~~~~~~- 225 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVL---KQVVRE- 225 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---HHHhhc-
Confidence 221111222345678999998743 456789999999999999999 78888643211 000 000000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.......+ ..+...+..+.+++..|| .||++||+++++++.|.
T Consensus 226 -~~~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 226 -QDIKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -cCccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00011111 122234567778999998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=295.16 Aligned_cols=257 Identities=22% Similarity=0.359 Sum_probs=191.5
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEE
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVY 157 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 157 (398)
.||+|+||.||+|.... ......+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||
T Consensus 2 ~lg~G~~g~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYT-------DTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEc-------CCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 59999999999986532 1134456777776433 234567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCC
Q 015909 158 EFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTG 237 (398)
Q Consensus 158 e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~ 237 (398)
||+++++|.+++.........++...+..++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcc
Confidence 999999999999875443455677888899999999999999998 999999999999999999999999998643222
Q ss_pred CCccccccccccccccccccccc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 238 DKSHVSTRVMGTYGYAAPEYLAT-------GHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
..........++..|+|||++.. ..++.++||||||+++|||++ |..||...... ........ .
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~--~ 224 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIK--D 224 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh--h
Confidence 21112234567889999998743 245778999999999999997 56777543211 11111111 1
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.......+.+ ....+..+.+++..|| .+|++||+++++++.|.
T Consensus 225 ~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 QQVKLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111112222 2224567888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=301.22 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=205.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|.+.. ++..|++|++.... ....+.+.+|+++++.++||||+++++.+..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 3568888999999999999997654 68899999886543 2335678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
....++||||+++++|.+++...+ .+++..+..++.+++.+|.|||+ ++ ++|+||+|+||+++.++.++|+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~ 148 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDF 148 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccC
Confidence 999999999999999999887643 58899999999999999999997 46 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc-----chhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH-----NLVEWAKP 303 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-----~~~~~~~~ 303 (398)
|++....... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......+. ........
T Consensus 149 gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 149 GVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred Ccccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 9986542211 12356899999999998889999999999999999999999999754332110 11111111
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
.. ............+.++.+|+.+||+.||++||++.+++++..-
T Consensus 225 ~~----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 225 IV----------QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred Hh----------hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 10 0000000111245678999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.24 Aligned_cols=252 Identities=29% Similarity=0.484 Sum_probs=200.3
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc------cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF------QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
+|++.+.||.|+||.||+|... ++..+|+|.+..... .....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 5888999999999999998642 578899998864321 123457889999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+.+.+..++++||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEec
Confidence 999999999999999999999997653 4788999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCC----CcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 227 DFGLARDGPTGD----KSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 227 Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
|||++....... .........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.... ..
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~---- 218 (265)
T cd06631 145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MF---- 218 (265)
T ss_pred cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HH----
Confidence 999987542211 11112235688999999999988899999999999999999999999964321110 00
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... .. ....+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 219 -~~~~~~----~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 219 -YIGAHR----GL----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -Hhhhcc----CC----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 00 111223346778999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=297.96 Aligned_cols=267 Identities=27% Similarity=0.349 Sum_probs=200.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 468899999999999999997654 688999998864321 233567899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....++||||+++++|..++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg 145 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFG 145 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccc
Confidence 99999999999988887766543 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh-hhhhhhhh-
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV-EWAKPYLT- 306 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~-~~~~~~~~- 306 (398)
++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............ ........
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 146 FARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223 (286)
T ss_pred cceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 9987544321 1223457889999999876 55788999999999999999999999754322110000 00000000
Q ss_pred ------ccccccccccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 ------SKRRIFRVLDPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ------~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..........+......+ ...+..+.+|+.+||+.||++||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000000000 1235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=299.89 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=201.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ......+.+|+.++++++|+||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 368889999999999999997654 68899999886532 22345788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..++||||+++++|..++.... ....+++..+..++.|++.||.|||+ .+ |+|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecC
Confidence 99999999999999988887532 12468999999999999999999996 46 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATG------HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||....... ......
T Consensus 149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~- 220 (286)
T cd06622 149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLS- 220 (286)
T ss_pred CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHH-
Confidence 987643221 2234578899999998554 35788999999999999999999996432111 000000
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... .....+...+.++.+++.+||+.+|++||++.+++++
T Consensus 221 ---------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 221 ---------AIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---------HHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00000 0112233467789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=322.53 Aligned_cols=282 Identities=20% Similarity=0.263 Sum_probs=190.6
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCccccc------CCCCCcEE----EEEEcccCCccchHHHHHHHHHHcCCCCC
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLAST------RPGTGMLI----AVKRLNQEGFQGHKEWLTEINYLGQLHHP 138 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~------~~~~~~~v----avK~~~~~~~~~~~~~~~E~~~l~~l~h~ 138 (398)
....+|++.+.||+|+||+||+|.++....... ....+... +.|.+.. .......+.+|+.+|+.++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987643110000 00001111 1111111 112235578999999999999
Q ss_pred cccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE
Q 015909 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGS-YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217 (398)
Q Consensus 139 ~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv 217 (398)
||+++++++...+..|+|++++ .++|.+++..... .........+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 9999999999999999999998 5577777654321 1122345667789999999999999998 9999999999999
Q ss_pred cCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCCCCCcc
Q 015909 218 DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRA-IDKNRPTGEHN 296 (398)
Q Consensus 218 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p-~~~~~~~~~~~ 296 (398)
+.++.+||+|||++........ .......||..|+|||++.+..++.++|||||||++|||++|..+ |..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999986543221 122345799999999999999999999999999999999998754 43322111111
Q ss_pred hhhhhhhhh-------hcccccccccccccc----CCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 297 LVEWAKPYL-------TSKRRIFRVLDPRLE----GQF-----SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 297 ~~~~~~~~~-------~~~~~~~~~~~~~~~----~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+........ .....+...+..... ... ....+.++.++|.+||+.||.+|||+.|++.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111110000 000000000000000 000 01124567889999999999999999999986
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.66 Aligned_cols=249 Identities=28% Similarity=0.455 Sum_probs=201.1
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-----cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-----QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
+|+..++||+|+||+||+|.... ++..|++|.+..... +..+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 57888999999999999997653 678999998864321 2346688999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
......++++||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d 145 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLAD 145 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999999999987653 4789999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH-LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||++....... ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||...... .. . ..
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~---~---~~ 213 (258)
T cd06632 146 FGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AA---V---FK 213 (258)
T ss_pred Cccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HH---H---HH
Confidence 99987643322 123456889999999987766 899999999999999999999999653211 00 0 00
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ........+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 214 ~~-------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 214 IG-------RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HH-------hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00 0000111222346788999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=296.08 Aligned_cols=261 Identities=27% Similarity=0.433 Sum_probs=200.7
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
|++.++||+|+||.||+|.+.. ...++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKS------EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeec------cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 6678899999999999997642 234678999999865422 23456889999999999999999999886532
Q ss_pred ------ceEEEEeecCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 152 ------HRLLVYEFMPRGSMENHLFRRG--SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 152 ------~~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
..+++++|+.+++|.+++.... .....++...++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCE
Confidence 2368899999999998875432 11234788999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||+++...............++..|++||.+.+..++.++||||||+++|+|++ |.+||...... ....+..
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~ 229 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI 229 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH
Confidence 9999999886543332222223345678999999988889999999999999999999 88888643211 1111100
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.... ...+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 230 ----~~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ----KGNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----cCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 011123456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=294.46 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=205.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||.|+||+||+|.... ++..+++|.+..... .....+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 468999999999999999997643 678899999865432 3456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++|||++++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccch
Confidence 999999999999999999976432 135789999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcc--cccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 231 ARDGPTGDKSH--VSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 231 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+.......... ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||........ +.... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~----~~ 222 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTL----QN 222 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHh----cC
Confidence 87654433221 22335689999999998776 788999999999999999999999965432210 00000 00
Q ss_pred cccccccccccccCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQF-SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..+...... ....+..+.+++.+||+.||++||++.+++++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001111111 12346788999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.05 Aligned_cols=264 Identities=24% Similarity=0.326 Sum_probs=201.8
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||.|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 58889999999999999997654 688999999875432 2346788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++|+||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~ 145 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGL 145 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeee
Confidence 9999999999 999999987654 46899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh---
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT--- 306 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--- 306 (398)
+........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|.++|....... ........+.
T Consensus 146 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~ 221 (286)
T cd07832 146 ARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPN 221 (286)
T ss_pred cccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCC
Confidence 886543321 112234689999999998654 46889999999999999999988886432211 0000000000
Q ss_pred --------cccccccccccccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 --------SKRRIFRVLDPRLE----GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 --------~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..........+... .......+..+.++|.+||+.||++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 00011235788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.60 Aligned_cols=246 Identities=33% Similarity=0.512 Sum_probs=197.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.+|++.+.||+|+||.||+|.. ++..|++|.+.... ....+.+|+.+++.++||||+++++++.. +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-N 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-C
Confidence 4688999999999999998743 46789999986542 34678899999999999999999998865 4
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~ 147 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLA 147 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccc
Confidence 57999999999999999976542 35788999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... .... .....
T Consensus 148 ~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~-- 213 (254)
T cd05083 148 RVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKE-CVEKG-- 213 (254)
T ss_pred eeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHH-HHhCC--
Confidence 7542211 12234567999999988899999999999999999997 99998653221 1100 01000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 214 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 214 --------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 001112234577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=293.51 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=199.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.+|++.+.||.|+||.||+|.+. .+..+++|.+..... ....+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL----------EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe----------CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 46788899999999999999763 256799998875432 3457889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++++|.+++.... ..+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999999999987643 35788999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... ... . .
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~---~~~-~---~ 216 (256)
T cd05112 148 RFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVV---ETI-N---A 216 (256)
T ss_pred eecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHH---HHH-h---C
Confidence 75432211 11112234668999999988899999999999999999998 99998642211 011 000 0 0
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.... ..+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 217 ~~~~-------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 217 GFRL-------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCC-------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 0000 01112356799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.81 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=202.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ...+.+.+|+++++++.||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 468899999999999999997654 688999999864322 33466789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++.... .++...+..++.||+.||.|||+.+ ++|+||+|.||+|+.++.++|+||
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~df 145 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDF 145 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeC
Confidence 9999999999999999999997763 5889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-- 212 (290)
T cd05580 146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILE-- 212 (290)
T ss_pred CCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc--
Confidence 998875433 22346889999999998888899999999999999999999999653310 00000000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
. ....+...+..+.+++.+||..||.+|+ ++++++++
T Consensus 213 --------~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 213 --------G--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --------C--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0 0112223367889999999999999998 78888766
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=299.00 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=204.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.+|.+.+.||.|+||.||+|.... ++..|++|.+........+.+.+|+.+++.++||||+++++.+...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 678999999999999999996543 57889999987554455577889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++|+||+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcce
Confidence 999999999999999998653 3788899999999999999999998 999999999999999999999999988
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
........ ......|++.|++||.+.+..++.++|+||||+++|+|++|+.||........... .
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--~----------- 227 (293)
T cd06647 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--I----------- 227 (293)
T ss_pred eccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--h-----------
Confidence 75443322 12234688899999999888899999999999999999999999965432211000 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..........+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 228 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 228 --ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000111222345678999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=305.09 Aligned_cols=250 Identities=30% Similarity=0.433 Sum_probs=208.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.+.|+.-++||+|+||.||-+..+. +|+.||+|.+.+... ......++|-.+|..++.+.||.+--.|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 3678888999999999999986654 899999999865433 2234568899999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+.+++||..++||+|.-.|...+. ..+++..+..++.+|+.||++||+.+ ||+|||||+|||+|+.|+++|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeec
Confidence 999999999999999999999998876 67999999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+|+|..+..+.. ....+||.+|||||++.++.|+...|+|||||++|||+.|+.||...........
T Consensus 331 LGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---------- 397 (591)
T KOG0986|consen 331 LGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---------- 397 (591)
T ss_pred cceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH----------
Confidence 999998765543 2334899999999999999999999999999999999999999964322111100
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD 350 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 350 (398)
.....+ .....++...+++++++.+.+|+.||.+|.-..
T Consensus 398 --vdrr~~--~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 398 --VDRRTL--EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --HHHHHh--cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 000111 113345666788999999999999999997554
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=297.27 Aligned_cols=265 Identities=26% Similarity=0.326 Sum_probs=204.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|+..+.||.|++|.||+|.+.. ++..+++|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 357888999999999999997754 688999999875432 3356688999999999999999999988653
Q ss_pred --CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 151 --DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 151 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+..++||||+++++|.+++.........++...+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeec
Confidence 4689999999999999987754433456889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...+.... ....
T Consensus 150 g~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~~~ 223 (287)
T cd06621 150 GVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSY-IVNM 223 (287)
T ss_pred cccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHH-HhcC
Confidence 9987543222 1234578899999999988999999999999999999999999975432111 11111110 0000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
. .... .. ........+..+.+++.+||..+|.+|||+.|++++-.
T Consensus 224 ~-~~~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 224 P-NPEL-KD--EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred C-chhh-cc--CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0 0000 00 00111234678999999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.10 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=196.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHH-HcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINY-LGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 468889999999999999997654 789999999875432 223445556664 666789999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
++..+++|||++ ++|.+++.........+++..++.++.||+.||.|||++ + ++||||||+||+++.++.++|+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeec
Confidence 999999999995 688888876443345789999999999999999999987 7 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|++....... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ... ....
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~-~~~~ 220 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQ-LKQV 220 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHH-HHHH
Confidence 9987653221 1222467889999998865 45688999999999999999999999642211 000 0000
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ...+.. .....+.++.+++.+||..+|++||++.+++++
T Consensus 221 ~~-------~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 221 VE-------EPSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred Hh-------cCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000 111245789999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=300.20 Aligned_cols=265 Identities=27% Similarity=0.376 Sum_probs=201.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||.||+|.+.+ ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 368899999999999999997654 68899999986532 2334678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||++++.+..+.... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g 145 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFG 145 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeee
Confidence 99999999999876666555432 34889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh---
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL--- 305 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--- 305 (398)
++......... ......++..|+|||.+.+. .++.++|+||||+++|+|++|++||....... .........
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~ 221 (288)
T cd07833 146 FARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPL 221 (288)
T ss_pred cccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence 98875443321 22335678899999999887 88999999999999999999999996532211 000000000
Q ss_pred --------hcccccc--ccccc----cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 --------TSKRRIF--RVLDP----RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 --------~~~~~~~--~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... +.... .....++...+.++.+|+.+||..+|++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000 00000 00011122236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=292.84 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=201.9
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||+|+||.||+|.... ++..+++|.+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 58889999999999999997654 688999999865432 3356788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC-CCEEEeecc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-YNAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~-~~~kl~Dfg 229 (398)
+..++||||+++++|.+++..... ..+++..+..++.+++.+|.|||+++ ++|+||+|+||+++.+ +.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~ 147 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFG 147 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCC
Confidence 999999999999999999976532 45889999999999999999999998 9999999999999854 468999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++........ .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~~-- 216 (256)
T cd08220 148 ISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMSG-- 216 (256)
T ss_pred CceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHhc--
Confidence 9986543321 223468889999999998889999999999999999999999996532210 01000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.....+...+.++.+++.+||+.||++|||+.+++.+
T Consensus 217 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 ---------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0011122346678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=298.58 Aligned_cols=265 Identities=25% Similarity=0.353 Sum_probs=196.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||.|++|.||+|.... ++..|++|.+...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 578999999999999999997653 6789999998654322 234567899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 76 ~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 76 KTLTLVFEYLD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred CeEEEEEecCC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECcccc
Confidence 99999999996 58999887654 35789999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc-
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK- 308 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 308 (398)
++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ........+...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~ 225 (291)
T cd07844 150 ARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPT 225 (291)
T ss_pred ccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCC
Confidence 875432211 1122346888999999865 4588999999999999999999999965431110 000000000000
Q ss_pred -c------cc---cc----cc-cccccCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 -R------RI---FR----VL-DPRLEGQF-SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 -~------~~---~~----~~-~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. .. .. .. ...+.... ......++.+++.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00 00 00 00000000 01112678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.00 Aligned_cols=267 Identities=26% Similarity=0.378 Sum_probs=199.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+++++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 368889999999999999997654 6889999988653322 34567899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+...++||||+++++|..+.... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg 145 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFG 145 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeee
Confidence 99999999999988888776543 24899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc-chhhh-------
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH-NLVEW------- 300 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-~~~~~------- 300 (398)
++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||......... .....
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07846 146 FARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223 (286)
T ss_pred eeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence 9876533321 2233467889999999865 45788899999999999999999999643321000 00000
Q ss_pred hhhhhhccccccccccccccC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEG-----QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
................+.... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000000000000 0011336779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.29 Aligned_cols=254 Identities=27% Similarity=0.388 Sum_probs=204.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||.|+||.||+|.+.. ++..+++|.+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 357788899999999999997654 688999999875432 3446688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
...++++||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g 146 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFG 146 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999998653 468899999999999999999999 88 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
.+....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...........
T Consensus 147 ~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~--- 218 (265)
T cd06605 147 VSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVN--- 218 (265)
T ss_pred cchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhc---
Confidence 987543221 1125688899999999999999999999999999999999999965432111 11111111111
Q ss_pred cccccccccccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLP-QAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ....+.. .+.++.++|.+||..||++||++.+++++
T Consensus 219 ----~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 219 ----EP----PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----CC----CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00 0111111 56789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.71 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=202.8
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||+|+||.||++.... ++..|++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 58889999999999999987654 68899999986432 23345788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++|+||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~ 147 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGI 147 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999999999999998876432 35788999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......|+..|+|||.+.+..++.++|+||||+++++|++|..||..... .........
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~---- 215 (256)
T cd08218 148 ARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR---- 215 (256)
T ss_pred eeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc----
Confidence 876433221 12234578899999999888899999999999999999999999864211 111111000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ....+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 216 --~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 216 --GS-----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CC-----CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 011223346688999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=302.18 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=199.7
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCce
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
|.....||.|+||.||++.... ++..|++|.+........+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence 3344679999999999987654 6889999998765545566788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 999999999999998754 24788999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
...... ......|+..|+|||.+.+..++.++|+||||+++|||++|..||....... . ... +..
T Consensus 168 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~~-------~~~ 232 (292)
T cd06658 168 VSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---A---MRR-------IRD 232 (292)
T ss_pred cccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHH-------HHh
Confidence 432221 1233568899999999988889999999999999999999999996432210 0 000 001
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... .....+..+.+++.+||..||.+|||+++++++
T Consensus 233 ~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 233 NLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111 112345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=297.67 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=199.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-----chHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-----GHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
+|++.+.||+|+||.||+|.+.. ++..|++|.+...... ....+..|+.+++.++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 47888999999999999997654 6889999999754332 234567899999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~d 145 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLAD 145 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEcc
Confidence 9999999999999 889999987643 35899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh-
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL- 305 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~- 305 (398)
||++........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|.++|........ +........
T Consensus 146 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~ 221 (298)
T cd07841 146 FGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGT 221 (298)
T ss_pred ceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCC
Confidence 999976543321 1222356788999998854 4678899999999999999999888865332110 000000000
Q ss_pred ------hcccccccccccccc-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 ------TSKRRIFRVLDPRLE-----GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ------~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
............... .......+..+.+++.+||+.||++||++.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000 00112236788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=298.32 Aligned_cols=262 Identities=28% Similarity=0.367 Sum_probs=202.5
Q ss_pred HHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccce
Q 015909 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKL 143 (398)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~ 143 (398)
.++....++|.+.+.||+|+||.||+|.... ++..+++|.+.... .....+.+|+.+++.+ +||||+++
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~ 84 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKF 84 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 4444457889999999999999999997654 68899999986532 2235677899999998 79999999
Q ss_pred eeEEEeC-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 144 VGYCLED-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 144 ~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
++++... ...++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~ 162 (291)
T cd06639 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT 162 (291)
T ss_pred EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc
Confidence 9998754 3579999999999999988754333356899999999999999999999998 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-----HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
.++.++|+|||++........ ......|+..|+|||.+... .++.++||||||+++|+|++|+.||.......
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 999999999999876543221 11234678899999998543 36789999999999999999999996432210
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. +... . ....+.. ..+......+.+++.+||+.+|++||++.+++++
T Consensus 241 ~--~~~~----~-------~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 T--LFKI----P-------RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H--HHHH----h-------cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0000 0 0000000 1122334578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=290.91 Aligned_cols=248 Identities=26% Similarity=0.466 Sum_probs=191.8
Q ss_pred ceecccCCceEEEEEecCCccc-ccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLA-STRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
+.||+|+||.||+|.+...... .........+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4699999999999987642100 011123356888877654333 5778899999999999999999999887 778999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-------CEEEeecc
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-------NAKLSDFG 229 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-------~~kl~Dfg 229 (398)
|||+++++|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999987542 5889999999999999999999998 99999999999999877 79999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATG--HLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
++..... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||........ ...+ .
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~------~~~~-~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------ERFY-Q 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH------HHHH-h
Confidence 9876433 1123467789999999776 78999999999999999999 5777755432110 0000 0
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.. ...+......+.+++.+||..+|.+||++.++++.|+
T Consensus 221 ~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQ------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cC------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0011111268889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=300.13 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=199.8
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCce
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
|.....||.|+||.||+|.... ++..|++|.+........+.+.+|+.+++.+.||||+++++.+...+..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 3445579999999999997654 6789999998765545567788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+++++|..++.. ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 94 ~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred EEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 999999999999987754 24789999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
...... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... . ......
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~---~~~~~~------- 231 (297)
T cd06659 167 ISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---A---MKRLRD------- 231 (297)
T ss_pred cccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHhc-------
Confidence 433221 1223568999999999998889999999999999999999999996432111 0 000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.... ........+..+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~--~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 232 SPPP--KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCC--CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 001112235678899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=291.23 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=202.3
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|.+.+.||+|+||.||+|.... ++..|++|.+...... ....+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 58889999999999999997654 6889999998765443 466788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++|+||+++++|.+++.... .+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~ 145 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGC 145 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999987643 4788899999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccc--ccccccccccccccccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 231 ARDGPTGDKSHV--STRVMGTYGYAAPEYLATGH---LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 231 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+........... .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... +...+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~ 218 (264)
T cd06626 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFH 218 (264)
T ss_pred ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHH
Confidence 887544322111 12346788999999998766 888999999999999999999999643211 000000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ...+.+ +.....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 219 ~~~-----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 219 VGA-----GHKPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred Hhc-----CCCCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 000001 1111236678899999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.60 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=203.5
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
+|++.++||.|+||.||+|.+.. ++..|++|.+..... ...+.+.+|+.++++++||||+++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 47889999999999999997654 688999999975432 235678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....++|+||+.+++|.+++... ..+++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~ 145 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFN 145 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecc
Confidence 99999999999999999998765 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+ ......
T Consensus 146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~-- 216 (258)
T cd05578 146 IATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET-- 216 (258)
T ss_pred cccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc--
Confidence 987654332 12235688899999999888899999999999999999999999976443211111 000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH--HHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM--DEVVK 354 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~ell~ 354 (398)
.....+...+.++.++|.+||+.||.+||++ +++++
T Consensus 217 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 ---------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1112233446789999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=308.10 Aligned_cols=263 Identities=25% Similarity=0.386 Sum_probs=218.4
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
+....+......||-|.||.||.|+|+. ....||||.++.+. ...++|+.|+.+|+.++|||+|+++++|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKk---------yslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeec---------cceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 3334455667889999999999999986 45679999998765 4468899999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
..+-.+|||+|||..|+|.+|+.+..+ ..++....+.++.||..||+||..++ +|||||...|+||.++..||++|
T Consensus 333 T~EpPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvAD 408 (1157)
T KOG4278|consen 333 THEPPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVAD 408 (1157)
T ss_pred ccCCCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeec
Confidence 999999999999999999999988765 56788889999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||+++......+..... ..-...|.|||.+....++.++|||+||++|||+.| |..||.+-+- .
T Consensus 409 FGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------S-------- 473 (1157)
T KOG4278|consen 409 FGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------S-------- 473 (1157)
T ss_pred cchhhhhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------H--------
Confidence 99999865544332111 122567999999999999999999999999999998 8888865321 1
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.+..+++....-.-+..++..+.+|++.||+++|.+||++.|+-+.|+.+-.-
T Consensus 474 ---qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 474 ---QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ---HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 12223333333344556788999999999999999999999999999988543
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=290.90 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=207.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||.|++|.||+|.+.. ++..|++|.+..... .....+.+|+.++..++|+||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 368889999999999999997654 688999999876543 3456789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~ 145 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFG 145 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999865 358999999999999999999999 88 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .........
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~---- 216 (264)
T cd06623 146 ISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAIC---- 216 (264)
T ss_pred cceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHh----
Confidence 98765433221 123467889999999998889999999999999999999999996543211 111111000
Q ss_pred cccccccccccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLP-QAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. .....+.. .+..+.+++.+||..+|++||++.+++++
T Consensus 217 ------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 ------DG-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ------cC-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 01112222 56789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=287.99 Aligned_cols=278 Identities=23% Similarity=0.277 Sum_probs=201.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
...|++...||+|.||.||+|.-.+ ....-.+.+|+|.++.+. ........+|+.+++.|+||||+.+..++.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~-----~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKN-----TNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHhhccceecccccceeeEeeecc-----CCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 3468899999999999999995432 111114589999997541 122356789999999999999999999987
Q ss_pred e-CCceEEEEeecCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC----CC
Q 015909 149 E-DDHRLLVYEFMPRGSMENHLFRRGS-YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN----YN 222 (398)
Q Consensus 149 ~-~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~----~~ 222 (398)
. +..+++++||.+. +|...|.-+.. ..+.++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCe
Confidence 7 8889999999965 88888864332 2356899999999999999999999998 9999999999999877 99
Q ss_pred EEEeeccCCcCCCCCCCcc-cccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc--h-
Q 015909 223 AKLSDFGLARDGPTGDKSH-VSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN--L- 297 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~--~- 297 (398)
|||+|||+++.+...-... .....+-|.+|.|||++.|. .|+.+.|||++|||+.||++-.+.|.+........ +
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999765443322 23446779999999999875 68889999999999999999999997643322111 0
Q ss_pred hhhhhhhh--------------hcccccccccc-ccccCCCC--HH--------HHHHHHHHHHHhccCCCCCCCCHHHH
Q 015909 298 VEWAKPYL--------------TSKRRIFRVLD-PRLEGQFS--LP--------QAQKAASLALQCLSVEPKLRPDMDEV 352 (398)
Q Consensus 298 ~~~~~~~~--------------~~~~~~~~~~~-~~~~~~~~--~~--------~~~~l~~li~~~l~~dP~~Rps~~el 352 (398)
...+..++ .........+. .......+ .. .++...+|+.++|..||-+|.|+++.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 00000000 00000000000 00000001 00 13347899999999999999999999
Q ss_pred HHHH
Q 015909 353 VKEL 356 (398)
Q Consensus 353 l~~L 356 (398)
+++.
T Consensus 335 leh~ 338 (438)
T KOG0666|consen 335 LEHP 338 (438)
T ss_pred hccc
Confidence 9874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=298.47 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=198.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 368889999999999999997654 688999999875432 23456778999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~df 145 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDF 145 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeC
Confidence 9999999999999999999997653 4889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc-------------ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 015909 229 GLARDGPTGDKS-------------HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295 (398)
Q Consensus 229 g~a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~ 295 (398)
|+++........ .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--- 222 (305)
T cd05609 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--- 222 (305)
T ss_pred CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 988642111000 0111245788999999998888999999999999999999999999643211
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.......... ...+ ......+.++.+++.+||+.||++||+..++++.|+
T Consensus 223 ---~~~~~~~~~~-----~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 223 ---ELFGQVISDD-----IEWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ---HHHHHHHhcc-----cCCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 1111000000 0000 001134567899999999999999998654444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=296.21 Aligned_cols=267 Identities=26% Similarity=0.375 Sum_probs=199.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||.|+||.||+|.+.. ++..+++|.++..... ....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 468889999999999999997654 6788999998654322 23356789999999999999999999887
Q ss_pred C--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 150 D--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 150 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
. ...++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEee
Confidence 7 88999999996 59999887654 35899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh-h------
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV-E------ 299 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~-~------ 299 (398)
||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||............ .
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (293)
T cd07843 150 FGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT 227 (293)
T ss_pred cCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 999886544321 12234578899999998764 4688999999999999999999999754321110000 0
Q ss_pred ---hhhh-hhh--ccccccccccccccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 ---WAKP-YLT--SKRRIFRVLDPRLEGQFSLP-QAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ---~~~~-~~~--~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
|... .+. ............+...++.. .+..+.++|.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000 00000000011111122222 36778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=291.91 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=200.8
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc----------cchHHHHHHHHHHcC-CCCCccc
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----------QGHKEWLTEINYLGQ-LHHPNLV 141 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~~I~ 141 (398)
.|++.+.||+|+||.||+|.+.. .++..+++|.+..... .....+..|+.++.. ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~--------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN--------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC--------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 47888999999999999997643 2467899998753211 223456778888865 7999999
Q ss_pred ceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCC
Q 015909 142 KLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~ 220 (398)
++++++..++..+++|||+++++|.+++.........+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~ 150 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED 150 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC
Confidence 99999999999999999999999999886543333568999999999999999999996 56 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
+.++|+|||++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||...... ..
T Consensus 151 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~ 221 (269)
T cd08528 151 DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SL 221 (269)
T ss_pred CcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HH
Confidence 999999999997654332 223456889999999999888999999999999999999999998643211 00
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
...... ....+ . .....+..+.+++.+||+.||++||++.++..++.
T Consensus 222 ~~~~~~------~~~~~-~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 ATKIVE------AVYEP-L---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHhh------ccCCc-C---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000000 00000 0 01123567899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=294.92 Aligned_cols=268 Identities=24% Similarity=0.317 Sum_probs=196.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+|++.+.||+|+||.||+|.... ++..|++|.+...... ....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 4679999999999999999997654 6789999998654322 23457789999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccc
Confidence 999999999995 67777765433 34678888899999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh---h--
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK---P-- 303 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~---~-- 303 (398)
+++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......+.-...+.. +
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07870 149 LARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226 (291)
T ss_pred cccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence 9875432221 1223457889999999875 457889999999999999999999997543211000000000 0
Q ss_pred ----hhhc-cccccccccccccCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 ----YLTS-KRRIFRVLDPRLEGQ-----FSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ----~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.... ............... .....+..+.+++.+||+.||.+|||+.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000 000000000000000 001124678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=336.65 Aligned_cols=254 Identities=28% Similarity=0.407 Sum_probs=206.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.-+|+-...||.|.||.||.|.+.+ +|+..|+|.+.... ....+.+.+|..+|..|+|||+++++++-.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~---------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLD---------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCC---------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence 3467777889999999999996654 89999999986432 233456789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..+|.||||++|+|.+++...+ ..++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++||
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecc
Confidence 9999999999999999999998654 3677777788999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCC--cccccccccccccccccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 229 GLARDGPTGDK--SHVSTRVMGTYGYAAPEYLATG---HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 229 g~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
|.|........ .......+||+.|||||++.+. ....++|||||||++.||+||+.||...+. +|+.-
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIM 1451 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIM 1451 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHH
Confidence 99987655421 1123357899999999999764 467789999999999999999999964321 12221
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+-. ...-..++|...+.+.++||..||..||++|.++.||+++
T Consensus 1452 y~V---------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHV---------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHH---------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111 1111234455678899999999999999999999998876
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=289.62 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=207.2
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||.|+||.||++.+.. ++..+++|.+..... .....+.+|+++++.++|+|++++.+.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 57888999999999999997654 688999999876543 4456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++|+|++++++|.+++.........+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccc
Confidence 9999999999999999999876433356899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+....... .......|++.|+|||.+.+..++.++|+||||+++++|++|..||...... ........
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~---- 217 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILK---- 217 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhc----
Confidence 87654332 1233456889999999998888999999999999999999999998643211 00000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......+...+.++.+++.+||..+|++||++.+++++
T Consensus 218 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 218 -------GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111222445788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=292.54 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=200.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
-|++.+.||.|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++.+..+.
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 47788899999999999997654 678999998864322 33456888999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccc
Confidence 99999999999999998864 24789999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .... ..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~----- 214 (277)
T cd06641 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-IP----- 214 (277)
T ss_pred eecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-Hh-----
Confidence 76533221 1223467889999999988888999999999999999999999986422110 0000 00
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ..........+.++.+++.+||+.+|.+||++.+++++
T Consensus 215 -~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 215 -K----NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -c----CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00111222345678899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=310.17 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=213.5
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeCCc
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~ 152 (398)
.++.++||+|.||.|++|.|+. -.++-..||||.++.+... ....|++|+.+|.+|+|+|++++||+..+ ..
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~------psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQ------PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccC------CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 4456889999999999998864 2245578999999877654 67889999999999999999999999876 78
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
..+|||+++.|+|.+.+.+. ....|.......++.||+.||.||.+++ +|||||...|+|+.....|||+|||+.+
T Consensus 185 ~mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hhHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeeccccee
Confidence 88999999999999999872 2356888899999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCCCcccccc-cccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 233 DGPTGDKSHVSTR-VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 233 ~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
-+..++..+.+.. ..-...|+|||.++...++.++|||+||+++|||++ |+.||.+.....
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------- 323 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------- 323 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------
Confidence 8877666554432 234668999999999999999999999999999999 899997643211
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
+.+.++..-...-+..+++++++++..||..+|.+||++..|.+.+-.
T Consensus 324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 112222222334466789999999999999999999999999855443
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=298.96 Aligned_cols=272 Identities=22% Similarity=0.268 Sum_probs=199.8
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
+|++.+.||+|+||.||+|..... .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 478889999999999999976431 257899999997632 2334667889999999999999999999998
Q ss_pred C--CceEEEEeecCCCCHHHHHhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC----CCC
Q 015909 150 D--DHRLLVYEFMPRGSMENHLFRRGSYF-QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS----NYN 222 (398)
Q Consensus 150 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~----~~~ 222 (398)
. ...++||||++ ++|.+++....... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccce
Confidence 8 78999999995 47777775443322 36899999999999999999999998 999999999999998 899
Q ss_pred EEEeeccCCcCCCCCCC-cccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch---
Q 015909 223 AKLSDFGLARDGPTGDK-SHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL--- 297 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~--- 297 (398)
++|+|||++........ ........++..|+|||.+.+. .++.++||||||+++|+|++|++||...........
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 99999999886543322 1122334678899999988664 578899999999999999999999976543321000
Q ss_pred ----hhhhhhhhh-----------ccccccccccccccCCCC---------H--HHHHHHHHHHHHhccCCCCCCCCHHH
Q 015909 298 ----VEWAKPYLT-----------SKRRIFRVLDPRLEGQFS---------L--PQAQKAASLALQCLSVEPKLRPDMDE 351 (398)
Q Consensus 298 ----~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~~l~~dP~~Rps~~e 351 (398)
..... .+. ................++ . ..+.++.+++.+||+.||++|||+.+
T Consensus 231 ~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e 309 (316)
T cd07842 231 RDQLERIFE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309 (316)
T ss_pred HHHHHHHHH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 00000 000 000000000000000000 0 23457889999999999999999999
Q ss_pred HHHH
Q 015909 352 VVKE 355 (398)
Q Consensus 352 ll~~ 355 (398)
++++
T Consensus 310 il~~ 313 (316)
T cd07842 310 ALEH 313 (316)
T ss_pred HhcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=296.01 Aligned_cols=248 Identities=29% Similarity=0.416 Sum_probs=197.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..|++.+.||+|+||+||+|.... ++..|++|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 458888999999999999997654 688999998864322 23356789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeec
Confidence 9999999999995 57777776543 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|++...... ....++..|+|||++. ...++.++||||||+++|+|++|..||........ . .
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~---~ 224 (307)
T cd06607 160 GSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L---Y 224 (307)
T ss_pred CcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------H---H
Confidence 998764322 2346788999999874 45688899999999999999999999864321100 0 0
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
. ..............+..+.+++.+||+.||++||++.+++.+.
T Consensus 225 ~-------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 225 H-------IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred H-------HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 0000000111223567899999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.34 Aligned_cols=264 Identities=26% Similarity=0.380 Sum_probs=198.3
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||.|++|.||+|.+.. ++..|++|.+..... .....+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 47888999999999999997654 688999999865432 2335688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+. ++|..++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999995 688888865432 45889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc--
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH-LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS-- 307 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 307 (398)
+........ ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||....... .........-..
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~ 222 (284)
T cd07860 147 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDE 222 (284)
T ss_pred hhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCh
Confidence 875433221 122235688899999887644 5888999999999999999999996533211 111100000000
Q ss_pred ------------cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 ------------KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
............ .......+.++.++|.+||+.||.+||++++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 223 VVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 00011235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=285.93 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=205.5
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCc
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~ 152 (398)
+|.+.+.||+|++|.||+|.+.. ++..+++|.+..........+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 47788999999999999997654 688999999977654566788999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
.++++||+++++|.+++.... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeeccccc
Confidence 999999999999999987753 45899999999999999999999988 9999999999999999999999999988
Q ss_pred CCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccc
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .. ......
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~---~~~~~~- 213 (253)
T cd05122 147 QLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LF---KIATNG- 213 (253)
T ss_pred ccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HH---HHHhcC-
Confidence 7544332 2345688999999999888899999999999999999999999965321100 00 000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+. .......+..+.+++.+||+.||++|||+.+++++
T Consensus 214 ---~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 214 ---PPG--LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---CCC--cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 01111125679999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=300.84 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=198.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++|+||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 46789999999999999999997654 78899999986432 23345677899999999999999999988
Q ss_pred EeC------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 148 LED------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 148 ~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
... ...++||||+. ++|.+.+... ++...+..++.|++.||.|||+++ |+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~ 155 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 155 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCC
Confidence 643 35699999995 5888877532 788899999999999999999998 99999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc------
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH------ 295 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~------ 295 (398)
.++|+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 156 ~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 232 (353)
T cd07850 156 TLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232 (353)
T ss_pred CEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 999999999976433221 22346788999999999999999999999999999999999999654321100
Q ss_pred ------chhhh----hhhhhhccc-----cccccccc----cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 296 ------NLVEW----AKPYLTSKR-----RIFRVLDP----RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 296 ------~~~~~----~~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+... ...+..... ........ ..........+..+.++|.+||+.||++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000000000 00000000 00001112346678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=286.41 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=206.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||+|++|.||+|.... ++..|++|.+..... ...+.+.+|+.++++++|+||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 47788999999999999997654 688999999875542 3456788999999999999999999999888
Q ss_pred --CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 151 --DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 151 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
...++++|++++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccc
Confidence 88999999999999999998654 5899999999999999999999988 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|.+................++..|+|||.+.+..++.++||||||+++|+|++|..||..... .....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~------- 213 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAAL------- 213 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHH-------
Confidence 998876544321112335688999999999888899999999999999999999999975431 00000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
............+...+..+.+++.+||+.||++||++.+++.+
T Consensus 214 ---~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 214 ---YKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---HhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00111111122333447789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=290.93 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=199.2
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCC---CCcccceeeEEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLH---HPNLVKLVGYCL 148 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~~I~~~~~~~~ 148 (398)
.|++.+.||.|+||.||+|.+.. ++..|++|.+.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 47788899999999999997654 68899999986542 233466788999999986 999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.....++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccC
Confidence 999999999999999999988643 5889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|++........ ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----------- 212 (277)
T cd06917 146 GVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----------- 212 (277)
T ss_pred CceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-----------
Confidence 99887544332 1233468899999998865 457889999999999999999999996532211100
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+.....+.+.. ...+.++.+++.+||+.||++||++.+++++
T Consensus 213 --~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 213 --LIPKSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --ccccCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000000011111 1145678999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=291.42 Aligned_cols=264 Identities=18% Similarity=0.222 Sum_probs=188.2
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccch-----------HHHHHHHHHHcCCCCC
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-----------KEWLTEINYLGQLHHP 138 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~ 138 (398)
..++|++.++||+|+||+||+|.+.... ..+..+++|.......... .....+...+..+.|+
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~------~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDH------CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCc------ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 3468999999999999999999865411 1145667776433221110 1123344566778899
Q ss_pred cccceeeEEEeCC----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCC
Q 015909 139 NLVKLVGYCLEDD----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASN 214 (398)
Q Consensus 139 ~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~N 214 (398)
+|+++++.+.... ..+++++++ ..++.+.+.... ..++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~N 156 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPEN 156 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 9999998765543 336788877 457777665432 3567888999999999999999998 9999999999
Q ss_pred EEEcCCCCEEEeeccCCcCCCCCCCc-----ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015909 215 ILLDSNYNAKLSDFGLARDGPTGDKS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 215 ilv~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~ 289 (398)
||++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999765332211 1112246999999999999999999999999999999999999999764
Q ss_pred CCCCCcchhhhhh-hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 290 RPTGEHNLVEWAK-PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 290 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
..... ...... .+.. ........ ....+.++.+++..|+..+|++||++.++++.|+
T Consensus 237 ~~~~~--~~~~~~~~~~~------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 237 GHNGN--LIHAAKCDFIK------RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred ccchH--HHHHhHHHHHH------Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 22211 110000 0000 00101000 1123577999999999999999999999998763
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.95 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=200.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCc
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~ 152 (398)
.|...+.||+|++|.||+|.... ++..+++|.+........+.+.+|+.+++.+.||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 34556789999999999997644 678999998865544555678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
.++++||+++++|.+++... .+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.+.
T Consensus 91 ~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred EEEEEeccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccch
Confidence 99999999999999998762 3788999999999999999999998 9999999999999999999999999876
Q ss_pred CCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccc
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....+. .......
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~------- 228 (285)
T cd06648 164 QVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR------- 228 (285)
T ss_pred hhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-------
Confidence 5432211 122346889999999998888999999999999999999999998653221 1111000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....+.. ......+..+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 229 DNLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred hcCCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0000001 1111245689999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=288.79 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=205.1
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||.|+||.||++.... ++..+++|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 47888999999999999986543 688999999875432 3345678899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++|+||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccc
Confidence 9999999999999999998774433456899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+...... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.. .+ ....
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~---~~~~------ 213 (256)
T cd08530 150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DL---RYKV------ 213 (256)
T ss_pred hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHH------
Confidence 8765443 122345788999999999988999999999999999999999999653211 00 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........+...+.++.+++.+||+.+|++||++.+++++
T Consensus 214 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 214 -----QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----hcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0001112233556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=288.22 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=199.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-----CccchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-----GFQGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
.+|++.+.||+|+||.||+|.+.. ++..|++|.+... .......+.+|+.+++.++|+||+++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 468999999999999999997654 7889999987532 11234567889999999999999999998
Q ss_pred EEeC--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 147 CLED--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 147 ~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
+.+. ...++++||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEE
Confidence 8764 45789999999999999987653 4788899999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 225 LSDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
|+|||++......... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------- 216 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------- 216 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----------
Confidence 9999999764321111 11123468899999999998889999999999999999999999996432110
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+.+..........+...+..+.+++.+||. +|..||++.+++++
T Consensus 217 ------~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 217 ------AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0001111111223344566789999999999 57999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=307.72 Aligned_cols=275 Identities=28% Similarity=0.395 Sum_probs=209.3
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEeCC-
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD- 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~- 151 (398)
|...+.||+|+||.||+|++++ +|..||||.++... ....+...+|+++|++|+|+|||+++++-.+..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnke---------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKE---------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeeecccc---------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4456789999999999997665 89999999998643 345677889999999999999999998754433
Q ss_pred -----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc--CCC--C
Q 015909 152 -----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD--SNY--N 222 (398)
Q Consensus 152 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~--~~~--~ 222 (398)
...+|||||.+|+|...+.+-.+ ...|++..++.++.++..||.|||+++ |+||||||.||++- .+| .
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceE
Confidence 45799999999999999986543 356999999999999999999999998 99999999999983 333 4
Q ss_pred EEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
.||+|||.|+....+. .....+||..|++||++.. ..|+..+|.|||||++|++.||..||.............|.
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 7999999999875544 5667899999999999984 78888999999999999999999999765443322222221
Q ss_pred hhhhhccccccccccc------------cccCCCCHHHHHHHHHHHHHhccCCCCCCC--CHHHHHHHHHHHHHHhh
Q 015909 302 KPYLTSKRRIFRVLDP------------RLEGQFSLPQAQKAASLALQCLSVEPKLRP--DMDEVVKELEQLQELRN 364 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp--s~~ell~~L~~l~~~~~ 364 (398)
...-. ...+.-.... +.....+......+-.++..+|..+|++|. .+.+....+..+..+..
T Consensus 240 ~~tkk-p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 240 IITKK-PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred hhccC-CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 11000 0000000000 011222334455667888899999999998 88888888877765543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=315.96 Aligned_cols=266 Identities=26% Similarity=0.450 Sum_probs=221.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
....+.++||.|.||.|++|+++.. .+....||||.++.... ..+..|+.|+.||.++.||||+++.|+....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~p------gkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLP------GKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccCC------CCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 4456889999999999999988642 23567999999986543 4467899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
....||.|||+.|+|+.++..+. ..++..++..+++.|+.||+||-+.+ +|||||..+||||+.+..+|++|||+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccc
Confidence 99999999999999999998876 34788889999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccccccccc--ccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 231 ARDGPTGDKSHVSTRVMG--TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
++.+.+.. ....+..-| ...|.|||.+....++.++||||+|+++||.++ |..||.+... ++.
T Consensus 778 SRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdV---------- 843 (996)
T KOG0196|consen 778 SRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDV---------- 843 (996)
T ss_pred eeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHH----------
Confidence 99765543 222222323 468999999999999999999999999999887 9999976432 121
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcc
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMH 366 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 366 (398)
..-++.....+.|.+++..+..|+..||++|-.+||.+.+|+..|+++-......
T Consensus 844 ----IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 844 ----IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred ----HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 1222333444567788999999999999999999999999999999875544433
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.16 Aligned_cols=256 Identities=25% Similarity=0.295 Sum_probs=200.3
Q ss_pred HhcCCCCC-ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 70 ATRNFRPD-SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
++++|++. ++||-|-.|.|-.|..+. +++.+|+|++... ....+|+++--.. .|||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~---------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR---------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc---------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 45566664 679999999999886554 8999999998654 4566788765444 599999999988
Q ss_pred Ee----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc---CC
Q 015909 148 LE----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD---SN 220 (398)
Q Consensus 148 ~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~---~~ 220 (398)
.+ ...+.+|||.++||.|...++.++. +.+++..+..|+.||..|+.|||+.+ |.||||||+|+|.. .+
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCC
Confidence 64 4567899999999999999998876 77999999999999999999999999 99999999999996 45
Q ss_pred CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
..+||+|||+|+.-.. .....+.+-|+.|.|||++....|+...|+||+|+++|-||+|.+||....... +...
T Consensus 201 a~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispg 274 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPG 274 (400)
T ss_pred cceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChh
Confidence 6799999999987432 222345678999999999999999999999999999999999999996432210 0000
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
++ .++... .-.+..+--..+++.++++|+++|..+|.+|.|+.+++++=
T Consensus 275 Mk------~rI~~g-qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 275 MK------RRIRTG-QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred HH------hHhhcc-CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 11 111000 00111111234588999999999999999999999998763
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.41 Aligned_cols=244 Identities=27% Similarity=0.367 Sum_probs=197.7
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
||.|+||.||+|.+.. ++..|++|.+..... ...+.+.+|+.+++.++||||+++++.+.++...+++
T Consensus 1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 6899999999997654 688999999865432 2346688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
+||+++++|.+++.+.. .++...+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 72 MEYCLGGELWTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred EecCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 99999999999997653 4889999999999999999999998 99999999999999999999999999887543
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.. ......|+..|++||.+.+..++.++|+||||+++|+|++|..||...... ....... ...
T Consensus 146 ~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~----------~~~ 208 (262)
T cd05572 146 GQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYND----------ILK 208 (262)
T ss_pred cc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHH----------Hhc
Confidence 32 122346888999999998888999999999999999999999999754321 0111110 110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
......++...+.++.+++.+||+.+|++||+ +.|++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 209 GNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 01111223333678999999999999999999 8888874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.82 Aligned_cols=268 Identities=24% Similarity=0.287 Sum_probs=197.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCC-CCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLH-HPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.+. |+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 368899999999999999997654 688999998865422 23456788999999995 699999999988
Q ss_pred eCCc-----eEEEEeecCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-CC
Q 015909 149 EDDH-----RLLVYEFMPRGSMENHLFRRGSY-FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NY 221 (398)
Q Consensus 149 ~~~~-----~~lv~e~~~~~~L~~~~~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-~~ 221 (398)
..+. .++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+++ |+||||+|+||+++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCC
Confidence 7665 7999999975 888888754332 356899999999999999999999998 999999999999998 89
Q ss_pred CEEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
.++|+|||++......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ....
T Consensus 149 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~ 224 (295)
T cd07837 149 LLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHI 224 (295)
T ss_pred eEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHH
Confidence 9999999998764332111 122356888999998865 4578999999999999999999999965332110 0000
Q ss_pred hhhhhhcccc-------ccccc-----cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTSKRR-------IFRVL-----DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~~~~-------~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......... +.... .+..........+.++.++|.+||..||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 00000 0000000112246778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=294.82 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=195.2
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCC-CCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLH-HPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~ 150 (398)
+|...+.||+|+||.||++.+.. ++..||+|.+..... .....+.+|+.++.++. |+||+++++++...
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 45566789999999999997654 688999999875432 33456788999999996 99999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 151 DHRLLVYEFMPRGSMENHLFRR-GSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
...+++|||+. +++.++.... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+||
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeec
Confidence 99999999984 4665544321 11124689999999999999999999974 7 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG---HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|++........ .....|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ......
T Consensus 153 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~--- 221 (288)
T cd06616 153 GISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLT--- 221 (288)
T ss_pred chhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHh---
Confidence 99875432211 1223578899999999765 688999999999999999999999964321 100000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......+.+........+.++.+|+.+||+.||++||++.+++++
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 222 ----QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----hhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011112222223456789999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.57 Aligned_cols=265 Identities=26% Similarity=0.346 Sum_probs=197.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 4578999999999999999997654 7889999998643221 2234568999999999999999999987
Q ss_pred eC--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 149 ED--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
.. +..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEC
Confidence 65 56899999995 58888887643 46899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|||++......... .....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||........... .....
T Consensus 151 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~---~~~~~ 225 (309)
T cd07845 151 DFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL---IIQLL 225 (309)
T ss_pred ccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhc
Confidence 99999875433211 222345788999999865 5678999999999999999999999975432211000 00000
Q ss_pred hcc-cc------------ccccccccccC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSK-RR------------IFRVLDPRLEG--QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~-~~------------~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... .. ........... ......+.++.++|.+||+.||++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00 00000000000 0001135678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=288.71 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=201.1
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||.|+||.||+|.... ++..+++|.+..... ...+.+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 47888999999999999997654 678899999865422 3345678999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-CEEEeecc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-~~kl~Dfg 229 (398)
...++|+||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~ 147 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFG 147 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccc
Confidence 999999999999999999876432 35789999999999999999999998 99999999999998775 46999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
.+........ ......|+..|+|||.+.+..++.++|+||||+++++|++|..||...... ........
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~--- 216 (257)
T cd08225 148 IARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ--- 216 (257)
T ss_pred cchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc---
Confidence 9876543221 122346889999999998888999999999999999999999998643211 11110000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... .......+.++.+++.+||..+|++||++.+++++
T Consensus 217 ---~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 ---GYF-----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---ccC-----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 11122345679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.52 Aligned_cols=252 Identities=28% Similarity=0.428 Sum_probs=199.0
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.|...+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++|||++++++++..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 36677889999999999997654 688999999864322 234568889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+...++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg 170 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFG 170 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCC
Confidence 999999999996 57877776543 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
++...... ....|+..|+|||.+. +..++.++|+||||+++|+|++|..||........ . .
T Consensus 171 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~----~---- 234 (317)
T cd06635 171 SASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----Y---- 234 (317)
T ss_pred CccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H----H----
Confidence 98654321 2346888999999873 45688899999999999999999999864311100 0 0
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
...............+..+.+++.+||+.+|.+||++.++++++..+..
T Consensus 235 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 235 ------HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ------HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0000000111122345678999999999999999999999998655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=289.89 Aligned_cols=246 Identities=29% Similarity=0.441 Sum_probs=194.7
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
||+|+||+||+|.... ++..|++|.+..... .....+..|+++++.++||||+++++.+...+..++|
T Consensus 1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 6899999999997654 688999999864321 2344567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 72 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred EecCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 999999999999976543 45899999999999999999999998 99999999999999999999999999876433
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ .. ....
T Consensus 148 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~-----~~~~ 212 (277)
T cd05577 148 GK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-------KR-----RTLE 212 (277)
T ss_pred CC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH-------Hh-----cccc
Confidence 11 122345788999999998888999999999999999999999999654321111100 00 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
.....+...+..+.++|.+||+.||.+|| ++.+++++
T Consensus 213 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 213 --MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred --ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 01112233467889999999999999999 66667653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=291.14 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=205.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+.|++.+.||.|++|.||+|.+.. ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++.+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 44568888899999999999997654 578899999875433 45678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccc
Confidence 999999999999999999998764 36899999999999999999999988 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++........ ......++..|++||.+.+..++.++|+||||+++|+|++|..||........ ...... .
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~--~ 231 (286)
T cd06614 162 FAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITT--K 231 (286)
T ss_pred hhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh--c
Confidence 8865433221 12234578899999999888899999999999999999999999864321100 000000 0
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. . ........+..+.+++.+||+.+|.+||++.+++++
T Consensus 232 ----~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 232 ----GI-P--PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----CC-C--CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 0 001112245789999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=295.38 Aligned_cols=270 Identities=25% Similarity=0.348 Sum_probs=195.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.... ++..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 3579999999999999999997654 788999998864322 22345678999999999999999999887
Q ss_pred eCC--------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 149 EDD--------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 149 ~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
... ..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~ 155 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD 155 (310)
T ss_pred cccccccCCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC
Confidence 654 3499999995 58888876543 35899999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCc--ccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 221 YNAKLSDFGLARDGPTGDKS--HVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
+.++|+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~ 235 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999998765332221 112234578889999988664 478899999999999999999999975432211111
Q ss_pred hhhhhhh-----hhccc--ccccccc--ccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 298 VEWAKPY-----LTSKR--RIFRVLD--PRLEGQF-----SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 298 ~~~~~~~-----~~~~~--~~~~~~~--~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... ..... ....... ....... ....+..+.++|.+||..||.+|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1110000 00000 0000000 0000000 00123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=302.63 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=213.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
...|.+.+.||+|.|+.|.+|+... ++..||+|.+.+.... ....+.+|+++|+.|+||||++++.+..
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 4568899999999999999997654 7999999999876443 2355889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
....+|+||||+.+|.+++++.+.+. +.+.....++.|+..|++|||+++ |||||||.+|||++.+.++||+||
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeecc
Confidence 99999999999999999999999875 555788889999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|++..+.... ...+++|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..-.
T Consensus 200 gfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------------- 261 (596)
T KOG0586|consen 200 GFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------------- 261 (596)
T ss_pred ccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---------------
Confidence 9998865333 3556899999999999998876 46799999999999999999999863211
Q ss_pred ccccccccccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 308 KRRIFRVLDPRLE--GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 308 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
..-+..+. ...+...+.++.++|+++|-.+|.+|++++++.++-......+
T Consensus 262 -----~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 262 -----ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred -----cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 11111111 1233445678899999999999999999999988755444333
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=290.10 Aligned_cols=268 Identities=24% Similarity=0.357 Sum_probs=199.9
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+|++.+.||.|++|.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 47889999999999999997654 688999999875433 23456778999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||++ ++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 9999999996 488888876542 245899999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc-hhhhh-hh-----
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN-LVEWA-KP----- 303 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~-~~~~~-~~----- 303 (398)
........ ......++..|++||.+.+. .++.++|+||||+++|+|++|..||.......... ..... .+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 75432211 12234578899999988654 57889999999999999999999997643221100 00000 00
Q ss_pred -hhhccccccccccc---cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 -YLTSKRRIFRVLDP---RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 -~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+............ ..........+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000000000 00001112335678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.44 Aligned_cols=265 Identities=26% Similarity=0.330 Sum_probs=196.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
+++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 4689999999999999999997654 78899999986432 2234567889999999999999999988765
Q ss_pred C-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 150 D-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 150 ~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
. ...++|+||++ ++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEE
Confidence 4 34789999995 588777754 34899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCc-cccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 225 LSDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
|+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~ 223 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLIL 223 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 9999998764332211 11223568999999998754 568899999999999999999999996532110 000000
Q ss_pred hhhhc--ccccc-----------ccccccccCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTS--KRRIF-----------RVLDPRLEGQ---FSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~--~~~~~-----------~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..+.. ..... .......... .....+.++.+++.+||+.||++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000 0000000000 001235678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=290.19 Aligned_cols=243 Identities=27% Similarity=0.391 Sum_probs=188.5
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHH---cCCCCCcccceeeEEEeCCc
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYL---GQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l---~~l~h~~I~~~~~~~~~~~~ 152 (398)
+||+|+||.||+|.... ++..+|+|.+...... ....+.+|..++ ....||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 48999999999997654 6889999988654321 122234444433 33479999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
.++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 999999999999999887653 4899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCCCcccccccccccccccccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
...... .....|+..|+|||.+. +..++.++|+||||+++|+|++|..||........... ....
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~------ 211 (279)
T cd05633 146 DFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT------ 211 (279)
T ss_pred eccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHh------
Confidence 543221 12346899999999986 45688999999999999999999999965432111000 0000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
.......+...+.++.++|.+||..||.+|| ++++++++
T Consensus 212 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 212 -----LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011122334567899999999999999999 59988886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=288.86 Aligned_cols=260 Identities=25% Similarity=0.317 Sum_probs=193.7
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCC-CCcccceeeEEEeC-
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLH-HPNLVKLVGYCLED- 150 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~- 150 (398)
|++.+.||+|+||.||+|.... ++..||+|.+..... .......+|+.++.++. |+||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 6778899999999999997654 688999999865422 22233457888999885 99999999999887
Q ss_pred -CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 -DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..++||||++ ++|.+.+.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecc
Confidence 88999999996 58887776543 35899999999999999999999998 999999999999999 999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++........ .....++..|+|||.+.. ..++.++|||||||++|+|++|.+||...+... ............
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~ 218 (282)
T cd07831 145 SCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTP 218 (282)
T ss_pred cccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCC
Confidence 9976533221 123457889999997644 557889999999999999999999996543211 111110000000
Q ss_pred c----------ccccccccccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 R----------RIFRVLDPRLE----GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~----------~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. .......+... .......+..+.++|.+||+.+|++||++++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0 00000000000 00012346889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=289.08 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=198.0
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
|++.+.||.|++|.||+|.+.. +|..|++|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 6778999999999999997654 688999999865432 22356788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..+++|||++ ++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~ 146 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLA 146 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccc
Confidence 9999999994 689998876542 35899999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc--
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK-- 308 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 308 (398)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|++||....... ......+......
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 222 (283)
T cd07835 147 RAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDED 222 (283)
T ss_pred cccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChH
Confidence 75432221 11223568899999988654 57889999999999999999999996543211 0111000000000
Q ss_pred --------cccccccc---ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 --------RRIFRVLD---PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 --------~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......+. ...........+..+.+++.+||+.||.+||++++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 000001112234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.34 Aligned_cols=258 Identities=24% Similarity=0.299 Sum_probs=209.4
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccc
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVK 142 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~ 142 (398)
+++...++|.++++||+|+||.|..++.+. ++..||+|++++-. .....-|..|-.+|..-+.+=|+.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~ 139 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQ 139 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHH
Confidence 445556899999999999999999986655 89999999998632 233456788999999888999999
Q ss_pred eeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
++-.|.++.++|+||||++||+|..++.+.. .+++..+.+++..|+.||.-||+.| +|||||||+|||+|..|+
T Consensus 140 LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 140 LHYAFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred HHHHhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCc
Confidence 9999999999999999999999999998764 5899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccc----c-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA----T-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
+||+|||.+-.... +..-.....+|||.|.|||++. + +.|+..+|+||+||++|||+.|..||....
T Consensus 214 ikLADFGsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------- 285 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------- 285 (1317)
T ss_pred EeeccchhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-------
Confidence 99999999877543 3333455678999999999984 3 578999999999999999999999995321
Q ss_pred hhhhhhhhhccccccccccccccCCCC--HHHHHHHHHHHHHhccCCCCCCCC---HHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFS--LPQAQKAASLALQCLSVEPKLRPD---MDEVVKEL 356 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~L 356 (398)
.......+... .-.-.+| ..++.++++||.+.+. +|+.|.. ++++..|-
T Consensus 286 ------lveTY~KIm~h---k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 286 ------LVETYGKIMNH---KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred ------HHHHHHHHhch---hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 11122222111 1111222 4478899999999886 6778877 88887663
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=283.59 Aligned_cols=249 Identities=30% Similarity=0.493 Sum_probs=204.5
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||+|++|.||+|.... ++..|++|.+..... .....+.+|++++++++|+|++++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 47889999999999999997654 678899999976644 3456789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEecccc
Confidence 9999999999999999998765 35899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+......... .....++..|+|||.+.+..++.++|||+||+++|+|++|..||...... ..... ...
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~----~~~- 213 (254)
T cd06627 146 ATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFR----IVQ- 213 (254)
T ss_pred ceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHH----Hhc-
Confidence 9875443321 23356888999999998888899999999999999999999999643211 00000 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......+...+..+.+++.+||..+|++||++.+++.+
T Consensus 214 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 214 -------DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -------cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 00111223346788999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=299.15 Aligned_cols=270 Identities=26% Similarity=0.365 Sum_probs=200.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||+||+|.... ++..|++|.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 4679999999999999999997654 78999999986532 223456778999999999999999999876
Q ss_pred eC-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 149 ED-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 149 ~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
.. ...++|+||+ +++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~ 147 (337)
T cd07858 75 PPHREAFNDVYIVYELM-DTDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDL 147 (337)
T ss_pred cccccccCcEEEEEeCC-CCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCE
Confidence 44 3479999999 46888888654 35899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh-hh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE-WA 301 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~-~~ 301 (398)
+|+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|++||............. ..
T Consensus 148 kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 225 (337)
T cd07858 148 KICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225 (337)
T ss_pred EECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 999999998653322 12233467889999998864 468899999999999999999999996532110000000 00
Q ss_pred h-------hhhhcc--cc----ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 015909 302 K-------PYLTSK--RR----IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE--LEQL 359 (398)
Q Consensus 302 ~-------~~~~~~--~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l 359 (398)
. ...... .. +......... ......+.++.+++.+||+.||++||++++++++ +..+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 000000 00 0000000000 0111346778999999999999999999999998 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=290.27 Aligned_cols=266 Identities=24% Similarity=0.320 Sum_probs=196.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|++|+||+|.+.. ++..|++|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 468899999999999999997654 688999999865432 223567889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-CCCEEEeec
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLSDF 228 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-~~~~kl~Df 228 (398)
....++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEccc
Confidence 999999999995 588887765432 33578888899999999999999998 999999999999985 567999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||........ ........-..
T Consensus 148 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~~~~~~~ 223 (294)
T PLN00009 148 GLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIFRILGTP 223 (294)
T ss_pred ccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCC
Confidence 9997543221 11223457889999998866 4578899999999999999999999975432111 00000000000
Q ss_pred cccc-------cc---cc---cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRI-------FR---VL---DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~-------~~---~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.... .. .. ............+.++.+++.+||+.+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00 00 0000000112235678999999999999999999999975
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=296.80 Aligned_cols=268 Identities=27% Similarity=0.374 Sum_probs=197.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC--CccchHHHHHHHHHHcCC-CCCcccceeeE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE--GFQGHKEWLTEINYLGQL-HHPNLVKLVGY 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~ 146 (398)
..++|++.+.||+|+||.||+|.+.. ++..+++|.+... .......+.+|+.+++++ +||||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 45678999999999999999997654 6789999988542 223345677899999999 99999999998
Q ss_pred EEeC--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 147 CLED--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 147 ~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
+... ...++||||++ ++|..++... .+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~k 147 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVK 147 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEE
Confidence 8653 36799999996 5898887653 4788888999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCc---cccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 225 LSDFGLARDGPTGDKS---HVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
|+|||++......... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..............
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~ 227 (337)
T cd07852 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227 (337)
T ss_pred EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999998865443321 12234568999999998754 5678899999999999999999999965332111000000
Q ss_pred hhh--------hh--hcccccccccc----ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKP--------YL--TSKRRIFRVLD----PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~--------~~--~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... .+ .....+..... .... ......+.++.+++.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhCCCCHHHHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 00 00000000000 0000 0011146788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=287.80 Aligned_cols=262 Identities=27% Similarity=0.338 Sum_probs=200.2
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
|++.+.||.|++|.||+|.... ++..+++|.+...... ....+.+|+.+++.++|+||+++++++...+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 6678899999999999997643 6889999998754332 3467788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++|+||+++ +|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeee
Confidence 99999999964 8888877643 46899999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc---
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS--- 307 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 307 (398)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ .......+..
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~ 220 (283)
T cd05118 146 RSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDP 220 (283)
T ss_pred EecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCch
Confidence 76544331 12234578899999998776 788999999999999999999999965432110 0000000000
Q ss_pred --cccccc--------ccc--ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 --KRRIFR--------VLD--PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 --~~~~~~--------~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... ... ...........+.++.++|.+||+.||.+||++.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 000 000001122346789999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=295.13 Aligned_cols=265 Identities=23% Similarity=0.286 Sum_probs=194.0
Q ss_pred ceeccc--CCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCCce
Q 015909 78 SVLGEG--GFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
..||+| +||+||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 346666 899999997654 789999999875432 2346678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++||+.+..
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999999999999999886542 35889999999999999999999998 99999999999999999999999986433
Q ss_pred CCCCCCcc-----cccccccccccccccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh---
Q 015909 234 GPTGDKSH-----VSTRVMGTYGYAAPEYLATG--HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP--- 303 (398)
Q Consensus 234 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~--- 303 (398)
........ ......++..|+|||++.+. .++.++|||||||++|+|++|..||....... ........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~ 228 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPY 228 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCC
Confidence 21111100 01112346679999999763 47889999999999999999999997542210 00000000
Q ss_pred ------hhhcc-----------------ccc-----cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 ------YLTSK-----------------RRI-----FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ------~~~~~-----------------~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ... .......+........+..+.+|+.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 000 00000111112233457789999999999999999999999876
Q ss_pred HH
Q 015909 356 LE 357 (398)
Q Consensus 356 L~ 357 (398)
--
T Consensus 309 ~~ 310 (328)
T cd08226 309 AF 310 (328)
T ss_pred HH
Confidence 43
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=291.24 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=197.4
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
...||+|+||.||+|.... ++..|++|.+..........+.+|+.+++.++|+||+++++.+...+..++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HHHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 3579999999999997654 7889999998654444556788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 96 MEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9999999999877542 4788999999999999999999998 99999999999999999999999998875433
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...... ....
T Consensus 169 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~~~----------~~~~ 233 (292)
T cd06657 169 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIR----------DNLP 233 (292)
T ss_pred ccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----------hhCC
Confidence 221 1233568899999999988889999999999999999999999986432110 000000 0001
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..+. .....+..+.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 234 PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1110 111235578899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.75 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=191.4
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
....+|+..++||+||||.||+++++- +|..||||++.... ......+.+|+..|.+|+|||||+++..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 345678888999999999999997654 79999999997553 23456688999999999999999987664
Q ss_pred EeCC----------------------------------------------------------------------------
Q 015909 148 LEDD---------------------------------------------------------------------------- 151 (398)
Q Consensus 148 ~~~~---------------------------------------------------------------------------- 151 (398)
.+..
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 3110
Q ss_pred -------------------------------------------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 015909 152 -------------------------------------------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188 (398)
Q Consensus 152 -------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~ 188 (398)
.+||-||||+..+|.+++.++... -.....+.++
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLF 703 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLF 703 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHH
Confidence 257889999887777777765421 1467889999
Q ss_pred HHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCC----C------------CCCccccccccccccc
Q 015909 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP----T------------GDKSHVSTRVMGTYGY 252 (398)
Q Consensus 189 ~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~----~------------~~~~~~~~~~~gt~~y 252 (398)
.+|++||.|+|+.| ||||||||.|||+++++.|||+|||++.... . +......+..+||..|
T Consensus 704 reIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY 781 (1351)
T KOG1035|consen 704 REILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY 781 (1351)
T ss_pred HHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence 99999999999999 9999999999999999999999999998621 0 0111123457899999
Q ss_pred ccccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccccccc--CCCCHHH
Q 015909 253 AAPEYLATG---HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLE--GQFSLPQ 327 (398)
Q Consensus 253 ~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 327 (398)
+|||++.+. .|+.++|+||||++|+||+. ||... +.....+..+-...++ ..+..+.
T Consensus 782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---------------MERa~iL~~LR~g~iP~~~~f~~~~ 843 (1351)
T KOG1035|consen 782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---------------MERASILTNLRKGSIPEPADFFDPE 843 (1351)
T ss_pred ecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch---------------HHHHHHHHhcccCCCCCCccccccc
Confidence 999999764 49999999999999999986 35321 1111111111111122 2223333
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 015909 328 AQKAASLALQCLSVEPKLRPDMDEVVK 354 (398)
Q Consensus 328 ~~~l~~li~~~l~~dP~~Rps~~ell~ 354 (398)
...-..+|.+||+.||.+|||+.|+|+
T Consensus 844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 844 HPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 445679999999999999999999886
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=297.39 Aligned_cols=269 Identities=22% Similarity=0.344 Sum_probs=199.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||.|+||.||+|.... ++..|++|.+.... ......+.+|+.+|+.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 4689999999999999999997654 68899999987542 234566788999999999999999998875
Q ss_pred e----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 149 E----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
. ....++||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~k 147 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELR 147 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEE
Confidence 3 346799999994 6888888654 34899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCc--cccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 225 LSDFGLARDGPTGDKS--HVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
|+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...............
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~ 227 (334)
T cd07855 148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227 (334)
T ss_pred ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHH
Confidence 9999998764332211 11223578899999998865 46889999999999999999999999654321110000000
Q ss_pred --hhhhh-----ccccccccccc-cccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 --KPYLT-----SKRRIFRVLDP-RLEGQF-----SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 --~~~~~-----~~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+... ....+...... ...... ....+.++.++|.+||+.+|++||++.+++.+
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 00000000000 000011 12236789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=281.41 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=195.0
Q ss_pred HHHHHHHhcCCCCCcee--cccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcc
Q 015909 64 YSDLRTATRNFRPDSVL--GEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNL 140 (398)
Q Consensus 64 ~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I 140 (398)
..+.....+.|.+.+.+ |.|+||.||++.... ++..+++|.+........ |+.....+ +||||
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~i 71 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNF 71 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCE
Confidence 34445556677887776 999999999986654 688999999865433221 22222222 69999
Q ss_pred cceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 141 VKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
+++++.+...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.+
T Consensus 72 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRA 145 (267)
T ss_pred EEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCC
Confidence 999999999999999999999999999997653 5899999999999999999999998 9999999999999988
Q ss_pred C-CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 221 Y-NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 221 ~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
+ .++|+|||++...... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... .+...
T Consensus 146 ~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~ 218 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLES 218 (267)
T ss_pred CCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHH
Confidence 8 9999999998754321 12457899999999998899999999999999999999999997432211 11111
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-MDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~ 355 (398)
+... ... ........+..+.++|.+||+.||.+||+ +++++++
T Consensus 219 ~~~~-----------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 219 LLKR-----------QQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHh-----------hcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 1110 000 01112245678999999999999999995 6998864
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=288.83 Aligned_cols=245 Identities=29% Similarity=0.427 Sum_probs=194.2
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
|...+.||+|+||+||+|.... ++..|++|.+..... .....+.+|+.+++.++|||++++++++.+.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 6667889999999999997644 688999999864332 2235678899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCC
Confidence 99999999995 57877776543 45889999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+..... .....|+..|+|||.+. +..++.++||||||+++|+|++|..||........ ......
T Consensus 168 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~- 234 (313)
T cd06633 168 ASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ- 234 (313)
T ss_pred CcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHh-
Confidence 864322 22356889999999984 45688899999999999999999999865322110 000000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ..........+..+.+++.+||+.+|.+||++.+++++
T Consensus 235 -----~----~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 -----N----DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----c----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00011112234568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=286.97 Aligned_cols=263 Identities=27% Similarity=0.359 Sum_probs=197.8
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEeC-
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED- 150 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~- 150 (398)
|++.+.||.|+||.||+|.+.. ++..+++|.+.... ......+.+|+.+++.++|+|++++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 6778899999999999997654 67899999997653 23345678999999999999999999999887
Q ss_pred -CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 -DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..++|+||++ ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 72 KGSIYMVFEYMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred CCcEEEEecccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEcccc
Confidence 88999999996 48888886543 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ..........
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~ 221 (287)
T cd07840 146 LARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSP 221 (287)
T ss_pred ceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCC
Confidence 9886544321 11223456888999998765 45789999999999999999999999754321110 0000000000
Q ss_pred -----ccccc-----cc------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 -----RRIFR-----VL------DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 -----~~~~~-----~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... .. ...+...+....+..+.+++.+||+.+|.+||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 00 0000000111126678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=284.81 Aligned_cols=244 Identities=28% Similarity=0.412 Sum_probs=193.7
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
||.|+||.||+|++.. ++..+++|.+..... ...+.+.+|+.+++.++||||+++++.+......+++
T Consensus 1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999997654 688999999875543 3456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
+||+++++|.+++...+ .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 72 MEYLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 99999999999998754 5899999999999999999999998 99999999999999999999999999876433
Q ss_pred CCC------cccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 237 GDK------SHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 237 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
... ........++..|++||.+.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~---- 215 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN---- 215 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc----
Confidence 321 11223356788999999998888999999999999999999999999643211 00000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 354 (398)
...........+..+.+++.+||+.+|.+||++..+.+
T Consensus 216 ------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 216 ------GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred ------CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 00000001113678899999999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=287.52 Aligned_cols=270 Identities=22% Similarity=0.295 Sum_probs=204.9
Q ss_pred CHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC--CC--
Q 015909 63 SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH--HP-- 138 (398)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~-- 138 (398)
-+.......++|.+.+.+|+|.||.|-.+++++ ++..||+|+++... ...+..+-|+++|.+|. .|
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g 149 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNG 149 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCC
Confidence 344444458899999999999999999998876 58899999997542 33455678999999994 22
Q ss_pred --cccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 139 --NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 139 --~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
-++.+.+||...++.++|+|.+ |.++.+++..++. .+++...+..++.|+++++++||+.+ ++|.||||+|||
T Consensus 150 ~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENIL 224 (415)
T KOG0671|consen 150 KFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENIL 224 (415)
T ss_pred ceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEE
Confidence 2677788899999999999998 7799999977553 67899999999999999999999999 999999999999
Q ss_pred EcC--------------------CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHH
Q 015909 217 LDS--------------------NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVL 276 (398)
Q Consensus 217 v~~--------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l 276 (398)
+.+ +..|+|+|||.|+...... ...+.|..|.|||++.+-.|+..+||||+||||
T Consensus 225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL 299 (415)
T ss_pred EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence 832 3358999999998743322 446789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCcchhhhhhhhhhc-----------------c----------ccccccccccccC----CCCH
Q 015909 277 LEILSGRRAIDKNRPTGEHNLVEWAKPYLTS-----------------K----------RRIFRVLDPRLEG----QFSL 325 (398)
Q Consensus 277 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------~----------~~~~~~~~~~~~~----~~~~ 325 (398)
+|+.+|...|...+..+.. ..+...+.. + .......++.... .-..
T Consensus 300 ~ElytG~~LFqtHen~EHL---aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d 376 (415)
T KOG0671|consen 300 VELYTGETLFQTHENLEHL---AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDD 376 (415)
T ss_pred EEeeccceecccCCcHHHH---HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCc
Confidence 9999999999765532211 111111110 0 0000000000000 0112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 326 PQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 326 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....++.+|+++||..||.+|+|+.|+|.+
T Consensus 377 ~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 377 LEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 235679999999999999999999999875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=284.80 Aligned_cols=243 Identities=26% Similarity=0.378 Sum_probs=188.4
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc---hHHHHHHH---HHHcCCCCCcccceeeEEEeCCc
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTEI---NYLGQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~h~~I~~~~~~~~~~~~ 152 (398)
+||+|+||.||+|.... +++.||+|.+....... ...+..|. ..++...||+|+++++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 48999999999997654 68899999986543221 12233343 34455679999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
.++||||+++++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 99999999999999888654 35899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
...... .....|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||............. . .
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~---~------ 211 (278)
T cd05606 146 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-M---T------ 211 (278)
T ss_pred ccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-H---h------
Confidence 543221 2234689999999998754 68999999999999999999999997542221111000 0 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
. ......+...+.++.+++.+||..+|.+|| ++.+++++
T Consensus 212 -~----~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 212 -L----TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -h----ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0 001112223467899999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=288.22 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=204.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCC-CCcccceeeEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLH-HPNLVKLVGYC 147 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~I~~~~~~~ 147 (398)
++|.+.+.||.|+||.||+|.... ++..|++|++..... .....+.+|+.+++.+. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 468899999999999999997654 688999999865322 22456788999999998 99999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++|||++++++|.+++...+ .+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecC
Confidence 99999999999999999999998753 5899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCc------------------ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015909 228 FGLARDGPTGDKS------------------HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 228 fg~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~ 289 (398)
||++......... .......++..|+|||.+.+..++.++|+||||++++++++|..||...
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9998765432211 1122346788999999998888999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH----HHHHHH
Q 015909 290 RPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM----DEVVKE 355 (398)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~ell~~ 355 (398)
.... . ..... ......+...+..+.+++.+||+.+|.+||++ ++++++
T Consensus 226 ~~~~---~---~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 226 NEYL---T---FQKIL------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred cHHH---H---HHHHH------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 3110 0 00000 01112333446788999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=289.23 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=196.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
+.|...+.||+|+||.||+|.... ++..+++|.+..... .....+.+|+.+++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 346667889999999999997654 678899998864322 23456788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.....++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCc
Confidence 9999999999995 68887776543 45789999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|++...... ....|+..|+|||.+. ...++.++||||||+++|+|++|..||....... ....
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~-- 225 (308)
T cd06634 160 GSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-- 225 (308)
T ss_pred ccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHH--
Confidence 998764322 2346788999999874 3567889999999999999999999986432110 0000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
..............+..+.++|.+||+.+|++||++.+++++...
T Consensus 226 --------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 226 --------IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred --------HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 000000111122345678999999999999999999999988553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=293.26 Aligned_cols=265 Identities=25% Similarity=0.326 Sum_probs=196.0
Q ss_pred hcCCC-CCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc--------------hHHHHHHHHHHcCC
Q 015909 71 TRNFR-PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--------------HKEWLTEINYLGQL 135 (398)
Q Consensus 71 ~~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l 135 (398)
.++|. +.+.||.|+||+||+|.+.. ++..||+|.+....... ...+.+|+.+++.+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 77 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence 34565 45789999999999997654 68899999986542221 12467899999999
Q ss_pred CCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 136 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
+|+||+++++++...+..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||
T Consensus 78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~ni 150 (335)
T PTZ00024 78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANI 150 (335)
T ss_pred CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHe
Confidence 99999999999999999999999995 6899888754 34889999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCC------------cccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDK------------SHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSG 282 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g 282 (398)
+++.++.++|+|||++........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999876431110 0111223468889999998764 468899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhhhcccc--cc------------ccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 015909 283 RRAIDKNRPTGEHNLVEWAKPYLTSKRR--IF------------RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD 348 (398)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 348 (398)
.+||........ ............. .. ....... .......+.++.++|.+||+.+|++||+
T Consensus 231 ~~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s 306 (335)
T PTZ00024 231 KPLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERIS 306 (335)
T ss_pred CCCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccC
Confidence 999975432111 0000000000000 00 0000000 0001123567889999999999999999
Q ss_pred HHHHHHH
Q 015909 349 MDEVVKE 355 (398)
Q Consensus 349 ~~ell~~ 355 (398)
+++++.+
T Consensus 307 ~~~~l~~ 313 (335)
T PTZ00024 307 AKEALKH 313 (335)
T ss_pred HHHHhcC
Confidence 9999975
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=294.14 Aligned_cols=264 Identities=27% Similarity=0.357 Sum_probs=200.7
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+|++.+.||.|++|.||+|.... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 58899999999999999997654 68899999987543 33456788999999999999999999998776
Q ss_pred C-----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 151 D-----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 151 ~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
. ..+++|||++ ++|..++.... .+++..++.++.||+.||.|||+++ |+|+||||.||+++.++.++|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L 144 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKI 144 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEE
Confidence 5 7899999996 58888886543 6899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCc-ccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 226 SDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||........ ......
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~ 221 (330)
T cd07834 145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVE 221 (330)
T ss_pred cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHH
Confidence 999999875443210 112334678899999999887 889999999999999999999999965432110 000000
Q ss_pred hhh----------cccccccccc---ccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLT----------SKRRIFRVLD---PRL---EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~----------~~~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... .......... ... ........+.++.+++.+||+.+|.+||++.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 0000000000 000 000111246778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=295.43 Aligned_cols=268 Identities=24% Similarity=0.297 Sum_probs=195.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|++.+.||.|+||.||+|.... ++..|++|.+........+.+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 4689999999999999999997654 7889999998766556667788999999999999999999776543
Q ss_pred --------------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 151 --------------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 151 --------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
...++||||++ ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nil 146 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVF 146 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEE
Confidence 35789999996 5888877532 4789999999999999999999998 999999999999
Q ss_pred Ec-CCCCEEEeeccCCcCCCCCCCcc-ccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 217 LD-SNYNAKLSDFGLARDGPTGDKSH-VSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 217 v~-~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
++ .++.++|+|||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+..
T Consensus 147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 226 (342)
T cd07854 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226 (342)
T ss_pred EcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 97 45678999999987643221111 1122357889999998754 567889999999999999999999997543211
Q ss_pred Ccchhhhhhhhhh--cccc----cccccc-ccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPYLT--SKRR----IFRVLD-PRLEGQF-----SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~--~~~~----~~~~~~-~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.........+... .... +..... ....... ....+.++.+|+.+||+.||++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 1000000000000 0000 000000 0000000 11235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=280.71 Aligned_cols=243 Identities=26% Similarity=0.334 Sum_probs=187.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHH-HcCCCCCcccceeeEEEeCCce
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINY-LGQLHHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~~I~~~~~~~~~~~~~ 153 (398)
+.||.|+||.||+|.... ++..||+|.+...... ....+..|..+ ...+.|+||+++++++...+..
T Consensus 2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 569999999999997654 6789999998654321 12233444444 4455899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred EEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeeccccee
Confidence 99999999999999997653 5889999999999999999999998 99999999999999999999999999875
Q ss_pred CCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~----- 209 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRR----- 209 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcc-----
Confidence 432 22346788999999998888899999999999999999999999643211 0000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH---HHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM---DEVVKE 355 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~~ 355 (398)
. ..........+.++.+++.+||+.||++||++ .+++.+
T Consensus 210 -~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 210 -I--NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred -c--CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0 00111122346789999999999999999966 455544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=274.27 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=198.3
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 156 (398)
++||+|+|+.|--|+. ..++..||||++.+..--.+..+.+|++++.+.+ |+||+.++++|.++..+|||
T Consensus 84 e~LGeGAyasVqtcv~---------i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVS---------IQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhcCccceeeeeeee---------eccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 6799999999998754 3489999999998775566788999999999996 99999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC---CEEEeeccCCcC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY---NAKLSDFGLARD 233 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~---~~kl~Dfg~a~~ 233 (398)
||-+.||.|...|.++. -+++..+..+..+|+.||.|||.+| |.||||||+|||..... -||||||.++..
T Consensus 155 fEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccc
Confidence 99999999999998875 4899999999999999999999999 99999999999997554 389999998764
Q ss_pred CCCCCCc-----ccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC----CCcchhh
Q 015909 234 GPTGDKS-----HVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT----GEHNLVE 299 (398)
Q Consensus 234 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~----~~~~~~~ 299 (398)
......- ....+.+|+..|||||++. ...|+.+.|.||||++||-||.|.+||.+.=.. .......
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 3222111 1123468999999999873 346888999999999999999999999652111 0011111
Q ss_pred hhhhhhhccccccccccccccC--CCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEG--QFS----LPQAQKAASLALQCLSVEPKLRPDMDEVVK 354 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 354 (398)
..+. .+++ ...++ ++| ...+.+..+++..+|..|+.+|.++.++++
T Consensus 309 ~CQ~------~LFe---sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 309 VCQN------KLFE---SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHH------HHHH---HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111 0111 11111 122 345888999999999999999999999888
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=287.39 Aligned_cols=247 Identities=24% Similarity=0.289 Sum_probs=184.6
Q ss_pred CCcEEEEEEcccC--CccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHH
Q 015909 105 TGMLIAVKRLNQE--GFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWS 182 (398)
Q Consensus 105 ~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~ 182 (398)
++..||+|++... .......+.+|+.+++.++|+||+++++++...+..+++|||+++++|.+++..... ..+++.
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~--~~~~~~ 101 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPEL 101 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc--cCCCHH
Confidence 6889999998754 233456789999999999999999999999999999999999999999999986532 358889
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCC-----cccccccccccccccccc
Q 015909 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDK-----SHVSTRVMGTYGYAAPEY 257 (398)
Q Consensus 183 ~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~ 257 (398)
.+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||.+........ ........++..|+|||+
T Consensus 102 ~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 179 (314)
T cd08216 102 AIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179 (314)
T ss_pred HHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHH
Confidence 99999999999999999998 99999999999999999999999998865432211 111223457788999999
Q ss_pred ccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh----h------hccccccc----ccc----c
Q 015909 258 LAT--GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY----L------TSKRRIFR----VLD----P 317 (398)
Q Consensus 258 ~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~----~------~~~~~~~~----~~~----~ 317 (398)
+.+ ..++.++|+||||+++|+|++|..||....... ......... + ........ ... .
T Consensus 180 ~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
T cd08216 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD 257 (314)
T ss_pred hcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhh
Confidence 865 358889999999999999999999997532211 000000000 0 00000000 000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 318 RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 318 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
..........+.++.+++.+||+.||++|||+++++++--
T Consensus 258 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 258 SVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0111223344678899999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.66 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=196.3
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEccc---CCc--cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ---EGF--QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~---~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
+|.+.+.||+|+||.||++.+.. .+..+++|.++. ... .....+..|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 58889999999999999997643 333444454432 111 2234567899999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+....++|+||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecc
Confidence 9999999999999999999998764444467899999999999999999999998 999999999999975 5799999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........
T Consensus 149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~-- 218 (260)
T cd08222 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV-- 218 (260)
T ss_pred cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH--
Confidence 999876533221 22335678899999999888889999999999999999999999853211 11111000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. .....+...+.++.+++.+||..||++||++.+++++
T Consensus 219 -----~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 -----EG----PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -----cC----CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00 0111233556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=286.02 Aligned_cols=268 Identities=25% Similarity=0.310 Sum_probs=197.4
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
...++|++.+.||+|+||.||+|.... ++..|++|.+..... .....+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~ 74 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence 345789999999999999999997754 678999999865422 223466789999999999999999998
Q ss_pred EEeCC----------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 147 CLEDD----------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 147 ~~~~~----------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
+.+.. ..++|+||+++ ++...+.... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nil 148 (302)
T cd07864 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNIL 148 (302)
T ss_pred ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence 87654 78999999965 7777766542 45899999999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~ 295 (398)
+++++.++|+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|++||.........
T Consensus 149 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~ 227 (302)
T cd07864 149 LNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227 (302)
T ss_pred ECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999876543322 11122345778999998865 45788999999999999999999999653321110
Q ss_pred chhhhhhhhhhcc-c-ccccc--------ccccc-----cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 296 NLVEWAKPYLTSK-R-RIFRV--------LDPRL-----EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 296 ~~~~~~~~~~~~~-~-~~~~~--------~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ........ . ..... .+... ........+..+.+++.+||+.||.+||++.+++++
T Consensus 228 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 228 EL---ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HH---HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00000000 0 00000 00000 000001135678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=290.92 Aligned_cols=261 Identities=26% Similarity=0.356 Sum_probs=204.2
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL 154 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~ 154 (398)
.++||.|.||+||-|+.+. +|+.||||++.+..+ .....+.+|+.||.++.||.|+.+...|...+..+
T Consensus 569 devLGSGQFG~VYgg~hRk---------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK---------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecceecc---------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 4889999999999996554 899999999976544 33467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC---CCCEEEeeccCC
Q 015909 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLA 231 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~---~~~~kl~Dfg~a 231 (398)
+|||-+.| ++.+.|..... ..+++.....++.||+.||.|||-++ |+|+||||+|||+.+ -..+||||||+|
T Consensus 640 VVMEKl~G-DMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 640 VVMEKLHG-DMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEehhhcc-hHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccce
Confidence 99999955 55555443322 56999999999999999999999998 999999999999963 457999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
+.+.... .....+||+.|+|||+++...|...-|+||+|+|+|--|.|..||....+..+ -++.+
T Consensus 715 RiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNA---------- 779 (888)
T KOG4236|consen 715 RIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNA---------- 779 (888)
T ss_pred eecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhhcc----------
Confidence 9875543 23457899999999999999999999999999999999999999964322111 00000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH-----HHHHHHHhhccCCch
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE-----LEQLQELRNMHKRPQ 370 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~-----L~~l~~~~~~~~~~~ 370 (398)
..+. ....-.+.+.++.+||..+|+..-++|-|.+..+.+ -+.+.+++..+.+.+
T Consensus 780 -aFMy---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~ig 839 (888)
T KOG4236|consen 780 -AFMY---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIG 839 (888)
T ss_pred -cccc---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhC
Confidence 0111 111112346788999999999999999999886654 334445555444444
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=254.69 Aligned_cols=264 Identities=25% Similarity=0.323 Sum_probs=199.7
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
|.-.+.||+|.||+||+|+..+ +++.||+|.++.+.. ......++|+-+|+.|+|.||++++++...++
T Consensus 4 ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk 74 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_pred hHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc
Confidence 4445789999999999997665 899999999975432 33567899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
.+-+|+||| ..+|..+..... ..++.+.+..++.|++.||.++|+++ +.||||||.|.||+.+|.+||+|||++
T Consensus 75 kltlvfe~c-dqdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 75 KLTLVFEFC-DQDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred eeEEeHHHh-hHHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchh
Confidence 999999999 668998887665 56899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+-+.-. .......+-|.+|.+|.++-|. -|+...|+||-||++.|+.. |++.|.+.+..+...-+-+.-.. ..+.
T Consensus 149 rafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~-p~ed 225 (292)
T KOG0662|consen 149 RAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT-PTED 225 (292)
T ss_pred hhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCC-Cccc
Confidence 865332 2233445679999999998775 57888999999999999988 77777654332221111111000 0000
Q ss_pred cc---cccccccc----cC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RI---FRVLDPRL----EG-----QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~---~~~~~~~~----~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. .+..+-.. .. +.-+.....-++++.++|..+|.+|.++++.+++
T Consensus 226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 00 01111000 00 0111223456899999999999999999998865
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=284.52 Aligned_cols=243 Identities=28% Similarity=0.421 Sum_probs=199.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCC-CCCcccceee
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQL-HHPNLVKLVG 145 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~~I~~~~~ 145 (398)
-..+|.++.+||+|+||.|.+| .+.++.+.||||+++++..- +.+--..|-++|... +-|.++.+..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLa---------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred eecccceEEEeccCccceeeee---------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 3457888999999999999998 44558999999999876442 223335677788776 4778899999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
.|..-+.+|+||||+.||+|-..++..++ +.+..+..++..|+-||-+||++| |++||||.+||+++.+|++||
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEe
Confidence 99999999999999999999999998876 555667888999999999999999 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+|||+++...... ....+++||+.|+|||++..++|+.++|+||+|++||||+.|++||++.++.. ..+.
T Consensus 492 ~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------lF~a-- 561 (683)
T KOG0696|consen 492 ADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQA-- 561 (683)
T ss_pred eecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHH--
Confidence 9999998643332 23556899999999999999999999999999999999999999998754321 1111
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 347 (398)
+.+ -...++...+.++.++....|.+.|.+|.
T Consensus 562 --------I~e--hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 562 --------IME--HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --------HHH--ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 111 12345666788999999999999999994
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=290.17 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=192.7
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCC-CCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQL-HHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~ 149 (398)
+|++.+.||+|+||.||+|.+... ..+..||+|.+..... ...+.+.+|+.+++.+ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 478889999999999999976531 1277899999864321 2245678899999999 59999999987543
Q ss_pred C----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 150 D----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 150 ~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
. ...+++++++ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|
T Consensus 74 ~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 74 FPGNFNELYLYEELM-EADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred ccccCCcEEEEEecc-cCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEe
Confidence 2 4568899988 46898888654 35889999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCc--cccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 226 SDFGLARDGPTGDKS--HVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|||++......... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|.+||....... ......
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~ 223 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQIL 223 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHH
Confidence 999999865432211 11223568999999998765 568899999999999999999999996533110 000000
Q ss_pred hhh-----------hccc--cccccccccccC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYL-----------TSKR--RIFRVLDPRLEG---QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~-----------~~~~--~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..+ .... ............ ......+..+.+++.+||+.||++|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 224 QVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 0000 000000000000 0011125678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=288.78 Aligned_cols=269 Identities=26% Similarity=0.336 Sum_probs=194.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||.|+||.||+|.+.. ++..|++|.+...... ....+.+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 4689999999999999999997654 6888999988643322 2345678999999999999999999875
Q ss_pred eCC--------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 149 EDD--------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 149 ~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
... ..++|+||+. ++|...+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.+
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~ 151 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ 151 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 433 4689999995 47777665433 45899999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCcc---------cccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015909 221 YNAKLSDFGLARDGPTGDKSH---------VSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNR 290 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~ 290 (398)
+.++|+|||++.......... ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+..
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999987643322111 11234578889999987654 57889999999999999999999997543
Q ss_pred CCCCcchhh-hhhh----hhhccccccc--------cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 291 PTGEHNLVE-WAKP----YLTSKRRIFR--------VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 291 ~~~~~~~~~-~~~~----~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......... .... .......+.. .....+... .......+.+++.+||+.||.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 221100000 0000 0000000000 000000000 01123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=285.06 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=195.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCC-CCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLH-HPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+..|+.++..+. |+||+++++++.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 3568889999999999999997754 688999999875432 23445667777666664 999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.....+++|||+ +++|.+++.... ..+++..+..++.|++.||.|||+ ++ |+||||+|+||+++.++.++|+|
T Consensus 85 ~~~~~~~v~e~~-~~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 85 TDSDVFICMELM-STCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred cCCeEEEEeecc-CcCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECc
Confidence 999999999998 557877776543 368999999999999999999997 47 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH----LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
||++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ......
T Consensus 159 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~ 230 (296)
T cd06618 159 FGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTK 230 (296)
T ss_pred cccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHH
Confidence 999876432221 12235788999999987553 788999999999999999999999642111 000000
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
..... .+.. ......+.++.+|+.+||+.||++||++.+++++-
T Consensus 231 ~~~~~-------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 231 ILQEE-------PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HhcCC-------CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 01000 0000 11112456789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=280.27 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=195.2
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCC---CCCcccceeeEEE
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQL---HHPNLVKLVGYCL 148 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~~I~~~~~~~~ 148 (398)
|++.+.||.|+||.||+|.+.. ++..|++|.+...... ....+.+|+.+++.+ .|+||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 6778899999999999997754 6889999999743222 123456677776655 6999999999998
Q ss_pred eCCc-----eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 149 EDDH-----RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 149 ~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
..+. .+++|||++ ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCE
Confidence 8776 899999996 589888876442 35899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
+|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|++|.+||....... ........
T Consensus 147 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~ 221 (287)
T cd07838 147 KIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDV 221 (287)
T ss_pred EEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHH
Confidence 9999999876533221 122357889999999999899999999999999999999999997533211 11111000
Q ss_pred hhhcc-------cc-cccccccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSK-------RR-IFRVLDPRLE---GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~-------~~-~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... .. .......... .......+..+.+++.+||+.||.+||++.+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000 00 0000000000 11112345778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=281.48 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=196.5
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCC-CCcccceeeEEEeCC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLH-HPNLVKLVGYCLEDD 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~~ 151 (398)
|++.+.||.|++|+||+|.... ++..|++|.+..... .......+|+..++.+. |+||+++++++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6778899999999999997754 678899999865432 22234567999999999 999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+ +++|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccc
Confidence 999999999 789988887654 145899999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch-h---------hh
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL-V---------EW 300 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~-~---------~~ 300 (398)
........ .....++..|+|||.+. +..++.++|+||||+++++|++|++||........... . .|
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 147 REIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 76533221 22346788999999875 44578899999999999999999999965432111000 0 00
Q ss_pred hhhhhhccccccccccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRL---EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... ........... ........+.++.+++.+||+.||++||+++|++.+
T Consensus 224 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 224 PEGYKLA-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhHhhhh-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00000000000 000001124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.65 Aligned_cols=262 Identities=31% Similarity=0.544 Sum_probs=203.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
...|...++||+|+||.||+|.... ++..||+|.+...... ...|++++++++||||+++++++.+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4567888899999999999997654 6889999998643221 23568899999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..++||||+++++|.+++.. +++..+..++.|++.||+|||.. ..+|+||||||+||+++.++..++. ||
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 999999999999999999852 78899999999999999999943 2239999999999999988887775 66
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
....... .....||..|+|||++.+..++.++|||||||++|||++|+.||..... .......|.+..... .
T Consensus 828 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~ 899 (968)
T PLN00113 828 LPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-C 899 (968)
T ss_pred ccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-c
Confidence 5443211 1123678999999999999999999999999999999999999954322 233444554433221 1
Q ss_pred cccccccccccC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEG--QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 310 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
......++.+.. ........++.+++.+||+.||++||++.++++.|+.+..
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 222333433322 2334556678899999999999999999999999987644
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=290.91 Aligned_cols=267 Identities=24% Similarity=0.352 Sum_probs=195.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 4789999999999999999997643 688999999865321 22356789999999999999999999886
Q ss_pred eC------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 ED------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
.. ...++|+||+. .+|..+.. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~ 155 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCE 155 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCC
Confidence 54 34689999985 46766542 24788999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...............
T Consensus 156 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 156 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred EEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998764221 123467889999999866 46888999999999999999999999754321100000000
Q ss_pred h----h----hhhcc--ccccccccccccCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHH
Q 015909 302 K----P----YLTSK--RRIFRVLDPRLEGQF---SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE--LEQLQ 360 (398)
Q Consensus 302 ~----~----~~~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l~ 360 (398)
. + ..... ............... ....+..+.++|.+||+.||.+||++.+++.+ ++.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0 0 00000 000000000000000 01234578899999999999999999999976 65553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=280.55 Aligned_cols=256 Identities=29% Similarity=0.382 Sum_probs=198.3
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc----cchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----QGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
.|++.+.||.|+||.||+|.... ...+|..||+|.+..... ...+.+.+|+.+++.+ +|+||+++++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVS------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEecc------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 47888999999999999987532 123688999999865322 2345678899999999 599999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
..+...++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEee
Confidence 99899999999999999999987653 4788999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG--HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||....... ..........
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~ 225 (290)
T cd05613 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRIL 225 (290)
T ss_pred Cccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhh
Confidence 9998765332211 12235688999999998653 46788999999999999999999996422111 1111111100
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
.. ...++...+..+.+++.+||+.||++|| ++.+++++
T Consensus 226 ~~------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 226 KS------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred cc------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00 0112233456788999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=288.35 Aligned_cols=268 Identities=24% Similarity=0.348 Sum_probs=199.3
Q ss_pred HHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCccc
Q 015909 64 YSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLV 141 (398)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~ 141 (398)
..++....++|.+.+.||+|+||.||+|.... ++..||+|.+.... ....+.+.+|+.++++++||||+
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv 79 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 79 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccc
Confidence 34556677999999999999999999997643 68899999986532 22345678899999999999999
Q ss_pred ceeeEEEeC------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 142 KLVGYCLED------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 142 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
++++++... ...+++++++ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI 151 (345)
T cd07877 80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNL 151 (345)
T ss_pred ceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHE
Confidence 999987643 3467888887 78998877542 4889999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE 294 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~ 294 (398)
+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........
T Consensus 152 ll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred EEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999998764221 223467889999998866 5688899999999999999999999964322110
Q ss_pred cchhhhhhhh----------hhcc--ccccccccccccC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 295 HNLVEWAKPY----------LTSK--RRIFRVLDPRLEG---QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 295 ~~~~~~~~~~----------~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+....... +... ......+...... ......+.++.++|.+||+.||.+||++.+++++
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 227 --LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred --HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000 0000 0000000000000 0001135678899999999999999999999988
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=279.48 Aligned_cols=262 Identities=28% Similarity=0.391 Sum_probs=198.9
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
|++.+.||+|++|.||+|.... ++..|++|.+.... ....+.+..|+.+++.++|+||+++++++...+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 5677889999999999997654 68899999987643 233456788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++|+||++ ++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcc
Confidence 9999999996 59999998753 35899999999999999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh----
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT---- 306 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---- 306 (398)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||........ .........
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 220 (282)
T cd07829 146 RAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTE 220 (282)
T ss_pred cccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcH
Confidence 76533221 12234467789999998766 788999999999999999999999965432110 000000000
Q ss_pred -------cc---ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 -------SK---RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 -------~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ...................+..+.+++.+||..||++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 221 ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 00000000000000011125689999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=288.20 Aligned_cols=265 Identities=25% Similarity=0.325 Sum_probs=197.8
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceee
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
..+.++|++.+.||.|+||.||+|.... ++..|++|.+..... ...+.+..|+.+++.++||||+++++
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 76 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence 4467889999999999999999997654 788999998864321 23466789999999999999999999
Q ss_pred EEEe-CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 146 YCLE-DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 146 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
++.. ....++++||+ +++|..++... .++...+..++.|++.||.|||+.+ |+|+||+|.||+++.++.++
T Consensus 77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~ 148 (328)
T cd07856 77 IFISPLEDIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLK 148 (328)
T ss_pred eEecCCCcEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEE
Confidence 8865 56789999998 66888877542 4788888899999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh-----
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV----- 298 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~----- 298 (398)
|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||............
T Consensus 149 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 223 (328)
T cd07856 149 ICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG 223 (328)
T ss_pred eCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998753221 123457888999998765 56899999999999999999999999654321100000
Q ss_pred ----hhhhhhhhccccccccccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 299 ----EWAKPYLTSKRRIFRVLDPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 299 ----~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+....... ....-...-......+ ...+..+.++|.+||+.+|++||++.+++.+
T Consensus 224 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 224 TPPDDVINTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCCHHHHHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0000000000001111 1235788999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=280.56 Aligned_cols=258 Identities=27% Similarity=0.358 Sum_probs=198.9
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc----cchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----QGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
+|++.+.||+|++|.||+|.... ...++..|++|.+..... ...+.+.+|+.++.++ +||||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 47788999999999999987532 223578899999864321 2345678899999999 599999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
......++||||+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||+|.||+++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEE
Confidence 9999999999999999999998754 34788999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH--LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
||++......... ......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||....... ..........
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~ 225 (288)
T cd05583 149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRIL 225 (288)
T ss_pred Ccccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHH
Confidence 9998765433211 122346889999999987654 7889999999999999999999996422111 0111111100
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
. . ....+...+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 226 ~-------~-----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 226 K-------S-----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred c-------c-----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 0 0 01122234567899999999999999999876665554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=289.14 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=197.0
Q ss_pred HHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCccccee
Q 015909 67 LRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLV 144 (398)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~ 144 (398)
+....++|++.+.||+|+||.||+|.... ++..||+|.+..... .....+.+|+.+++.++||||++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 80 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccee
Confidence 34456789999999999999999997654 688999999864321 2235678999999999999999999
Q ss_pred eEEEeCC------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 145 GYCLEDD------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 145 ~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
+++..+. ..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~ 152 (343)
T cd07880 81 DVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN 152 (343)
T ss_pred eeecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence 9887553 358999998 7799888754 34889999999999999999999998 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
.++.++|+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........ +
T Consensus 153 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~ 225 (343)
T cd07880 153 EDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--L 225 (343)
T ss_pred CCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H
Confidence 9999999999998764321 123457889999999866 4588899999999999999999999975322100 0
Q ss_pred hhhhh-----------hhhhc-ccccccccccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 298 VEWAK-----------PYLTS-KRRIFRVLDPRLE---GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 298 ~~~~~-----------~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ..... .......+..... .......+..+.++|.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000 0000000000000 00111235578899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=274.33 Aligned_cols=278 Identities=24% Similarity=0.355 Sum_probs=229.0
Q ss_pred CCHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcc
Q 015909 62 FSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNL 140 (398)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I 140 (398)
....++.....+++...++-+|.||.||.|.+.+. ....+.+.|.+|.++... .-....++.|...+..+.|||+
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE----dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nl 349 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE----DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNL 349 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeeccc----CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCc
Confidence 34567777778899999999999999999988752 223345677788886542 2335667899999999999999
Q ss_pred cceeeEEEeC-CceEEEEeecCCCCHHHHHhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 141 VKLVGYCLED-DHRLLVYEFMPRGSMENHLFRRG----SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 141 ~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
+.+.++..++ ...++++.+...|+|..++...+ ...+.++..+...++.|++.|++|||+++ |||.||..+|+
T Consensus 350 l~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNC 427 (563)
T KOG1024|consen 350 LSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNC 427 (563)
T ss_pred cceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcc
Confidence 9999988764 55678889998999999998332 23356788888999999999999999999 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGE 294 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~ 294 (398)
+|++..+|||+|=.+++.+.+.++.+..........||+||.+.+..|+.++|+||||+++|||+| |+.|+..-++.+
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE- 506 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE- 506 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence 999999999999999999999999888887788889999999999999999999999999999999 999986543321
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
+..++.++.++ .-|..++++++.++..||+.+|++||+++++...|.++...
T Consensus 507 ------m~~ylkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 ------MEHYLKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ------HHHHHhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 11223333222 23556789999999999999999999999999999987644
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=291.58 Aligned_cols=265 Identities=25% Similarity=0.340 Sum_probs=197.7
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
...++|++.+.||+|++|.||+|.+.. ++..|++|.+.... ......+.+|+.+++.+.|+||+++.++
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHH
Confidence 356789999999999999999997754 68899999986432 2234567789999999999999999988
Q ss_pred EEeCCc------eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 147 CLEDDH------RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 147 ~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
+...+. .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~ 154 (343)
T cd07851 83 FTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED 154 (343)
T ss_pred hhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC
Confidence 766554 89999998 6799998865 34899999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch-h
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL-V 298 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~-~ 298 (398)
+.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... .
T Consensus 155 ~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~ 229 (343)
T cd07851 155 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM 229 (343)
T ss_pred CCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999998765332 223467889999998865 4678899999999999999999999965432110000 0
Q ss_pred h--------hhhhhhhc-cccccccccccccCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 299 E--------WAKPYLTS-KRRIFRVLDPRLEGQF---SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 299 ~--------~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. +....... ...............+ ....+..+.++|.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 00000000 0000000000000000 01125689999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=296.60 Aligned_cols=259 Identities=29% Similarity=0.421 Sum_probs=211.2
Q ss_pred HHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccce
Q 015909 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKL 143 (398)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~ 143 (398)
+.+.....-|++.++||.|.+|.||++.... ++...|+|+..... +..+++..|.++|+.+ .|||++.+
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~f 81 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATF 81 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceE
Confidence 3334445678899999999999999986544 77888888876543 3446778899999988 59999999
Q ss_pred eeEEEe-----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 144 VGYCLE-----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 144 ~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
+++|.. ++.+|||||||.+|+..|++.... ...+.+..+..|+..++.|+.+||.+. ++|||||-.|||++
T Consensus 82 yg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT 157 (953)
T KOG0587|consen 82 YGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT 157 (953)
T ss_pred EEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe
Confidence 999864 578999999999999999998765 467999999999999999999999998 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
.++.|||+|||++....... ....+..||+.|||||++.. ..|+.++|+||||++..||-.|.+|+-+..+.
T Consensus 158 ~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm- 234 (953)
T KOG0587|consen 158 ENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM- 234 (953)
T ss_pred ccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-
Confidence 99999999999988754332 23456789999999999954 35777899999999999999999999764432
Q ss_pred Ccchhhhhhhhhhccccccccc-cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVL-DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+-++.+. +++....-+...+.++-++|..||.+|-++||+..++++|
T Consensus 235 ---------------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 ---------------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1222222 2222333356678999999999999999999999998865
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=272.64 Aligned_cols=240 Identities=32% Similarity=0.426 Sum_probs=194.2
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
||.|+||.||++.... ++..+++|.+...... ....+..|+.+++.++|+||+++++.+..+...++|
T Consensus 1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 6899999999997653 6789999998754332 345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 72 LEYAPGGELFSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99999999999997653 4899999999999999999999988 99999999999999999999999999876533
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... .........
T Consensus 146 ~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~---------- 207 (250)
T cd05123 146 EG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK---------- 207 (250)
T ss_pred CC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc----------
Confidence 22 112335678899999999888889999999999999999999999964321 000000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH---HHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM---DEVVK 354 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~ell~ 354 (398)
.....+...+..+.+++.+||..||++||++ .++++
T Consensus 208 --~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 208 --DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 0112222336788999999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=292.74 Aligned_cols=245 Identities=27% Similarity=0.303 Sum_probs=198.0
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
....|.+...+|.|+|+.|-.+.... +++..++|++.+... ...+|+.++... +||||+++.+.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~---------t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP---------TDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc---------cccchhheecccccc----ccccccchhhhhcCCCcceeecceec
Confidence 35678888889999999999886544 788999999976521 223566555554 6999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE-cCCCCEEEee
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL-DSNYNAKLSD 227 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv-~~~~~~kl~D 227 (398)
+..+.|+|||.+.++-|.+.+.... .....+..|+.+|+.|+.|||++| ||||||||+|||+ ++.++++|+|
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEE
Confidence 9999999999999998888776653 223677789999999999999998 9999999999999 6899999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||.++..... ....+-|..|.|||++....|++++||||||++||+||+|+.||...... .
T Consensus 460 FG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~--------- 520 (612)
T KOG0603|consen 460 FGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----I--------- 520 (612)
T ss_pred echhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----H---------
Confidence 9999876444 22335688999999999999999999999999999999999999653221 0
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
++........++..++..+++|+.+||+.||.+||++.++..+=..
T Consensus 521 -----ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 521 -----EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -----HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1111112233446678899999999999999999999999987443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=283.75 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=204.8
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcc--cCCccc-----hHHHHHHHHHHcCCCCC
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN--QEGFQG-----HKEWLTEINYLGQLHHP 138 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~-----~~~~~~E~~~l~~l~h~ 138 (398)
+-+...++|-++.+||+|+|+.||+|.+-. ....||+|+-. +...+. .+...+|..|-+.|.||
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHp 527 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHP 527 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcc
Confidence 334455788899999999999999997643 67899999753 221111 23467899999999999
Q ss_pred cccceeeEEEe-CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE
Q 015909 139 NLVKLVGYCLE-DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217 (398)
Q Consensus 139 ~I~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv 217 (398)
.||++|++|.. .+.+|-|+|||+|.+|.-++..+. .+++..+..|+.||+.||.||....++|||-||||.|||+
T Consensus 528 RIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 528 RIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL 603 (775)
T ss_pred eeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence 99999999865 567889999999999999998774 4899999999999999999999999999999999999999
Q ss_pred c---CCCCEEEeeccCCcCCCCCCCcc-----ccccccccccccccccccc----CCCCCchhHHHHHHHHHHHHhCCCC
Q 015909 218 D---SNYNAKLSDFGLARDGPTGDKSH-----VSTRVMGTYGYAAPEYLAT----GHLTAKSDIYSFGVVLLEILSGRRA 285 (398)
Q Consensus 218 ~---~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~p 285 (398)
. .-|.+||+|||+++......... ......||.+|++||.+.- ...+.++||||+|+|+|.++.|+.|
T Consensus 604 v~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKP 683 (775)
T KOG1151|consen 604 VNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKP 683 (775)
T ss_pred ecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCC
Confidence 4 45789999999999875544332 2344689999999998843 3578899999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 286 IDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
|..+... ++++.. . .+.... ...-+..+.++.++.+||++||+..-++|.+..++..+
T Consensus 684 FGhnqsQ--QdILqe-------N-TIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 684 FGHNQSQ--QDILQE-------N-TILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred CCCchhH--HHHHhh-------h-chhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 9764322 111111 0 000000 01112223457789999999999999999988887654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=306.48 Aligned_cols=146 Identities=26% Similarity=0.372 Sum_probs=130.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|++.. ++..||+|++...... ....+..|+.+++.++||||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 578999999999999999997754 6889999999754322 2356788999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.....|+||||+.+++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.++|+||
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeC
Confidence 9999999999999999999997653 4788999999999999999999998 999999999999999999999999
Q ss_pred cCCc
Q 015909 229 GLAR 232 (398)
Q Consensus 229 g~a~ 232 (398)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=289.91 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=208.3
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
+++.+.-||.|+||.|=++..+. ....+|+|++++... ...+.+..|-.||...+.|+|+++|..|.+
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~---------~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNS---------QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred hhhhhhhcccCccceEEEEEecc---------cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 44556679999999999887654 233578888876433 445678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+...|++||-|-||.|+..+..++. ++..+...++..+++|++|||+++ ||+|||||+|++++.+|-+||.|||
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehh
Confidence 9999999999999999999998864 777888889999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+|+....+.. ..+++||+.|.|||++.+...+.++|.||||+++||||+|.+||.+.++....+++-..
T Consensus 566 FAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-------- 634 (732)
T KOG0614|consen 566 FAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-------- 634 (732)
T ss_pred hHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh--------
Confidence 9998766654 44689999999999999999999999999999999999999999876654332222111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKELE 357 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~L~ 357 (398)
.-...+|...+..+.+|+++++..+|.+|.- +.+|.+|-.
T Consensus 635 --------id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 635 --------IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred --------hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 1122455566778899999999999999964 666666644
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=295.61 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=214.4
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCCCCCcccceeeEEEeCCc
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~ 152 (398)
.+..++||.|+||+||+|.+-- ....-+.+||+|++... ..+...++++|+.+|.+|.|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~P-----ege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIP-----EGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEec-----CCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 3456789999999999998753 22334678999998654 3445678999999999999999999999998765
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
..||++|+++|+|.+++..++ ..+..+..+.+..||++||.|||.+. ++||||-.+||||.+-.++||.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhh
Confidence 789999999999999999876 56888999999999999999999887 9999999999999999999999999999
Q ss_pred CCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
...............-.+.|||-|.+....|+.++||||||+++||++| |..|+++....+..+
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d--------------- 911 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD--------------- 911 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH---------------
Confidence 8776665544444444678999999999999999999999999999999 999997643322211
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.+.......-+.-++.++.-++.+||..|+..||+++++...+.++-
T Consensus 912 --lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 912 --LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 22222222335567889999999999999999999999999988763
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=267.29 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=199.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCC-CCCcccceeeE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL-HHPNLVKLVGY 146 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~I~~~~~~ 146 (398)
.++|.++++||+|+|++|..+++.. +.+.||+|+++++-+ ++......|-.+..+- +||.++.+...
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~---------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccceeeeeecCcchhhhhheehcc---------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 4689999999999999999986654 889999999986533 3344556677777665 69999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
|.....+++|.||++||+|--.+++.. .++++.+..+...|+.||.|||+.| |++||||.+|+|++..|++||+
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeec
Confidence 999999999999999999988887764 4899999999999999999999999 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCCCCcchhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN-RPTGEHNLVEWAKPYL 305 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~-~~~~~~~~~~~~~~~~ 305 (398)
|+|+++.... ......+++||+.|.|||++++..|+..+|+|+||++++||+.|+.||+-- ....+.+...+.-..+
T Consensus 394 dygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi 471 (593)
T KOG0695|consen 394 DYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI 471 (593)
T ss_pred ccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence 9999986332 223456789999999999999999999999999999999999999999741 1112222222211111
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 347 (398)
. +.. ...+...+..+..+++..|++||.+|.
T Consensus 472 l---------ekq--iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 L---------EKQ--IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred h---------hhc--ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 111 122333455677899999999999994
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=269.51 Aligned_cols=266 Identities=21% Similarity=0.327 Sum_probs=199.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-----C---Ccccce
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-----H---PNLVKL 143 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~I~~~ 143 (398)
.+|.+.++||.|.|++||+|++.. ....||+|+++... -..+..+.||++|++++ | .+||++
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 789999999999999999999876 67899999997653 22456789999999984 2 479999
Q ss_pred eeEEEe----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC
Q 015909 144 VGYCLE----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219 (398)
Q Consensus 144 ~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~ 219 (398)
++.|.. ..++++|+|++ |.+|..+|....- +.++...+.+|+.||+.||.|||..- +|||.||||+|||+..
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLCS 223 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeeec
Confidence 999865 56899999999 8899999987654 67999999999999999999999863 6999999999999821
Q ss_pred C-------------------------------------------------------------------------------
Q 015909 220 N------------------------------------------------------------------------------- 220 (398)
Q Consensus 220 ~------------------------------------------------------------------------------- 220 (398)
+
T Consensus 224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~ 303 (590)
T KOG1290|consen 224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY 303 (590)
T ss_pred cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 015909 221 -------------------------------------------------------------------------------- 220 (398)
Q Consensus 221 -------------------------------------------------------------------------------- 220 (398)
T Consensus 304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~ 383 (590)
T KOG1290|consen 304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD 383 (590)
T ss_pred ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence
Q ss_pred -------CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 221 -------YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 221 -------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
-+|||+|||.|..... .++.-..|..|+|||++.|..|++.+||||++|++|||.||...|+......
T Consensus 384 ~~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~ 458 (590)
T KOG1290|consen 384 IPLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGEN 458 (590)
T ss_pred CCCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCC
Confidence 0034444444433211 1122345889999999999999999999999999999999999997643322
Q ss_pred ---Ccchhh------------------hhhhhhhcccccccccccc-------c--cCCCCHHHHHHHHHHHHHhccCCC
Q 015909 294 ---EHNLVE------------------WAKPYLTSKRRIFRVLDPR-------L--EGQFSLPQAQKAASLALQCLSVEP 343 (398)
Q Consensus 294 ---~~~~~~------------------~~~~~~~~~~~~~~~~~~~-------~--~~~~~~~~~~~l~~li~~~l~~dP 343 (398)
+.+-+. +.+.++.....+..+-.-. + ...++...+.++.+|+.-||+.+|
T Consensus 459 Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~P 538 (590)
T KOG1290|consen 459 YSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDP 538 (590)
T ss_pred CCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCc
Confidence 111111 1223333322222221100 0 124566678899999999999999
Q ss_pred CCCCCHHHHHHHH
Q 015909 344 KLRPDMDEVVKEL 356 (398)
Q Consensus 344 ~~Rps~~ell~~L 356 (398)
++|||+.++|++=
T Consensus 539 eKR~tA~~cl~hP 551 (590)
T KOG1290|consen 539 EKRPTAAQCLKHP 551 (590)
T ss_pred cccccHHHHhcCc
Confidence 9999999999763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=266.33 Aligned_cols=270 Identities=27% Similarity=0.394 Sum_probs=201.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
...|.-..+||+|.||.||+|+... +++.||+|++-.++. .-....++|+.+|..|+|+|++.++++|.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 3456666789999999999986654 788899987643222 22356789999999999999999988875
Q ss_pred e--------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 149 E--------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 149 ~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
. ...+|+||.+|+. +|..++.... ..++...+..++.+++.||.|+|... |+|||+|+.|+||+.+
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d 160 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD 160 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC
Confidence 3 2458999999965 8888887654 45889999999999999999999999 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCc--ccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 221 YNAKLSDFGLARDGPTGDKS--HVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
|.++|+|||+++.+...+.. ...+..+.|.+|.+||.+.|. .|+++.|||.-||++.||+++.+.+.++.......+
T Consensus 161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 99999999999765444322 223445679999999998774 689999999999999999999999987655433222
Q ss_pred hhhhh--------hhhhccccccccc--cccccCCC--------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 298 VEWAK--------PYLTSKRRIFRVL--DPRLEGQF--------SLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 298 ~~~~~--------~~~~~~~~~~~~~--~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
+...- |....- .+.+.+ ++.....+ +....+++.+|+.++|..||.+|+++++++++-
T Consensus 241 Is~LcGs~tkevWP~~d~l-pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNL-PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred HHHHhccCCcccCCCcccc-hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 22110 000000 000111 00000111 112245788999999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=267.47 Aligned_cols=220 Identities=22% Similarity=0.237 Sum_probs=176.9
Q ss_pred cCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEEeecCC
Q 015909 83 GGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPR 162 (398)
Q Consensus 83 G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 162 (398)
|.+|.||++++.. ++..||+|.+.... ....|...+....||||+++++++...+..++||||+++
T Consensus 4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8999999997654 78899999997642 223445555556799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccc
Q 015909 163 GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242 (398)
Q Consensus 163 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~ 242 (398)
++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+......
T Consensus 70 ~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----- 138 (237)
T cd05576 70 GKLWSHISKFL----NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----- 138 (237)
T ss_pred CCHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence 99999987653 4899999999999999999999998 999999999999999999999999987654322
Q ss_pred ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCC
Q 015909 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQ 322 (398)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..|+....... . . .....
T Consensus 139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~------~----~~~~~ 196 (237)
T cd05576 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N------T----HTTLN 196 (237)
T ss_pred cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c------c----ccccC
Confidence 122345778999999988889999999999999999999998875321100 0 0 00001
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCH
Q 015909 323 FSLPQAQKAASLALQCLSVEPKLRPDM 349 (398)
Q Consensus 323 ~~~~~~~~l~~li~~~l~~dP~~Rps~ 349 (398)
.+...+..+.+++.+||+.||++||++
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 222345678999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=272.10 Aligned_cols=268 Identities=27% Similarity=0.419 Sum_probs=200.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcC--CCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQ--LHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~~I~~~~~~~~~~ 150 (398)
..++.++||+|.||.||+|.+ +++.||||++... ....+.+|-+|.+. ++|+||++++++-...
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-----------~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-----------DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred chhhHHHhhcCccceeehhhc-----------cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 345678899999999999976 4689999999753 34566677777666 5799999999876554
Q ss_pred C----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCceecCCCCCCEEEcC
Q 015909 151 D----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-------EPKVIYRDFKASNILLDS 219 (398)
Q Consensus 151 ~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------~~~ivH~Dlkp~Nilv~~ 219 (398)
. .++||++|.+.|+|.+++..+. ++|.....++..++.||+|||+. .++|+|||||.+||||..
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~ 351 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN 351 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence 4 7899999999999999998864 89999999999999999999974 256999999999999999
Q ss_pred CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccC-CCC-----CchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLT-----AKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
++...|+|||+|..+.........-..+||..|||||++.+. ++. .+.||||+|.+||||++...-+.. .+.+
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp 430 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVP 430 (534)
T ss_pred CCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCC
Confidence 999999999999988765544444457899999999999653 222 248999999999999997665532 1111
Q ss_pred Cc-----------chhhhhhhhhhccccccccccccccCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 294 EH-----------NLVEWAKPYLTSKRRIFRVLDPRLEGQF-SLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 294 ~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
+. .-.+-++.....+ ...+.+.... ......-+.+.+..||..||+-|.|+.=+.+.+.++..
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~k-----K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRK-----KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhh-----ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 11 1111111111111 1111111100 11224568899999999999999999999888888877
Q ss_pred Hhhc
Q 015909 362 LRNM 365 (398)
Q Consensus 362 ~~~~ 365 (398)
+...
T Consensus 506 ~~~~ 509 (534)
T KOG3653|consen 506 LWED 509 (534)
T ss_pred cCCc
Confidence 6654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=265.41 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=189.7
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcC-CCCCcccceeeEEEeCCceE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQ-LHHPNLVKLVGYCLEDDHRL 154 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~~I~~~~~~~~~~~~~~ 154 (398)
+..||.|+||+|++-.+ ..+|+..|||.++.... .+.++++.|.+...+ -++|||+++||....++..|
T Consensus 69 lg~iG~G~fG~V~KM~h---------k~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLH---------KPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred HHHhcCCcchhhhhhhc---------CccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 35699999999998644 44899999999986554 445667777775444 57999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 155 LVYEFMPRGSMENHLFR-RGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
+.||.+ ..+|..+... .......+++..+-.|....+.||.||...- .|+|||+||+|||++..|.+||||||++..
T Consensus 140 iCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 140 ICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeecccchHh
Confidence 999999 5566554431 0111145889998899999999999997652 499999999999999999999999999876
Q ss_pred CCCCCCccccccccccccccccccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 234 GPTGDKSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
+... ...+.-.|...|||||.+.. ..|+.++||||||++|||+.||..|+..++.. .+... .+
T Consensus 218 Lv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~-------~V 282 (361)
T KOG1006|consen 218 LVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLC-------QV 282 (361)
T ss_pred HHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHH-------HH
Confidence 4322 12233468889999999843 45899999999999999999999999764321 11110 00
Q ss_pred ccccccccc-CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLE-GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...-.+.+. ..-....+..+..+|.-||.+|-..||.+.+++++
T Consensus 283 v~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 283 VIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 011111111 11224467789999999999999999999998875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.47 Aligned_cols=268 Identities=31% Similarity=0.461 Sum_probs=210.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++..+.+.||+|.||.|++|......... ......||||.++.... .+.+.+..|+++|+.+ .|+||+.+++++.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 344466779999999999999865411100 11367899999975433 4567789999999999 5999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRG---SY-------F--QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~-------~--~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
..+..++|+||+..|+|.+++...+ .. . ..++....+.++.||+.|++||++.. ++||||-.+|||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVL 450 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVL 450 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEE
Confidence 9999999999999999999998776 11 1 13889999999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCccccccccc--ccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG--TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTG 293 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~ 293 (398)
+..+..+||+|||+++.......... ....| ...|||||.+....|+.++||||||++|||+++ |..||.+...
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-- 527 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-- 527 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence 99999999999999997544433221 11122 335999999999999999999999999999999 9999965110
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
..++.+ .+.....-..|..++.++.++++.||+.+|++||++.++.+.|+..
T Consensus 528 ~~~l~~--------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 TEELLE--------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHH--------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111111 1111222234555678999999999999999999999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=265.67 Aligned_cols=272 Identities=28% Similarity=0.426 Sum_probs=206.1
Q ss_pred CCHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcC--CCCCc
Q 015909 62 FSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQ--LHHPN 139 (398)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~~ 139 (398)
.+.--.+...++.++.+.||+|.||.||+|.|+ |+.||||++.... ...+.+|.+|... |+|+|
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHEN 266 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHEN 266 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccch
Confidence 334445677889999999999999999999984 7899999997653 3456677777766 59999
Q ss_pred ccceeeEEEeC----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCceecC
Q 015909 140 LVKLVGYCLED----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA------EPKVIYRD 209 (398)
Q Consensus 140 I~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~ivH~D 209 (398)
|+.+++.-..+ ..+|||.+|.+.|+|.|++.+. .++....++++..++.||+|||.. .+.|.|||
T Consensus 267 ILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 267 ILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred hhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 99999876544 3578999999999999999884 489999999999999999999953 35699999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcCCCCCC--CcccccccccccccccccccccCC----C-C-CchhHHHHHHHHHHHHh
Q 015909 210 FKASNILLDSNYNAKLSDFGLARDGPTGD--KSHVSTRVMGTYGYAAPEYLATGH----L-T-AKSDIYSFGVVLLEILS 281 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DvwslG~~l~ell~ 281 (398)
||..||||..++.+-|+|+|+|....... .....+..+||..|||||++...- + + ..+||||||.++||+.-
T Consensus 342 lKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 342 LKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred cccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99999999999999999999998654432 112234578999999999995421 1 2 24899999999999875
Q ss_pred C----------CCCCCCCCCCCCcchhhhhhhhhhcccc--ccccccccc-cCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 015909 282 G----------RRAIDKNRPTGEHNLVEWAKPYLTSKRR--IFRVLDPRL-EGQFSLPQAQKAASLALQCLSVEPKLRPD 348 (398)
Q Consensus 282 g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps 348 (398)
. ++||.+..+.+- -+.+.+. ..+.+.|.+ +...+.+.-..+.++++.||..+|.-|.|
T Consensus 422 Rc~~ggi~eey~~Pyyd~Vp~DP---------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 422 RCESGGIVEEYQLPYYDVVPSDP---------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred HhhcCCEehhhcCCcccCCCCCC---------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence 3 346654322211 0111111 112222222 22334455677889999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 015909 349 MDEVVKELEQLQE 361 (398)
Q Consensus 349 ~~ell~~L~~l~~ 361 (398)
+-.+.+.|.++.+
T Consensus 493 ALriKKtl~~l~~ 505 (513)
T KOG2052|consen 493 ALRIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHHHHhc
Confidence 9999999988875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=278.54 Aligned_cols=242 Identities=26% Similarity=0.378 Sum_probs=191.3
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccch---HHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
|..++-||-|+||.|.+++-.+ +...||+|.+++.++..+ ..+..|-.||..-.++-||++|-.|.+.
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred eEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 4556779999999999985433 688999999987655333 3457799999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+++|+||+|++||++-.++.+.+- +.+..+..++..+.+|+++.|..| +|||||||+|||||.+|++||+|||+
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccc
Confidence 999999999999999999998864 788899999999999999999999 99999999999999999999999999
Q ss_pred CcCC---------CCCCCcc-------------------------------cccccccccccccccccccCCCCCchhHH
Q 015909 231 ARDG---------PTGDKSH-------------------------------VSTRVMGTYGYAAPEYLATGHLTAKSDIY 270 (398)
Q Consensus 231 a~~~---------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 270 (398)
++-+ ..++... ..-.++||+.|+|||++....|+..+|+|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 8632 1111000 00126899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCc-chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCC
Q 015909 271 SFGVVLLEILSGRRAIDKNRPTGEH-NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR 346 (398)
Q Consensus 271 slG~~l~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 346 (398)
|.|+|||||+.|++||....+.+.+ .+.+|-. .++- .+-...+.++.++|.+++. +++.|
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-----------~l~~----~~~~~ls~e~~~li~kLc~-sad~R 916 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRN-----------FLHI----PYQGNLSKEALDLIQKLCC-SADSR 916 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-----------cccc----ccccccCHHHHHHHHHHhc-Chhhh
Confidence 9999999999999999887766543 2233322 1111 1222345677777777553 45555
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=286.77 Aligned_cols=267 Identities=21% Similarity=0.259 Sum_probs=171.0
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeE---
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGY--- 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~--- 146 (398)
..++|.+.++||+|+||.||+|++..+. ...+..||+|.+..... .+....| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~-----~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ-----SKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCc-----cccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 4468999999999999999999876511 12378999998764321 1111111 1222222222222221
Q ss_pred ---EEeCCceEEEEeecCCCCHHHHHhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015909 147 ---CLEDDHRLLVYEFMPRGSMENHLFRRGSY----------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIY 207 (398)
Q Consensus 147 ---~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH 207 (398)
.......++|+||+++++|.+++...... ........+..++.||+.||.|||+++ |+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 23456789999999999999998754210 001123446689999999999999998 999
Q ss_pred cCCCCCCEEEcC-CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccC----------------------CCC
Q 015909 208 RDFKASNILLDS-NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG----------------------HLT 264 (398)
Q Consensus 208 ~Dlkp~Nilv~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 264 (398)
|||||+|||++. ++.+||+|||+++...... ........+++.|+|||.+... .+.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999999985 6899999999997643322 1223456789999999976332 234
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCC-------CCCcchhhhhhhhhhccccccccccccccCCC--CHHHHHHHHHHH
Q 015909 265 AKSDIYSFGVVLLEILSGRRAIDKNRP-------TGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQF--SLPQAQKAASLA 335 (398)
Q Consensus 265 ~~~DvwslG~~l~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 335 (398)
.++|||||||++|||+++..+++.... ....+...|....... ..+.+...+ .........+||
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-------ASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-------cchhhhhhhhhccccchHHHHHH
Confidence 456999999999999997766432100 0000111111100000 000000000 001123456899
Q ss_pred HHhccCCCCCCCCHHHHHHH
Q 015909 336 LQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 336 ~~~l~~dP~~Rps~~ell~~ 355 (398)
.+||+.||++|||+.++++|
T Consensus 431 ~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHccCCcccCCCHHHHhCC
Confidence 99999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=254.50 Aligned_cols=239 Identities=32% Similarity=0.458 Sum_probs=193.0
Q ss_pred CCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc-hHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEEeecCC
Q 015909 84 GFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPR 162 (398)
Q Consensus 84 ~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 162 (398)
+||.||+|.+.. ++..+++|.+....... .+.+.+|+..++.++|+||+++++.+......++++|++++
T Consensus 1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 589999997754 68899999997665444 67889999999999999999999999999999999999998
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccc
Q 015909 163 GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242 (398)
Q Consensus 163 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~ 242 (398)
++|.+++.... .++...++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 72 ~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 72 GDLFDLLKKRG----RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred CCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence 89999987653 2789999999999999999999998 9999999999999999999999999998754432 2
Q ss_pred ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCC
Q 015909 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQ 322 (398)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.....++..|++||.+.+..++.++|+|+||+++++|++|..||...... ....... .. ......
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~----~~---------~~~~~~ 207 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI----GK---------PKPPFP 207 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH----hc---------cCCCCc
Confidence 23456788999999998888999999999999999999999998642111 0010000 00 000000
Q ss_pred CCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 323 FSL-PQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 323 ~~~-~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ..+.++.+++.+||..+|++||++.+++++
T Consensus 208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred cccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 000 045688999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=284.45 Aligned_cols=246 Identities=30% Similarity=0.441 Sum_probs=187.4
Q ss_pred CCceecccCCce-EEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEEeCCce
Q 015909 76 PDSVLGEGGFGS-VFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 76 ~~~~lg~G~~g~-Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~~~~ 153 (398)
-.+++|.|+.|+ ||+|.+ .++.||||.+-.+.. ..+.+|+..|+.- .||||+++++.-.+.+..
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-----------e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~ 578 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-----------EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFL 578 (903)
T ss_pred cHHHcccCCCCcEEEEEee-----------CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence 346789999876 899987 578999998865432 3457899999987 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-----CCCEEEeec
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-----NYNAKLSDF 228 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-----~~~~kl~Df 228 (398)
||..|.| ..+|.+++...+...........+.++.|++.||++||+.+ ||||||||.||||+. ..+++|+||
T Consensus 579 YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf 655 (903)
T KOG1027|consen 579 YIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF 655 (903)
T ss_pred EEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence 9999999 67999999874221111222445778999999999999998 999999999999975 257899999
Q ss_pred cCCcCCCCCCCcc-cccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 229 GLARDGPTGDKSH-VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 229 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|+++....+..+- ......||-+|+|||++....-..++|||||||++|+.++ |..||.+.-.... .++.
T Consensus 656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~ 727 (903)
T KOG1027|consen 656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILT 727 (903)
T ss_pred ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhc
Confidence 9999875543322 2345679999999999999888889999999999999999 5999975322111 0111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....+..+- +.. ..++.+||.+|++.+|..||++.+++.|
T Consensus 728 ~~~~L~~L~--------~~~-d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 728 GNYTLVHLE--------PLP-DCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred Cccceeeec--------cCc-hHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111111110 001 1178999999999999999999999865
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=271.60 Aligned_cols=272 Identities=19% Similarity=0.251 Sum_probs=183.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcc-------cccCCCCCcEEEEEEcccCCccchH--------------HHHHH
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSL-------ASTRPGTGMLIAVKRLNQEGFQGHK--------------EWLTE 128 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-------~~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~E 128 (398)
..++|++.++||+|+||+||+|.+..... .......+..||||.+........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 35689999999999999999997532110 0112235678999998654322222 23446
Q ss_pred HHHHcCCCCCcc-----cceeeEEEe--------CCceEEEEeecCCCCHHHHHhhcCCC--------------------
Q 015909 129 INYLGQLHHPNL-----VKLVGYCLE--------DDHRLLVYEFMPRGSMENHLFRRGSY-------------------- 175 (398)
Q Consensus 129 ~~~l~~l~h~~I-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------- 175 (398)
+.++.+++|.++ +++++++.. ....++||||+++++|.+++......
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 566666543 35679999999999999998743210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccc
Q 015909 176 FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAP 255 (398)
Q Consensus 176 ~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 255 (398)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.++|+|||++......... ......+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 123466788899999999999999998 999999999999999999999999999764332211 11122357899999
Q ss_pred cccccCC--------------------CC--CchhHHHHHHHHHHHHhCCC-CCCCCCCCC------Ccchhhhhhhhhh
Q 015909 256 EYLATGH--------------------LT--AKSDIYSFGVVLLEILSGRR-AIDKNRPTG------EHNLVEWAKPYLT 306 (398)
Q Consensus 256 E~~~~~~--------------------~~--~~~DvwslG~~l~ell~g~~-p~~~~~~~~------~~~~~~~~~~~~~ 306 (398)
|.+.... ++ ...|+||+||++|+|++|.. ||....... ..+...|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~---- 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM---- 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh----
Confidence 9885432 11 24699999999999999875 664321110 001111100
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEP---KLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~ell~~ 355 (398)
..............+....+|+.+||..+| .+|+|++|+|+|
T Consensus 456 -------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 -------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000001111112346788999999999866 689999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=237.31 Aligned_cols=204 Identities=26% Similarity=0.344 Sum_probs=166.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCC-CCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL-HHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~ 149 (398)
+...-+..||+|++|.|=+-++. .+|...|+|.+... +.+..++.++|+.+..+. .+|+++.+||.+..
T Consensus 46 d~L~~i~elGrGayG~vekmrh~---------~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHI---------QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred hhhhhhhhhcCCccchhhheeec---------cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 33444567999999998775443 48999999999754 234456678888876665 69999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....|+.||.+ ..+|..+...--.....+++..+-+|+..+++||.|||++- .++|||+||+|||++..|+||+||||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccc
Confidence 99999999999 55777776554444577999999999999999999999873 59999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT----GHLTAKSDIYSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~p~~~~ 289 (398)
.+..+.+.- ..+...|...|||||.+.. ..|+.++||||||++++||.+++.||+.+
T Consensus 195 IsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 195 ISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 987754322 1222457888999998843 47899999999999999999999999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=239.52 Aligned_cols=262 Identities=18% Similarity=0.261 Sum_probs=195.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~ 148 (398)
..++|++.+.+|+|.++.||.|... .+++.++||+++.. ..+.+.+|+.||..|. ||||++++++..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~---------~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINI---------TNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccccc---------CCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 3467899999999999999999643 37889999999753 2467889999999997 999999999987
Q ss_pred eC--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc-CCCCEEE
Q 015909 149 ED--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD-SNYNAKL 225 (398)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-~~~~~kl 225 (398)
+. ....+|+||++..+...+. +.++.-.+..++.+++.||.|+|+.| |+|||+||.|++|+ ..-.++|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred CccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeee
Confidence 64 4567999999877765554 34777888999999999999999999 99999999999998 4567999
Q ss_pred eeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC----------
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE---------- 294 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~---------- 294 (398)
+|||+|....++... +-.+.+..|..||++.. ..|+.+-|+|||||+|..|+..+.||-.....-+
T Consensus 175 IDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred eecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 999999987665433 22456788999999865 5688899999999999999999999855432211
Q ss_pred -cchhhhhhhhhhc-ccccccccc--------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 295 -HNLVEWAKPYLTS-KRRIFRVLD--------PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 295 -~~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.++..+...+... ......++. .........-.++++.+|+.++|..|-.+|+|++|.+.|
T Consensus 252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111121111100 000000000 000111111125788999999999999999999999876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=254.11 Aligned_cols=268 Identities=25% Similarity=0.384 Sum_probs=198.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEccc--CCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ--EGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
+.+..+.||-|+||.||.+ .++.+|+.|++|++.. ......+.+.+|+++|..++|.|++..+++....
T Consensus 54 Di~PDRPIGYGAFGVVWsV---------TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp 124 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSV---------TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA 124 (449)
T ss_pred cCCCCCcccccceeEEEec---------cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence 3455688999999999986 4455899999998853 2334457788999999999999999998877543
Q ss_pred -----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 151 -----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 151 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
.++|+++|.+ ..+|..+|..- +.++...+.-++.||+.||+|||+.+ |.||||||.|+||+.+..+||
T Consensus 125 h~dfFqEiYV~TELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKI 197 (449)
T KOG0664|consen 125 NPSFFQELYVLTELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKI 197 (449)
T ss_pred CchHHHHHHHHHHHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEe
Confidence 3467888888 55777776544 56888999999999999999999999 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh--h
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA--K 302 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~--~ 302 (398)
||||+++.....+ ...++..+-|.+|.|||++.|. .|+.+.||||+||++.||+..+..|..-.+....+++.-. .
T Consensus 198 CDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT 276 (449)
T KOG0664|consen 198 CDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT 276 (449)
T ss_pred cccccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence 9999998754433 3334556679999999999885 6899999999999999999999999765554333332110 0
Q ss_pred hhhhcc--------cc-cccccc-ccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 303 PYLTSK--------RR-IFRVLD-PRLEG----QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 303 ~~~~~~--------~~-~~~~~~-~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
+-++.. .. +..... +.+.. ..+.....+...++.++|..||+.|.+..+.+.++.
T Consensus 277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000 00 000000 00000 011123456778999999999999999999888754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=245.89 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=198.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC--CccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE--GFQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..+|..++.+|.|.- .|..|.+. ..+..|++|++... .....+...+|..++..++|+||++++.+|.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~---------v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQ---------VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchh---------hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 457888889999998 66665443 37889999988654 3345677889999999999999999999986
Q ss_pred eC------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 ED------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
-. ..+|+|||++ ..+|...+... ++-+.+..++.|++.|++|||+.+ |+||||||+||+|..++.
T Consensus 86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~ 156 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCT 156 (369)
T ss_pred ccccHHHHHhHHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhh
Confidence 54 4579999999 67998888733 678899999999999999999999 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+||.|||+++..... -..+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+.+ .+.+|.+
T Consensus 157 lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~k 228 (369)
T KOG0665|consen 157 LKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNK 228 (369)
T ss_pred eeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHH
Confidence 999999999864332 24556788999999999999889999999999999999999999997532 2222211
Q ss_pred ---------------------hhhhcccc-----cccccc-ccc--cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 015909 303 ---------------------PYLTSKRR-----IFRVLD-PRL--EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVV 353 (398)
Q Consensus 303 ---------------------~~~~~~~~-----~~~~~~-~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 353 (398)
.+...... ..+.+. ..+ ..+.+.-....+++++.+||..||++|.|++++|
T Consensus 229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 11110000 000000 000 0011122356789999999999999999999999
Q ss_pred HH
Q 015909 354 KE 355 (398)
Q Consensus 354 ~~ 355 (398)
+|
T Consensus 309 ~H 310 (369)
T KOG0665|consen 309 RH 310 (369)
T ss_pred cC
Confidence 87
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=262.89 Aligned_cols=210 Identities=22% Similarity=0.263 Sum_probs=175.8
Q ss_pred CCHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCC----
Q 015909 62 FSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH---- 137 (398)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---- 137 (398)
|.+...+..-.+|.+..-.|+|-|++|.+|.+.. .|..||||++..... ..+.=+.|+++|++|+.
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPE 491 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCch
Confidence 4444555666889999999999999999996654 567999999975422 23445789999999963
Q ss_pred --CcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 138 --PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 138 --~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
-|++.++..|...+++|||+|.+ ..+|.+++.+.+.. -.|....+..++.|+..||..|-..+ |+|.||||+||
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNi 567 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNI 567 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccce
Confidence 48999999999999999999998 77999999988764 45788899999999999999999998 99999999999
Q ss_pred EEcCC-CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015909 216 LLDSN-YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 216 lv~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~ 289 (398)
||++. ..+||||||.|......... .+..+.-|.|||++.|.+|+...|+||+||+||||.||+..|.+.
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred EeccCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 99854 56899999999876544322 233456799999999999999999999999999999999999764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=237.04 Aligned_cols=271 Identities=25% Similarity=0.366 Sum_probs=200.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeE-E
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGY-C 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~-~ 147 (398)
..+.|.+.+.||+|.||.+-+|.++. ++..+++|.+.... ....+|.+|...--.| .|.||+..|++ |
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~---------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQ---------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccC---------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 34678899999999999999986654 78899999997654 3457788998876666 48999988775 5
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc--CCCCEEE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD--SNYNAKL 225 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~--~~~~~kl 225 (398)
...+.+++++||++.|+|.+.+...+ +.+.....++.|++.|+.|||+.+ +||||||.+||||- +..+|||
T Consensus 92 qt~d~YvF~qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 92 QTSDAYVFVQEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred hcCceEEEeeccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEe
Confidence 66778889999999999999887754 788888999999999999999999 99999999999994 4568999
Q ss_pred eeccCCcCCCCCCCccccccccccccccccccccc---C--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT---G--HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
||||.++..... ......+..|.+||+... + ...+.+|+|.||+++|.+++|.+||. ....++..+.+|
T Consensus 165 cDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~ 238 (378)
T KOG1345|consen 165 CDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEW 238 (378)
T ss_pred eecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHH
Confidence 999998763221 122345677999997743 2 24677999999999999999999998 444455555555
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH--HHHhhccCCchhh
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL--QELRNMHKRPQKE 372 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l--~~~~~~~~~~~~~ 372 (398)
.+........+.+. + ...++.+..+.++-|..++++|--+.+..+....+ ..+.++.++++..
T Consensus 239 ~~w~~rk~~~~P~~--------F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~ 303 (378)
T KOG1345|consen 239 EQWLKRKNPALPKK--------F-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEED 303 (378)
T ss_pred HHHhcccCccCchh--------h-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhc
Confidence 54322221111111 1 13356788999999999999995554444443332 3444555555544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=261.84 Aligned_cols=197 Identities=26% Similarity=0.352 Sum_probs=170.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--------chHHHHHHHHHHcCCC---CCcc
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--------GHKEWLTEINYLGQLH---HPNL 140 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~~I 140 (398)
.+|...+.+|+|+||.|++|.+++ +...|++|.+.++..- ..-.+-.|+.||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~---------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE---------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEeeecc---------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 468889999999999999998776 5778999998765321 1122456999999997 9999
Q ss_pred cceeeEEEeCCceEEEEeec-CCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC
Q 015909 141 VKLVGYCLEDDHRLLVYEFM-PRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219 (398)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~ 219 (398)
++++++|.+++.+||+||.. ++.+|.++|..+. .+++.....|+.||+.|+++||+.| |||||||-+||.|+.
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDS 705 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEec
Confidence 99999999999999999975 3668999998764 5899999999999999999999999 999999999999999
Q ss_pred CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCC-chhHHHHHHHHHHHHhCCCCCC
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTA-KSDIYSFGVVLLEILSGRRAID 287 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~~l~ell~g~~p~~ 287 (398)
+|.+||+|||.+.....+ ....++||..|.|||++.|..|-- .-|||+||++||.++....||.
T Consensus 706 ~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999998765433 355688999999999999988754 5899999999999999888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=266.90 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=208.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|.+...+|.|+||.||+|++.. +++..|+|.++.+.-....-+..|+-+++..+||||+.+++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 4578899999999999999997654 8999999999987777777788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..|+.||||.+|+|.+..+.-+ ++++.++..+.+..+.+++|||+.+ -+|||||-.||++++.|.+|++|||.
T Consensus 85 dklwicMEycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred cCcEEEEEecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCc
Confidence 99999999999999999887664 6899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccccccccccccccccccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYL---ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+-.+...- .....+.||++|||||+. +.+.|...+|||++|++..|+-.-++|..+..+. ...++..
T Consensus 159 saqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--------r~l~LmT 228 (829)
T KOG0576|consen 159 SAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--------RALFLMT 228 (829)
T ss_pred hhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--------HHHHHhh
Confidence 86643321 123457899999999986 4578999999999999999998888875433222 1112222
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+.. +.+ .........+..+.+|++.+|.++|++||+++.+|.|
T Consensus 229 kS~----~qp-p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 229 KSG----FQP-PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccC----CCC-CcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111 111 1112233456778899999999999999999988764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=227.08 Aligned_cols=212 Identities=39% Similarity=0.594 Sum_probs=183.1
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEEe
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYE 158 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 158 (398)
||+|.+|.||++.... ++..+++|.+...... ....+.+|+..++.+.|++|+++++++......++++|
T Consensus 1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 6899999999997643 5889999999765432 34678899999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-CCCEEEeeccCCcCCCCC
Q 015909 159 FMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLSDFGLARDGPTG 237 (398)
Q Consensus 159 ~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-~~~~kl~Dfg~a~~~~~~ 237 (398)
++++++|.+++.... ..++...+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 72 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 72 YCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred cCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 999899999988653 35789999999999999999999998 999999999999998 899999999998765433
Q ss_pred CCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccccc
Q 015909 238 DKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316 (398)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (398)
.. ......+...|++||.+... .++.++|+|+||+++++|
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------- 187 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------- 187 (215)
T ss_pred cc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence 21 12234578889999999877 788899999999999998
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 317 PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
..+.+++.+|++.||.+||++.++++++
T Consensus 188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3577999999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=237.87 Aligned_cols=274 Identities=26% Similarity=0.346 Sum_probs=201.1
Q ss_pred HHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccce
Q 015909 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKL 143 (398)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~ 143 (398)
+.+....+.|+.+.+||+|.|++||+|.+.. +...+..||+|.+... .....+.+|+++|..+. +.||+++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~------~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~ 100 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIE------QDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKL 100 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhh------hccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcc
Confidence 3456677889999999999999999997654 1346789999999765 33466889999999995 9999999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc-CCCC
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD-SNYN 222 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-~~~~ 222 (398)
.+.+...+...+||||++.....++... ++...+..++..++.||.++|.+| ||||||||.|+|.+ ..++
T Consensus 101 ~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 101 NGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred hhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCC
Confidence 9999999999999999999998888754 677889999999999999999999 99999999999997 5678
Q ss_pred EEEeeccCCcCCCCC-------C-------C---c-----------------c--------ccccccccccccccccccc
Q 015909 223 AKLSDFGLARDGPTG-------D-------K---S-----------------H--------VSTRVMGTYGYAAPEYLAT 260 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~-------~-------~---~-----------------~--------~~~~~~gt~~y~aPE~~~~ 260 (398)
-.|+|||+|...... . . . . ......||++|.|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 999999998721000 0 0 0 0 0012469999999999865
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc-----------chhh----------hhhhh---hhccccccccc
Q 015909 261 -GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH-----------NLVE----------WAKPY---LTSKRRIFRVL 315 (398)
Q Consensus 261 -~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-----------~~~~----------~~~~~---~~~~~~~~~~~ 315 (398)
...+++.||||.|+|+..+++++.||-.....-.. .+.. |.+.. ......-++.+
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 56788999999999999999999998543221100 0000 00000 00000000001
Q ss_pred --ccccc--------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 316 --DPRLE--------GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 316 --~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... .......+..+.+|+.+||..||.+|.|+++.|+|
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00000 11112224578999999999999999999999976
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=223.08 Aligned_cols=200 Identities=36% Similarity=0.481 Sum_probs=172.7
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeCCc
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~ 152 (398)
|.+.+.||.|++|.||+|.... ++..+++|.+...... ..+.+.+|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5677899999999999997654 5789999999866544 56788899999999999999999999998899
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
.++++|++++++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 9999999999999999986542 1788999999999999999999998 9999999999999999999999999988
Q ss_pred CCCCCCCccccccccccccccccccc-ccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYL-ATGHLTAKSDIYSFGVVLLEILSGRRAIDK 288 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g~~p~~~ 288 (398)
....... .......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 7544321 122335678889999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=213.76 Aligned_cols=263 Identities=17% Similarity=0.225 Sum_probs=207.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~ 149 (398)
+-.|++++.||+|.||..+.|..- -+++.||||.-... ....++..|.+..+.|. .++|..++-+..+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl---------~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqe 95 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNL---------YNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE 95 (449)
T ss_pred cccceeccccccCcceeeeccccc---------ccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccc
Confidence 346999999999999999999543 37999999987544 33466778888888884 7999999988888
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-----CCCEE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-----NYNAK 224 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-----~~~~k 224 (398)
..+..||||++ |.+|+|++.-++ ..++.+++..++.|++.-++|+|+++ +|+|||||+|+||.. ...+.
T Consensus 96 G~~NiLVidLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~Ih 169 (449)
T KOG1165|consen 96 GKYNILVIDLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIH 169 (449)
T ss_pred cchhhhhhhhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEE
Confidence 99999999999 899999999887 46899999999999999999999999 999999999999963 34699
Q ss_pred EeeccCCcCCCCCCCcc-----cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 225 LSDFGLARDGPTGDKSH-----VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
|+|||+|+.+.+..... ....+.||..||+-....|...+.+.|+-|||-+++++|-|..||.+........-.
T Consensus 170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY- 248 (449)
T KOG1165|consen 170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY- 248 (449)
T ss_pred EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH-
Confidence 99999999876554322 123478999999999999999999999999999999999999999875332221111
Q ss_pred hhhhhhhcccccccccccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 300 WAKPYLTSKRRIFRVLDPRLE---GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
.++-+.... ...-...+.++..-+.-.-..+-.+-|+.+-+...+..+.+..
T Consensus 249 ------------eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 249 ------------EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ------------HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 111111100 0111123567777777777888888899999988888876543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=261.29 Aligned_cols=197 Identities=22% Similarity=0.275 Sum_probs=138.8
Q ss_pred CCCC-CcccceeeEE-------EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 015909 134 QLHH-PNLVKLVGYC-------LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKV 205 (398)
Q Consensus 134 ~l~h-~~I~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~i 205 (398)
.+.| .||+.+++++ .....+++++|++ +++|.+++.... ..+++..++.++.||+.||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g--I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG--I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 3445 5777777776 2335678889987 679999997532 45899999999999999999999998 9
Q ss_pred eecCCCCCCEEEcCCCC-------------------EEEeeccCCcCCCCCCC--------------ccccccccccccc
Q 015909 206 IYRDFKASNILLDSNYN-------------------AKLSDFGLARDGPTGDK--------------SHVSTRVMGTYGY 252 (398)
Q Consensus 206 vH~Dlkp~Nilv~~~~~-------------------~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y 252 (398)
+||||||+||||+..+. +||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 55555555543110000 0001124588999
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHH
Q 015909 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAA 332 (398)
Q Consensus 253 ~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 332 (398)
||||++.+..++.++|||||||+||||++|.+|+..... . ..... ...+.+. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~---~~~~~------~~~~~~~-----~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----T---MSSLR------HRVLPPQ-----ILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----H---HHHHH------HhhcChh-----hhhcCHHHH
Confidence 999999999999999999999999999999888642110 0 00000 0001000 011123456
Q ss_pred HHHHHhccCCCCCCCCHHHHHHH
Q 015909 333 SLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 333 ~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.++.+||+.||.+||++.+++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 88999999999999999999865
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=219.38 Aligned_cols=265 Identities=23% Similarity=0.236 Sum_probs=200.4
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCC----CcccceeeEE-
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH----PNLVKLVGYC- 147 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~~I~~~~~~~- 147 (398)
+|++.+.||+|+||.||.|..... ....+|+|............+..|..++..+.. +++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~--------~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSE--------KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCC--------CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 799999999999999999976541 145788888865433322367788888888863 6899999998
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC-----CC
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-----YN 222 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~-----~~ 222 (398)
......++||+.+ |.+|.++..... .+.++..++..++.|++.+|++||+.| ++||||||.|+++... ..
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccce
Confidence 4777889999998 899999887665 367999999999999999999999999 9999999999999754 46
Q ss_pred EEEeeccCCc--CCCCCCCc----c-c-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 015909 223 AKLSDFGLAR--DGPTGDKS----H-V-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE 294 (398)
Q Consensus 223 ~kl~Dfg~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~ 294 (398)
+.|.|||+++ ........ . . .....||..|+++++..+...+.+.|+||++.++.+|+.|..||........
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 9999999998 32222211 1 1 1235699999999999999999999999999999999999999965433222
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
.... .. ... ...........+.++.++...+-..+..++|....+...|.......
T Consensus 246 ~~~~--~~-~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 KSKF--EK-DPR----------KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHH--HH-Hhh----------hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1100 00 000 00000012223456677777777799999999999999988776655
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=202.29 Aligned_cols=170 Identities=24% Similarity=0.221 Sum_probs=128.2
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccc
Q 015909 163 GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242 (398)
Q Consensus 163 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~ 242 (398)
|+|.+++...+ ..+++..++.++.||+.||.|||+++ ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997654 46899999999999999999999875 999999999999999 99987643321
Q ss_pred ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCC
Q 015909 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQ 322 (398)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............ . .+ ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~---~-~~-~~~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNGMPA---D-DP-RDRS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHHhcc---C-Cc-cccc
Confidence 258999999999999999999999999999999999999996432211 001111100000 0 00 0001
Q ss_pred CCHHHHH--HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 323 FSLPQAQ--KAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 323 ~~~~~~~--~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
....... ++.+++.+||+.||.+||++.++++++..+...
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 1222333 689999999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=197.81 Aligned_cols=264 Identities=19% Similarity=0.210 Sum_probs=201.2
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCC-CcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH-PNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~I~~~~~~~~ 148 (398)
....|++++.||.|+||.+|.|..- .+|..||||+-.... ...++..|..+.+.|++ ..|..+..++.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i---------~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISI---------TSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeeeeec---------cCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 4578999999999999999999654 389999999876542 23467788899888874 67777777888
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc---CCCCEEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD---SNYNAKL 225 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~---~~~~~kl 225 (398)
+.....+||+.+ |.+|.+++.-.. ..++..+++-++-|++.-++|+|.++ ++||||||+|+|+. ....+.|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEE
Confidence 888899999998 889999998765 45899999999999999999999998 99999999999996 3457999
Q ss_pred eeccCCcCCCCCCCc-----ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 226 SDFGLARDGPTGDKS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
+|||+|+.+.+.... .....+.||..|.+-....+...+.+.|+-|+|.+|.++.-|..||.+..........+.
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 999999876543322 123357899999999988888889999999999999999999999987544322211111
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.. +.+. ......+.. ..|.++.-.+.-|-..-=++-|+..-+-+.+.-|.
T Consensus 236 I~---EkK~---s~~ie~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 236 IS---EKKM---STPIEVLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HH---Hhhc---CCCHHHHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 00 0000 000001111 12456667778888888888899888877776664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=211.47 Aligned_cols=171 Identities=20% Similarity=0.132 Sum_probs=130.0
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-----ccchHHHHHHHHHHcCCCCCcc
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-----FQGHKEWLTEINYLGQLHHPNL 140 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~I 140 (398)
.+.....+|.+.++||+|+||+||+|.+.. .++..||+|.+.... ......+.+|+++|+.++|+||
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~--------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~i 83 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAG--------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGV 83 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcC--------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCC
Confidence 445567889999999999999999997643 146678999865321 1124568899999999999999
Q ss_pred cceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCC-CCCCEEEcC
Q 015909 141 VKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDF-KASNILLDS 219 (398)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dl-kp~Nilv~~ 219 (398)
++.+.. .+..++||||++|++|.. +.. .. ...++.+++.+|.|||+++ |+|||| ||+|||++.
T Consensus 84 v~~l~~---~~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~ 147 (365)
T PRK09188 84 VPQLLA---TGKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGP 147 (365)
T ss_pred CcEEEE---cCCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcC
Confidence 863322 246799999999999962 211 11 1357889999999999998 999999 999999999
Q ss_pred CCCEEEeeccCCcCCCCCCCccc------cccccccccccccccccc
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHV------STRVMGTYGYAAPEYLAT 260 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 260 (398)
++.++|+|||+|+.......... .....+++.|+|||.+..
T Consensus 148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999999999987644321111 124578889999999854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=229.61 Aligned_cols=256 Identities=21% Similarity=0.284 Sum_probs=186.8
Q ss_pred CCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcc-----cCCccc-hHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 75 RPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN-----QEGFQG-HKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
....++|.|++|.|+.+.... .......|.+. ...... ...+..|+.+-..|.|+|++..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~---------~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRS---------DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecC---------CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 456789999999777664332 12222222221 111111 112567888888899999988877776
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.....-.||||++ +|..++...+ .+....+..++.|++.|+.|||+.| |.|||||++|+++..+|.+||+||
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Df 464 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDF 464 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeec
Confidence 66666666999998 9999988753 3777888999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCc--ccccccccccccccccccccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKS--HVSTRVMGTYGYAAPEYLATGHLTAK-SDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|.+..+...... ......+|+..|+|||++.+..|.+. .||||.|++++.|.+|+.||........... .
T Consensus 465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------~ 537 (601)
T KOG0590|consen 465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------T 537 (601)
T ss_pred CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-------h
Confidence 999876554444 45566889999999999999999876 8999999999999999999976433322110 0
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........... -........+...+.+|.+||+.||.+|.|+++|++.
T Consensus 538 ~~~~~~~~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 538 NNYSDQRNIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hcccccccccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00000000000 0111223346778899999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-23 Score=194.34 Aligned_cols=261 Identities=32% Similarity=0.447 Sum_probs=196.4
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCC-cccceeeEEEe
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHP-NLVKLVGYCLE 149 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-~I~~~~~~~~~ 149 (398)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 677889999999999999653 67889988765433 366789999999999988 79999999977
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-CEEEeec
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKLSDF 228 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-~~kl~Df 228 (398)
....+++++++.++++.+++...... ..+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEecc
Confidence 77789999999999999666654321 25888999999999999999999999 99999999999999888 7999999
Q ss_pred cCCcCCCCCCCcc----ccccccccccccccccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC-CCcchhhh
Q 015909 229 GLARDGPTGDKSH----VSTRVMGTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT-GEHNLVEW 300 (398)
Q Consensus 229 g~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~-~~~~~~~~ 300 (398)
|.+.......... ......|+..|++||.+.+ ..++...|+|++|++++++++|..||...... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9987544333221 2355789999999999987 57888999999999999999999997654321 00011000
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ...... .................+.+++..++..+|..|.+..+....
T Consensus 227 ~---~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 I---LELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred H---HhcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000 000000000002223578899999999999999999887776
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-24 Score=184.80 Aligned_cols=173 Identities=13% Similarity=0.075 Sum_probs=132.4
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHH---------HHHHHHHHcCCCCC
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---------WLTEINYLGQLHHP 138 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~ 138 (398)
....++|++.++||.|+||.||++.. ++..+|+|.+.......... +.+|+..+.++.|+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~ 95 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE 95 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence 34578999999999999999998632 25579999997543322222 57899999999999
Q ss_pred cccceeeEEEeC--------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCC
Q 015909 139 NLVKLVGYCLED--------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDF 210 (398)
Q Consensus 139 ~I~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dl 210 (398)
+|..+.+++... ...+++|||++|.+|.++.. ++.. ...+++.+|..||..| ++|||+
T Consensus 96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~~----~~~~i~~~l~~lH~~g--i~H~Di 161 (232)
T PRK10359 96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISED----VKAKIKASIESLHQHG--MVSGDP 161 (232)
T ss_pred CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccHH----HHHHHHHHHHHHHHcC--CccCCC
Confidence 999998886643 35789999999999987631 2322 4568999999999999 999999
Q ss_pred CCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHH
Q 015909 211 KASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEIL 280 (398)
Q Consensus 211 kp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 280 (398)
+|.||+++.+| ++|+|||............ ..+....|..++|+|+||+++..+.
T Consensus 162 kp~Nili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 162 HKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ChHHEEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 99999999888 9999999886542211110 0233455677899999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-24 Score=213.99 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=179.5
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-c---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-F---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
+|...+.||.+.|=+|.+|.+++ |. |++|++-+.. . ....+.+.|++ ...+++||.+++..+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 57778999999999999987643 44 8899885432 2 33344455665 56678999999988878
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.+...|+|-+|. ..+|+|.+..+ +-+...+.+.|+.|++.||..+|..| |+|||||.+||||+.-+-+.|+||
T Consensus 92 t~kAAylvRqyv-khnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDF 164 (1431)
T KOG1240|consen 92 TDKAAYLVRQYV-KHNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDF 164 (1431)
T ss_pred hhHHHHHHHHHH-hhhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcc
Confidence 888889999998 55999988765 34777888899999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCC-CC----cccccccccccccccccccccC----------C-CCCchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 015909 229 GLARDGPTG-DK----SHVSTRVMGTYGYAAPEYLATG----------H-LTAKSDIYSFGVVLLEILS-GRRAIDKNRP 291 (398)
Q Consensus 229 g~a~~~~~~-~~----~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~ell~-g~~p~~~~~~ 291 (398)
..-+..... +. ...+.+...-.+|.|||.+... . .+++.||||+||++.||++ |++||.-.
T Consensus 165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-- 242 (1431)
T KOG1240|consen 165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-- 242 (1431)
T ss_pred cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--
Confidence 876532221 11 1122223344589999987431 1 5678999999999999988 89888521
Q ss_pred CCCcchhhhhhh-hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 292 TGEHNLVEWAKP-YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 292 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+..|... .......+.++ .+..++.+|..|++.||.+|.++++.|+.
T Consensus 243 ----QL~aYr~~~~~~~e~~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 243 ----QLLAYRSGNADDPEQLLEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ----HHHhHhccCccCHHHHHHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 01111000 00000001111 12368899999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=186.63 Aligned_cols=235 Identities=20% Similarity=0.256 Sum_probs=150.0
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCC----------Cc
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHH----------PN 139 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~~ 139 (398)
.+...+.||.|+++.||.+.+.+ +++.+++|++..... ...+.+.+|.-....+.+ -.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 44567889999999999997765 899999999854332 335566666655554322 23
Q ss_pred ccceeeEEEeC------------C-----ceEEEEeecCCCCHHHHHhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015909 140 LVKLVGYCLED------------D-----HRLLVYEFMPRGSMENHLFR---RGSYFQPLSWSLRMKIALGAANGLAFLH 199 (398)
Q Consensus 140 I~~~~~~~~~~------------~-----~~~lv~e~~~~~~L~~~~~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH 199 (398)
++..++..... . +.+++|+-+ .++|.+++.. .......+.......+..|++..+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 33333333211 1 336788877 5688877653 3221222445566778899999999999
Q ss_pred cCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc--------CCCCCchhHHH
Q 015909 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT--------GHLTAKSDIYS 271 (398)
Q Consensus 200 ~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvws 271 (398)
+.| ++|+||+|+|++++.+|.+.|+||+........ ... ...+..|.+||.... -.++.+.|.|+
T Consensus 163 ~~G--lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 163 SYG--LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp HTT--EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred hcc--eEecccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 999 999999999999999999999999877653221 111 234577999997743 24788899999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCC
Q 015909 272 FGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR 346 (398)
Q Consensus 272 lG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 346 (398)
||+++|.|++|..||....+....+. .+. ... +.++.++.||..+|+.||.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW--------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG--------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc--------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999975322211100 111 122 677889999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-24 Score=182.18 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=189.0
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL 154 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~ 154 (398)
..+|.+...|..|+|+++. ..++.|+++.... .....|..|.-.|+-+.||||+.+++.|...-+..
T Consensus 195 ~tkl~e~hsgelwrgrwqg-----------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-----------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhccCCCcccccccccC-----------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 3458889999999999864 3466777754332 22356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe--eccCCc
Q 015909 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS--DFGLAR 232 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~--Dfg~a~ 232 (398)
++..|++.|+|+..+..... -.++..+...++.+++.|+.|||+..+-|.---|....++|+++...+|. |--++.
T Consensus 264 ~isq~mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred EeeeeccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence 99999999999999986543 34667788899999999999999998545555788999999988766653 322221
Q ss_pred CCCCCCCcccccccccccccccccccccCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLT---AKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
. .....-.+.||+||.+...+-+ .++|+|||++++|||.|...||.+..+.+-.
T Consensus 342 q---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------------- 398 (448)
T KOG0195|consen 342 Q---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------------- 398 (448)
T ss_pred e---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------
Confidence 1 1112347889999999765543 4689999999999999999999865443211
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.++.-..+.-..++..+..+..|+.-|++.||.+||.+..++-.|++++
T Consensus 399 --mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 399 --MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1122233444566777888999999999999999999999999888764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=173.09 Aligned_cols=139 Identities=17% Similarity=0.173 Sum_probs=106.7
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--c------------------------hHHHHHHHH
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--G------------------------HKEWLTEIN 130 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~ 130 (398)
...||+|+||.||+|... +|+.||+|+++..... . ......|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 467999999999999642 5899999999654211 1 012235999
Q ss_pred HHcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCceecC
Q 015909 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL-HSAEPKVIYRD 209 (398)
Q Consensus 131 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~ivH~D 209 (398)
++..+.++++.....+.. ...++||||++++++....... ..++...+..++.|++.+|.+| |+.+ |+|||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrD 143 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR--LVHAD 143 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCC
Confidence 999998877744333222 2348999999887776543332 3578899999999999999999 6888 99999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 210 FKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
|||+|||++ ++.++|+|||+|...
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCHHHEEEE-CCcEEEEEccccccC
Confidence 999999998 478999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=179.29 Aligned_cols=198 Identities=20% Similarity=0.227 Sum_probs=142.3
Q ss_pred CCCcccceeeEEEe---------------------------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 015909 136 HHPNLVKLVGYCLE---------------------------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188 (398)
Q Consensus 136 ~h~~I~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~ 188 (398)
+||||+.+..+|.+ ...+|+||..+ ..+|..++-.+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHHHHH
Confidence 59999999887753 23578999998 559999987643 5677778899
Q ss_pred HHHHHHHHHHHcCCCCceecCCCCCCEEEc--CC--CCEEEeeccCCcCCCCC----CCccccccccccccccccccccc
Q 015909 189 LGAANGLAFLHSAEPKVIYRDFKASNILLD--SN--YNAKLSDFGLARDGPTG----DKSHVSTRVMGTYGYAAPEYLAT 260 (398)
Q Consensus 189 ~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~--~~--~~~kl~Dfg~a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 260 (398)
.|+++|+.|||.+| |.|||+|.+||||. ++ ..++|+|||++---... .........-|....||||+...
T Consensus 348 aQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999999 99999999999993 33 45899999987532110 11111223467888999999854
Q ss_pred CC------CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHH
Q 015909 261 GH------LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASL 334 (398)
Q Consensus 261 ~~------~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 334 (398)
-+ --.++|.|+.|.+.||+++...||....+ ...+... ..+. .....+..++..++++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~-----------Yqe~----qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT-----------YQES----QLPALPSRVPPVARQL 489 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh-----------hhhh----hCCCCcccCChHHHHH
Confidence 22 13479999999999999999999965111 1111111 1111 1122345567789999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHH
Q 015909 335 ALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 335 i~~~l~~dP~~Rps~~ell~~L~ 357 (398)
+..+|+.||.+|++..-..+.|.
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 99999999999998876666554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-23 Score=198.68 Aligned_cols=229 Identities=29% Similarity=0.381 Sum_probs=182.7
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc--hHHHHHHHHHHcCCC-CCcccceeeEEEeCCceEE
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLL 155 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~~~~~l 155 (398)
++|.|+||.|+++.- +.....+..|++|++++..... ......|..++..++ ||.++++...+..+...++
T Consensus 1 vlg~g~~gkvfLvrk------~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRK------AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHH------hccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 479999999998642 2334467889999887653321 123345777888886 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCC
Q 015909 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235 (398)
Q Consensus 156 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~ 235 (398)
++++..+|.|...+.... .+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-
T Consensus 75 ~ld~~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhhhcccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhH
Confidence 999999999887776654 3677778888889999999999999 9999999999999999999999999998754
Q ss_pred CCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccc
Q 015909 236 TGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315 (398)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
.... .+||..|||||+++ ....++|.||||+++++|++|..||... ... .++
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~----------~Il 200 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMK----------RIL 200 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----------HHH----------HHh
Confidence 3332 28999999999998 5678899999999999999999999640 011 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 015909 316 DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM 349 (398)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 349 (398)
...-.++......+++++..++..+|..|.-.
T Consensus 201 --~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 201 --KAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11234566678889999999999999999644
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=165.47 Aligned_cols=187 Identities=18% Similarity=0.132 Sum_probs=138.0
Q ss_pred CCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc----hHHHHHHHHHHcCCC-CCcccceeeEEEeC
Q 015909 76 PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG----HKEWLTEINYLGQLH-HPNLVKLVGYCLED 150 (398)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~ 150 (398)
+...|++|+||+||.+.. .+.+++.+.+....... ...+.+|+++|++|. |++|++++++
T Consensus 6 ~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---- 70 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---- 70 (218)
T ss_pred cceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----
Confidence 457899999999997632 46778877776543311 124788999999995 5889998886
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCC-CCCCEEEcCCCCEEEeecc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDF-KASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dl-kp~Nilv~~~~~~kl~Dfg 229 (398)
+..+++|||+.|.+|...... . ...++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||
T Consensus 71 ~~~~lvmeyI~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred cCEEEEEeeecCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECC
Confidence 446999999999888653311 1 1346788999999999999 999999 7999999999999999999
Q ss_pred CCcCCCCCCCc----c---c----ccccccccccccccccccC-CCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 015909 230 LARDGPTGDKS----H---V----STRVMGTYGYAAPEYLATG-HLT-AKSDIYSFGVVLLEILSGRRAIDKNR 290 (398)
Q Consensus 230 ~a~~~~~~~~~----~---~----~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~~l~ell~g~~p~~~~~ 290 (398)
++......... . . ..-...++.|++|+...-. ..+ .+.++++.|+-+|.++|+..++....
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 99864432210 0 0 0012357788888765332 233 56899999999999999998875443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=198.16 Aligned_cols=249 Identities=19% Similarity=0.216 Sum_probs=181.3
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC---CCccccee
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH---HPNLVKLV 144 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~~I~~~~ 144 (398)
+..+..|.|.+.||+|+||.||+|... +|..||+|+-+.....+. +-=..++.+|+ -+.|+.+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~----------~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHS----------NGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHIS 760 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecC----------CCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHH
Confidence 445567888899999999999999543 389999999876544321 11112233333 34566666
Q ss_pred eEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc------
Q 015909 145 GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD------ 218 (398)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~------ 218 (398)
..+.-.+..++|+||.+.|+|.+++... +.+++..++.+..|++..+++||..+ |||+||||+|+||.
T Consensus 761 ~a~~~~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~ 834 (974)
T KOG1166|consen 761 SAHVFQNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICAD 834 (974)
T ss_pred HHHccCCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCC
Confidence 6667778889999999999999999844 56899999999999999999999999 99999999999994
Q ss_pred -CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 219 -SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 219 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
+..-++|+|||.+.....-.........++|-.+-.+|...|.+|++..|.|.|+.+++-||.|+..-
T Consensus 835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------- 903 (974)
T KOG1166|consen 835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------- 903 (974)
T ss_pred CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------
Confidence 23459999999998655444444566678899999999999999999999999999999999997321
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHH-HHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQA-QKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
...+. .... ...++.-.. +-.-+++..+|+.|-..=|.+.+|...|+..
T Consensus 904 -------~~~g~--~~~~----~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 904 -------VKNGS--SWMV----KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred -------hcCCc--ceec----cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 00000 0000 011222222 2345788888884444447777776666654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=166.11 Aligned_cols=140 Identities=17% Similarity=0.160 Sum_probs=108.3
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---------------------c-----hHHHHHHHH
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---------------------G-----HKEWLTEIN 130 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~ 130 (398)
.+.||+|+||.||+|.+. +|..||+|+++..... . ...+..|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 578999999999999642 5899999998754211 0 112357889
Q ss_pred HHcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecC
Q 015909 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRD 209 (398)
Q Consensus 131 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~D 209 (398)
.+.++.|++|.....+... ..++||||++++++....... ..++......++.|++.++.+||+ .| |+|||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrD 143 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGD 143 (190)
T ss_pred HHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCC
Confidence 9999999987554444332 348999999887554432222 246788889999999999999999 88 99999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcCCC
Q 015909 210 FKASNILLDSNYNAKLSDFGLARDGP 235 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~~~ 235 (398)
|||+||+++ ++.++|+|||++....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999998 7899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=161.45 Aligned_cols=135 Identities=18% Similarity=0.197 Sum_probs=104.3
Q ss_pred CCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-----CCCcccceeeEEEeC
Q 015909 76 PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-----HHPNLVKLVGYCLED 150 (398)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~I~~~~~~~~~~ 150 (398)
-.++||+|+||.||. +.. ++.. +||++........+.+.+|+.+++.+ .||||+++++++.++
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~ 73 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD 73 (210)
T ss_pred CcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence 357899999999995 221 3444 68988765444567789999999999 579999999999886
Q ss_pred C---c-eEEEEee--cCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCceecCCCCCCEEEcC----
Q 015909 151 D---H-RLLVYEF--MPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL-AFLHSAEPKVIYRDFKASNILLDS---- 219 (398)
Q Consensus 151 ~---~-~~lv~e~--~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~ivH~Dlkp~Nilv~~---- 219 (398)
. . +.+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++.
T Consensus 74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~ 144 (210)
T PRK10345 74 CGTGYVYDVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISES 144 (210)
T ss_pred CCCeEEEEEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCC
Confidence 4 3 3378999 5579999999653 24444 34577777777 9999999 999999999999973
Q ss_pred CCCEEEeeccCC
Q 015909 220 NYNAKLSDFGLA 231 (398)
Q Consensus 220 ~~~~kl~Dfg~a 231 (398)
++.++|+||+.+
T Consensus 145 ~~~~~LiDg~G~ 156 (210)
T PRK10345 145 EVIPVVCDNIGE 156 (210)
T ss_pred CCcEEEEECCCC
Confidence 347999995444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=178.19 Aligned_cols=219 Identities=26% Similarity=0.403 Sum_probs=164.4
Q ss_pred HcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc-eecCC
Q 015909 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKV-IYRDF 210 (398)
Q Consensus 132 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~i-vH~Dl 210 (398)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.... ..+++.....+..+|+.||.|||+.- | .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 467899999999999999999999999999999999998744 56899999999999999999999876 5 89999
Q ss_pred CCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCC-------CCCchhHHHHHHHHHHHHhCC
Q 015909 211 KASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH-------LTAKSDIYSFGVVLLEILSGR 283 (398)
Q Consensus 211 kp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~~l~ell~g~ 283 (398)
+..|++++....+||+|||+.................-...|.|||.+++.. .+.+.|+||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987754311111111122355799999997642 355699999999999999999
Q ss_pred CCCCCCCCCCCc-chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 284 RAIDKNRPTGEH-NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 284 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.||......... ......+. .....+.+.+.... ....++..++..||..+|.+||+++.+-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999763332221 22222111 00111111111111 3344789999999999999999999999888877654
Q ss_pred h
Q 015909 363 R 363 (398)
Q Consensus 363 ~ 363 (398)
.
T Consensus 228 ~ 228 (484)
T KOG1023|consen 228 G 228 (484)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.8e-21 Score=188.90 Aligned_cols=210 Identities=26% Similarity=0.370 Sum_probs=143.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|..++.|-.|+||.||..+++. +.+.+|+| +++.+. +++- ++....+|.++
T Consensus 82 e~df~~IklisngAygavylvrh~~---------trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccc---------cccchhhc-ccccch-----hhhc--cccccCCccee---------
Confidence 3567778999999999999986654 67788884 443321 1110 22222333333
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
|+-...+...+ +++... +.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+
T Consensus 136 ------------gDc~tllk~~g----~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIG----PLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGL 189 (1205)
T ss_pred ------------chhhhhcccCC----CCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhh
Confidence 33333333322 233322 67899999999 99999999999999999999999999
Q ss_pred CcCCCCCCCcc-------------cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 231 ARDGPTGDKSH-------------VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 231 a~~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
++......... .....+||+.|.|||++....|+..+|+|++|+|+|+++-|+.||.++.+..-
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--- 266 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--- 266 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---
Confidence 87532211110 11235899999999999999999999999999999999999999987644321
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 347 (398)
+..++.+...+. +-....+.++++++.++|+.+|.+|.
T Consensus 267 ---fg~visd~i~wp---------E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 267 ---FGQVISDDIEWP---------EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---Hhhhhhhhcccc---------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 111111111110 11234467899999999999999994
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-19 Score=153.68 Aligned_cols=134 Identities=18% Similarity=0.292 Sum_probs=111.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--------chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--------GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
+.||+|++|.||+|.+ .+..+++|........ ....+.+|+.++..+.|++|.....++..
T Consensus 2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 5799999999999965 3667888876543221 12346789999999999998877777777
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..+++|||++|++|.+++.... . ....++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECC
Confidence 788899999999999999886532 1 67889999999999999998 99999999999999 7899999999
Q ss_pred CCcC
Q 015909 230 LARD 233 (398)
Q Consensus 230 ~a~~ 233 (398)
++..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 8764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=157.92 Aligned_cols=144 Identities=15% Similarity=0.125 Sum_probs=108.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc------------------------chHHHHH
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ------------------------GHKEWLT 127 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~ 127 (398)
.-|.+.+.||+|+||.||+|++. ..+|..||+|.+...... ....+..
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~--------~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDF--------DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred chHHhCCeeccCcceeEEEEEec--------CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 45889999999999999999621 126899999998743210 0123467
Q ss_pred HHHHHcCCCCCc--ccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 015909 128 EINYLGQLHHPN--LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKV 205 (398)
Q Consensus 128 E~~~l~~l~h~~--I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~i 205 (398)
|+.++.++.+.+ +.+++++ ...++||||+++.+|....... ..+.......++.||+.++.+||+++ +|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~g-~i 170 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKEG-EL 170 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhcC-CE
Confidence 999999997532 3344432 2358999999888876654322 23556667889999999999999875 49
Q ss_pred eecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 206 IYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 206 vH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
+||||||+||+++ ++.++|+|||.+..
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 9999999999999 88999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-20 Score=172.30 Aligned_cols=170 Identities=26% Similarity=0.384 Sum_probs=128.0
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
.+|+.|++|...+|.+++.++.. ....++.....++.|++.|++| ++ .+|+|+||.||+...+..++|+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 57899999999999999975433 2456788899999999999999 66 999999999999999999999999998
Q ss_pred cCCCCCC----CcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 232 RDGPTGD----KSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 232 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
....... .....+...||..||+||++.+..|+.++||||||++|+|++. -...|+..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------------- 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------------- 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------------
Confidence 7654433 1122345689999999999999999999999999999999998 33333210
Q ss_pred ccccccccccccccCCCC---HHHHHHHHHHHHHhccCCCCCCCCHH
Q 015909 307 SKRRIFRVLDPRLEGQFS---LPQAQKAASLALQCLSVEPKLRPDMD 350 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ 350 (398)
..+..+ ..+.++ ....++-..|+.++|...|.+||++.
T Consensus 467 --~t~~d~----r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 467 --ATLTDI----RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred --Hhhhhh----hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 000000 011111 11122446899999999999999443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=150.65 Aligned_cols=130 Identities=18% Similarity=0.301 Sum_probs=105.6
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--------chHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--------GHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.||+|+||.||+|.+ .+..+++|........ ....+.+|+.++..+.|+++....-++...
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999964 4667889986432211 124567899999999988766655566667
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||++|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCC
Confidence 77899999999999998875432 0 67889999999999998 99999999999999 78999999999
Q ss_pred CcC
Q 015909 231 ARD 233 (398)
Q Consensus 231 a~~ 233 (398)
+..
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 876
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-18 Score=170.86 Aligned_cols=138 Identities=20% Similarity=0.250 Sum_probs=109.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEc-ccC-Cc------cchHHHHHHHHHHcCCCCCccc
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQE-GF------QGHKEWLTEINYLGQLHHPNLV 141 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~-~~~-~~------~~~~~~~~E~~~l~~l~h~~I~ 141 (398)
....|...++||+|+||+||+|.+.. ..+++|.. ... .. ...+.+.+|+.+++.++|++|+
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 399 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVP 399 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCC
Confidence 34456778999999999999987643 22333332 111 00 1134578899999999999998
Q ss_pred ceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 142 KLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
....++......++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ +++
T Consensus 400 ~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~ 464 (535)
T PRK09605 400 TPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDD 464 (535)
T ss_pred eeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECC
Confidence 88777777778899999999999998875 23568899999999999998 9999999999999 678
Q ss_pred CEEEeeccCCcC
Q 015909 222 NAKLSDFGLARD 233 (398)
Q Consensus 222 ~~kl~Dfg~a~~ 233 (398)
.++|+|||+++.
T Consensus 465 ~~~liDFGla~~ 476 (535)
T PRK09605 465 RLYLIDFGLGKY 476 (535)
T ss_pred cEEEEeCccccc
Confidence 999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=7e-18 Score=146.60 Aligned_cols=144 Identities=14% Similarity=0.057 Sum_probs=109.1
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--c--------------------chH
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--Q--------------------GHK 123 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~--------------------~~~ 123 (398)
.+......|.+.+.||+|+||.||+|... +|..||+|++..... . ...
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRL 78 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHH
Confidence 34444455888999999999999998642 588999998754320 0 011
Q ss_pred HHHHHHHHHcCCCCCc--ccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 015909 124 EWLTEINYLGQLHHPN--LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA 201 (398)
Q Consensus 124 ~~~~E~~~l~~l~h~~--I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 201 (398)
.+..|+.++..+.|++ +...++ ....++||||+++++|..+... .....++.+++.++.++|+.
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~ 144 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH 144 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC
Confidence 3567888888887774 444443 2455899999999988765321 23456888999999999999
Q ss_pred CCCceecCCCCCCEEEcCCCCEEEeeccCCcCCC
Q 015909 202 EPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235 (398)
Q Consensus 202 ~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~ 235 (398)
+ |+|+||+|.||+++.++.++|+|||++....
T Consensus 145 g--i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 G--IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred C--CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 8 9999999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.1e-19 Score=174.99 Aligned_cols=257 Identities=23% Similarity=0.280 Sum_probs=190.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCC-CCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLH-HPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~ 149 (398)
.|.+.+.||+|+|+.|-...... .....++.|.+.... .........|..+-+.+. |.|++.+++....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~--------~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSR--------DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcC--------CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 46667779999999998764322 245667777765443 222344455777777787 9999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHh-hcCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCceecCCCCCCEEEcCCC-CEEEe
Q 015909 150 DDHRLLVYEFMPRGSMENHLF-RRGSYFQPLSWSLRMKIALGAANGLAFLH-SAEPKVIYRDFKASNILLDSNY-NAKLS 226 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~ivH~Dlkp~Nilv~~~~-~~kl~ 226 (398)
.+..++++++..++++.+.+. ... ...+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~ 167 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIA 167 (601)
T ss_pred CcccccccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCC
Confidence 999999999999999988883 322 13455566778999999999999 887 99999999999999999 99999
Q ss_pred eccCCcCCCC-CCCccccccccc-ccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 227 DFGLARDGPT-GDKSHVSTRVMG-TYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 227 Dfg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
|||+|..+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..||........ .+..|..
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~- 245 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKS- 245 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecc-
Confidence 9999998766 444444455678 9999999999884 556779999999999999999999976443321 1111111
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.... ..............+++.+++..+|..|.+.+++...
T Consensus 246 ---~~~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 246 ---NKGR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---cccc--------cccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0000 0011112234567789999999999999999887654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.8e-16 Score=138.47 Aligned_cols=135 Identities=22% Similarity=0.225 Sum_probs=101.5
Q ss_pred ceec-ccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-------------cchHHHHHHHHHHcCCCCCcc--c
Q 015909 78 SVLG-EGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-------------QGHKEWLTEINYLGQLHHPNL--V 141 (398)
Q Consensus 78 ~~lg-~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~I--~ 141 (398)
.+|| .|+.|+||.+.. .+..+++|.+..... .....+.+|+.++..|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~-----------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-----------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEe-----------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4677 788888888754 356788887743211 123457889999999998875 5
Q ss_pred ceeeEEEeCCc----eEEEEeecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 142 KLVGYCLEDDH----RLLVYEFMPR-GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 142 ~~~~~~~~~~~----~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
..+++...... .++|||++++ .+|.+++... .++.. .+.+|+.+|.+||+.| |+|+||||.|||
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NIL 174 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNIL 174 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEE
Confidence 66665443222 2599999987 6888887542 34544 3568899999999999 999999999999
Q ss_pred EcCCCCEEEeeccCCcCC
Q 015909 217 LDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~ 234 (398)
++.++.++|+|||.+...
T Consensus 175 v~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 175 LDPDGKFWLIDFDRGELR 192 (239)
T ss_pred EcCCCCEEEEECCCcccC
Confidence 998889999999998763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-16 Score=134.64 Aligned_cols=135 Identities=20% Similarity=0.172 Sum_probs=94.3
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHH----------------------HHHHHHHH
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKE----------------------WLTEINYL 132 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l 132 (398)
.+.||+|+||+||+|... ++..||+|++...... .... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 568999999999999643 5789999988643211 1111 12455555
Q ss_pred cCCCCCc--ccceeeEEEeCCceEEEEeecCCCCHHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceec
Q 015909 133 GQLHHPN--LVKLVGYCLEDDHRLLVYEFMPRGSMEN-HLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYR 208 (398)
Q Consensus 133 ~~l~h~~--I~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~ 208 (398)
..+.+.+ +.++++. ...++||||++++.+.. .+.... .. .....++.+++.++.++|. .+ |+|+
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~ 139 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG--LVHG 139 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC--cCcC
Confidence 5554332 3444432 34689999998854321 111111 01 4567889999999999999 88 9999
Q ss_pred CCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 209 DFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 209 Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
||||+||+++ ++.++|+|||.+...
T Consensus 140 Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 140 DLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCChhhEEEE-CCcEEEEECcccccc
Confidence 9999999999 899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.8e-16 Score=126.88 Aligned_cols=134 Identities=19% Similarity=0.113 Sum_probs=109.4
Q ss_pred CCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCC--CcccceeeEEEeCCce
Q 015909 76 PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH--PNLVKLVGYCLEDDHR 153 (398)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~~I~~~~~~~~~~~~~ 153 (398)
+.+.||.|.++.||++... +..+++|....... ...+..|+.+++.+.| .++++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4577999999999998652 35789998865432 4568899999999976 5888988888877889
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE-PKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
+++|||+++..+..+ +......++.+++.++.+||... .+++|+||+|.||+++..+.++++|||.+.
T Consensus 69 ~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 69 YLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred EEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 999999988776543 34556678889999999999852 239999999999999998999999999886
Q ss_pred C
Q 015909 233 D 233 (398)
Q Consensus 233 ~ 233 (398)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 4
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=143.48 Aligned_cols=253 Identities=26% Similarity=0.274 Sum_probs=185.4
Q ss_pred cCCCCCceecc--cCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCC-CCcccceeeE
Q 015909 72 RNFRPDSVLGE--GGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLH-HPNLVKLVGY 146 (398)
Q Consensus 72 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~I~~~~~~ 146 (398)
..+.+.+.+|. |.+|.||.+.+.. ..++..+|+|.-.... ......=++|+...+.++ |++.++.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred hhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 45677888999 9999999987621 2367888888743221 122233356777777774 9999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCceecCCCCCCEEEcCC-C
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN----GLAFLHSAEPKVIYRDFKASNILLDSN-Y 221 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~ivH~Dlkp~Nilv~~~-~ 221 (398)
+...+..++-+|+| +.+|..+...... .++...++..+.+... ||.++|+.+ ++|-|+||.||+...+ .
T Consensus 187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 187 WEGSGILFIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWT 260 (524)
T ss_pred cccCCcceeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccc
Confidence 99999999999999 6788888776543 3677788888888888 999999998 9999999999999988 8
Q ss_pred CEEEeeccCCcCCCCCCCcccc---cccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVS---TRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~ 298 (398)
..+++|||+...+......... ....|...|++||... +-++...|+|+||.++.+..++..+....- ..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~ 333 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK------NS 333 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC------CC
Confidence 8999999999887665533222 2336788999999985 567889999999999999998877654320 00
Q ss_pred hhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.|.. . .... +..++-...+..+...+..|+..+|..|++.+.+..+
T Consensus 334 ~W~~----~----r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 334 SWSQ----L----RQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred Cccc----c----cccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0110 0 0000 1112222334566679999999999999998876653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3e-15 Score=132.40 Aligned_cols=206 Identities=24% Similarity=0.316 Sum_probs=145.3
Q ss_pred HHcCCCCCcccceeeEEEeCC-----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 015909 131 YLGQLHHPNLVKLVGYCLEDD-----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKV 205 (398)
Q Consensus 131 ~l~~l~h~~I~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~i 205 (398)
-|-++.|.||++++.++.+.+ ...++.||+..|+|..++.+.......+......+++-||+.||.|||+..++|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344556999999999886543 468999999999999999988887788999999999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCEEEeeccCCcCCCCC--CCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCC
Q 015909 206 IYRDFKASNILLDSNYNAKLSDFGLARDGPTG--DKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283 (398)
Q Consensus 206 vH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~ 283 (398)
+|+++..+.|++..+|.+|+.--.-....... ..........+.++|.+||.=.....+.++|||+||+...+|..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999999988887422111000000 0000011234678899999766667788899999999999998876
Q ss_pred CCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 284 RAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.--.......... .........+.. ..-+.++.+|++..|..||++++++.|.
T Consensus 280 iq~tnseS~~~~e---------e~ia~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 280 IQSTNSESKVEVE---------ENIANVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eccCCCcceeehh---------hhhhhheeeccC-----------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 5422211110000 000000001111 1124788999999999999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-13 Score=132.55 Aligned_cols=140 Identities=17% Similarity=0.153 Sum_probs=95.1
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccch--------------------------H-------
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH--------------------------K------- 123 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------~------- 123 (398)
.+.||.|++|.||+|+.. +|+.||||+.+....... .
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 367999999999999864 588999999864321100 0
Q ss_pred -------HHHHHHHHHcCCC-----CCcccceeeEE-EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 015909 124 -------EWLTEINYLGQLH-----HPNLVKLVGYC-LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190 (398)
Q Consensus 124 -------~~~~E~~~l~~l~-----h~~I~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~q 190 (398)
.+.+|+..+.++. +++| .+-.++ ......++||||++|.+|.++...... ... ...++..
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~ 264 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAEN 264 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHH
Confidence 1334555444442 2332 221222 223457899999999999887653211 122 2345555
Q ss_pred HHH-HHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCC
Q 015909 191 AAN-GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235 (398)
Q Consensus 191 i~~-al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~ 235 (398)
++. .+..+|..| ++|+|++|.||+++.++.++|+|||++....
T Consensus 265 ~~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 265 LARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 555 467889888 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-12 Score=125.29 Aligned_cols=165 Identities=16% Similarity=0.190 Sum_probs=126.0
Q ss_pred CCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHH
Q 015909 104 GTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSL 183 (398)
Q Consensus 104 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~ 183 (398)
.++.+|.|...............+-++.|+.|+||||+++++.+..++..|+|+|.+ ..|..++.+.+ ...
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-------~~~ 105 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-------KEE 105 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-------HHH
Confidence 367788888776554444456778899999999999999999999999999999987 36777776543 566
Q ss_pred HHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCC
Q 015909 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL 263 (398)
Q Consensus 184 ~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 263 (398)
+..-+.||+.||.|||..+ .++|++|....|+|+..|..||++|.++.......... ....--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCccc-
Confidence 7778899999999998553 59999999999999999999999998876533222100 1111223466676553322
Q ss_pred CCchhHHHHHHHHHHHHhC
Q 015909 264 TAKSDIYSFGVVLLEILSG 282 (398)
Q Consensus 264 ~~~~DvwslG~~l~ell~g 282 (398)
-..|.|.|||++++++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.2e-13 Score=112.41 Aligned_cols=130 Identities=18% Similarity=0.074 Sum_probs=94.3
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCccc-ceeeEEEeCCceEE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLV-KLVGYCLEDDHRLL 155 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~-~~~~~~~~~~~~~l 155 (398)
.+.|+.|.++.||++.. .+..|++|....... ....+..|+.+++.+.+.+++ +++.. .....++
T Consensus 3 ~~~l~~G~~~~vy~~~~-----------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEE-----------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeE
Confidence 35688999999999864 367899998765421 123456889999988655544 44443 3344689
Q ss_pred EEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---CceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEP---KVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 156 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~---~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
|||+++|.++... . . ....++.+++.+|..||+.+. .++|+|++|.||+++ ++.++++|||.+.
T Consensus 69 v~e~i~G~~l~~~----~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 69 ITEFIEGSELLTE----D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEEecCCCccccc----c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999999887543 0 0 112356789999999998861 149999999999998 6789999999876
Q ss_pred C
Q 015909 233 D 233 (398)
Q Consensus 233 ~ 233 (398)
.
T Consensus 136 ~ 136 (170)
T cd05151 136 M 136 (170)
T ss_pred C
Confidence 4
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.3e-13 Score=134.84 Aligned_cols=146 Identities=15% Similarity=0.122 Sum_probs=92.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc------------------------------
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG------------------------------ 121 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------ 121 (398)
..|.. +.||.|++|.||+|+.++ +|+.||||+.+..-...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 34665 789999999999998764 58999999987431100
Q ss_pred ----hHH------HHHHHHHHcCCC----CCcccceeeEEE-eCCceEEEEeecCCCCHHHHH--hhcCCCCCCCCHHHH
Q 015909 122 ----HKE------WLTEINYLGQLH----HPNLVKLVGYCL-EDDHRLLVYEFMPRGSMENHL--FRRGSYFQPLSWSLR 184 (398)
Q Consensus 122 ----~~~------~~~E~~~l~~l~----h~~I~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~--~~~~~~~~~l~~~~~ 184 (398)
.+. +.+|+..+.++. +...+.+=.++. .....++||||++|+.+.++. ...+.....+....+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 011 233444333332 222222222222 245568999999999998753 222211112333334
Q ss_pred HHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC----CEEEeeccCCcCCCC
Q 015909 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY----NAKLSDFGLARDGPT 236 (398)
Q Consensus 185 ~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~----~~kl~Dfg~a~~~~~ 236 (398)
..++.|+ ...| ++|+|+||.||+|+.++ .++++|||++.....
T Consensus 270 ~~~~~Qi-------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQV-------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4444444 3467 99999999999999887 999999999877644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.5e-13 Score=128.16 Aligned_cols=254 Identities=22% Similarity=0.179 Sum_probs=178.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHH--HHHHHHHHcCC-CCCcccceeeE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE--WLTEINYLGQL-HHPNLVKLVGY 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~~I~~~~~~ 146 (398)
...+|..+..||.|.|+.|+.+. ++..++..|++|.+.........+ -+.|+.+...+ .|.+++.++..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~--------~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVS--------KRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ecCCcceeEEccCCccccceeee--------ecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 34567888899999999999874 333478889999876543332222 24566666665 48888888888
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC-CCEEE
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-YNAKL 225 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~-~~~kl 225 (398)
|......|+-.|||.++++...+.-. ..+.+..++.+..|++.++.++|+.. ++|+|+||+||++..+ +..++
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhc
Confidence 88888888999999998877666322 34677788899999999999999998 9999999999999875 78899
Q ss_pred eeccCCcCCCCCCCccccccccccccc-ccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGY-AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
.|||+...+...... ....+..| .+++......+..+.|++|||..+.+.+++...-.....
T Consensus 409 ~~~~~~t~~~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------- 471 (524)
T KOG0601|consen 409 GDFGCWTRLAFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------- 471 (524)
T ss_pred cccccccccceeccc----ccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------
Confidence 999988642211111 11123333 255555566788899999999999999998764332110
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
...+..... ........++..+...++..++..||.+.++..+.+-....
T Consensus 472 ------~~~i~~~~~--p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 472 ------SLTIRSGDT--PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred ------ceeeecccc--cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 000111000 01112236778899999999999999999988877665543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1e-10 Score=107.46 Aligned_cols=279 Identities=15% Similarity=0.159 Sum_probs=168.8
Q ss_pred CCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeE------E
Q 015909 75 RPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGY------C 147 (398)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~------~ 147 (398)
.....||+|+-+.+|-.- .-...+.|++.........+ .+..|... .||-+..-+.| .
T Consensus 14 ~~gr~LgqGgea~ly~l~------------e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG------------EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred CCCccccCCccceeeecc------------hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhC
Confidence 345779999999999531 11223456665443322222 22233333 46543321111 1
Q ss_pred Ee-CCceEEEEeecCCCC-HHHHHh--hcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 148 LE-DDHRLLVYEFMPRGS-MENHLF--RRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 148 ~~-~~~~~lv~e~~~~~~-L~~~~~--~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
-+ ....-++|+.+.+.. ..++.. .+........|...+.++..++.+...||.+| .+-+|+.++|+||++++.|
T Consensus 79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceE
Confidence 11 223568888887653 222222 23334566889999999999999999999999 8999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCC---C
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSG-RRAIDKNRPTG---E 294 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g-~~p~~~~~~~~---~ 294 (398)
.|.|=..-... .........+|...|.+||.-+ +-.-+...|.|.||++++++|.| +.||.+-.... .
T Consensus 157 ~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~ 233 (637)
T COG4248 157 VLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN 233 (637)
T ss_pred EEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC
Confidence 99986543322 1111223357899999999765 33446678999999999999885 99997632111 0
Q ss_pred cchhhhhh-hhhhccccccccccccccCCCCHH-HHHHHHHHHHHhccC--CCCCCCCHHHHHHHHHHHHHHh-hccCCc
Q 015909 295 HNLVEWAK-PYLTSKRRIFRVLDPRLEGQFSLP-QAQKAASLALQCLSV--EPKLRPDMDEVVKELEQLQELR-NMHKRP 369 (398)
Q Consensus 295 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~--dP~~Rps~~ell~~L~~l~~~~-~~~~~~ 369 (398)
.-...... .+......-.....+ ....+.. .+.++..|..+|+.. ++.-|||++.++..|..+.+.. +-.-+.
T Consensus 234 p~E~~Ia~g~f~ya~~~~~g~~p~--P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a 311 (637)
T COG4248 234 PLETDIAHGRFAYASDQRRGLKPP--PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSA 311 (637)
T ss_pred cchhhhhcceeeechhccCCCCCC--CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcc
Confidence 00000000 000001110111111 1122222 356788899999964 3678999999999999996544 344455
Q ss_pred hhhhhc
Q 015909 370 QKEHQA 375 (398)
Q Consensus 370 ~~~~~~ 375 (398)
+|..++
T Consensus 312 ~H~y~~ 317 (637)
T COG4248 312 MHVYPV 317 (637)
T ss_pred cccccC
Confidence 564444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.8e-12 Score=106.38 Aligned_cols=143 Identities=13% Similarity=0.100 Sum_probs=97.7
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---------------c------c-hHHH----HHHHH
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---------------Q------G-HKEW----LTEIN 130 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------------~------~-~~~~----~~E~~ 130 (398)
...||.|--+.||.|...... .....+..+|+|+.+.... . . ...+ .+|+.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 457999999999999643210 0011357899998753210 0 0 1122 37999
Q ss_pred HHcCCCC--CcccceeeEEEeCCceEEEEeecCCCCHHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCce
Q 015909 131 YLGQLHH--PNLVKLVGYCLEDDHRLLVYEFMPRGSMEN-HLFRRGSYFQPLSWSLRMKIALGAANGLAFL-HSAEPKVI 206 (398)
Q Consensus 131 ~l~~l~h--~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~iv 206 (398)
.|+++.. -++..++++ ..-++||||+.+..+.. .+.. ..++......+..+++.+|..| |..+ |+
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g--lV 147 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN--LV 147 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 9999853 345556653 45689999996543321 1211 1244556677789999999999 8888 99
Q ss_pred ecCCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 207 YRDFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 207 H~Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
|+||++.||++. ++.+.|+|||.+...
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999997 468999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.8e-11 Score=101.07 Aligned_cols=131 Identities=18% Similarity=0.262 Sum_probs=97.8
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--------chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--------GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++++|+-+.+|.+.+ -|..+++|.-...... ....-.+|+.++..+.--.|.-.+=+..+
T Consensus 2 ~~i~~GAEa~i~~~~~-----------~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-----------LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeec-----------cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 4578999999999855 2445667654322111 12334679999998876566555556678
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+...|+|||++|..|.+.+.... ..++..+-..+.-||..| |+|+||.++||++..++ +.++|||
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~~-----------~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEAR-----------PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhcc-----------hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECC
Confidence 888899999999988988887641 335666667778899999 99999999999997654 9999999
Q ss_pred CCcC
Q 015909 230 LARD 233 (398)
Q Consensus 230 ~a~~ 233 (398)
++..
T Consensus 137 Lg~~ 140 (204)
T COG3642 137 LGEF 140 (204)
T ss_pred cccc
Confidence 9875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.4e-11 Score=99.86 Aligned_cols=143 Identities=18% Similarity=0.192 Sum_probs=105.4
Q ss_pred CCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--------cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 76 PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--------QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
...+|-+|+-+.|+++.+ .|+.++||.-..... -.....++|++.|.++.--.|.-..=++
T Consensus 11 ~l~likQGAEArv~~~~~-----------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeecc-----------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 456788999999999976 577778876532211 1234557899999887655555444466
Q ss_pred EeCCceEEEEeecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC---CE
Q 015909 148 LEDDHRLLVYEFMPR-GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY---NA 223 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~---~~ 223 (398)
.+...-.|+|||++| .++.+++..... ..........++..|-+.+.-||.++ |+|+||..+||++..++ .+
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~ 155 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITP 155 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCce
Confidence 777778899999966 478888876543 22233333678888999999999999 99999999999996443 45
Q ss_pred EEeeccCCcC
Q 015909 224 KLSDFGLARD 233 (398)
Q Consensus 224 kl~Dfg~a~~ 233 (398)
.++|||++..
T Consensus 156 ~lIdfgls~~ 165 (229)
T KOG3087|consen 156 ILIDFGLSSV 165 (229)
T ss_pred EEEeecchhc
Confidence 8999999865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.8e-13 Score=134.08 Aligned_cols=247 Identities=22% Similarity=0.224 Sum_probs=163.9
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.+.+.+.+-+|.++.++.+. ...++-..+.|+...... ...+....+-.++-...+|.++...-.+..
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~---------pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPAS---------PAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred cceecccccCCCCcccccCC---------ccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence 34455677889999998753 223444444444332211 111222223333333345666554444555
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....+|+++|+.+++|...+...+ ..+.+........+..++++||+.. +.|+|++|.|++...++..++.|||
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccc
Confidence 678899999999999999988765 3444455556667888999999987 9999999999999999999999998
Q ss_pred CCcCCCCC----------------C-------------CcccccccccccccccccccccCCCCCchhHHHHHHHHHHHH
Q 015909 230 LARDGPTG----------------D-------------KSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEIL 280 (398)
Q Consensus 230 ~a~~~~~~----------------~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 280 (398)
........ . .........||+.|.+||.+.+......+|+|++|++++|.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 43211100 0 000112357899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCcchhhhhhhhhhcccccccccccccc-CCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 015909 281 SGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLE-GQFSLPQAQKAASLALQCLSVEPKLRPDMD 350 (398)
Q Consensus 281 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 350 (398)
+|.+||....+.... ..++..... ...+...+.++.+++...+..+|.+|..+.
T Consensus 1030 ~g~pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999765433211 011111111 112233466788999999999999997664
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.8e-10 Score=108.44 Aligned_cols=219 Identities=15% Similarity=0.195 Sum_probs=153.2
Q ss_pred CCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEE----eCCceEEEEee
Q 015909 84 GFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCL----EDDHRLLVYEF 159 (398)
Q Consensus 84 ~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~----~~~~~~lv~e~ 159 (398)
--.+.|+++... +|..|++|++.............-++.++++.|+|||++.++|. .+..+++|++|
T Consensus 288 ~~~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDY 358 (655)
T KOG3741|consen 288 FSITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDY 358 (655)
T ss_pred ccceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEec
Confidence 346788886554 78899999995443333334445678899999999999999886 34567899999
Q ss_pred cCC-CCHHHHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 160 MPR-GSMENHLFRRGSY-----------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 160 ~~~-~~L~~~~~~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
+++ ++|.++....... ...+++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++.+.+++|..
T Consensus 359 yP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~ 436 (655)
T KOG3741|consen 359 YPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISG 436 (655)
T ss_pred CCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEec
Confidence 985 5677776543222 234778999999999999999999999 88899999999999988999998
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+|.......... |.+. --.+-|.=.||.++..|.+|..--...+... ..
T Consensus 437 C~i~Dvl~~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~-----~s------- 485 (655)
T KOG3741|consen 437 CGIMDVLQEDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQ-----SS------- 485 (655)
T ss_pred ccceeeecCCCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchH-----HH-------
Confidence 888765433220 1111 1224688899999999999864321110000 00
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
. ........+.++++++.-....++++ -++.+++.++
T Consensus 486 --~---------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 486 --H---------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred --H---------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 0 00112345667888888888888887 5677766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.2e-10 Score=101.12 Aligned_cols=141 Identities=21% Similarity=0.274 Sum_probs=103.1
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCC--cccceeeEEEeC---C
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHP--NLVKLVGYCLED---D 151 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--~I~~~~~~~~~~---~ 151 (398)
+.|+.|..+.||++... +|..+++|....... .....+..|+.+++.+.+. .+.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 56899999999998642 257899999865422 2345678999999999753 456677766543 2
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE----------------------------- 202 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------------------------- 202 (398)
..++||||++|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred CceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 56899999999887665421 13556666667777777777777421
Q ss_pred -------------------------CCceecCCCCCCEEEcC--CCCEEEeeccCCcC
Q 015909 203 -------------------------PKVIYRDFKASNILLDS--NYNAKLSDFGLARD 233 (398)
Q Consensus 203 -------------------------~~ivH~Dlkp~Nilv~~--~~~~kl~Dfg~a~~ 233 (398)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23799999999999988 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.4e-09 Score=96.56 Aligned_cols=141 Identities=16% Similarity=0.108 Sum_probs=97.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-----------chHHHHHHHHHHcCCCCCcc--ccee
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-----------GHKEWLTEINYLGQLHHPNL--VKLV 144 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~I--~~~~ 144 (398)
+++-......|+++.+ .|..|.+|........ ....+.+|...+..|...+| +..+
T Consensus 28 e~v~~~~~rrvvr~~~-----------~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pV 96 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-----------AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGV 96 (268)
T ss_pred cEEecCCCceEEEEEE-----------CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCee
Confidence 3444444445666544 4668899976433211 01136788888888754333 3344
Q ss_pred eEEEe-----CCceEEEEeecCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 145 GYCLE-----DDHRLLVYEFMPRG-SMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 145 ~~~~~-----~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
.++.. ....++|+|++++. +|.+++..... .+.+......++.+++..+.-||..| |+|+|+++.|||++
T Consensus 97 a~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~ 172 (268)
T PRK15123 97 AFGERGSNPATRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLH 172 (268)
T ss_pred EEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEe
Confidence 44432 23468999999875 79888864321 33556777889999999999999999 99999999999997
Q ss_pred C-------CCCEEEeeccCCcC
Q 015909 219 S-------NYNAKLSDFGLARD 233 (398)
Q Consensus 219 ~-------~~~~kl~Dfg~a~~ 233 (398)
. ++.+.|+||+.+..
T Consensus 173 ~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 173 LPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccccCCCCCceEEEEECCcccc
Confidence 4 46899999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-09 Score=90.92 Aligned_cols=97 Identities=23% Similarity=0.239 Sum_probs=63.3
Q ss_pred HHHHHHHHcCCCCC--cccceeeEEEeCCceEEEEeecC--CCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HH
Q 015909 125 WLTEINYLGQLHHP--NLVKLVGYCLEDDHRLLVYEFMP--RGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF-LH 199 (398)
Q Consensus 125 ~~~E~~~l~~l~h~--~I~~~~~~~~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH 199 (398)
..+|++.|..+..- ++.+++++. .-++||||++ |..+..+.... ++......++.+++..+.. +|
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~ 124 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLH 124 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHH
Confidence 46799999999765 456666442 4479999997 55554443322 1122345566777775555 57
Q ss_pred cCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 200 ~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
..| |+|+||.+.||+++++ .+.|+|||.+...
T Consensus 125 ~~g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 125 KAG--IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp CTT--EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred hcC--ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 888 9999999999999877 9999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6e-10 Score=108.57 Aligned_cols=150 Identities=24% Similarity=0.325 Sum_probs=106.0
Q ss_pred HHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccc-------ccccccccccccccccccC
Q 015909 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV-------STRVMGTYGYAAPEYLATG 261 (398)
Q Consensus 189 ~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 261 (398)
.+++.|+.|+|..- .+||++|.|++|+++..+..||+.|+.+........... ..-......|.|||.+.+.
T Consensus 106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34558999999874 699999999999999999999999998876544221100 0112346689999999988
Q ss_pred CCCCchhHHHHHHHHHHHH-hCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhcc
Q 015909 262 HLTAKSDIYSFGVVLLEIL-SGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLS 340 (398)
Q Consensus 262 ~~~~~~DvwslG~~l~ell-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 340 (398)
..+.++|+||||+++|.+. .|+..+........ +.. ....+......++...+.++++-+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~---------~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSF---------SRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch-----hhh---------hhcccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999998 46655543221111 100 01111111223345668899999999999
Q ss_pred CCCCCCCCHHHHH
Q 015909 341 VEPKLRPDMDEVV 353 (398)
Q Consensus 341 ~dP~~Rps~~ell 353 (398)
.++.-||++.+++
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999777654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.6e-08 Score=88.68 Aligned_cols=135 Identities=16% Similarity=0.109 Sum_probs=95.5
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--c--------------------cchHHHHHHHHH
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--F--------------------QGHKEWLTEINY 131 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~--------------------~~~~~~~~E~~~ 131 (398)
+.++..||.|.-+.||.|... +|..+++|.=+... + -......+|.++
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 456788999999999999764 58899999633110 0 012235789999
Q ss_pred HcCCCCC--cccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecC
Q 015909 132 LGQLHHP--NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRD 209 (398)
Q Consensus 132 l~~l~h~--~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~D 209 (398)
|..|... .+.+.+++ +.-.+|||+++|-.|...-. +....-.++..|++-+..+-..| |||+|
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~G--iVHGD 227 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRRG--IVHGD 227 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHcC--ccccC
Confidence 9999755 67776654 34469999998866654321 12233344555555555555667 99999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcC
Q 015909 210 FKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
+++-||+|+++|.++++||--+..
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred CchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999976654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.3e-08 Score=81.98 Aligned_cols=139 Identities=19% Similarity=0.152 Sum_probs=99.5
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC---C---ccchHHHHHHHHHHcCCCCCc--ccceeeEEEe--
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE---G---FQGHKEWLTEINYLGQLHHPN--LVKLVGYCLE-- 149 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~~--I~~~~~~~~~-- 149 (398)
-|+||.+.|++..+. |..+-+|.-... . .-....|.+|+..|..|..-+ +.++......
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~ 94 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKI 94 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeecc
Confidence 467999999987553 335777765411 0 124577899999999985322 4444422111
Q ss_pred --CCceEEEEeecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC--EE
Q 015909 150 --DDHRLLVYEFMPR-GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN--AK 224 (398)
Q Consensus 150 --~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~--~k 224 (398)
.-..+||+|-+++ .+|.+++..... .+.+......++.+++.++.-||..| +.|+|+.+.||+++.++. +.
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEE
Confidence 1235799997743 578888765432 34577778889999999999999999 999999999999986667 99
Q ss_pred EeeccCCcC
Q 015909 225 LSDFGLARD 233 (398)
Q Consensus 225 l~Dfg~a~~ 233 (398)
++||.-++.
T Consensus 171 lIDlEk~r~ 179 (216)
T PRK09902 171 FLDLEKSRR 179 (216)
T ss_pred EEEhhccch
Confidence 999987764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.5e-08 Score=97.46 Aligned_cols=143 Identities=16% Similarity=0.155 Sum_probs=91.0
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccch------------------------------H----
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH------------------------------K---- 123 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------------------~---- 123 (398)
+.|+.++-|.||+|++. +|+.||||+.+..-.... +
T Consensus 131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 67999999999999886 499999999764311100 0
Q ss_pred ------HHHHHHHHHcCCC-----CCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 015909 124 ------EWLTEINYLGQLH-----HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192 (398)
Q Consensus 124 ------~~~~E~~~l~~l~-----h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~ 192 (398)
.+.+|+..+.++. .++|.-..=++.-.....++|||++|-.+.+...... ..++...+...+.++.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f 277 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF 277 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 1234555444442 2332211112333566789999999988888753322 1244333333222221
Q ss_pred HHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCC
Q 015909 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTG 237 (398)
Q Consensus 193 ~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~ 237 (398)
+..+-..| ++|.|..|.||+|+.+|++.+.|||+.....+.
T Consensus 278 --~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 278 --LRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --HHHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 22222356 999999999999999999999999998765443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.7e-07 Score=81.49 Aligned_cols=140 Identities=14% Similarity=0.134 Sum_probs=84.0
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCc--ccceeeEEEeCCceEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN--LVKLVGYCLEDDHRLL 155 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~--I~~~~~~~~~~~~~~l 155 (398)
.+||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++....+...+
T Consensus 7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEe-------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 56899999999984 24457788876532 3455788999998886433 4667777777777889
Q ss_pred EEeecCCCC-HHHHH--------------hh-----cCCCCCCCCHHHHHH-HHH----------HHHH-HHHHH--HcC
Q 015909 156 VYEFMPRGS-MENHL--------------FR-----RGSYFQPLSWSLRMK-IAL----------GAAN-GLAFL--HSA 201 (398)
Q Consensus 156 v~e~~~~~~-L~~~~--------------~~-----~~~~~~~l~~~~~~~-i~~----------qi~~-al~~L--H~~ 201 (398)
|||+++|.+ +...+ .. +.............. +.. .+.. ...+| +..
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998863 21111 00 000000111111000 000 0001 11122 122
Q ss_pred CCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 202 EPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 202 ~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
...++|+|+.|.||++++++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 23478999999999999888 99999988754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.7e-08 Score=83.88 Aligned_cols=106 Identities=25% Similarity=0.229 Sum_probs=81.6
Q ss_pred hHHHHHHHHHHcCCCCCc--ccceeeEEEeC----CceEEEEeecCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 015909 122 HKEWLTEINYLGQLHHPN--LVKLVGYCLED----DHRLLVYEFMPRG-SMENHLFRRGSYFQPLSWSLRMKIALGAANG 194 (398)
Q Consensus 122 ~~~~~~E~~~l~~l~h~~--I~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 194 (398)
.....+|...+..|..-+ +.+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 345677888777775333 34555555442 2358999999874 78888876432 4566778899999999
Q ss_pred HHHHHcCCCCceecCCCCCCEEEcCCC---CEEEeeccCCcC
Q 015909 195 LAFLHSAEPKVIYRDFKASNILLDSNY---NAKLSDFGLARD 233 (398)
Q Consensus 195 l~~LH~~~~~ivH~Dlkp~Nilv~~~~---~~kl~Dfg~a~~ 233 (398)
+.-||..| |+|+|+++.||||+.++ .+.|+||+.++.
T Consensus 131 i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 99999999999998776 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.3e-07 Score=77.66 Aligned_cols=137 Identities=14% Similarity=0.094 Sum_probs=88.3
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHH---------HHHHHHHHcCCC---C
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---------WLTEINYLGQLH---H 137 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h 137 (398)
...+|.+.+++-......|.+-.. ++..+++|..+......... ..+++..+..+. -
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~ 97 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF 97 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence 456777778887777777766543 57889999887653322111 223344333332 2
Q ss_pred CcccceeeEEE-----eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCC
Q 015909 138 PNLVKLVGYCL-----EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKA 212 (398)
Q Consensus 138 ~~I~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp 212 (398)
..+..++.+.. -....+++|||++|..|.+... ++. .++..+.+++.-||..| ++|+|..|
T Consensus 98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hp 163 (229)
T PF06176_consen 98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHP 163 (229)
T ss_pred cccccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC--CccCCCCc
Confidence 22223222221 2244568999999988766532 222 24456777899999999 99999999
Q ss_pred CCEEEcCCCCEEEeeccCCc
Q 015909 213 SNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 213 ~Nilv~~~~~~kl~Dfg~a~ 232 (398)
.|++++++ .++++||+..+
T Consensus 164 gNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 164 GNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CcEEEECC-cEEEEECcccc
Confidence 99999855 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.1e-06 Score=70.84 Aligned_cols=129 Identities=15% Similarity=0.125 Sum_probs=89.3
Q ss_pred CCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccc-eeeEEEeCCce
Q 015909 75 RPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVK-LVGYCLEDDHR 153 (398)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~-~~~~~~~~~~~ 153 (398)
++.+.|++|++|.||+|.+ .|..+|+|+-+.+ .....+..|+++|..++-.++-+ ++.+. ..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-----------~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~ 87 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-----------RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----ED 87 (201)
T ss_pred hhhhhhhcccccEEEEeec-----------cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hh
Confidence 4567899999999999987 3568999987765 34567889999999887666543 34332 22
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCC-CCEEEcCCCCEEEeeccCCc
Q 015909 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKA-SNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 154 ~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp-~Nilv~~~~~~kl~Dfg~a~ 232 (398)
++.|||+.|-.|.++.... +... +..+++.---|-..| |-|+.|.- ...++..++.+.|+||..|+
T Consensus 88 ~i~me~i~G~~L~~~~~~~-------~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG-------DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc-------cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 4559999887887665421 1222 334555555566667 99998874 44444445599999999887
Q ss_pred C
Q 015909 233 D 233 (398)
Q Consensus 233 ~ 233 (398)
.
T Consensus 155 ~ 155 (201)
T COG2112 155 F 155 (201)
T ss_pred h
Confidence 3
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.4e-06 Score=73.86 Aligned_cols=75 Identities=16% Similarity=0.096 Sum_probs=51.2
Q ss_pred ecccCC-ceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEeCCceEEEE
Q 015909 80 LGEGGF-GSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLLVY 157 (398)
Q Consensus 80 lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~ 157 (398)
|-.|.. ..||+... .+..+++|...... ...+.+|+.+++.+. +--+.+++++....+..++||
T Consensus 6 ~~~g~~~~~v~~~~~-----------~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDG-----------KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcC-----------CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 444555 88998732 23578888876542 345668888888874 334567777776666789999
Q ss_pred eecCCCCHHHH
Q 015909 158 EFMPRGSMENH 168 (398)
Q Consensus 158 e~~~~~~L~~~ 168 (398)
++++|.+|...
T Consensus 72 e~i~G~~l~~~ 82 (244)
T cd05150 72 SAVPGVPAAAL 82 (244)
T ss_pred EeeCCccHhHh
Confidence 99998777643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.7e-06 Score=72.68 Aligned_cols=151 Identities=18% Similarity=0.156 Sum_probs=97.6
Q ss_pred CCHHHHHHHhcCCCCCceec---ccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc-----------------
Q 015909 62 FSYSDLRTATRNFRPDSVLG---EGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG----------------- 121 (398)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg---~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------------- 121 (398)
.+...+....++..+..+.| .|.-+.||+|.. +.+..+|+|+++......
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~----------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~ 104 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET----------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSR 104 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc----------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCC
Confidence 44556666667777766655 566777999853 258899999986432211
Q ss_pred --hH-----HHHHHHHHHcCCC--CCcccceeeEEEeCCceEEEEeecCCCCH-HHHHhhcCCCCCCCCHHHHHHHHHHH
Q 015909 122 --HK-----EWLTEINYLGQLH--HPNLVKLVGYCLEDDHRLLVYEFMPRGSM-ENHLFRRGSYFQPLSWSLRMKIALGA 191 (398)
Q Consensus 122 --~~-----~~~~E~~~l~~l~--h~~I~~~~~~~~~~~~~~lv~e~~~~~~L-~~~~~~~~~~~~~l~~~~~~~i~~qi 191 (398)
.. ....|+.-|+++. +=.+.+.+.+. ...|||||+....+ .-.+.. -++.......+..++
T Consensus 105 ~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~ 175 (268)
T COG1718 105 SNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDV 175 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHH
Confidence 01 1245777777774 33344445443 34799999954310 000111 112222456667778
Q ss_pred HHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 192 ANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 192 ~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
++.+.-|-. .+ +||+||+.-|||+. ++.+.|+|||-|...
T Consensus 176 v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 176 VEYMRRLYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHHHHHhcC--cccccchhhheEEE-CCeEEEEECcccccc
Confidence 888887776 56 99999999999999 889999999998764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.4e-06 Score=74.05 Aligned_cols=77 Identities=16% Similarity=0.226 Sum_probs=53.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCC--cccceeeEEEe---CCc
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP--NLVKLVGYCLE---DDH 152 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--~I~~~~~~~~~---~~~ 152 (398)
+.|+.|..+.||+.... +..+++|..... .....+..|..+++.|... .+.+++..... ...
T Consensus 3 ~~l~~G~~n~~~~v~~~-----------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD-----------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEESSSSEEEEEEET-----------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred ccCCCCCeeeEEEEEEC-----------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 57899999999998542 358999987654 3446677888888887533 34566654322 234
Q ss_pred eEEEEeecCCCCHHH
Q 015909 153 RLLVYEFMPRGSMEN 167 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~ 167 (398)
.+++|++++|..+..
T Consensus 70 ~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEEEESSEEHHH
T ss_pred ceEEEEEeccccccc
Confidence 689999999887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.5e-08 Score=95.54 Aligned_cols=188 Identities=19% Similarity=0.125 Sum_probs=130.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCc-ccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN-LVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~-I~~~~~~~~~~ 150 (398)
..|....-+++|++++++|.+.. ..+....+.+... ....-++++|.+++||| .+..++.+..+
T Consensus 242 kws~~fh~fvK~altknpKkRpt----------aeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E 306 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPT----------AEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGE 306 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCC----------hhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence 34444455889999999986432 1222234544333 34456889999999999 66777767777
Q ss_pred CceEEEEeecCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 DHRLLVYEFMPRG-SMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 ~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..+++++++.++ +-........ ..+..-....+...-+.++++||+.. -+|+| ||+..+ +..+..||+
T Consensus 307 ~~~~i~~~i~s~~rs~~~~~~~se---~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSALEMTVSE---IALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred cccchhhhhhcCCccccccCChhh---Hhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-ccccccccc
Confidence 8889999999766 1111111000 01222233445566677899999875 58998 776654 689999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~ 287 (398)
....+.... ......+|+.|+|||+..+..+....|+|++|.-..+|--|-+|-.
T Consensus 377 v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 377 VPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 887654433 3445679999999999999999999999999998888888877754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.3e-06 Score=81.71 Aligned_cols=141 Identities=15% Similarity=0.087 Sum_probs=88.0
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc-------------------------------hH--
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-------------------------------HK-- 123 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~-- 123 (398)
.+.||.-+.|.||+|+.+ +|+.||||+-+..-... .+
T Consensus 166 ~~piaaASlaQVhrA~L~----------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L 235 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLK----------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSL 235 (538)
T ss_pred cchhhhcchhheEEEEec----------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhh
Confidence 367999999999999875 38999999865321100 00
Q ss_pred ----HHHHHHHHHcC----CCCCc------ccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHH
Q 015909 124 ----EWLTEINYLGQ----LHHPN------LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189 (398)
Q Consensus 124 ----~~~~E~~~l~~----l~h~~------I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~ 189 (398)
.|.+|++-..+ +.|-+ |.+++ +.......|+|||++|..+.++-.-.. ..++...+..-+.
T Consensus 236 ~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~ 310 (538)
T KOG1235|consen 236 PQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLV 310 (538)
T ss_pred HhhcchHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHH
Confidence 12234433222 22333 33333 233456789999999987766543222 1255555444444
Q ss_pred HHHHHHHHHHcCCCCceecCCCCCCEEEc----CCCCEEEeeccCCcCCCC
Q 015909 190 GAANGLAFLHSAEPKVIYRDFKASNILLD----SNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 190 qi~~al~~LH~~~~~ivH~Dlkp~Nilv~----~~~~~kl~Dfg~a~~~~~ 236 (398)
++..-+- -..| ++|+|=.|.||+|+ .++.+.+.|||+......
T Consensus 311 ~~~~~qI--f~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 311 EAYLEQI--FKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHH--HhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4332222 2246 99999999999998 367899999999876544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.4e-05 Score=65.98 Aligned_cols=102 Identities=25% Similarity=0.242 Sum_probs=77.7
Q ss_pred HHHHHHcCCCC-CcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CC
Q 015909 127 TEINYLGQLHH-PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE-PK 204 (398)
Q Consensus 127 ~E~~~l~~l~h-~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~ 204 (398)
.|.-+|+.+++ +++++++|+|- .++|.||...+++........ ..-..+|..+.+|+.++++.+.+|+... ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~-~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLS-QFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccc-cccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 57888888875 69999999984 367899997665542200000 0123589999999999999999998732 13
Q ss_pred ceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 205 VIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 205 ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
+.-.|++++|+-|++++++|++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.4e-05 Score=66.31 Aligned_cols=129 Identities=18% Similarity=0.246 Sum_probs=89.7
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC----------------ccchHHHHHHHHHHcCCC----
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG----------------FQGHKEWLTEINYLGQLH---- 136 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 136 (398)
..+||+|+.-.||.- + .+...+||+..... .....+..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H-----------P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH-----------P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC-----------C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 457999999999962 1 34456788887654 122345566666655554
Q ss_pred --CCcccceeeEEEeCCceEEEEeecCC------CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceec
Q 015909 137 --HPNLVKLVGYCLEDDHRLLVYEFMPR------GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYR 208 (398)
Q Consensus 137 --h~~I~~~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~ 208 (398)
+.+|.+++|+...+....+|+|.+.+ .+|.+++.... ++. .....+. +-..||-.+. |+.+
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~L~---~f~~~l~~~~--Iv~~ 142 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQALD---EFKRYLLDHH--IVIR 142 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHHHH---HHHHHHHHcC--Ceec
Confidence 78999999999999999999997642 46888885432 454 3333333 4456777777 9999
Q ss_pred CCCCCCEEEcCC--C--CEEEeec
Q 015909 209 DFKASNILLDSN--Y--NAKLSDF 228 (398)
Q Consensus 209 Dlkp~Nilv~~~--~--~~kl~Df 228 (398)
||+|.||++... + .+.|+|-
T Consensus 143 dl~~~NIv~~~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 143 DLNPHNIVVQRRDSGEFRLVLIDG 166 (199)
T ss_pred CCCcccEEEEecCCCceEEEEEeC
Confidence 999999999522 2 5777774
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.8e-05 Score=70.48 Aligned_cols=73 Identities=15% Similarity=0.161 Sum_probs=44.8
Q ss_pred ceecccCCc-eEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCC---cccceeeEEEeC---
Q 015909 78 SVLGEGGFG-SVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP---NLVKLVGYCLED--- 150 (398)
Q Consensus 78 ~~lg~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---~I~~~~~~~~~~--- 150 (398)
+.|+.|+.. .||+. +..+++|..... .....+.+|+++|..|... -+..+++.....
T Consensus 3 ~~~~~gG~~n~vy~~--------------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~ 66 (235)
T cd05155 3 EPVDSGGTDNATFRL--------------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY 66 (235)
T ss_pred eeccCCCcccceEEc--------------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence 567766665 59974 234677875542 2345788899999887532 234444433222
Q ss_pred CceEEEEeecCCCCHH
Q 015909 151 DHRLLVYEFMPRGSME 166 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~ 166 (398)
...+++|++++|.++.
T Consensus 67 ~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 67 PWPWSVYRWLEGETAT 82 (235)
T ss_pred CcceEEEEeecCCCCC
Confidence 2347899999886663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.8e-05 Score=79.00 Aligned_cols=81 Identities=17% Similarity=0.222 Sum_probs=54.8
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCC-CCcc--cceeeEEEeC--
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLH-HPNL--VKLVGYCLED-- 150 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~I--~~~~~~~~~~-- 150 (398)
.+.|+.|.+..+|+...... .....+++|+..... ......+.+|+.+|+.|. |.+| .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~-------~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG-------GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCC-------CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 46688999999998754320 011356777664322 233457889999999995 6665 6777766553
Q ss_pred -CceEEEEeecCCCC
Q 015909 151 -DHRLLVYEFMPRGS 164 (398)
Q Consensus 151 -~~~~lv~e~~~~~~ 164 (398)
+..|+||||++|..
T Consensus 116 ~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 IGTAFYIMEYLEGRI 130 (822)
T ss_pred CCCceEEEEecCCcc
Confidence 45789999998764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.5e-05 Score=68.88 Aligned_cols=138 Identities=17% Similarity=0.092 Sum_probs=75.5
Q ss_pred ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-cceeeEEEeCCceEEEEe
Q 015909 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-VKLVGYCLEDDHRLLVYE 158 (398)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e 158 (398)
+..|-...+|+... ++..+++|........-.-...+|..+++.+....+ .+++... . .++|||
T Consensus 4 ~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE 68 (256)
T ss_pred CCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence 45677888998642 456788887654321110124678888888864333 3344332 2 368999
Q ss_pred ecCCCCHHHH-----------H---h---hcCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHcC------CCCc
Q 015909 159 FMPRGSMENH-----------L---F---RRGSYFQPLSWSL-RMKIALGA---------ANGLAFLHSA------EPKV 205 (398)
Q Consensus 159 ~~~~~~L~~~-----------~---~---~~~~~~~~l~~~~-~~~i~~qi---------~~al~~LH~~------~~~i 205 (398)
|++|..+... . . .......+++... +..+..++ ...+..+-.. ...+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9988665321 1 1 1111111222211 11111111 1112222111 1238
Q ss_pred eecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 206 IYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 206 vH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
+|+|+.|.||++++++ +.|+||+.+..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999876 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.8e-05 Score=80.85 Aligned_cols=197 Identities=21% Similarity=0.233 Sum_probs=136.8
Q ss_pred HHHHHHHHcCCCCCcccceeeEEEeCCceE----EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 015909 125 WLTEINYLGQLHHPNLVKLVGYCLEDDHRL----LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS 200 (398)
Q Consensus 125 ~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~----lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 200 (398)
...|+..+..+.|+|+..++.|.......- +..++|..-++...+...+ .++....+.+..++++|+.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH
Confidence 345777888889999999998876643332 3457788888888887664 47888999999999999999998
Q ss_pred CCCCceecCCCCC---CEEEcCCCCEEEe--eccCCcCCCCCCCcccccccccccccccccccccCCCCCc--hhHHHHH
Q 015909 201 AEPKVIYRDFKAS---NILLDSNYNAKLS--DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAK--SDIYSFG 273 (398)
Q Consensus 201 ~~~~ivH~Dlkp~---Nilv~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwslG 273 (398)
.. ..|.-|... +.-++..+.+.+. ||+.+.......... ...-+..+.++|......+..+ .|+|.+|
T Consensus 305 ~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 LS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred hc--cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 86 655555444 4444566667777 898887654443321 1233556788888766655544 7999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 015909 274 VVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVV 353 (398)
Q Consensus 274 ~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 353 (398)
.++..+..|..+-.... .....++. .......+.+.+|+..++++|+++.+++
T Consensus 380 ll~~~~~~~~~i~~~~~-------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA-------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCccccccc-------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 99999998765432110 00011100 0111567889999999999999999999
Q ss_pred HHHH
Q 015909 354 KELE 357 (398)
Q Consensus 354 ~~L~ 357 (398)
.+.-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 8743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00013 Score=62.31 Aligned_cols=125 Identities=30% Similarity=0.408 Sum_probs=86.8
Q ss_pred cCCCCCceecccCC-ceEEEEEecCCcccccCCCCCcEEEEEEccc---CC-------cc-----------chHHHHHHH
Q 015909 72 RNFRPDSVLGEGGF-GSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ---EG-------FQ-----------GHKEWLTEI 129 (398)
Q Consensus 72 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~---~~-------~~-----------~~~~~~~E~ 129 (398)
.+++.++.||.|.- |.||++.. .|..||+|++.. .. .. ...-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 67788899999999 99999976 577999999321 10 00 112356777
Q ss_pred HHHcCCC---CCcc--cceeeEEEeCC------------------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 015909 130 NYLGQLH---HPNL--VKLVGYCLEDD------------------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186 (398)
Q Consensus 130 ~~l~~l~---h~~I--~~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~ 186 (398)
+...+|+ +.++ ++++||..-.. ...||.||.+... .+....
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~--- 169 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD--- 169 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH---
Confidence 7766664 5566 89999874321 1357888775533 122233
Q ss_pred HHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 187 i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
+.+|..-|..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 170 -~~~~~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 -IPQMLRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -HHHHHHHHHHHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence 445666778899999 999999999986 3478999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=65.11 Aligned_cols=75 Identities=19% Similarity=0.150 Sum_probs=45.6
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-cceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-VKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-~~~~~~~~~~~~~~lv 156 (398)
+.|..|-...+|+..... ..+..|++|+....... .....+|+.+++.+...++ .+++.... -.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~--------~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKE--------DNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCC--------CCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence 457778888999874321 02467889977543221 1223478888888854333 34443322 2489
Q ss_pred EeecCCCCH
Q 015909 157 YEFMPRGSM 165 (398)
Q Consensus 157 ~e~~~~~~L 165 (398)
|||++|.++
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00035 Score=64.47 Aligned_cols=77 Identities=10% Similarity=-0.019 Sum_probs=53.8
Q ss_pred CCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCC---CcccceeeEEEe---
Q 015909 76 PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH---PNLVKLVGYCLE--- 149 (398)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~~I~~~~~~~~~--- 149 (398)
-.+.||.|..+.||+... .+..+++|..+.. .....+..|+..|+.|.- -.+.++++++..
T Consensus 18 ~~~~i~~G~~~~vy~~~~-----------~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 18 RVECISEQPYAALWALYD-----------SQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred eeeecCCccceeEEEEEc-----------CCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 346799999999998643 1234667775331 123577899999988853 357788877654
Q ss_pred CCceEEEEeecCCCCH
Q 015909 150 DDHRLLVYEFMPRGSM 165 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L 165 (398)
.+..++|||++++.++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 3668999999988654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0015 Score=61.11 Aligned_cols=30 Identities=27% Similarity=0.362 Sum_probs=25.6
Q ss_pred CceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 204 KVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 204 ~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
++||+|+.|.||+++++...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 499999999999998665568999988754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00065 Score=62.71 Aligned_cols=143 Identities=15% Similarity=0.110 Sum_probs=80.1
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCc--ccceee------EEE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN--LVKLVG------YCL 148 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~--I~~~~~------~~~ 148 (398)
.+.|..|....+|+... .+..+++|+... .....+..|+.++..|.+.+ +.+++. +..
T Consensus 19 i~~i~~G~~n~~y~v~~-----------~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTT-----------DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEe-----------CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 34577787789998643 234688898764 22345667777777774322 333332 112
Q ss_pred eCCceEEEEeecCCCCHHH----HHh----------hcC-CCCC------CCCHHHHH----------HHHHHHHHHHHH
Q 015909 149 EDDHRLLVYEFMPRGSMEN----HLF----------RRG-SYFQ------PLSWSLRM----------KIALGAANGLAF 197 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~----~~~----------~~~-~~~~------~l~~~~~~----------~i~~qi~~al~~ 197 (398)
..+..++|+++++|..+.. ... ... .... ...+.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456689999998865421 110 000 0000 00111000 011112233444
Q ss_pred HHc-----CCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 198 LHS-----AEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 198 LH~-----~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
+.. ....++|+|+.|.||++++++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 442 112499999999999999877778999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0014 Score=62.60 Aligned_cols=76 Identities=20% Similarity=0.170 Sum_probs=51.2
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEccc------CC-ccchHHHHHHHHHHcCCC---CCcccceeeEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ------EG-FQGHKEWLTEINYLGQLH---HPNLVKLVGYC 147 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~---h~~I~~~~~~~ 147 (398)
+.||-|.+..||++...+ .+..|+||.-.. +. ....+....|.+.|+.+. ..++.+++.+
T Consensus 32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 568999999999986532 224789997431 11 123456677888888763 2456667765
Q ss_pred EeCCceEEEEeecCCCC
Q 015909 148 LEDDHRLLVYEFMPRGS 164 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~ 164 (398)
+.+..++|||++++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 4566789999997643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00058 Score=63.29 Aligned_cols=81 Identities=19% Similarity=0.193 Sum_probs=47.7
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-cceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-VKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-~~~~~~~~~~~~~~lv 156 (398)
+.|..|-...||+....... .....+..+++|+..... .......+|+.++..+...++ .+++..+. -.+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCch
Confidence 34556777789987543210 012246789999876542 222345678888888753333 34454442 2368
Q ss_pred EeecCCCCHH
Q 015909 157 YEFMPRGSME 166 (398)
Q Consensus 157 ~e~~~~~~L~ 166 (398)
++|++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9998887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=9.1e-06 Score=86.28 Aligned_cols=159 Identities=14% Similarity=0.008 Sum_probs=119.2
Q ss_pred HHHHHHHcCCCCCcccceeeEEEe--CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--
Q 015909 126 LTEINYLGQLHHPNLVKLVGYCLE--DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-- 201 (398)
Q Consensus 126 ~~E~~~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-- 201 (398)
+.|..-++...|+++.....-... ....+..++++.+|.+.+.+.+.-...+++....+.....+.+.+..-+|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344445555678887765554432 3456889999999999999988776667776666555555445566665544
Q ss_pred -CCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHH
Q 015909 202 -EPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEIL 280 (398)
Q Consensus 202 -~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 280 (398)
+.-.+|++||+-|.+|..+..++++++|+.+...+ .........+++.|++|++...-.++.++|+|..|+.+|...
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 33478999999999999999999999999983221 222234466788999999998888998999999999999999
Q ss_pred hCCCCC
Q 015909 281 SGRRAI 286 (398)
Q Consensus 281 ~g~~p~ 286 (398)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888776
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0015 Score=60.61 Aligned_cols=157 Identities=16% Similarity=0.128 Sum_probs=83.1
Q ss_pred HHHHHHHhcCCCC-----CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCC
Q 015909 64 YSDLRTATRNFRP-----DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138 (398)
Q Consensus 64 ~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 138 (398)
.+.+......|.+ .+.++.|....+|+... ++..+++|+..... ....+..|+.++..|...
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t-----------~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~ 75 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTT-----------DVGRYILTLYEKRV--KAEELPFFLALTTHLAAR 75 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEe-----------CCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHC
Confidence 3444444445544 34567777789998642 23357788765421 234455667777666422
Q ss_pred c--ccceeeE------EEeCCceEEEEeecCCCCHH----HHH----------hhcCC-CCCC------CC-HHHHH---
Q 015909 139 N--LVKLVGY------CLEDDHRLLVYEFMPRGSME----NHL----------FRRGS-YFQP------LS-WSLRM--- 185 (398)
Q Consensus 139 ~--I~~~~~~------~~~~~~~~lv~e~~~~~~L~----~~~----------~~~~~-~~~~------l~-~~~~~--- 185 (398)
+ +.+++.. ....+..+++++|++|..+. ... ..... ...+ +. |....
T Consensus 76 g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~ 155 (307)
T TIGR00938 76 GLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKC 155 (307)
T ss_pred CCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhh
Confidence 2 3333321 12245678999999875431 111 11000 0000 00 00000
Q ss_pred ---------HHHHHHHHHHHHHHc-----CCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 186 ---------KIALGAANGLAFLHS-----AEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 186 ---------~i~~qi~~al~~LH~-----~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
.....+...++++.. ....++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 156 ~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 156 FEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 001112334444532 123499999999999999887778999988753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0019 Score=60.92 Aligned_cols=145 Identities=16% Similarity=0.105 Sum_probs=78.4
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-cceeeEEEeCCceEEEE
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-VKLVGYCLEDDHRLLVY 157 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~ 157 (398)
.|-.|-.-.+|++...+. ....+..|++|+.......... ...|+.+++.+..-++ .++++.+... .|.
T Consensus 43 ~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 454577888998754321 1113468899988654322222 2578888888854433 3455554322 578
Q ss_pred eecCCCCHHHH-------H----------hhcCCCC-C-CCCHHHHHHHHHHH-----------------HHHHHH----
Q 015909 158 EFMPRGSMENH-------L----------FRRGSYF-Q-PLSWSLRMKIALGA-----------------ANGLAF---- 197 (398)
Q Consensus 158 e~~~~~~L~~~-------~----------~~~~~~~-~-~l~~~~~~~i~~qi-----------------~~al~~---- 197 (398)
+|+++.+|... + +...... . ...+..+..++.++ ...+..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 88877665421 0 0000000 0 11122222222111 111111
Q ss_pred HHc--CCCCceecCCCCCCEEEcC-CCCEEEeeccCCcC
Q 015909 198 LHS--AEPKVIYRDFKASNILLDS-NYNAKLSDFGLARD 233 (398)
Q Consensus 198 LH~--~~~~ivH~Dlkp~Nilv~~-~~~~kl~Dfg~a~~ 233 (398)
+.. ....++|+|+++.||++++ ++.+.|+||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 221 1124899999999999976 46899999988753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.00026 Score=64.26 Aligned_cols=134 Identities=13% Similarity=0.107 Sum_probs=88.8
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC--Cc---c-----------------chHHHHHHHHH
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE--GF---Q-----------------GHKEWLTEINY 131 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~---~-----------------~~~~~~~E~~~ 131 (398)
+.++..||-|.-+-||.+-+. .|...++|.=+.. .+ . ++-...+|+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred hhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 567788999999999998654 4777777753211 00 0 01123568888
Q ss_pred HcCCCC-C-cccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecC
Q 015909 132 LGQLHH-P-NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRD 209 (398)
Q Consensus 132 l~~l~h-~-~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~D 209 (398)
|+.|.. - -+.+.+++ +.-++|||++.+..|...-.. .+... +...+..-+--|-.+| +||+|
T Consensus 164 mkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~---ly~~lm~~Iv~la~~G--lIHgD 227 (465)
T KOG2268|consen 164 MKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPT---LYDDLMGLIVRLANHG--LIHGD 227 (465)
T ss_pred HHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CChHH---HHHHHHHHHHHHHHcC--ceecc
Confidence 888753 2 24444443 344789999988777544322 22233 3334444556677778 99999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcC
Q 015909 210 FKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
..-=||+|.+++.++++||--+..
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred cchheeEEecCCCEEEeechHhhc
Confidence 999999999999999999975543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0039 Score=56.87 Aligned_cols=30 Identities=23% Similarity=0.374 Sum_probs=25.3
Q ss_pred CceecCCCCCCEEEcCCCC-EEEeeccCCcC
Q 015909 204 KVIYRDFKASNILLDSNYN-AKLSDFGLARD 233 (398)
Q Consensus 204 ~ivH~Dlkp~Nilv~~~~~-~kl~Dfg~a~~ 233 (398)
.++|+|+.|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999987555 46999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.01 Score=54.32 Aligned_cols=73 Identities=21% Similarity=0.237 Sum_probs=46.3
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC---CCcccceeeEEEeCCce
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH---HPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~~I~~~~~~~~~~~~~ 153 (398)
.+.|+-|....+|+.. .++..+.+|.-... ....+..|++-|+.|. .-.+.+++++....+..
T Consensus 22 ~~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-----------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEE-----------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEE-----------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 3568888899999864 25778999987632 2345677888888773 44677889888888888
Q ss_pred EEEEeecCCC
Q 015909 154 LLVYEFMPRG 163 (398)
Q Consensus 154 ~lv~e~~~~~ 163 (398)
+|||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.014 Score=53.93 Aligned_cols=122 Identities=20% Similarity=0.269 Sum_probs=73.2
Q ss_pred CcEEEEEEcc-cCCccchHHHHHHHHHHcCCCC--CcccceeeEEEeCC--ceEEEEeecCCCCHHHHHhhcCCCCCCCC
Q 015909 106 GMLIAVKRLN-QEGFQGHKEWLTEINYLGQLHH--PNLVKLVGYCLEDD--HRLLVYEFMPRGSMENHLFRRGSYFQPLS 180 (398)
Q Consensus 106 ~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~~I~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~l~ 180 (398)
++.++++.-. ...........+|+.+++.+.- --+...++.+.++. ..|.||+|++|..+.+..... +
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~-------~ 120 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE-------S 120 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc-------c
Confidence 6677777221 2233445666788888888743 22334455555544 569999999874332221110 0
Q ss_pred HHHHHHHH-HHHHHHHHHHHcC--------------------------------------------------C------C
Q 015909 181 WSLRMKIA-LGAANGLAFLHSA--------------------------------------------------E------P 203 (398)
Q Consensus 181 ~~~~~~i~-~qi~~al~~LH~~--------------------------------------------------~------~ 203 (398)
.. ..++ ..++..|.-||+- . .
T Consensus 121 ~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 121 LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 00 1111 1344444444432 1 1
Q ss_pred CceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 204 KVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 204 ~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
.++|+|+.+.|++++.++-+=++||+++....+
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 389999999999999888899999999876433
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0022 Score=61.81 Aligned_cols=50 Identities=24% Similarity=0.366 Sum_probs=40.4
Q ss_pred hHHHHHHHHHHcCCCCCcccceeeEEEeC-CceEEEEeecCCCCHHHHHhhc
Q 015909 122 HKEWLTEINYLGQLHHPNLVKLVGYCLED-DHRLLVYEFMPRGSMENHLFRR 172 (398)
Q Consensus 122 ~~~~~~E~~~l~~l~h~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~ 172 (398)
..+++..+.+++.+.|+|...++++.... ...++|||++ +.+|++++..+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 45677888999999999999998876543 4468899999 77999988754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0069 Score=52.24 Aligned_cols=102 Identities=14% Similarity=0.127 Sum_probs=66.6
Q ss_pred EEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 015909 108 LIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186 (398)
Q Consensus 108 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~ 186 (398)
+..+|++..-... ....+..+..++.++. .|+++..- +.-.+-+++|.|..... .. ..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~----~N 145 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NF----SN 145 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------ch----hH
Confidence 4556666544333 3445677888888764 46666532 33345689999843111 11 11
Q ss_pred HHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 187 i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
++..=+.+|.-.|+.....+|+|..|+||+-|..|.+||.|=+.
T Consensus 146 ~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 146 FITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 11112467888897766799999999999999999999999765
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.024 Score=52.63 Aligned_cols=29 Identities=24% Similarity=0.310 Sum_probs=25.2
Q ss_pred CceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 204 KVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 204 ~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 4899999999999987 6789999987643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.034 Score=52.18 Aligned_cols=73 Identities=16% Similarity=0.138 Sum_probs=45.5
Q ss_pred eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcc-------cCCccchHHHHHHHHHHcCCC--CC-cccceeeEEE
Q 015909 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN-------QEGFQGHKEWLTEINYLGQLH--HP-NLVKLVGYCL 148 (398)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~-------~~~~~~~~~~~~E~~~l~~l~--h~-~I~~~~~~~~ 148 (398)
.||-|....||++.... .+..|+||.-. .......+...-|.+.|+... .| ++.+++. .
T Consensus 2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~ 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F 70 (370)
T ss_pred cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence 47889999999986421 23578888632 111233445566777777653 34 4455553 4
Q ss_pred eCCceEEEEeecCC
Q 015909 149 EDDHRLLVYEFMPR 162 (398)
Q Consensus 149 ~~~~~~lv~e~~~~ 162 (398)
+.+...+|||+++.
T Consensus 71 D~e~~~~vMEdL~~ 84 (370)
T TIGR01767 71 DTEMAVTVMEDLSH 84 (370)
T ss_pred ccccceehHhhCcc
Confidence 55666799998854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.002 Score=56.30 Aligned_cols=28 Identities=32% Similarity=0.466 Sum_probs=20.1
Q ss_pred ceecCCCCCCEEE-cCCCCEEEeeccCCc
Q 015909 205 VIYRDFKASNILL-DSNYNAKLSDFGLAR 232 (398)
Q Consensus 205 ivH~Dlkp~Nilv-~~~~~~kl~Dfg~a~ 232 (398)
++|+||.+.||++ +.++.++|+||..|.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 7899999999999 888999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.013 Score=54.47 Aligned_cols=139 Identities=17% Similarity=0.165 Sum_probs=87.1
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cc------------------------hHHHHHHHH
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QG------------------------HKEWLTEIN 130 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~------------------------~~~~~~E~~ 130 (398)
...|..|--+-||.|.-. +|..+|||+++..-+ .+ .-....|++
T Consensus 149 nGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~R 218 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMR 218 (520)
T ss_pred ccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHH
Confidence 345777888899987543 577799998753211 00 012356888
Q ss_pred HHcCCCCCcccceeeEEEeCCceEEEEeecCCCCHH-HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecC
Q 015909 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSME-NHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRD 209 (398)
Q Consensus 131 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~D 209 (398)
-|++|+...|.-.--+.. ..-.|||+|+...... -.+.. -.++...+..+-.+++.-|.-|.+.- ++||.|
T Consensus 219 NLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c-~LVHAD 290 (520)
T KOG2270|consen 219 NLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC-RLVHAD 290 (520)
T ss_pred HHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh-ceeccc
Confidence 888887655432111111 2336999998422111 11111 23555566667777777777775442 499999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 210 FKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
|.--|+|+. +|.+.|+|.+-+...
T Consensus 291 LSEfN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 291 LSEFNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred hhhhhheEE-CCEEEEEEccccccC
Confidence 999999995 578999999887653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.017 Score=54.13 Aligned_cols=77 Identities=16% Similarity=0.178 Sum_probs=43.9
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-cceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-VKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-~~~~~~~~~~~~~~lv 156 (398)
+.|..|--..+|+...... ..++..|++|+...... ..-.-.+|..+++.+..-++ .++++++. . .+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~------~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEE------NGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-N---GMI 88 (330)
T ss_pred EEeCCcccceEEEEEecCC------CCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-C---cEe
Confidence 3454477788998754321 11234788998764322 11223478888888865444 34555442 2 158
Q ss_pred EeecCCCCH
Q 015909 157 YEFMPRGSM 165 (398)
Q Consensus 157 ~e~~~~~~L 165 (398)
.+|+++.+|
T Consensus 89 ~~fi~g~~l 97 (330)
T PLN02421 89 QSFINARTL 97 (330)
T ss_pred ehhhcCCCC
Confidence 888877654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.037 Score=51.44 Aligned_cols=30 Identities=17% Similarity=0.184 Sum_probs=27.3
Q ss_pred CceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 204 KVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 204 ~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
.+||+|+.+.||++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.089 Score=50.35 Aligned_cols=73 Identities=10% Similarity=0.033 Sum_probs=46.2
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-------cchHHHHHHHHHHcCCC---CCcccceeeE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-------QGHKEWLTEINYLGQLH---HPNLVKLVGY 146 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~~I~~~~~~ 146 (398)
.+.||-|....||+... .+..++||.-..... -.......|+..|+.+. ..++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~-----------~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-----------SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEc-----------CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 45689999999999753 234578887541100 12334445667666653 2467777776
Q ss_pred EEeCCceEEEEeecCC
Q 015909 147 CLEDDHRLLVYEFMPR 162 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~ 162 (398)
+. +..+++||++++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 55 557889999966
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.019 Score=53.34 Aligned_cols=72 Identities=19% Similarity=0.167 Sum_probs=53.8
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..|++|++- |+.+.. + +...++++..++.+.+..+.-+..+ -+.-|||+.-.||||+ +|+|.|+||-++
T Consensus 300 y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEeeee
Confidence 446777764 544432 2 2245677888888888777666654 3688999999999999 999999999999
Q ss_pred cCC
Q 015909 232 RDG 234 (398)
Q Consensus 232 ~~~ 234 (398)
+..
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 853
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.02 Score=53.96 Aligned_cols=60 Identities=18% Similarity=0.166 Sum_probs=40.0
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
..++=+|..|..+..++...+ .+++....++.-...|+..+---+ +++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~vD-NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLIVD-NFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHHhh-cceecccCCCcEEEE
Confidence 345556777888888887654 355555666655555554443222 399999999999994
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.046 Score=52.02 Aligned_cols=75 Identities=19% Similarity=0.226 Sum_probs=47.4
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcc------cCCccchHHHHHHHHHHcCCC--CC-cccceeeEE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN------QEGFQGHKEWLTEINYLGQLH--HP-NLVKLVGYC 147 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~------~~~~~~~~~~~~E~~~l~~l~--h~-~I~~~~~~~ 147 (398)
.+.||-|.-..||++.+.. .+..|+||.-. .+..-..++..-|.+.|+.+. .| ++.+++.
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-- 102 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-- 102 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence 3578999999999986521 24567887532 111233456667788887663 34 4555553
Q ss_pred EeCCceEEEEeecCC
Q 015909 148 LEDDHRLLVYEFMPR 162 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~ 162 (398)
.+.....+|||+++.
T Consensus 103 ~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 103 FDSVMNCCVMEDLSD 117 (409)
T ss_pred ECcHHhhHHHHhCcc
Confidence 455666788888854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.3 Score=42.71 Aligned_cols=59 Identities=24% Similarity=0.303 Sum_probs=41.5
Q ss_pred CCcEEEEEEcccCCccchHHHHHHHHHHcCCC---CCcccceeeEEEeCCceEEEEeecCCCCHH
Q 015909 105 TGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH---HPNLVKLVGYCLEDDHRLLVYEFMPRGSME 166 (398)
Q Consensus 105 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~ 166 (398)
....+.+|+-... ....|..|+.-|..|. .-.+.+++.+....++.|+||||++.+.+.
T Consensus 38 g~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 38 GTDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 3467888875433 2244566776666653 456778888888999999999999875544
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.19 Score=48.05 Aligned_cols=81 Identities=12% Similarity=0.092 Sum_probs=43.8
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-cceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-VKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-~~~~~~~~~~~~~~lv 156 (398)
+.|..|-...+|++...+.. ...-....|.++...... ...-.-.+|+.+++.+...++ .++++.+. .+++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~---~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGD---KDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCC---CCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 44555888999998654310 000011224555432211 111122468888888865544 44555543 2699
Q ss_pred EeecCCCCHH
Q 015909 157 YEFMPRGSME 166 (398)
Q Consensus 157 ~e~~~~~~L~ 166 (398)
.||++|.+|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999887654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.26 Score=48.13 Aligned_cols=82 Identities=10% Similarity=0.084 Sum_probs=45.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCccc-ceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLV-KLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~-~~~~~~~~~~~~~lv 156 (398)
+.|..|-.-.+|++...... ....+..+..|++++.......-. .-..|..+++.+...+|- ++++.+. -+.|
T Consensus 111 ~~l~gGlTN~~f~v~~~~~~-~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 111 NQILSGLTNQLFEVSLKEET-ANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEecCcccCceEEEEecCCC-CccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 44656777888888654311 000112356888998865432211 234577777777544443 3444432 3567
Q ss_pred EeecCCCCH
Q 015909 157 YEFMPRGSM 165 (398)
Q Consensus 157 ~e~~~~~~L 165 (398)
.+|++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899987644
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.037 Score=46.92 Aligned_cols=28 Identities=25% Similarity=0.330 Sum_probs=25.0
Q ss_pred ceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 205 VIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 205 ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
.+|+|+.|.||++++++ ++|+||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998777 99999998754
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.05 E-value=0.062 Score=49.57 Aligned_cols=52 Identities=23% Similarity=0.274 Sum_probs=34.0
Q ss_pred HHHHHHHHHHHHHHHHHHH--cC--CCCceecCCCCCCEEEcCC------------------CCEEEeeccCCcCC
Q 015909 181 WSLRMKIALGAANGLAFLH--SA--EPKVIYRDFKASNILLDSN------------------YNAKLSDFGLARDG 234 (398)
Q Consensus 181 ~~~~~~i~~qi~~al~~LH--~~--~~~ivH~Dlkp~Nilv~~~------------------~~~kl~Dfg~a~~~ 234 (398)
..-+..++.||+ |-|+- .. -...+|-||||+||||-+. -..+|.||.+|+..
T Consensus 274 ~~YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 345677788875 44421 11 1238999999999999432 23677888887653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 398 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-56 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-47 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-47 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-46 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-44 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-17 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-16 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 530 bits (1368), Expect = 0.0
Identities = 115/323 (35%), Positives = 180/323 (55%), Gaps = 30/323 (9%)
Query: 50 EGEILQ--SSNIKNFSYSDLRTATRNFRP------DSVLGEGGFGSVFKGWVDEHSLAST 101
E + L+ + +FS+ +L+ T NF + +GEGGFG V+KG+V+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN------- 53
Query: 102 RPGTGMLIAVKRL----NQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVY 157
+AVK+L + + +++ EI + + H NLV+L+G+ + D LVY
Sbjct: 54 ----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109
Query: 158 EFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217
+MP GS+ + L PLSW +R KIA GAANG+ FLH E I+RD K++NILL
Sbjct: 110 VYMPNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILL 166
Query: 218 DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLL 277
D + AK+SDFGLAR ++ +++R++GT Y APE L G +T KSDIYSFGVVLL
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLL 225
Query: 278 EILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQ 337
EI++G A+D++R L++ + ++ I +D ++ + S+A Q
Sbjct: 226 EIITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQ 282
Query: 338 CLSVEPKLRPDMDEVVKELEQLQ 360
CL + RPD+ +V + L+++
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 520 bits (1342), Expect = 0.0
Identities = 120/330 (36%), Positives = 179/330 (54%), Gaps = 16/330 (4%)
Query: 35 SGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVD 94
K S + L DL AT NF ++G G FG V+KG +
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 95 EHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL 154
+ G +A+KR E QG +E+ TEI L HP+LV L+G+C E + +
Sbjct: 62 D----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111
Query: 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASN 214
L+Y++M G+++ HL+ +SW R++I +GAA GL +LH +I+RD K+ N
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSIN 169
Query: 215 ILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGV 274
ILLD N+ K++DFG+++ G D++H+ST V GT GY PEY G LT KSD+YSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 275 VLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASL 334
VL E+L R AI ++ P NL EWA ++ +++DP L + +K
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDT 288
Query: 335 ALQCLSVEPKLRPDMDEVVKELE---QLQE 361
A++CL++ + RP M +V+ +LE +LQE
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 442 bits (1139), Expect = e-156
Identities = 124/316 (39%), Positives = 187/316 (59%), Gaps = 16/316 (5%)
Query: 46 TPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGT 105
P E + +K FS +L+ A+ NF ++LG GGFG V+KG +
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------D 53
Query: 106 GMLIAVKRLNQEGFQGHK-EWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGS 164
G L+AVKRL +E QG + ++ TE+ + H NL++L G+C+ RLLVY +M GS
Sbjct: 54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113
Query: 165 MENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH-SAEPKVIYRDFKASNILLDSNYNA 223
+ + L R PL W R +IALG+A GLA+LH +PK+I+RD KA+NILLD + A
Sbjct: 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
+ DFGLA+ D +HV+T V GT G+ APEYL+TG + K+D++ +GV+LLE+++G+
Sbjct: 174 VVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 284 RAIDKNRPTGEH--NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSV 341
RA D R + L++W K L ++++ ++D L+G + + ++ +AL C
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 291
Query: 342 EPKLRPDMDEVVKELE 357
P RP M EVV+ LE
Sbjct: 292 SPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 1e-89
Identities = 73/329 (22%), Positives = 123/329 (37%), Gaps = 43/329 (13%)
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
+ +L + + V G FG V+K + +AVK + Q
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ 61
Query: 121 GHKEWL--TEINYLGQLHHPNLVKLVGYCLEDDH----RLLVYEFMPRGSMENHLFRRGS 174
W E+ L + H N+++ +G L+ F +GS+ + L
Sbjct: 62 ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--- 115
Query: 175 YFQPLSWSLRMKIALGAANGLAFLHS--------AEPKVIYRDFKASNILLDSNYNAKLS 226
+SW+ IA A GLA+LH +P + +RD K+ N+LL +N A ++
Sbjct: 116 --NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-----TAKSDIYSFGVVLLEILS 281
DFGLA G + + +GT Y APE L + D+Y+ G+VL E+ S
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 282 GRRAIDKNRPTGEHNLVEWAKPYLT----SKRRIFRVLDPRLEGQF-SLPQAQKAASLAL 336
A D E + + + + + P L +
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 337 QCLSVEPKLRPDMDEVVKELEQLQELRNM 365
+C + + R V + + Q+Q L N+
Sbjct: 294 ECWDHDAEARLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-69
Identities = 64/353 (18%), Positives = 124/353 (35%), Gaps = 55/353 (15%)
Query: 62 FSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG 121
+ S+ N + ++G G +G+V+KG +D +AVK + Q
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANRQ- 50
Query: 122 HKEWLTE--INYLGQLHHPNLVKLVGYCLEDD-----HRLLVYEFMPRGSMENHLFRRGS 174
++ E I + + H N+ + + LLV E+ P GS+ +L
Sbjct: 51 --NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--- 105
Query: 175 YFQPLSWSLRMKIALGAANGLAFLHS-------AEPKVIYRDFKASNILLDSNYNAKLSD 227
W ++A GLA+LH+ +P + +RD + N+L+ ++ +SD
Sbjct: 106 --HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 228 FGLAR------DGPTGDKSHVSTRVMGTYGYAAPEYL-------ATGHLTAKSDIYSFGV 274
FGL+ G++ + + +GT Y APE L + D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 275 VLLEILSGRRAIDKNRPTGEHNL----VEWAKPYLTSKRRI--FRVLDPRLEGQFSLPQA 328
+ EI + E+ + P + + P+ +
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283
Query: 329 --QKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRP-QKEHQAKGH 378
+ C + + R + + +L + +K H H
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHHH 336
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-67
Identities = 87/333 (26%), Positives = 147/333 (44%), Gaps = 45/333 (13%)
Query: 34 SSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKG-W 92
S + +P T + + + + DL + +G G FG+V + W
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK-------IGAGSFGTVHRAEW 58
Query: 93 VDEHSLASTRPGTGMLIAVKRLNQEGFQGH--KEWLTEINYLGQLHHPNLVKLVGYCLED 150
G +AVK L ++ F E+L E+ + +L HPN+V +G +
Sbjct: 59 ------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106
Query: 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDF 210
+ +V E++ RGS+ L + G+ L R+ +A A G+ +LH+ P +++R+
Sbjct: 107 PNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL 165
Query: 211 KASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIY 270
K+ N+L+D Y K+ DFGL+R + S S GT + APE L KSD+Y
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVY 223
Query: 271 SFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR--IFRVLDPRLEGQFSLPQA 328
SFGV+L E+ + + +P G N + +R I R L+P++
Sbjct: 224 SFGVILWELATLQ------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV--------- 268
Query: 329 QKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
A++ C + EP RP ++ L L +
Sbjct: 269 ---AAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-65
Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 57/300 (19%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-------KEWLTEIN 130
+G+GGFG V KG V ++A+K L +G +E+ E+
Sbjct: 26 QIGKGGFGLVHKGRLV----------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
+ L+HPN+VKL G +V EF+P G + + L + P+ WS+++++ L
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLD 130
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDS-----NYNAKLSDFGLARDGPTGDKSHVSTR 245
A G+ ++ + P +++RD ++ NI L S AK++DFGL++ H +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSG 185
Query: 246 VMGTYGYAAPEYLATGHL--TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL--VEWA 301
++G + + APE + T K+D YSF ++L IL+G P E++ +++
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIKFI 239
Query: 302 KPYLTSKRR--IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
R I PRL ++ C S +PK RP +VKEL +L
Sbjct: 240 NMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 6e-65
Identities = 76/317 (23%), Positives = 128/317 (40%), Gaps = 51/317 (16%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
VLG+G FG K T TG ++ +K L + + + +L E+ + L HP
Sbjct: 17 VLGKGCFGQAIKV---------THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N++K +G +D + E++ G++ + S WS R+ A A+G+A+L
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYL 124
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR------------DGPTGDKSHVSTRV 246
HS +I+RD + N L+ N N ++DFGLAR V
Sbjct: 125 HSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306
+G + APE + K D++SFG+VL EI+ A P
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----------------DPDYL 226
Query: 307 SKRRIFRVLDPRLEGQFSLPQAQKA----ASLALQCLSVEPKLRPDMDEVVKELEQLQE- 361
+ F + + G + ++C ++P+ RP ++ LE L+
Sbjct: 227 PRTMDFGL---NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
Query: 362 -LRNMHKRPQKEHQAKG 377
++ PQ E +G
Sbjct: 284 LAGHLPLGPQLEQLDRG 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 6e-65
Identities = 81/286 (28%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
V+G G FG V K W +A+K++ E + K ++ E+ L +++H
Sbjct: 15 VVGRGAFGVVCKAKW------------RAKDVAIKQIESESER--KAFIVELRQLSRVNH 60
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
PN+VKL G CL + LV E+ GS+ N L + + M L + G+A+
Sbjct: 61 PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAY 117
Query: 198 LHSAEPK-VIYRDFKASNILLDSNYN-AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAP 255
LHS +PK +I+RD K N+LL + K+ DFG A D T G+ + AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAP 172
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315
E + + K D++S+G++L E+++ R +P E + +
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFRIMWAVHNGT----- 221
Query: 316 DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
R +LP+ SL +C S +P RP M+E+VK + L
Sbjct: 222 --RPPLIKNLPKP--IESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 8e-65
Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 49/293 (16%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGH--KEWLTEINYLGQL 135
L E G ++KG W G I VK L + +++ E L
Sbjct: 17 KLNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 136 HHPNLVKLVGYCLE--DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
HPN++ ++G C H L+ +MP GS+ N L ++ + S +K AL A
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMAR 122
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
G+AFLH+ EP + + ++++D + A++S + S S M +
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWV 175
Query: 254 APEYL---ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
APE L +D++SF V+L E+++ P + + +E R
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLR 229
Query: 311 --IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
I + P + + L C++ +P RP D +V LE++Q+
Sbjct: 230 PTIPPGISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-61
Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 55/297 (18%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGH----KEWLTEINYLG 133
++G GGFG V++ W G +AVK + + + E
Sbjct: 14 IIGIGGFGKVYRAFW------------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
L HPN++ L G CL++ + LV EF G + L + + + + A+ A
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIAR 116
Query: 194 GLAFLHS-AEPKVIYRDFKASNILLD--------SNYNAKLSDFGLARDGPTGDKSHVST 244
G+ +LH A +I+RD K+SNIL+ SN K++DFGLAR+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKM 172
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
G Y + APE + + SD++S+GV+L E+L+G P + + A
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGV 226
Query: 305 LTSKRR--IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
+K I A L C + +P RP ++ +L +
Sbjct: 227 AMNKLALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-60
Identities = 69/295 (23%), Positives = 128/295 (43%), Gaps = 53/295 (17%)
Query: 80 LGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGH--KEWLTEINYLGQLH 136
+G G FG+V+KG W + +AVK LN + + E+ L +
Sbjct: 32 IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
H N++ +GY +V ++ S+ +HL + + IA A G+
Sbjct: 79 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMD 134
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+LH+ +I+RD K++NI L + K+ DFGLA + SH ++ G+ + APE
Sbjct: 135 YLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 257 ---YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LTSKRRI 311
+ + +SD+Y+FG+VL E+++G+ PY + ++ +I
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQL------------------PYSNINNRDQI 234
Query: 312 FRVLD------PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
++ + + + P+ L +CL + RP ++ E+E+L
Sbjct: 235 IEMVGRGSLSPDLSKVRSNCPKR--MKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-59
Identities = 62/357 (17%), Positives = 126/357 (35%), Gaps = 68/357 (19%)
Query: 32 SSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKG 91
+ S+ S P+ LQ +I + L +G+G FG V+ G
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIP---FEQLEIGEL-------IGKGRFGQVYHG 52
Query: 92 -WVDEHSLASTRPGTGMLIAVKRLNQEGFQGH--KEWLTEINYLGQLHHPNLVKLVGYCL 148
W E +A++ ++ E K + E+ Q H N+V +G C+
Sbjct: 53 RWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYR 208
H ++ ++ + + L + +IA G+ +LH+ ++++
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA--KGILHK 154
Query: 209 DFKASNILLDSNYNAKLSDFGLAR---DGPTGDKSHVSTRVMGTYGYAAPEYL------- 258
D K+ N+ D N ++DFGL G + G + APE +
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 259 --ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFRV 314
+ SD+++ G + E+ + P+ ++ I+++
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHARE------------------WPFKTQPAEAIIWQM 255
Query: 315 LDP--RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRP 369
Q + + + + L C + E + RP +++ LE+L + P
Sbjct: 256 GTGMKPNLSQIGMGKE--ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-57
Identities = 70/322 (21%), Positives = 121/322 (37%), Gaps = 55/322 (17%)
Query: 68 RTATRNFRPDSVLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL 126
RT R+ +G+G +G V++G W E+ +AVK + + K W
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 48
Query: 127 --TEINYLGQLHHPNLVKLVGYCLEDDHR----LLVYEFMPRGSMENHLFRRGSYFQPLS 180
TE+ L H N++ + + H L+ + GS+ ++L L
Sbjct: 49 RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLD 103
Query: 181 WSLRMKIALGAANGLAFLHS------AEPKVIYRDFKASNILLDSNYNAKLSDFGLAR-- 232
++I L A+GLA LH +P + +RD K+ NIL+ N ++D GLA
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPE------YLATGHLTAKSDIYSFGVVLLEILSGRRAI 286
T + +GT Y APE + + DI++FG+VL E+ +
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
Query: 287 DKNRP--------TGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKA-ASLALQ 337
E + + ++ R P + ++ + A L +
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ--R---PNIPNRWFSDPTLTSLAKLMKE 278
Query: 338 CLSVEPKLRPDMDEVVKELEQL 359
C P R + K L ++
Sbjct: 279 CWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-57
Identities = 83/354 (23%), Positives = 134/354 (37%), Gaps = 55/354 (15%)
Query: 42 SLPQTPRSEGEILQSSNIKNFS--------YSDLRTATRNFRPDSVLGEGGFGSVFKG-W 92
SL + SEG L+ + RT R +G+G FG V++G W
Sbjct: 4 SLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW 63
Query: 93 VDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTE--INYLGQLHHPNLVKLVGYCLED 150
E +AVK + + + W E I L H N++ + +D
Sbjct: 64 RGEE------------VAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 151 D----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS------ 200
+ LV ++ GS+ ++L R ++ +K+AL A+GLA LH
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 201 AEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGPTGDKSHVSTRVMGTYGYAAPEYL 258
+P + +RD K+ NIL+ N ++D GLA D T +GT Y APE L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 259 ----ATGHLTA--KSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312
H + ++DIY+ G+V EI R +I + + + +
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 313 RVLDPRL-----EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
V + +L S + A + +C R + K L QL +
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-56
Identities = 69/324 (21%), Positives = 124/324 (38%), Gaps = 45/324 (13%)
Query: 68 RTATRNFRPDSVLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL 126
RT + + +G+G +G V+ G W E +AVK W
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEK------------VAVKVFFTTEEA---SWF 77
Query: 127 --TEINYLGQLHHPNLVKLVGYCLEDDHR----LLVYEFMPRGSMENHLFRRGSYFQPLS 180
TEI + H N++ + ++ L+ ++ GS+ ++L L
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLD 132
Query: 181 WSLRMKIALGAANGLAFLHS------AEPKVIYRDFKASNILLDSNYNAKLSDFGLAR-- 232
+K+A + +GL LH+ +P + +RD K+ NIL+ N ++D GLA
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTA------KSDIYSFGVVLLEILSGRRAI 286
T + +GT Y PE L +D+YSFG++L E+ +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 287 DKNRPTGE-HNLVEWAKPYLTSKRRI--FRVLDPRLEGQFSLPQAQKA-ASLALQCLSVE 342
++ + + P R I + L P ++S + + L +C +
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312
Query: 343 PKLRPDMDEVVKELEQLQELRNMH 366
P R V K L ++ E +++
Sbjct: 313 PASRLTALRVKKTLAKMSESQDIK 336
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 70/302 (23%), Positives = 125/302 (41%), Gaps = 32/302 (10%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
R+ + LG+G FGSV + TG ++AVK+L + +++ EI
Sbjct: 10 RHLKFLQQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 132 LGQLHHPNLVKLVGYCLEDDHR--LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L L H N+VK G C R L+ E++P GS+ ++L + + + ++
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTS 121
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG- 248
G+ +L + + I+RD NIL+++ K+ DFGL + P DK + G
Sbjct: 122 QICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGE 178
Query: 249 -----TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303
APE L + SD++SFGVVL E+ + P E +
Sbjct: 179 SPIFWY----APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDK 232
Query: 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
+++ L+ LP+ + +C + RP ++ ++Q+
Sbjct: 233 QGQMIVF--HLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
Query: 360 QE 361
++
Sbjct: 290 RD 291
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-45
Identities = 76/291 (26%), Positives = 119/291 (40%), Gaps = 45/291 (15%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
+G G FG VF G L+AVK + ++L E L Q
Sbjct: 121 QIGRGNFGEVFSGRLR----------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
HPN+V+L+G C + +V E + G L G L +++ AA G+
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGME 227
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+L S I+RD A N L+ K+SDFG++R+ G + + APE
Sbjct: 228 YLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
Query: 257 YLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFR 313
L G +++SD++SFG++L E S G PY L++++
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGAS------------------PYPNLSNQQTREF 327
Query: 314 VLDP-RLEGQFSLPQA--QKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
V RL P+ L QC + EP RP + +EL+ +++
Sbjct: 328 VEKGGRLP----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-45
Identities = 69/296 (23%), Positives = 123/296 (41%), Gaps = 32/296 (10%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
LG+G FGSV + TG ++AVK+L + +++ EI L L H
Sbjct: 47 QQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 138 PNLVKLVGYCLEDDHR--LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
N+VK G C R L+ E++P GS+ ++L + + + ++ G+
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGM 158
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG------T 249
+L + + I+RD NIL+++ K+ DFGL + P DK + + G
Sbjct: 159 EYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWY 215
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
APE L + SD++SFGVVL E+ + P E +
Sbjct: 216 ----APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 310 RIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQE 361
+++ L+ LP+ + +C + RP ++ ++Q+++
Sbjct: 270 F--HLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 78/302 (25%), Positives = 126/302 (41%), Gaps = 36/302 (11%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEIN 130
R + LGEG FG V TG +AVK L E G + EI
Sbjct: 21 RFLKRIRDLGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 131 YLGQLHHPNLVKLVGYCLEDDHR--LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
L L+H N+VK G C ED L+ EF+P GS++ +L + ++ ++K A
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYA 132
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
+ G+ +L S + ++RD A N+L++S + K+ DFGL + T DK + + +
Sbjct: 133 VQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDR 189
Query: 249 ------TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWA 301
APE L SD++SFGV L E+L+ + L
Sbjct: 190 DSPVFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDS----DSSPMALFLKMIG 241
Query: 302 KPYLTSKRRIFRVLDPRLEGQFSLPQ----AQKAASLALQCLSVEPKLRPDMDEVVKELE 357
+ + + R+++ L+ LP + L +C +P R +++ E
Sbjct: 242 PTH--GQMTVTRLVN-TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
Query: 358 QL 359
L
Sbjct: 299 AL 300
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 84/305 (27%), Positives = 129/305 (42%), Gaps = 40/305 (13%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEIN 130
R + LGEG FG V D T GTG ++AVK L + G Q W EI+
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 131 YLGQLHHPNLVKLVGYCLEDDHR--LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
L L+H +++K G C + LV E++P GS+ ++L R + + + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFA 140
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD---KSHVSTR 245
G+A+LH+ I+RD A N+LLD++ K+ DFGLA+ P G +
Sbjct: 141 QQICEGMAYLHAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 246 V----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEW 300
APE L SD++SFGV L E+L+ D ++ L
Sbjct: 199 SPVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHC----DSSQSPPTKFLELI 248
Query: 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQ----AQKAASLALQCLSVEPKLRPDMDEVVKEL 356
+ + R+ + LE LP+ + L C E RP + ++ L
Sbjct: 249 GIAQ--GQMTVLRLTE-LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
Query: 357 EQLQE 361
+ + E
Sbjct: 306 KTVHE 310
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-43
Identities = 71/310 (22%), Positives = 115/310 (37%), Gaps = 54/310 (17%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
+++ LGEGGF V G A+KR+ Q +E E +
Sbjct: 29 KHYLFIQKLGEGGFSYVDLV---------EGLHDGHFYALKRILCHEQQDREEAQREADM 79
Query: 132 LGQLHHPNLVKLVGYCLEDDHR----LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
+HPN+++LV YCL + L+ F RG++ N + R L+ + +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
LG GL +H+ +RD K +NILL L D G + +
Sbjct: 140 LLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 248 -------GTYGYAAPE------YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE 294
T Y APE + ++D++S G VL ++ G D G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQA----QKAASLALQCLSVEPKLRPDMD 350
S ++ Q S+PQ+ L ++V+P RP +
Sbjct: 255 ------------SVALA-------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295
Query: 351 EVVKELEQLQ 360
++ +LE LQ
Sbjct: 296 LLLSQLEALQ 305
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-42
Identities = 77/304 (25%), Positives = 121/304 (39%), Gaps = 37/304 (12%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
R+ + S LG+G FGSV TG L+AVK+L G +++ EI
Sbjct: 23 RHLKYISQLGKGNFGSVELC-----RYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 132 LGQLHHPNLVKLVGYCLEDDHR--LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L LH +VK G + LV E++P G + + L R L S + +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSS 134
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD---KSHVSTRV 246
G+ +L S + ++RD A NIL++S + K++DFGLA+ P +
Sbjct: 135 QICKGMEYLGSR--RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 247 ----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWA 301
APE L+ + +SD++SFGVVL E+ + +
Sbjct: 193 PIFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCD------KSCSPSAEFLRM 240
Query: 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELE 357
+ R+L+ LE LP L C + P+ RP + +L+
Sbjct: 241 MGCERDVPALSRLLE-LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
Query: 358 QLQE 361
L
Sbjct: 300 MLWS 303
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-42
Identities = 72/302 (23%), Positives = 128/302 (42%), Gaps = 57/302 (18%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLH 136
+LGEG FGSV +G GT + +AVK + + + +E+L+E +
Sbjct: 41 ILGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 137 HPNLVKLVGYCLEDD-----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLR--MKIAL 189
HPN+++L+G C+E +++ FM G + +L P L+ +K +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHVSTRV- 246
A G+ +L + ++RD A N +L + ++DFGL++ +GD + ++
Sbjct: 155 DIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 247 ---MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302
+ A E LA T+KSD+++FGV + EI + G
Sbjct: 213 VKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGM------------------T 248
Query: 303 PYLT-SKRRIFRVLDP--RLEGQFSLPQA--QKAASLALQCLSVEPKLRPDMDEVVKELE 357
PY ++ L RL+ P+ + + C +P RP + +LE
Sbjct: 249 PYPGVQNHEMYDYLLHGHRLK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 358 QL 359
+L
Sbjct: 305 KL 306
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 65/288 (22%), Positives = 125/288 (43%), Gaps = 40/288 (13%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
VLG G FG+V+KG W+ E +A+K L + + +KE L E + +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
+P++ +L+G CL L+ + MP G + +++ L + + A G+
Sbjct: 76 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQY--L-LNWCVQIAKGMN 131
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+L + ++++RD A N+L+ + + K++DFGLA+ +K + + + A E
Sbjct: 132 YL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 257 YLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315
+ T +SD++S+GV + E+++ G + PY +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPAS--EIS 229
Query: 316 DPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
LE LPQ + +C ++ RP E++ E ++
Sbjct: 230 S-ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 65/313 (20%), Positives = 115/313 (36%), Gaps = 63/313 (20%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEIN 130
+F +VLG+G FG V K A+K++ + L+E+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRL-------------LVYEFMPRGSMENHLFRRGSYFQ 177
L L+H +V+ LE + + + E+ G++ + + Q
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 178 P-LSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR---- 232
W L +I L+++HS +I+RD K NI +D + N K+ DFGLA+
Sbjct: 115 RDEYWRLFRQILEA----LSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 233 ---------DGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSG 282
G ++++ + GT Y A E L TGH K D+YS G++ E++
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
Query: 283 RRAIDKNRPTGEHNLVEWAKPYLTSK-RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSV 341
+ V + K R + P + + + +
Sbjct: 228 --------FSTGMERVN-----ILKKLRSVSIEFPPDFDDNKM----KVEKKIIRLLIDH 270
Query: 342 EPKLRPDMDEVVK 354
+P RP ++
Sbjct: 271 DPNKRPGARTLLN 283
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 80/334 (23%), Positives = 120/334 (35%), Gaps = 50/334 (14%)
Query: 30 SLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATR---NFRPDSVLGEGGFG 86
L + + S Q R S +++ Y R + +F+ S LG G +G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYG 71
Query: 87 SVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQL-HHPNLVK 142
VFK G L AVKR F+G K+ L E+ ++ HP V+
Sbjct: 72 EVFKV---------RSKEDGRLYAVKRSMSP-FRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQ-PLSWSLRMKIALGAANGLAFLHSA 201
L E L E S++ H G+ W L LA LHS
Sbjct: 122 LEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LAHLHSQ 176
Query: 202 EPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG 261
+++ D K +NI L KL DFGL + T V G Y APE L
Sbjct: 177 --GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGS 231
Query: 262 HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR-VLDPRLE 320
+ +D++S G+ +LE+ P H W + + + L P
Sbjct: 232 Y-GTAADVFSLGLTILEVACNMEL-----P---HGGEGWQQ--------LRQGYLPPEFT 274
Query: 321 GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
S + S+ + L +PKLR + ++
Sbjct: 275 AGLS----SELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-41
Identities = 84/326 (25%), Positives = 131/326 (40%), Gaps = 61/326 (18%)
Query: 58 NIKNFSYS-DLRTATRNFRPD---------SVLGEGGFGSVFKGWVDEHSLASTRPGTGM 107
+I + + +L A ++ V+G G FG V+ G G +
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG------TLLDNDGKKI 54
Query: 108 LIAVKRLNQE-GFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH-RLLVYEFMPRGSM 165
AVK LN+ ++LTE + HPN++ L+G CL + L+V +M G +
Sbjct: 55 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114
Query: 166 ENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225
N + R P L + L A G+ +L A K ++RD A N +LD + K+
Sbjct: 115 RNFI--RNETHNPTVKDL-IGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKV 169
Query: 226 SDFGLARDGPTGDKSHVSTRVMGTYGYA------APEYLATGHLTAKSDIYSFGVVLLEI 279
+DFGLARD + V G A E L T T KSD++SFGV+L E+
Sbjct: 170 ADFGLARDMYDKE----YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225
Query: 280 LS-GRRAIDKNRPTGEHNLVEWAKPYLT-SKRRIFRVLDP--RLEGQFSLPQA--QKAAS 333
++ G PY + I L RL P+
Sbjct: 226 MTRGAP------------------PYPDVNTFDITVYLLQGRRLL----QPEYCPDPLYE 263
Query: 334 LALQCLSVEPKLRPDMDEVVKELEQL 359
+ L+C + ++RP E+V + +
Sbjct: 264 VMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-41
Identities = 76/314 (24%), Positives = 131/314 (41%), Gaps = 58/314 (18%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLH 136
+LG+G FGSV + G+ + +AVK L + +E+L E + +
Sbjct: 30 MLGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 137 HPNLVKLVGYCLEDDHR------LLVYEFMPRGSMENHLFRRGSYFQPLSWSLR--MKIA 188
HP++ KLVG L + +++ FM G + L P + L+ ++
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHVSTRV 246
+ A G+ +L + I+RD A N +L + ++DFGL+R +GD + ++++
Sbjct: 144 VDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 247 ----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWA 301
+ A E LA T SD+++FGV + EI++ G+
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ------------------ 237
Query: 302 KPYLT-SKRRIFRVLDP--RLEGQFSLPQA--QKAASLALQCLSVEPKLRPDMDEVVKEL 356
PY I+ L RL+ P ++ L QC S +PK RP + EL
Sbjct: 238 TPYAGIENAEIYNYLIGGNRLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
Query: 357 EQLQELRNMHKRPQ 370
E + ++ Q
Sbjct: 294 ENILGHLSVLSTSQ 307
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 75/305 (24%), Positives = 131/305 (42%), Gaps = 43/305 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
LG G +G V++G + +AVK L E +E+L E + ++ HP
Sbjct: 227 KLGGGQYGEVYEG---------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHP 276
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
NLV+L+G C + ++ EFM G++ ++L Q +S + + +A ++ + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYL 334
Query: 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL 258
I+R+ A N L+ N+ K++DFGL+R TGD + APE L
Sbjct: 335 EKK--NFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESL 391
Query: 259 ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFRVLD 316
A + KSD+++FGV+L EI + PY + +V +
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGM-----------------SPYPGIDLS----QVYE 430
Query: 317 PRLEGQFSLPQAQKA----ASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQKE 372
LE + + + + L C P RP E+ + E + + ++ +KE
Sbjct: 431 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489
Query: 373 HQAKG 377
+G
Sbjct: 490 LGKRG 494
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 77/320 (24%), Positives = 120/320 (37%), Gaps = 65/320 (20%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
LG+G F +FKG + + +K L++ + + + + +L H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
+LV G C+ D +LV EF+ GS++ +L + + + W L + A A + F
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCI-NILWKLEV--AKQLAAAMHF 128
Query: 198 LHSAEPKVIYRDFKASNILLDS--------NYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
L E +I+ + A NILL KLSD G++ V+
Sbjct: 129 L--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPK 174
Query: 250 YGY------AAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302
PE + +L +D +SFG L EI SG G+ K
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG----------GD-------K 217
Query: 303 PY--LTSKRRIFRVLDPRLEGQFSLPQAQKA--ASLALQCLSVEPKLRPDMDEVVKELEQ 358
P L S+ R L E + LP + A A+L C+ EP RP ++
Sbjct: 218 PLSALDSQ----RKLQ-FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAII---RD 269
Query: 359 LQELRNMHKRPQKEHQAKGH 378
L L P+ H H
Sbjct: 270 LNSLFTPDLVPRGSHHHHHH 289
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 51/292 (17%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
LG G FG V G W ++ +AVK + EG E+ E + +L H
Sbjct: 15 ELGSGQFGVVKLGKWKGQYD-----------VAVKMIK-EGSMSEDEFFQEAQTMMKLSH 62
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
P LVK G C ++ +V E++ G + N+L G +P S +++ G+AF
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAF 119
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT---YGYAA 254
L + I+RD A N L+D + K+SDFG+ R +GT ++A
Sbjct: 120 L--ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSA 173
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313
PE ++KSD+++FG+++ E+ S G+ PY
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKM------------------PYDLYTNS--E 213
Query: 314 VLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQE 361
V+ ++ L + A+ + C P+ RP +++ +E L+E
Sbjct: 214 VVL-KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 72/304 (23%), Positives = 129/304 (42%), Gaps = 57/304 (18%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTG-MLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
LG+G FG V++G +A+K +N+ + E+L E + + + +
Sbjct: 32 ELGQGSFGMVYEG-----VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 86
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL------FRRGSYFQPLSWSLRMKIALG 190
++V+L+G + L++ E M RG ++++L P S S +++A
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHVSTRV-- 246
A+G+A+L K ++RD A N ++ ++ K+ DFG+ RD D + +
Sbjct: 147 IADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 247 --MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKP 303
M +PE L G T SD++SFGVVL EI + +P
Sbjct: 205 RWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAE------------------QP 240
Query: 304 Y--LTSKRRIFRVLDPRLEGQFSLPQ----AQKAASLALQCLSVEPKLRPDMDEVVKELE 357
Y L+++ +VL + L + L C PK+RP E++ ++
Sbjct: 241 YQGLSNE----QVLR-FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
Query: 358 QLQE 361
+ E
Sbjct: 296 EEME 299
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 77/312 (24%), Positives = 134/312 (42%), Gaps = 57/312 (18%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
LG G +G V++G W + +AVK L E +E+L E + ++ H
Sbjct: 20 KLGGGQYGEVYEGVW----------KKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKH 68
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
PNLV+L+G C + ++ EFM G++ ++L R Q +S + + +A ++ + +
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEY 126
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD-KSHVSTRV----MGTYGY 252
L + I+RD A N L+ N+ K++DFGL+R +H +
Sbjct: 127 L--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----- 179
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPY--LTSKR 309
APE LA + KSD+++FGV+L EI + G PY +
Sbjct: 180 -APESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------------PYPGIDLS- 219
Query: 310 RIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365
+V + LE + + + + L C P RP E+ + E + + ++
Sbjct: 220 ---QVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275
Query: 366 HKRPQKEHQAKG 377
+KE +G
Sbjct: 276 SDEVEKELGKRG 287
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 80/386 (20%), Positives = 147/386 (38%), Gaps = 66/386 (17%)
Query: 8 RIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDL 67
+ P+ + + R ++S+ S + + + P + + S+
Sbjct: 9 HHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEY 68
Query: 68 RTAT--------RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-G 118
LGEG FG V + +P + +AVK L +
Sbjct: 69 ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDAT 126
Query: 119 FQGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQ 177
+ + ++E+ + + H N++ L+G C +D ++ E+ +G++ +L R
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 178 PLSWSLR------------MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225
S+ + + A G+ +L A K I+RD A N+L+ N K+
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKI 244
Query: 226 SDFGLARDGPTGD--KSHVSTRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEI 279
+DFGLARD D K + R+ M APE L T +SD++SFGV++ EI
Sbjct: 245 ADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 280 LS-GRRAIDKNRPTGEHNLVEWAKPYLT-SKRRIFRVLDPRLEGQFSLPQAQKAA----S 333
+ G PY +F++L EG + +
Sbjct: 299 FTLGG------------------SPYPGIPVEELFKLLK---EG-HRMDKPANCTNELYM 336
Query: 334 LALQCLSVEPKLRPDMDEVVKELEQL 359
+ C P RP ++V++L+++
Sbjct: 337 MMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 7e-40
Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 51/292 (17%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
+G G FG V G W+++ +A+K + EG ++++ E + +L H
Sbjct: 15 EIGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSH 62
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
P LV+L G CLE LV EFM G + ++L + F + + + L G+A+
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAY 119
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT---YGYAA 254
L E VI+RD A N L+ N K+SDFG+ R T GT +A+
Sbjct: 120 L--EEACVIHRDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWAS 173
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313
PE + ++KSD++SFGV++ E+ S G+ PY R
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI------------------PY--ENRSNSE 213
Query: 314 VLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQE 361
V++ + F L + + A+ + C P+ RP ++++L ++ E
Sbjct: 214 VVE-DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 92/377 (24%), Positives = 140/377 (37%), Gaps = 66/377 (17%)
Query: 6 SNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYS 65
S P + S + S S S Q + L + N
Sbjct: 20 SVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN------P 73
Query: 66 DLRTATRNFRPD---------SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ 116
+L A ++ V+G G FG V+ G G + AVK LN+
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNR 127
Query: 117 E-GFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH-RLLVYEFMPRGSMENHLFRRGS 174
++LTE + HPN++ L+G CL + L+V +M G + N + R
Sbjct: 128 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNE 185
Query: 175 YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234
P L + L A G+ FL A K ++RD A N +LD + K++DFGLARD
Sbjct: 186 THNPTVKDL-IGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242
Query: 235 PTGDKSHVSTRVMG------TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAID 287
+ V + A E L T T KSD++SFGV+L E+++ G
Sbjct: 243 YDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--- 295
Query: 288 KNRPTGEHNLVEWAKPYLT-SKRRIFRVLDP--RLEGQFSLPQA--QKAASLALQCLSVE 342
PY + I L RL P+ + L+C +
Sbjct: 296 ---------------PYPDVNTFDITVYLLQGRRLL----QPEYCPDPLYEVMLKCWHPK 336
Query: 343 PKLRPDMDEVVKELEQL 359
++RP E+V + +
Sbjct: 337 AEMRPSFSELVSRISAI 353
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 73/346 (21%), Positives = 138/346 (39%), Gaps = 43/346 (12%)
Query: 37 KASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEH 96
++ P P+ + Q + + Y+ L NFR + +G G F V++
Sbjct: 4 QSQGMQGPPVPQFQP---QKALRPDMGYNTLA----NFRIEKKIGRGQFSEVYRA----- 51
Query: 97 SLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQLHHPNLVKLVGYCLEDDHR 153
G+ +A+K++ K + EI+ L QL+HPN++K +ED+
Sbjct: 52 ----ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107
Query: 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKAS 213
+V E G + + + + K + + L +HS +V++RD K +
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--RVMHRDIKPA 165
Query: 214 NILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFG 273
N+ + + KL D GL R + + + V GT Y +PE + KSDI+S G
Sbjct: 166 NVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 274 VVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR-VLDPRLEGQFSLPQAQKAA 332
+L E+ + + + ++L ++I + P +S ++
Sbjct: 224 CLLYEMAALQSPFYGD-KMNLYSLC----------KKIEQCDYPPLPSDHYS----EELR 268
Query: 333 SLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQKEHQAKGH 378
L C++ +P+ RPD V + + + + EH H
Sbjct: 269 QLVNMCINPDPEKRPD----VTYVYDVAKRMHACTASSLEHHHHHH 310
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 84/308 (27%), Positives = 129/308 (41%), Gaps = 64/308 (20%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQL- 135
V+GEG FG V K + + G M A+KR+ E H+++ E+ L +L
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 83
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL-FRRGSYFQPLSWSLR---------- 184
HHPN++ L+G C + L E+ P G++ + L R P
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 185 -MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS 243
+ A A G+ +L ++ + I+RD A NIL+ NY AK++DFGL+R K
Sbjct: 144 LLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-M 200
Query: 244 TRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLV 298
R+ M A E L T SD++S+GV+L EI+S G
Sbjct: 201 GRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------------- 240
Query: 299 EWAKPYLT-SKRRIFRVLDP--RLEGQFSLPQA--QKAASLALQCLSVEPKLRPDMDEVV 353
PY + ++ L RLE P + L QC +P RP +++
Sbjct: 241 ----PYCGMTCAELYEKLPQGYRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292
Query: 354 KELEQLQE 361
L ++ E
Sbjct: 293 VSLNRMLE 300
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 72/315 (22%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 77 DSVLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQ 134
D LG G FGSV +G + + +A+K L Q +E + E + Q
Sbjct: 15 DIELGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
L +P +V+L+G C + +LV E G + L + ++ ++ + G
Sbjct: 67 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPV--SNV-AELLHQVSMG 122
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG------ 248
+ +L E ++RD A N+LL + + AK+SDFGL++ D S+ + R G
Sbjct: 123 MKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKW 179
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307
APE + +++SD++S+GV + E LS G++ PY
Sbjct: 180 Y----APECINFRKFSSRSDVWSYGVTMWEALSYGQK------------------PYKKM 217
Query: 308 KRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQELR 363
K V+ +E + + +L C + + RPD V + +
Sbjct: 218 KGP--EVMA-FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC--YY 272
Query: 364 NMHKRPQKEHQAKGH 378
++ + + H H
Sbjct: 273 SLASKVEGHHHHHHH 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 65/294 (22%), Positives = 115/294 (39%), Gaps = 54/294 (18%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEI 129
R + D +G G F +V+KG +D T + +A L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKG-LDT--------ETTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 130 NYLGQLHHPNLVKLVGYCL---EDDHRLLVY-EFMPRGSMENHLFRRGSYFQPLSWSLRM 185
L L HPN+V+ + +++ E M G+++ +L R F+ + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLR 132
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKLSDFGLARDGPTGDKSHVST 244
GL FLH+ P +I+RD K NI + + K+ D GLA T ++ +
Sbjct: 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAK 188
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
V+GT + APE + D+Y+FG+ +LE+ T E+ PY
Sbjct: 189 AVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMA-----------TSEY-------PY 229
Query: 305 --LTSKRRIFR-----VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDE 351
+ +I+R V + P+ + + C+ R + +
Sbjct: 230 SECQNAAQIYRRVTSGVKPASFDKVAI-PEVK---EIIEGCIRQNKDERYSIKD 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 69/313 (22%), Positives = 125/313 (39%), Gaps = 58/313 (18%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
+F+ ++G GGFG VFK G +KR+ +++ E+
Sbjct: 11 MDFKEIELIGSGGFGQVFKA---------KHRIDGKTYVIKRVKYN----NEKAEREVKA 57
Query: 132 LGQLHHPNLVKLVGYCLEDDHRL----------------LVYEFMPRGSMENHLFRRGSY 175
L +L H N+V G D+ + EF +G++E + +R
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG- 116
Query: 176 FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235
+ L L +++ G+ ++HS K+I RD K SNI L K+ DFGL
Sbjct: 117 -EKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVT--- 170
Query: 236 TGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295
+ TR GT Y +PE +++ + D+Y+ G++L E+L
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------- 217
Query: 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355
+ + + D + F +K +L + LS +P+ RP+ E+++
Sbjct: 218 -----CDTAFETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRT 268
Query: 356 LEQLQELRNMHKR 368
L ++ ++R
Sbjct: 269 LTVWKKSPEKNER 281
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 47/301 (15%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
LG+G FG V+ G W +A+K L G + +L E + +L H
Sbjct: 191 KLGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRH 238
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
LV+L E+ +V E+M +GS+ + L + L + M A A+G+A+
Sbjct: 239 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAY 295
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEY 257
+ ++RD +A+NIL+ N K++DFGLAR ++ + APE
Sbjct: 296 VERM--NYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEA 352
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFRVL 315
G T KSD++SFG++L E+ + R PY + ++ VL
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGR-----------------VPYPGMVNR----EVL 391
Query: 316 DPRLEGQFSLPQAQKA----ASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQK 371
D ++E + +P + L QC EP+ RP + + LE +P +
Sbjct: 392 D-QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450
Query: 372 E 372
Sbjct: 451 N 451
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
VLG G FG+V KG W+ E + +K + + G Q + + +G L
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
H ++V+L+G C LV +++P GS+ +H+ + P L + + A G+
Sbjct: 74 HAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGP---QLLLNWGVQIAKGMY 129
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+L E +++R+ A N+LL S +++DFG+A P DK + + + A E
Sbjct: 130 YL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 257 YLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315
+ G T +SD++S+GV + E+++ G PY + V
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAE------------------PYAGLRLA--EVP 227
Query: 316 DPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
D LE L Q Q + ++C ++ +RP E+ E ++
Sbjct: 228 D-LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-39
Identities = 73/292 (25%), Positives = 129/292 (44%), Gaps = 55/292 (18%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
+G+G FG V G + G +AVK + + + +L E + + QL H
Sbjct: 200 TIGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 245
Query: 138 PNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
NLV+L+G +E+ L +V E+M +GS+ ++L RG L +K +L +
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAME 303
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+L ++RD A N+L+ + AK+SDFGL ++ + + ++ + APE
Sbjct: 304 YL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKL--PVKWTAPE 356
Query: 257 YLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFR 313
L + KSD++SFG++L EI S GR PY + K
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIPLK----D 394
Query: 314 VLDPRLEGQFSLPQAQKA----ASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
V+ R+E + + + C ++ RP ++ ++LE ++
Sbjct: 395 VVP-RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 84/354 (23%), Positives = 139/354 (39%), Gaps = 62/354 (17%)
Query: 34 SSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATR-NFRPDSVLGEGGFGSVFKGW 92
+ G SS S + S + N + FS + + R + LGEG FG VF
Sbjct: 2 AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLA- 60
Query: 93 VDEHSLASTRPGTG-MLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151
+ P ML+AVK L + +++ E L L H ++V+ G C E
Sbjct: 61 ----ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 152 HRLLVYEFMPRGSMENHLFRR-----------GSYFQPLSWSLRMKIALGAANGLAFLHS 200
L+V+E+M G + L PL + +A A G+ +L
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL-- 174
Query: 201 AEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHVSTRV----MGTYGYAA 254
A ++RD N L+ K+ DFG++RD + D + T + M
Sbjct: 175 AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------P 228
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPY--LTSKRRI 311
PE + T +SD++SFGVVL EI + G++ P+ L++
Sbjct: 229 PESILYRKFTTESDVWSFGVVLWEIFTYGKQ------------------PWYQLSNT--- 267
Query: 312 FRVLDPRLEGQFSLPQ----AQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
+D +G+ L + + ++ C EP+ R + +V L+ L +
Sbjct: 268 -EAIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-39
Identities = 65/288 (22%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
VLG G FG+V+KG W+ E +A+K L + + +KE L E + +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
+P++ +L+G CL L+ + MP G + +++ L + + A G+
Sbjct: 76 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQY--L-LNWCVQIAKGMN 131
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE 256
+L + ++++RD A N+L+ + + K++DFGLA+ +K + + + A E
Sbjct: 132 YL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 257 YLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315
+ T +SD++S+GV + E+++ G + PY +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPAS--EIS 229
Query: 316 DPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
LE LPQ + ++C ++ RP E++ E ++
Sbjct: 230 S-ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-39
Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 42/290 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHH 137
V+G G FG V+KG L ++ + +A+K L + ++L E +GQ H
Sbjct: 51 VIGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
N+++L G + +++ E+M G+++ L + S + + G A G+ +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKY 162
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT---YGYAA 254
L A ++RD A NIL++SN K+SDFGL+R D + G + A
Sbjct: 163 L--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTA 218
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313
PE ++ T+ SD++SFG+V+ E+++ G R PY
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGER------------------PYWELSNH--E 258
Query: 314 VLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
V+ + F LP L +QC E RP ++V L++L
Sbjct: 259 VMK-AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 63/296 (21%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
+G+G FG V G + G +AVK + + +L E + + QL H
Sbjct: 28 TIGKGEFGDVMLGDY------------RGNKVAVKCIK-NDAT-AQAFLAEASVMTQLRH 73
Query: 138 PNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
NLV+L+G +E+ L +V E+M +GS+ ++L R L +K +L +
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV----MGTYGY 252
+L ++RD A N+L+ + AK+SDFGL ++ + + ++
Sbjct: 132 YL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWT----- 181
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPY--LTSKR 309
APE L + KSD++SFG++L EI S GR PY + K
Sbjct: 182 -APEALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIPLK- 221
Query: 310 RIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQE 361
V+ R+E + + + C ++ +RP ++ ++LE ++
Sbjct: 222 ---DVVP-RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 62/290 (21%), Positives = 112/290 (38%), Gaps = 51/290 (17%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
LG G FG V G W ++ +A+K + EG E++ E + L H
Sbjct: 31 ELGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSH 78
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
LV+L G C + ++ E+M G + N+L +++ + +
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEY 135
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT---YGYAA 254
L + ++RD A N L++ K+SDFGL+R T +G+ ++
Sbjct: 136 L--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSP 189
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313
PE L ++KSDI++FGV++ EI S G+ PY +
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM------------------PY--ERFTNSE 229
Query: 314 VLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
+ + L + A+ ++ C + RP ++ + +
Sbjct: 230 TAE-HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 77/317 (24%), Positives = 133/317 (41%), Gaps = 48/317 (15%)
Query: 59 IKNFSYSDLRTATRNFR----PDSV-----LGEGGFGSVFKGWVDEHSLASTRPGTGMLI 109
+ +Y + A R+F + +G G G V G + +
Sbjct: 27 AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYG------RLRVPGQRDVPV 80
Query: 110 AVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENH 168
A+K L + +++L+E + +GQ HPN+++L G ++V E+M GS++
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 169 LFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228
L + + + G G+ +L ++ ++RD A N+L+DSN K+SDF
Sbjct: 141 LRTHD---GQFTIMQLVGMLRGVGAGMRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 229 GLARD-GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAI 286
GL+R D ++ +T + APE +A ++ SD++SFGVV+ E+L+ G R
Sbjct: 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER-- 253
Query: 287 DKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVE 342
PY R V+ +E + LP L L C +
Sbjct: 254 ----------------PYWNMTNR--DVIS-SVEEGYRLPAPMGCPHALHQLMLDCWHKD 294
Query: 343 PKLRPDMDEVVKELEQL 359
RP ++V L+ L
Sbjct: 295 RAQRPRFSQIVSVLDAL 311
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 73/311 (23%), Positives = 124/311 (39%), Gaps = 55/311 (17%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQ 134
D LG G FG+V KG+ +AVK L E E L E N + Q
Sbjct: 22 DKELGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
L +P +V+++G C + +LV E G + +L ++ + + + +++ + G
Sbjct: 75 LDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKN---IIELVHQVSMG 129
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG------ 248
+ +L E ++RD A N+LL + + AK+SDFGL++ D+++ + G
Sbjct: 130 MKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKW 186
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307
APE + ++KSD++SFGV++ E S G++ PY
Sbjct: 187 Y----APECINYYKFSSKSDVWSFGVLMWEAFSYGQK------------------PYRGM 224
Query: 308 KRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQELR 363
K V LE + L C + + + RP V L
Sbjct: 225 KGS--EVTA-MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY--YY 279
Query: 364 NMHKRPQKEHQ 374
++ H
Sbjct: 280 DVVNEGHHHHH 290
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 51/297 (17%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK---EWLTEINYLGQ 134
LG+G FG V +G W G + +AVK L + + +++ E+N +
Sbjct: 25 KLGDGSFGVVRRGEW-------DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
L H NL++L G L +V E P GS+ + L + +F + A+ A G
Sbjct: 78 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEG 133
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT---YG 251
+ +L S + I+RD A N+LL + K+ DFGL R P D +V +
Sbjct: 134 MGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT-SKR 309
+ APE L T + SD + FGV L E+ + G+ +P++ +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------------EPWIGLNGS 231
Query: 310 RIFRVLDP---RLEGQFSLPQA--QKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
+I +D RL P+ Q ++ +QC + +P+ RP + L + Q
Sbjct: 232 QILHKIDKEGERLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 82/307 (26%), Positives = 129/307 (42%), Gaps = 60/307 (19%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTG-MLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
LGEG FG VF + P ML+AVK L K++ E L L H
Sbjct: 23 LGEGAFGKVFLA-----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF------------QPLSWSLRMK 186
++VK G C + D ++V+E+M G + L G L S +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHVST 244
IA A+G+ +L A ++RD N L+ +N K+ DFG++RD + D + T
Sbjct: 138 IASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 245 RV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRP-TGEHN-- 296
+ M PE + T +SD++SFGV+L EI + G+ +P N
Sbjct: 196 MLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGK------QPWFQLSNTE 243
Query: 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQA--QKAASLALQCLSVEPKLRPDMDEVVK 354
++E +T R L+ P+ ++ + L C EP+ R ++ E+ K
Sbjct: 244 VIE----CITQGRV----LER--------PRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
Query: 355 ELEQLQE 361
L L +
Sbjct: 288 ILHALGK 294
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 67/343 (19%), Positives = 118/343 (34%), Gaps = 42/343 (12%)
Query: 56 SSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN 115
+N + + + +GEG FG G +K +N
Sbjct: 12 DLGTENLYFQSME----KYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEIN 58
Query: 116 QEGFQGHKEW---LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR 172
KE E+ L + HPN+V+ E+ +V ++ G + + +
Sbjct: 59 ISR-MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ 117
Query: 173 GSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232
+ + L +H K+++RD K+ NI L + +L DFG+AR
Sbjct: 118 K--GVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292
+ GT Y +PE KSDI++ G VL E+ + + A +
Sbjct: 174 VL-NSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM- 230
Query: 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
NLV +I P + +S SL Q P+ RP ++ +
Sbjct: 231 --KNLV----------LKIISGSFPPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSI 274
Query: 353 VKELEQLQELRNMHKRPQKEHQAKGHVHFKGRATTYPRPSASP 395
++ + + PQ + F + + P P+ P
Sbjct: 275 LE-KGFIAKRIEKFLSPQLIAEEFCLKTFS-KFGSQPIPAKRP 315
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-38
Identities = 79/301 (26%), Positives = 127/301 (42%), Gaps = 51/301 (16%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
LG G FG V+ G + +AVK L +G +L E N + QL H
Sbjct: 20 RLGAGQFGEVWMGYYNGHTK-----------VAVKSLK-QGSMSPDAFLAEANLMKQLQH 67
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
LV+L ++ ++ E+M GS+ + L + L+ + + +A A G+AF
Sbjct: 68 QRLVRLYAVVTQE-PIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD-KSHVSTRVMGTYGYAAPE 256
+ E I+RD +A+NIL+ + K++DFGLAR + + + + APE
Sbjct: 125 I--EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPE 180
Query: 257 YLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFR 313
+ G T KSD++SFG++L EI++ GR PY +T+
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI------------------PYPGMTNP----E 218
Query: 314 VLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRP 369
V+ LE + + + L C P+ RP D + LE +P
Sbjct: 219 VIQ-NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277
Query: 370 Q 370
Q
Sbjct: 278 Q 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-38
Identities = 76/335 (22%), Positives = 129/335 (38%), Gaps = 62/335 (18%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
R VL EGGF V++ G+G A+KRL + ++ + E+ +
Sbjct: 28 LRLRVRRVLAEGGFAFVYEA---------QDVGSGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 132 LGQL-HHPNLVKLVGYCLEDDHR-------LLVYEFMPRGSMENHLFRRGSYFQPLSWSL 183
+ +L HPN+V+ L+ + +G + L + S PLS
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDT 137
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA---RDGPTGDKS 240
+KI + +H +P +I+RD K N+LL + KL DFG A P S
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 241 HVSTRVM-------GTYGYAAPE---YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNR 290
++ T Y PE + + K DI++ G +L + + +
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG- 256
Query: 291 PTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLP----QAQKAASLALQCLSVEPKLR 346
+K RI + G++S+P Q SL L V P+ R
Sbjct: 257 ----------------AKLRI-------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEER 293
Query: 347 PDMDEVVKELEQLQELRNMHKR---PQKEHQAKGH 378
+ EVV +L+++ RN++ + + Q G+
Sbjct: 294 LSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGY 328
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 43/290 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHH 137
V+G G FG V G + +A+K L + +++L E + +GQ H
Sbjct: 52 VVGAGEFGEVCSG------RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
PN+++L G + ++V E+M GS+++ L + + + + + G A+G+ +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT---YGYAA 254
L ++ ++RD A NIL++SN K+SDFGL R D + G + +
Sbjct: 163 L--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTS 218
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313
PE +A T+ SD++S+G+VL E++S G R PY +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGER------------------PYWEMSNQ--D 258
Query: 314 VLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
V+ ++ + LP L L C + RP +++V L++L
Sbjct: 259 VIK-AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 74/309 (23%), Positives = 128/309 (41%), Gaps = 58/309 (18%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL-H 136
LGEG FG V + +P + +AVK L + + + ++E+ + +
Sbjct: 42 PLGEGAFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLR------------ 184
H N++ L+G C +D ++ E+ +G++ +L R S+ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHV 242
+ A G+ +L A K I+RD A N+L+ N K++DFGLARD D K
Sbjct: 160 VSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 243 STRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNL 297
+ R+ M APE L T +SD++SFGV++ EI + G
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGG-------------- 257
Query: 298 VEWAKPYLT-SKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEV 352
PY +F++L EG + + + C P RP ++
Sbjct: 258 ----SPYPGIPVEELFKLLK---EG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 353 VKELEQLQE 361
V++L+++
Sbjct: 310 VEDLDRILT 318
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-38
Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 55/297 (18%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHH 137
V+G+G FG V+ G + + A+K L++ Q + +L E + L+H
Sbjct: 28 VIGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 138 PNLVKLVGYCLEDD-HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
PN++ L+G L + ++ +M G + + + + + L A G+
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGME 138
Query: 197 FLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD----GPTGDKSHVSTRV----MG 248
+L AE K ++RD A N +LD ++ K++DFGLARD + H R+
Sbjct: 139 YL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT- 195
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT- 306
A E L T T KSD++SFGV+L E+L+ G PY
Sbjct: 196 -----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAP------------------PYRHI 232
Query: 307 SKRRIFRVLDP--RLEGQFSLPQA--QKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
+ L RL P+ + QC +P +RP +V E+EQ+
Sbjct: 233 DPFDLTHFLAQGRRLP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 72/294 (24%), Positives = 126/294 (42%), Gaps = 54/294 (18%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHH 137
+LGEG FG V++G + + G + +AVK ++ +++++E + L H
Sbjct: 19 ILGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
P++VKL+G E+ ++ E P G + ++L R + + L+ + +L +A+
Sbjct: 73 PHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAY 128
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV-------MGTY 250
L ++RD NIL+ S KL DFGL+R D+ + V M
Sbjct: 129 L--ESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWM--- 181
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
+PE + T SD++ F V + EILS G++ P+ +
Sbjct: 182 ---SPESINFRRFTTASDVWMFAVCMWEILSFGKQ------------------PFFWLEN 220
Query: 310 RIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
+ V+ LE LP+ +L +C +P RP E+V L +
Sbjct: 221 K--DVIG-VLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 71/309 (22%), Positives = 121/309 (39%), Gaps = 63/309 (20%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTG-MLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
LGE FG V+KG L PG +A+K L + +E+ E +L
Sbjct: 16 ELGEDRFGKVYKG-----HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ 70
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF------------QPLSWSLR 184
HPN+V L+G +D +++ + G + L R + L
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHV 242
+ + A G+ +L + V+++D N+L+ N K+SD GL R+ D K
Sbjct: 131 VHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 243 STRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNL 297
++ + M APE + G + SDI+S+GVVL E+ S G +
Sbjct: 189 NSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ------------- 229
Query: 298 VEWAKPY--LTSKRRIFRVLDPRLEGQFSLPQ----AQKAASLALQCLSVEPKLRPDMDE 351
PY +++ V++ + + LP +L ++C + P RP +
Sbjct: 230 -----PYCGYSNQ----DVVE-MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD 279
Query: 352 VVKELEQLQ 360
+ L
Sbjct: 280 IHSRLRAWG 288
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 47/301 (15%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
LG+G FG V+ G W +A+K L G + +L E + +L H
Sbjct: 274 KLGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRH 321
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
LV+L E+ +V E+M +GS+ + L + L + M A A+G+A+
Sbjct: 322 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAY 378
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEY 257
+ ++RD +A+NIL+ N K++DFGLAR ++ + APE
Sbjct: 379 VERM--NYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEA 435
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFRVL 315
G T KSD++SFG++L E+ + R PY + ++ VL
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGR-----------------VPYPGMVNR----EVL 474
Query: 316 DPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQK 371
D ++E + +P + L QC EP+ RP + + LE +P +
Sbjct: 475 D-QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533
Query: 372 E 372
Sbjct: 534 N 534
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 76/303 (25%), Positives = 123/303 (40%), Gaps = 59/303 (19%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQL 135
LG G FG V++G + S + +AVK L E Q ++L E + +
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSP-----LQVAVKTLP-EVCSEQDELDFLMEALIISKF 90
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL-FRRGSYFQPLSWSLR--MKIALGAA 192
+H N+V+ +G L+ R ++ E M G +++ L R QP S ++ + +A A
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLD---SNYNAKLSDFGLARDGPTGD--KSHVSTRV- 246
G +L E I+RD A N LL AK+ DFG+ARD + +
Sbjct: 151 CGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 247 ---MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302
M PE G T+K+D +SFGV+L EI S G
Sbjct: 209 VKWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------------------ 244
Query: 303 PY--LTSKRRIFRVLDPRLEGQFSLPQ----AQKAASLALQCLSVEPKLRPDMDEVVKEL 356
PY +++ VL+ + + + QC +P+ RP+ +++ +
Sbjct: 245 PYPSKSNQ----EVLE-FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
Query: 357 EQL 359
E
Sbjct: 300 EYC 302
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 79/371 (21%), Positives = 134/371 (36%), Gaps = 55/371 (14%)
Query: 5 CSNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSY 64
C A + ++ + SE + + +Y
Sbjct: 318 CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY 377
Query: 65 SDLRTATRNFRPDSV-----LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-G 118
+ T + + + +GEG FG V +G + + M +A+K
Sbjct: 378 TMPSTRDYEIQRERIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTS 431
Query: 119 FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQP 178
+++L E + Q HP++VKL+G E+ ++ E G + + L R
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDL 490
Query: 179 LSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP--- 235
S + A + LA+L + ++RD A N+L+ SN KL DFGL+R
Sbjct: 491 AS---LILYAYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
Query: 236 --TGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPT 292
K + + M APE + T+ SD++ FGV + EIL G +
Sbjct: 546 YYKASKGKLPIKWM------APESINFRRFTSASDVWMFGVCMWEILMHGVK-------- 591
Query: 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPD 348
P+ K V+ R+E LP SL +C + +P RP
Sbjct: 592 ----------PFQGVKNN--DVIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPR 638
Query: 349 MDEVVKELEQL 359
E+ +L +
Sbjct: 639 FTELKAQLSTI 649
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-37
Identities = 77/304 (25%), Positives = 123/304 (40%), Gaps = 61/304 (20%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTG--MLIAVKRLNQEGF--QGHKEWLTEINYLGQ 134
LG G FG V++G S P + +AVK L E Q ++L E + +
Sbjct: 78 GLGHGAFGEVYEG------QVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISK 130
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL-FRRGSYFQPLSWSLR--MKIALGA 191
+H N+V+ +G L+ R ++ E M G +++ L R QP S ++ + +A
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLD---SNYNAKLSDFGLARDGPTGD--KSHVSTRV 246
A G +L E I+RD A N LL AK+ DFG+ARD + +
Sbjct: 191 ACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248
Query: 247 ----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWA 301
M PE G T+K+D +SFGV+L EI S G
Sbjct: 249 PVKWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM----------------- 285
Query: 302 KPY--LTSKRRIFRVLDPRLEGQFSLPQ----AQKAASLALQCLSVEPKLRPDMDEVVKE 355
PY +++ VL+ + + + QC +P+ RP+ +++
Sbjct: 286 -PYPSKSNQ----EVLE-FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
Query: 356 LEQL 359
+E
Sbjct: 340 IEYC 343
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 49/289 (16%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH 137
LG G FG V+ + +AVK + G + +L E N + L H
Sbjct: 195 KLGAGQFGEVWMATYNKHTK-----------VAVKTMK-PGSMSVEAFLAEANVMKTLQH 242
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
LVKL ++ ++ EFM +GS+ + L QPL + + A G+AF
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAF 299
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEY 257
+ + I+RD +A+NIL+ ++ K++DFGLAR ++ + APE
Sbjct: 300 I--EQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEA 356
Query: 258 LATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFRV 314
+ G T KSD++SFG++L+EI++ GR PY +++ V
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRI------------------PYPGMSNP----EV 394
Query: 315 LDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
+ LE + +P+ + ++ ++C P+ RP + + L+
Sbjct: 395 IR-ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 72/292 (24%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHH 137
+GEG FG V +G + + + +A+K +++L E + Q H
Sbjct: 22 CIGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
P++VKL+G E+ ++ E G + + L R S + A + LA+
Sbjct: 76 PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLAS---LILYAYQLSTALAY 131
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP-----TGDKSHVSTRVMGTYGY 252
L + ++RD A N+L+ SN KL DFGL+R K + + M
Sbjct: 132 L--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----- 184
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311
APE + T+ SD++ FGV + EIL G + P+ K
Sbjct: 185 -APESINFRRFTSASDVWMFGVCMWEILMHGVK------------------PFQGVKNN- 224
Query: 312 FRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVKELEQL 359
V+ R+E LP SL +C + +P RP E+ +L +
Sbjct: 225 -DVIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 69/324 (21%), Positives = 121/324 (37%), Gaps = 55/324 (16%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINY 131
+F P LG GGFG VF+ A+KR+ + +E + E+
Sbjct: 6 DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 132 LGQLHHPNLVKLVGYCLEDD---------HRLLVY---EFMPRGSMENHLFRRGSYFQPL 179
L +L HP +V+ LE + ++ +Y + + ++++ + R + +
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEER 115
Query: 180 SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR------- 232
S+ + I L A + FLHS +++RD K SNI + K+ DFGL
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 233 ---DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289
T +GT Y +PE + + K DI+S G++L E+L
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------- 225
Query: 290 RPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM 349
+ + V + + P L Q + LS P RP+
Sbjct: 226 PFSTQMERVRTLT-------DVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPMERPEA 274
Query: 350 DEVVKELEQLQELRNMHKRPQKEH 373
++ E ++L K ++
Sbjct: 275 INII-ENAVFEDLDFPGKTVLRQR 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 67/323 (20%), Positives = 114/323 (35%), Gaps = 47/323 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINY 131
+ +LG+G +VF+G TG L A+K N F + + E
Sbjct: 10 LWLLSDILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 132 LGQLHHPNLVKLVGYCLEDD----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
L +L+H N+VKL + +E++ H++L+ EF P GS+ L + + L S + +
Sbjct: 61 LKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIV 117
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILL----DSNYNAKLSDFGLARDGPTGDKSHVS 243
G+ L +++R+ K NI+ D KL+DFG AR+ D
Sbjct: 118 LRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFV 173
Query: 244 TRVMGTYGYAAPEYLATGHL--------TAKSDIYSFGVVLLEILSGR------------ 283
+ GT Y P+ L A D++S GV +G
Sbjct: 174 SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 284 RAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEP 343
+ + TG+ + + + P S + L +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILEADQ 291
Query: 344 KLRPDMDEVVKELEQLQELRNMH 366
+ D+ E + N H
Sbjct: 292 EKCWGFDQFFAETSDILHRGNSH 314
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 73/306 (23%), Positives = 122/306 (39%), Gaps = 59/306 (19%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL-H 136
LG G FG V + + + +AVK L + ++E+ + L
Sbjct: 53 TLGAGAFGKVVEATAFGLG----KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQ----------PLSWSLRMK 186
H N+V L+G C L++ E+ G + N L R+ + S +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHVST 244
+ A G+AFL A I+RD A N+LL + + AK+ DFGLARD +
Sbjct: 169 FSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 245 RV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVE 299
R+ M APE + T +SD++S+G++L EI S G
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLN--------------- 265
Query: 300 WAKPY--LTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVV 353
PY + + ++ ++ + + Q A S+ C ++EP RP ++
Sbjct: 266 ---PYPGILVNSKFYK----LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318
Query: 354 KELEQL 359
L++
Sbjct: 319 SFLQEQ 324
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 82/312 (26%), Positives = 119/312 (38%), Gaps = 64/312 (20%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL- 135
LG G FG V + A+ R +AVK L + H+ ++E+ L +
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRT-----VAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 136 HHPNLVKLVGYCL-EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLR---------- 184
HH N+V L+G C +++ EF G++ +L + + F P +
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 185 --MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KS 240
+ + A G+ FL A K I+RD A NILL K+ DFGLARD
Sbjct: 149 HLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 241 HVSTRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEH 295
R+ M APE + T +SD++SFGV+L EI S G
Sbjct: 207 KGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGA------------ 248
Query: 296 NLVEWAKPY--LTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDM 349
PY + R RL+ + L C EP RP
Sbjct: 249 ------SPYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 298
Query: 350 DEVVKELEQLQE 361
E+V+ L L +
Sbjct: 299 SELVEHLGNLLQ 310
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-36
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 60/308 (19%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL-H 136
LGEG FG V L +P +AVK L + + + ++E+ + +
Sbjct: 76 PLGEGAFGQVVLAEA--IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS--------WSLRMK-- 186
H N++ L+G C +D ++ E+ +G++ +L R S L K
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 187 --IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KSHV 242
A A G+ +L A K I+RD A N+L+ + K++DFGLARD D K
Sbjct: 194 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 243 STRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNL 297
+ R+ M APE L T +SD++SFGV+L EI + G
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 292
Query: 298 VEWAKPY--LTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDE 351
PY + + + L+ + + + C P RP +
Sbjct: 293 -----PYPGVPVE----ELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 342
Query: 352 VVKELEQL 359
+V++L+++
Sbjct: 343 LVEDLDRI 350
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-36
Identities = 66/323 (20%), Positives = 114/323 (35%), Gaps = 47/323 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINY 131
+ +LG+G +VF+G TG L A+K N F + + E
Sbjct: 10 LWLLSDILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 132 LGQLHHPNLVKLVGYCLEDD----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
L +L+H N+VKL + +E++ H++L+ EF P GS+ L + + L S + +
Sbjct: 61 LKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIV 117
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILL----DSNYNAKLSDFGLARDGPTGDKSHVS 243
G+ L +++R+ K NI+ D KL+DFG AR+ D
Sbjct: 118 LRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFV 173
Query: 244 TRVMGTYGYAAPEYLATGHL--------TAKSDIYSFGVVLLEILSGR------------ 283
+ GT Y P+ L A D++S GV +G
Sbjct: 174 SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 284 RAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEP 343
+ + TG+ + + + P S + L +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILEADQ 291
Query: 344 KLRPDMDEVVKELEQLQELRNMH 366
+ D+ E + +H
Sbjct: 292 EKCWGFDQFFAETSDILHRMVIH 314
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-36
Identities = 76/318 (23%), Positives = 128/318 (40%), Gaps = 71/318 (22%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTG-MLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
+GEG FG VF+ P ++AVK L +E ++ E + +
Sbjct: 54 DIGEGAFGRVFQA-----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 108
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF-------------------- 176
+PN+VKL+G C L++E+M G + L +
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 177 QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236
PLS + ++ IA A G+A+L +E K ++RD N L+ N K++DFGL+R+ +
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 237 GD--KSHVSTRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKN 289
D K+ + + M PE + T +SD++++GVVL EI S G +
Sbjct: 227 ADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ----- 275
Query: 290 RPTGEHNLVEWAKPY--LTSKRRIFRVLDPRLEGQFSLPQ----AQKAASLALQCLSVEP 343
PY + + V+ + L + +L C S P
Sbjct: 276 -------------PYYGMAHE----EVIY-YVRDGNILACPENCPLELYNLMRLCWSKLP 317
Query: 344 KLRPDMDEVVKELEQLQE 361
RP + + L+++ E
Sbjct: 318 ADRPSFCSIHRILQRMCE 335
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-35
Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 69/315 (21%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLH 136
LGEG FG V K A +AVK L + ++ L+E N L Q++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTT-----VAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF-------------------- 176
HP+++KL G C +D LL+ E+ GS+ L
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 177 QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236
+ L+ + A + G+ +L AE K+++RD A NIL+ K+SDFGL+RD
Sbjct: 145 RALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 237 GD--KSHVSTRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKN 289
D R+ M A E L T +SD++SFGV+L EI++ G
Sbjct: 203 EDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGG------ 250
Query: 290 RPTGEHNLVEWAKPYLT-SKRRIFRVLDP--RLEGQFSLPQA--QKAASLALQCLSVEPK 344
PY R+F +L R+E P ++ L LQC EP
Sbjct: 251 ------------NPYPGIPPERLFNLLKTGHRME----RPDNCSEEMYRLMLQCWKQEPD 294
Query: 345 LRPDMDEVVKELEQL 359
RP ++ K+LE++
Sbjct: 295 KRPVFADISKDLEKM 309
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 35/290 (12%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEI 129
++ +G G +G K R G ++ K L+ + ++E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEV 56
Query: 130 NYLGQLHHPNLVKLVG-YCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
N L +L HPN+V+ + L +V E+ G + + + + Q L +++
Sbjct: 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 188 ALGAANGLAFLHS---AEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST 244
L H V++RD K +N+ LD N KL DFGLAR D S T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT 175
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
V GT Y +PE + KSDI+S G +L E+ + A
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------------AFSQ 221
Query: 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+I R+ ++S + + + L+++ RP ++E+++
Sbjct: 222 KELAGKIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 267
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-35
Identities = 75/310 (24%), Positives = 121/310 (39%), Gaps = 63/310 (20%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL-H 136
LG G FG V + + M +AVK L + ++E+ L L +
Sbjct: 30 TLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL-FRRGSYFQPLSWSLR----------- 184
H N+V L+G C L++ E+ G + N L +R S+ +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 185 --MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD--KS 240
+ + A G+AFL A I+RD A NILL K+ DFGLARD
Sbjct: 146 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 241 HVSTRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEH 295
+ R+ M APE + T +SD++S+G+ L E+ S G
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSS----------- 246
Query: 296 NLVEWAKPY--LTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDM 349
PY + + ++++ EG F + + A + C +P RP
Sbjct: 247 -------PYPGMPVDSKFYKMIK---EG-FRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 350 DEVVKELEQL 359
++V+ +E+
Sbjct: 296 KQIVQLIEKQ 305
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 73/322 (22%), Positives = 123/322 (38%), Gaps = 61/322 (18%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+F P VLG G G++ +AVKR+ E F E+ L
Sbjct: 25 SFCPKDVLGHGAEGTIVY----RGMF------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 133 GQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
+ HPN+++ + + + E +++ ++ ++ L + +
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQT 127
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILL-----DSNYNAKLSDFGLAR--DGPTGDKSHVST 244
+GLA LHS +++RD K NIL+ A +SDFGL + S S
Sbjct: 128 TSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 245 RVMGTYGYAAPEYL---ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301
GT G+ APE L + T DI+S G V ++S G H
Sbjct: 186 VP-GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE----------GSH------ 228
Query: 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAAS-----LALQCLSVEPKLRPDMDEVVK-- 354
P+ S +R +L +K L + ++++P+ RP V+K
Sbjct: 229 -PFGKSLQRQANIL--LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 355 ----ELEQLQELRNMHKRPQKE 372
+QLQ +++ R +KE
Sbjct: 286 FFWSLEKQLQFFQDVSDRIEKE 307
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 78/365 (21%), Positives = 141/365 (38%), Gaps = 56/365 (15%)
Query: 13 TPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATR 72
P+H + R +S G + +P + +++ +SD
Sbjct: 270 LPAHPSTLTHPQRR--IDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKD 327
Query: 73 NF---------RPDSVLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQG 121
D LG G FGSV +G + + +A+K L Q
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKAD 379
Query: 122 HKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSW 181
+E + E + QL +P +V+L+G C + +LV E G + L + +
Sbjct: 380 TEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPV 435
Query: 182 SLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH 241
S ++ + G+ +L E ++R+ A N+LL + + AK+SDFGL++ D S+
Sbjct: 436 SNVAELLHQVSMGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SY 492
Query: 242 VSTRVMGTYGYA--APEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLV 298
+ R G + APE + +++SD++S+GV + E LS G++
Sbjct: 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-------------- 538
Query: 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEPKLRPDMDEVVK 354
PY K V+ +E + + +L C + + RPD V +
Sbjct: 539 ----PYKKMKGP--EVMA-FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591
Query: 355 ELEQL 359
+
Sbjct: 592 RMRAC 596
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 76/370 (20%), Positives = 128/370 (34%), Gaps = 55/370 (14%)
Query: 17 TDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRP 76
V+S + A + S ++ + E + + + R
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH 136
+G G FG V + D+ TG AVK++ E F+ E+ L
Sbjct: 63 QPRVGRGSFGEVHRM-KDK--------QTGFQCAVKKVRLEVFRVE-----ELVACAGLS 108
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA 196
P +V L G E + E + GS+ + + G L + A GL
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLE 164
Query: 197 FLHSAEPKVIYRDFKASNILLDSN-YNAKLSDFGLAR---DGPTGDKSHVSTRVMGTYGY 252
+LH+ ++++ D KA N+LL S+ A L DFG A G + GT +
Sbjct: 165 YLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 253 AAPE-YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311
APE + AK DI+S ++L +L+G P W +
Sbjct: 223 MAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGC------HP--------WTQ--YFRGPLC 265
Query: 312 FRV-----LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK----ELEQLQEL 362
++ + + A + L EP R E+ + L+++ L
Sbjct: 266 LKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
Query: 363 RNMHKRPQKE 372
++ K KE
Sbjct: 322 KSPWKGEYKE 331
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 38/253 (15%), Positives = 74/253 (29%), Gaps = 19/253 (7%)
Query: 44 PQTPRSEGEILQSSNIKNFS-YSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTR 102
+ ++ + ++ +LGEG F V++
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA----TQGDLND 91
Query: 103 PGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPR 162
+K + L +K L + +LV E
Sbjct: 92 AKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151
Query: 163 GSMENHLFRRGSY-FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL---- 217
G++ N + + + + L + A+ + +H E +I+ D K N +L
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGF 209
Query: 218 -------DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIY 270
D + L D G + D K + T T G+ E L+ + D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 271 SFGVVLLEILSGR 283
+ +L G
Sbjct: 270 GVAATVYCMLFGT 282
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 42/281 (14%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
VLG+G +G V+ G + IA+K + + + + EI L H
Sbjct: 29 VLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+V+ +G E+ + E +P GS+ L + + GL +L
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL-KDNEQTIGFYTKQILEGLKYL 138
Query: 199 HSAEPKVIYRDFKASNILLDS-NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPE- 256
H ++++RD K N+L+++ + K+SDFG ++ + + GT Y APE
Sbjct: 139 HDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEI 194
Query: 257 --YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314
G+ +DI+S G ++E+ +G+ P + L E +F+V
Sbjct: 195 IDKGPRGY-GKAADIWSLGCTIIEMATGK------PPF--YELGEPQ-------AAMFKV 238
Query: 315 ----LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDE 351
+ P + S +A + L+C +P R ++
Sbjct: 239 GMFKVHPEIPESMS----AEAKAFILKCFEPDPDKRACAND 275
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 73/316 (23%), Positives = 118/316 (37%), Gaps = 70/316 (22%)
Query: 79 VLGEGGFGSVFKG-WVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL- 135
VLG G FG V ++ G + +AVK L ++ + ++E+ + QL
Sbjct: 52 VLGSGAFGKVMNATAYGI-----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLR----------- 184
H N+V L+G C L++E+ G + N+L + F
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 185 --------MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236
+ A A G+ FL ++RD A N+L+ K+ DFGLARD +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 237 GD--KSHVSTRV----MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKN 289
+ R+ M APE L G T KSD++S+G++L EI S G
Sbjct: 225 DSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVN----- 273
Query: 290 RPTGEHNLVEWAKPY--LTSKRRIFRVLDPRLEGQFSLPQAQKAA----SLALQCLSVEP 343
PY + ++++ G F + Q A + C + +
Sbjct: 274 -------------PYPGIPVDANFYKLIQ---NG-FKMDQPFYATEEIYIIMQSCWAFDS 316
Query: 344 KLRPDMDEVVKELEQL 359
+ RP + L
Sbjct: 317 RKRPSFPNLTSFLGCQ 332
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 64/299 (21%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK---EWLTE 128
R + LG+GGF F+ + T + A K + + + E
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGS--------YFQPL 179
I+ L H ++V G+ ED+ + +V E R S+ RR + Y + +
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 180 SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA-RDGPTGD 238
G +LH +VI+RD K N+ L+ + K+ DFGLA + G+
Sbjct: 125 ------------VLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170
Query: 239 KSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297
+ V GT Y APE L+ GH + + D++S G ++ +L G+ P L
Sbjct: 171 RKKVLC---GTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK------PPFETSCL 220
Query: 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
E Y RI + ++S+P+ AASL + L +P RP ++E++
Sbjct: 221 KET---Y----LRIKK-------NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-34
Identities = 70/322 (21%), Positives = 115/322 (35%), Gaps = 50/322 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINY 131
+ LG GGFG V + H TG +A+K+ QE ++E W EI
Sbjct: 15 PWEMKERLGTGGFGYVLRW---IHQD------TGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 132 LGQLHHPNLVKLV------GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
+ +L+HPN+V +D LL E+ G + +L + + L+
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-----CCGLKE 120
Query: 186 KIALGA----ANGLAFLHSAEPKVIYRDFKASNILLDSNYNA---KLSDFGLARDGPTGD 238
++ L +LH ++I+RD K NI+L K+ D G A++ G+
Sbjct: 121 GPIRTLLSDISSALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 239 KSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT------ 292
V GT Y APE L T D +SFG + E ++G R N
Sbjct: 179 LCT--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 293 ---GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM 349
+ + + + + P S A K L + R
Sbjct: 236 VREKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRGTD 292
Query: 350 DEVV-----KELEQLQELRNMH 366
+ + L+ + L+ +
Sbjct: 293 PQNPNVGCFQALDSILSLKLLS 314
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 61/315 (19%), Positives = 115/315 (36%), Gaps = 54/315 (17%)
Query: 56 SSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN 115
+N + + R + +G GG VF+ ++E + A+K +N
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNE---------KKQIYAIKYVN 61
Query: 116 QEGFQGH--KEWLTEINYLGQLHHPNL--VKLVGYCLEDDHRLLVYEFMPRGSMENHLFR 171
E + EI YL +L + ++L Y + D + +V E + + L +
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK 120
Query: 172 RGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
+ S + R + +H +++ D K +N L+ KL DFG+A
Sbjct: 121 KKS----IDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIVDG-MLKLIDFGIA 173
Query: 232 RDGPTGDKSHVSTRVMGTYGYAAPEYL-----------ATGHLTAKSDIYSFGVVLLEIL 280
S V +GT Y PE + + ++ KSD++S G +L +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 281 SGRRAIDKNRPTGEHNLVEWAKPY---LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQ 337
G+ P+ + ++ ++DP E +F + +
Sbjct: 234 YGKT------------------PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC 275
Query: 338 CLSVEPKLRPDMDEV 352
CL +PK R + E+
Sbjct: 276 CLKRDPKQRISIPEL 290
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-34
Identities = 64/322 (19%), Positives = 107/322 (33%), Gaps = 66/322 (20%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE--GFQGHKEWLTE 128
T F +G G FGSVFK + G + A+KR + G + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 129 INYLGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
+ L H ++V+ EDDH L+ E+ GS+ + + + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-------------------YNAKLSDF 228
L GL ++HS +++ D K SNI + K+ D
Sbjct: 121 LLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLA--TGHLTAKSDIYSFGVVLLEILSGRRAI 286
G S G + A E L HL K+DI++ + ++
Sbjct: 179 GHV-----TRISSPQVEE-GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL- 230
Query: 287 DKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR 346
N +W + I + PR+ S Q+ L + +P+ R
Sbjct: 231 -------PRNGDQWHE--------IRQGRLPRIPQVLS----QEFTELLKVMIHPDPERR 271
Query: 347 PDMDEVVKELEQLQELRNMHKR 368
P L + L + ++
Sbjct: 272 PS----AMALVKHSVLLSASRK 289
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 76/347 (21%), Positives = 133/347 (38%), Gaps = 76/347 (21%)
Query: 24 SSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEG 83
+ + + + + P ++ + + Y R LG+G
Sbjct: 5 ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRR--YVRGRF----------LGKG 52
Query: 84 GFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK---EWLTEINYLGQLHHPNL 140
GF F+ + T + A K + + + EI+ L H ++
Sbjct: 53 GFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 141 VKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGS--------YFQPLSWSLRMKIALGA 191
V G+ ED+ + +V E R S+ RR + Y + +
Sbjct: 104 VGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------------ 150
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA-RDGPTGDKSHVSTRVMGTY 250
G +LH +VI+RD K N+ L+ + K+ DFGLA + G++ V GT
Sbjct: 151 VLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTP 205
Query: 251 GYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
Y APE L+ GH + + D++S G ++ +L G+ P L E Y
Sbjct: 206 NYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK------PPFETSCLKET---Y----L 251
Query: 310 RIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
RI + ++S+P+ AASL + L +P RP ++E++
Sbjct: 252 RIKK-------NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 65/360 (18%), Positives = 125/360 (34%), Gaps = 68/360 (18%)
Query: 11 AETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTA 70
P + + +++ + S + + + I ++K YS L+
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECI----SVKGRIYSILKQ- 63
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTE 128
+G GG VF+ + A+K +N E Q + E
Sbjct: 64 ---------IGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNE 104
Query: 129 INYLGQLHHPNL--VKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186
I YL +L + ++L Y + D + +V E + + L ++ S + R
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKS 159
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
+ +H +++ D K +N L+ KL DFG+A S V
Sbjct: 160 YWKNMLEAVHTIHQH--GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 247 MGTYGYAAPEYL-----------ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295
+G Y PE + + ++ KSD++S G +L + G+
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------------ 264
Query: 296 NLVEWAKPY---LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
P+ + ++ ++DP E +F + + CL +PK R + E+
Sbjct: 265 ------TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 54/292 (18%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH--KEWLTEINYLGQLH 136
+G GG VF+ + A+K +N E + EI YL +L
Sbjct: 16 QIGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 137 HPNL--VKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
+ ++L Y + D + +V E + + L ++ S + R
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEA 120
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
+ +H +++ D K +N L+ KL DFG+A S V +GT Y
Sbjct: 121 VHTIHQH--GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 255 PEYL-----------ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303
PE + + ++ KSD++S G +L + G+ P
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------------P 219
Query: 304 Y---LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV 352
+ + ++ ++DP E +F + + CL +PK R + E+
Sbjct: 220 FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 1e-32
Identities = 40/334 (11%), Positives = 77/334 (23%), Gaps = 59/334 (17%)
Query: 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE 124
S L R + L G VF A+K E
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFLV---------RDVERLEDFALKVFTMGAENSRSE 105
Query: 125 W---LTEINYLGQLHHPNLVKLVGYC-----------------------LEDDHRLLVYE 158
+L + + +D
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 159 FMPR-----GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKAS 213
MP + + L + + A L S +++ F
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPD 223
Query: 214 NILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL--TAKSDIYS 271
N+ + + L D G + S+ YA E+L T + +
Sbjct: 224 NLFIMPDGRLMLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQ 278
Query: 272 FGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKA 331
G+ + + P + + R+ LP
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKG-------SWKRPSLRVPGTDSLAFGSCTPLPDF--V 329
Query: 332 ASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365
+L + L+ + + R E ++ + +L+N
Sbjct: 330 KTLIGRFLNFDRRRRLLPLEAMET-PEFLQLQNE 362
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 86/343 (25%), Positives = 135/343 (39%), Gaps = 60/343 (17%)
Query: 40 SFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLA 99
Q R E + Q + D S LG G G VFK H
Sbjct: 8 ELDEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKV---SH--- 54
Query: 100 STRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYE 158
+P +G+++A K ++ E + + E+ L + + P +V G D + E
Sbjct: 55 --KP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 159 FMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218
M GS++ L + G + + K+++ GL +L + K+++RD K SNIL++
Sbjct: 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVN 166
Query: 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLE 278
S KL DFG++ G D S ++ V GT Y +PE L H + +SDI+S G+ L+E
Sbjct: 167 SRGEIKLCDFGVS--GQLID-SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
Query: 279 ILSGR----------------------RAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD 316
+ GR A RP + IF +LD
Sbjct: 223 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282
Query: 317 -------PRL-EGQFSLPQAQKAASLALQCLSVEPKLRPDMDE 351
P+L G FS + +CL P R D+ +
Sbjct: 283 YIVNEPPPKLPSGVFS----LEFQDFVNKCLIKNPAERADLKQ 321
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-32
Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 65/307 (21%)
Query: 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK- 123
+ + +F+ ++LG+G F V+ A + TG+ +A+K ++++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVY--------RAESIH-TGLEVAIKMIDKKAMYKAGM 54
Query: 124 --EWLTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRG------- 173
E+ QL HP++++L Y ED + + LV E G M +L R
Sbjct: 55 VQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE 113
Query: 174 --SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
+ + G+ +LHS +++RD SN+LL N N K++DFGLA
Sbjct: 114 ARHFMHQI------------ITGMLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLA 159
Query: 232 -RDGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289
+ +K + GT Y +PE + H +SD++S G + +L GR
Sbjct: 160 TQLKMPHEKHYTLC---GTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR------ 209
Query: 290 RPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRP 347
P + ++ + +P + +A L Q L P R
Sbjct: 210 PPFDTDTVKN---TL----NKVVL-------ADYEMPSFLSIEAKDLIHQLLRRNPADRL 255
Query: 348 DMDEVVK 354
+ V+
Sbjct: 256 SLSSVLD 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 75/291 (25%), Positives = 121/291 (41%), Gaps = 64/291 (21%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK---EWLTEINYLGQL 135
LG+G FG+V+ LA + + ++A+K L + + + E+ L
Sbjct: 16 PLGKGKFGNVY--------LAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRG--------SYFQPLSWSLRMK 186
HPN+++L GY D R+ L+ E+ P G++ L + +Y L
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------- 118
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
AN L++ HS +VI+RD K N+LL S K++DFG + P
Sbjct: 119 -----ANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTD 166
Query: 247 M-GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
+ GT Y PE + K D++S GV+ E L G+ P + E
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQE------ 214
Query: 306 TSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
+ +RI R +F+ P + A L + L P RP + EV++
Sbjct: 215 -TYKRISR-------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 87/324 (26%), Positives = 129/324 (39%), Gaps = 71/324 (21%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT-EINYL 132
F +G+G FG VFKG T ++A+K ++ E + E + EI L
Sbjct: 24 FTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
Q P + K G L+D ++ E++ GS L G PL + I
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPG----PLDETQIATILREIL 129
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL-ARDGPTGDKSHVSTRVMGTYG 251
GL +LHS K I+RD KA+N+LL + KL+DFG+ + T K + +GT
Sbjct: 130 KGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPF 184
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGR---------RA---IDKNRPTGEHNLVE 299
+ APE + +K+DI+S G+ +E+ G + I KN P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------- 236
Query: 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDE-------- 351
P LEG +S + CL+ EP RP E
Sbjct: 237 -----------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
Query: 352 -VVKELEQLQELRNMHKRPQKEHQ 374
K+ L EL + +KR + E
Sbjct: 276 RNAKKTSYLTELIDRYKRWKAEQS 299
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 72/293 (24%), Positives = 114/293 (38%), Gaps = 68/293 (23%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWLTEINYLG 133
LG+G FG+V+ LA + ++A+K +L +EG + EI
Sbjct: 21 PLGKGKFGNVY--------LAREK-QNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQS 69
Query: 134 QLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRG--------SYFQPLSWSLR 184
L HPN++++ Y D R+ L+ EF PRG + L + G ++ + L
Sbjct: 70 HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----- 123
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST 244
A+ L + H KVI+RD K N+L+ K++DFG + P+
Sbjct: 124 -------ADALHYCHER--KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RR 169
Query: 245 RVM-GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303
R M GT Y PE + K D++ GV+ E L G P + E
Sbjct: 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM------PPFDSPSHTE---- 219
Query: 304 YLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
+ RRI P + + L + L P R + V++
Sbjct: 220 ---THRRIVN-------VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 45/255 (17%), Positives = 92/255 (36%), Gaps = 43/255 (16%)
Query: 55 QSSNIKNFSYSDLRTATR--NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK 112
SN+ + ++R L +G F + E A+K
Sbjct: 12 NYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC---EK--------DNKFYALK 60
Query: 113 RLNQEGFQGHKEWLT-----------------EINYLGQLHHPNLVKLVGYCLEDDHRL- 154
+ + + +++ E+ + + + + G + + +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVY 119
Query: 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL----GAANGLAFLHSAEPKVIYRDF 210
++YE+M S+ + + + +++ N +++H+ E + +RD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDV 178
Query: 211 KASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT--GHLTAKSD 268
K SNIL+D N KLSDFG + + GTY + PE+ + + AK D
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEYMVDK---KIKG-SRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 269 IYSFGVVLLEILSGR 283
I+S G+ L +
Sbjct: 235 IWSLGICLYVMFYNV 249
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 49/334 (14%), Positives = 95/334 (28%), Gaps = 84/334 (25%)
Query: 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL---------- 114
S+L R +VLG+ + + T TG V
Sbjct: 66 SELGERPRTLVRGTVLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNA 116
Query: 115 ------------------NQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156
NQ+ + H ++ + + ++++ D L
Sbjct: 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSR 175
Query: 157 YEFMPR-----GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFK 211
+ PR + L S + L R+++ L LA LH +++ +
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLR 233
Query: 212 ASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT----------- 260
+I+LD L+ F + + G+ PE A
Sbjct: 234 PVDIVLDQRGGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 261 GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLE 320
+T D ++ G+V+ I P + + + IFR
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCAD------LPITKDAALGGS-------EWIFR------- 327
Query: 321 GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
++PQ +L L + R + ++
Sbjct: 328 SCKNIPQP--VRALLEGFLRYPKEDRLLPLQAME 359
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 82/364 (22%), Positives = 141/364 (38%), Gaps = 84/364 (23%)
Query: 55 QSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL 114
+ +NI NF ++ + +LG G G+V V + S G +AVKR+
Sbjct: 2 RIANIPNFE----QSLKNLVVSEKILGYGSSGTV----VFQGSF------QGRPVAVKRM 47
Query: 115 NQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG 173
+ EI L + HPN+++ D + E ++++ + +
Sbjct: 48 LIDFCDIALM---EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN 103
Query: 174 SYFQPLSWSLRM---KIALGAANGLAFLHSAEPKVIYRDFKASNILLDS----------- 219
+ L + A+G+A LHS K+I+RD K NIL+ +
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTG 161
Query: 220 --NYNAKLSDFGLAR---DGPTGDKSHVSTRVMGTYGYAAPEYL-------ATGHLTAKS 267
N +SDFGL + G + +++++ GT G+ APE L LT
Sbjct: 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSI 220
Query: 268 DIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ 327
DI+S G V ILS G+H P+ R + + G FSL +
Sbjct: 221 DIFSMGCVFYYILSK----------GKH-------PFGDKYSRESNI----IRGIFSLDE 259
Query: 328 AQK---------AASLALQCLSVEPKLRPDMDEVVK------ELEQLQELRNMHKRPQKE 372
+ A L Q + +P RP +V++ + ++L+ L + R + E
Sbjct: 260 MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIE 319
Query: 373 HQAK 376
++
Sbjct: 320 NRDP 323
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 71/288 (24%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEIN-Y 131
P LG G +G V K H P +G ++AVKR+ Q K L +++
Sbjct: 9 LEPIMELGRGAYGVVEKM---RH-----VP-SGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
+ + P V G + + E M S++ + Q + + KIA+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
L LHS + VI+RD K SN+L+++ K+ DFG++ G
Sbjct: 119 VKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKP 174
Query: 252 YAAPE----YLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
Y APE L + KSDI+S G+ ++E+ A W P+
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIEL-----A------ILRFPYDSWGTPF--- 220
Query: 308 KRRIFRVLD---PRL-EGQFSLPQAQKAASLALQCLSVEPKLRPDMDE 351
+++ +V++ P+L +FS + QCL K RP E
Sbjct: 221 -QQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERPTYPE 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 72/317 (22%), Positives = 126/317 (39%), Gaps = 51/317 (16%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEIN 130
+ + +G+G G+V+ TG +A++++N + + + EI
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
+ + +PN+V + L D +V E++ GS+ + + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTET----CMDEGQIAAVCRE 124
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
L FLHS +VI+RD K+ NILL + + KL+DFG T ++S ST V GT
Sbjct: 125 CLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTP 180
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK-- 308
+ APE + K DI+S G++ +E ++E PYL
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIE------------------MIEGEPPYLNENPL 222
Query: 309 RRIFRVLD---PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDE--------VVKELE 357
R ++ + P L+ L + +CL ++ + R E + K L
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFR--DFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280
Query: 358 QLQELRNMHKRPQKEHQ 374
L L K K +
Sbjct: 281 SLTPLIAAAKEATKNNH 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 57/374 (15%), Positives = 104/374 (27%), Gaps = 84/374 (22%)
Query: 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL---------- 114
S+L R +VLG+ + + T TG V
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNA 121
Query: 115 ------------------NQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156
NQ+ + H ++ + + +++ V D L
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR-VRLDERDMWVLSR 180
Query: 157 YEFMPRGSME-----NHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFK 211
+ PR L S + L R+++ L LA LH +++ +
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLR 238
Query: 212 ASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA----------TG 261
+I+LD L+ F + S G+A PE A
Sbjct: 239 PVDIVLDQRGGVFLTGFEHLV------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPT 292
Query: 262 HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEG 321
+T D ++ G+ + I P + + ++ S + I
Sbjct: 293 LMTFAFDTWTLGLAIYWIWCAD------LPNTDDAALGGSEWIFRSCKNI---------- 336
Query: 322 QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQKEHQAKGHVHF 381
PQ +L L + R + + E + ++LR +Q G
Sbjct: 337 ----PQP--VRALLEGFLRYPKEDRLLPLQAM-ETPEYEQLRTELSAALPLYQTDGEPTR 389
Query: 382 KGRATTYPRPSASP 395
+G A
Sbjct: 390 EGGAPPSGTSQPDE 403
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 69/353 (19%), Positives = 114/353 (32%), Gaps = 103/353 (29%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEIN 130
+F P +G GGFG VF+ A+KR+ + +E + E+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYE-------------------------------- 158
L +L HP +V+ LE E
Sbjct: 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116
Query: 159 ---------FMPRGSMENHLF---------------RRGSYFQPLSWSLRMKIALGAANG 194
+ S + +L+ R + + + I + A
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD----------GPTGDKSHVST 244
+ FLHS +++RD K SNI + K+ DFGL T
Sbjct: 177 VEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
+GT Y +PE + + + K DI+S G++L E+L +
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---------------------SF 273
Query: 305 LTSKRRIFRVLDPRLEGQFSLPQAQK---AASLALQCLSVEPKLRPDMDEVVK 354
T R+ + D R +F L QK + LS P RP+ ++++
Sbjct: 274 STQMERVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 79/361 (21%), Positives = 129/361 (35%), Gaps = 78/361 (21%)
Query: 54 LQSSNIKNFS-YSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK 112
++SS S + + +G G +GSV K H +P +G ++AVK
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKM---VH-----KP-SGQIMAVK 53
Query: 113 RLNQEGF-QGHKEWLTEIN-YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF 170
R+ + K+ L +++ + P +V+ G + + E M + + +
Sbjct: 54 RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKY 113
Query: 171 RRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230
+ + KI L L L K+I+RD K SNILLD + N KL DFG+
Sbjct: 114 VYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGI 172
Query: 231 ARDGPTG--DKSHVSTRVMGTYGYAAPEYLATGHL----TAKSDIYSFGVVLLEILSGRR 284
+ G S TR G Y APE + +SD++S G+ L E+ +G
Sbjct: 173 S-----GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG-- 225
Query: 285 AIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD-------PRL----EGQFSLPQAQKAAS 333
R PY +F L P+L E +FS +
Sbjct: 226 -----RF-----------PYPKWN-SVFDQLTQVVKGDPPQLSNSEEREFS----PSFIN 264
Query: 334 LALQCLSVEPKLRP-------------------DMDEVVKE-LEQLQELRNMHKRPQKEH 373
CL+ + RP ++ V + L+Q+ + H
Sbjct: 265 FVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVDHHH 324
Query: 374 Q 374
Sbjct: 325 H 325
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 73/302 (24%), Positives = 115/302 (38%), Gaps = 62/302 (20%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL-TEINYLGQLHH 137
V+G G V +A+KR+N E Q + L EI + Q HH
Sbjct: 22 VIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLR-MKIAL---GAAN 193
PN+V + D LV + + GS+ + + + + S L IA
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL-ARDGPTGDKSHVSTR--VMGTY 250
GL +LH I+RD KA NILL + + +++DFG+ A GD + R +GT
Sbjct: 133 GLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 251 GYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGR---------RA---IDKNRPTGEHNL 297
+ APE + K+DI+SFG+ +E+ +G + +N P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP------ 244
Query: 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLAL-----QCLSVEPKLRPDMDEV 352
P LE + K + CL +P+ RP E+
Sbjct: 245 -------------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
Query: 353 VK 354
++
Sbjct: 286 LR 287
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 67/220 (30%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
F VLG GGFG VF A TG L A K+LN++ + K + + E
Sbjct: 186 WFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK-- 186
L ++H +V L Y E L LV M G + H++ R
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFY 294
Query: 187 ---IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS 243
I G L LH +IYRD K N+LLD + N ++SD GLA + G
Sbjct: 295 TAQIVSG----LEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TK 347
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
GT G+ APE L D ++ GV L E+++ R
Sbjct: 348 GYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT----EI 129
+R ++G GG G V++ D ++A+K +++ + T E
Sbjct: 36 YRLRRLVGRGGMGDVYEA-EDTV--------RERIVALKLMSET-LSSDPVFRTRMQREA 85
Query: 130 NYLGQLHHPNLVKL--VGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186
G+L P++V + G E D +L + + + L R+G PL+ +
Sbjct: 86 RTAGRLQEPHVVPIHDFG---EIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVA 138
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
I + L H+A +RD K NIL+ ++ A L DFG+A + +
Sbjct: 139 IVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-T 195
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284
+GT Y APE + H T ++DIY+ VL E L+G
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 78/329 (23%), Positives = 126/329 (38%), Gaps = 67/329 (20%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEIN 130
F LGEG +GSV+K TG ++A+K++ E +E + EI+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKA---------IHKETGQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
+ Q P++VK G ++ +V E+ GS+ + + R L+ I
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQS 133
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL-ARDGPTGDKSHVSTRVMGT 249
GL +LH + I+RD KA NILL++ +AKL+DFG+ + T K + V+GT
Sbjct: 134 TLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGT 188
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR---------RA---IDKNRPTGEHNL 297
+ APE + +DI+S G+ +E+ G+ RA I N P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP------ 242
Query: 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV----- 352
P QCL P+ R ++
Sbjct: 243 -------------------PTFRKPELWSDNFT--DFVKQCLVKSPEQRATATQLLQHPF 281
Query: 353 ---VKELEQLQELRNMHKRPQKEHQAKGH 378
K + L++L N + + Q
Sbjct: 282 VRSAKGVSILRDLINEAMDVKLKRQESQQ 310
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 64/312 (20%), Positives = 121/312 (38%), Gaps = 53/312 (16%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEIN 130
+GEG G V +G +AVK ++ Q + E+
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLA---------REKHSGRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
+ H N+V++ L + ++ EF+ G++ + + + L+ +
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQV----RLNEEQIATVCEA 149
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL-ARDGPTGDKSHVSTRVMGT 249
LA+LH+ VI+RD K+ +ILL + KLSDFG A+ K + V GT
Sbjct: 150 VLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GT 204
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK- 308
+ APE ++ + DI+S G++++E +V+ PY +
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIE------------------MVDGEPPYFSDSP 246
Query: 309 -RRIFRVLD---PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV--------VKEL 356
+ + R+ D P+L+ + + + L +P+ R E+
Sbjct: 247 VQAMKRLRDSPPPKLKNSHKVSPVLR--DFLERMLVRDPQERATAQELLDHPFLLQTGLP 304
Query: 357 EQLQELRNMHKR 368
E L L ++++
Sbjct: 305 ECLVPLIQLYRK 316
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT----EI 129
++ LG GG +V+ D L + +A+K + + +E L E+
Sbjct: 13 YKIVDKLGGGGMSTVYLA-ED-TIL-------NIKVAIKAIFIP-PREKEETLKRFEREV 62
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+ QL H N+V ++ EDD LV E++ ++ ++ G PLS +
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTN 118
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST-RVMG 248
+G+ H ++++RD K NIL+DSN K+ DFG+A+ + S T V+G
Sbjct: 119 QILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLG 174
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284
T Y +PE +DIYS G+VL E+L G
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 72/256 (28%), Positives = 107/256 (41%), Gaps = 36/256 (14%)
Query: 37 KASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEH 96
+ F+ LQ ++ + FR VLG+GGFG V
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTK-----NTFRQYRVLGKGGFGEVC------- 201
Query: 97 SLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQLHHPNLVKLVGYCLEDDHR 153
A TG + A K+L ++ + K L E L +++ +V L Y E
Sbjct: 202 --ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDA 258
Query: 154 L-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK-----IALGAANGLAFLHSAEPKVIY 207
L LV M G ++ H++ G P + R I G L LH +++Y
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCG----LEDLHRE--RIVY 309
Query: 208 RDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKS 267
RD K NILLD + + ++SD GLA P G RV GT GY APE + T
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSP 366
Query: 268 DIYSFGVVLLEILSGR 283
D ++ G +L E+++G+
Sbjct: 367 DWWALGCLLYEMIAGQ 382
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 81/388 (20%), Positives = 141/388 (36%), Gaps = 86/388 (22%)
Query: 21 SKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTA---TRNFRPD 77
S Y + + F P G ++ ++K+ ++L + F
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGG--RAGSLKDPDVAELFFKDDPEKLFSDL 59
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQ 134
+G G FG+V+ ++A+K+++ G Q +++W + E+ +L +
Sbjct: 60 REIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
L HPN ++ G L + LV E+ + + + PL + GA G
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQG 166
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR--VMGTYGY 252
LA+LHS +I+RD KA NILL KL DFG A S ++ +GT +
Sbjct: 167 LAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYW 216
Query: 253 AAPEYLAT---GHLTAKSDIYSFGVVLLEILSGR---------RA---IDKNRPTGEHNL 297
APE + G K D++S G+ +E+ + A I +N
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------ 270
Query: 298 VEWAKPYLTSKRRIFRVLDPRLE-GQFSLPQAQKAASLALQCLSVEPKLRPDMDEV---- 352
P L+ G +S + + CL P+ RP + +
Sbjct: 271 -------------------PALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHR 307
Query: 353 ----VKELEQLQELRNMHKRPQKEHQAK 376
+ + +L K +E
Sbjct: 308 FVLRERPPTVIMDLIQRTKDAVRELDNL 335
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 73/307 (23%), Positives = 134/307 (43%), Gaps = 63/307 (20%)
Query: 63 SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH 122
S +D + N+R +G+G F V H L TG +A+K +++
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLA---RHIL------TGREVAIKIIDKTQLNPT 56
Query: 123 --KEWLTEINYLGQLHHPNLVKLVGY-CLEDDHRL-LVYEFMPRGSMENHLFRRG----- 173
++ E+ + L+HPN+VKL + +E + L L+ E+ G + ++L G
Sbjct: 57 SLQKLFREVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK 114
Query: 174 ---SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230
S F+ + + + + H ++++RD KA N+LLD++ N K++DFG
Sbjct: 115 EARSKFRQI------------VSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGF 160
Query: 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289
+ + G K G YAAPE + + D++S GV+L ++SG
Sbjct: 161 SNEFTVGGKLDAFC---GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS------ 211
Query: 290 RPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRP 347
P NL L + R+ L G++ +P + +L + L + P R
Sbjct: 212 LPFDGQNL-----KEL--RERV-------LRGKYRIPFYMSTDCENLLKRFLVLNPIKRG 257
Query: 348 DMDEVVK 354
+++++K
Sbjct: 258 TLEQIMK 264
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 74/327 (22%), Positives = 125/327 (38%), Gaps = 74/327 (22%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLG 133
+ LG+G FG V+K TG L A K + + + ++++ EI L
Sbjct: 21 WEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
HP +VKL+G D ++ EF P G+++ + + L+ +
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLE 128
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL-ARDGPTGDKSHVSTRVMGTYGY 252
L FLHS ++I+RD KA N+L+ + +L+DFG+ A++ T K +GT +
Sbjct: 129 ALNFLHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYW 183
Query: 253 AAPEYLATGHLT-----AKSDIYSFGVVLLEILSGR---------RA---IDKNRPTGEH 295
APE + + K+DI+S G+ L+E+ R I K+ P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---- 239
Query: 296 NLVEWAKPYLTSKRRIFRVLDPRLE--GQFSLPQAQKAASLALQCLSVEPKLRPDMDEV- 352
P L ++S + L P+ RP ++
Sbjct: 240 ---------------------PTLLTPSKWS----VEFRDFLKIALDKNPETRPSAAQLL 274
Query: 353 -------VKELEQLQELRNMHKRPQKE 372
+ + L+EL K E
Sbjct: 275 EHPFVSSITSNKALRELVAEAKAEVME 301
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 67/334 (20%), Positives = 116/334 (34%), Gaps = 66/334 (19%)
Query: 42 SLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLAST 101
S + +G + + ++ LG G +G V
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGE---SYFKVRKLGSGAYGEVLLC---------K 56
Query: 102 RPGTGMLIAVKRLN------------QEGFQGHKEWL-TEINYLGQLHHPNLVKLVGYCL 148
A+K + + + E + EI+ L L HPN++KL
Sbjct: 57 EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF- 115
Query: 149 EDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIY 207
ED LV EF G + + R + + + ++ MK L + +LH +++
Sbjct: 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-MKQILSG---ICYLHKH--NIVH 169
Query: 208 RDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLT 264
RD K NILL++ N K+ DFGL+ K +GT Y APE L
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAPEVL-KKKYN 225
Query: 265 AKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFS 324
K D++S GV++ +L G + + + I + + +G++
Sbjct: 226 EKCDVWSCGVIMYILLCGYPPF-------------GGQ----NDQDIIKKV---EKGKYY 265
Query: 325 LPQA------QKAASLALQCLSVEPKLRPDMDEV 352
+A L L+ + R +E
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 68/300 (22%), Positives = 108/300 (36%), Gaps = 72/300 (24%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT----EINYLGQ 134
+LGEG +G V + S T AVK L ++ + EI L +
Sbjct: 12 LLGEGSYGKVKEV---LDSE------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 135 LHHPNLVKL--VGYCLEDDHRLLVYEFMPRGSMENHLF-------------RRGSYFQPL 179
L H N+++L V Y E +V E+ G E + YF L
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHG--YFCQL 118
Query: 180 SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDK 239
+GL +LHS ++++D K N+LL + K+S G+A
Sbjct: 119 ------------IDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLT---AKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296
G+ + PE +A G T K DI+S GV L I +G P N
Sbjct: 165 DDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL------YPFEGDN 217
Query: 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
+ + + I + G +++P + L L EP R + ++ +
Sbjct: 218 IYKL---F----ENIGK-------GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 68/331 (20%), Positives = 120/331 (36%), Gaps = 58/331 (17%)
Query: 36 GKASSFSLPQTPRSEGEI-LQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVD 94
S + +G++ L ++ LG G +G V
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSE---MYQRVKKLGSGAYGEVLLC--- 56
Query: 95 EHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQLHHPNLVKLVGYCLEDDH 152
T + A+K + + + + L E+ L L HPN++KL + ED
Sbjct: 57 ------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKR 109
Query: 153 RL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFK 211
LV E G + + + R + + + + +K L + +LH +++RD K
Sbjct: 110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-IKQVLSG---VTYLHKH--NIVHRDLK 163
Query: 212 ASNILLDS---NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSD 268
N+LL+S + K+ DFGL+ K +GT Y APE L K D
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPEVL-RKKYDEKCD 219
Query: 269 IYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP-YLTSKRRIFRVLDPRLEGQFSLPQ 327
++S GV+L +L+G P + + I R + +G+++
Sbjct: 220 VWSIGVILFILLAGYP------------------PFGGQTDQEILRKV---EKGKYTFDS 258
Query: 328 A------QKAASLALQCLSVEPKLRPDMDEV 352
+ A L Q L + + R +
Sbjct: 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 55/288 (19%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQL 135
VLG+G FG V TG AVK +++ + + L E+ L QL
Sbjct: 33 VLGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
HPN++KL + ED LV E G + + + R + + + + ++ L
Sbjct: 84 DHPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSG--- 138
Query: 195 LAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
+ ++H K+++RD K N+LL+S + N ++ DFGL+ + S +GT
Sbjct: 139 ITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAY 193
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP-YLTSKRR 310
Y APE L G K D++S GV+L +LSG P ++
Sbjct: 194 YIAPEVL-HGTYDEKCDVWSTGVILYILLSGCP------------------PFNGANEYD 234
Query: 311 IFRVLDPRLEGQFSLPQA------QKAASLALQCLSVEPKLRPDMDEV 352
I + + +G+++ + A L + L+ P +R +
Sbjct: 235 ILKKV---EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 38/224 (16%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
+F ++G GGFG V+ + TG + A+K L+++ + + L E
Sbjct: 190 DFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 130 NYLGQLH---HPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
L + P +V + Y +L + + M G + HL + G + + M
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DM 294
Query: 186 K-----IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
+ I LG L +H+ V+YRD K +NILLD + + ++SD GLA D K
Sbjct: 295 RFYAAEIILG----LEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKP 347
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKS-DIYSFGVVLLEILSGR 283
H V GT+GY APE L G S D +S G +L ++L G
Sbjct: 348 H--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 64/375 (17%), Positives = 113/375 (30%), Gaps = 65/375 (17%)
Query: 54 LQSSNIKNFSYSDLRTA---TRNFRPDSVLGEG--GFGSVFKGWVDEHSLASTRPGTGML 108
+++N + + + + +V+G+G +V TG
Sbjct: 4 HHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLA---------RYKPTGEY 54
Query: 109 IAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSME 166
+ V+R+N E E++ +HPN+V + D+ +V FM GS +
Sbjct: 55 VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 167 NHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226
+ + + ++ I G L ++H ++R KAS+IL+ + LS
Sbjct: 115 DLI--CTHFMDGMNELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLS 170
Query: 227 DFG-LARDGPTGDKSHV----STRVMGTYGYAAPEYLATGHL--TAKSDIYSFGVVLLEI 279
G + V + + +PE L AKSDIYS G+ E+
Sbjct: 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
Query: 280 LSGR---------RA---IDKNRP---TGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFS 324
+G + + S+ L L
Sbjct: 231 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTP 290
Query: 325 LPQAQKAASLAL-------------QCLSVEPKLRPDMDEVVK----------ELEQLQE 361
P + S QCL P RP ++ E L E
Sbjct: 291 RPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPE 350
Query: 362 LRNMHKRPQKEHQAK 376
L ++
Sbjct: 351 LLRPVTPITNFEGSQ 365
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 69/321 (21%), Positives = 119/321 (37%), Gaps = 60/321 (18%)
Query: 49 SEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGML 108
S G + + + + +G G G V+K TG +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMR---FR------KTGHV 52
Query: 109 IAVKRLNQEG-FQGHKEWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLLVYEFMPRGSME 166
IAVK++ + G + +K L +++ + + H P +V+ G + + + E M + +
Sbjct: 53 IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK 112
Query: 167 NHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226
+G P+ + K+ + L +L + VI+RD K SNILLD KL
Sbjct: 113 LKKRMQG----PIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLC 167
Query: 227 DFGLARDGPTG--DKSHVSTRVMGTYGYAAPEYLATGHL-----TAKSDIYSFGVVLLEI 279
DFG++ G R G Y APE + ++D++S G+ L+E+
Sbjct: 168 DFGIS-----GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
Query: 280 LSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLD-------PRLEG--QFSLPQAQK 330
+G+ + F VL P L G FS
Sbjct: 223 ATGQFPYKNCKT-------------------DFEVLTKVLQEEPPLLPGHMGFS----GD 259
Query: 331 AASLALQCLSVEPKLRPDMDE 351
S CL+ + + RP ++
Sbjct: 260 FQSFVKDCLTKDHRKRPKYNK 280
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 59/330 (17%), Positives = 109/330 (33%), Gaps = 59/330 (17%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINYL 132
+ + GG G ++ + RP + +K L G + + E +L
Sbjct: 82 YEVKGCIAHGGLGWIYLA---LDRNVNGRP-----VVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 133 GQLHHPNLVKLVGYCLEDDHRL-----LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
++ HP++V++ + D +V E++ S++ + L + +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAY 187
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPTGDKSHVSTRV 246
L L++LHS ++Y D K NI+L KL D G G +
Sbjct: 188 LLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YL 237
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306
GT G+ APE + T +DIY+ G L +
Sbjct: 238 YGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP------------------TRNG 278
Query: 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-DMDEVVKELEQLQELRNM 365
DP L+ S L + + +P+ R +E+ +L + LR +
Sbjct: 279 RYVDGLPEDDPVLKTYDSY------GRLLRRAIDPDPRQRFTTAEEMSAQLTGV--LREV 330
Query: 366 HKRPQKEHQAKGHVHFKGRATTYPRPSASP 395
+ + F +T+
Sbjct: 331 VAQDTGVPRPGLSTIFSPSRSTFGVDLLVA 360
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 69/357 (19%), Positives = 123/357 (34%), Gaps = 92/357 (25%)
Query: 24 SSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEG 83
SS SS S P ++ + ++ +LG G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLE--------SQYQVGPLLGSG 54
Query: 84 GFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWLT-EINYLGQLHH 137
GFGSV+ G R + +A+K R++ G + + E+ L ++
Sbjct: 55 GFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 138 --PNLVKLVGYCLEDDHRLLVYEFMPRGSME--NHLFRRG--------SYFQPLSWSLRM 185
+++L+ + D +L+ E P + + + RG S+F +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQV------ 158
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKLSDFGLA---RDGPTGDKSH 241
+ H+ V++RD K NIL+D N KL DFG +D
Sbjct: 159 ------LEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------V 204
Query: 242 VSTRVMGTYGYAAPEYLATGHL--TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299
+ GT Y+ PE++ H + ++S G++L +++ G +
Sbjct: 205 YTDFD-GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFE------------ 250
Query: 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
I R GQ Q + + L CL++ P RP +E+
Sbjct: 251 -------HDEEIIR-------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 25/220 (11%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT----EI 129
+ +LG GG V D +AVK L + + E
Sbjct: 14 YELGEILGFGGMSEVHLA-RD-LRD-------HRDVAVKVLRAD-LARDPSFYLRFRREA 63
Query: 130 NYLGQLHHPNLVKL--VGYCLEDDHRL--LVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
L+HP +V + G L +V E++ ++ + + G P++ +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAI 119
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVST- 244
++ A L F H +I+RD K +NI++ + K+ DFG+AR S T
Sbjct: 120 EVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284
V+GT Y +PE + A+SD+YS G VL E+L+G
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 64/291 (21%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL---TEINYLGQLH 136
LG G FG V G EH L TG +AVK LN++ + EI L
Sbjct: 19 LGVGTFGKVKIG---EHQL------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 137 HPNLVKLVGY-CLEDDHRL-LVYEFMPRGSMENHLFRRG--------SYFQPLSWSLRMK 186
HP+++KL Y + +V E++ G + +++ + G FQ +
Sbjct: 70 HPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------- 120
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
+ + + H V++RD K N+LLD++ NAK++DFGL+ G+ S
Sbjct: 121 -----LSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 171
Query: 247 MGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
G+ YAAPE ++ + + DI+S GV+L +L G P + ++ P L
Sbjct: 172 -GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT------LPFDDEHV-----PTL 219
Query: 306 TSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
++I G F +P+ + A+L + L V+P R + ++ +
Sbjct: 220 --FKKIRG-------GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 72/303 (23%), Positives = 114/303 (37%), Gaps = 58/303 (19%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HH 137
VLGEG V T AVK + ++ E+ L Q H
Sbjct: 20 VLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLR-----MKIALGAA 192
N+++L+ + E+D LV+E M GS+ +H+ +R + + ++ A
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF------NELEASVVVQDVASA- 123
Query: 193 NGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLSDFGLARD-GPTGDKSHVSTRVM- 247
L FLH+ + +RD K NIL + K+ DF L GD S +ST +
Sbjct: 124 --LDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 248 ---GTYGYAAPEYLATGHLTAKS-----DIYSFGVVLLEILSGRRAIDKNRP----TGEH 295
G+ Y APE + A D++S GV+L +LSG P G
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCGSD 233
Query: 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQA------QKAASLALQCLSVEPKLRPDM 349
+ + + +F + EG++ P A L + L + K R
Sbjct: 234 CGWDRGEACPACQNMLFESI---QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 350 DEV 352
+V
Sbjct: 291 AQV 293
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 73/312 (23%), Positives = 121/312 (38%), Gaps = 58/312 (18%)
Query: 55 QSSNIKNFSYS-DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKR 113
SS +N + + +LG+G FG V K T AVK
Sbjct: 7 HSSGRENLYFQGTFA---ERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKV 54
Query: 114 LNQEGFQG--HKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLF 170
+N+ + L E+ L +L HPN++KL ED +V E G + + +
Sbjct: 55 INKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEII 113
Query: 171 RRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSD 227
+R + + + + +K + ++H +++RD K NILL+S + + K+ D
Sbjct: 114 KRKRFSEHDAARI-IKQVFSG---ITYMHKH--NIVHRDLKPENILLESKEKDCDIKIID 167
Query: 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287
FGL+ K +GT Y APE L G K D++S GV+L +LSG
Sbjct: 168 FGLSTCFQQNTKMK---DRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTP--- 220
Query: 288 KNRPTGEHNLVEWAKP-YLTSKRRIFRVLDPRLEGQFSLPQA------QKAASLALQCLS 340
P Y ++ I + + G+++ A L + L+
Sbjct: 221 ---------------PFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 341 VEPKLRPDMDEV 352
P LR +
Sbjct: 263 FHPSLRITATQC 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 33/214 (15%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT-EINYLGQLHHP 138
LGEG +G V + + T +AVK ++ + E + EI L+H
Sbjct: 15 LGEGAYGEVQLA---VNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG--------SYFQPLSWSLRMKIALG 190
N+VK G+ E + + L E+ G + + + +F L
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 115 -MAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 251 GYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGR 283
Y APE L D++S G+VL +L+G
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 87/358 (24%), Positives = 137/358 (38%), Gaps = 81/358 (22%)
Query: 56 SSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN 115
+ ++ S LR F ++G G +G V+KG TG L A+K ++
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKVMD 58
Query: 116 QEGFQGHKEWLTEINYLGQL-HHPNLVK-----LVGYCLEDDHRL-LVYEFMPRGSMENH 168
G +E EIN L + HH N+ + D +L LV EF GS+ +
Sbjct: 59 VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 169 LFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228
+ + + L I GL+ LH KVI+RD K N+LL N KL DF
Sbjct: 118 I--KNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 229 GLARD-GPTGDKSHVSTRVMGTYGYAAPEYLATGHLT-----AKSDIYSFGVVLLEILSG 282
G++ T + + +GT + APE +A KSD++S G+ +E+ G
Sbjct: 174 GVSAQLDRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 283 R---------RA---IDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEG-QFSLPQAQ 329
RA I +N PRL+ ++S +
Sbjct: 231 APPLCDMHPMRALFLIPRNPA-------------------------PRLKSKKWS----K 261
Query: 330 KAASLALQCLSVEPKLRPDMDEVVK---------ELEQLQELRNMHKRPQKEHQAKGH 378
K S CL RP ++++K E + +L++ R +K+ K
Sbjct: 262 KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDE 319
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 60/304 (19%), Positives = 106/304 (34%), Gaps = 76/304 (25%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWLT 127
+ S LG G FG V W + VK ++ ++ + +
Sbjct: 25 KYSTMSPLGSGAFGFV---WTAVDKE------KNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 128 ---EINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSME--NHLFRRG-------- 173
EI L ++ H N++K++ E+ LV E G ++ + R
Sbjct: 76 VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLAS 133
Query: 174 SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233
F+ L + + +L +I+RD K NI++ ++ KL DFG A
Sbjct: 134 YIFRQL------------VSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179
Query: 234 GPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292
G + GT Y APE L + + +++S GV L ++ P
Sbjct: 180 LERGKLFYTFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE------NP- 229
Query: 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMD 350
F L+ +E P +++ SL L P+ R ++
Sbjct: 230 -------------------FCELEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLE 270
Query: 351 EVVK 354
++V
Sbjct: 271 KLVT 274
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 71/246 (28%), Positives = 111/246 (45%), Gaps = 36/246 (14%)
Query: 50 EGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLA--STRPGTGM 107
EG I + + + + F VLG+G FG VF L +
Sbjct: 2 EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVF--------LVKKISGSDARQ 53
Query: 108 LIAVKRLNQEGFQGHKEW--LTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGS 164
L A+K L + + E + L +++HP +VKL Y + + +L L+ +F+ G
Sbjct: 54 LYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGD 112
Query: 165 MENHLFRRGSYFQPLSWSLRMK-----IALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219
+ L + + + +K +AL L LHS +IYRD K NILLD
Sbjct: 113 LFTRLSKEVMFTEE-----DVKFYLAELALA----LDHLHSL--GIIYRDLKPENILLDE 161
Query: 220 NYNAKLSDFGLARDGPTGDKSHVSTRVM-GTYGYAAPEYLA-TGHLTAKSDIYSFGVVLL 277
+ KL+DFGL+++ +K GT Y APE + GH T +D +SFGV++
Sbjct: 162 EGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMF 217
Query: 278 EILSGR 283
E+L+G
Sbjct: 218 EMLTGT 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 38/281 (13%)
Query: 19 VNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDS 78
+ + + + SS +S + N + + NF
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60
Query: 79 VLGEGGFGSVFKGWVDEHSLA--STRPGTGMLIAVKRLNQEGFQGHKEW----LTEINYL 132
VLG G +G VF L + TG L A+K L + + TE L
Sbjct: 61 VLGTGAYGKVF--------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 133 GQL-HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK---- 186
+ P LV L Y + + +L L+ +++ G + HL +R + + ++
Sbjct: 113 EHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIYVG 166
Query: 187 -IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
I L L LH +IYRD K NILLDSN + L+DFGL+++ +
Sbjct: 167 EIVLA----LEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
Query: 246 VMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGR 283
GT Y AP+ + +GH A D +S GV++ E+L+G
Sbjct: 221 C-GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGA 259
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTE 128
+F+ +LGEG F +V LA T A+K L + + E
Sbjct: 30 EDFKFGKILGEGSFSTVV--------LAREL-ATSREYAIKILEKRHIIKENKVPYVTRE 80
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
+ + +L HP VKL + +DD +L + G + ++ + GS+ + + R
Sbjct: 81 RDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RFYT 136
Query: 188 A-LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
A + +A L +LH +I+RD K NILL+ + + +++DFG A+ K +
Sbjct: 137 AEIVSA--LEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 247 MGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGR 283
+GT Y +PE L + SD+++ G ++ ++++G
Sbjct: 193 VGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGL 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 73/296 (24%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 6 SNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYS 65
R + S +AK L+ + K + Q+ E E+ + K F
Sbjct: 36 QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF--- 92
Query: 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW 125
+ + P V+G G V + TG AVK + + E
Sbjct: 93 -----YQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 126 L--------TEINYLGQLH-HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF----RR 172
L E + L Q+ HP+++ L+ LV++ M +G E LF +
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG--E--LFDYLTEK 194
Query: 173 GSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232
+ + + S+ M+ L A ++FLH+ +++RD K NILLD N +LSDFG +
Sbjct: 195 VALSEKETRSI-MRSLLEA---VSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSC 248
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTA------KSDIYSFGVVLLEILSG 282
G+K + GT GY APE L + D+++ GV+L +L+G
Sbjct: 249 HLEPGEK--LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 70/290 (24%), Positives = 113/290 (38%), Gaps = 35/290 (12%)
Query: 6 SNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYS 65
N + D +S+ +AK + S++ + S + + F +
Sbjct: 17 ENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHR 76
Query: 66 DLRTATRNFR------PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF 119
+ +LG G FG V K TG+ +A K + G
Sbjct: 77 IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---------EETATGLKLAAKIIKTRGM 127
Query: 120 QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRR----GS 174
+ +E EI+ + QL H NL++L E + + LV E++ G E LF R
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGG--E--LFDRIIDESY 182
Query: 175 YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA--KLSDFGLAR 232
L L MK G+ +H +++ D K NIL + K+ DFGLAR
Sbjct: 183 NLTELDTILFMKQIC---EGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
+K V GT + APE + ++ +D++S GV+ +LSG
Sbjct: 238 RYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN 139
+G G +G V+K A+K++ G EI L +L HPN
Sbjct: 29 VGRGTYGHVYKAK-------RKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 140 LVKLVGYCLED-DHRL-LVYEFMP---RGSMENHLFRRGSY-FQPLSWSLRMKIALGAAN 193
++ L L D ++ L++++ ++ H + + L + + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNA----KLSDFGLAR--DGPTGDKSHVSTRVM 247
G+ +LH+ V++RD K +NIL+ K++D G AR + P + + V+
Sbjct: 140 GIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 248 GTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
T+ Y APE L A H T DI++ G + E+L+
Sbjct: 198 -TFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSE 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 76/351 (21%), Positives = 123/351 (35%), Gaps = 100/351 (28%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEW----- 125
+ +GEG +G VFK + TG ++A+K +++
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESED-----DPVIKKIA 49
Query: 126 LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
L EI L QL HPNLV L+ LV+E+ ++ + L R + + L
Sbjct: 50 LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ---RGVPEHLVK 105
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD--GPTGDKSH-V 242
I + F H I+RD K NIL+ + KL DFG AR GP+ V
Sbjct: 106 SITWQTLQAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 243 STRVMGTYGYAAPEYLATGHLTAKS-----DIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297
+TR Y +PE L + D+++ G V E+LSG
Sbjct: 164 ATR-----WYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV-------------- 200
Query: 298 VEWAKPYLTSK------RRIFRVL------------DPRLEGQFSLPQAQKAASLAL--- 336
P K I + L + +P + L L
Sbjct: 201 -----PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFP 255
Query: 337 -----------QCLSVEPKLRPDMDEVVK-----ELEQLQELRNMHKRPQK 371
CL ++P R ++++ + ++++L H +P +
Sbjct: 256 NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAE 306
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
VLG G F VF + TG L A+K + + EI L ++ H
Sbjct: 16 VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+V L H LV + + G + + + RG Y + + + ++ L A + +L
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVLSA---VKYL 122
Query: 199 HSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAP 255
H +++RD K N+L + N ++DFGL++ +++ + + GT GY AP
Sbjct: 123 HEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAP 176
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILSG 282
E LA + D +S GV+ +L G
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 74/331 (22%), Positives = 126/331 (38%), Gaps = 68/331 (20%)
Query: 52 EI-LQSSNIKNFSYSDLRTATRNFRPDSV---------LGEGGFGSVFKGWVDEHSLAST 101
EI L S K F + DL ++ P ++ LG G G V
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------F 155
Query: 102 RPGTGMLIAVKRLNQEGFQGHKEW--------LTEINYLGQLHHPNLVKLVGYCLEDDHR 153
T +A++ +++ F TEI L +L+HP ++K+ + + +
Sbjct: 156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDY 214
Query: 154 LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKAS 213
+V E M G + + + + ++ + +LH +I+RD K
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM----LLAVQYLHEN--GIIHRDLKPE 268
Query: 214 NILLDS---NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL---TAKS 267
N+LL S + K++DFG ++ G+ S + T GT Y APE L +
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAV 325
Query: 268 DIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ 327
D +S GV+L LSG P EH ++ + + G+++
Sbjct: 326 DCWSLGVILFICLSGY------PPFSEHR----------TQVSLKDQI---TSGKYNFIP 366
Query: 328 A------QKAASLALQCLSVEPKLRPDMDEV 352
+KA L + L V+PK R +E
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/283 (25%), Positives = 111/283 (39%), Gaps = 36/283 (12%)
Query: 11 AETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTA 70
ETP + ++++ +A++ ++ + + R
Sbjct: 90 VETP---EEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVT 146
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LT 127
F +LG+G FG V L + TG A+K L +E E LT
Sbjct: 147 MNEFEYLKLLGKGTFGKVI--------LVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLT 197
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186
E L HP L L Y + RL V E+ G + HL R + + R +
Sbjct: 198 ENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RAR 251
Query: 187 -----IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH 241
I L +LHS E V+YRD K N++LD + + K++DFGL ++G
Sbjct: 252 FYGAEIVSA----LDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 304
Query: 242 VSTRVM-GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
+ + GT Y APE L D + GVV+ E++ GR
Sbjct: 305 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 33/214 (15%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT-EINYLGQLHHP 138
LGEG +G V + + T +AVK ++ + E + EI L+H
Sbjct: 15 LGEGAYGEVQLA---VNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG--------SYFQPLSWSLRMKIALG 190
N+VK G+ E + + L E+ G + + + +F L
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 115 -MAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 251 GYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGR 283
Y APE L D++S G+VL +L+G
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQL 135
+G+G FG V V ++ T + A+K +N++ E E+ + L
Sbjct: 22 AIGKGSFGKVCI--VQKN-------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK-----IAL 189
HP LV L Y +D+ + +V + + G + HL + + + +K + +
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-----TVKLFICELVM 126
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
L +L + ++I+RD K NILLD + + ++DF +A P + T + GT
Sbjct: 127 A----LDYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 250 YGYAAPEYLA----TGHLTAKSDIYSFGVVLLEILSGRR 284
Y APE + G+ A D +S GV E+L GRR
Sbjct: 178 KPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRR 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 64/280 (22%), Positives = 116/280 (41%), Gaps = 52/280 (18%)
Query: 24 SSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEG 83
++ A+S ++ S+ + +G + + R ++ V+G G
Sbjct: 7 TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATP-GQGPDRPQEVSYTDTKVIGNG 65
Query: 84 GFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKL 143
FG V++ + + +G L+A+K++ Q + E+ + +L H N+V+L
Sbjct: 66 SFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 144 VGYCLEDDHRL------LVYEFMPRGSMENHLFRRGSYFQPLSWS---------LRMKIA 188
+ + LV +++P ++ Q L R
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR---- 167
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA-KLSDFGLARDGPTGDK--SHVSTR 245
LA++HS + +RD K N+LLD + KL DFG A+ G+ S++ +R
Sbjct: 168 -----SLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 246 VMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
Y Y APE + AT T+ D++S G VL E+L G+
Sbjct: 221 ----Y-YRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 54/291 (18%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWLTEINYLG 133
V+G+G F V + TG AVK + ++ E +
Sbjct: 31 VIGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS---WSLRMKIALG 190
L HP++V+L+ D +V+EFM + + +R S S M+ L
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSHVSTRVM 247
A L + H +I+RD K +LL S + KL FG+A G+ V+ +
Sbjct: 142 A---LRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRV 194
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
GT + APE + D++ GV+L +LSG P+ +
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL------------------PFYGT 236
Query: 308 KRRIFRVLDPRLEGQFSLPQAQ------KAASLALQCLSVEPKLRPDMDEV 352
K R+F + ++G++ + Q A L + L ++P R + E
Sbjct: 237 KERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
+F +LG+G FG V L + TG A+K L +E E +TE
Sbjct: 6 DFDYLKLLGKGTFGKVI--------LVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK-- 186
L HP L L Y + RL V E+ G + HL R + + R +
Sbjct: 57 RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFY 110
Query: 187 ---IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS 243
I L +LHS V+YRD K N++LD + + K++DFGL ++G + +
Sbjct: 111 GAEIVSA----LEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---T 161
Query: 244 TRVM-GTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGR 283
+ GT Y APE L + D + GVV+ E++ GR
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 63/290 (21%), Positives = 95/290 (32%), Gaps = 33/290 (11%)
Query: 5 CSNRIKAETPSHTD--VNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNF 62
N+ P V R + + T S + K +
Sbjct: 84 AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQY 143
Query: 63 SYSDLRTATRNFRP----DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG 118
+ + LG G FG V + T TG A K +
Sbjct: 144 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPH 194
Query: 119 FQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR----GS 174
+ EI + L HP LV L +D+ +++YEFM G E LF + +
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHN 250
Query: 175 YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA--KLSDFGLAR 232
M+ GL +H ++ D K NI+ + + KL DFGL
Sbjct: 251 KMSEDEAVEYMRQVC---KGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
V GT +AAPE + +D++S GV+ +LSG
Sbjct: 306 HLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-24
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 36/217 (16%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL---NQEGFQGHKEWLT---EINYLG 133
LG G + +V+KG TG+ +A+K + ++EG T EI+ +
Sbjct: 13 LGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTP-----STAIREISLMK 58
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWSLRMKIALG 190
+L H N+V+L ++ LV+EFM + M++ + L +L
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP--RGLELNLVKYFQWQ 116
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD--GPTGDKSHVSTRVMG 248
GLAF H K+++RD K N+L++ KL DFGLAR P S V+
Sbjct: 117 LLQGLAFCHEN--KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV- 170
Query: 249 TYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
T Y AP+ L + + T+ DI+S G +L E+++G+
Sbjct: 171 TLWYRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-24
Identities = 62/283 (21%), Positives = 108/283 (38%), Gaps = 48/283 (16%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
+G G +G V + GT + A K++ + + + EI + L HP
Sbjct: 16 TIGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFL 198
N+++L ++ LV E G + + + + + + + MK L A +A+
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSA---VAYC 122
Query: 199 HSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAP 255
H V +RD K N L + + KL DFGLA + +GT Y +P
Sbjct: 123 HKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSP 177
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315
+ L + + D +S GV++ +L G P A + + +
Sbjct: 178 QVLEGLY-GPECDEWSAGVMMYVLLCGY------PPF-------SAP----TDSEVMLKI 219
Query: 316 DPRLEGQFSLPQA------QKAASLALQCLSVEPKLRPDMDEV 352
EG F+ P+ +A SL + L+ PK R +
Sbjct: 220 ---REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 1e-23
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLA--STRPGTGMLIAVKRLNQEGFQGHK---EW-L 126
F VLG+GG+G VF T TG + A+K L + +
Sbjct: 18 CFELLRVLGKGGYGKVF--------QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK 69
Query: 127 TEINYLGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
E N L ++ HP +V L+ Y + +L L+ E++ G + L R G + +
Sbjct: 70 AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-----TA 123
Query: 186 K-----IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
I++ L LH +IYRD K NI+L+ + KL+DFGL ++
Sbjct: 124 CFYLAEISMA----LGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT- 176
Query: 241 HVSTRVM-GTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGR 283
T GT Y APE L +GH D +S G ++ ++L+G
Sbjct: 177 --VTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 41/224 (18%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL---NQEGFQGHKEWLT-- 127
+ LGEG + +V+KG T L+A+K + ++EG T
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAP-----CTAI 48
Query: 128 -EINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWSL 183
E++ L L H N+V L + LV+E++ + +++ ++
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC-------GNIINMHN 101
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD--GPTGDKSH 241
GLA+ H KV++RD K N+L++ KL+DFGLAR PT +
Sbjct: 102 VKLFLFQLLRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159
Query: 242 VSTRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
V+ T Y P+ L +T + T D++ G + E+ +GR
Sbjct: 160 ---EVV-TLWYRPPDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 55/256 (21%), Positives = 93/256 (36%), Gaps = 38/256 (14%)
Query: 49 SEGEILQSSNIKNF--SYSDLRTATRNFRPD-------SVLGEGGFGSVFKGWVDEHSLA 99
E+ Q + +F + + R V+G G F V +
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVA--------VV 80
Query: 100 STRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQLHHPNLVKLVGYCLEDDHRL-L 155
+ TG + A+K +N+ E + E + L + +L + +D++ L L
Sbjct: 81 KMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYL 138
Query: 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA-LGAANGLAFLHSAEPKVIYRDFKASN 214
V E+ G + L + G P + R +A + A + +H ++RD K N
Sbjct: 139 VMEYYVGGDLLTLLSKFGERI-PAEMA-RFYLAEIVMA--IDSVHRL--GYVHRDIKPDN 192
Query: 215 ILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIY---- 270
ILLD + +L+DFG V GT Y +PE L + Y
Sbjct: 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPEC 251
Query: 271 ---SFGVVLLEILSGR 283
+ GV E+ G+
Sbjct: 252 DWWALGVFAYEMFYGQ 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 76/291 (26%), Positives = 110/291 (37%), Gaps = 60/291 (20%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL-TEINYLGQLHH 137
LG G FG V +G+ +K +N++ Q E + EI L L H
Sbjct: 29 KLGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 138 PNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLF-------RRGSYFQPLSWSLRMKIAL 189
PN++K+ ED H + +V E G E L RG + MK +
Sbjct: 80 PNIIKIFEVF-EDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSHVSTRV 246
A LA+ HS V+++D K NIL + K+ DFGLA ST
Sbjct: 135 NA---LAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNA 186
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306
GT Y APE +T K DI+S GVV+ +L+G P
Sbjct: 187 AGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGC------LPF-------TGT---- 228
Query: 307 SKRRIFRVLDPRLEGQFSLPQA-----QKAASLALQCLSVEPKLRPDMDEV 352
S + + + + +A L Q L+ +P+ RP +V
Sbjct: 229 SLEEVQQKA---TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 53/261 (20%), Positives = 93/261 (35%), Gaps = 25/261 (9%)
Query: 29 KSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRP----DSVLGEGG 84
G ++ + K + + + LG G
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63
Query: 85 FGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLV 144
FG V + TG + K +N EI+ + QLHHP L+ L
Sbjct: 64 FGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 145 GYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEP 203
ED + + L+ EF+ G + + + M+ A GL +H
Sbjct: 115 DAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC---EGLKHMHEH-- 168
Query: 204 KVIYRDFKASNILLDSNYNA--KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG 261
+++ D K NI+ ++ + K+ DFGLA + + T +AAPE +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 262 HLTAKSDIYSFGVVLLEILSG 282
+ +D+++ GV+ +LSG
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG 246
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 42/225 (18%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEW----- 125
+ ++GEG +G V K + TG ++A+K + + +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDD-----DKMVKKIA 71
Query: 126 LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWS 182
+ EI L QL H NLV L+ C + LV+EF+ +E L +
Sbjct: 72 MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-------PNGLDYQ 124
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD--GPTGDKS 240
+ K NG+ F HS +I+RD K NIL+ + KL DFG AR P
Sbjct: 125 VVQKYLFQIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 241 H-VSTRVMGTYGYAAPEYL-ATGHLTAKSDIYSFGVVLLEILSGR 283
V+TR Y APE L D+++ G ++ E+ G
Sbjct: 183 DEVATR-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 34/228 (14%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN--------QEGFQGH 122
N+ P +LG G V + T AVK ++ E Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 123 KEWL-TEINYLGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
+E E++ L ++ HPN+++L + LV++ M +G + ++L + + + +
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
+ M+ L + LH +++RD K NILLD + N KL+DFG + G+K
Sbjct: 127 RKI-MRALLEV---ICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK- 179
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKS------DIYSFGVVLLEILSG 282
+ GT Y APE + D++S GV++ +L+G
Sbjct: 180 -LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 70/288 (24%), Positives = 112/288 (38%), Gaps = 47/288 (16%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HH 137
LGEG F K + AVK +++ ++ EI L H
Sbjct: 18 PLGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGH 65
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
PN+VKL + H LV E + G + + ++ + + + + M+ + A ++
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-MRKLVSA---VSH 121
Query: 198 LHSAEPKVIYRDFKASNILL---DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAA 254
+H V++RD K N+L + N K+ DFG AR P ++ + T T YAA
Sbjct: 122 MHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAA 177
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP--TGEHNLVEWAKPYLTSKRRIF 312
PE L D++S GV+L +LSG + TS I
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSG-------QVPFQSHDR-----SLTCTSAVEIM 225
Query: 313 RVLDPRLEGQFSLPQA------QKAASLALQCLSVEPKLRPDMDEVVK 354
+ + +G FS Q+A L L+V+P R M +
Sbjct: 226 KKI---KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 6e-23
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLT---EINYL 132
+GEG +G+VFK E T ++A+KR+ + EG + EI L
Sbjct: 10 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVP-----SSALREICLL 55
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+L H N+V+L D LV+EF + ++ L +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLF 108
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD--GPTGDKSHVSTRVM 247
GL F HS V++RD K N+L++ N KL++FGLAR P S V+
Sbjct: 109 QLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV 163
Query: 248 GTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGRRAI 286
T Y P+ L A + T+ D++S G + E+ + R +
Sbjct: 164 -TLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPL 202
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-23
Identities = 60/308 (19%), Positives = 115/308 (37%), Gaps = 82/308 (26%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWLT 127
+R +LG+GGFG+VF G R + +A+K R+
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 128 -EINYLGQLH----HPNLVKLVGYCLEDDHRLLVYEF-MPRGSMENHLFRRG-------- 173
E+ L ++ HP +++L+ + + +LV E +P + +++ +G
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142
Query: 174 SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA-KLSDFGLA- 231
+F + + HS V++RD K NIL+D KL DFG
Sbjct: 143 CFFGQV------------VAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGA 188
Query: 232 --RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLT-AKSDIYSFGVVLLEILSGRRAIDK 288
D P + GT Y+ PE+++ + ++S G++L +++ G +
Sbjct: 189 LLHDEP------YTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE- 240
Query: 289 NRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLR 346
+ I + P + +L +CL+ +P R
Sbjct: 241 ------------------RDQEILE-------AELHFPAHVSPDCCALIRRCLAPKPSSR 275
Query: 347 PDMDEVVK 354
P ++E++
Sbjct: 276 PSLEEILL 283
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 64/291 (21%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT---EINYLGQLH 136
LG G FG V G +H L TG +AVK LN++ + EI L
Sbjct: 24 LGVGTFGKVKVG---KHEL------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 137 HPNLVKLVGY-CLEDDHRL-LVYEFMPRGSMENHLFRRG--------SYFQPLSWSLRMK 186
HP+++KL Y + + +V E++ G + +++ + G FQ +
Sbjct: 75 HPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------- 125
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
+G+ + H V++RD K N+LLD++ NAK++DFGL+ G+ S
Sbjct: 126 -----LSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 176
Query: 247 MGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
G+ YAAPE ++ + + DI+S GV+L +L G P + ++ P L
Sbjct: 177 -GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT------LPFDDDHV-----PTL 224
Query: 306 TSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
++I G F PQ SL L V+P R + ++ +
Sbjct: 225 --FKKICD-------GIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 9e-23
Identities = 73/308 (23%), Positives = 124/308 (40%), Gaps = 52/308 (16%)
Query: 56 SSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN 115
SS +N + T + +LG+G FG V K T AVK +N
Sbjct: 8 SSGRENLYFQG--TFAERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVIN 56
Query: 116 QEGFQG--HKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG 173
+ + L E+ L +L HPN++KL + +V E G + + + +R
Sbjct: 57 KASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK 116
Query: 174 SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGL 230
+ + + + +K + ++H +++RD K NILL+S + + K+ DFGL
Sbjct: 117 RFSEHDAARI-IKQVFSG---ITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNR 290
+ K + R+ GT Y APE L G K D++S GV+L +LSG
Sbjct: 171 STCFQQNTK--MKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT------P 220
Query: 291 PTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQA------QKAASLALQCLSVEPK 344
P + K ++ I + + G+++ A L + L+ P
Sbjct: 221 PF-------YGK----NEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 345 LRPDMDEV 352
LR +
Sbjct: 267 LRITATQC 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 9e-23
Identities = 56/254 (22%), Positives = 94/254 (37%), Gaps = 62/254 (24%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWLTEINYLG 133
+G+G +G V T + A+K ++ Q + + TE+ +
Sbjct: 33 AIGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 134 QLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+LHHPN+ +L ED+ + LV E G + + L +K +
Sbjct: 84 KLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 193 ------------------------------------NGLAFLHSAEPKVIYRDFKASNIL 216
+ L +LH+ + +RD K N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GICHRDIKPENFL 200
Query: 217 LDSNYNA--KLSDFGLAR---DGPTGDKSHVSTRVMGTYGYAAPEYLATGHL--TAKSDI 269
+N + KL DFGL++ G+ ++T+ GT + APE L T + K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDA 259
Query: 270 YSFGVVLLEILSGR 283
+S GV+L +L G
Sbjct: 260 WSAGVLLHLLLMGA 273
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 41/228 (17%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW------- 125
+ LG G G V T +A+K +++ F
Sbjct: 11 EYIMSKTLGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 126 -LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF----RRGSYFQPLS 180
TEI L +L+HP ++K+ + + + +V E M G E LF +
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG--E--LFDKVVGNKRLKEATC 116
Query: 181 WSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTG 237
L A + +LH +I+RD K N+LL S + K++DFG ++ G
Sbjct: 117 KLY-FYQMLLA---VQYLHEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILG 168
Query: 238 DKSHVSTRVMGTYGYAAPEYLATGHL---TAKSDIYSFGVVLLEILSG 282
+ S + T GT Y APE L + D +S GV+L LSG
Sbjct: 169 ETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 67/292 (22%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL---TEINYLGQLH 136
LGEG FG V H T +A+K ++++ + + EI+YL L
Sbjct: 17 LGEGSFGKVKLA---THYK------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 137 HPNLVKLVGY-CLEDDHRL-LVYEF---------MPRGSMENHLFRRGSYFQPLSWSLRM 185
HP+++KL Y + + +V E+ + + M RR +FQ +
Sbjct: 68 HPHIIKL--YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRR--FFQQI------ 117
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
+ + H K+++RD K N+LLD N N K++DFGL+ G+ S
Sbjct: 118 ------ICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC- 168
Query: 246 VMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
G+ YAAPE + + + D++S G+VL +L GR P + + P
Sbjct: 169 --GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR------LPFDDEFI-----PN 215
Query: 305 LTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
L +++ + +P + A SL + + +P R + E+ +
Sbjct: 216 L--FKKVNS-------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 56/244 (22%), Positives = 94/244 (38%), Gaps = 67/244 (27%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT------------ 127
+G+G +G V + A+K L+++ +
Sbjct: 21 IGKGSYGVVKLA---YNEN------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 128 --------------EINYLGQLHHPNLVKL--VGYCLEDDHRLLVYEFMP---------R 162
EI L +L HPN+VKL V +DH +V+E +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 163 GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222
+ R YFQ L G+ +LH K+I+RD K SN+L+ + +
Sbjct: 132 KPLSEDQARF--YFQDL------------IKGIEYLHYQ--KIIHRDIKPSNLLVGEDGH 175
Query: 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLT---AKSDIYSFGVVLLEI 279
K++DFG++ + G + +S V GT + APE L+ D+++ GV L
Sbjct: 176 IKIADFGVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 280 LSGR 283
+ G+
Sbjct: 234 VFGQ 237
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 71/259 (27%), Positives = 109/259 (42%), Gaps = 42/259 (16%)
Query: 42 SLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPD-----SVLGEGGFGSVFKGWVDEH 96
S PQ P + + ++ + +P V+G+G FG V
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVL------- 55
Query: 97 SLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQ-LHHPNLVKLVGYCLEDDH 152
LA + + AVK L ++ KE ++E N L + + HP LV L + +
Sbjct: 56 -LARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTAD 112
Query: 153 RL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK-----IALGAANGLAFLHSAEPKVI 206
+L V +++ G + HL R + +P R + IA L +LHS ++
Sbjct: 113 KLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASA----LGYLHSL--NIV 161
Query: 207 YRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM-GTYGYAAPEYLA-TGHLT 264
YRD K NILLDS + L+DFGL ++ + +T GT Y APE L +
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCGTPEYLAPEVLHKQPY-D 217
Query: 265 AKSDIYSFGVVLLEILSGR 283
D + G VL E+L G
Sbjct: 218 RTVDWWCLGAVLYEMLYGL 236
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 65/291 (22%), Positives = 108/291 (37%), Gaps = 60/291 (20%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT-EINYLGQLHHP 138
+G G FG L T L+AVK + + E + EI L HP
Sbjct: 28 IGSGNFGVARLM---RDKL------TKELVAVKYIERG--AAIDENVQREIINHRSLRHP 76
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG--------SYFQPLSWSLRMKIALG 190
N+V+ L H ++ E+ G + + G +FQ L
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL----------- 125
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNY--NAKLSDFGLARDGPTGDKSHVSTRVMG 248
+G+++ HS ++ +RD K N LLD + K+ DFG ++ + + V G
Sbjct: 126 -LSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-G 179
Query: 249 TYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
T Y APE L + +D++S GV L +L G P + + Y +
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA------YPFEDPEE---PRDYRKT 230
Query: 308 KRRIFRVLDPRLEGQFSLPQA----QKAASLALQCLSVEPKLRPDMDEVVK 354
+RI ++S+P + L + +P R + E+
Sbjct: 231 IQRILS-------VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-22
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 31/221 (14%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTE 128
+ N+ LG+G F V + TG+ A K +N + ++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF----RRGSYFQPLSWSLR 184
+L HPN+V+L E+ LV++ + G E LF R Y + +
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFEDIVAREFYSEADASHCI 111
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA---KLSDFGLARDGPTGDKSH 241
+I +A+ HS +++R+ K N+LL S KL+DFGLA + +
Sbjct: 112 QQI----LESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
GT GY +PE L + DI++ GV+L +L G
Sbjct: 164 WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 43/218 (19%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKE-----WLTEINYL 132
+GEG +G V+K + G A+K RL +E E + EI+ L
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIRLEKE-----DEGIPSTTIREISIL 54
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+L H N+VKL +LV+E + + ++ L L
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-------GGLESVTAKSFLL 107
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD--GPTGDKSHVSTRVM 247
NG+A+ H +V++RD K N+L++ K++DFGLAR P +H ++
Sbjct: 108 QLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV 162
Query: 248 GTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
T Y AP+ L + + T DI+S G + E+++G
Sbjct: 163 -TLWYRAPDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 39/216 (18%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLT---EINYL 132
+GEG +G V+K + G ++A+KR+ EG T EI+ L
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIP-----STAIREISLL 73
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+LHHPN+V L+ + LV+EFM + ++ + L S
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-------TGLQDSQIKIYLY 126
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
G+A H ++++RD K N+L++S+ KL+DFGLAR G T + T
Sbjct: 127 QLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVT 182
Query: 250 YGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
Y AP+ L + + T+ DI+S G + E+++G+
Sbjct: 183 LWYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 56/299 (18%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTE 128
T ++ LG+G F V + + G A +N + H++ E
Sbjct: 10 TEEYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF----RRGSYFQPLSWSLR 184
L HPN+V+L E+ H L+++ + G E LF R Y + +
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG--E--LFEDIVAREYYSEADASHC- 115
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSH 241
++ L A + H V++R+ K N+LL S KL+DFGLA + G++
Sbjct: 116 IQQILEA---VLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQA 169
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301
GT GY +PE L D+++ GV+L +L G P W
Sbjct: 170 WFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGY------PPF-------WD 215
Query: 302 KPYLTSKRRIFRVLDPRLEGQFSLPQA------QKAASLALQCLSVEPKLRPDMDEVVK 354
+ + R+++ + G + P +A L + L++ P R E +K
Sbjct: 216 E----DQHRLYQQI---KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTE 128
+ N+ LG+G F V + TG+ A K +N + ++ E
Sbjct: 28 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLF----RRGSYFQPLSWSLR 184
+L HPN+V+L E+ LV++ + G E LF R Y + +
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFEDIVAREFYSEADASHC- 133
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSH 241
++ L + +A+ HS +++R+ K N+LL S KL+DFGLA + +
Sbjct: 134 IQQILES---IAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 186
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
GT GY +PE L + DI++ GV+L +L G
Sbjct: 187 WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 61/250 (24%), Positives = 102/250 (40%), Gaps = 47/250 (18%)
Query: 55 QSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL 114
S N + R F+ + + G+G FG+V G TGM +A+K++
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKV 56
Query: 115 NQEGFQGHKEWLTEINYLGQLHHPNLVKL------VGYCLEDDHRL-LVYEFMPRGSMEN 167
Q+ ++E L + L LHHPN+V+L +G D L +V E++P ++
Sbjct: 57 IQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114
Query: 168 HLFRRGSYFQPLSWS---------LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218
+R + LH V +RD K N+L++
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIR---------SIGCLHLPSVNVCHRDIKPHNVLVN 165
Query: 219 -SNYNAKLSDFGLARDGPTGDK--SHVSTRVMGTYGYAAPEYL--ATGHLTAKSDIYSFG 273
++ KL DFG A+ + +++ +R Y Y APE + H T DI+S G
Sbjct: 166 EADGTLKLCDFGSAKKLSPSEPNVAYICSR----Y-YRAPELIFGNQ-HYTTAVDIWSVG 219
Query: 274 VVLLEILSGR 283
+ E++ G
Sbjct: 220 CIFAEMMLGE 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 57/254 (22%), Positives = 93/254 (36%), Gaps = 36/254 (14%)
Query: 49 SEGEILQSSNIKNF--SYSDLRTATRNFRPD-------SVLGEGGFGSVFKGWVDEHSLA 99
+ + + NI + + + R V+G G FG V +
Sbjct: 42 NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVA--------VV 93
Query: 100 STRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQLHHPNLVKLVGYCLEDDHRL-L 155
+ + A+K LN+ E + E + L + L Y +DD+ L L
Sbjct: 94 KLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYL 151
Query: 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA-LGAANGLAFLHSAEPKVIYRDFKASN 214
V ++ G + L + P + R +A + A + +H ++RD K N
Sbjct: 152 VMDYYVGGDLLTLLSKFEDRL-PEEMA-RFYLAEMVIA--IDSVHQL--HYVHRDIKPDN 205
Query: 215 ILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKS-----DI 269
IL+D N + +L+DFG S V GT Y +PE L D
Sbjct: 206 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDW 264
Query: 270 YSFGVVLLEILSGR 283
+S GV + E+L G
Sbjct: 265 WSLGVCMYEMLYGE 278
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWL-TEINYL 132
LG G F V K TG+ A K + +E + E++ L
Sbjct: 19 ELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
Q+ HPN++ L +L+ E + G + + L ++ S + + S +K L
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQIL--- 125
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDS----NYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
+G+ +LH+ K+ + D K NI+L + KL DFGLA + G + + G
Sbjct: 126 DGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
T + APE + L ++D++S GV+ +LSG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-22
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWL-TEINYL 132
LG G F V K TG+ A K + +E + E++ L
Sbjct: 19 ELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 133 GQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
Q+ H N++ L E+ + L+ E + G + + L ++ S + + S +K L
Sbjct: 70 RQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQIL-- 125
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDS----NYNAKLSDFGLARDGPTGDKSHVSTRVM 247
+G+ +LH+ K+ + D K NI+L + KL DFGLA + G + +
Sbjct: 126 -DGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IF 179
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
GT + APE + L ++D++S GV+ +LSG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-22
Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 34/274 (12%)
Query: 12 ETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTAT 71
+ V+ + +S+SS + A+ + P + + +F
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDF--------- 54
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
F +S LG G V++ + GT A+K L + K TEI
Sbjct: 55 --FEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVRTEIGV 101
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
L +L HPN++KL LV E + G + + + +G Y + + +K L A
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-VKQILEA 160
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
+A+LH +++RD K N+L + K++DFGL++ + + V G
Sbjct: 161 ---VAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCG 212
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
T GY APE L + D++S G++ +L G
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 65/222 (29%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
+F +LG+G FG VF LA + T A+K L ++ + + E
Sbjct: 18 DFILHKMLGKGSFGKVF--------LAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 130 NYLGQ-LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK- 186
L HP L + + L V E++ G + H+ + R
Sbjct: 69 RVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATF 122
Query: 187 ----IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
I LG L FLHS ++YRD K NILLD + + K++DFG+ ++ GD
Sbjct: 123 YAAEIILG----LQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--- 173
Query: 243 STRVM-GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
T GT Y APE L D +SFGV+L E+L G+
Sbjct: 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 9e-22
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWL-TEINYL 132
LG G F V K + GTG A K RL+ +E + E+N L
Sbjct: 12 ELGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 133 GQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
++ HPN++ L E+ + L+ E + G + + L + S + + +K L
Sbjct: 63 REIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQIL-- 118
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDS----NYNAKLSDFGLARDGPTGDKSHVSTRVM 247
+G+ +LHS ++ + D K NI+L N KL DFG+A G++ +
Sbjct: 119 -DGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IF 172
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
GT + APE + L ++D++S GV+ +LSG
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 43/207 (20%), Positives = 76/207 (36%), Gaps = 22/207 (10%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP 138
LG G FG V + + K + +G EI+ L H
Sbjct: 12 DLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHR 61
Query: 139 NLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAF 197
N++ L E L +++EF+ + + + L F
Sbjct: 62 NILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQF 117
Query: 198 LHSAEPKVIYRDFKASNILLDSNYNA--KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAP 255
LHS + + D + NI+ + ++ K+ +FG AR GD + + Y AP
Sbjct: 118 LHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172
Query: 256 EYLATGHLTAKSDIYSFGVVLLEILSG 282
E ++ +D++S G ++ +LSG
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE- 124
D+++ + + LGEG F +V+K T ++A+K++ K+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDG 54
Query: 125 ----WLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQ 177
L EI L +L HPN++ L+ + LV++FM ++++
Sbjct: 55 INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-------SL 107
Query: 178 PLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGP 235
L+ S L GL +LH +++RD K +N+LLD N KL+DFGLA+ P
Sbjct: 108 VLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 236 TGDKSH-VSTRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
+H V TR Y APE L A + D+++ G +L E+L
Sbjct: 166 NRAYTHQVVTR-----WYRAPELLFGARMYGVG-VDMWAVGCILAELLLRV 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 52/230 (22%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLG 133
+ V+G G FG VF+ + E + +A+K++ Q+ + E+ +
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVE---------SDE-VAIKKVLQD----KRFKNRELQIMR 87
Query: 134 QLHHPNLVKLVGYCLEDDHRL------LVYEFMPRGSMENHLFRRGSYFQPLSWS----- 182
+ HPN+V L + + + LV E++P ++ Q +
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLY 146
Query: 183 ----LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA-KLSDFGLARDGPTG 237
LR LA++HS + +RD K N+LLD KL DFG A+ G
Sbjct: 147 MYQLLR---------SLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195
Query: 238 DK--SHVSTRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
+ S++ +R Y Y APE + AT + T DI+S G V+ E++ G+
Sbjct: 196 EPNVSYICSR----Y-YRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 74/369 (20%), Positives = 127/369 (34%), Gaps = 78/369 (21%)
Query: 29 KSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTA---TRNFRPDSVLGEGGF 85
++ G + + + + +S + + ++ +G G
Sbjct: 16 VKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQ 75
Query: 86 GSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEINYLGQLHHPNLVK 142
G V D +A+K+L++ FQ K E+ + ++H N++
Sbjct: 76 GIVCAA-YDAV--------LDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 143 LV-----GYCLEDDHRL-LVYEFMP--------RGSMENHLFRRGSYFQPLSWSLRMKIA 188
L+ LE+ + LV E M + SY L L
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM----SYL--LYQMLC---- 175
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS--HVSTRV 246
G+ LHSA +I+RD K SNI++ S+ K+ DFGLAR T +V TR
Sbjct: 176 -----GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR------------RAIDK--NRPT 292
Y APE + DI+S G ++ E++ + + + P
Sbjct: 229 -----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 293 GE--HNLVEWAKPYLTS----KRRIFRVLDPRLEGQFSLPQAQKAASLAL----QCLSVE 342
E L + Y+ + F L P + AS A + L ++
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 343 PKLRPDMDE 351
P R +D+
Sbjct: 344 PAKRISVDD 352
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 32/276 (11%)
Query: 14 PSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRN 73
P + + K + G+ + +T + + + N +D
Sbjct: 290 PVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD------- 342
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEIN 130
F VLG+G FG V L+ + GT L AVK L ++ + + E
Sbjct: 343 FNFLMVLGKGSFGKVM--------LSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 131 YLGQ-LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
L P L +L C + RL V E++ G + H+ + G + +P + +IA
Sbjct: 394 VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM- 247
+G L FL S +IYRD K N++LDS + K++DFG+ ++ +T+
Sbjct: 453 IG----LFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFC 503
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
GT Y APE +A D ++FGV+L E+L+G+
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWL-TEINYL 132
LG G F V K TG+ A K R +E + E++ L
Sbjct: 18 ELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 133 GQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
++ HPN++ L E+ + L+ E + G + + L + S + + +K L
Sbjct: 69 KEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQIL-- 124
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDS----NYNAKLSDFGLARDGPTGDKSHVSTRVM 247
NG+ +LHS ++ + D K NI+L K+ DFGLA D + +
Sbjct: 125 -NGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIF 178
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
GT + APE + L ++D++S GV+ +LSG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-21
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 49/221 (22%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQL 135
LG G FG V L +R G A+K L +E K+ E L +
Sbjct: 13 TLGTGSFGRVH--------LIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 136 HHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK-----IAL 189
HP ++++ +D ++ ++ +++ G + + L + + P K + L
Sbjct: 64 THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAAEVCL 117
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM-G 248
L +LHS + +IYRD K NILLD N + K++DFG A+ P T + G
Sbjct: 118 A----LEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCG 165
Query: 249 TYGYAAPEYLA------TGHLTAKSDIYSFGVVLLEILSGR 283
T P+Y+A + + D +SFG+++ E+L+G
Sbjct: 166 T-----PDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGY 200
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 38/261 (14%)
Query: 34 SSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTAT-RNFRPDSVLGEGGFGSVFKGW 92
++ A S ++ + + +K + TA F LG G FG V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVM--- 58
Query: 93 VDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQLHHPNLVKLVGYCLE 149
L + +G A+K L+++ K+ L E L ++ P LVKL + +
Sbjct: 59 -----LVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFK 111
Query: 150 DDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK-----IALGAANGLAFLHSAEP 203
D+ L +V E++ G M +HL R G + +P + I L +LHS +
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-----HARFYAAQIVLT----FEYLHSLD- 161
Query: 204 KVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GH 262
+IYRD K N+L+D +++DFG A+ + + GT APE + + G+
Sbjct: 162 -LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY 215
Query: 263 LTAKSDIYSFGVVLLEILSGR 283
A D ++ GV++ E+ +G
Sbjct: 216 NKA-VDWWALGVLIYEMAAGY 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 63/292 (21%), Positives = 102/292 (34%), Gaps = 59/292 (20%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HH 137
+G G + + T M AVK +++ EI L + H
Sbjct: 29 DIGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQH 75
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLR-----MKIALGAA 192
PN++ L + + +V E M G + + + R+ + S R +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF------SEREASAVLFTITKT- 128
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNA----KLSDFGLARDGPTGDKSHVSTRVMG 248
+ +LH+ V++RD K SNIL ++ DFG A+ + + T
Sbjct: 129 --VEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-Y 182
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308
T + APE L A DI+S GV+L +L+G +
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI----------L 232
Query: 309 RRIFRVLDPRLEGQFSLPQA------QKAASLALQCLSVEPKLRPDMDEVVK 354
RI G+FSL A L + L V+P R V++
Sbjct: 233 ARI-------GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 48/223 (21%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLT---EINYL 132
LGEG +G V+K T +A+KR+ +EG T E++ L
Sbjct: 42 LGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVP-----GTAIREVSLL 87
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMP---RGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+L H N+++L + L++E+ + M+ + +S +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN--------PDVSMRVIKSFLY 139
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA-----KLSDFGLARD--GPTGDKSHV 242
NG+ F HS + ++RD K N+LL + + K+ DFGLAR P +H
Sbjct: 140 QLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH- 196
Query: 243 STRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
++ T Y PE L + + T+ DI+S + E+L
Sbjct: 197 --EII-TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLT---EINYL 132
+G+G FG VFK TG +A+K++ +EGF +T EI L
Sbjct: 25 IGQGTFGEVFKA-RHRK--------TGQKVALKKVLMENEKEGFP-----ITALREIKIL 70
Query: 133 GQLHHPNLVKLVGYCLEDDHRL--------LVYEFMP---RGSMENHLFRRGSYFQPLSW 181
L H N+V L+ C LV++F G + N L +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-------VKFTL 123
Query: 182 SLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGPTGDK 239
S ++ NGL ++H K+++RD KA+N+L+ + KL+DFGLAR +
Sbjct: 124 SEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 240 SHVSTRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGR 283
+ T + T Y PE L + D++ G ++ E+ +
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAEMWTRS 226
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
+F VLG+G FG V L+ + GT L AVK L ++ + + E
Sbjct: 21 DFNFLMVLGKGSFGKVM--------LSERK-GTDELYAVKILKKDVVIQDDDVECTMVEK 71
Query: 130 NYLGQ-LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
L P L +L C + RL V E++ G + H+ + G + +P + +I
Sbjct: 72 RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 130
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
A+G L FL S +IYRD K N++LDS + K++DFG+ ++ +T+
Sbjct: 131 AIG----LFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTF 181
Query: 248 -GTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGR 283
GT Y APE +A + D ++FGV+L E+L+G+
Sbjct: 182 CGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
+F V+G G + V L + T + A+K + +E ++ TE
Sbjct: 10 DFDLLRVIGRGSYAKVL--------LVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 130 NYLGQ-LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
+ Q +HP LV L C + + RL V E++ G + H+ R+ + + +I
Sbjct: 61 HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
+L L +LH +IYRD K N+LLDS + KL+D+G+ ++G +T
Sbjct: 120 SLA----LNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 170
Query: 248 -GTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGR 283
GT Y APE L + D ++ GV++ E+++GR
Sbjct: 171 CGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-21
Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 44 PQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRP 103
P+ EG + ++ + F VLG+G FG V LA +
Sbjct: 2 PKESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVM--------LARVK- 45
Query: 104 GTGMLIAVKRLNQEGFQGHKEW---LTEINYLGQ-LHHPNLVKLVGYCLEDDHRL-LVYE 158
TG L AVK L ++ + +TE L +HP L +L C + RL V E
Sbjct: 46 ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVME 104
Query: 159 FMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218
F+ G + H+ + + + + +I L FLH +IYRD K N+LLD
Sbjct: 105 FVNGGDLMFHIQKSRRFDEARARFYAAEIISA----LMFLHDK--GIIYRDLKLDNVLLD 158
Query: 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVM-GTYGYAAPEYLA-TGHLTAKSDIYSFGVVL 276
+ KL+DFG+ ++G +T GT Y APE L + D ++ GV+L
Sbjct: 159 HEGHCKLADFGMCKEGICNGV---TTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLL 214
Query: 277 LEILSGR 283
E+L G
Sbjct: 215 YEMLCGH 221
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-21
Identities = 64/292 (21%), Positives = 107/292 (36%), Gaps = 56/292 (19%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HH 137
VLG G G V + TG A+K L + E+++ Q
Sbjct: 36 VLGLGVNGKVLEC---------FHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81
Query: 138 PNLVKLVGYCLEDDHR-----LLVYEFMPRGSMENHLFRRG-SYFQPLSWSLRMKIALGA 191
P++V ++ E+ H L++ E M G + + + RG F + M+ A
Sbjct: 82 PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
+ FLHS + +RD K N+L + + KL+DFG A++ + T
Sbjct: 141 ---IQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-Y 191
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308
T Y APE L D++S GV++ +L G P ++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF------PPF-------YSNTGQAIS 238
Query: 309 RRIFRVLDPRLEGQFSLPQA------QKAASLALQCLSVEPKLRPDMDEVVK 354
+ R + GQ+ P + A L L +P R + + +
Sbjct: 239 PGMKRRI---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 72/326 (22%), Positives = 117/326 (35%), Gaps = 79/326 (24%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
+ ++ +G G G V D +A+K+L++ FQ K
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA-YDAI--------LERNVAIKKLSRP-FQNQTHAKRAYR 73
Query: 128 EINYLGQLHHPNLVKLV-----GYCLEDDHRL-LVYEFMP--------RGSMENHLFRRG 173
E+ + ++H N++ L+ LE+ + +V E M +
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM---- 129
Query: 174 SYF--QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
SY Q L G+ LHSA +I+RD K SNI++ S+ K+ DFGLA
Sbjct: 130 SYLLYQML-------------CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 232 RDGPTGDKS--HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR------ 283
R T +V TR Y APE + DI+S G ++ E++ G
Sbjct: 175 RTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229
Query: 284 ------RAIDK--NRPTGE--HNLVEWAKPYLTS----KRRIFRVLDPRLEGQFSLPQAQ 329
+ + P E L + Y+ + F L P + +
Sbjct: 230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 289
Query: 330 KAASLAL----QCLSVEPKLRPDMDE 351
AS A + L ++ R +DE
Sbjct: 290 LKASQARDLLSKMLVIDASKRISVDE 315
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 74/364 (20%), Positives = 120/364 (32%), Gaps = 60/364 (16%)
Query: 6 SNRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYS 65
SN P + +L + P + + IK +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPP--PPPQQFPQFHVKSGLQIKKNAII 60
Query: 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW 125
D T VLG G G V + T A+K L +
Sbjct: 61 DDYKVT-----SQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKA 101
Query: 126 LTEINYLGQL-HHPNLVKLVGYC----LEDDHRLLVYEFMPRGSMENHLFRRG-SYFQPL 179
E+ + P++V++V L+V E + G + + + RG F
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161
Query: 180 SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPT 236
S MK A + +LHS + +RD K N+L S N KL+DFG A++ +
Sbjct: 162 EASEIMKSIGEA---IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296
+ ++T T Y APE L D++S GV++ +L G P
Sbjct: 217 HNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPF---- 263
Query: 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQA------QKAASLALQCLSVEPKLRPDMD 350
++ L + + GQ+ P ++ L L EP R +
Sbjct: 264 ---YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 317
Query: 351 EVVK 354
E +
Sbjct: 318 EFMN 321
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
+F V+G G + V L + T + A++ + +E ++ TE
Sbjct: 53 DFDLLRVIGRGSYAKVL--------LVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 130 NYLGQ-LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
+ Q +HP LV L C + + RL V E++ G + H+ R+ + + +I
Sbjct: 104 HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
+L L +LH +IYRD K N+LLDS + KL+D+G+ ++G +T
Sbjct: 163 SLA----LNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 213
Query: 248 -GTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGR 283
GT Y APE L + D ++ GV++ E+++GR
Sbjct: 214 CGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 250
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 52/219 (23%), Positives = 82/219 (37%), Gaps = 40/219 (18%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK-----RLNQEGFQGHKEWLTEINYLG 133
LG G F V + TG A K R Q+ E L EI L
Sbjct: 36 ELGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDC---RAEILHEIAVLE 83
Query: 134 QL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR------GSYFQPLSWSLRMK 186
P ++ L +L+ E+ G E +F + L +K
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRL-IK 138
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLSDFGLARDGPTGDKSHVS 243
L G+ +LH +++ D K NILL + K+ DFG++R +
Sbjct: 139 QIL---EGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE- 192
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG 282
+MGT Y APE L +T +D+++ G++ +L+
Sbjct: 193 --IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 61/244 (25%), Positives = 89/244 (36%), Gaps = 64/244 (26%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW----- 125
+ + G +G+V G VD G+ +A+KR+ G
Sbjct: 21 QSPYTVQRFISSGSYGAVCAG-VDS---------EGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 126 ------LTEINYLGQLHHPNLVKL----VGYCLEDDHRL-LVYEFM----------PRGS 164
L EI L HHPN++ L V + H+L LV E M R
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV 130
Query: 165 MENHLFRRGSYF--QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222
+ + YF L GL LH A V++RD NILL N +
Sbjct: 131 ISPQHIQ---YFMYHIL-------------LGLHVLHEAG--VVHRDLHPGNILLADNND 172
Query: 223 AKLSDFGLARDGPTGDKS--HVSTRVMGTYGYAAPEY-LATGHLTAKSDIYSFGVVLLEI 279
+ DF LAR+ +V+ R Y APE + T D++S G V+ E+
Sbjct: 173 ITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 280 LSGR 283
+ +
Sbjct: 228 FNRK 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 42/229 (18%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL----NQEGFQGHKEWLT- 127
+ + +GEG +G VFK D + G +A+KR+ +EG L+
Sbjct: 12 QYECVAEIGEGAYGKVFKAR-DLKN-------GGRFVALKRVRVQTGEEGMP-----LST 58
Query: 128 --EINYLGQLH---HPNLVKL----VGYCLEDDHRL-LVYEFMP---RGSMENHLFRRGS 174
E+ L L HPN+V+L + + +L LV+E + ++
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEP 115
Query: 175 YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234
+ M L GL FLHS +V++RD K NIL+ S+ KL+DFGLAR
Sbjct: 116 GVPTETIKDMMFQLL---RGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLAR-- 168
Query: 235 PTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
+ +++ V+ T Y APE L D++S G + E+ +
Sbjct: 169 IYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 54/233 (23%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
+ + + +G G +GSV +D+ +G +A+K+L++ FQ K
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA-IDKR--------SGEKVAIKKLSRP-FQSEIFAKRAYR 72
Query: 128 EINYLGQLHHPNLVKLV-----GYCLEDDHRL-LVYEFMP--------RGSMENHLFRRG 173
E+ L + H N++ L+ L + + LV FM E +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI---- 128
Query: 174 SYF--QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
Y Q L GL ++HSA V++RD K N+ ++ + K+ DFGLA
Sbjct: 129 QYLVYQML-------------KGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 232 RDGPTGDKSHVSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGR 283
R +V TR Y APE L+ H DI+S G ++ E+L+G+
Sbjct: 174 RHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 54/239 (22%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
+ +F+ S+LGEG +G V + TG ++A+K++ F L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA-THKP--------TGEIVAIKKIEP--FDKPLFALRTLR 58
Query: 128 EINYLGQLHHPNLVKLV----GYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWS 182
EI L H N++ + E+ + + ++ E M + + + Q LS
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST----QMLSDD 112
Query: 183 ---------LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR- 232
LR + LH + VI+RD K SN+L++SN + K+ DFGLAR
Sbjct: 113 HIQYFIYQTLR---------AVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 233 ---DGPTGDKSHVSTRVMGTY----GYAAPEY-LATGHLTAKSDIYSFGVVLLEILSGR 283
+ M + Y APE L + + D++S G +L E+ R
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 71/253 (28%), Positives = 107/253 (42%), Gaps = 37/253 (14%)
Query: 49 SEGEILQSSNIKNFS--YSDLRTATRNFR--PDS-----VLGEGGFGSVFKGWVDEHSLA 99
+ ++ NI NF Y D R+ R + V+G G FG V L
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQ--------LV 88
Query: 100 STRPGTGMLIAVKRLNQEGFQGHKE---WLTEINYLGQLHHPNLVKLVGYCLEDDHRL-L 155
+ T + A+K L++ + + E + + + P +V+L Y +DD L +
Sbjct: 89 RHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146
Query: 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA-LGAANGLAFLHSAEPKVIYRDFKASN 214
V E+MP G + N + P W+ R A + A L +HS I+RD K N
Sbjct: 147 VMEYMPGGDLVNLMSNYD--V-PEKWA-RFYTAEVVLA--LDAIHSMG--FIHRDVKPDN 198
Query: 215 ILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL----ATGHLTAKSDIY 270
+LLD + + KL+DFG T V GT Y +PE L G+ + D +
Sbjct: 199 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWW 257
Query: 271 SFGVVLLEILSGR 283
S GV L E+L G
Sbjct: 258 SVGVFLYEMLVGD 270
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW-----LT 127
+ P + +G G +G+V+K D H +G +A+K + G +
Sbjct: 10 RYEPVAEIGVGAYGTVYKA-RDPH--------SGHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 128 EINYLGQLH---HPNLVKL----VGYCLEDDHRL-LVYEFMP---RGSMENHLFRRGSYF 176
E+ L +L HPN+V+L + + ++ LV+E + R ++
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGL 117
Query: 177 QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236
+ M+ L GL FLH+ +++RD K NIL+ S KL+DFGLAR
Sbjct: 118 PAETIKDLMRQFL---RGLDFLHAN--CIVHRDLKPENILVTSGGTVKLADFGLAR--IY 170
Query: 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
+ ++ V+ T Y APE L D++S G + E+ +
Sbjct: 171 SYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 57/237 (24%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
+ S +GEG +G V D + +A+K+++ F+ + L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA-YDNL--------NKVRVAIKKISP--FEHQTYCQRTLR 74
Query: 128 EINYLGQLHHPNLVKLVG----YCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWS 182
EI L + H N++ + +E + +V + M + L + Q LS
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKT----QHLSND 128
Query: 183 ---------LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233
LR GL ++HSA V++RD K SN+LL++ + K+ DFGLAR
Sbjct: 129 HICYFLYQILR---------GLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 234 GPTGDKS------HVSTRVMGTYGYAAPEY-LATGHLTAKSDIYSFGVVLLEILSGR 283
+V+TR Y APE L + T DI+S G +L E+LS R
Sbjct: 178 ADPDHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 51/232 (21%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
+R +G G +G+V VD TG +A+K+L + FQ K
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA-VDGR--------TGAKVAIKKLYRP-FQSELFAKRAYR 73
Query: 128 EINYLGQLHHPNLVKLV-----GYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSW 181
E+ L + H N++ L+ L+D LV FM G+ L + + L
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH----EKLGE 127
Query: 182 S---------LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232
L+ GL ++H+A +I+RD K N+ ++ + K+ DFGLAR
Sbjct: 128 DRIQFLVYQMLK---------GLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 176
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPEY-LATGHLTAKSDIYSFGVVLLEILSGR 283
+ +V TR Y APE L T DI+S G ++ E+++G+
Sbjct: 177 QADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 57/210 (27%), Positives = 75/210 (35%), Gaps = 31/210 (14%)
Query: 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216
E +E Y L+ + + A G+ FL A K I+RD A NIL
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNIL 225
Query: 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVL 276
L K+ DFGLARD + APE + T +SD++SFGV+L
Sbjct: 226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285
Query: 277 LEILS-GRRAIDKNRPTGEHNLVEWAKPY--LTSKRRIFRVLDPRLEGQFSLPQAQKAA- 332
EI S G A PY + R RL+ +
Sbjct: 286 WEIFSLG------------------ASPYPGVKIDEEFCR----RLKEGTRMRAPDYTTP 323
Query: 333 ---SLALQCLSVEPKLRPDMDEVVKELEQL 359
L C EP RP E+V+ L L
Sbjct: 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 7/106 (6%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL 135
LG G FG V + + T +AVK L + H+ ++E+ L +
Sbjct: 27 GKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 136 -HHPNLVKLVGYCLEDDHRLLV-YEFMPRGSMENHLFRRGSYFQPL 179
HH N+V L+G C + L+V EF G++ +L + + F P
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 47/221 (21%), Positives = 81/221 (36%), Gaps = 47/221 (21%)
Query: 80 LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHP 138
LG G + VF+ + VK L K+ EI L L P
Sbjct: 44 LGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWS---------LRMKIAL 189
N++ L + R F + N F++ +Q L+ L+
Sbjct: 92 NIITLADIVKDPVSRTPALVFEH---VNNTDFKQ--LYQTLTDYDIRFYMYEILK----- 141
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLSDFGLARDGPTGDK--SHVSTRV 246
L + HS +++RD K N+++D + +L D+GLA G + V++R
Sbjct: 142 ----ALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 247 MGTYGYAAPEYLATGHLTAKS-DIYSFGVVLLEILSGRRAI 286
+ PE L + S D++S G +L ++ +
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 51/232 (21%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
++ S +G G +GSV + + TG+ +AVK+L++ FQ K
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRP-FQSIIHAKRTYR 77
Query: 128 EINYLGQLHHPNLVKLV-----GYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSW 181
E+ L + H N++ L+ LE+ + + LV M G+ N++ + Q L+
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKC----QKLTD 131
Query: 182 S---------LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232
LR GL ++HSA+ +I+RD K SN+ ++ + K+ DFGLAR
Sbjct: 132 DHVQFLIYQILR---------GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 233 DGPTGDKSHVSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSGR 283
+V+TR Y APE L H DI+S G ++ E+L+GR
Sbjct: 181 HTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 60/319 (18%), Positives = 111/319 (34%), Gaps = 76/319 (23%)
Query: 21 SKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTA---TRNFRPD 77
S ++ + S + S R + S+ S + +
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQ----HHSSKPTASMPRPHSDWQIPDRYEIR 58
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLTEINYLGQ 134
++G G +G V + D+ ++A+K++ + F+ K L EI L +
Sbjct: 59 HLIGTGSYGHVCEA-YDKL--------EKRVVAIKKILRV-FEDLIDCKRILREIAILNR 108
Query: 135 LHHPNLVKLV----GYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWS------- 182
L+H ++VK++ +E L +V E S LFR L+
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTP---VYLTELHIKTLLY 163
Query: 183 --LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS 240
L G+ ++HSA +++RD K +N L++ + + K+ DFGLAR +
Sbjct: 164 NLLV---------GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 241 HVSTRVMGTYG-------------------------YAAPE-YLATGHLTAKSDIYSFGV 274
+ + Y APE L + T D++S G
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 275 VLLEILSGRRAIDKNRPTG 293
+ E+L+ +
Sbjct: 273 IFAELLNMIKENVAYHADR 291
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 68/247 (27%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
+ LG GG G VF VD +A+K++ K L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSA-VDND--------CDKRVAIKKIV---LTDPQSVKHALR 57
Query: 128 EINYLGQLHHPNLVKL-------------VGYCLEDDHRL-LVYEFMPRGSMENHLFRRG 173
EI + +L H N+VK+ L + + + +V E+M + ++ +
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQ- 114
Query: 174 SYFQPLSWS---------LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNA 223
PL LR GL ++HSA V++RD K +N+ +++ +
Sbjct: 115 ---GPLLEEHARLFMYQLLR---------GLKYIHSAN--VLHRDLKPANLFINTEDLVL 160
Query: 224 KLSDFGLAR--DGPTGDKSH----VSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVL 276
K+ DFGLAR D K H + T+ Y +P L+ + T D+++ G +
Sbjct: 161 KIGDFGLARIMDPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIF 215
Query: 277 LEILSGR 283
E+L+G+
Sbjct: 216 AEMLTGK 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 53/266 (19%), Positives = 99/266 (37%), Gaps = 81/266 (30%)
Query: 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTE 128
T+++ + LG G FG V + + E +G A+K++ Q+ + E
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP----RYKNRE 50
Query: 129 INYLGQLHHPNLVKL-------------------------------------VGYCLEDD 151
++ + L H N++KL V +
Sbjct: 51 LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 152 HRL-LVYEFMPRGSMENHLFRRGSYFQPLSWS---------LRMKIALGAANGLAFLHSA 201
L ++ E++P ++ L + + + R + F+HS
Sbjct: 111 KYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFR---------AVGFIHSL 160
Query: 202 EPKVIYRDFKASNILLDSNYNA-KLSDFGLARDGPTGDK--SHVSTRVMGTYGYAAPE-Y 257
+ +RD K N+L++S N KL DFG A+ + +++ +R + Y APE
Sbjct: 161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELM 213
Query: 258 LATGHLTAKSDIYSFGVVLLEILSGR 283
L T D++S G V E++ G+
Sbjct: 214 LGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 60/265 (22%), Positives = 100/265 (37%), Gaps = 74/265 (27%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
N+ ++G G +G V+ D++ T +A+K++N+ F+ K L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA-YDKN--------TEKNVAIKKVNRM-FEDLIDCKRILR 74
Query: 128 EINYLGQLHHPNLVKLV-----GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWS 182
EI L +L +++L L+ D +V E S LF+ L+
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP---IFLTEE 129
Query: 183 ---------LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233
L G F+H + +I+RD K +N LL+ + + K+ DFGLAR
Sbjct: 130 HIKTILYNLLL---------GENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLART 178
Query: 234 GPTGDKS-------------------------HVSTRVMGTYGYAAPEY-LATGHLTAKS 267
+ + HV TR Y APE L + T
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSI 233
Query: 268 DIYSFGVVLLEILSGRRAIDKNRPT 292
DI+S G + E+L+ ++ +
Sbjct: 234 DIWSTGCIFAELLNMLQSHINDPTN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 66/250 (26%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH---KEWLT 127
R + LG+G +G V+K +D TG ++AVK++ FQ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS-IDRR--------TGEVVAVKKIFD-AFQNSTDAQRTFR 57
Query: 128 EINYLGQLH-HPNLVKLVGYCLEDDHR--LLVYEFMP-------RGSM--ENHLFRRGSY 175
EI L +L H N+V L+ D+ R LV+++M R ++ H Y
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK----QY 113
Query: 176 F--QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233
Q + + +LHS +++RD K SNILL++ + K++DFGL+R
Sbjct: 114 VVYQLI-------------KVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRS 158
Query: 234 GPTGDKSHVSTRVMGTYG-------------------YAAPEY-LATGHLTAKSDIYSFG 273
+ + + Y APE L + T D++S G
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
Query: 274 VVLLEILSGR 283
+L EIL G+
Sbjct: 219 CILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 61/295 (20%), Positives = 93/295 (31%), Gaps = 82/295 (27%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HH 137
VLG G G V + T A+K L + E+ +
Sbjct: 25 VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 70
Query: 138 PNLVKLVGYC----LEDDHRLLVYEFMPRGSMENHLF-----RRGSYFQPLSWSLRMKIA 188
P++V++V L+V E + G E LF R F S MK
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGG--E--LFSRIQDRGDQAFTEREASEIMKSI 126
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLSDFGLARDGPTGDKSHVSTR 245
A + +LHS + +RD K N+L S N KL+DFG
Sbjct: 127 GEA---IQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
A E + D++S GV++ +L G P ++ L
Sbjct: 167 --------AKETTGEKY-DKSCDMWSLGVIMYILLCGY------PPF-------YSNHGL 204
Query: 306 TSKRRIFRVLDPRLEGQFSLPQA------QKAASLALQCLSVEPKLRPDMDEVVK 354
+ + GQ+ P ++ L L EP R + E +
Sbjct: 205 AISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 8e-13
Identities = 41/226 (18%), Positives = 82/226 (36%), Gaps = 38/226 (16%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEWLTEINYLGQLH 136
LG G F +V+ D +A+K + + + + EI L +++
Sbjct: 25 RKLGWGHFSTVWLAK-DMV--------NNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVN 73
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHL-------------FRRGSYFQPLSWSL 183
+ K +LL + F +G H+ + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 132
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD------SNYNAKLSDFGLARDGPTG 237
+I+ GL ++H +I+ D K N+L++ + K++D G A
Sbjct: 133 VKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 238 DKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
+ + TR Y +PE L +DI+S ++ E+++G
Sbjct: 192 YTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 34/290 (11%), Positives = 81/290 (27%), Gaps = 63/290 (21%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEIN 130
+R G ++ +D +A+ ++ +G +E L+
Sbjct: 33 YRLLIFHGGVPPLQFWQA-LDTA--------LDRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
L ++ P + +++ L+V E++ GS++ S ++
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQS 137
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
A H A V S + + + + L+ D
Sbjct: 138 LAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPATMPDA---------------- 179
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDK-NRPTGEHNLVEWAKPYLTSKR 309
+ DI G L +L R + + +G
Sbjct: 180 -------------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226
Query: 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
I R + ++ ++A + + + +R ++ ++Q
Sbjct: 227 DIDRDIPFQIS------------AVAARSVQGDGGIRSA-STLLNLMQQA 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEWLTEINYLGQL- 135
S++G+G FG V K + D +A+K + N++ F + E+ L +
Sbjct: 60 SLIGKGSFGQVVKAY-DRV--------EQEWVAIKIIKNKKAF--LNQAQIEVRLLELMN 108
Query: 136 -------HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
++ +V L + + +H LV+E + S + R + F+ +S +L K A
Sbjct: 109 KHDTEMKYY--IVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA--KLSDFGLARDGPTGDKSHVSTRV 246
L FL + E +I+ D K NILL + + K+ DFG + ++ +R
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 223
Query: 247 MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
Y +PE L D++S G +L+E+ +G
Sbjct: 224 -----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEWLTEINYLGQL 135
V+G+G FG V K + D +A+K + N++ F H++ EI L L
Sbjct: 102 LKVIGKGSFGQVVKAY-DHK--------VHQHVALKMVRNEKRF--HRQAAEEIRILEHL 150
Query: 136 ------HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+ N++ ++ +H + +E + SM + + + FQ S L K A
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAH 207
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA--KLSDFGLARDGPTGDKSHVSTRVM 247
L LH ++I+ D K NILL + K+ DFG + +++ +R
Sbjct: 208 SILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF- 264
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR 283
Y APE + D++S G +L E+L+G
Sbjct: 265 ----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 46/285 (16%), Positives = 89/285 (31%), Gaps = 58/285 (20%)
Query: 28 AKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGS 87
L + + S + G +L + R ++ S G
Sbjct: 10 GVDLGTENLYFQSMTTSLEALPTGTVLTD------------KSGRQWKLKSFQTRDNQGI 57
Query: 88 VFKGWVDEHSLASTRPGTGMLIAVK------RLNQEG-----FQGHKEWLTEINYLGQLH 136
+++ +L ++K RL E + L
Sbjct: 58 LYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKK-LYSTP 115
Query: 137 HPNLVKLVGY-CLEDDHRLLVYEFMPR--GSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
+ +G+ +D +R LV +P S++ LS +++A +
Sbjct: 116 LLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPK-HVLSERSVLQVACRLLD 170
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAK--LSDFGLA---RDGPTGDKSHVSTR--- 245
L FLH E ++ + A NI +D ++ L+ +G A HV+
Sbjct: 171 ALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP----SGKHVAYVEGS 224
Query: 246 ---VMGTYGYAAPEYLATGHL----TAKSDIYSFGVVLLEILSGR 283
G + + + H + +SD+ S G +L+ L G
Sbjct: 225 RSPHEGDLEFIS---MDL-HKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 46/230 (20%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEWLTEIN 130
+R +G G FG ++ G T G +A+K + + Q H E
Sbjct: 10 RYRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKTKHPQLHIES----K 56
Query: 131 YLGQLHH-PNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM--KI 187
+ + + E D+ ++V E + S+E LF F +SL+ +
Sbjct: 57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFN----FCSRKFSLKTVLLL 110
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK---LSDFGLA---RDGPTGDKSH 241
A + + ++HS I+RD K N L+ + DFGLA RD T H
Sbjct: 111 ADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QH 166
Query: 242 VSTR----VMGTYGYAAPEYLATGHL----TAKSDIYSFGVVLLEILSGR 283
+ R + GT YA+ + T HL + + D+ S G VL+ G
Sbjct: 167 IPYRENKNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 50/231 (21%), Positives = 86/231 (37%), Gaps = 46/231 (19%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQGHKEWLTEIN 130
+++ +GEG FG +F+G T +A+K + Q E+ T
Sbjct: 11 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM--KIA 188
G P + + E H +LV + + S+E L +S++ A
Sbjct: 62 LAGCTGIP---NVYYFGQEGLHNVLVIDLLGP-SLE-DLLD----LCGRKFSVKTVAMAA 112
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK-----LSDFGLA---RDGPTGDKS 240
+ +H ++YRD K N L+ + + DFG+ RD T
Sbjct: 113 KQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--Q 168
Query: 241 HVSTR----VMGTYGYAAPEYLATGHL----TAKSDIYSFGVVLLEILSGR 283
H+ R + GT Y + + T HL + + D+ + G V + L G
Sbjct: 169 HIPYREKKNLSGTARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 47/296 (15%), Positives = 100/296 (33%), Gaps = 75/296 (25%)
Query: 25 SRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGG 84
S K+ + ++ L + + GEI+ ++ ++ +G+GG
Sbjct: 1 SMRVKAAQAGRQSSAKRHLAE-QFAVGEIIT--DMAA----------AAWKVGLPIGQGG 47
Query: 85 FGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLV--- 141
FG ++ +S G+ VK + + TE+ + + P +
Sbjct: 48 FGCIYLA----DMNSSESVGSDAPCVVKVEPSD----NGPLFTELKFYQRAAKPEQIQKW 99
Query: 142 ------------KLVGY----CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
K G +R ++ + ++ F S +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRF-----SRKT 153
Query: 186 --KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK--LSDFGLA---RDGPTG- 237
+++L + L ++H E ++ D KASN+LL+ + L D+GLA
Sbjct: 154 VLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 238 ------DKSHVSTRVMGTYGYAAPEYLATGHL----TAKSDIYSFGVVLLEILSGR 283
+ H GT + + + H + + D+ G +++ L+G
Sbjct: 212 AYAADPKRCHD-----GTIEFTS---IDA-HNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 45/283 (15%), Positives = 82/283 (28%), Gaps = 88/283 (31%)
Query: 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDF 210
H +V+E + + + S +Q L KI GL +LH+ + ++I+ D
Sbjct: 118 THICMVFEVL-GHHL--LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDI 173
Query: 211 KASNILL-------------------------------------------------DSNY 221
K NILL
Sbjct: 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL 233
Query: 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS 281
K++D G A + TR Y + E L +DI+S + E+ +
Sbjct: 234 KVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELAT 288
Query: 282 GRRAIDKNRPTGEHNLV---------------------EWAKPYLTSK---RRIFRVLDP 317
G + + +++K + T K + I ++
Sbjct: 289 GDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348
Query: 318 RLEG------QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
L ++S +A L L + P+ R E ++
Sbjct: 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 54/241 (22%), Positives = 88/241 (36%), Gaps = 47/241 (19%)
Query: 63 SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQ 120
S L FR +G G FG + G T +A+K + Q
Sbjct: 1 SMGVLMVGPN-FRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSRAPQ 50
Query: 121 GHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLS 180
H E+ P ++ + + +V E + S+E LF +
Sbjct: 51 LHLEYRFYKQLGSGDGIP---QVYYFGPCGKYNAMVLELLGP-SLE-DLFD----LCDRT 101
Query: 181 WSLRM--KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK-----LSDFGLA-- 231
+SL+ IA+ + + ++HS +IYRD K N L+ N + DF LA
Sbjct: 102 FSLKTVLMIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
Query: 232 -RDGPTGDKSHVSTR----VMGTYGYAAPEYLATGHL----TAKSDIYSFGVVLLEILSG 282
D T H+ R + GT Y + + T HL + + D+ + G + + L G
Sbjct: 160 YIDPETK--KHIPYREHKSLTGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRG 213
Query: 283 R 283
Sbjct: 214 S 214
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 47/234 (20%), Positives = 78/234 (33%), Gaps = 52/234 (22%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEWLTEINYLGQL- 135
LGEG FG V + D +A+K + N + + EIN L ++
Sbjct: 25 GNLGEGTFGKVVECL-DHAR-------GKSQVALKIIRNVGKY--REAARLEINVLKKIK 74
Query: 136 -------HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
V + + H + +E + F + + FQP +A
Sbjct: 75 EKDKENKFL--CVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH------- 241
+ L FLH ++ + D K NIL ++ L + + + + +
Sbjct: 130 YQLCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 242 ------------VSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSG 282
V+TR Y PE L G D++S G +L E G
Sbjct: 188 SATFDHEHHTTIVATRH-----YRPPEVILELGWAQP-CDVWSIGCILFEYYRG 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 42/228 (18%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
FR +G G FG ++ G T T +A+K N + H + L E
Sbjct: 8 KFRLGRKIGSGSFGEIYLG---------TNIQTNEEVAIKLENVK--TKHPQLLYESKIY 56
Query: 133 GQLH-HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM--KIAL 189
L + + + +E D+ +LV + + S+E LF F SL+ +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFN----FCSRKLSLKTVLMLAD 110
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK---LSDFGLA---RDGPTGDKSHVS 243
N + F+HS ++RD K N L+ A + DFGLA RD T H+
Sbjct: 111 QMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIP 166
Query: 244 TR----VMGTYGYAAPEYLATGHL----TAKSDIYSFGVVLLEILSGR 283
R + GT YA+ + T HL + + D+ S G VL+ L G
Sbjct: 167 YRENKNLTGTARYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 7e-08
Identities = 46/277 (16%), Positives = 72/277 (25%), Gaps = 79/277 (28%)
Query: 55 QSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL 114
FS+ T + +GEG FG VF+ D +A+K +
Sbjct: 6 SQKGPVPFSHCL---PTEKLQRCEKIGEGVFGEVFQTIAD-----------HTPVAIKII 51
Query: 115 --------NQEGFQGHKEWLTEINYLGQLH---------HPNLVKLVGYCL--------- 148
N + +E L EI +L + L
Sbjct: 52 AIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLL 111
Query: 149 ---------------------EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
+DD +V EF G + + S + I
Sbjct: 112 LKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSI 166
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG--PTGDKSHV--- 242
LA + + +RD N+LL KL + P+
Sbjct: 167 LHQLTASLAVAEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID 225
Query: 243 -STRVMGTYG------YAAPEYLATGHLTAKSDIYSF 272
+ + G + E L TG + DIY
Sbjct: 226 YTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 56/232 (24%), Positives = 88/232 (37%), Gaps = 48/232 (20%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEWLTEINYLGQLH 136
LGEG FG V + D + G +AVK + N + + + +EI L L+
Sbjct: 20 DTLGEGAFGKVVECI-DHKA-------GGRHVAVKIVKNVDRY--CEAARSEIQVLEHLN 69
Query: 137 HP------NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
V+++ + H +V+E + + + F + + F P K+A
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH--------- 241
+ FLHS K+ + D K NIL + + + + RD T
Sbjct: 127 ICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 242 ----------VSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSG 282
VSTR Y APE LA G D++S G +L+E G
Sbjct: 185 TYDDEHHSTLVSTRH-----YRAPEVILALGWSQP-CDVWSIGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 53/240 (22%), Positives = 83/240 (34%), Gaps = 60/240 (25%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRL-NQEGFQGHKEWLTEINYLGQL- 135
+G+G FG V AVK + N + + + E + L ++
Sbjct: 41 RKMGDGTFGRVLLCQ-HID--------NKKYYAVKVVRNIKKY--TRSAKIEADILKKIQ 89
Query: 136 ----HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
++ N+VK G + DH L++E + + + + +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEI 146
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNA-------------------------KLS 226
L +L + + D K NILLD Y KL
Sbjct: 147 LKALNYLRKM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 227 DFGLARDGPTGDKSH---VSTRVMGTYGYAAPE-YLATGHLTAKSDIYSFGVVLLEILSG 282
DFG A H ++TR Y APE L G + SD++SFG VL E+ +G
Sbjct: 205 DFGCATFK---SDYHGSIINTRQ-----YRAPEVILNLGWDVS-SDMWSFGCVLAELYTG 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 46/294 (15%), Positives = 91/294 (30%), Gaps = 82/294 (27%)
Query: 29 KSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSV 88
S G + + P EG++L + +G GGFG +
Sbjct: 7 HSSGVDLGTENLYFQSM-PFPEGKVLD------------DMEGNQWVLGKKIGSGGFGLI 53
Query: 89 FKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLV------- 141
+ A + E +Q + +E+ + ++ + +
Sbjct: 54 YLA---------FPTNKPEKDARHVVKVE-YQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 142 --------KLVGY----CLEDDHRLLVYEFMPR--GSMENHLFRRGSYFQPLSWSLRM-- 185
G +R +V M R ++ + + F
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNGTF-----KKSTVL 154
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK--LSDFGLA---RDGPTG--- 237
++ + + L ++H E ++ D KA+N+LL + L+D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 238 ----DKSHVSTRVMGTYGYAAPEYLATGHL----TAKSDIYSFGVVLLEILSGR 283
K H GT + + L H + +SD+ G +L L G+
Sbjct: 213 QENPRKGHN-----GTIEFTS---LDA-HKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 6e-06
Identities = 56/389 (14%), Positives = 109/389 (28%), Gaps = 136/389 (34%)
Query: 7 NRIKAETPSHTDVNSKYSSRDAKSLSSSSGKASSFSLPQTPRSEGEILQSSNIKNFSYSD 66
+ IK E + + Y + + + + F+ R + Y
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYNDNQ----VFAKYNVSRLQ------------PYLK 139
Query: 67 LRTATRNFRPDS---VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK 123
LR A RP + G G G K W +A + ++ K + F+
Sbjct: 140 LRQALLELRPAKNVLIDGVLGSG---KTW-----VALD-----VCLSYKVQCKMDFKIF- 185
Query: 124 EWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR--GSYFQPLSW 181
WL + C + L M L + ++
Sbjct: 186 -WLN----------------LKNCNSPETVLE---------MLQKLLYQIDPNWTSRSDH 219
Query: 182 SLRMKIALGAANGLAFLHSAEPK----VIYRDFKASNILLDSNYNAK-LSDFGLARDGPT 236
S +K+ +HS + + + + ++ ++L + NAK + F L
Sbjct: 220 SSNIKLR---------IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL------ 264
Query: 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296
K ++TR V + LS T +
Sbjct: 265 SCKILLTTR----------------------FK---QVT--DFLSAAT-------TTHIS 290
Query: 297 LVEWAKPYLTSK-RRIF-RVLDPRLEGQFSLP-QAQKAASLALQCLSV---EPKLRPD-- 348
L + + + + + LD R + LP + L ++ + D
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQ---DLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 349 -------MDEVVKE-LEQLQ--ELRNMHK 367
+ +++ L L+ E R M
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFD 376
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 9e-04
Identities = 57/448 (12%), Positives = 120/448 (26%), Gaps = 136/448 (30%)
Query: 1 MGACCSNR--IKAETPSHTDVNSKYSSRDAKS----LSSSSGKASS---FSLPQTPRS-- 49
+ C S ++ ++ ++SR S L S +A
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 50 ------EGEILQSSNIK--------NFSYSDLRTATRNFRPDSVLGEGGFG-----SVFK 90
+ + N+ +D +A S+
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 91 GWVDE------HSLASTRPGTGMLIAV--KRLNQEGFQGHKEWLTEINYLGQLHHPNLVK 142
++D + +T P +++ + + ++ L + ++ L
Sbjct: 309 KYLDCRPQDLPREVLTTNP---RRLSIIAESI--------RDGLATWDNWKHVNCDKLTT 357
Query: 143 LVGYCLE----DDHRLLVYEF--MPRGS---------------------MENHLFRRGSY 175
++ L ++R + P + + N L +
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY--- 414
Query: 176 FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKAS--------NILLDSNYNAKLSD 227
SL + + S IY + K ++D YN +
Sbjct: 415 ------SL---VEKQPKESTISIPS-----IYLELKVKLENEYALHRSIVDH-YNIPKTF 459
Query: 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKS---DIYSFGVVLLEI--LSG 282
D + + Y Y ++ HL + F +V L+ L
Sbjct: 460 ----------DSDDLIPPYLDQYFY---SHIGH-HLKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 283 R-RAID--KNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLE------GQFSLPQAQKAAS 333
+ R N N ++ K Y K I DP+ E F LP+ ++
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFY---KPYICDN-DPKYERLVNAILDF-LPKIEENLI 560
Query: 334 LALQCLSVEPKLRPDMDEVVKELE-QLQ 360
+ + L + + + +E Q+Q
Sbjct: 561 CSKYTDLLRIALMAEDEAIFEEAHKQVQ 588
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 398 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.79 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.45 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.12 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.79 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.77 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.65 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.26 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.87 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.52 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.49 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.73 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.83 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.26 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=431.69 Aligned_cols=267 Identities=29% Similarity=0.448 Sum_probs=216.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|.+.+.||+|+||+||+|.+.. .....++..||||.++.......+.|.+|+.+|++|+||||+++++++.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYN----LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECS----CC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC----cccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 568888999999999999998753 1223468899999998766566778999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRG---------SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
..++|||||++|+|.+++...+ .....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCc
Confidence 9999999999999999997643 22356999999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~ 301 (398)
+||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... .+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~-- 241 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE-- 241 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH--
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH--
Confidence 99999999986544433333344579999999999999999999999999999999998 99999753211 1111
Q ss_pred hhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
. +... .....+..++.++.+|+.+||+.||++|||++++++.|+++.+
T Consensus 242 -~-i~~~----------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 242 -C-ITQG----------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -H-HHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -H-HHcC----------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 1110 0112233456789999999999999999999999998887754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=437.79 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=205.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++++.||+|+||+||+|++.. +|+.||||++..... ...+.+.+|+.+|++|+||||+++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 589999999999999999997754 789999999975533 335678999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++.+|||||||+||+|.+++...+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFG 170 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFG 170 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccc
Confidence 9999999999999999999976543 45789999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+|+..... .......+||+.|||||++.+..|+.++|||||||++|||++|++||.+... ..........
T Consensus 171 la~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~-- 240 (350)
T 4b9d_A 171 IARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISG-- 240 (350)
T ss_dssp EESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHT--
T ss_pred cceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcC--
Confidence 99875321 1123456899999999999999999999999999999999999999975321 1111111110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ...+...+.++.+||.+||+.||++|||++|++++
T Consensus 241 --------~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 241 --------SF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --------CC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------CC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 11233456789999999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-59 Score=432.21 Aligned_cols=267 Identities=28% Similarity=0.439 Sum_probs=210.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|.+.+.||+|+||+||+|.+.. .....++..||||.++.......+.|.+|+.+|++|+||||+++++++.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHN----LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESS----SCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECC----cccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 457788999999999999998754 1233468899999998766666778999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSY-----------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
..+||||||++|+|.+++...... ..++++..++.++.||+.||.|||+++ |+||||||+||||+.+
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG 194 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC
Confidence 999999999999999999865421 246899999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhh
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~ 299 (398)
+.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...... ...
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~- 270 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI- 270 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH-
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH-
Confidence 9999999999987655444444455789999999999999999999999999999999999 89999753211 111
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.. +... .....+..++.++.+|+.+||+.||++|||++|++++|+.+.+
T Consensus 271 --~~-i~~g----------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 --DC-ITQG----------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --HH-HHHT----------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HH-HHcC----------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11 1110 0112233456789999999999999999999999999988754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-58 Score=426.64 Aligned_cols=265 Identities=25% Similarity=0.261 Sum_probs=216.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+.|++.+.||+|+||+||+|++.. +|..||||+++.+... .+|+.+|+.|+||||+++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 467888999999999999997765 7999999999765332 47999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-CEEEeeccC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKLSDFGL 230 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-~~kl~Dfg~ 230 (398)
.+|||||||+||+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||||+.+| .+||+|||+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 9999999999999999998764 4899999999999999999999998 99999999999999887 699999999
Q ss_pred CcCCCCCCCcc---cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 231 ARDGPTGDKSH---VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 231 a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|+......... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+...... .. .....
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~---~i~~~ 271 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CL---KIASE 271 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HH---HHHHS
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---HHHcC
Confidence 98764432211 22346799999999999999999999999999999999999999976433221 10 01111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhccCCchh
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQK 371 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~~~~~ 371 (398)
... ....+...+.++.+||.+||+.||.+|||+.|++++|..........+.+|.
T Consensus 272 ~~~---------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 272 PPP---------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp CCG---------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred CCC---------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 000 0122334567899999999999999999999999999988777666666664
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-59 Score=428.13 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=213.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.++||+|+||+||+|++.. +++.||+|++.... ....+.+.+|+.+|+.|+||||+++++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 469999999999999999997665 79999999997532 234567899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+++.+|+|||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEc
Confidence 9999999999999999999998775 4899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|+..............+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+. ..........
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~- 249 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKL- 249 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT-
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-
Confidence 999976554444445667999999999999999999999999999999999999999975321 1111111111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...++...+.++++||.+||+.||++|||++|++++
T Consensus 250 -----------~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 250 -----------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -----------CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 011233346789999999999999999999997655
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-59 Score=431.89 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=211.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
..|++.+.||+|+||+||+|++.. +|+.||||++........+.+.+|+.+|+.++||||+++++++.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 569999999999999999997765 79999999997665566677899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
.+|||||||++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla 217 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFC 217 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCc
Confidence 999999999999999998753 4899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
+...... ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.... .......
T Consensus 218 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~------ 283 (346)
T 4fih_A 218 AQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIR------ 283 (346)
T ss_dssp EECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH------
T ss_pred eecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH------
Confidence 8754322 2244578999999999999999999999999999999999999999753211 1111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....+. .......+.++.+||.+||+.||++|||+.|+++|
T Consensus 284 -~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 284 -DNLPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -HSSCCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cCCCCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 11223456789999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=419.19 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=203.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.+++++.+.||+|+||+||+|.+. ..||||+++.... ...+.|.+|+.+|++++||||+++++++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 356788999999999999999753 2589999875432 34567899999999999999999999875
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
++..+||||||++|+|.+++.... ..+++..+..++.||+.||.|||+++ ||||||||+||||++++.+||+||
T Consensus 103 -~~~~~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 103 -KDNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCC
T ss_pred -CCeEEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeec
Confidence 467899999999999999997654 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|+|+..............+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+..... . .....
T Consensus 177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~---~~~~~ 250 (307)
T 3omv_A 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---Q---IIFMV 250 (307)
T ss_dssp SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---H---HHHHH
T ss_pred cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---H---HHHHH
Confidence 99987654444444456789999999999964 358999999999999999999999997532211 0 00001
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
... ...+. ....+..++.++.+|+.+||+.||++|||+.++++.|+.|+
T Consensus 251 ~~~-----~~~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 251 GRG-----YASPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HTT-----CCCCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred hcC-----CCCCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 100 01111 11233345678999999999999999999999999998775
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=424.98 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=213.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++++.+.||+|+||+||+|.+.. .....++..||||.++.... ...+.|.+|+.+|++|+||||+++++++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFG----PAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcC----CccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 346778899999999999998743 12234678999999975432 3457899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSY------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
+..++|||||++|+|.+++...... ...+++..+..++.||+.||.|||+++ ||||||||+||||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY 179 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC
Confidence 9999999999999999999754321 245899999999999999999999998 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNL 297 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~ 297 (398)
+++.+||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |..||.+... .++
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 999999999999987544443334455689999999999999999999999999999999998 8999975421 111
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.... .. ....+.+..++.++.+|+.+||+.||++|||+++|++.|+.+
T Consensus 257 ~~~i----~~----------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMI----RN----------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH----HT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHH----Hc----------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 11 011123345567899999999999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=434.53 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=212.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
..|++.+.||+|+||+||+|++.. +|+.||||++........+.+.+|+.+|+.|+||||++++++|.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 569999999999999999997765 79999999998766666778999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
.+|||||||+||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccc
Confidence 999999999999999998753 3899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
+...... ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.... .......
T Consensus 295 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~------ 360 (423)
T 4fie_A 295 AQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIR------ 360 (423)
T ss_dssp EECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH------
T ss_pred eECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH------
Confidence 8754332 2234578999999999999999999999999999999999999999653211 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....+.+ ......+.++.+||.+||+.||++|||+.|+++|
T Consensus 361 -~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 361 -DNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -HSCCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 1122346789999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=414.73 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=200.6
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe--
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE-- 149 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~-- 149 (398)
|++.+.||+|+||+||+|.+.. ++..||+|.+..... ...+.+.+|+.+|++|+||||+++++++..
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 4677889999999999997765 789999999965432 335678999999999999999999999865
Q ss_pred --CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-CCCEEEe
Q 015909 150 --DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLS 226 (398)
Q Consensus 150 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-~~~~kl~ 226 (398)
...+|+|||||++|+|.+++.+.+ .+++..+..++.||+.||.|||+++++|+||||||+||||+. ++.+||+
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEE
Confidence 355799999999999999998764 589999999999999999999998777999999999999974 7999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.... .........
T Consensus 175 DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i~~ 244 (290)
T 3fpq_A 175 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTS 244 (290)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTT
T ss_pred eCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHHHc
Confidence 99999864321 2345789999999999865 6999999999999999999999999643211 111110000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ...++...+.++.+||.+||+.||++|||++++++|
T Consensus 245 -------~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 245 -------GVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------TCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCC---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 001111234578999999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=403.18 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=194.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.+.. +++.||+|++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 579999999999999999997654 799999999975432 33567899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..|+||||+ +|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCS
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeec
Confidence 999999999999 689999998764 5999999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|+|+...... .....+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+... ..........
T Consensus 157 Gla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~ 227 (275)
T 3hyh_A 157 GLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNG 227 (275)
T ss_dssp SCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT
T ss_pred CCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcC
Confidence 9998654322 2345689999999999998876 5789999999999999999999965321 1111111111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...++...+.++.+||.+||+.||++|||++|++++
T Consensus 228 ------------~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 228 ------------VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 011223346789999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-57 Score=422.90 Aligned_cols=278 Identities=27% Similarity=0.364 Sum_probs=222.6
Q ss_pred CHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCC-Ccc
Q 015909 63 SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHH-PNL 140 (398)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~~I 140 (398)
..+..+...++|++.+.||+|+||+||+|.+.. .....+++.||+|.+..... ...+.+.+|+.+|.++.| |||
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~----~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEET----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcC----CCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE
Confidence 334445556889999999999999999998754 12334567899999976543 335678999999999965 899
Q ss_pred cceeeEEEeC-CceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015909 141 VKLVGYCLED-DHRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIY 207 (398)
Q Consensus 141 ~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH 207 (398)
++++++|... +.+++|||||++|+|.+++..... ....+++..+..++.||+.||.|||+++ |||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiH 208 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIH 208 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eec
Confidence 9999998764 568999999999999999976432 1245899999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 015909 208 RDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAI 286 (398)
Q Consensus 208 ~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~ 286 (398)
|||||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987655444434455679999999999999999999999999999999998 99999
Q ss_pred CCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 287 DKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.+..... .+.. .+... .....+...+.++.+++.+||+.||++|||+.+|+++|+.+.+.
T Consensus 289 ~~~~~~~--~~~~----~i~~g----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 289 PGVKIDE--EFCR----RLKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp TTCCCSH--HHHH----HHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHH--HHHH----HHHcC----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 7543211 1111 11111 11122334567899999999999999999999999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=413.75 Aligned_cols=252 Identities=27% Similarity=0.348 Sum_probs=201.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||+||+|+... ...+++.||+|+++.... .....+.+|+.+|++++||||+++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKIS------GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECS------STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEcc------CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 579999999999999999997632 233688999999975432 233467889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++.+|+|||||+||+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccc
Confidence 999999999999999999998764 5899999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.. .........
T Consensus 172 la~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~-- 241 (304)
T 3ubd_A 172 LSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILKA-- 241 (304)
T ss_dssp EEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC--
T ss_pred cceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHcC--
Confidence 9986433222 234578999999999999999999999999999999999999999753211 111111110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM-----DEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 355 (398)
...++...+.++.+||.+||+.||++|||+ +|+++|
T Consensus 242 ----------~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 242 ----------KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ----------CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 112233456789999999999999999984 677654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-55 Score=401.56 Aligned_cols=271 Identities=26% Similarity=0.324 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|.+.+.||+|+||+||+|.+ +|..||||++...... ......|+..+.+++||||+++++++..+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~ 69 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEec
Confidence 45688899999999999999976 4788999999754221 12234566666788999999999999875
Q ss_pred C----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCceecCCCCCCEEEcCC
Q 015909 151 D----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA------EPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 151 ~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~ivH~Dlkp~Nilv~~~ 220 (398)
+ .++||||||++|+|.+++... .+++..+..++.|++.||.|||++ .++|+||||||+||||+.+
T Consensus 70 ~~~~~~~~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 70 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCceEEEEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence 4 579999999999999999764 489999999999999999999987 1239999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCc--ccccccccccccccccccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 015909 221 YNAKLSDFGLARDGPTGDKS--HVSTRVMGTYGYAAPEYLATG------HLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g~~p~~~~~~~ 292 (398)
+.+||+|||+|+........ ......+||+.|||||++.+. .++.++|||||||++|||++|.+||......
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 99999999999865433221 122346799999999999764 4677899999999999999999887543221
Q ss_pred CC--cc------hhhhhhhhhhccccccccccccccC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 293 GE--HN------LVEWAKPYLTSKRRIFRVLDPRLEG-QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 293 ~~--~~------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
.. .+ ......... ....+.+.+.. ..+...+..+.+|+.+||+.||++|||+.++++.|++|.+.+
T Consensus 225 ~~p~~~~~~~~~~~~~~~~~~-----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 225 QLPYYDLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccchhcccccchHHHHHHHH-----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 10 00 000000000 01111121111 112345678899999999999999999999999999887654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=399.48 Aligned_cols=250 Identities=25% Similarity=0.401 Sum_probs=190.2
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||+|+||+||+|++.. ++..||||++..... ...+.+.+|+.+|++|+||||+++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 458999999999999999997754 789999999975433 2346788999999999999999999998765
Q ss_pred C------------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 151 D------------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 151 ~------------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
+ .+|+|||||++|+|.+++..... .....+..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~ 152 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT 152 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC
Confidence 4 36899999999999999986543 233566778899999999999999999 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCcc----------cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSH----------VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDK 288 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~ 288 (398)
.++.+||+|||+|+......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999999999998754432211 1234579999999999999999999999999999999996 6642
Q ss_pred CCCCCCcchhhhhhhhhhccccccccccccccCCCC---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 289 NRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFS---LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. +...... .. ....++ ...++.+.+||.+||+.||++|||+.+++++
T Consensus 230 ~~-----~~~~~~~----------~~----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 230 QM-----ERVRTLT----------DV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH-----HHHHHHH----------HH----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc-----HHHHHHH----------HH----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 10 0000000 00 011122 1234567899999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=403.15 Aligned_cols=264 Identities=24% Similarity=0.342 Sum_probs=203.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++++.||+|+||+||+|++.. +|+.||||++..... ...+.+.+|+.+|+.|+||||+++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 4689999999999999999997765 799999999975432 33466889999999999999999999876
Q ss_pred e------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 E------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
. .+.+|+|||||+ |+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~ 196 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCE 196 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCC
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCC
Confidence 4 357899999995 6899998765 35999999999999999999999999 999999999999999999
Q ss_pred EEEeeccCCcCCCCCC--CcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 223 AKLSDFGLARDGPTGD--KSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
+||+|||+|+...... ........+||+.|||||++.+. .++.++|||||||++|||++|++||.+.+.......+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I- 275 (398)
T 4b99_A 197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI- 275 (398)
T ss_dssp EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH-
T ss_pred EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH-
Confidence 9999999998754322 12234457899999999998775 5689999999999999999999999764321110000
Q ss_pred hhhhhhhc-ccc------------ccccccccccCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPYLTS-KRR------------IFRVLDPRLEGQFSL-----PQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~-~~~------------~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... ... ....+.. ....+. ..+.++.+||.+||..||++|||+.|+|+|
T Consensus 276 --~~~~g~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 276 --MMVLGTPSPAVIQAVGAERVRAYIQSLPP--RQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp --HHHHCCCCGGGTC-----CHHHHHHSSCC--CCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --HHhcCCCChHHhhhhhhhhhhhhhhcCCC--cCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000 0000000 001111 235688999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=393.36 Aligned_cols=206 Identities=26% Similarity=0.353 Sum_probs=174.1
Q ss_pred HHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceee
Q 015909 67 LRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVG 145 (398)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~ 145 (398)
+....++|++.+.||+|+||+||+|+++. ...+++.||+|.+... .....+.+|+.+|+.+ +||||+++++
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~ 87 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQL------QVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKY 87 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEB------TTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcc------cCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEE
Confidence 34456889999999999999999997642 2346889999998654 3345678999999988 6999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC-CCEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-YNAK 224 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~-~~~k 224 (398)
++.+.+.+|+||||+++++|.+++. .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+|
T Consensus 88 ~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 88 CFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp EEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEE
T ss_pred EEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEE
Confidence 9999999999999999999999883 3899999999999999999999999 9999999999999876 7999
Q ss_pred EeeccCCcCCCCCCCc--------------------------ccccccccccccccccccccC-CCCCchhHHHHHHHHH
Q 015909 225 LSDFGLARDGPTGDKS--------------------------HVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLL 277 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ 277 (398)
|+|||+|+........ ......+||+.|+|||++.+. .|+.++||||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 9999999754332111 112335799999999999775 5899999999999999
Q ss_pred HHHhCCCCCCCC
Q 015909 278 EILSGRRAIDKN 289 (398)
Q Consensus 278 ell~g~~p~~~~ 289 (398)
||++|+.||...
T Consensus 239 ell~G~~Pf~~~ 250 (361)
T 4f9c_A 239 SLLSGRYPFYKA 250 (361)
T ss_dssp HHHHTCSSSSCC
T ss_pred HHHHCCCCCCCC
Confidence 999999999653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=408.58 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=203.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHH---HHHHHHHcCCCCCcccceee
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEW---LTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~~I~~~~~ 145 (398)
++|++.++||+|+||+||+|+... +|..||+|++.+... .....+ ..++.+++.++||||+++++
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~ 259 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence 679999999999999999997654 899999999964321 122223 34467788899999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
+|.+.+.+|+|||||+||+|.+++.+.+ .+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||
T Consensus 260 ~f~~~~~lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 260 AFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEE
T ss_pred EEEECCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEe
Confidence 9999999999999999999999998875 4899999999999999999999999 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
+|||+|+...... ....+||+.|||||++. +..|+.++|||||||++|||++|++||.+...... .......
T Consensus 334 ~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i 406 (689)
T 3v5w_A 334 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMT 406 (689)
T ss_dssp CCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHH
T ss_pred cccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhh
Confidence 9999998754332 33468999999999996 45799999999999999999999999965322211 1111111
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
... ...++...+.++.+||.+||+.||.+|++ ++++++|
T Consensus 407 ~~~------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 407 LTM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHC------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred cCC------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 110 11233345678999999999999999998 6777765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=411.48 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=211.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.++. +|..||+|.+........+.+.+|+.+|+.|+||||++++++|.+.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3689999999999999999997765 7999999999876655667789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC--CCEEEeec
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN--YNAKLSDF 228 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~--~~~kl~Df 228 (398)
+.+|+|||||+||+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEeecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeec
Confidence 99999999999999999986543 35899999999999999999999999 9999999999999854 89999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|+...... .....+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.... ..........
T Consensus 302 G~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~ 372 (573)
T 3uto_A 302 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD 372 (573)
T ss_dssp SSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTC
T ss_pred cceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCC
Confidence 9998764432 234568999999999999999999999999999999999999999753221 1111111100
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. .+........+.++.+||.+||+.||.+|||+.|+++|
T Consensus 373 ~--------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 373 W--------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp C--------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C--------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00111112345788999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=375.78 Aligned_cols=284 Identities=40% Similarity=0.710 Sum_probs=238.6
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceee
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
++....++|++.+.||+|+||+||+|.+. ++..||+|.+........+.+.+|+.+++.++||||+++++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 102 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34446689999999999999999999753 47899999987766566778999999999999999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
++...+..++||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl 180 (321)
T 2qkw_B 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKI 180 (321)
T ss_dssp ECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEE
T ss_pred EEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999998765544456899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+|||++................||+.|+|||++.+..++.++||||||+++|+|++|+.||....+........|.....
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 99999986544333333344568999999999999999999999999999999999999998766555555555443322
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
....+....++......+...+..+.+++.+||+.||++|||+.+++++|+.+.++
T Consensus 261 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 261 -NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp -TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 22233444555555667788899999999999999999999999999999988654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=367.38 Aligned_cols=291 Identities=41% Similarity=0.726 Sum_probs=238.5
Q ss_pred cccCCCCCCCHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHH
Q 015909 54 LQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYL 132 (398)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l 132 (398)
........++..++....++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.++
T Consensus 12 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l 81 (326)
T 3uim_A 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMI 81 (326)
T ss_dssp ---CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGG
T ss_pred cccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHH
Confidence 34455667899999999999999999999999999999542 478899999975432 2334688999999
Q ss_pred cCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCceecC
Q 015909 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA---EPKVIYRD 209 (398)
Q Consensus 133 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~~~ivH~D 209 (398)
+.++||||+++++++...+..++||||+++++|.+++.........+++..+..++.|++.||.|||++ + |+|||
T Consensus 82 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~D 159 (326)
T 3uim_A 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRD 159 (326)
T ss_dssp GTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCC
T ss_pred HhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCC
Confidence 999999999999999999999999999999999999988766666799999999999999999999999 8 99999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015909 210 FKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~ 289 (398)
|||+|||++.++.++|+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 160 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (326)
T 3uim_A 160 VKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238 (326)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHH
T ss_pred CchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccc
Confidence 999999999999999999999986543322 2233456999999999999999999999999999999999999999631
Q ss_pred --CCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 290 --RPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 290 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
..........|...... ...+....+.......+...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 239 RLANDDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHTTTSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 11222233334333222 233444555556667788889999999999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=360.91 Aligned_cols=265 Identities=27% Similarity=0.424 Sum_probs=215.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.++||+|+||+||+|.+.. ++..||+|.+........+.+.+|+.+++.++||||+++++++.++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 3578899999999999999997754 7889999998765555667889999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTT
T ss_pred CeeEEEEEecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeeccc
Confidence 99999999999999999998754 45899999999999999999999999 99999999999999999999999999
Q ss_pred CcCCCCCCCcc------------cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh
Q 015909 231 ARDGPTGDKSH------------VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298 (398)
Q Consensus 231 a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~ 298 (398)
+.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~ 234 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh
Confidence 98654332211 011457999999999999999999999999999999999999998654332211100
Q ss_pred hhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
. .... .. ...+...+..+.+++.+||+.||++|||+.++++.|+.++....
T Consensus 235 ~-~~~~----------~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 235 N-VRGF----------LD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp C-HHHH----------HH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred h-hhcc----------cc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 0000 00 01122234578899999999999999999999999999976544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=370.24 Aligned_cols=273 Identities=25% Similarity=0.388 Sum_probs=219.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.... .....++..||+|.+..... ...+.+.+|+.+|+.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 467999999999999999999864311 11234677899999976532 3356789999999999 8999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSY------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
..+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 235 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEE
Confidence 999999999999999999999875421 235889999999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEH 295 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~ 295 (398)
|+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--- 312 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 312 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999986554433333344567889999999999999999999999999999999 99999753211
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
.+... +. .......+...+.++.+++.+||+.||.+||++.++++.|+.+..+..
T Consensus 313 ~~~~~----~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 ELFKL----LK----------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp GHHHH----HH----------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHH----Hh----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11110 00 001112233456789999999999999999999999999999887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=357.87 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=210.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 4689999999999999999997644 7899999999766556677889999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999999999764 3899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .........
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~-- 232 (297)
T 3fxz_A 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-- 232 (297)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC--
T ss_pred ceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC--
Confidence 886543322 2334679999999999999999999999999999999999999996532110 000000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......+...+..+.+||.+||+.||++|||+.+++++
T Consensus 233 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 233 -------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -------SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00111223446778999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=362.99 Aligned_cols=275 Identities=25% Similarity=0.313 Sum_probs=211.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.++||+|+||+||+|.+ .+..||+|++.... ........|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-----------LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-----------TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-----------CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 46799999999999999999975 36889999996543 2234456789999999999999999999875
Q ss_pred Cc----eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCceecCCCCCCEE
Q 015909 151 DH----RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA----------EPKVIYRDFKASNIL 216 (398)
Q Consensus 151 ~~----~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~~~ivH~Dlkp~Nil 216 (398)
.. .++||||+++++|.+++... .+++..++.++.||+.||.|||+. + |+||||||+|||
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nil 163 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVL 163 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEE
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEE
Confidence 43 69999999999999999764 389999999999999999999998 8 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~ 291 (398)
++.++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999999999999976544433333344679999999999976 3556788999999999999999999976544
Q ss_pred CCCcchhhhhhhhhhcc----ccccccccccccC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 292 TGEHNLVEWAKPYLTSK----RRIFRVLDPRLEG-QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
.....+........... ........+.+.. ......+.++.+||.+||+.||++|||+.++++.|++++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~~ 321 (322)
T 3soc_A 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN 321 (322)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 32222211100000000 0000001111111 1123456779999999999999999999999999999988754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=365.25 Aligned_cols=280 Identities=26% Similarity=0.364 Sum_probs=222.1
Q ss_pred CCHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCc
Q 015909 62 FSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPN 139 (398)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~ 139 (398)
+.........++|++.+.||+|+||.||+|.+.. .....++..||+|.+..... ...+.+.+|+.++..+ +|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEecc----ccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence 3445555667899999999999999999997643 12345789999999976432 3345689999999999 7999
Q ss_pred ccceeeEEEeCCc-eEEEEeecCCCCHHHHHhhcCCC-------------------------------------------
Q 015909 140 LVKLVGYCLEDDH-RLLVYEFMPRGSMENHLFRRGSY------------------------------------------- 175 (398)
Q Consensus 140 I~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~------------------------------------------- 175 (398)
|+++++++...+. .++||||+++++|.+++......
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9999999887554 89999999999999999865421
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCC
Q 015909 176 -------------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236 (398)
Q Consensus 176 -------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~ 236 (398)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 122889999999999999999999998 99999999999999999999999999987644
Q ss_pred CCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccccc
Q 015909 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVL 315 (398)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (398)
...........||+.|+|||++.+..++.++||||||+++|+|++ |..||....... .... ....
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~-------- 311 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKE-------- 311 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHH--------
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHc--------
Confidence 443333445678999999999999999999999999999999998 999997543221 1100 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 316 DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
......+...+.++.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus 312 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 312 --GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0011122234567999999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=358.47 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=208.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. +|..||+|++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4579999999999999999997654 789999999965432 33566889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECST
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeec
Confidence 9999999999999999999998764 4899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLT-AKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|++....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+... ..........
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~ 229 (328)
T 3fe3_A 159 GFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRG 229 (328)
T ss_dssp TCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC
T ss_pred cCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC
Confidence 9997654332 23456899999999999888775 789999999999999999999975321 1111111110
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....+...+.++.+|+.+||+.||.+|||+++++++
T Consensus 230 ------------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 ------------KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------------CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111223346788999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=354.04 Aligned_cols=263 Identities=28% Similarity=0.455 Sum_probs=204.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||+||+|.+ ++..||+|++..... ...+.+.+|+.++++++||||+++++++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 356799999999999999999965 467899999876543 2345688999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++.+|+||||||+||+++.++.++|+|
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999999999999976431 1238899999999999999999999876699999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ... .....
T Consensus 183 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~---~~~~~- 253 (309)
T 3p86_A 183 FGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVV---AAVGF- 253 (309)
T ss_dssp CC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHH---HHHHH-
T ss_pred CCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHh-
Confidence 99997543221 1223457999999999999999999999999999999999999999653211 000 00000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.......+...+.++.+||.+||+.||.+|||+.++++.|+.+.+.
T Consensus 254 ---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 ---------KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0011122334567899999999999999999999999999887643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=343.56 Aligned_cols=285 Identities=39% Similarity=0.647 Sum_probs=227.7
Q ss_pred CCCCCCHHHHHHHhcCCCCC------ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC----ccchHHHHH
Q 015909 58 NIKNFSYSDLRTATRNFRPD------SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG----FQGHKEWLT 127 (398)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~ 127 (398)
....|++.++....+.|... +.||+|+||.||+|.+ ++..||+|.+.... ....+.+.+
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~ 79 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQ 79 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHH
Confidence 34568888999988887766 8999999999999965 46789999986432 223567889
Q ss_pred HHHHHcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015909 128 EINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIY 207 (398)
Q Consensus 128 E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH 207 (398)
|+.+++.++||||+++++++...+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|
T Consensus 80 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H 156 (307)
T 2nru_A 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH--HIH 156 (307)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eec
Confidence 99999999999999999999999999999999999999999975432 246899999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015909 208 RDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287 (398)
Q Consensus 208 ~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~ 287 (398)
|||||+||+++.++.++|+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999999986544333333344679999999999865 58899999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 288 KNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
...... ....+..........+...++..+ ...+...+..+.+++.+||+.||.+|||+.+++++|+++.
T Consensus 236 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTBSSS--BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred cCcchH--HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 643322 111121111111222222222222 3456677889999999999999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=356.33 Aligned_cols=250 Identities=29% Similarity=0.378 Sum_probs=208.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.++||+|+||+||+|.... ++..||+|++.... ......+.+|+.+|+.++||||+++++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 74 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence 3578999999999999999997654 78999999997532 23456788999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++||||+++++|..++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~D 148 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEee
Confidence 99999999999999999999998764 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 149 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~ 220 (337)
T 1o6l_A 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILME 220 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC
T ss_pred ccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcC
Confidence 99998643222 123456899999999999999999999999999999999999999965321 1111111110
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
...++...+.++.+||.+||+.||.+|| +++++++|
T Consensus 221 ------------~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 ------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0112334567899999999999999999 89999887
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=356.42 Aligned_cols=264 Identities=25% Similarity=0.414 Sum_probs=211.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+.. ....+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRV------PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECC------TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEec------CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4679999999999999999998753 11245679999997542 2335678999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCC
Confidence 999999999999999999997553 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 230 LARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .... .
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~---~---- 266 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVIS---S---- 266 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH---H----
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHH---H----
Confidence 99875443221 12223456788999999999999999999999999999999 99999653211 1100 0
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.........+...+..+.+|+.+||+.||++|||+.++++.|+.+.+.
T Consensus 267 -------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 267 -------VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 000111122334567899999999999999999999999999988654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=367.04 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=212.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+|+.++||||+++++++.
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred chHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34678899999999999999998754 688999999875422 22346789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++...+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcC
Confidence 9999999999999999999998654 35899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... ... .....
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~----~~~~~ 330 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTR----EFVEK 330 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHH----HHHHT
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHc
Confidence 99986433221111122335778999999998999999999999999999998 99999653211 111 01111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
. .....+...+.++.+|+.+||+.||++|||+.++++.|+.+++.
T Consensus 331 ~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 331 G----------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0 11122333467899999999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=358.70 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=207.2
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc------chHHHHHHHHHHcCCCCCcccce
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ------GHKEWLTEINYLGQLHHPNLVKL 143 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~~I~~~ 143 (398)
..++|++.+.||+|+||+||+|.... +|..||+|.+...... ..+.+.+|+.+|+.++||||+++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l 80 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence 35679999999999999999997654 7899999999754322 34678999999999999999999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC--
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-- 221 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-- 221 (398)
++++.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~ 154 (361)
T 2yab_A 81 HDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIP 154 (361)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSS
T ss_pred EEEEEeCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCC
Confidence 99999999999999999999999999764 35899999999999999999999998 99999999999998776
Q ss_pred --CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 222 --NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 222 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
.++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... .
T Consensus 155 ~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~ 225 (361)
T 2yab_A 155 IPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------E 225 (361)
T ss_dssp SCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------H
T ss_pred ccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence 79999999998754432 233467999999999999999999999999999999999999999653211 1
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......... .+.+. .....+.++.+||.+||..||.+|||+.+++++
T Consensus 226 ~~~~i~~~~~----~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 226 TLANITAVSY----DFDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHTTCC----CCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCC----CCCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111100000 00000 001235678999999999999999999999964
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=353.15 Aligned_cols=270 Identities=29% Similarity=0.402 Sum_probs=217.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..++|++.+.||+|+||.||+|.+.. .....++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFH----LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEET----GGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred chhheeeeeeecccCCeeEEEEEEec----cCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 35679999999999999999997643 1123357899999997543 233567889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSY--------------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYR 208 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~ 208 (398)
..+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~ 174 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHR 174 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cccc
Confidence 999999999999999999999875431 134889999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 015909 209 DFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAID 287 (398)
Q Consensus 209 Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~ 287 (398)
||||+||+++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987644433323334567889999999999999999999999999999999 999997
Q ss_pred CCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 288 KNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
..... ..... .. .......+...+.++.+++.+||+.||.+||++.+++++|+++...
T Consensus 255 ~~~~~---~~~~~----~~----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPE---RLFNL----LK----------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGG---GHHHH----HH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHH---HHHHH----hh----------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 54321 11110 00 0011122234467899999999999999999999999999988654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=364.78 Aligned_cols=271 Identities=26% Similarity=0.359 Sum_probs=213.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|.+... ....++..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 46789999999999999999986531 133468899999996542 2334568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC---CE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGS---YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY---NA 223 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~---~~ 223 (398)
....++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999987653 2245899999999999999999999999 99999999999998554 59
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (398)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~--- 297 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE--- 297 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH---
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---
Confidence 9999999874322222222334568999999999999999999999999999999998 99999653211 1111
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
. ... ......+...+..+.+|+.+||+.||.+|||+.+++++|+.+.+...
T Consensus 298 ~-i~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 298 F-VTS----------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp H-HHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred H-HHc----------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 0 000 00111223345678999999999999999999999999998876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=349.58 Aligned_cols=278 Identities=23% Similarity=0.359 Sum_probs=211.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|++.. .+..++..||+|++........+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4689999999999999999997542 23447899999999876555567789999999999999999999998653
Q ss_pred --CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 151 --DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 151 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
...++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccC
Confidence 56899999999999999998754 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh--
Q 015909 229 GLARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL-- 305 (398)
Q Consensus 229 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-- 305 (398)
|++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... .........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~ 234 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQG 234 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCT
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCcccc
Confidence 999875433221 1222345778899999999999999999999999999999999998542100 000000000
Q ss_pred -hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 306 -TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 306 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.....+............+...+.++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000000011111112223344567899999999999999999999999999988653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=346.13 Aligned_cols=276 Identities=23% Similarity=0.308 Sum_probs=215.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.++||+|+||+||+|.+.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 4679999999999999999997754 68899999997543 2445678899999999999999999999887
Q ss_pred CC--ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE----cCCCCE
Q 015909 150 DD--HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL----DSNYNA 223 (398)
Q Consensus 150 ~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv----~~~~~~ 223 (398)
.. ..++||||+++++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceE
Confidence 65 779999999999999999865431 34899999999999999999999998 9999999999999 778889
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccc--------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA--------TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~ 295 (398)
||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||.........
T Consensus 156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 9999999987544332 23457999999999986 578899999999999999999999999754332211
Q ss_pred chhhhhhhhhhcc-cc----ccccc--------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 296 NLVEWAKPYLTSK-RR----IFRVL--------DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 296 ~~~~~~~~~~~~~-~~----~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
. .......... .. +.... ........+...+..+.+++.+||+.||++|||++|++++..+-.-.
T Consensus 233 ~--~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 233 K--EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp H--HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred H--HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 1 1111111100 00 00000 01112245677888999999999999999999999999998865433
Q ss_pred h
Q 015909 363 R 363 (398)
Q Consensus 363 ~ 363 (398)
.
T Consensus 311 ~ 311 (319)
T 4euu_A 311 G 311 (319)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=359.61 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=205.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCC-CCCcccceeeE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQL-HHPNLVKLVGY 146 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~~I~~~~~~ 146 (398)
.++|++.++||+|+||+||+|++.. ++..||+|++..... .....+..|..+|.++ +||||++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 3579999999999999999997754 789999999975432 2345578899999886 89999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+.+.+..++||||+++|+|..++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEe
Confidence 999999999999999999999998764 4899999999999999999999999 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc--chhhh-hhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH--NLVEW-AKP 303 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~--~~~~~-~~~ 303 (398)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ...
T Consensus 196 DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 196 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred ecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 999998632222 2244578999999999999999999999999999999999999999653222111 01111 111
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM------DEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 355 (398)
.... ...++...+.++.+||.+||+.||.+||++ .+++++
T Consensus 274 i~~~------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 274 ILEK------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHC------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred Hhcc------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1110 112233456789999999999999999985 566654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=356.84 Aligned_cols=257 Identities=24% Similarity=0.313 Sum_probs=206.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-----ccchHHHHHHHHHHcCCCCCcccceee
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-----FQGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 4579999999999999999997654 78999999985321 124577899999999999999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC---
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN--- 222 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~--- 222 (398)
++.+.+..++||||+++++|.+++.........+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCc
Confidence 999999999999999999999888765433356899999999999999999999998 999999999999976554
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
++|+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .. ..
T Consensus 172 vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~---~~ 242 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RL---FE 242 (351)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HH---HH
T ss_pred EEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HH---HH
Confidence 9999999998754322 123345799999999999999999999999999999999999999965210 11 11
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........ ..+.. ....+.++.+||.+||+.||++|||+.+++++
T Consensus 243 ~i~~~~~~----~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 243 GIIKGKYK----MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHTCCC----CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCC----CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11100000 00000 01235688999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.22 Aligned_cols=275 Identities=26% Similarity=0.367 Sum_probs=220.3
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||+||+|.+.... ......+..||+|++..... .....+.+|+.+++.+ +||||+++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 3468999999999999999999864311 11223567899999976532 3346788999999999 899999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSY------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
...+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 222 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 222 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceE
Confidence 9999999999999999999999876421 245899999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGE 294 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~ 294 (398)
||+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-- 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987654443333444567889999999999999999999999999999999 99999653211
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
..... +. .......+...+.++.+|+.+||+.||++|||+.+++++|+.+......
T Consensus 301 ----~~~~~-~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 301 ----ELFKL-LK----------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp ----HHHHH-HH----------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred ----HHHHH-HH----------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11110 00 0011112233457899999999999999999999999999999766543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=343.37 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=210.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEec----------CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 357899999999999999999764 36679999997654 3346789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred CceEEEEEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccc
Confidence 99999999999999999997654 45899999999999999999999999 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ........
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~--- 222 (269)
T 4hcu_A 153 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDIST--- 222 (269)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHT---
T ss_pred cccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhc---
Confidence 97643321 111223456788999999999999999999999999999999 99999653211 11110000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
......+...+..+.+++.+||+.||++||++.+++++|+++.+
T Consensus 223 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 223 --------GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp --------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 01111222335678999999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=347.23 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=205.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 4689999999999999999997654 788999999854332 2345688999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~D 154 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFD 154 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECC
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998764 5899999999999999999999999 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .........
T Consensus 155 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~ 227 (294)
T 4eqm_A 155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD 227 (294)
T ss_dssp CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS
T ss_pred CCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc
Confidence 999986543221 1233457999999999999999999999999999999999999999653211 000000000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-DMDEVVKELEQLQ 360 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~l~ 360 (398)
. .+..........+..+.+++.+||+.||.+|| +++++.+.|..+.
T Consensus 228 ------~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 228 ------S-VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ------C-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ------c-CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0 00011111223457889999999999999998 8898888887543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=354.09 Aligned_cols=262 Identities=23% Similarity=0.398 Sum_probs=205.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.++||+|+||+||+|.+... .......|++|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPE-----GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCT-----TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCC-----CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 35789999999999999999987541 11123458888875432 233456678999999999999999999875
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCS
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCC
Confidence 567899999999999999997653 35888999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+++...............||..|+|||++.+..++.++||||||+++|+|++ |..||....... .... ....
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~ 233 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDL----LEKG 233 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHH----HHTT
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHH----HHcC
Confidence 9987655544444455678889999999999999999999999999999999 999997643221 1110 0000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.....+...+.++.+++.+||+.||.+||++.+++++|+.+.
T Consensus 234 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 234 ----------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001111223446789999999999999999999999998774
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=347.92 Aligned_cols=268 Identities=19% Similarity=0.209 Sum_probs=213.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++.... ....+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 4679999999999999999997654 78999999986543 234578999999999 89999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC-----EE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN-----AK 224 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~-----~k 224 (398)
.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEE
T ss_pred CCccEEEEEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEE
Confidence 99999999999 999999998753 46899999999999999999999998 999999999999998877 99
Q ss_pred EeeccCCcCCCCCCCcc-----cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 225 LSDFGLARDGPTGDKSH-----VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
|+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~- 229 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY- 229 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH-
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH-
Confidence 99999998654332211 123467999999999999999999999999999999999999999765322211111
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcc
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMH 366 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 366 (398)
.......... ....+. ...+ ++.+++..||+.||.+||++++|++.|+++.+.....
T Consensus 230 --~~i~~~~~~~---~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 230 --QKIGDTKRAT---PIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp --HHHHHHHHHS---CHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred --HHHHhhhccC---CHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1110000000 000000 0123 8999999999999999999999999999887665543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=356.05 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=205.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4689999999999999999997654 788999999864432 234567899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEee
Confidence 99999999999999999988654 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++................||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ....+. ...
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~ 225 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKK 225 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTC
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----ccc
Confidence 9976543333333445689999999999987765 7789999999999999999999975432211 111110 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.........+..+.+||.+||+.||++|||+.|++++-
T Consensus 226 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 226 ----------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp ----------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ----------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 00011123456788999999999999999999998863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=346.72 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=213.1
Q ss_pred CCHHHHHHHhcC----------CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHH
Q 015909 62 FSYSDLRTATRN----------FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131 (398)
Q Consensus 62 ~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~ 131 (398)
++.+++....+. |...+.||+|+||.||+|.+.. +|..||||++........+.+.+|+.+
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~ 95 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVI 95 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHHH
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHHH
Confidence 556666555543 6677899999999999997654 689999999987666667789999999
Q ss_pred HcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCC
Q 015909 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFK 211 (398)
Q Consensus 132 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlk 211 (398)
++.++||||+++++++...+..++||||+++++|.+++... .+++..+..++.||+.||.|||+++ |+|||||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlk 168 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIK 168 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCC
Confidence 99999999999999999999999999999999999988643 4899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015909 212 ASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291 (398)
Q Consensus 212 p~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~ 291 (398)
|+||+++.++.++|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 169 p~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 169 SDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999876543221 22346799999999999999999999999999999999999999965321
Q ss_pred CCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 292 TGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ....... ....+.. ......+..+.+++.+||+.||++|||+.+++++
T Consensus 247 ~------~~~~~~~-------~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 247 V------QAMKRLR-------DSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H------HHHHHHH-------HSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H------HHHHHHh-------cCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111100 0000100 1122345678999999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=351.03 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=206.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3579999999999999999997654 78999999986432 12345788999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++||||+ +|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~D 151 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIAD 151 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECC
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEE
Confidence 9999999999999 789999887764 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||++....... .....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.........
T Consensus 152 FG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------- 217 (336)
T 3h4j_B 152 FGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------- 217 (336)
T ss_dssp SSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------
T ss_pred eccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------
Confidence 99998654332 2334579999999999988776 68899999999999999999999753221110
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
..... .....+...+.++.+||.+||+.||.+|||+++++++-.
T Consensus 218 ------~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 218 ------KKVNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp ------CCCCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred ------HHHHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 00000 011223334678899999999999999999999998743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=343.42 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=210.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 467999999999999999999764 36679999997654 3346789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||+++++|.+++...+ ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTC
T ss_pred CceEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCcc
Confidence 99999999999999999998764 35899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ........
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~--- 220 (268)
T 3sxs_A 151 TRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQ--- 220 (268)
T ss_dssp EEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHT---
T ss_pred ceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHc---
Confidence 9865443221 2223456778999999999899999999999999999999 99999643211 00000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
......+...+..+.+++.+||+.||.+|||+.+++++|+.+++..
T Consensus 221 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 221 --------GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --------TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --------CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 0011112223567899999999999999999999999999886543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=357.89 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=203.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCC-CCCcccceee
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQL-HHPNLVKLVG 145 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~I~~~~~ 145 (398)
..++|++.++||+|+||+||+|++.. ++..||+|++.... ....+.+.+|..+++.+ +||||+++++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 91 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC 91 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence 34689999999999999999997754 78999999997532 23456678899999988 6999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
++.+.+..|+||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 92 CFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEE
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999998764 4899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 166 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~ 237 (353)
T 3txo_A 166 ADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAIL 237 (353)
T ss_dssp CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH
T ss_pred ccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 9999998633222 2234568999999999999999999999999999999999999999753211 1111111
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM------DEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 355 (398)
.. ...++...+.++.+||.+||+.||.+||++ .++++|
T Consensus 238 ~~------------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 238 ND------------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred cC------------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11 111233345778999999999999999998 777774
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=361.82 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=206.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||+||+|.... ++..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 45689999999999999999997654 789999999976543 2345688999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc---CCCCEE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD---SNYNAK 224 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~---~~~~~k 224 (398)
.+.+..++||||+++++|.+.+...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vk 153 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVK 153 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEE
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEE
Confidence 99999999999999999999998764 4899999999999999999999999 99999999999998 568899
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.... ......
T Consensus 154 L~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i 225 (444)
T 3soa_A 154 LADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQI 225 (444)
T ss_dssp ECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHH
T ss_pred EccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHH
Confidence 999999987543322 233467999999999999999999999999999999999999999653211 111111
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ..........+.++.+||.+||+.||.+|||+.+++++
T Consensus 226 ~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 226 KAGAY--------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHTCC--------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCC--------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 10000 00111112345789999999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=350.10 Aligned_cols=271 Identities=25% Similarity=0.382 Sum_probs=198.0
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
...++|++.+.||+|+||+||+|.+... ......||+|.+.... ....+.+.+|+.+++.++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQE------DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEccc------CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 3456899999999999999999976531 1122489999997542 2345778999999999999999999999
Q ss_pred EEeCCce------EEEEeecCCCCHHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 147 CLEDDHR------LLVYEFMPRGSMENHLFRRGS--YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 147 ~~~~~~~------~lv~e~~~~~~L~~~~~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
+...... ++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~ 171 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA 171 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc
Confidence 9877655 999999999999999975432 2235899999999999999999999998 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcch
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNL 297 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~ 297 (398)
.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~ 248 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I 248 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H
Confidence 999999999999987644443333334567889999999999999999999999999999999 999997543211 1
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
.. .... ......+...+.++.+|+.+||+.||++|||+.++++.|+++.+-.-
T Consensus 249 ~~---~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 249 YN---YLIG-----------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HH---HHHT-----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HH---HHhc-----------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 10 0000 00111223345689999999999999999999999999998865433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=355.53 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=205.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|.+.. ++..||+|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 578999999999999999997654 78999999986432 234567889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEecc
Confidence 9999999999999999999998653 5899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............. ...
T Consensus 160 G~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~ 233 (384)
T 4fr4_A 160 NIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFE 233 (384)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHH
T ss_pred ceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHh
Confidence 9998754332 2345689999999999964 458999999999999999999999997543322111111 100
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-MDEVVK 354 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~ 354 (398)
. ....++...+.++.+||.+||+.||.+||+ ++++++
T Consensus 234 ~------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 T------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp H------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred h------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 011223344678999999999999999998 666665
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=355.13 Aligned_cols=271 Identities=25% Similarity=0.385 Sum_probs=214.3
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|.+.. .....++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYG----ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEES----CSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeec----cccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45789999999999999999998632 1223467899999997542 23456789999999999 899999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceec
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSY-------------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYR 208 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~ 208 (398)
...+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 196 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 196 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence 9999999999999999999999865421 134789999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 015909 209 DFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAID 287 (398)
Q Consensus 209 Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~ 287 (398)
||||+|||++.++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986544333333344567889999999999999999999999999999998 999997
Q ss_pred CCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 288 KNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
...... .+... .. .......+...+.++.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus 277 ~~~~~~--~~~~~----~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDA--NFYKL----IQ----------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSH--HHHHH----HH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHH--HHHHH----Hh----------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 543211 11110 10 0111122233467899999999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=351.64 Aligned_cols=255 Identities=19% Similarity=0.233 Sum_probs=208.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 4689999999999999999997654 78999999987543 3345678999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC--CCCEEEeec
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS--NYNAKLSDF 228 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~--~~~~kl~Df 228 (398)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.++|+||
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Df 148 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEEC
Confidence 99999999999999999997643 35899999999999999999999998 999999999999986 789999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 149 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~ 219 (321)
T 1tki_A 149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAE 219 (321)
T ss_dssp TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC
T ss_pred CCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCC
Confidence 9998764432 233467999999999999988999999999999999999999999653211 1111111100
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.. +... .....+.++.+|+.+||..||.+|||+.+++++-.
T Consensus 220 ~~----~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 220 YT----FDEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CC----CCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CC----CChh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 00 0000 00123568899999999999999999999999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=348.55 Aligned_cols=271 Identities=25% Similarity=0.366 Sum_probs=218.4
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|.+.. .....++..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYG----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEee----ccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 34689999999999999999997532 12344788999999975433 3456788999999999 899999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCC
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSY--------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKAS 213 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~ 213 (398)
...+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~ 174 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccc
Confidence 9999999999999999999999876421 125899999999999999999999998 999999999
Q ss_pred CEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 015909 214 NILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPT 292 (398)
Q Consensus 214 Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~ 292 (398)
||+++.++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987655443333344567889999999999999999999999999999999 99999754321
Q ss_pred CCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
. ..... ... ......+...+.++.+++.+||+.||.+|||+.+++++|+++...
T Consensus 255 ~--~~~~~----~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 255 S--KFYKM----IKE----------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp H--HHHHH----HHH----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h--HHHHH----hcc----------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 11110 000 011111223457899999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=342.64 Aligned_cols=265 Identities=24% Similarity=0.367 Sum_probs=202.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+... ...+..||+|.+..... ...+.+.+|+.+++.++||||+++++++ .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSP------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 46799999999999999999987531 12467899999875432 3356788999999999999999999987 4
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccc
Confidence 567899999999999999998654 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... +..... ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i----~~~ 233 (281)
T 1mp8_A 162 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----ENG 233 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----HTT
T ss_pred cccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH----HcC
Confidence 99875432211 1223456788999999999999999999999999999997 99999753221 111100 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
.....+...+..+.+++.+||+.||++|||+.++++.|+++.+.++.
T Consensus 234 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 280 (281)
T 1mp8_A 234 ----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 280 (281)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 01112334467899999999999999999999999999999876653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=351.92 Aligned_cols=263 Identities=22% Similarity=0.388 Sum_probs=204.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.++||+|+||+||+|.+... .......||+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCC-----CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 35789999999999999999987541 11123457889886432 2445778999999999999999999999886
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
. ..++|+|++.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg 162 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTT
T ss_pred C-CeEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCc
Confidence 5 4789999999999999998754 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+++...............||..|+|||++.+..++.++||||||+++|+|++ |+.||....... +... .
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----~--- 232 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----L--- 232 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----H---
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHH----H---
Confidence 9986544433333334567889999999999999999999999999999999 999997542211 1110 0
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
........+...+.++.+++.+||+.||.+||++.+++++|+.+..
T Consensus 233 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 233 -------EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -------HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111112233345689999999999999999999999999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=356.31 Aligned_cols=264 Identities=26% Similarity=0.433 Sum_probs=201.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+|++.+.||+|+||.||+|++.. ...++..||+|.+..... ...+.+.+|+.++++++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKL------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBC------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEec------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3579999999999999999997642 123577899999975432 335678999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCc
Confidence 999999999999999999997654 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcc-cccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 230 LARDGPTGDKSH-VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 230 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+++......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..... ..
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~----i~- 264 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKA----VD- 264 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHH----HH-
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HH-
Confidence 998754332111 1122345778999999999999999999999999999998 99999653211 11110 00
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.......+...+..+.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 265 ---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 265 ---------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ---------TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0111112234467899999999999999999999999999988653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.59 Aligned_cols=270 Identities=25% Similarity=0.353 Sum_probs=214.5
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
...++|++.+.||+|+||.||+|.+... ....++..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3457899999999999999999987531 1123568999999976432 3356788999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSY--------------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIY 207 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH 207 (398)
...+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 9999999999999999999999875321 156899999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 015909 208 RDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAI 286 (398)
Q Consensus 208 ~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~ 286 (398)
|||||+|||++.++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999876433322222334568899999999999999999999999999999999 99999
Q ss_pred CCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 287 DKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
...... .. ... .... .....+...+.++.+++.+||+.||++|||+.++++.|+++.+
T Consensus 278 ~~~~~~---~~---~~~-~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 278 YGMAHE---EV---IYY-VRDG----------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTSCHH---HH---HHH-HHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCChH---HH---HHH-HhCC----------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 653211 11 100 0000 0011223345689999999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=345.02 Aligned_cols=267 Identities=25% Similarity=0.397 Sum_probs=219.4
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.+.||+|+||+||+|.+.. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45679999999999999999998764 68899999997543 345778899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCCEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCc
Confidence 9999999999999999999987543 56899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~-------- 224 (288)
T 3kfa_A 157 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL-------- 224 (288)
T ss_dssp GGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH--------
T ss_pred cceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH--------
Confidence 9987543322 22333457889999999999999999999999999999999 999996542211 1110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhccCC
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKR 368 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~~ 368 (398)
.........+...+..+.+++.+||+.||.+|||+.++++.|+.+.........
T Consensus 225 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~~ 278 (288)
T 3kfa_A 225 ------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278 (288)
T ss_dssp ------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ------HhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccch
Confidence 001111122234457899999999999999999999999999998766554433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=350.20 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=206.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc------chHHHHHHHHHHcCCCCCccccee
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ------GHKEWLTEINYLGQLHHPNLVKLV 144 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~~I~~~~ 144 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.+|+.++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 4569999999999999999997654 7899999998654321 356789999999999999999999
Q ss_pred eEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC---
Q 015909 145 GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY--- 221 (398)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~--- 221 (398)
+++......++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCC
Confidence 9999999999999999999999999764 35899999999999999999999998 99999999999998877
Q ss_pred -CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 222 -NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 222 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
.++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 155 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~ 225 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ET 225 (326)
T ss_dssp CCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HH
T ss_pred CCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HH
Confidence 89999999998754322 123457999999999999999999999999999999999999999653211 00
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......... ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus 226 ~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 226 LANVSAVNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHTCC--------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcCC--------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000 00000001235678999999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=347.59 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=206.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||+||+|.... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 75 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence 3578999999999999999997654 78999999997532 23456778999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEee
Confidence 99999999999999999999998754 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..........
T Consensus 150 fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~ 218 (318)
T 1fot_A 150 FGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA 218 (318)
T ss_dssp CSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC
T ss_pred cCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC
Confidence 9999864321 2346799999999999999999999999999999999999999965321 1111111111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
...++...+.++.++|.+||+.||.+|| +++++++|
T Consensus 219 ------------~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 219 ------------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0112333457899999999999999999 89999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=350.00 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=205.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
++|++.+.||+|+||.||+|.+.. ++..||+|++...... ..+.+.+|+.++..+ +||||+++++++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 568999999999999999997754 7899999999765332 245578899999887 899999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998764 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc--chhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH--NLVEWAKPYL 305 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~ 305 (398)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........
T Consensus 154 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 154 YGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp GGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred ccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 99998633222 1234568999999999999999999999999999999999999999653221110 0000000000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM------DEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 355 (398)
. .. ...++...+.++.+||.+||+.||.+||++ .++++|
T Consensus 232 ~---------~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 232 L---------EK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp H---------HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred H---------cC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0 00 112233456789999999999999999995 666655
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=353.53 Aligned_cols=256 Identities=22% Similarity=0.301 Sum_probs=197.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.... ++..||+|++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 4579999999999999999997654 78999999997543 2346688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC--EEEeec
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN--AKLSDF 228 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~--~kl~Df 228 (398)
+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Df 162 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDF 162 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeec
Confidence 99999999999999999998764 4899999999999999999999999 999999999999987665 999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAK-SDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ..........
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~- 236 (361)
T 3uc3_A 163 GYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILS- 236 (361)
T ss_dssp CCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHT-
T ss_pred CccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhc-
Confidence 9987432221 2234579999999999988887666 8999999999999999999976433221 1111111111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
...........+.++.+||.+||+.||++|||+.+++++-.
T Consensus 237 ---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 237 ---------VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp ---------TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred ---------CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 11111111123568899999999999999999999999843
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=356.01 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=208.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|.+..........+.+|+.+|+.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 4679999999999999999997654 7889999999766544556788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc--CCCCEEEeec
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD--SNYNAKLSDF 228 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~--~~~~~kl~Df 228 (398)
...++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.++|+||
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEec
Confidence 99999999999999999887543 35899999999999999999999998 99999999999997 4578999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..........
T Consensus 196 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~ 266 (387)
T 1kob_A 196 GLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCD 266 (387)
T ss_dssp TTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCC
T ss_pred ccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC
Confidence 9998754332 223457999999999999999999999999999999999999999753211 1111110000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...........+.++.+||.+||+.||.+|||+.+++++
T Consensus 267 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 267 --------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 001111122346789999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=339.53 Aligned_cols=255 Identities=29% Similarity=0.554 Sum_probs=204.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc-------hHHHHHHHHHHcCCCCCccccee
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-------HKEWLTEINYLGQLHHPNLVKLV 144 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~~I~~~~ 144 (398)
++|++.+.||+|+||+||+|.+.. ++..||+|.+....... .+.+.+|+.+++.++||||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 578999999999999999997754 78899999986543221 26788999999999999999999
Q ss_pred eEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC--
Q 015909 145 GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN-- 222 (398)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~-- 222 (398)
+++.+.. ++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++.+|+||||||+||+++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~ 164 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCC
Confidence 9886544 79999999999999887654 4689999999999999999999998766999999999999987776
Q ss_pred ---EEEeeccCCcCCCCCCCccccccccccccccccccc--ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 223 ---AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL--ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 223 ---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
++|+|||++..... ......||+.|+|||++ ....++.++||||||+++|+|++|+.||........
T Consensus 165 ~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--- 236 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--- 236 (287)
T ss_dssp SCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH---
T ss_pred ceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH---
Confidence 99999999975322 23346799999999998 345678899999999999999999999975432211
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
....... ........+...+.++.+++.+||+.||.+|||+.++++.|++|
T Consensus 237 -~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 237 -KFINMIR----------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -HHHHHHH----------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -HHHHHHh----------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0000000 01111122334467899999999999999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=341.21 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=201.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 579999999999999999997754 789999999975433 234678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++ +|.+.+.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999965 6666665543 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc-
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH-LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS- 307 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~- 307 (398)
++....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...... .+...........
T Consensus 147 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~ 222 (292)
T 3o0g_A 147 LARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTP 222 (292)
T ss_dssp TCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred cceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCC
Confidence 998653322 1233457899999999997765 899999999999999999988886432211 0111000000000
Q ss_pred ccc----cccc---------ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRR----IFRV---------LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~----~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... .... .............+.++.+||.+||+.||++|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000 00000111222346788999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=353.02 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=206.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45679999999999999999997654 789999999975433 2346688999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC---CCEE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN---YNAK 224 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~---~~~k 224 (398)
.+.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+|
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEE
Confidence 99999999999999999999987653 5899999999999999999999998 9999999999999754 4599
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ......
T Consensus 172 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i 242 (362)
T 2bdw_A 172 LADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQI 242 (362)
T ss_dssp ECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred EeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH
Confidence 99999998754332 223467999999999999999999999999999999999999999653211 111110
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... . .........+.++.+||.+||+.||++||++.+++++
T Consensus 243 ~~~~~---~-----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 243 KAGAY---D-----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHTCC---C-----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HhCCC---C-----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0 0001112345788999999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=341.56 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=207.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 467899999999999999999764 46689999997654 3346789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred CCeEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccc
Confidence 99999999999999999997643 35899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... . ......
T Consensus 167 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~---~~~~~~---- 235 (283)
T 3gen_A 167 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---E---TAEHIA---- 235 (283)
T ss_dssp GGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---H---HHHHHH----
T ss_pred ccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---H---HHHHHh----
Confidence 976433211 11223456788999999999999999999999999999998 99999653211 0 000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.. .....+...+..+.+++.+||+.||.+|||+.+++++|.++.+.
T Consensus 236 ---~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 236 ---QG----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ---TT----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cc----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00 11111223356789999999999999999999999999988764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=346.78 Aligned_cols=263 Identities=22% Similarity=0.384 Sum_probs=203.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.++||+|+||+||+|.+... .......|++|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCT-----TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCC-----CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 36799999999999999999987541 1112335688887543 33456788999999999999999999999886
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
. ..++|++++.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 89 ~-~~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG 162 (327)
T 3lzb_A 89 S-TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp S-SEEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTT
T ss_pred C-CceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCc
Confidence 5 4789999999999999998754 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... +...
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~-------- 231 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI-------- 231 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH--------
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH--------
Confidence 9987644433333334567889999999999999999999999999999999 999997542211 1110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
+........+...+.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 232 ------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 232 ------LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ------HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 00111112233345679999999999999999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=341.70 Aligned_cols=268 Identities=18% Similarity=0.194 Sum_probs=213.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... ....+.+|+.+++.+ +|+||+++++++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 35679999999999999999997644 78999999986542 234578899999999 7999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC-----E
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN-----A 223 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~-----~ 223 (398)
.....++||||+ +++|.+++...+ ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++. +
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~ 150 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMI 150 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCE
T ss_pred CCceeEEEEEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeE
Confidence 999999999999 999999998764 35899999999999999999999998 999999999999987765 9
Q ss_pred EEeeccCCcCCCCCCCc-----ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh
Q 015909 224 KLSDFGLARDGPTGDKS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~ 298 (398)
+|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 230 (298)
T 1csn_A 151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230 (298)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence 99999999865443221 1123467999999999999999999999999999999999999999764433221111
Q ss_pred hhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
..... ... ....+.. ....+.++.+++.+||+.||++||+++++++.|+++.+..+
T Consensus 231 ~~~~~---~~~---~~~~~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 231 ERIGE---KKQ---STPLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHH---HHH---HSCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHh---hcc---CccHHHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 11100 000 0000000 11235688999999999999999999999999999876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=349.37 Aligned_cols=280 Identities=26% Similarity=0.358 Sum_probs=221.2
Q ss_pred CHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcc
Q 015909 63 SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNL 140 (398)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I 140 (398)
.........++|++.+.||+|+||+||+|.+.. .....++..||+|.+..... .....+.+|+.+++.+ +||||
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEec----CCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence 344455567889999999999999999997643 12334788999999976433 2345688999999999 69999
Q ss_pred cceeeEEEeCC-ceEEEEeecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015909 141 VKLVGYCLEDD-HRLLVYEFMPRGSMENHLFRRGSY------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIY 207 (398)
Q Consensus 141 ~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH 207 (398)
+++++++...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+|
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H 171 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIH 171 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 99999987754 489999999999999999875431 123789999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 015909 208 RDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAI 286 (398)
Q Consensus 208 ~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~ 286 (398)
|||||+||+++.++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654433333344568899999999999999999999999999999998 99999
Q ss_pred CCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 287 DKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
....... .+.. ..... .....+...+.++.+++.+||+.||.+|||+.+++++|+.+.+...
T Consensus 252 ~~~~~~~--~~~~----~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 252 PGVKIDE--EFCR----RLKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TTCCCSH--HHHH----HHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccchhH--HHHH----HhccC----------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 6533211 1110 00000 0011122345678999999999999999999999999999876554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=345.82 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=201.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||+||+|.+. ++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 467999999999999999999763 478999999975432 22467889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADF 163 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccC
Confidence 9999999999996 58888887654 45899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .........
T Consensus 164 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~ 238 (311)
T 3niz_A 164 GLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGT 238 (311)
T ss_dssp TTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCC
T ss_pred cCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCC
Confidence 99986533221 2334578999999999876 56899999999999999999999999764432211 110000000
Q ss_pred c--c-------------cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 K--R-------------RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~--~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. . ..................+.++.+||.+||+.||++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0 0000000000000011234678999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=350.78 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=207.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|.+.. ++..||+|++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 579999999999999999997654 78999999986532 234567889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEccc
Confidence 9999999999999999999998764 4899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..........
T Consensus 186 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~- 253 (350)
T 1rdq_E 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSG- 253 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-
T ss_pred ccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcC-
Confidence 999865332 2345799999999999999999999999999999999999999965321 1111111110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
...++...+.++.++|.+||+.||.+||+ +++++++
T Consensus 254 -----------~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 254 -----------KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----------CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 01123334678999999999999999998 8888875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=348.14 Aligned_cols=274 Identities=24% Similarity=0.376 Sum_probs=216.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.... .....++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 468999999999999999999875311 11234678999999975432 3356788999999999 8999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSY------------FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
..+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl 189 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVL 189 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEE
Confidence 999999999999999999999865421 134889999999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEH 295 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~ 295 (398)
++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 99999999999999987554333222334567889999999998899999999999999999999 9999965321
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
....... .. ......+...+.++.+++.+||+.||.+||++.++++.|+.+......
T Consensus 266 --~~~~~~~-~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 266 --EELFKLL-KE----------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp --HHHHHHH-HH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --HHHHHHH-hc----------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1111100 00 001112233456899999999999999999999999999999876554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=353.93 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=206.4
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCC-CCCccccee
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQL-HHPNLVKLV 144 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~I~~~~ 144 (398)
...++|++.++||+|+||+||+|.+.. ++..||+|.+.... ......+..|..++..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 445789999999999999999997754 78999999997542 23456678899999876 899999999
Q ss_pred eEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 145 GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
+++.+.+..|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEE
Confidence 99999999999999999999999998764 4899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ......
T Consensus 159 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i 230 (345)
T 1xjd_A 159 IADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSI 230 (345)
T ss_dssp ECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred EeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHH
Confidence 999999986432221 234568999999999999999999999999999999999999999653211 111111
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD-EVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~ 355 (398)
... ...++...+.++.+||.+||+.||.+||++. +++++
T Consensus 231 ~~~------------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 231 RMD------------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHC------------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HhC------------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 110 0112233467899999999999999999997 66643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=350.69 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=206.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCC-CCCcccceee
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQL-HHPNLVKLVG 145 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~I~~~~~ 145 (398)
..++|++.++||+|+||+||+|.... ++..||+|++.... ....+.+..|..+|..+ +||||+++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 35689999999999999999997654 68899999997542 23456778999999988 7999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
++.+.+..|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEE
Confidence 9999999999999999999999998764 4899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 163 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~ 234 (353)
T 2i0e_A 163 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM 234 (353)
T ss_dssp CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred EeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHH
Confidence 9999998633222 123456899999999999999999999999999999999999999965321 11111111
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
.. ...++...+.++.+||.+||+.||.+||+ +++++++
T Consensus 235 ~~------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 EH------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HC------------CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred hC------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 11123345678999999999999999995 5777765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=344.05 Aligned_cols=273 Identities=23% Similarity=0.334 Sum_probs=204.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3579999999999999999997654 688999999975332 2346688999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.++|+|
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECC
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEe
Confidence 9999999999999999999999764433456899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 180 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~- 252 (310)
T 2wqm_A 180 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ- 252 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT-
T ss_pred ccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc-
Confidence 999876533221 223356899999999999999999999999999999999999999653211 1111111000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhccCCch
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQ 370 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~~~~ 370 (398)
. ..........+.++.+++.+||+.||.+|||+.++++.|+++...++-..+.-
T Consensus 253 ------~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~~ 306 (310)
T 2wqm_A 253 ------C---DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHH 306 (310)
T ss_dssp ------T---CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred ------c---cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhhh
Confidence 0 00001112345689999999999999999999999999999998877655443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=344.87 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=196.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--------------------------chHH
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--------------------------GHKE 124 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~ 124 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... ..+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 3579999999999999999997654 7899999998654321 1356
Q ss_pred HHHHHHHHcCCCCCcccceeeEEEe--CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 015909 125 WLTEINYLGQLHHPNLVKLVGYCLE--DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE 202 (398)
Q Consensus 125 ~~~E~~~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 202 (398)
+.+|+.+|+.++||||+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.||+.||.|||+++
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 8899999999999999999999986 5678999999999998775432 46899999999999999999999998
Q ss_pred CCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCC---CCCchhHHHHHHHHHHH
Q 015909 203 PKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH---LTAKSDIYSFGVVLLEI 279 (398)
Q Consensus 203 ~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el 279 (398)
|+||||||+|||++.++.++|+|||++........ ......||+.|+|||++.+.. ++.++||||||+++|+|
T Consensus 158 --ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 158 --IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp --EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred --eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 99999999999999999999999999986543321 233457999999999997765 37789999999999999
Q ss_pred HhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 280 LSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 280 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
++|+.||..... .......... ..........+.++.+||.+||+.||++|||+.+++++
T Consensus 234 ~~g~~pf~~~~~------~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 234 VFGQCPFMDERI------MCLHSKIKSQ----------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHSSCSSCCSSH------HHHHHHHHHC----------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHCCCCCCCccH------HHHHHHHhcc----------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 999999964321 1111110000 00001112345678999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=363.44 Aligned_cols=269 Identities=21% Similarity=0.308 Sum_probs=187.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.++||+|+||+||+|.+.. ++..||||++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 4689999999999999999997654 78999999986532 233567889999999999999999999985
Q ss_pred eC-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 149 ED-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 149 ~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
.. ...|+||||+ +++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCE
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCE
Confidence 43 5689999998 67999988754 35899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCc-------------------------cccccccccccccccccc-ccCCCCCchhHHHHHHHHH
Q 015909 224 KLSDFGLARDGPTGDKS-------------------------HVSTRVMGTYGYAAPEYL-ATGHLTAKSDIYSFGVVLL 277 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ 277 (398)
||+|||+++........ ......+||+.|+|||++ .+..++.++|||||||++|
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 99999999875432111 123346789999999976 5667999999999999999
Q ss_pred HHHh-----------CCCCCCCCCCCCCc-----------------chhhhhhhhhhcc-------------cccccccc
Q 015909 278 EILS-----------GRRAIDKNRPTGEH-----------------NLVEWAKPYLTSK-------------RRIFRVLD 316 (398)
Q Consensus 278 ell~-----------g~~p~~~~~~~~~~-----------------~~~~~~~~~~~~~-------------~~~~~~~~ 316 (398)
||++ |+++|.+....... +........+... ......+.
T Consensus 276 elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 355 (458)
T 3rp9_A 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355 (458)
T ss_dssp HHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSC
T ss_pred HHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcC
Confidence 9999 66666543211000 0000000000000 00000000
Q ss_pred cccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 317 PRLE---GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 317 ~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.... .......+.++.+||.+||..||++|||++|+++|
T Consensus 356 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00011236788999999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=345.08 Aligned_cols=271 Identities=25% Similarity=0.406 Sum_probs=204.0
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccce
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKL 143 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~ 143 (398)
++....++|++.+.||+|+||.||+|.+.. ...++..||+|.+..... ...+.+.+|+.+++.++||||+++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEEC------TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEec------cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence 334456789999999999999999997643 223567899999975432 334668899999999999999999
Q ss_pred eeEEEeCC-----ceEEEEeecCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 144 VGYCLEDD-----HRLLVYEFMPRGSMENHLFRRG--SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 144 ~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
++++...+ ..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIl 179 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCM 179 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEE
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEE
Confidence 99988755 3499999999999999986432 22356899999999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEH 295 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~ 295 (398)
++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 256 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--- 256 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---
Confidence 99999999999999987544333223334567889999999999999999999999999999999 89998653221
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.... ..... .....+...+.++.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus 257 ~~~~---~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 257 EMYD---YLLHG-----------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp GHHH---HHHTT-----------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH---HHHcC-----------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1110 00000 0111222345689999999999999999999999999998865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=359.36 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=208.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||.||+|.+ .+..||||.++... ..+.+.+|+.+|++++||||+++++++...
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-----------cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 46788899999999999999976 36689999997653 457889999999999999999999998776
Q ss_pred C-ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 D-HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
. ..++||||+++++|.+++...+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCT
T ss_pred CCceEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCC
Confidence 5 78999999999999999987653 34789999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+++..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||....... .... +..
T Consensus 335 ~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~- 401 (450)
T 1k9a_A 335 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEK- 401 (450)
T ss_dssp TCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHT-
T ss_pred Cccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHc-
Confidence 99854321 122357889999999999999999999999999999998 999997543221 1110 110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
......+..++.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 402 ---------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 402 ---------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 011122334567899999999999999999999999999988754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=340.25 Aligned_cols=272 Identities=24% Similarity=0.352 Sum_probs=218.2
Q ss_pred cCCCCCc-eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDS-VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|.+.+ .||+|+||.||+|.+.. ..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++ .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred HHhhhhhccccccCceeEEEeEecc-------CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4566666 89999999999997642 22578899999976432 3456788999999999999999999998 5
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECccc
Confidence 667899999999999999997543 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 230 LARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----i~~ 228 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQ 228 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHT
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----Hhc
Confidence 99875433221 11223456889999999998899999999999999999998 99999653321 11110 000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhccCCchhhh
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQKEH 373 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~~~~~~~ 373 (398)
. .....+...+.++.+++.+||+.||.+||++.+++++|+.+.........+++.+
T Consensus 229 ~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~ 284 (287)
T 1u59_A 229 G----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHH 284 (287)
T ss_dssp T----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCCT
T ss_pred C----------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCccc
Confidence 0 0112233456789999999999999999999999999999999888887776653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.99 Aligned_cols=267 Identities=23% Similarity=0.377 Sum_probs=191.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 4579999999999999999997654 789999999975432 334678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRG--SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+..++||||++ ++|.+++.... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECc
Confidence 999999999996 69999887543 22245899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..........
T Consensus 152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~ 226 (317)
T 2pmi_A 152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMG 226 (317)
T ss_dssp CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Confidence 999986533221 2234578999999999976 468999999999999999999999997543211 0000000000
Q ss_pred cc--------ccccccccccc------------cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SK--------RRIFRVLDPRL------------EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~--------~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ..+.. ..+.. ........+.++.+||.+||+.||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 227 TPNESLWPSVTKLPK-YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp SCCTTTCGGGGGCTT-CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCChhHhhhhhhhhh-cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 00000 00000 000111235689999999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=352.06 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=198.3
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEEE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~lv 156 (398)
.++||+|+||.||+|.+.. ++..||+|++........+.+.+|+.+|+.++||||+++++++...+..++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5689999999999997654 7899999999876656667889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE--cCCCCEEEeeccCCcCC
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL--DSNYNAKLSDFGLARDG 234 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv--~~~~~~kl~Dfg~a~~~ 234 (398)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.++|+|||++...
T Consensus 165 ~E~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EECCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999887643 35899999999999999999999998 9999999999999 56788999999999875
Q ss_pred CCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccccc
Q 015909 235 PTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314 (398)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (398)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............
T Consensus 240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~---- 306 (373)
T 2x4f_A 240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD---- 306 (373)
T ss_dssp CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC----
T ss_pred CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC----
Confidence 44322 23356999999999999999999999999999999999999999653211 111111111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 315 LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+ ........+.++.+||.+||+.||.+||++.+++++
T Consensus 307 ~----~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 307 L----EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp S----CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000011235689999999999999999999999984
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=351.37 Aligned_cols=274 Identities=25% Similarity=0.364 Sum_probs=216.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|.+... ........||+|.+..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGL----GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTC----SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCC----CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 356899999999999999999987541 1122446899999975432 3456788999999999 899999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGS----------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL 217 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv 217 (398)
...+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL 197 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEE
Confidence 999999999999999999999976431 1245899999999999999999999998 9999999999999
Q ss_pred cCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 015909 218 DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHN 296 (398)
Q Consensus 218 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~ 296 (398)
+.++.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--K 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--H
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--H
Confidence 9999999999999986543333223334567889999999999999999999999999999998 999997543211 1
Q ss_pred hhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
.... ... ......+...+..+.+++.+||+.||.+|||+.+++++|+.+....+.
T Consensus 276 ~~~~----~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 276 FYKL----VKD----------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp HHHH----HHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHH----Hhc----------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence 1110 000 001111222356889999999999999999999999999988765543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=361.11 Aligned_cols=258 Identities=23% Similarity=0.267 Sum_probs=207.1
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCccccee
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLV 144 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~ 144 (398)
....++|++.++||+|+||+||+|.+.. ++..||+|++.... ......+.+|+.+++.++||||++++
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 135 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3345789999999999999999997754 78999999986421 12334578999999999999999999
Q ss_pred eEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 145 GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
+++.+.+..|+||||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEE
Confidence 9999999999999999999999998753 3899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH----LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
|+|||+++...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..
T Consensus 209 L~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~ 281 (410)
T 3v8s_A 209 LADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GT 281 (410)
T ss_dssp ECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH
T ss_pred EeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hH
Confidence 99999998654322 11233568999999999997765 889999999999999999999999753211 11
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL--RPDMDEVVKEL 356 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~L 356 (398)
....+..... +..+.....+.++.+||.+||..+|.+ ||+++++++|-
T Consensus 282 ~~~i~~~~~~--------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 282 YSKIMNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HHHHHTHHHH--------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred HHHHHhcccc--------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 1111110000 000111124578999999999999988 99999999873
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=346.11 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=199.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 4579999999999999999997754 788999999975432 345678999999999999999999999865
Q ss_pred CC---------------------------------------------------------ceEEEEeecCCCCHHHHHhhc
Q 015909 150 DD---------------------------------------------------------HRLLVYEFMPRGSMENHLFRR 172 (398)
Q Consensus 150 ~~---------------------------------------------------------~~~lv~e~~~~~~L~~~~~~~ 172 (398)
.. ..++||||+++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 43 279999999999999999875
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCc----------cc
Q 015909 173 GSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKS----------HV 242 (398)
Q Consensus 173 ~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~----------~~ 242 (398)
.. ....++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......... ..
T Consensus 156 ~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 156 CS-LEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp CS-GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred cC-ccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence 43 234567788999999999999999998 999999999999999999999999999875443211 11
Q ss_pred ccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCC
Q 015909 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQ 322 (398)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (398)
.....||+.|+|||++.+..++.++||||||+++|+|++|..|+... ..... .. ....
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~----------~~----~~~~ 290 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIIT----------DV----RNLK 290 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHH----------HH----HTTC
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHH----------Hh----hccC
Confidence 23357999999999999999999999999999999999987765210 00000 00 0011
Q ss_pred CC---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 323 FS---LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 323 ~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+ ...+.++.+|+.+||+.||++|||+.+++++
T Consensus 291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 11 2335678899999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=369.02 Aligned_cols=259 Identities=26% Similarity=0.405 Sum_probs=213.8
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
...+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ...+.+.+|+.+|++++||||+++++++..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34678899999999999999998764 57899999997654 346789999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTT
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecc
Confidence 9999999999999999999986543 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||...... ..... +
T Consensus 364 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~--- 432 (495)
T 1opk_A 364 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----L--- 432 (495)
T ss_dssp CEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----H---
T ss_pred cceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----H---
Confidence 9987543221 12223456788999999999999999999999999999999 99999754211 11110 1
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
........+...+.++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 433 -------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 433 -------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -------HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111111223345678999999999999999999999999988763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=343.31 Aligned_cols=276 Identities=27% Similarity=0.387 Sum_probs=211.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+.. ....++..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhccCCCCceEEEEEEEcc-----ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3458899999999999999997542 233478999999997543 2345778999999999999999999999987
Q ss_pred C--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 150 D--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 150 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
. ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECC
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECc
Confidence 6 66899999999999999997654 45899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+...... ......+...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~ 245 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHG 245 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCG
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCccc
Confidence 9999876443321 2233456888999999999999999999999999999999999987432100 0000000000
Q ss_pred --ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 307 --SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 307 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
....+............+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000000111111122233445678999999999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=356.70 Aligned_cols=255 Identities=23% Similarity=0.290 Sum_probs=194.9
Q ss_pred hcCCCCC-ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHc-CCCCCcccceeeEEE
Q 015909 71 TRNFRPD-SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLG-QLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~~I~~~~~~~~ 148 (398)
.++|.+. ++||+|+||+||+|.+.. ++..||+|++... ..+.+|+.++. .++||||+++++++.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 3466666 789999999999997654 7899999998632 45678888874 458999999999987
Q ss_pred e----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC---CC
Q 015909 149 E----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NY 221 (398)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~---~~ 221 (398)
. ....++||||+++|+|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTC
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCc
Confidence 5 5678999999999999999986542 45899999999999999999999998 999999999999987 78
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc-hhhh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN-LVEW 300 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~-~~~~ 300 (398)
.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ....
T Consensus 202 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 278 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 278 (400)
T ss_dssp CEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH
T ss_pred cEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH
Confidence 99999999998653322 2334678999999999999999999999999999999999999997644322110 1000
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
. .... . ..........+.++.+||.+||+.||++|||+.+++++-.
T Consensus 279 i---~~~~------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 279 I---RMGQ------Y--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp H---HHTC------C--CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred H---HcCc------c--cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0 0000 0 0000111234578999999999999999999999998743
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=337.73 Aligned_cols=264 Identities=25% Similarity=0.376 Sum_probs=209.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|.+.. ...++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTN------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEC------TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcC------CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 4678999999999999999997653 22346679999997653 2345678899999999999999999998764
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccC
Confidence 56789999999999999998764 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ...... ...
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~----~~~ 230 (281)
T 3cc6_A 159 LSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVL----EKG 230 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHH----HHT
T ss_pred CCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHH----hcC
Confidence 99865433211 1233457889999999998999999999999999999998 99999643221 111100 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
.....+...+..+.+++.+||+.||++||++.+++++|+.+.+..+
T Consensus 231 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 231 ----------DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 0011122345679999999999999999999999999999987654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=334.67 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=206.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+ .+..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-----------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-----------CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 35789999999999999999976 367899999976532 33457899999999999999999999998
Q ss_pred eC--CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 149 ED--DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
.. ...++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++..|+||||||+||+++.++.++|+
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~ 155 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEE
Confidence 77 788999999999999999986542 35899999999999999999999987679999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCC---chhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTA---KSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
|||++..... ....||+.|+|||++.+..++. ++||||||+++|+|++|+.||...... .....
T Consensus 156 ~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~ 222 (271)
T 3kmu_A 156 MADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMK 222 (271)
T ss_dssp GGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHH
T ss_pred eccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHH
Confidence 9988754222 2346899999999998765554 799999999999999999999643211 00000
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
. .........+...+.++.+++.+||+.||++|||++++++.|+.+.
T Consensus 223 ~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 223 V----------ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp H----------HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred H----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0 0011111223345678999999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=336.95 Aligned_cols=253 Identities=28% Similarity=0.473 Sum_probs=195.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc----cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
.++|++.+.||+|+||.||+|.+ ++..||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 35789999999999999999975 467899999865422 235678899999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CceecCCCCCCEEEcC------
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEP-KVIYRDFKASNILLDS------ 219 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-~ivH~Dlkp~Nilv~~------ 219 (398)
+...+..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+++. +|+||||||+||+++.
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred EecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence 9999999999999999999998853 358999999999999999999999872 3889999999999985
Q ss_pred --CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 220 --NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 220 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
++.++|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~ 222 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---V 222 (271)
T ss_dssp CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---H
T ss_pred ccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 7789999999997643322 223568999999999999999999999999999999999999996532110 0
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.. ...........+...+..+.+++.+||+.||.+|||+.+++++|+++
T Consensus 223 ---~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 ---AY----------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HH----------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---HH----------hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00 00011111222334467899999999999999999999999999754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=363.03 Aligned_cols=262 Identities=21% Similarity=0.261 Sum_probs=208.4
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccc
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVK 142 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~ 142 (398)
++....++|++.++||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.++..++||||++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 138 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 334455789999999999999999997764 788999999864211 22344788999999999999999
Q ss_pred eeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
+++++.+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSC
T ss_pred EEEEEeeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCC
Confidence 9999999999999999999999999998643 45899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
+||+|||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 214 vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~----- 287 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----- 287 (437)
T ss_dssp EEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred EEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-----
Confidence 99999999976543322 2233468999999999997 467899999999999999999999999753211
Q ss_pred hhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 015909 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKL--RPDMDEVVKE 355 (398)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 355 (398)
......+..... ...+. .....+.++.+||.+||..+|++ ||+++++++|
T Consensus 288 -~~~~~i~~~~~~---~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 288 -ETYGKIMNHKER---FQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -HHHHHHHTHHHH---CCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -HHHHhhhhcccc---ccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111111110000 00000 01124568899999999998888 9999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=338.97 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=199.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcC--CCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQ--LHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||+||+|.+ ++..||+|++... ....+..|.+++.. ++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 357899999999999999999975 4788999998654 23445556666555 7999999999987
Q ss_pred EeC----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCceecCCCCCCE
Q 015909 148 LED----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH--------SAEPKVIYRDFKASNI 215 (398)
Q Consensus 148 ~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~ivH~Dlkp~Ni 215 (398)
... ...++||||+++++|.+++.. ..+++..++.++.||+.||.||| +++ |+||||||+||
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Ni 144 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNI 144 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGE
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhE
Confidence 553 457899999999999999954 35899999999999999999999 887 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcc--cccccccccccccccccccC------CCCCchhHHHHHHHHHHHHhC-----
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSH--VSTRVMGTYGYAAPEYLATG------HLTAKSDIYSFGVVLLEILSG----- 282 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g----- 282 (398)
|++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 145 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~ 224 (301)
T 3q4u_A 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224 (301)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcc
Confidence 99999999999999997543322211 12234799999999999876 455789999999999999999
Q ss_pred -----CCCCCCCCCCCCcchhhhhhhhhhccccccccccccc-cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 283 -----RRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRL-EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 283 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
..||......... .... ....... ...+.. ....+...+.++.+|+.+||+.||++|||+.++++.|
T Consensus 225 ~~~~~~~pf~~~~~~~~~-~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 225 IVEDYKPPFYDVVPNDPS-FEDM-RKVVCVD-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp BCCCCCCTTTTTSCSSCC-HHHH-HHHHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccccccccccCCCCcc-hhhh-hHHHhcc-----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 7777543322211 1111 1000000 000001 1112345678899999999999999999999999999
Q ss_pred HHH
Q 015909 357 EQL 359 (398)
Q Consensus 357 ~~l 359 (398)
+++
T Consensus 298 ~~i 300 (301)
T 3q4u_A 298 TKI 300 (301)
T ss_dssp HHH
T ss_pred hcc
Confidence 876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=337.92 Aligned_cols=261 Identities=26% Similarity=0.448 Sum_probs=195.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||+||+|.+. ..||+|++..... ...+.+.+|+.+++.++||||++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 3567999999999999999999653 3599999875432 3346788999999999999999999954
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~D 163 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGD 163 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECC
T ss_pred -cCCccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEcc
Confidence 5667899999999999999996554 45899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
||++................||+.|+|||++. +..++.++||||||+++|+|++|+.||....... .... .
T Consensus 164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~ 237 (289)
T 3og7_A 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----M 237 (289)
T ss_dssp CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----H
T ss_pred ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----H
Confidence 99998654433333344567999999999986 5678889999999999999999999996532211 1111 0
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.... ...+ .........+..+.+|+.+||+.||.+|||+.++++.|+++.
T Consensus 238 ~~~~-----~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 238 VGRG-----SLSP-DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHT-----SCCC-CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hccc-----ccCc-chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1000 0000 011122344578999999999999999999999999998763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=349.17 Aligned_cols=278 Identities=27% Similarity=0.376 Sum_probs=215.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEE--
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCL-- 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~-- 148 (398)
.++|++.+.||+|+||.||+|.+.. ....++..||+|.+........+.+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 3679999999999999999997532 234478999999998765555677899999999999999999999887
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccc
Confidence 4566899999999999999998754 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcc-cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh--hhhh
Q 015909 229 GLARDGPTGDKSH-VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA--KPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~~ 305 (398)
|++.......... ......||..|+|||++.+..++.++||||||+++|+|++|..||...... ..... ....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~ 247 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDV 247 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----C
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhccccccc
Confidence 9998754433221 223356888899999999999999999999999999999999998642110 00000 0000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.....+............+...+..+.+|+.+||+.||++|||+.+++++|+.+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp CHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred ccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 000001111111122233445567899999999999999999999999999877543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=352.69 Aligned_cols=271 Identities=21% Similarity=0.265 Sum_probs=206.1
Q ss_pred HhcCCCCCceeccc--CCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceee
Q 015909 70 ATRNFRPDSVLGEG--GFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 70 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
..++|++.++||+| +||+||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 93 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeE
Confidence 35679999999999 999999997754 789999999975432 23456788999999999999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
++...+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl 169 (389)
T 3gni_B 94 TFIADNELWVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYL 169 (389)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEE
T ss_pred EEEECCEEEEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999999999987532 45899999999999999999999999 999999999999999999999
Q ss_pred eeccCCcCCCCCCC-----ccccccccccccccccccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh
Q 015909 226 SDFGLARDGPTGDK-----SHVSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~ 298 (398)
+|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ..
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~ 247 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LL 247 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HH
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HH
Confidence 99998764322111 111223478999999999987 6799999999999999999999999976433211 00
Q ss_pred hhhhhhhh---cc-----c-------------cccccc---------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 015909 299 EWAKPYLT---SK-----R-------------RIFRVL---------DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD 348 (398)
Q Consensus 299 ~~~~~~~~---~~-----~-------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 348 (398)
........ .. . .+.... ........+...+.++.+||.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 327 (389)
T 3gni_B 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327 (389)
T ss_dssp HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence 00000000 00 0 000000 000001122334677999999999999999999
Q ss_pred HHHHHHH
Q 015909 349 MDEVVKE 355 (398)
Q Consensus 349 ~~ell~~ 355 (398)
+.+++++
T Consensus 328 a~ell~h 334 (389)
T 3gni_B 328 ASTLLNH 334 (389)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999976
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=349.01 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=198.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCC--Ccccceee
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHH--PNLVKLVG 145 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~~I~~~~~ 145 (398)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.+|+.++| +||+++++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 76 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence 3567999999999999999999653 478899999875432 234678899999999976 99999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
++...+..++|||+ .+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||
T Consensus 77 ~~~~~~~~~lv~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 77 YEITDQYIYMVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp EEECSSEEEEEECC-CSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEE
T ss_pred eEeeCCEEEEEEeC-CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEE
Confidence 99999999999995 5889999998753 5899999999999999999999998 99999999999997 578999
Q ss_pred eeccCCcCCCCCCCccccccccccccccccccccc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----------GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE 294 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~ 294 (398)
+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-- 226 (343)
T 3dbq_A 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-- 226 (343)
T ss_dssp CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--
T ss_pred eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--
Confidence 99999987654443333445679999999999865 67889999999999999999999999642110
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
... +.....+.....++...+.++.+|+.+||+.||.+|||+.+++++-.
T Consensus 227 ---~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 227 ---ISK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp ---HHH----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ---HHH----------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 000 11111111222233333567899999999999999999999998743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=340.82 Aligned_cols=269 Identities=24% Similarity=0.350 Sum_probs=212.6
Q ss_pred hcCCCCCc-eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDS-VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+ .||+|+||.||+|.+.. ..++..||+|++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecC-------CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45788888 99999999999996532 225789999999754322 256789999999999999999999998
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
..+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECC
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEcc
Confidence 6678899999999999999998753 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcc-cccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhh
Q 015909 228 FGLARDGPTGDKSH-VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 228 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ..... .
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~ 233 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----L 233 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----H
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----H
Confidence 99998754433221 1222346788999999998889999999999999999999 99999753211 11100 0
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhccCCch
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQ 370 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~~~~ 370 (398)
.. ......+...+..+.+++.+||+.||.+||++.++++.|+.+.......++++
T Consensus 234 ~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 288 (291)
T 1xbb_A 234 EK----------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHH 288 (291)
T ss_dssp HT----------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHHC-
T ss_pred Hc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccccc
Confidence 00 00112233446789999999999999999999999999999988776665544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=344.45 Aligned_cols=264 Identities=26% Similarity=0.348 Sum_probs=206.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe-
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE- 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~- 149 (398)
.++|++.+.||+|+||.||+|.... ++..||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 4679999999999999999997654 689999999876555556778999999999999999999999873
Q ss_pred ---CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 150 ---DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 150 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
....++||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEEC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEE
Confidence 34778999999999999999875444467999999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcc-------cccccccccccccccccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 015909 227 DFGLARDGPTGDKSH-------VSTRVMGTYGYAAPEYLATGH---LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~ 296 (398)
|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ .
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~ 255 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-S 255 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-C
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-h
Confidence 999987543211110 012245799999999997654 68899999999999999999999953110000 0
Q ss_pred hhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
... ... ...........+.++.++|.+||+.||.+||++.+++++|+.++
T Consensus 256 ~~~----~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 256 VAL----AVQ----------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHH----HHH----------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhH----Hhh----------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000 000 00111112234568999999999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=343.61 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=198.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc----cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
.++|++.+.||+|+||.||+|+... ...++..||+|++..... .....+.+|+.+|+.++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVT------GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECS------STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEec------cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 3579999999999999999997632 224789999999976432 234557889999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+...+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEEC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEE
Confidence 999999999999999999999998764 4889999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 164 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~ 235 (327)
T 3a62_A 164 DFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK 235 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH
T ss_pred eCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh
Confidence 999987543221 1233467999999999999999999999999999999999999999653211 11111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
. ...++...+.++.+||.+||+.||.+|| ++.++++|
T Consensus 236 ~------------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 236 C------------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp T------------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C------------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 0112233467899999999999999999 78888875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=342.89 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=205.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.+..... .....+..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4678999999999999999998754110 00012357999999776556677899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC--------
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN-------- 222 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~-------- 222 (398)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999998754 34899999999999999999999999 999999999999988877
Q ss_pred EEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
++|+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+...... ....
T Consensus 160 ~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~ 228 (289)
T 4fvq_A 160 IKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKL 228 (289)
T ss_dssp EEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHH
T ss_pred eeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHH
Confidence 99999999865422 223458899999999987 77899999999999999999955444321110 0000
Q ss_pred hhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
...... ...+...+.++.+++.+||+.||.+|||+.+++++|+.+..-
T Consensus 229 -~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 229 -QFYEDR------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp -HHHHTT------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred -HHhhcc------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 000000 011112244688999999999999999999999999877553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=346.66 Aligned_cols=269 Identities=24% Similarity=0.383 Sum_probs=213.3
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
....++|++.+.||+|+||.||+|.+.. .....++..||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEE----EETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecC----ccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3456789999999999999999997652 11223578899999975432 334568899999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRG------SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
+...+..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence 999999999999999999999997532 11245789999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhh
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~ 299 (398)
+.++|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...... .
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~--- 248 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---Q--- 248 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---H---
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---H---
Confidence 9999999999976433322222334467889999999999999999999999999999999 89998653211 1
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
....... . .....+...+..+.+++.+||+.||.+|||+.+++++|+++
T Consensus 249 ~~~~~~~-~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 249 VLRFVME-G----------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHHHHT-T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHc-C----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 1110000 0 00112233457789999999999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=342.97 Aligned_cols=265 Identities=25% Similarity=0.421 Sum_probs=205.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+|++.+.||+|+||.||+|.+... ....+..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecC-----CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 45788889999999999999987531 112356799999975432 334568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999999999998653 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 230 LARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
++......... .......+|..|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .. +..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~---~~-~~~ 265 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVM---KA-IND 265 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HH-HHT
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHH---HH-HHC
Confidence 99875433211 11222346788999999999999999999999999999999 99999643211 111 00 000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
......+...+..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 266 ----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 266 ----------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001112234467899999999999999999999999999988653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.47 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=210.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 357889999999999999999764 367899999976543 346789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccc
Confidence 99999999999999999998654 45899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+....... ........++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ........ .
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~-~- 221 (267)
T 3t9t_A 151 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDIST-G- 221 (267)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHT-T-
T ss_pred cccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhc-C-
Confidence 87643211 111223456788999999998999999999999999999999 89999653211 11110000 0
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.....+...+..+.+++.+||+.||++||++.+++++|+++.+
T Consensus 222 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 222 ---------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111122345678999999999999999999999999998875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=349.14 Aligned_cols=280 Identities=17% Similarity=0.201 Sum_probs=211.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-----------chHHHHHHHHHHcCCCCCc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-----------GHKEWLTEINYLGQLHHPN 139 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~ 139 (398)
.++|++.+.||+|+||.||+|.+... .....+..||+|++...... ....+..|+..++.++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 45799999999999999999987642 12234688999998654321 1123455777888899999
Q ss_pred ccceeeEEEeC----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 140 LVKLVGYCLED----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 140 I~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
|+++++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Ni 183 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNL 183 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHE
Confidence 99999998775 4579999999 999999998753 46899999999999999999999998 99999999999
Q ss_pred EEc--CCCCEEEeeccCCcCCCCCCCcc-----cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015909 216 LLD--SNYNAKLSDFGLARDGPTGDKSH-----VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDK 288 (398)
Q Consensus 216 lv~--~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~ 288 (398)
|++ .++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998 88999999999997653322111 11235699999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhccC
Q 015909 289 NRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHK 367 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 367 (398)
.... ........... ...+...++..+. ....+.++.+++..||+.||.+||++.+|++.|+.+.+......
T Consensus 264 ~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 264 NLKD--PKYVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp GTTC--HHHHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred cccC--HHHHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 3221 11111111100 0111112211111 01235678999999999999999999999999998877655443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=347.16 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=191.8
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.+.||+|+||+||+|.+.. ++..||+|++.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 45789999999999999999997754 68899999997542 34567889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC---CCCEEEe
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAKLS 226 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~---~~~~kl~ 226 (398)
.+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.++|+
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~ 193 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIA 193 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEc
Confidence 999999999999999999997653 4899999999999999999999998 999999999999975 8899999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........
T Consensus 194 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~ 265 (349)
T 2w4o_A 194 DFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILN 265 (349)
T ss_dssp CCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHT
T ss_pred cCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHh
Confidence 999998653321 2234579999999999999999999999999999999999999996532110 00111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ..........+.++.+||.+||+.||++|||+.+++++
T Consensus 266 ~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 266 CEY--------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TCC--------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC--------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00111122345788999999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=338.24 Aligned_cols=274 Identities=23% Similarity=0.358 Sum_probs=206.4
Q ss_pred CHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC--CCCcc
Q 015909 63 SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL--HHPNL 140 (398)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~~I 140 (398)
.........++|++.+.||+|+||.||+|.+ ++..||+|++... ....+..|.+++..+ +||||
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i 93 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-----------RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENI 93 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTB
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEE-----------CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCe
Confidence 3444455668899999999999999999975 3788999998543 224445566666654 89999
Q ss_pred cceeeEEEeC----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------CCCceec
Q 015909 141 VKLVGYCLED----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA--------EPKVIYR 208 (398)
Q Consensus 141 ~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~~ivH~ 208 (398)
+++++++... ...++||||+++++|.+++... .+++..++.++.|++.||.|||++ + |+||
T Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~ 166 (337)
T 3mdy_A 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHR 166 (337)
T ss_dssp CCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECS
T ss_pred eeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEec
Confidence 9999999887 6789999999999999999754 489999999999999999999998 7 9999
Q ss_pred CCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcc--cccccccccccccccccccCCCCCc------hhHHHHHHHHHHHH
Q 015909 209 DFKASNILLDSNYNAKLSDFGLARDGPTGDKSH--VSTRVMGTYGYAAPEYLATGHLTAK------SDIYSFGVVLLEIL 280 (398)
Q Consensus 209 Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~~l~ell 280 (398)
||||+|||++.++.+||+|||++.......... ......||+.|+|||++.+..+... +|||||||++|||+
T Consensus 167 Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 246 (337)
T 3mdy_A 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246 (337)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH
Confidence 999999999999999999999997654332211 1224579999999999987766665 99999999999999
Q ss_pred hC----------CCCCCCCCCCCCcchhhhhhhhhhccccccccccccccC-CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 015909 281 SG----------RRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEG-QFSLPQAQKAASLALQCLSVEPKLRPDM 349 (398)
Q Consensus 281 ~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~ 349 (398)
+| ..||......... ... ...... .....+.... ......+.++.+|+.+||+.||.+|||+
T Consensus 247 tg~~~~~~~~~~~~p~~~~~~~~~~-~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 247 RRCVSGGIVEEYQLPYHDLVPSDPS-YED-MREIVC-----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCC-HHH-HHHHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred hccCcccccccccccHhhhcCCCCc-hhh-hHHHHh-----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence 99 5555432221110 000 000000 0011111111 1123677889999999999999999999
Q ss_pred HHHHHHHHHHHHHhh
Q 015909 350 DEVVKELEQLQELRN 364 (398)
Q Consensus 350 ~ell~~L~~l~~~~~ 364 (398)
.+++++|+.+.+...
T Consensus 320 ~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 320 LRVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHhhcc
Confidence 999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=360.63 Aligned_cols=250 Identities=29% Similarity=0.379 Sum_probs=198.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC---CccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE---GFQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.++||+|+||.||+|.+.. ++..||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 4679999999999999999997654 7899999998753 223345678899999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++ |+||||||+||||+.++.+||+
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEEC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999998764 58999999999999999999998 88 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .........
T Consensus 292 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~ 363 (446)
T 4ejn_A 292 DFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILM 363 (446)
T ss_dssp CCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH
T ss_pred cCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHh
Confidence 999997643222 223446899999999999999999999999999999999999999965321 111111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
. ...++...+.++.+||.+||+.||.+|| +++++++|
T Consensus 364 ~------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 364 E------------EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C------------CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 0112333457899999999999999999 99999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=338.44 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=198.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||+||+|.+. ++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 47899999999999999999762 578999999865432 234678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++ +|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 145 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFG 145 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCeEEEEEEecCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECc
Confidence 9999999999964 9999887653 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... .+..... .....
T Consensus 146 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~-~~~~~ 220 (288)
T 1ob3_A 146 LARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFR-ILGTP 220 (288)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHCCC
T ss_pred cccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HHCCC
Confidence 987543221 11233568999999999976 458999999999999999999999997532111 0000000 00000
Q ss_pred --c---ccc--ccccccc-------cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 --R---RIF--RVLDPRL-------EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 --~---~~~--~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ... ...++.. ........+.++.+||.+||+.||++|||+.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000 0000000 001112345788999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=346.52 Aligned_cols=210 Identities=25% Similarity=0.306 Sum_probs=181.6
Q ss_pred CCCCHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC---
Q 015909 60 KNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH--- 136 (398)
Q Consensus 60 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--- 136 (398)
..+++.+.....++|++.+.||+|+||+||+|.+.. ++..||+|++.... .....+..|+.+++.+.
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~ 92 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDD 92 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCS
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccC
Confidence 345566666677899999999999999999997754 68899999997432 33455678999999886
Q ss_pred --CCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCC
Q 015909 137 --HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASN 214 (398)
Q Consensus 137 --h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~N 214 (398)
||||+++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~N 167 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPEN 167 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCccc
Confidence 999999999999999999999999 8999999987653 45899999999999999999999999 9999999999
Q ss_pred EEEcC-------------------------CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhH
Q 015909 215 ILLDS-------------------------NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDI 269 (398)
Q Consensus 215 ilv~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 269 (398)
||++. ++.++|+|||++...... .....||+.|+|||++.+..++.++||
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di 242 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDM 242 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccch
Confidence 99975 789999999999864332 234578999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q 015909 270 YSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 270 wslG~~l~ell~g~~p~~~~ 289 (398)
|||||++|+|++|+.||...
T Consensus 243 wslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 243 WSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=333.89 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=207.3
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35679999999999999999997654 688999999977656667889999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE---cCCCCEEEe
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLS 226 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv---~~~~~~kl~ 226 (398)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.++|+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~ 151 (277)
T 3f3z_A 78 NTDIYLVMELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLI 151 (277)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEE
Confidence 999999999999999999988764 4899999999999999999999999 9999999999999 788999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...... . .......
T Consensus 152 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~~ 221 (277)
T 3f3z_A 152 DFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---E---VMLKIRE 221 (277)
T ss_dssp CCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHH
T ss_pred ecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---H---HHHHHHh
Confidence 999997654332 23345799999999998654 899999999999999999999999653211 0 0000000
Q ss_pred ccccccccccccccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSL----PQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ....+. ..+..+.+++.+||+.||.+||++.+++++
T Consensus 222 ~------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 222 G------------TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp C------------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred C------------CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001111 235688999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.25 Aligned_cols=277 Identities=29% Similarity=0.417 Sum_probs=212.5
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC--
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED-- 150 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~-- 150 (398)
|++.+.||+|+||+||+|.+.. ....++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 4889999999999999987643 4445789999999976532 3356688999999999999999999999874
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
...++||||+++++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ceEEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccc
Confidence 5789999999999999999764 3899999999999999999999999 99999999999999999999999999
Q ss_pred CcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+......... .......||..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.... ....
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~-~~~~ 258 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQ-MTVL 258 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHH-HHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccc-hhHH
Confidence 9876543322 12234567889999999999999999999999999999999999986421000 0000000000 0000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
.+............+...+.++.+||.+||+.||++|||+.++++.|+.+.+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 0111111112223334456789999999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=340.53 Aligned_cols=262 Identities=24% Similarity=0.279 Sum_probs=200.5
Q ss_pred hcCCCCC-ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPD-SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++. ++||+|+||+||+|.+.. ++..||+|++..........+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3568874 789999999999997644 7889999999766555677889999999885 7999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC---EEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN---AKL 225 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~---~kl 225 (398)
+.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++. ++|
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl 155 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKI 155 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEE
Confidence 9999999999999999999998764 4899999999999999999999998 999999999999987765 999
Q ss_pred eeccCCcCCCCCCC-----ccccccccccccccccccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 015909 226 SDFGLARDGPTGDK-----SHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~ 295 (398)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999876432211 111223569999999999975 56889999999999999999999999764432210
Q ss_pred chh-hh----hhhhhhccccccccccccccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 296 NLV-EW----AKPYLTSKRRIFRVLDPRLEGQFSL----PQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 296 ~~~-~~----~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... .. ...... .+... ...++. ..+.++.+||.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~------~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 236 WDRGEACPACQNMLFE------SIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp C----CCHHHHHHHHH------HHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccchhHHHHHHH------HHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000 00 000000 00000 001111 135678999999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=335.91 Aligned_cols=255 Identities=27% Similarity=0.353 Sum_probs=200.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.... ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 4579999999999999999997654 68899999987543 2346788999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE---cCCCCEEEe
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLS 226 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv---~~~~~~kl~ 226 (398)
.+..++||||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+||++ +.++.++|+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEE
Confidence 99999999999999999998754333356899999999999999999999998 9999999999999 456889999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||...... ........
T Consensus 170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~ 239 (285)
T 3is5_A 170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATY 239 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH
T ss_pred eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhcc
Confidence 999997654322 233457899999999985 56889999999999999999999999753211 00000000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. .... ......+.++.+|+.+||+.||++|||+.+++++
T Consensus 240 ~~--------~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 240 KE--------PNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CC--------CCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CC--------cccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000 0001135678899999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=342.24 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=195.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc---hHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++....... ...+.+|+.+++.++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 4689999999999999999997654 78999999997653332 35678999999999999999999998
Q ss_pred EeCCce----EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 148 LEDDHR----LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 148 ~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
...... ++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCE
Confidence 776544 99999999999999998764 4899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~ 229 (311)
T 3ork_A 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAY 229 (311)
T ss_dssp EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH
T ss_pred EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHH
Confidence 99999999865433221 1223457899999999999999999999999999999999999999653211 0000
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........ + ........+.++.++|.+||+.||++||+..+++.+
T Consensus 230 ~~~~~~~~------~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 230 QHVREDPI------P--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HHHHCCCC------C--HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHhcCCCC------C--cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 00000000 0 000011235678999999999999999977766654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=351.55 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=197.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCC--CCcccceeeE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLH--HPNLVKLVGY 146 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~~I~~~~~~ 146 (398)
.++|++.+.||+|+||+||+|.+. ++..||+|++..... ...+.+.+|+.+|+.+. ||||++++++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 356999999999999999998643 378899999865432 33467889999999996 5999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+...+..++||| +.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+
T Consensus 125 ~~~~~~~~lv~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 125 EITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp EECSSEEEEEEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEEC
T ss_pred EecCCEEEEEEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEE
Confidence 999999999999 55889999998764 5888999999999999999999998 99999999999995 5899999
Q ss_pred eccCCcCCCCCCCccccccccccccccccccccc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----------GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~ 295 (398)
|||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--- 273 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 273 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---
Confidence 9999987654433333345679999999999865 46888999999999999999999999643211
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
..... .+........++...+.++.+||.+||+.||.+||++.+++++-
T Consensus 274 --~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 274 --ISKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp --HHHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --HHHHH----------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 00111 11111111122222356789999999999999999999999873
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=356.48 Aligned_cols=261 Identities=21% Similarity=0.255 Sum_probs=206.7
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccc
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVK 142 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~ 142 (398)
+.....++|++.++||+|+||+||+|+... ++..||+|++..... ...+.+.+|..++..++||||++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 125 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence 334445789999999999999999997754 789999999965321 22345788999999999999999
Q ss_pred eeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 143 LVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
+++++.+.+..|+||||+++|+|.+++.+.+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+++
T Consensus 126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSC
T ss_pred EEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCC
Confidence 9999999999999999999999999998764 35899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccc-------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-------TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~ 295 (398)
+||+|||+++....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--- 276 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--- 276 (412)
T ss_dssp EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---
T ss_pred EEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---
Confidence 99999999987543222 1223468999999999997 357899999999999999999999999653211
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR---PDMDEVVKE 355 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~ell~~ 355 (398)
............ ...+ ......+.++.+||.+||. +|.+| |+++++++|
T Consensus 277 ---~~~~~i~~~~~~---~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 277 ---ETYGKIVHYKEH---LSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---HHHHHHHTHHHH---CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---HHHHHHHhcccC---cCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111111110000 0000 0112345789999999999 99998 589999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=349.08 Aligned_cols=274 Identities=23% Similarity=0.303 Sum_probs=214.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.++||+|+||+||+|.+.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 4679999999999999999997764 78999999997543 2345678899999999999999999999987
Q ss_pred CC--ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE----cCCCCE
Q 015909 150 DD--HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL----DSNYNA 223 (398)
Q Consensus 150 ~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv----~~~~~~ 223 (398)
.+ ..++||||+++++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeE
Confidence 65 679999999999999999765421 33899999999999999999999999 9999999999999 777889
Q ss_pred EEeeccCCcCCCCCCCccccccccccccccccccccc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT--------GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~ 295 (398)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 999999998654322 2234579999999999865 56788999999999999999999999754332211
Q ss_pred chhhhhhhhhhcc-cc----ccccc--------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 296 NLVEWAKPYLTSK-RR----IFRVL--------DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 296 ~~~~~~~~~~~~~-~~----~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.. ......... .. +.... ........+...+..+.+++.+||+.||++||++.++++.++.+.+
T Consensus 233 ~~--~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 233 KE--VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HH--HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HH--HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11 111111100 00 00000 0111224457788899999999999999999999999999988754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=355.67 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=195.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC--CccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE--GFQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 4789999999999999999997654 7899999999754 2233567889999999999999999999997
Q ss_pred eCC------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 EDD------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
... ..|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~ 202 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 202 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSC
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCC
Confidence 553 56999999965 56666642 3889999999999999999999999 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh----
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV---- 298 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~---- 298 (398)
+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.......+
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~l 279 (464)
T 3ttj_A 203 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279 (464)
T ss_dssp EEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999998654322 234468999999999999999999999999999999999999999764321100000
Q ss_pred ------------hhhhhhhhcccc-----ccccccccccC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 299 ------------EWAKPYLTSKRR-----IFRVLDPRLEG---QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 299 ------------~~~~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.....+...... +...+...+.. ......+.++.+||.+||..||++|||++|+++|
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 00000000000 0011226789999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=342.69 Aligned_cols=261 Identities=30% Similarity=0.459 Sum_probs=207.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcE--EEEEEcccC-CccchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGML--IAVKRLNQE-GFQGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
++|++.+.||+|+||.||+|.+.. ++.. +++|.+... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 578999999999999999997754 4554 489988643 223456788999999999 899999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRG------------SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
...+..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI 173 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 173 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceE
Confidence 99999999999999999999998653 22346899999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGE 294 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~ 294 (398)
+++.++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-- 248 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-- 248 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred EEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--
Confidence 99999999999999987432211 1223456889999999998899999999999999999998 99999653211
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
..... + ........+...+.++.+|+.+||+.||.+|||+.+++++|+.+.+..
T Consensus 249 ----~~~~~-~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 249 ----ELYEK-L----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ----HHHHH-G----------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ----HHHHH-h----------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 00000 0 000111223344578999999999999999999999999999887654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=362.46 Aligned_cols=255 Identities=29% Similarity=0.426 Sum_probs=210.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... ......+.+|+.+|+.++||||+++++++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 4679999999999999999997654 78999999986532 23446678999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+..++||||+++|+|.+++...+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEe
Confidence 999999999999999999999986543 45899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........
T Consensus 330 FGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~i~~- 403 (576)
T 2acx_A 330 LGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERLVKE- 403 (576)
T ss_dssp CTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHHHHH-
T ss_pred cccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHHhhc-
Confidence 99998754332 2234589999999999999999999999999999999999999997643321111 11110000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
....++...+.++.+||.+||+.||.+|| +++++++|
T Consensus 404 -----------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 -----------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01122334567899999999999999999 78888876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=343.69 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=204.0
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--------chHHHHHHHHHHcCCCCCccc
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--------GHKEWLTEINYLGQLHHPNLV 141 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~I~ 141 (398)
..++|++.+.||+|+||+||+|.+.. ++..||+|.+...... ....+.+|+.+++.++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 45789999999999999999997654 7899999999754321 234567899999999999999
Q ss_pred ceeeEEEeCCceEEEEeecCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 142 KLVGYCLEDDHRLLVYEFMPRG-SMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
++++++.+.+..++||||+.+| +|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED 166 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC
Confidence 9999999999999999998766 9999987653 5899999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
+.++|+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 167 ~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------- 236 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------- 236 (335)
T ss_dssp SCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------
T ss_pred CcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------
Confidence 9999999999987544322 234579999999999988777 78899999999999999999999642110
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ..+...+.++.+||.+||+.||++|||+.+++++
T Consensus 237 -----------~~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----------VEAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----------TTTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----------Hhhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 1111245678999999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=344.16 Aligned_cols=269 Identities=25% Similarity=0.335 Sum_probs=196.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~ 149 (398)
..+|++.++||+|+||.||+|.+.. ++..||+|.+..........+.+|+.+++.+. ||||+++++++..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 4579999999999999999997654 78899999986655555677889999999996 9999999999853
Q ss_pred --------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 150 --------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 150 --------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
....++||||+. |+|.+++..... ...+++..++.++.||+.||.|||+++.+|+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence 344789999995 799998875322 1458999999999999999999999866699999999999999999
Q ss_pred CEEEeeccCCcCCCCCCCcc----------ccccccccccccccccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015909 222 NAKLSDFGLARDGPTGDKSH----------VSTRVMGTYGYAAPEYL---ATGHLTAKSDIYSFGVVLLEILSGRRAIDK 288 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~ell~g~~p~~~ 288 (398)
.++|+|||++.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998754432211 11134689999999998 567789999999999999999999999965
Q ss_pred CCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhccCC
Q 015909 289 NRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKR 368 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~~ 368 (398)
...... .............+..+.+|+.+||+.||.+|||+.+++++|+.+.........
T Consensus 256 ~~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~ 315 (337)
T 3ll6_A 256 GAKLRI--------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315 (337)
T ss_dssp ------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred hhHHHh--------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence 322110 000000111112234578999999999999999999999999999877665554
Q ss_pred ch
Q 015909 369 PQ 370 (398)
Q Consensus 369 ~~ 370 (398)
..
T Consensus 316 ~~ 317 (337)
T 3ll6_A 316 SP 317 (337)
T ss_dssp SC
T ss_pred cc
Confidence 43
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=346.55 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=203.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
..++|++.+.||+|+||+||+|.+.. ++..||+|++...... ..+|++++.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 45679999999999999999997654 7899999999765322 34688888887 7999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC----CCEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN----YNAK 224 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~----~~~k 224 (398)
+.+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||+... +.+|
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~k 160 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIR 160 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEE
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEE
Confidence 9999999999999999999997653 5899999999999999999999999 9999999999998533 3599
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|+|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+ ....
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~i 235 (342)
T 2qr7_A 161 ICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARI 235 (342)
T ss_dssp ECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHHH
T ss_pred EEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHHH
Confidence 999999986543221 23346789999999999888899999999999999999999999975322111111 1111
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.... ...........+.++.+||.+||..||++||++.+++++-.
T Consensus 236 ~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 236 GSGK--------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp HHCC--------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ccCC--------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 1100 01111122345678999999999999999999999998743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=349.72 Aligned_cols=245 Identities=28% Similarity=0.363 Sum_probs=194.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHH-HcCCCCCcccceeeE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINY-LGQLHHPNLVKLVGY 146 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~~I~~~~~~ 146 (398)
.++|++.++||+|+||+||+|++.. ++..||+|++..... .....+..|..+ ++.++||||++++++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 3579999999999999999997654 789999999976433 223455667776 577899999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+.+.+..|+||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 108 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~ 181 (373)
T 2r5t_A 108 FQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLT 181 (373)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEe
Confidence 999999999999999999999998764 4889999999999999999999999 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... .........
T Consensus 182 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~ 253 (373)
T 2r5t_A 182 DFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN 253 (373)
T ss_dssp CCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHH
T ss_pred eCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh
Confidence 999997532221 123456899999999999999999999999999999999999999964321 111111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD 350 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 350 (398)
. . ..++...+.++.+||.+||+.||.+||++.
T Consensus 254 ~----------~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 254 K----------P--LQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp S----------C--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred c----------c--cCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1 0 112223456889999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=356.97 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=205.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|.+.+.||+|+||.||+|.+.. +|..||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 579999999999999999997654 78999999996532 233567889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEec
Confidence 999999999999999999998764 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .........
T Consensus 161 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~ 231 (476)
T 2y94_A 161 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKICDG 231 (476)
T ss_dssp SSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHHHTT
T ss_pred cchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcC
Confidence 9998754432 2334679999999999988766 67899999999999999999999753211 111111100
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ...+...+.++.+||.+||+.||.+|||+.+++++
T Consensus 232 ----------~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 232 ----------I--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----------C--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----------C--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 01122335678999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=334.41 Aligned_cols=269 Identities=19% Similarity=0.233 Sum_probs=207.9
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEE-
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYC- 147 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~- 147 (398)
...++|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+.+|+.+++.++|++++..+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec
Confidence 345789999999999999999997654 788999998755422 24577899999999988877766655
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE---cCCCCEE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL---DSNYNAK 224 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv---~~~~~~k 224 (398)
...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.++
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 75 AEGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEE
T ss_pred CCCCceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEE
Confidence 5677789999999 999999998654 45899999999999999999999999 9999999999999 7889999
Q ss_pred EeeccCCcCCCCCCCc-----ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 225 LSDFGLARDGPTGDKS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence 9999999865443221 12234679999999999999999999999999999999999999998654433322221
Q ss_pred hhh-hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 300 WAK-PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 300 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
... ...... ..... ...+.++.+++.+||+.||++|||++++++.|+++.+....
T Consensus 229 ~~~~~~~~~~-------~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 229 RISEKKMSTP-------IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHSC-------HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhcccccch-------hhhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 111 000000 00000 11246789999999999999999999999999998776554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=340.00 Aligned_cols=279 Identities=23% Similarity=0.358 Sum_probs=214.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||.||+|.+.. ....++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 4578999999999999999997532 23347899999999876555567889999999999999999999988764
Q ss_pred C--ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 151 D--HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 151 ~--~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+ ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecC
Confidence 4 7899999999999999998764 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcc-cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh---
Q 015909 229 GLARDGPTGDKSH-VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY--- 304 (398)
Q Consensus 229 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--- 304 (398)
|++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||..... .+.......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~ 265 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQG 265 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCT
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccch
Confidence 9998754433211 12234567889999999988899999999999999999999999853200 000000000
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
......+...+........+...+.++.++|.+||+.||++|||+.++++.|+.+++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000000111111111223345678999999999999999999999999999997653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=344.31 Aligned_cols=270 Identities=26% Similarity=0.371 Sum_probs=207.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+... ....++..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 46799999999999999999975421 123468899999996442 2334568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC---CCCE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSY---FQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNA 223 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~---~~~~ 223 (398)
....++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999876432 134889999999999999999999998 999999999999984 4569
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~-- 257 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF-- 257 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH--
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHH--
Confidence 9999999875433222222334567899999999999999999999999999999998 99999653211 11110
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
.... .....+...+..+.+++.+||+.||.+||++.+++++|+.+....
T Consensus 258 --~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 258 --VTSG----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp --HHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred --HhcC----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 0000 011122234568899999999999999999999999999886544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=337.00 Aligned_cols=266 Identities=24% Similarity=0.327 Sum_probs=200.3
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-----cchHHHHHHHHHHcCCC---CCccc
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-----QGHKEWLTEINYLGQLH---HPNLV 141 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~~I~ 141 (398)
..++|++.+.||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.+++.++ ||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 45789999999999999999997544 789999999864321 22345677888777764 99999
Q ss_pred ceeeEEEeCC-----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 142 KLVGYCLEDD-----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 142 ~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
++++++.... ..++||||+. ++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil 152 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENIL 152 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence 9999998765 4789999995 699999987543 34899999999999999999999999 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~ 296 (398)
++.++.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.......
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--- 226 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--- 226 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---
T ss_pred EcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 9999999999999998654322 2344678999999999999999999999999999999999999996543211
Q ss_pred hhhhhhhhhhc--cccccc---cccccccC--C-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 297 LVEWAKPYLTS--KRRIFR---VLDPRLEG--Q-----FSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 297 ~~~~~~~~~~~--~~~~~~---~~~~~~~~--~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........... ...... .....+.. . .....+..+.+||.+||+.||++|||+.+++++
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 10000000000 000000 00000000 0 011235678999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=340.69 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=206.4
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc------chHHHHHHHHHHcCCCCCcccce
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ------GHKEWLTEINYLGQLHHPNLVKL 143 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~~I~~~ 143 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.+++.++||||+++
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 80 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceE
Confidence 34679999999999999999997654 7899999998654321 35678999999999999999999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC--
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-- 221 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-- 221 (398)
++++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 81 HDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSS
T ss_pred EEEEecCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCC
Confidence 99999999999999999999999999764 35899999999999999999999998 99999999999999887
Q ss_pred --CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 222 --NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 222 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
.++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~ 225 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------E 225 (321)
T ss_dssp SCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------H
T ss_pred cCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------H
Confidence 79999999998654332 123457999999999999999999999999999999999999999653211 1
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......... ...+.. ....+..+.+||.+||+.||++|||+.+++++
T Consensus 226 ~~~~i~~~~~----~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 226 TLANITSVSY----DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHTTCC----CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccc----ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110000000 000000 01234678999999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=348.06 Aligned_cols=265 Identities=24% Similarity=0.255 Sum_probs=203.3
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-----CccchHHHHHHHHHHcCCCCCcc
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-----GFQGHKEWLTEINYLGQLHHPNL 140 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~I 140 (398)
.+....++|++.+.||+|+||+||+|.+.. ++..||+|++... .....+.+.+|+.+++.++||||
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 90 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTB
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCc
Confidence 445677889999999999999999997654 7889999998643 22445678999999999999999
Q ss_pred cceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCC------------------------------------CCCCCHHHH
Q 015909 141 VKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSY------------------------------------FQPLSWSLR 184 (398)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------------------------------------~~~l~~~~~ 184 (398)
+++++++.+.+..++||||+++++|.+++...... ...+++..+
T Consensus 91 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (345)
T 3hko_A 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170 (345)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHH
T ss_pred ceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHH
Confidence 99999999999999999999999999988521100 112357778
Q ss_pred HHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC--CEEEeeccCCcCCCCCCC--ccccccccccccccccccccc
Q 015909 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY--NAKLSDFGLARDGPTGDK--SHVSTRVMGTYGYAAPEYLAT 260 (398)
Q Consensus 185 ~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~ 260 (398)
+.++.||+.||.|||+++ |+||||||+||+++.++ .++|+|||++........ ........||+.|+|||++.+
T Consensus 171 ~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 171 SNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 899999999999999998 99999999999998766 899999999975432211 112334679999999999965
Q ss_pred --CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHh
Q 015909 261 --GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQC 338 (398)
Q Consensus 261 --~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 338 (398)
..++.++||||||+++|+|++|+.||...... ............ .........+.++.+||.+|
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLC--------FENPNYNVLSPLARDLLSNL 314 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--------TTSGGGGGSCHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccc--------cCCcccccCCHHHHHHHHHH
Confidence 67899999999999999999999999653211 111111111000 00011112356889999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 015909 339 LSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 339 l~~dP~~Rps~~ell~~ 355 (398)
|+.||.+||++.+++++
T Consensus 315 l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 315 LNRNVDERFDAMRALQH 331 (345)
T ss_dssp SCSCTTTSCCHHHHHHS
T ss_pred cCCChhHCCCHHHHhcC
Confidence 99999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=354.27 Aligned_cols=267 Identities=24% Similarity=0.331 Sum_probs=192.9
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCC-CCcccceee
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLH-HPNLVKLVG 145 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~I~~~~~ 145 (398)
...++|++.+.||+|+||.||+|.+.. ++..||+|++.... ......+.+|+.+|+.+. ||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 356789999999999999999997654 78999999986432 233566789999999997 999999999
Q ss_pred EEEeCC--ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 146 YCLEDD--HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 146 ~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
++...+ ..|+||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCE
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCE
Confidence 997644 6899999996 6899988763 4899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCCCC-------------------Cccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCC
Q 015909 224 KLSDFGLARDGPTGD-------------------KSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGR 283 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~ 283 (398)
||+|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 999999997643211 1112334689999999999976 67899999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhhhhccc--ccccc------------------ccccccCC------------CCHHHHHHH
Q 015909 284 RAIDKNRPTGEHNLVEWAKPYLTSKR--RIFRV------------------LDPRLEGQ------------FSLPQAQKA 331 (398)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~------------------~~~~~~~~------------~~~~~~~~l 331 (398)
+||.+....... ......+.... .+... ........ .....+.++
T Consensus 229 ~pf~~~~~~~~~---~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (388)
T 3oz6_A 229 PIFPGSSTMNQL---ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305 (388)
T ss_dssp CSCCCSSHHHHH---HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHH
T ss_pred CCCCCCCHHHHH---HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHH
Confidence 999764321110 00000000000 00000 00000000 001225678
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHH
Q 015909 332 ASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 332 ~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+||.+||+.||++|||++++++|
T Consensus 306 ~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 306 LDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhhccCcccCCCHHHHhCC
Confidence 999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=334.12 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.+ ++..||+|.+... ...+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 46799999999999999999965 4678999999754 3457789999999999999999999987654
Q ss_pred -CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 151 -DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 151 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecc
Confidence 478999999999999999976532 23788999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++...... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...... .... . ..
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~---~-~~-- 228 (278)
T 1byg_A 163 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP---R-VE-- 228 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH---H-HT--
T ss_pred cccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-Hh--
Confidence 98754322 122357889999999999999999999999999999998 99999653211 1110 0 00
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
.......+...+..+.+++.+||+.||.+||++.++++.|+.++..+
T Consensus 229 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 229 --------KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00111223344678999999999999999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=333.69 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=206.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence 34679999999999999999997654 68899999986443 234567889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 149 (276)
T 2yex_A 76 EGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDF 149 (276)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeC
Confidence 999999999999999999988654 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|++................||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ....+.. .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----~ 224 (276)
T 2yex_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE----K 224 (276)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT----T
T ss_pred CCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh----c
Confidence 99976533322222344678999999999987665 7789999999999999999999976432211 1111100 0
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. .........+..+.++|.+||+.||.+|||+.+++++
T Consensus 225 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 225 K----------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp C----------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c----------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0 0000112345678999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=333.73 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=204.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 3579999999999999999997654 68899999986432 12346688999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECS
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEe
Confidence 99999999999999999999998764 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 153 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~- 221 (279)
T 3fdn_A 153 FGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISR- 221 (279)
T ss_dssp CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-
T ss_pred ccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHh-
Confidence 99986543322 23457899999999999999999999999999999999999999643211 11110000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.....+...+..+.+||.+||+.||.+|||+.+++++-.
T Consensus 222 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 222 -----------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp -----------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred -----------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 011122334567899999999999999999999999843
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=359.13 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=210.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.++||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 678899999999999999997654 789999999965322 33467889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..|+||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+||
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeec
Confidence 999999999999999999999876544467999999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++........ .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...........
T Consensus 334 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~- 408 (543)
T 3c4z_A 334 GLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQ- 408 (543)
T ss_dssp TTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHC-
T ss_pred ceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhc-
Confidence 99987543322 12345899999999999999999999999999999999999999976432211 11111111111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM-----DEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 355 (398)
...++...+.++.+||.+||+.||.+||++ +++++|
T Consensus 409 -----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 409 -----------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -----------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 112233456789999999999999999965 666654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=333.13 Aligned_cols=264 Identities=25% Similarity=0.365 Sum_probs=206.6
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
.|++.++||+|+||+||+|.+.. ...++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYID------QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEEC------SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEec------CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 46667899999999999997643 112455899999875432 34567889999999999999999999998766
Q ss_pred ce-EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 152 HR-LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 152 ~~-~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
.. ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCC
Confidence 65 99999999999999997643 46899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCC--cccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 231 ARDGPTGDK--SHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 231 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+........ ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+...... ....... ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~----~~- 243 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFL----AQ- 243 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHH----HT-
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHh----hc-
Confidence 986533221 11223356789999999999999999999999999999999955554322111 1111100 00
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
......+...+..+.+++.+||+.||.+|||+.++++.|+++.+..
T Consensus 244 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 244 ---------GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---------CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 0011122234568999999999999999999999999999886643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=335.57 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=205.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEE-
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCL- 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~- 148 (398)
..+|++.++||+|+||+||+|.+.. .......+++|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEec------CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 4578899999999999999997643 12245578999987532 234567889999999999999999999864
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Df 172 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADF 172 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcc
Confidence 4567899999999999999997644 45899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCc--ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKS--HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||....... .... ..
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~ 246 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LL 246 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HH
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---Hh
Confidence 999865433211 11233467889999999999999999999999999999999 566665432211 1100 00
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.. .....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 247 ~~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 247 QG-----------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp TT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cC-----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00111222356799999999999999999999999999988653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=350.68 Aligned_cols=269 Identities=22% Similarity=0.256 Sum_probs=210.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCC-CcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH-PNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~I~~~~~~~~~ 149 (398)
.++|++.++||+|+||.||+|.+.. ++..||||++..... ...+..|+.+++.|+| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 5789999999999999999997654 688999998865432 2457889999999987 555566666677
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE---cCCCCEEEe
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLS 226 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv---~~~~~~kl~ 226 (398)
.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEE
Confidence 88889999999 999999998654 45899999999999999999999998 9999999999999 588999999
Q ss_pred eccCCcCCCCCCCcc-----cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 227 DFGLARDGPTGDKSH-----VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
|||+++......... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 999998654433211 122567999999999999999999999999999999999999999765433222211111
Q ss_pred hhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcc
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMH 366 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 366 (398)
..... ..... .+.. ..+.++.+|+.+||+.||++||++.+|++.|+.+.......
T Consensus 229 ~~~~~-----~~~~~-~l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 229 SEKKV-----ATSIE-ALCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HHHHH-----HSCHH-HHHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hhccc-----cccHH-HHhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 10000 00000 0001 12468899999999999999999999999999997765443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=331.47 Aligned_cols=254 Identities=25% Similarity=0.349 Sum_probs=206.2
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 35789999999999999999997654 688999999865432 2346678999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC---EE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN---AK 224 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~---~k 224 (398)
...+..++||||+++++|.+.+.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. ++
T Consensus 75 ~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~k 148 (284)
T 3kk8_A 75 QEESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVK 148 (284)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEE
T ss_pred EcCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEE
Confidence 99999999999999999999988764 4899999999999999999999998 999999999999976555 99
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 149 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~ 219 (284)
T 3kk8_A 149 LADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQI 219 (284)
T ss_dssp ECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred EeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHH
Confidence 99999997654322 223457899999999999999999999999999999999999999653211 001100
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.... .. .........+.++.+|+.+||+.||++|||+.+++++
T Consensus 220 ~~~~---~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 220 KAGA---YD-----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHTC---CC-----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Hhcc---cc-----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 00 0011112335678999999999999999999999996
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=359.22 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=208.6
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
....++|++.+.||+|+||+||+|.+. .+..||||.+.... ...+.+.+|+.+|+.++||||+++++++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 252 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 252 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC----------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 334567899999999999999999764 36789999997654 4567899999999999999999999987
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
. .+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D 327 (454)
T 1qcf_A 253 T-KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIAD 327 (454)
T ss_dssp C-SSSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECS
T ss_pred e-CCccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEee
Confidence 6 6778999999999999999975431 24788999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.+.... .... . +.
T Consensus 328 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~---~-i~ 399 (454)
T 1qcf_A 328 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR---A-LE 399 (454)
T ss_dssp TTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH---H-HH
T ss_pred CCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-HH
Confidence 999986532211 11122346788999999998999999999999999999999 99999653211 1111 0 00
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.. .....+...+.++.+|+.+||+.||++|||++++++.|+.+.
T Consensus 400 ~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 400 RG----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp HT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred cC----------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00 111122345678999999999999999999999999988653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=335.02 Aligned_cols=268 Identities=25% Similarity=0.334 Sum_probs=199.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 72 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR 72 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence 3679999999999999999997754 6889999998654322 2456789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Df 146 (311)
T 4agu_A 73 RKRRLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDF 146 (311)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCeEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeC
Confidence 999999999999998998887654 35899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh------
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA------ 301 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~------ 301 (398)
|++........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...............
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
T 4agu_A 147 GFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224 (311)
T ss_dssp TTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence 99986543221 2234578999999999976 67899999999999999999999999754321111000000
Q ss_pred --hhhhhccccccccccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 --KPYLTSKRRIFRVLDPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 --~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...............+......+ ...+.++.+|+.+||+.||.+|||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000000000000001 1235678999999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=343.07 Aligned_cols=251 Identities=27% Similarity=0.353 Sum_probs=180.7
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEeCCceEE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLL 155 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~~~~~l 155 (398)
.+.||+|+||+||+|.+.. ++..||+|++... ....+.+|+.+++.+. ||||+++++++.+....++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 3789999999999997754 7899999999653 3456788999999997 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC---CEEEeeccCCc
Q 015909 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY---NAKLSDFGLAR 232 (398)
Q Consensus 156 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~---~~kl~Dfg~a~ 232 (398)
||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .++|+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EECCCCSCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999999999998753 5899999999999999999999998 99999999999997665 89999999998
Q ss_pred CCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC-cchhhhhhhhhhccccc
Q 015909 233 DGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE-HNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 311 (398)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ..............
T Consensus 158 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--- 232 (325)
T 3kn6_A 158 LKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--- 232 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC---
T ss_pred ecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC---
Confidence 6443222 23345789999999999999999999999999999999999999976433211 11111111100000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...........+.++.+||.+||+.||.+|||+++++++
T Consensus 233 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 233 -----FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp -----CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred -----CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 000000011236789999999999999999999999865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=339.46 Aligned_cols=248 Identities=27% Similarity=0.333 Sum_probs=194.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCC-CCCcccceeeE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQL-HHPNLVKLVGY 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~~I~~~~~~ 146 (398)
..++|++.+.||+|+||+||+|.+.. ++..||||++..... ........|+..+..+ +||||++++++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~ 125 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA 125 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence 34679999999999999999997764 689999999865432 2233445566555554 89999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+.+.+..++||||+ +++|.+++...+ ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 126 WEEGGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEEC
T ss_pred EEeCCEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEc
Confidence 99999999999999 779999888765 46899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||++....... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.... .... +.
T Consensus 200 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~-----~~ 265 (311)
T 3p1a_A 200 DFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQ-----LR 265 (311)
T ss_dssp CCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHH-----HT
T ss_pred cceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHH-----Hh
Confidence 999987653322 2334569999999999876 79999999999999999999977664310 0000 00
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ....+. .+...+.++.++|.+||+.||++|||+.+++++
T Consensus 266 ~-----~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 266 Q-----GYLPPE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp T-----TCCCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c-----cCCCcc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0 000000 111235789999999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=332.44 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=186.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF 80 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence 3579999999999999999997654 688999999864321 2346788999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 81 EDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEe
Confidence 99999999999999999999998653 46899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------- 222 (278)
T 3cok_A 156 FGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------- 222 (278)
T ss_dssp CTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------
T ss_pred ecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-----------
Confidence 999986543221 1223568999999999999899999999999999999999999997543221100
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ....+...+.++.++|.+||+.||++|||+++++++
T Consensus 223 -----~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 223 -----KVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ------CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----HHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00000 011222345688999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=332.26 Aligned_cols=269 Identities=19% Similarity=0.231 Sum_probs=211.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEE-Ee
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYC-LE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~-~~ 149 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... ....+.+|+.+++.++|++++..+..+ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 5789999999999999999997654 78999999986543 235688999999999988877666655 55
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE---cCCCCEEEe
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLS 226 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv---~~~~~~kl~ 226 (398)
.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.++|+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEe
Confidence 67789999999 899999997544 45899999999999999999999998 9999999999999 488899999
Q ss_pred eccCCcCCCCCCCcc-----cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 227 DFGLARDGPTGDKSH-----VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence 999998654432211 123457999999999999999999999999999999999999999865433322222111
Q ss_pred hhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcc
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMH 366 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 366 (398)
...... ...+.+ ....+.++.+++.+||+.||++|||+.++++.|+++.......
T Consensus 231 ~~~~~~------~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 231 SEKKMS------TPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHH------SCHHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cccccC------CchHHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 110000 000000 1123467899999999999999999999999999987766543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=345.40 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=202.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..|++.+.||+|+||+||+|.+.. ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 458899999999999999997654 7899999998754322 2356889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Df 198 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDF 198 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCC
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeec
Confidence 9999999999996 68888886544 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|++..... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||...... .......
T Consensus 199 G~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~ 266 (348)
T 1u5q_A 199 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA 266 (348)
T ss_dssp TTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH
T ss_pred cCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHH
Confidence 99976532 22357999999999984 567899999999999999999999999653211 0010000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.. ..+ ...+...+..+.+||.+||+.||++|||+++++++..
T Consensus 267 ~~-------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 267 QN-------ESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HS-------CCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred hc-------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 00 000 1112234567899999999999999999999997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=335.16 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=205.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 45679999999999999999997654 688999999976544455678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE---cCCCCEEEe
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLS 226 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv---~~~~~~kl~ 226 (398)
.+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||++ +.++.++|+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~ 151 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMIT 151 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred CCEEEEEEEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEc
Confidence 999999999999999999997764 4899999999999999999999998 9999999999999 788999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... . .......
T Consensus 152 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~---~~~~i~~ 221 (304)
T 2jam_A 152 DFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---K---LFEKIKE 221 (304)
T ss_dssp SCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---H---HHHHHHH
T ss_pred cCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---H---HHHHHHc
Confidence 99998764322 223356899999999999999999999999999999999999999653211 1 1111110
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
... ..........+.++.++|.+||+.||.+||++.+++++-
T Consensus 222 ~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 222 GYY--------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp CCC--------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCC--------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 000 011112223457899999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=334.29 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=206.2
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
....+|++.+.||+|+||.||+|.+.. ++..||+|.+.... +.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence 355679999999999999999997754 68899999997543 35678999999999999999999885
Q ss_pred e----------------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCC
Q 015909 149 E----------------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKA 212 (398)
Q Consensus 149 ~----------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp 212 (398)
. ....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp 150 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKP 150 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCH
Confidence 4 4457999999999999999976532 46899999999999999999999998 99999999
Q ss_pred CCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 015909 213 SNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT 292 (398)
Q Consensus 213 ~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~ 292 (398)
+||+++.++.++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus 151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--- 224 (284)
T 2a19_B 151 SNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--- 224 (284)
T ss_dssp GGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---
T ss_pred HHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---
Confidence 999999999999999999886544321 23356899999999999999999999999999999999999887321
Q ss_pred CCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
..... ..... ..+...+..+.+++.+||+.||.+|||+.+++++|+.+++.
T Consensus 225 -----~~~~~----------~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 -----SKFFT----------DLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -----HHHHH----------HHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -----HHHHH----------Hhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 00000 00001 11222346788999999999999999999999999877543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=334.44 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=208.8
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 78 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence 4568999999999999999999764 36689999997543 34577899999999999999999999876
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCc
Confidence 5568999999999999999875421 24899999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++........ .......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ... .. +..
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~---~~-~~~- 225 (279)
T 1qpc_A 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI---QN-LER- 225 (279)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH---HH-HHT-
T ss_pred ccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHH---HH-Hhc-
Confidence 9987543321 11223456889999999998899999999999999999999 99999653211 111 10 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
. .....+...+.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 226 -----~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 226 -----G----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -----T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----c----cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 0 01112223457899999999999999999999999999988654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=338.73 Aligned_cols=275 Identities=20% Similarity=0.334 Sum_probs=200.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHH--HcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY--LGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+ ++..||+|++.... ...+..|.++ +..++||||+++++.+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 36799999999999999999965 47899999986432 2334444444 45589999999998654
Q ss_pred e-----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCceecCCCCCC
Q 015909 149 E-----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA---------EPKVIYRDFKASN 214 (398)
Q Consensus 149 ~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~~~ivH~Dlkp~N 214 (398)
. ....++||||+++++|.+++.... .++..++.++.||+.||.|||+. + |+||||||+|
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~N 150 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRN 150 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGG
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccce
Confidence 3 235689999999999999997653 58899999999999999999999 7 9999999999
Q ss_pred EEEcCCCCEEEeeccCCcCCCCCCC------ccccccccccccccccccccc-------CCCCCchhHHHHHHHHHHHHh
Q 015909 215 ILLDSNYNAKLSDFGLARDGPTGDK------SHVSTRVMGTYGYAAPEYLAT-------GHLTAKSDIYSFGVVLLEILS 281 (398)
Q Consensus 215 ilv~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~ 281 (398)
||++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230 (336)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence 9999999999999999976543221 112234579999999999976 456778999999999999999
Q ss_pred CCCCCCCCCCCCCcchhhhh----hhhhhcccc--cccccccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 015909 282 GRRAIDKNRPTGEHNLVEWA----KPYLTSKRR--IFRVLDPRLE--GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVV 353 (398)
Q Consensus 282 g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 353 (398)
|..||............... .+....... ......+.+. .......+.++.+||.+||+.||++|||+.+++
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l 310 (336)
T 3g2f_A 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310 (336)
T ss_dssp TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence 98777543322211110000 000000000 0000011111 112334677899999999999999999999999
Q ss_pred HHHHHHHHHhhcc
Q 015909 354 KELEQLQELRNMH 366 (398)
Q Consensus 354 ~~L~~l~~~~~~~ 366 (398)
+.|+.+.+.+...
T Consensus 311 ~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 311 ERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHHCCCC-
T ss_pred HHHHHHHHHHHhc
Confidence 9999887655443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=331.77 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=200.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.+.|++.+.||+|+||+||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 3457888999999999999997654 788999999875432 33566889999999999999999999987
Q ss_pred e----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc-CCCCE
Q 015909 149 E----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD-SNYNA 223 (398)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-~~~~~ 223 (398)
. ....++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+.+|+||||||+||+++ .++.+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCE
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCE
Confidence 5 355799999999999999998764 48999999999999999999999866699999999999997 78999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
+|+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||...... ......
T Consensus 172 kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~ 241 (290)
T 1t4h_A 172 KIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRR 241 (290)
T ss_dssp EECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHH
T ss_pred EEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHH
Confidence 99999999754332 223457899999999886 45899999999999999999999999643211 111110
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... . . .....+...+.++.++|.+||+.||.+|||+.+++++
T Consensus 242 ~~~-~-----~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 242 VTS-G-----V----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HTT-T-----C----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hhc-c-----C----CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000 0 0 0001111223578999999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=334.91 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=200.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc---hHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++....... .+.+.+|+.+++.++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 4689999999999999999997654 68899999997543322 36688999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECS
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEec
Confidence 99999999999999999999998764 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++........ .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 178 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~ 249 (309)
T 2h34_A 178 FGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQ 249 (309)
T ss_dssp CCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHS
T ss_pred CccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhcc
Confidence 999876543221 1223456899999999999999999999999999999999999999643210 01111110
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-DMDEVVKELEQLQE 361 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~l~~ 361 (398)
.. . .....+...+.++.++|.+||+.||++|| +++++++.|+.+..
T Consensus 250 ~~------~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 250 AI------P--RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CC------C--CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CC------C--CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 00 0 00111223456789999999999999999 99999999886643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=342.06 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=196.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc-hHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++|++.+.||+|+||+||+|.+.. ++..||+|.+....... ...+.+|+.+++.++||||+++++++...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 579999999999999999997754 68899999986543221 12345799999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||++ ++|.+++...+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSE
T ss_pred CEEEEEecccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcc
Confidence 99999999996 59999888764 45899999999999999999999999 99999999999999999999999999
Q ss_pred CcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc-
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK- 308 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 308 (398)
+....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+..... ............
T Consensus 147 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~ 221 (324)
T 3mtl_A 147 ARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPT 221 (324)
T ss_dssp EECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC
T ss_pred cccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 97643222 12334578999999999876 568999999999999999999999997543211 111100000000
Q ss_pred -cccccc---------ccccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 -RRIFRV---------LDPRLEG----QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 -~~~~~~---------~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... ..+.... ......+.++.+||.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 0000000 0011235678999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=346.00 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=198.5
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe-
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE- 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~- 149 (398)
..|++.++||+|+||+||+|.+.. ....+..||+|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEE------TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEEC------CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 357778999999999999997643 11234578999986532 2345778999999999999999999998754
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CCCeEEEEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecc
Confidence 567899999999999999997654 45789999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcc--cccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 230 LARDGPTGDKSH--VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 230 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||....... ..... .
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~----~ 310 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----L 310 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH----H
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH----H
Confidence 998654332111 1223457889999999999999999999999999999999 777886533221 11110 0
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
... ....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 311 ~~~----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 311 QGR----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 000 0011223456799999999999999999999999999987653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=364.03 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=206.0
Q ss_pred CCCCCc-eecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 73 NFRPDS-VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 73 ~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
++.+.+ .||+|+||.||+|.+.. ..++..||||+++.... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEEC-------SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEec-------CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 344444 79999999999997643 12567899999976432 356789999999999999999999999875
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCST
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 67899999999999999997543 46899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcc-cccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 231 ARDGPTGDKSH-VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 231 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ..... +...
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i~~~ 555 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQG 555 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHH----HHTT
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcC
Confidence 98754332211 1122345688999999999999999999999999999998 99999754321 11111 1110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
.....+..++.++.+|+.+||+.||++||++.++++.|+.+......
T Consensus 556 ----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 556 ----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred ----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 11122334567899999999999999999999999999988655433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=342.75 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=194.4
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||+||+|.+.. ++..||+|++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI 102 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE
Confidence 34679999999999999999997654 7899999999754322 245577999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc-----CCCC
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD-----SNYN 222 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-----~~~~ 222 (398)
...+..++||||++ ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.
T Consensus 103 ~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 103 HHNHRLHLIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp EETTEEEEEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCE
T ss_pred ecCCEEEEEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccce
Confidence 99999999999996 59999998764 4899999999999999999999998 99999999999994 4556
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
++|+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .+....
T Consensus 176 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~ 251 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIF 251 (329)
T ss_dssp EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred EEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHH
Confidence 9999999997643221 122345689999999999774 58999999999999999999999996532211 000000
Q ss_pred hhhhhcc-cc------ccccc--cccccC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTSK-RR------IFRVL--DPRLEG-----QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~~-~~------~~~~~--~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... .. ..... .+.... ......+.++.+||.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0000000 00 00000 000000 0011135788999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=335.90 Aligned_cols=275 Identities=26% Similarity=0.381 Sum_probs=212.6
Q ss_pred CCHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcC--CCCCc
Q 015909 62 FSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQ--LHHPN 139 (398)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~~ 139 (398)
.+........++|++.+.||+|+||.||+|.+ ++..||+|.+... ....+.+|++++.. ++|||
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~n 97 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHEN 97 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTT
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCc
Confidence 44555566778999999999999999999975 4788999998653 34567788888876 78999
Q ss_pred ccceeeEEEeCC----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCcee
Q 015909 140 LVKLVGYCLEDD----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH--------SAEPKVIY 207 (398)
Q Consensus 140 I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~ivH 207 (398)
|+++++++.... ..++||||+++++|.+++... .+++..++.++.|++.||.||| +.+ |+|
T Consensus 98 i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH 170 (342)
T 1b6c_B 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAH 170 (342)
T ss_dssp BCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EEC
T ss_pred EEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eee
Confidence 999999998876 789999999999999999764 4899999999999999999999 777 999
Q ss_pred cCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcc--cccccccccccccccccccC------CCCCchhHHHHHHHHHHH
Q 015909 208 RDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH--VSTRVMGTYGYAAPEYLATG------HLTAKSDIYSFGVVLLEI 279 (398)
Q Consensus 208 ~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el 279 (398)
|||||+|||++.++.++|+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|+|
T Consensus 171 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el 250 (342)
T 1b6c_B 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250 (342)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence 9999999999999999999999997643332211 12345799999999999765 234689999999999999
Q ss_pred HhC----------CCCCCCCCCCCCcchhhhhhhhhhccccccccccccccC-CCCHHHHHHHHHHHHHhccCCCCCCCC
Q 015909 280 LSG----------RRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEG-QFSLPQAQKAASLALQCLSVEPKLRPD 348 (398)
Q Consensus 280 l~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps 348 (398)
++| ..||........ ....+...... ....+.+.. ..+...+..+.+|+.+||+.||++|||
T Consensus 251 ~tg~~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 251 ARRCSIGGIHEDYQLPYYDLVPSDP-SVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSC-CHHHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred HhccCcCCcccccccCccccCcCcc-cHHHHHHHHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC
Confidence 999 667754322211 11111111100 011111111 112356788999999999999999999
Q ss_pred HHHHHHHHHHHHHHhh
Q 015909 349 MDEVVKELEQLQELRN 364 (398)
Q Consensus 349 ~~ell~~L~~l~~~~~ 364 (398)
+.+++++|+++.+..+
T Consensus 324 ~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 324 ALRIKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhc
Confidence 9999999999987654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=341.06 Aligned_cols=264 Identities=17% Similarity=0.204 Sum_probs=209.3
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC---CCcccceee
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH---HPNLVKLVG 145 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~~I~~~~~ 145 (398)
...++|++.+.||+|+||+||+|++.. .....++..||+|++.... ...+..|+.+++.++ |+||+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGD----LNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecC----CcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 345789999999999999999996432 1223478899999997543 456677777777776 999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-----
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGS-YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS----- 219 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~----- 219 (398)
++...+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCc
Confidence 99999999999999999999999986432 2356999999999999999999999998 999999999999988
Q ss_pred ------CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 220 ------NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 220 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999975433333334455689999999999999999999999999999999999999985321110
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHHHHh
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR-PDMDEVVKELEQLQELR 363 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-ps~~ell~~L~~l~~~~ 363 (398)
..+ ...+. .. ..+..+.+++..||+.+|.+| |++.++.+.|+.+-...
T Consensus 293 ---------------~~~----~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ---------------CKP----EGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ---------------EEE----CSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------------eee----chhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 000 00011 01 235678899999999999999 68889998888876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=352.99 Aligned_cols=201 Identities=26% Similarity=0.370 Sum_probs=167.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 4689999999999999999997754 78999999997542 233567889999999999999999999987
Q ss_pred eC-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 149 ED-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 149 ~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
.. ...|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCE
Confidence 76 56899999985 6999998764 35899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCc--------------------cccccccccccccccccc-ccCCCCCchhHHHHHHHHHHHHhC
Q 015909 224 KLSDFGLARDGPTGDKS--------------------HVSTRVMGTYGYAAPEYL-ATGHLTAKSDIYSFGVVLLEILSG 282 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g 282 (398)
||+|||+++........ ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999999875433211 123456899999999986 566799999999999999999986
Q ss_pred CCCCC
Q 015909 283 RRAID 287 (398)
Q Consensus 283 ~~p~~ 287 (398)
..||.
T Consensus 249 ~~p~~ 253 (432)
T 3n9x_A 249 LQSHI 253 (432)
T ss_dssp CTTTC
T ss_pred ccccc
Confidence 55553
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=336.30 Aligned_cols=253 Identities=30% Similarity=0.476 Sum_probs=197.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||+|+||+||+|.+ .+..||+|.+... ...+.+.+|+.++++++||||+++++++. +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-----------RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--N 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred hHeeeeeEeecCCCceEEEEEE-----------CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 5788999999999999999976 3678999999654 34567899999999999999999999776 4
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCceecCCCCCCEEEcCCCC-EEEee
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS---AEPKVIYRDFKASNILLDSNYN-AKLSD 227 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~~~ivH~Dlkp~Nilv~~~~~-~kl~D 227 (398)
..++||||+++++|.+++..... ...++...++.++.|++.||.|||+ ++ |+||||||+||+++.++. +||+|
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECC
T ss_pred CcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcc
Confidence 58999999999999999976532 2347889999999999999999999 66 999999999999998886 79999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 150 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~-- 218 (307)
T 2eva_A 150 FGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVH-- 218 (307)
T ss_dssp CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHH--
T ss_pred cccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHh--
Confidence 9998754321 223468999999999999999999999999999999999999996432110 00000000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.... .......+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 219 -----~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 219 -----NGTR----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp -----TTCC----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred -----cCCC----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 111223456789999999999999999999999999987543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=355.30 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=203.4
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45678999999999999999997753 4579999997654 345789999999999999999999998865
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred -CceEEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCc
Confidence 778999999999999999975421 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+.... .... . +..
T Consensus 326 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~---~-i~~- 396 (452)
T 1fmk_A 326 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---Q-VER- 396 (452)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH---H-HHT-
T ss_pred cceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-HHc-
Confidence 99865432211 1223456788999999999999999999999999999999 99999653211 1110 0 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
......+...+..+.+|+.+||+.||++|||++++++.|+.+.
T Consensus 397 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 397 ---------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0111223345678999999999999999999999999988653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=332.66 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=201.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCC-CCCcccceeeE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQL-HHPNLVKLVGY 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~~I~~~~~~ 146 (398)
..++|++.+.||+|+||+||+|.+.. ++..||+|.+..... .....+.+|+..+..+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 34679999999999999999997754 689999999875422 3356678899999998 89999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-------
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS------- 219 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~------- 219 (398)
+.+.+..++||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccc
Confidence 99999999999999999999999875433356899999999999999999999998 999999999999984
Q ss_pred ------------CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCC
Q 015909 220 ------------NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAI 286 (398)
Q Consensus 220 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~ 286 (398)
...++|+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+++
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 4479999999998754322 23589999999999765 5668999999999999999998876
Q ss_pred CCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 287 DKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.... .... .. .... ...+...+.++.+++.+||+.||++|||+.+++++
T Consensus 232 ~~~~-----~~~~-----~~------~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 232 RNGD-----QWHE-----IR------QGRL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSSH-----HHHH-----HH------TTCC----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cchh-----HHHH-----HH------cCCC----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 4321 0000 00 0000 11222345688999999999999999999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=334.67 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=205.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 4679999999999999999997654 789999999975432 33466889999999999999999999875
Q ss_pred e--CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---CCceecCCCCCCEEEcCCCCE
Q 015909 149 E--DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE---PKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 149 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
. ....++||||+++++|.+++.........+++..++.++.||+.||.|||+.+ .+|+||||||+||+++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 4 56789999999999999999876544456899999999999999999999875 239999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
+|+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ... ...
T Consensus 156 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~ 227 (279)
T 2w5a_A 156 KLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL---AGK 227 (279)
T ss_dssp EECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHH
T ss_pred EEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHH---HHH
Confidence 999999987653321 122345689999999999998999999999999999999999999975321 011 110
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.... . ....+...+.++.+++.+||+.||.+||++.++++++.
T Consensus 228 i~~~-------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 228 IREG-------K----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHT-------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred Hhhc-------c----cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0000 0 01122334578999999999999999999999998653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=353.82 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=204.0
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC--CccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE--GFQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.++||+|+||+||+|.+.. ++..||+|++... .......+.+|+.+|+.++||||+++++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 90 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 45679999999999999999997654 7899999998643 223457789999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc---CCCCEE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD---SNYNAK 224 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~---~~~~~k 224 (398)
.+....++||||+.+++|.+.+...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 91 EDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEE
T ss_pred EcCCEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEE
Confidence 99999999999999999999988764 4899999999999999999999999 99999999999995 456799
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... . .....
T Consensus 165 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~---~~~~i 234 (486)
T 3mwu_A 165 IIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---D---ILKRV 234 (486)
T ss_dssp ECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHH
T ss_pred EEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H---HHHHH
Confidence 99999998654332 2334579999999999976 5899999999999999999999999653211 1 11111
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ..........+.++.+||.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 235 ETGKY--------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHTCC--------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HhCCC--------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000112345789999999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=339.59 Aligned_cols=265 Identities=21% Similarity=0.270 Sum_probs=209.8
Q ss_pred CCCHHHHHHHhcCCCCC-ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCC-
Q 015909 61 NFSYSDLRTATRNFRPD-SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLH- 136 (398)
Q Consensus 61 ~~~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~- 136 (398)
+..+.......++|.+. +.||+|+||.||+|.+.. ++..||+|++.... ......+.+|+.+++.+.
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~ 87 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC
Confidence 34556667778889988 899999999999997654 78999999987532 234577899999999995
Q ss_pred CCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 137 h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
||||+++++++...+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 88 ~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl 163 (327)
T 3lm5_A 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNIL 163 (327)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred CCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEE
Confidence 6999999999999999999999999999999885432 256899999999999999999999998 999999999999
Q ss_pred EcC---CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 217 LDS---NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 217 v~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
++. ++.++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 239 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ- 239 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-
Confidence 987 7899999999998754322 123457999999999999999999999999999999999999999653211
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......... ............+..+.+||.+||+.||++|||+++++++
T Consensus 240 -----~~~~~i~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 240 -----ETYLNISQV--------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----HHHHHHHHT--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----HHHHHHHhc--------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000000000 0011111222345778999999999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=329.84 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=202.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc------cchHHHHHHHHHHcCCCCCccccee
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF------QGHKEWLTEINYLGQLHHPNLVKLV 144 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~I~~~~ 144 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 4579999999999999999997654 688999999865432 1357789999999999999999999
Q ss_pred eEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC---
Q 015909 145 GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY--- 221 (398)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~--- 221 (398)
+++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSS
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCC
Confidence 99999999999999999999999998753 5899999999999999999999998 99999999999998776
Q ss_pred -CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 222 -NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 222 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
.++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 149 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~ 219 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ET 219 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH
T ss_pred CceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HH
Confidence 89999999998654322 123456899999999999999999999999999999999999999653211 00
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......... ..... .....+..+.+++.+||+.||++||++.+++++
T Consensus 220 ~~~~~~~~~----~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 220 LTNISAVNY----DFDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHTTCC----CCCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHhHhccc----CCcch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 000000000 00000 001224678999999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=339.74 Aligned_cols=265 Identities=26% Similarity=0.414 Sum_probs=200.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 579999999999999999997754 7899999998654322 24557899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCC
Confidence 99999999999988888876644 34899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh------
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK------ 302 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~------ 302 (398)
++........ ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||........ +.....
T Consensus 170 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 245 (331)
T 4aaa_A 170 FARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLI 245 (331)
T ss_dssp TC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCC
T ss_pred CceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCC
Confidence 9976433221 23345789999999999775 789999999999999999999999975432110 000000
Q ss_pred ----hhhhccccccccccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 ----PYLTSKRRIFRVLDPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..............+......+ ...+..+.+||.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000111111111111 1236789999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=340.20 Aligned_cols=269 Identities=24% Similarity=0.308 Sum_probs=198.0
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-----chHHHHHHHHHHcCCCCCcccce
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-----GHKEWLTEINYLGQLHHPNLVKL 143 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~I~~~ 143 (398)
...++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++||||+++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 345789999999999999999997654 7899999999753221 13467899999999999999999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
++++...+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCE
Confidence 9999999999999999965 8888887543 45788899999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+..... .+.....
T Consensus 152 kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~ 227 (346)
T 1ua2_A 152 KLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFE 227 (346)
T ss_dssp EECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH
Confidence 9999999987543221 23345789999999999664 58899999999999999999999996542110 0000000
Q ss_pred hhhhc-ccc------ccccccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 303 PYLTS-KRR------IFRVLDPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 303 ~~~~~-~~~------~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
..... ... .............+ ...+.++.+||.+||+.||.+|||+.|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000 000 00000000000011 22357899999999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=345.70 Aligned_cols=268 Identities=24% Similarity=0.346 Sum_probs=205.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 3679999999999999999997754 789999999975432 334678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.++|+||
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEEC
Confidence 999999999999999999998764 489999999999999999999985 7 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh--------
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW-------- 300 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~-------- 300 (398)
|++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..............
T Consensus 177 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 177 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp CCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred CCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 998643211 12335789999999999999999999999999999999999999975321100000000
Q ss_pred -----------hhhhh---hcccc----ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 301 -----------AKPYL---TSKRR----IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 301 -----------~~~~~---~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
...+. ..... .................+.++.+||.+||+.||++|||+++++++-.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 00000 00000 00000000001111223567999999999999999999999999744
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.91 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=205.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 579999999999999999997654 68899999986432 223467889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecc
Confidence 9999999999999999999998764 4899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... .........
T Consensus 159 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~- 227 (284)
T 2vgo_A 159 GWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNV- 227 (284)
T ss_dssp TTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTT-
T ss_pred cccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhcc-
Confidence 9987643321 23457899999999999999999999999999999999999999643211 011111100
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...++...+.++.++|.+||+.||.+||++.+++++
T Consensus 228 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 -----------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -----------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 011223345788999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=331.93 Aligned_cols=254 Identities=28% Similarity=0.389 Sum_probs=202.0
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
...++|++.+.||+|+||.||+|.+.. ++..||+|.+... ...+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 345789999999999999999997654 6889999999754 33467889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
..+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCC
T ss_pred eCCEEEEEeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997543 46899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ........
T Consensus 170 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~- 240 (314)
T 3com_A 170 GVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTN- 240 (314)
T ss_dssp TTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-
T ss_pred ccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcC-
Confidence 9997653321 12234578999999999999999999999999999999999999996432110 00000000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..+ ....+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 241 ------~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 241 ------PPP--TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ------CCC--CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ------CCc--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 011122345688999999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=355.99 Aligned_cols=254 Identities=26% Similarity=0.370 Sum_probs=206.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
..++|++.++||+|+||.||+|.+.. ++..||+|++.... ......+.+|+.++++++||||++++++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 94 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34679999999999999999997654 78999999986543 2346778999999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE---cCCCCE
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL---DSNYNA 223 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv---~~~~~~ 223 (398)
+...+..++||||+.+++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcE
Confidence 999999999999999999999997654 5899999999999999999999998 9999999999999 567899
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
+|+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... .. ...
T Consensus 169 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~ 238 (484)
T 3nyv_A 169 RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DI---LKK 238 (484)
T ss_dssp EECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHH
T ss_pred EEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HH---HHH
Confidence 999999997654332 2334579999999999976 6999999999999999999999999753211 11 111
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
....... .........+.++.+||.+||+.||.+|||+.+++++-
T Consensus 239 i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 239 VEKGKYT--------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HHHCCCC--------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred HHcCCCC--------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 1000000 00001123457899999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=337.43 Aligned_cols=267 Identities=24% Similarity=0.335 Sum_probs=201.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence 3679999999999999999997754 789999999865432 23457789999999999999999999987
Q ss_pred e--------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 149 E--------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 149 ~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
. .+..++||||++ ++|.+.+.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~ 160 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD 160 (351)
T ss_dssp EC--------CEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT
T ss_pred ccccccccCCceEEEEEeccC-CCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC
Confidence 7 346899999996 47777776543 35899999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCC--ccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 221 YNAKLSDFGLARDGPTGDK--SHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
+.++|+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+......
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--- 237 (351)
T 3mi9_A 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--- 237 (351)
T ss_dssp SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---
T ss_pred CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---
Confidence 9999999999986543221 122334578999999999876 4689999999999999999999999975432111
Q ss_pred hhhhhhhhhc----------cccccccccccccCCCCHH-------HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 298 VEWAKPYLTS----------KRRIFRVLDPRLEGQFSLP-------QAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 298 ~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......... ................... .+..+.+||.+||+.||++|||+++++++
T Consensus 238 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000 0000000000000000111 14568899999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=353.06 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=200.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
..++|++.+.||+|+||+||+|.+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 105 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF 105 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34579999999999999999997654 78899999987543 23456789999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC---CCCEE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYNAK 224 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~---~~~~k 224 (398)
.+....++||||+++++|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+|
T Consensus 106 ~~~~~~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 179 (494)
T 3lij_A 106 EDKRNYYLVMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIK 179 (494)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEE
T ss_pred EeCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEE
Confidence 99999999999999999999988764 4899999999999999999999998 999999999999975 45599
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.... ......
T Consensus 180 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i 249 (494)
T 3lij_A 180 IVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKV 249 (494)
T ss_dssp ECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred EEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence 99999998654322 233467999999999986 56999999999999999999999999753221 111111
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... . +.. ......+..+.+||.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~---~-~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 250 EKGKY---T-FDS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHTCC---C-CCS----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HhCCC---C-CCc----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 10000 0 000 0011235678999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=331.26 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=208.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.+.|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 3568999999999999999997654 78899999996543 2445778999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecc
Confidence 9999999999999999999864 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .. ... ..
T Consensus 165 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~-~~--- 232 (303)
T 3a7i_A 165 VAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KV---LFL-IP--- 232 (303)
T ss_dssp TCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH---HHH-HH---
T ss_pred cceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HH---HHH-hh---
Confidence 9976533221 223457899999999999999999999999999999999999999643211 00 000 00
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
....+ ..+...+..+.+|+.+||+.||.+|||+.+++++..-..
T Consensus 233 ---~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 233 ---KNNPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp ---HSCCC----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred ---cCCCC----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 00011 112233567899999999999999999999999765433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=327.88 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=200.4
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCCc
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDH 152 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~ 152 (398)
+|....+||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 34555689999999999997654 688999999977655556788999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-CCCEEEeeccCC
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLSDFGLA 231 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-~~~~kl~Dfg~a 231 (398)
.++||||+++++|.+++..... ...+++..+..++.||+.||.|||+++ |+|+||||+||+++. ++.++|+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccc
Confidence 9999999999999999986532 234678899999999999999999998 999999999999987 899999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGH--LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
........ ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ... .....
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~-~~~~~----- 239 (295)
T 2clq_A 171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAA-MFKVG----- 239 (295)
T ss_dssp EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHH-HHHHH-----
T ss_pred cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHH-HHhhc-----
Confidence 76533221 123457899999999997654 788999999999999999999999642111 000 00000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. . ......+...+.++.+++.+||+.||++||++.+++++
T Consensus 240 -~-~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 240 -M-F----KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -H-H----CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -c-c----cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0 01112233446788999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=338.52 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=207.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4679999999999999999997754 688999999865432 2356688999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~D 184 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGD 184 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECC
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEee
Confidence 99999999999999999999988753 5899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++........ ......||..|+|||++.+..++.++||||||+++|+|++|+.||..... ..........
T Consensus 185 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~ 256 (335)
T 2owb_A 185 FGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKN 256 (335)
T ss_dssp CTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHT
T ss_pred ccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcC
Confidence 999986543221 22345789999999999999999999999999999999999999964321 0100000000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....+...+..+.+||.+||+.||++||++.+++++
T Consensus 257 ------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 257 ------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011222345678999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=364.75 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=207.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCC-CCCcccceee
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQL-HHPNLVKLVG 145 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~I~~~~~ 145 (398)
..++|++.++||+|+||+||+|.+.. ++..||+|++.... ....+.+..|..+|..+ +||+|+++++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 44689999999999999999997764 78999999987531 23456678899999988 6999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
++.+.+.+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL 483 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKI 483 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEE
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEE
Confidence 9999999999999999999999998764 4899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+|||+++...... ......+||+.|+|||++.+..|+.++||||||+++|||++|++||.+... ........
T Consensus 484 ~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~ 555 (674)
T 3pfq_A 484 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM 555 (674)
T ss_dssp CCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred eecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHH
Confidence 9999998643222 123457899999999999999999999999999999999999999975321 11111111
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM-----DEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 355 (398)
. . ...++...+.++.+||.+||+.||.+||++ ++++++
T Consensus 556 ~----------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 556 E----------H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp S----------S--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred h----------C--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1 1 112333456789999999999999999997 777664
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=353.72 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=202.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-------------cchHHHHHHHHHHcCCC
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-------------QGHKEWLTEINYLGQLH 136 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~ 136 (398)
..++|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+.+.+|+.+|+.++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 46789999999999999999997654 788999999865432 23467889999999999
Q ss_pred CCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 137 h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
||||+++++++.+....++|||||++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil 178 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENIL 178 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEE
Confidence 9999999999999999999999999999999998764 4899999999999999999999998 999999999999
Q ss_pred EcCCC---CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 217 LDSNY---NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 217 v~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
++.++ .++|+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+....
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 253 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ- 253 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 98765 69999999998754332 233457999999999986 46899999999999999999999999753211
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFS----LPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.. ........ ..++ ...+.++.+||.+||+.||.+|||+.+++++-
T Consensus 254 --~~---~~~i~~~~------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 254 --DI---IKKVEKGK------------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp --HH---HHHHHHCC------------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --HH---HHHHHcCC------------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 11 11100000 0011 12356899999999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=340.57 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=196.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. +|..||+|++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 4679999999999999999997654 789999999965422 23466889999999999999999999997
Q ss_pred eCC------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 EDD------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
... ..++||||+ +++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~ 166 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCE 166 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCC
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCC
Confidence 653 459999999 88999998763 4899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ....
T Consensus 167 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i 238 (367)
T 1cm8_A 167 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEI 238 (367)
T ss_dssp EEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH
T ss_pred EEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 999999999874322 234578999999999877 6799999999999999999999999975432110 0000
Q ss_pred hhhhhc-c----------------ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTS-K----------------RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~-~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... . ..+.......+. ......+.++.+||.+||+.||.+|||+.+++++
T Consensus 239 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000 0 000000000000 1112335789999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=343.78 Aligned_cols=269 Identities=19% Similarity=0.217 Sum_probs=199.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-----------chHHHHHHHHHHcCCCCCc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-----------GHKEWLTEINYLGQLHHPN 139 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~ 139 (398)
.++|++.+.||+|+||+||+|.+... ..++..+|+|.+...... ....+.+|+.+++.++|||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNK------PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSS------CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCC------CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 46799999999999999999987531 125778999998754321 1234667889999999999
Q ss_pred ccceeeEEEe----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 140 LVKLVGYCLE----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 140 I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
|+++++++.. ....++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 182 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANL 182 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHE
Confidence 9999999988 67889999999 999999987664 5899999999999999999999998 99999999999
Q ss_pred EEcCCC--CEEEeeccCCcCCCCCCC-----cccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015909 216 LLDSNY--NAKLSDFGLARDGPTGDK-----SHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDK 288 (398)
Q Consensus 216 lv~~~~--~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~ 288 (398)
|++.++ .++|+|||+++....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998777 999999999976532211 1112345799999999999999999999999999999999999999964
Q ss_pred CCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 289 NRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
...... ........... .+........ .....+.++.+++.+||+.||++||++.++++.|+.+
T Consensus 263 ~~~~~~-~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 263 NLKDPV-AVQTAKTNLLD---ELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp GTTCHH-HHHHHHHHHHH---TTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred cccccH-HHHHHHHhhcc---cccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 221110 00000000000 0000000000 0012346899999999999999999999999998864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=345.78 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=194.0
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--------cchHHHHHHHHHHcCCCCCc
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--------QGHKEWLTEINYLGQLHHPN 139 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~ 139 (398)
....++|++.+.||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.+|++++|||
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 201 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTT
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCC
Confidence 3456899999999999999999997765 789999999865321 12234789999999999999
Q ss_pred ccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC
Q 015909 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219 (398)
Q Consensus 140 I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~ 219 (398)
|+++++++. .+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 202 iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 202 IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSS 274 (419)
T ss_dssp BCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESS
T ss_pred EeeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEec
Confidence 999999875 55689999999999998887654 35899999999999999999999998 999999999999975
Q ss_pred C---CCEEEeeccCCcCCCCCCCccccccccccccccccccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 220 N---YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 220 ~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
+ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 275 ~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 275 QEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp SSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred CCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 4 459999999998754322 2344679999999999853 678889999999999999999999997533221
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. +.... .... ... .+.. ....+..+.+||.+||+.||++||++.+++++
T Consensus 352 ~--~~~~i----~~~~--~~~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 352 S--LKDQI----TSGK--YNF-IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp C--HHHHH----HTTC--CCC-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H--HHHHH----hcCC--CCC-Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 11100 0000 000 0000 01135678999999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=330.74 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=207.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 4679999999999999999997654 688999999865432 2346678999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d 158 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGD 158 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEe
Confidence 99999999999999999999987764 5899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .........
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~ 230 (294)
T 2rku_A 159 FGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKN 230 (294)
T ss_dssp CTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTT
T ss_pred ccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhc
Confidence 999986543221 223457899999999999989999999999999999999999999653211 000000000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
....+...+..+.+++.+||+.||++|||+++++++-
T Consensus 231 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 231 ------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ------------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0112223456789999999999999999999999873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=342.48 Aligned_cols=272 Identities=23% Similarity=0.317 Sum_probs=200.4
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
....++|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+|+.+|+.++||||+++++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhhee
Confidence 3456789999999999999999997654 789999999865422 223799999999999999999998
Q ss_pred EeC--------------------------------------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHH
Q 015909 148 LED--------------------------------------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189 (398)
Q Consensus 148 ~~~--------------------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~ 189 (398)
... ...++||||++ ++|.+.+.........+++..+..++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 543 34789999996 588888765333335799999999999
Q ss_pred HHHHHHHHHHcCCCCceecCCCCCCEEEc-CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCCch
Q 015909 190 GAANGLAFLHSAEPKVIYRDFKASNILLD-SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKS 267 (398)
Q Consensus 190 qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 267 (398)
||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++
T Consensus 149 qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 149 QLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence 9999999999998 99999999999997 688999999999986543322 2345789999999998765 589999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh--------hhhccccccccc-----cccccCCCCHHHHHHHHHH
Q 015909 268 DIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP--------YLTSKRRIFRVL-----DPRLEGQFSLPQAQKAASL 334 (398)
Q Consensus 268 DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~l 334 (398)
|||||||++|+|++|+.||.+..... .+...... ............ .......++...+.++.+|
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence 99999999999999999997542211 01000000 000000000000 0000111222346779999
Q ss_pred HHHhccCCCCCCCCHHHHHHH--HHHHH
Q 015909 335 ALQCLSVEPKLRPDMDEVVKE--LEQLQ 360 (398)
Q Consensus 335 i~~~l~~dP~~Rps~~ell~~--L~~l~ 360 (398)
|.+||+.||.+|||+.+++++ ++.++
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred HHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence 999999999999999999965 44443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=338.73 Aligned_cols=258 Identities=29% Similarity=0.390 Sum_probs=199.4
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCccccee
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLV 144 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~ 144 (398)
.+....++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.+++.+ +||||++++
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeee
Confidence 334456789999999999999999997754 68899999986543 3456788999999998 799999999
Q ss_pred eEEEe------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 145 GYCLE------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 145 ~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
+++.. .+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+|+||||+||+++
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~ 163 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT 163 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc
Confidence 99987 4678999999999999999986532 45899999999999999999999998 99999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
.++.++|+|||++........ ......||+.|+|||++. +..++.++||||||+++|+|++|..||.......
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 241 (326)
T 2x7f_A 164 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241 (326)
T ss_dssp TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 999999999999876532211 123457899999999986 5678899999999999999999999996432110
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... ... ........+..+.+||.+||..||.+||++.+++++
T Consensus 242 ------~~~~~~~-------~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 ------ALFLIPR-------NPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ------HHHHHHH-------SCC---CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ------HHHHhhc-------Ccc---ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 000 001112235688999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=328.81 Aligned_cols=254 Identities=23% Similarity=0.266 Sum_probs=201.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC----ccchHHHHHHHHHHcCCCCCcccceee
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG----FQGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... ......+.+|+.+++.++||||+++++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 73 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 34789999999999999999997654 78899999997532 233567899999999999999999999
Q ss_pred EEE--eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 146 YCL--EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 146 ~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
++. +....++||||++++ |.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 74 VLYNEEKQKMYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp EEECC---CEEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCE
T ss_pred EEEcCCCCeEEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcE
Confidence 984 456789999999765 7777766433 56899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH--LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
+|+|||++................||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ....
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~ 222 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLF 222 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHH
Confidence 999999998765433333344567999999999997644 37789999999999999999999975321 1111
Q ss_pred hhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... ....+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 223 ~~i~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 223 ENIGKG------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHC------------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHhcC------------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110000 001222345678899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=331.94 Aligned_cols=263 Identities=27% Similarity=0.389 Sum_probs=199.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||+||+|.+.. ..+.+..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEecc------CCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3579999999999999999997642 112345799999875432 3356788999999999999999999998
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.... .++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECC
T ss_pred ccCC-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcc
Confidence 7654 899999999999999998754 35899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcc-cccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhh
Q 015909 228 FGLARDGPTGDKSH-VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 228 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
||++.......... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||...... .......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~ 238 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKID 238 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHH
Confidence 99998764433221 1223457888999999998889999999999999999999 99999653211 1111110
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.. ......+...+.++.+++.+||+.||.+|||+.+++++|+++..
T Consensus 239 ~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 239 KE----------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TS----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cc----------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 00 00111223346789999999999999999999999999987753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=333.81 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=201.1
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 45689999999999999999997754 688999999987666667889999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999999999987654 45899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccc-----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYL-----ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
++...... ........||+.|+|||++ .+..++.++||||||+++|+|++|..||...... ......
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~ 234 (302)
T 2j7t_A 163 VSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKI 234 (302)
T ss_dssp HHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH
T ss_pred CCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHH
Confidence 87531110 0111234689999999998 4667899999999999999999999999653211 001100
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.... .+ ....+...+..+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~-------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 235 AKSD-------PP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHSC-------CC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred hccC-------Cc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 00 001122345678999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.24 Aligned_cols=251 Identities=19% Similarity=0.193 Sum_probs=193.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC---CccchHHHHHHH---HHHcCCCCCccccee
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE---GFQGHKEWLTEI---NYLGQLHHPNLVKLV 144 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~~I~~~~ 144 (398)
.++|++.+.||+|+||+||+|.+.. ++..||||++... .....+.+.+|+ .+|+.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 4678899999999999999997643 6899999999743 223456788999 555666899999998
Q ss_pred -------eEEEeCC-----------------ceEEEEeecCCCCHHHHHhhcCCCC---CCCCHHHHHHHHHHHHHHHHH
Q 015909 145 -------GYCLEDD-----------------HRLLVYEFMPRGSMENHLFRRGSYF---QPLSWSLRMKIALGAANGLAF 197 (398)
Q Consensus 145 -------~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~~~---~~l~~~~~~~i~~qi~~al~~ 197 (398)
+++...+ ..++||||+ +|+|.+++...+... ..+++..++.++.||+.||.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 6666543 278999999 689999998653211 123358888899999999999
Q ss_pred HHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccC-----------CCCCc
Q 015909 198 LHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-----------HLTAK 266 (398)
Q Consensus 198 LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 266 (398)
||+++ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.+
T Consensus 222 LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 99998 99999999999999999999999999985322 2334567 999999999887 89999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCC
Q 015909 267 SDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLR 346 (398)
Q Consensus 267 ~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 346 (398)
+|||||||++|+|++|+.||.......... ..... ....+.++.+||.+||+.||++|
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~~~------~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGGSE----------------WIFRS------CKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CCSG----------------GGGSS------CCCCCHHHHHHHHHHTCSSGGGC
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccchh----------------hhhhh------ccCCCHHHHHHHHHHcCCCchhC
Confidence 999999999999999999996543221100 00000 01234678999999999999999
Q ss_pred CCHHHHHH--HHHHHHH
Q 015909 347 PDMDEVVK--ELEQLQE 361 (398)
Q Consensus 347 ps~~ell~--~L~~l~~ 361 (398)
|++.++++ .+..+++
T Consensus 352 pt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 352 LLPLQAMETPEYEQLRT 368 (377)
T ss_dssp CCHHHHHTSHHHHHHHH
T ss_pred CCHHHHhhChHHHHHHH
Confidence 99999997 4555443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=330.82 Aligned_cols=255 Identities=23% Similarity=0.280 Sum_probs=189.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|.+...... ....+.++...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 4679999999999999999997654 7899999999754322 2233445555688899999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEEcCCCCEEEee
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
..+..++||||++ ++|.+++.........+++..++.++.||+.||.|||++ + |+||||||+||+++.++.++|+|
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCC
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEee
Confidence 9999999999996 588888765433336799999999999999999999997 8 99999999999999999999999
Q ss_pred ccCCcCCCCCCCccccccccccccccccccc----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYL----ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
||++........ .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||...... ..... .
T Consensus 154 fg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~ 225 (290)
T 3fme_A 154 FGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQLK-Q 225 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHHHH-H
T ss_pred cCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHHHH-H
Confidence 999976533221 2234689999999996 5667899999999999999999999999642211 11100 0
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ...........+.++.+++.+||+.||++|||+.+++++
T Consensus 226 ~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 226 VVE----------EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHH----------SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred Hhc----------cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 000 000111112345678999999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=342.62 Aligned_cols=265 Identities=21% Similarity=0.261 Sum_probs=204.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC--------CCcccc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH--------HPNLVK 142 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~~I~~ 142 (398)
.++|++.+.||+|+||+||+|++.. ++..||+|++.... ...+.+.+|+.+++.++ |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 4689999999999999999997654 78999999997542 33466789999999885 788999
Q ss_pred eeeEEE----eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEE
Q 015909 143 LVGYCL----EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILL 217 (398)
Q Consensus 143 ~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv 217 (398)
+++++. .....++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||++ + |+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll 180 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEE
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeE
Confidence 999987 456789999999 6677777665432 4689999999999999999999998 8 9999999999999
Q ss_pred cCCC-------------------------------------------------CEEEeeccCCcCCCCCCCccccccccc
Q 015909 218 DSNY-------------------------------------------------NAKLSDFGLARDGPTGDKSHVSTRVMG 248 (398)
Q Consensus 218 ~~~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~g 248 (398)
+.++ .++|+|||++...... .....|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence 8765 7999999999865332 233578
Q ss_pred ccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh---------------------c
Q 015909 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT---------------------S 307 (398)
Q Consensus 249 t~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------~ 307 (398)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.................... .
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 9999999999999999999999999999999999999976543322111111110000 0
Q ss_pred cccccccccc---------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 KRRIFRVLDP---------RLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 ~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......... ......+...+..+.+||.+||+.||++|||+.+++++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000000000 00113456678889999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=338.76 Aligned_cols=278 Identities=16% Similarity=0.216 Sum_probs=208.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccc--------
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVK-------- 142 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~-------- 142 (398)
.++|++.+.||+|+||.||+|.+..... ......+..||+|.+... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~-~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLT-CDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCcc-ccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4679999999999999999998754100 000113789999998654 45789999999999999887
Q ss_pred -------eeeEEEe-CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCC
Q 015909 143 -------LVGYCLE-DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASN 214 (398)
Q Consensus 143 -------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~N 214 (398)
+++++.. ....++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 6677766 67889999999 9999999987521 45899999999999999999999998 9999999999
Q ss_pred EEEcCCC--CEEEeeccCCcCCCCCCCc-----ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015909 215 ILLDSNY--NAKLSDFGLARDGPTGDKS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287 (398)
Q Consensus 215 ilv~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~ 287 (398)
||++.++ .++|+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 9999999999765432211 11233579999999999999999999999999999999999999997
Q ss_pred CCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhcc
Q 015909 288 KNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMH 366 (398)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 366 (398)
...... .........+...... ..... ......+.++.+|+.+||+.||.+||+++++++.|+++.+.....
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDKPGP---FVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHSCCC---EECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCcCH-HHHHHHHHhccCChhh---hhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 543211 1111111111111100 00000 000123468999999999999999999999999999987665543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.82 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=207.2
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
...++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345678899999999999999998753 4679999997654 34578999999999999999999999886
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+ +..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 333 ~-~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DF 407 (535)
T 2h8h_A 333 E-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADF 407 (535)
T ss_dssp S-SSCEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCT
T ss_pred e-ccceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEccc
Confidence 5 778999999999999999975421 35889999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
|+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.+.... ..... +..
T Consensus 408 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~----i~~ 479 (535)
T 2h8h_A 408 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----VER 479 (535)
T ss_dssp TSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHH----HHT
T ss_pred ccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHc
Confidence 99986532211 11122356788999999999999999999999999999999 99999653211 11110 000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
......+..++..+.+||.+||+.||++|||+++|++.|+.+
T Consensus 480 ----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 480 ----------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011112334567899999999999999999999999998865
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=335.56 Aligned_cols=260 Identities=20% Similarity=0.258 Sum_probs=200.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++... ..+.+.+|+.+++.++ ||||+++++++..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 3679999999999999999997654 6889999998743 3467889999999997 9999999999987
Q ss_pred --CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-CEEEe
Q 015909 150 --DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKLS 226 (398)
Q Consensus 150 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-~~kl~ 226 (398)
....++||||+++++|.+++.. +++..+..++.||+.||.|||+++ |+||||||+|||++.++ .++|+
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred CCCCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEE
Confidence 6678999999999999988742 788999999999999999999999 99999999999999766 89999
Q ss_pred eccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh--
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP-- 303 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~-- 303 (398)
|||++........ .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+......
T Consensus 174 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~ 249 (330)
T 3nsz_A 174 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLG 249 (330)
T ss_dssp CCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHC
T ss_pred eCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcC
Confidence 9999986543322 234578999999999977 6789999999999999999999999954322110 00000000
Q ss_pred ------hhhcc-------------ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 ------YLTSK-------------RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ------~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ...................+.++.+||.+||+.||++|||+++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 00000000011111122246789999999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=332.90 Aligned_cols=268 Identities=25% Similarity=0.358 Sum_probs=187.8
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
...++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 345789999999999999999997654 688999999865432 3356678999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRG----SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
...+..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCE
Confidence 99999999999999999999987421 11245899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCC---ccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 224 KLSDFGLARDGPTGDK---SHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
+|+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ .
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~- 236 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L- 236 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H-
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H-
Confidence 9999999876433221 111234578999999999876 5689999999999999999999999975432110 0
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
............ ............+.++.+++.+||+.||.+||++.+++++
T Consensus 237 -~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 237 -MLTLQNDPPSLE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -HHHHTSSCCCTT---C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHhccCCCccc---cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000000000000 0000011112235678999999999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=334.66 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=206.0
Q ss_pred HHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--------chHHHHHHHHHHcCC-
Q 015909 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--------GHKEWLTEINYLGQL- 135 (398)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l- 135 (398)
.......++|++.++||+|+||.||+|.+.. +|..||||++...... ..+.+.+|+.+++.+
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 157 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 3345556789999999999999999997754 6899999998654311 134578899999999
Q ss_pred CCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 136 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
+||||+++++++......++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+||
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NI 231 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENI 231 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence 79999999999999999999999999999999998653 5899999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc------CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT------GHLTAKSDIYSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~p~~~~ 289 (398)
|++.++.++|+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 232 l~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 232 LLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp EECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999987544322 234679999999999864 35888999999999999999999999653
Q ss_pred CCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 290 RPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ........... ....+. . ...+..+.++|.+||+.||++|||+.+++++
T Consensus 309 ~~~------~~~~~i~~~~~---~~~~~~-~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 309 RQI------LMLRMIMEGQY---QFSSPE-W----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SHH------HHHHHHHHTCC---CCCHHH-H----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHH------HHHHHHHhCCC---CCCCcc-c----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 210 00000000000 000000 0 0124578999999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=360.87 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=200.7
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLL 155 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~l 155 (398)
+.||+|+||+||+|.+.. ..++..||||+++.... ...+.+.+|+.+|+.++||||+++++++. .+..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred CEeccCCCEEEEEEEEcC-------CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEE
Confidence 479999999999997643 23578999999976432 33578999999999999999999999886 456899
Q ss_pred EEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCC
Q 015909 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235 (398)
Q Consensus 156 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~ 235 (398)
||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 447 v~E~~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred EEEccCCCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 999999999999997653 5899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 236 TGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 236 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
..... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.... .... .+.
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~------- 586 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLE------- 586 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHH-------
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHH-------
Confidence 33221 12223456788999999999999999999999999999998 99999753221 1110 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.......+...+.++.+||.+||+.||++||++.++++.|+++..
T Consensus 587 ---~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 587 ---KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ---TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111112233456789999999999999999999999999998753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=337.74 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=193.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 4689999999999999999997654 788999999865322 33456789999999999999999999997
Q ss_pred eCC------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 EDD------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
..+ ..++||||++ ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSC
T ss_pred cccccccccceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCC
Confidence 655 6799999996 578887752 3889999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh----
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV---- 298 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~---- 298 (398)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..........
T Consensus 166 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 242 (371)
T 2xrw_A 166 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242 (371)
T ss_dssp EEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-C
T ss_pred EEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999997643221 223457899999999999999999999999999999999999999754321000000
Q ss_pred -----hh-------hhhhhhcccc-----ccccccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 299 -----EW-------AKPYLTSKRR-----IFRVLDPRL---EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 299 -----~~-------~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
.+ ...+...... ....+.... ........+.++.+||.+||+.||.+|||+++++++=
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00 0000000000 000000000 0001123367899999999999999999999999873
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=345.24 Aligned_cols=200 Identities=24% Similarity=0.337 Sum_probs=172.3
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC------CCCcccce
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL------HHPNLVKL 143 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~~I~~~ 143 (398)
...+|++.++||+|+||+||+|.+.. ++..||+|++.... .....+.+|+.+++.+ +|+||+++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 35679999999999999999997654 78999999997542 2234566777777766 57899999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC-
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN- 222 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~- 222 (398)
++++...+..++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~ 239 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRS 239 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSC
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCc
Confidence 999999999999999995 699999887543 45899999999999999999999998 999999999999998887
Q ss_pred -EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015909 223 -AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 223 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~ 289 (398)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 240 ~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999764322 22357899999999999999999999999999999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=344.62 Aligned_cols=264 Identities=25% Similarity=0.336 Sum_probs=195.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|++.++||+|+||+||+|.+.. ++..||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEecc
Confidence 3468999999999999999998754 68999999986542 1234799999999999999999988642
Q ss_pred ------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC-CCE
Q 015909 151 ------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-YNA 223 (398)
Q Consensus 151 ------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~-~~~ 223 (398)
...++||||+++ +|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||||+.+ +.+
T Consensus 120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp ETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEE
T ss_pred CCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeE
Confidence 236799999965 777766543333357999999999999999999999998 9999999999999955 568
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+..... .+.....
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~ 271 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK 271 (420)
T ss_dssp EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 9999999986543322 2345789999999998764 78999999999999999999999997643211 1111111
Q ss_pred hh-------h-hccccccccccccccC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PY-------L-TSKRRIFRVLDPRLEG-----QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~-------~-~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. + ...........+.... .++...+.++.+||.+||+.||.+||++.|+++|
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 0 0000000000000000 0122335789999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=337.93 Aligned_cols=260 Identities=28% Similarity=0.369 Sum_probs=205.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc----cchHHHHHHHHHHcCC-CCCcccceee
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----QGHKEWLTEINYLGQL-HHPNLVKLVG 145 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~~I~~~~~ 145 (398)
.++|++.+.||+|+||+||+|+... ...++..||+|++..... ...+.+.+|+.+|+.+ +||||+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcc------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 3579999999999999999997632 223789999999875321 2345567899999999 6999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
++...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEE
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEE
Confidence 9999999999999999999999998764 4899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCccccccccccccccccccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .......
T Consensus 201 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~ 277 (355)
T 1vzo_A 201 TDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRR 277 (355)
T ss_dssp SCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHH
T ss_pred eeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHH
Confidence 9999997643222 122334679999999999986 3478899999999999999999999975432221 1111111
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKELE 357 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~L~ 357 (398)
.... ...++...+..+.+||.+||+.||.+|| ++.+++++.-
T Consensus 278 ~~~~------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 278 ILKS------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp HHHC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred Hhcc------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 1110 1122333456789999999999999999 9999988753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=338.51 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=201.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..+|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 5689999999999999999997654 788999999975332 234678899999999999999999999876
Q ss_pred C-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 150 D-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 150 ~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
. ...++||||++ ++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEE
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEE
Confidence 5 36899999995 5999988753 4899999999999999999999999 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCc-cccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 225 LSDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
|+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ....
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~ 245 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHIL 245 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHH
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHH
Confidence 9999999865432211 11234579999999998754 55899999999999999999999999764322111 1000
Q ss_pred hhhhccc--ccc--------ccc-cccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTSKR--RIF--------RVL-DPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~--~~~--------~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..+.... .+. ... ........+ ...+.++.+||.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000 000 000000111 1235678999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=323.93 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=197.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 4679999999999999999997654 68899999986432 23456788999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d 154 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIAD 154 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEee
Confidence 99999999999999999999998764 4899999999999999999999998 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... .........
T Consensus 155 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~ 225 (276)
T 2h6d_A 155 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRG 225 (276)
T ss_dssp CCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH
T ss_pred cccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhc
Confidence 99998754332 1233568999999999987765 6889999999999999999999964311 111111000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 226 ~------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 226 G------------VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp C------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred C------------cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 001122335678999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=359.85 Aligned_cols=267 Identities=24% Similarity=0.364 Sum_probs=210.7
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
....++|++.+.||+|+||.||+|.+... ...+..||+|.+..... ...+.+.+|+.+++.++||||++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSP------ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCS------SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecC------CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 33457899999999999999999987531 12467899999875432 334678899999999999999999998
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+. ++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEEC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEE
Confidence 84 567899999999999999998654 35899999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+.... +... ..
T Consensus 534 DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~---~i- 605 (656)
T 2j0j_A 534 DFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---RI- 605 (656)
T ss_dssp CCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HH-
T ss_pred ecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HH-
Confidence 9999987543322 12223456789999999999999999999999999999997 99999653211 1111 00
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhh
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRN 364 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 364 (398)
... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.++
T Consensus 606 ~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~k 654 (656)
T 2j0j_A 606 ENG----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 654 (656)
T ss_dssp HHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HcC----------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 000 0111233446789999999999999999999999999999976654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=341.65 Aligned_cols=254 Identities=13% Similarity=0.021 Sum_probs=183.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHH---HHHHcCCCCCccccee-
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTE---INYLGQLHHPNLVKLV- 144 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~l~h~~I~~~~- 144 (398)
..|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+.+.+| +.+|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 458899999999999999997654 689999999987543 224456677 455555 799988754
Q ss_pred ------eEEEeC-----------------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHH------HHHHHHHHHHH
Q 015909 145 ------GYCLED-----------------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLR------MKIALGAANGL 195 (398)
Q Consensus 145 ------~~~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~------~~i~~qi~~al 195 (398)
+++... ...++||||++ ++|.+++...+. .+....+ ..++.||+.||
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL 207 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLA 207 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHH
Confidence 455433 23799999997 899999987542 2344445 67789999999
Q ss_pred HHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc--CCCCCchhHHHHH
Q 015909 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFG 273 (398)
Q Consensus 196 ~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG 273 (398)
.|||+++ |+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||
T Consensus 208 ~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 208 ANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp HHHHHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred HHHHHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence 9999999 999999999999999999999999999864321 113457799999999987 7799999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 015909 274 VVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVV 353 (398)
Q Consensus 274 ~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 353 (398)
|++|+|++|+.||.............. ..................+..+.+||.+||+.||++|||+.+++
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred HHHHHHHhCCCCCCCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 999999999999976533221111000 00000001111111123467899999999999999999999998
Q ss_pred HH
Q 015909 354 KE 355 (398)
Q Consensus 354 ~~ 355 (398)
++
T Consensus 352 ~h 353 (371)
T 3q60_A 352 ET 353 (371)
T ss_dssp TS
T ss_pred cC
Confidence 74
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=336.44 Aligned_cols=267 Identities=19% Similarity=0.325 Sum_probs=199.1
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
...++|++.+.||+|+||.||+|.+.. .+++|.+.... ....+.+.+|+.+++.++||||++++++
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 345789999999999999999997632 48999986532 2234557789999999999999999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+......++||||+++++|.+++...+ ..+++..++.++.||+.||.|||+++ |+||||||+||+++ ++.++|+
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~ 171 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVIT 171 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEEC
T ss_pred EecCCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEe
Confidence 999999999999999999999987643 45889999999999999999999998 99999999999998 6799999
Q ss_pred eccCCcCCCCCC---Cccccccccccccccccccccc---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 015909 227 DFGLARDGPTGD---KSHVSTRVMGTYGYAAPEYLAT---------GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE 294 (398)
Q Consensus 227 Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~ 294 (398)
|||++....... .........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-- 249 (319)
T 2y4i_B 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-- 249 (319)
T ss_dssp CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--
T ss_pred ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 999987543211 1112233568999999999864 45788999999999999999999999653211
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhccCCc
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRP 369 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~~~ 369 (398)
.. ... ... ...+. ......+.++.+++.+||+.||.+|||+.++++.|+.+.+.......+
T Consensus 250 -~~---~~~-~~~------~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~ 310 (319)
T 2y4i_B 250 -AI---IWQ-MGT------GMKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310 (319)
T ss_dssp -HH---HHH-HHT------TCCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred -HH---HHH-hcc------CCCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence 00 000 000 00000 011123456889999999999999999999999999988766554433
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=339.25 Aligned_cols=273 Identities=21% Similarity=0.298 Sum_probs=185.6
Q ss_pred cCCCC-CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe-
Q 015909 72 RNFRP-DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE- 149 (398)
Q Consensus 72 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~- 149 (398)
+.|++ .++||+|+||+||+|.+.. ..++..||+|.+..... ...+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~-------~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESS-------SSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEcc-------CCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 44666 5689999999999998643 22678999999975532 3568899999999999999999999965
Q ss_pred -CCceEEEEeecCCCCHHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE----cC
Q 015909 150 -DDHRLLVYEFMPRGSMENHLFRRG-----SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL----DS 219 (398)
Q Consensus 150 -~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv----~~ 219 (398)
....++||||++ ++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||| +.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCC
Confidence 678899999995 58888776332 11234899999999999999999999999 9999999999999 67
Q ss_pred CCCEEEeeccCCcCCCCCCCc-cccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc--
Q 015909 220 NYNAKLSDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH-- 295 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~-- 295 (398)
++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.........
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 789999999999875432211 22334679999999999987 45899999999999999999999999764332100
Q ss_pred ----chhhhhhhhhhcc--c------------cccccccccccCCC---------CHHHHHHHHHHHHHhccCCCCCCCC
Q 015909 296 ----NLVEWAKPYLTSK--R------------RIFRVLDPRLEGQF---------SLPQAQKAASLALQCLSVEPKLRPD 348 (398)
Q Consensus 296 ----~~~~~~~~~~~~~--~------------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps 348 (398)
+........+... . .....+........ ....+..+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 0000000000000 0 00000000000000 0011457889999999999999999
Q ss_pred HHHHHHHH
Q 015909 349 MDEVVKEL 356 (398)
Q Consensus 349 ~~ell~~L 356 (398)
+++++++=
T Consensus 328 a~e~L~hp 335 (405)
T 3rgf_A 328 SEQAMQDP 335 (405)
T ss_dssp HHHHHTSG
T ss_pred HHHHhcCh
Confidence 99999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=328.97 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=197.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--------cchHHHHHHHHHHcCCCCCccc
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--------QGHKEWLTEINYLGQLHHPNLV 141 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~I~ 141 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 45689999999999999999997654 789999999865422 1223578999999999999999
Q ss_pred ceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC
Q 015909 142 KLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY 221 (398)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~ 221 (398)
++++++... ..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 79 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 79 KIKNFFDAE-DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQE 151 (322)
T ss_dssp CEEEEEESS-SEEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSS
T ss_pred eEeeEEcCC-ceEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCC
Confidence 999998665 489999999999999988754 35899999999999999999999998 99999999999998665
Q ss_pred C---EEEeeccCCcCCCCCCCcccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 015909 222 N---AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295 (398)
Q Consensus 222 ~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~ 295 (398)
. ++|+|||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|..||........
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 227 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS- 227 (322)
T ss_dssp SSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-
T ss_pred CCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-
Confidence 4 999999999865332 1223457899999999974 46788999999999999999999999975432211
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
+..... ..... ..+.. ....+..+.+||.+||+.||++||++.+++++
T Consensus 228 -~~~~~~---~~~~~----~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 228 -LKDQIT---SGKYN----FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -HHHHHH---HTCCC----CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHHH---hCccc----cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111000 00000 00000 01235678999999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=338.49 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=184.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4689999999999999999997654 789999999965422 33567889999999999999999999986
Q ss_pred eC------CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 ED------DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
.. ...++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCC
Confidence 54 5679999999 7899988865 34899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ....
T Consensus 171 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i 242 (367)
T 2fst_X 171 LKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLI 242 (367)
T ss_dssp EEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH
T ss_pred EEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 999999999764321 234578999999999877 6789999999999999999999999975432110 0000
Q ss_pred hhhhhcc-------------ccccccccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTSK-------------RRIFRVLDPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~~-------------~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....... ......+.. ....+ ...+..+.+||.+||+.||.+|||+.+++++
T Consensus 243 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 243 LRLVGTPGAELLKKISSESARNYIQSLTQ--MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHCSCCHHHHTTCCCHHHHHHHHTSCC--CCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHhhhHHHHHHHhccCC--CCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 000000000 00011 1125678999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=324.13 Aligned_cols=254 Identities=25% Similarity=0.349 Sum_probs=204.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---------cchHHHHHHHHHHcCCC-CCc
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---------QGHKEWLTEINYLGQLH-HPN 139 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~~ 139 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++++. |||
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hhhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 35689999999999999999997654 789999999865431 12356789999999995 999
Q ss_pred ccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC
Q 015909 140 LVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219 (398)
Q Consensus 140 I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~ 219 (398)
|+++++++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDD 159 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECT
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcC
Confidence 9999999999999999999999999999998753 5899999999999999999999998 999999999999999
Q ss_pred CCCEEEeeccCCcCCCCCCCcccccccccccccccccccc------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA------TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
++.++|+|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~- 235 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM- 235 (298)
T ss_dssp TCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred CCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-
Confidence 9999999999998654332 223457899999999985 456888999999999999999999999643211
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........... ..........+..+.+++.+||+.||.+|||+.+++++
T Consensus 236 -----~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 236 -----LMLRMIMSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp -----HHHHHHHHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -----HHHHHHhcCCc--------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11111111000 00011112346789999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=338.69 Aligned_cols=263 Identities=25% Similarity=0.316 Sum_probs=192.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..+|++.++||+|+||+||+|.+.. ++ .||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~---------~~-~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVE---------SD-EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETT---------TE-EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECC---------CC-eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 4579999999999999999997653 33 488887754321 123799999999999999999998664
Q ss_pred Cc------eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc-CCCCE
Q 015909 151 DH------RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD-SNYNA 223 (398)
Q Consensus 151 ~~------~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-~~~~~ 223 (398)
.. .++||||+++ ++...+.........+++..+..++.||+.||.|||+++ |+||||||+||||+ .++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEE
T ss_pred CCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcE
Confidence 43 7899999965 554444432222356899999999999999999999998 99999999999998 79999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..... .+.....
T Consensus 182 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~ 256 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIK 256 (394)
T ss_dssp EECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 9999999987543322 2345789999999998764 58999999999999999999999997643211 1111100
Q ss_pred hh--------hhccccc-----cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PY--------LTSKRRI-----FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~--------~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ....... .......+...++...+.++.+||.+||+.||.+|||+.++++|
T Consensus 257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 0000000 00000000011122245789999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=331.96 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=199.2
Q ss_pred CHHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCC--CC
Q 015909 63 SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLH--HP 138 (398)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~ 138 (398)
.++.+....++|++.+.||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|+.+++.++ |+
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 88 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCT
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCC
Confidence 33344445678999999999999999999653 478899999965432 33567889999999997 59
Q ss_pred cccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc
Q 015909 139 NLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD 218 (398)
Q Consensus 139 ~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~ 218 (398)
||+++++++...+..++||| +.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++
T Consensus 89 ~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 89 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV 161 (313)
T ss_dssp TBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE
T ss_pred ceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE
Confidence 99999999999999999999 55889999998753 5899999999999999999999998 99999999999996
Q ss_pred CCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc-----------CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-----------GHLTAKSDIYSFGVVLLEILSGRRAID 287 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~p~~ 287 (398)
+ +.++|+|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 162 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 162 D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 4 8999999999987544333223344578999999999865 468889999999999999999999996
Q ss_pred CCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 288 KNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
..... ..... ..........++...+.++.+++.+||+.||.+||++.+++++-
T Consensus 241 ~~~~~-----~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 241 QIINQ-----ISKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp TCCSH-----HHHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hHHHH-----HHHHH----------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 43211 00011 11111111122222356789999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=335.20 Aligned_cols=270 Identities=22% Similarity=0.300 Sum_probs=197.7
Q ss_pred HHHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-----------chHHHHHHHHHH
Q 015909 64 YSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-----------GHKEWLTEINYL 132 (398)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l 132 (398)
..++....++|++.+.||+|+||.||+|.+. ++..||+|.+...... ..+.+.+|+.++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 83 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHH
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHH
Confidence 4567778899999999999999999999653 4889999998643221 126789999999
Q ss_pred cCCCCCcccceeeEEEeC-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015909 133 GQLHHPNLVKLVGYCLED-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIY 207 (398)
Q Consensus 133 ~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH 207 (398)
+.++||||+++++++... ...++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+++ |+|
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH 157 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAG--VVH 157 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc--CEe
Confidence 999999999999998543 35799999996 68888887543 46899999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 015909 208 RDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAI 286 (398)
Q Consensus 208 ~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~ 286 (398)
|||||+||+++.++.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 158 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 158 RDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp CCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 9999999999999999999999997543222 2234578999999999877 67899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhhhc----------cccccccccccc---cC----CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 015909 287 DKNRPTGEHNLVEWAKPYLTS----------KRRIFRVLDPRL---EG----QFSLPQAQKAASLALQCLSVEPKLRPDM 349 (398)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~ 349 (398)
....... ........... ............ .. ......+..+.+||.+||+.||.+|||+
T Consensus 235 ~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 311 (362)
T 3pg1_A 235 RGSTFYN---QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311 (362)
T ss_dssp CCSSHHH---HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCHHH---HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 7542111 00000000000 000000000000 00 0111225678999999999999999999
Q ss_pred HHHHHH
Q 015909 350 DEVVKE 355 (398)
Q Consensus 350 ~ell~~ 355 (398)
.+++++
T Consensus 312 ~ell~h 317 (362)
T 3pg1_A 312 EQALRH 317 (362)
T ss_dssp HHHHTS
T ss_pred HHHHcC
Confidence 999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=329.74 Aligned_cols=272 Identities=25% Similarity=0.339 Sum_probs=191.9
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceee
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
......++|++.+.||+|+||+||+|.+.. ++..||+|.+.... .......+++..++.++||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~ 86 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQS 86 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEE
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHH
Confidence 445667899999999999999999997754 68899999886543 22345677888888899999999999
Q ss_pred EEEeCCc-------eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCceecCCCCCCEE
Q 015909 146 YCLEDDH-------RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH--SAEPKVIYRDFKASNIL 216 (398)
Q Consensus 146 ~~~~~~~-------~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~ivH~Dlkp~Nil 216 (398)
++..... .++||||+++ +|...+.........+++..+..++.|++.||.||| +++ |+||||||+|||
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIl 163 (360)
T 3e3p_A 87 YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVL 163 (360)
T ss_dssp EEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEE
T ss_pred hhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEE
Confidence 9976443 7899999965 666555543333356899999999999999999999 777 999999999999
Q ss_pred EcC-CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 015909 217 LDS-NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE 294 (398)
Q Consensus 217 v~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~ 294 (398)
++. ++.++|+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 164 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 239 (360)
T 3e3p_A 164 VNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG- 239 (360)
T ss_dssp EETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred EeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-
Confidence 996 89999999999987544322 2345789999999998664 48999999999999999999999997643211
Q ss_pred cchhhhhhhhhhccccc----------ccccc------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRI----------FRVLD------PRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~----------~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+.............. ..... ...........+.++.+||.+||+.||.+|||+.+++++
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 240 -QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp -HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111110000000000 00000 000011122346789999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=322.49 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=194.5
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence 35679999999999999999997654 6889999998643 2334678899999999999999999998865
Q ss_pred -------------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 150 -------------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 150 -------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil 148 (303)
T 1zy4_A 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIF 148 (303)
T ss_dssp CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEE
Confidence 356789999999999999998654 35788999999999999999999998 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCC------------cccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCC
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDK------------SHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGR 283 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~ 283 (398)
++.++.++|+|||++........ ........||+.|+|||++.+. .++.++||||||+++|+|++
T Consensus 149 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 99999999999999986542210 1122345689999999999764 68999999999999999998
Q ss_pred CCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 284 RAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
||... .+.......... ........++...+..+.+++.+||+.||.+|||+.+++++
T Consensus 227 -p~~~~-----~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 227 -PFSTG-----MERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -CCSSH-----HHHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -ccCCc-----hhHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 44311 000111110000 01112223334456678999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=320.55 Aligned_cols=255 Identities=27% Similarity=0.368 Sum_probs=204.1
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceee
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~ 145 (398)
....++|++.+.||+|+||.||+|.+.. ++..||+|++.... ......+.+|+.++++++||||+++++
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEE
Confidence 3456789999999999999999997654 68899999986432 244677899999999999999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC---CC
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN---YN 222 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~---~~ 222 (398)
++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~ 162 (287)
T 2wei_A 89 ILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCD 162 (287)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred EEeCCCeEEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCccc
Confidence 9999999999999999999999987664 4899999999999999999999998 9999999999999754 47
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
++|+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ....
T Consensus 163 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~ 232 (287)
T 2wei_A 163 IKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILK 232 (287)
T ss_dssp EEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred EEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 99999999876533221 223458999999999875 4899999999999999999999999653211 1111
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........ .. .......+.++.++|.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~----~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 233 RVETGKYA----FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHCCCC----CC----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHcCCCC----CC----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 11100000 00 00001235678999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=332.15 Aligned_cols=261 Identities=19% Similarity=0.257 Sum_probs=202.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc-----------------hHHHHHHHHHHc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-----------------HKEWLTEINYLG 133 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~ 133 (398)
.++|++.+.||+|+||.||+|.+ ++..||+|.+....... .+.+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999965 58899999986432211 177899999999
Q ss_pred CCCCCcccceeeEEEeCCceEEEEeecCCCCHHHH------HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCce
Q 015909 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENH------LFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVI 206 (398)
Q Consensus 134 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~iv 206 (398)
.++||||+++++++.+.+..++||||+++++|.++ +.... ...+++..++.++.||+.||.|||+ ++ |+
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~ 174 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEKN--IC 174 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTSC--EE
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccCC--Ee
Confidence 99999999999999999999999999999999988 44321 3569999999999999999999998 88 99
Q ss_pred ecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCC-chhHHHHHHHHHHHHhCCC
Q 015909 207 YRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTA-KSDIYSFGVVLLEILSGRR 284 (398)
Q Consensus 207 H~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~~l~ell~g~~ 284 (398)
||||||+||+++.++.++|+|||++...... ......||..|+|||++.+. .++. ++||||||+++|+|++|..
T Consensus 175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865332 23446789999999999877 6666 8999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhhhccccccc----c---ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 285 AIDKNRPTGEHNLVEWAKPYLTSKRRIFR----V---LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
||...... ..... ........... . .............+.++.+|+.+||+.||.+|||+.+++++
T Consensus 251 pf~~~~~~--~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 251 PFSLKISL--VELFN---NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SSCCSSCS--HHHHH---HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCCcH--HHHHH---HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99754321 11111 00000000000 0 00000000112346789999999999999999999999984
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=327.95 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=203.8
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCC------cccce
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP------NLVKL 143 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------~I~~~ 143 (398)
..++|++.+.||+|+||+||+|.+.. .++..||+|++.... ...+.+.+|+.+++.++|+ +|+++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHK--------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecC--------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 35689999999999999999997632 268899999997532 3345678899998888655 59999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC----
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---- 219 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~---- 219 (398)
++++...+..++||||+ +++|.+++...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEE
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccc
Confidence 99999999999999999 8899999987643 46889999999999999999999998 999999999999987
Q ss_pred ---------------CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCC
Q 015909 220 ---------------NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284 (398)
Q Consensus 220 ---------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~ 284 (398)
++.++|+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 678999999999764322 234578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhhhc--------c--ccc------------------cccccc-cccCCCCHHHHHHHHHHH
Q 015909 285 AIDKNRPTGEHNLVEWAKPYLTS--------K--RRI------------------FRVLDP-RLEGQFSLPQAQKAASLA 335 (398)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~--------~--~~~------------------~~~~~~-~~~~~~~~~~~~~l~~li 335 (398)
||........ .......... . ... .....+ ..........+.++.+||
T Consensus 233 pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 309 (339)
T 1z57_A 233 VFPTHDSKEH---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309 (339)
T ss_dssp SCCCSCHHHH---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCChHHH---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence 9975432111 1000000000 0 000 000000 000112345578899999
Q ss_pred HHhccCCCCCCCCHHHHHHH
Q 015909 336 LQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 336 ~~~l~~dP~~Rps~~ell~~ 355 (398)
.+||+.||.+|||+.|++++
T Consensus 310 ~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 310 QKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHTCSSTTTSCCHHHHTTS
T ss_pred HHHhCcCcccccCHHHHhcC
Confidence 99999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=325.24 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=194.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEE--
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCL-- 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~-- 148 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 4689999999999999999997754 78999999987665555677899999999999999999999873
Q ss_pred ------------eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 149 ------------EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 149 ------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
.....++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil 152 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLF 152 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEE
Confidence 3467899999996 699998864 35899999999999999999999998 999999999999
Q ss_pred Ec-CCCCEEEeeccCCcCCCCCCC-ccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 217 LD-SNYNAKLSDFGLARDGPTGDK-SHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 217 v~-~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
++ .++.++|+|||++........ ........+|..|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 232 (320)
T 2i6l_A 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232 (320)
T ss_dssp EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 97 567999999999986533211 111233467999999998865 678999999999999999999999997543211
Q ss_pred Ccchhhhhhhh--hh--ccccccc----ccccccc-CCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPY--LT--SKRRIFR----VLDPRLE-GQF-----SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~--~~--~~~~~~~----~~~~~~~-~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ........ .. ....+.. ....... ... ....+.++.+||.+||+.||++|||+.+++++
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 233 Q--MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp H--HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred H--HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 00000000 00 0000000 0000000 000 11235789999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=331.85 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=198.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 4689999999999999999997654 789999999964322 234567899999999999999999998765
Q ss_pred C-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEE
Q 015909 150 D-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 150 ~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
. ...++||||+. ++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEE
T ss_pred cccCccceEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEE
Confidence 4 67899999995 6999988763 4899999999999999999999998 99999999999999999999
Q ss_pred EeeccCCcCCCCCCCcc--------ccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 015909 225 LSDFGLARDGPTGDKSH--------VSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEH 295 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~ 295 (398)
|+|||++.......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+......
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 231 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ- 231 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence 99999998654322111 1223578999999998754 6789999999999999999999999975431100
Q ss_pred chhhhhhhhhhcc---cc--------cccccc--cccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 296 NLVEWAKPYLTSK---RR--------IFRVLD--PRLE----GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 296 ~~~~~~~~~~~~~---~~--------~~~~~~--~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........... .. ...... +... .......+.++.+||.+||+.||++|||+.+++++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 232 --LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp --HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 00 000000 0000 00011235778999999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=333.97 Aligned_cols=265 Identities=18% Similarity=0.245 Sum_probs=201.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-----------CCc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-----------HPN 139 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~ 139 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|++.... ...+.+.+|+.+++.+. |||
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 3579999999999999999997654 78999999997542 23456788999998886 899
Q ss_pred ccceeeEEEeCC----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCC
Q 015909 140 LVKLVGYCLEDD----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASN 214 (398)
Q Consensus 140 I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~N 214 (398)
|+++++++...+ ..++|||++ +++|.+++..... ..+++..+..++.||+.||.|||++ + |+||||||+|
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~N 162 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPEN 162 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGG
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHH
Confidence 999999988654 789999999 8899999987543 4589999999999999999999998 8 9999999999
Q ss_pred EEEc------CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015909 215 ILLD------SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDK 288 (398)
Q Consensus 215 ilv~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~ 288 (398)
||++ ..+.++|+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9994 4457999999999765322 2335789999999999999999999999999999999999999976
Q ss_pred CCCCCCcchhhhhhhhh---------------------hccccccccccc---------cccCCCCHHHHHHHHHHHHHh
Q 015909 289 NRPTGEHNLVEWAKPYL---------------------TSKRRIFRVLDP---------RLEGQFSLPQAQKAASLALQC 338 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~ 338 (398)
................. ............ .....++...+.++.+||.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 317 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence 43221110000000000 000000000000 001234567788999999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 015909 339 LSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 339 l~~dP~~Rps~~ell~~ 355 (398)
|+.||++|||+.+++++
T Consensus 318 L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 318 LQLDPRKRADAGGLVNH 334 (373)
T ss_dssp GCSSTTTCBCHHHHHTC
T ss_pred hccCccccCCHHHHhhC
Confidence 99999999999999885
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.34 Aligned_cols=260 Identities=25% Similarity=0.353 Sum_probs=182.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHH-HHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEIN-YLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+..|+. +++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 3678999999999999999997654 789999999975432 22344555665 778889999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEEcCCCCEEEe
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRR-GSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
..+..++||||+++ +|.+++... ......+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEEC
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEc
Confidence 99999999999964 888777632 11125689999999999999999999998 8 9999999999999999999999
Q ss_pred eccCCcCCCCCCCccccccccccccccccccc----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL----ATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
|||++....... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||........ .
T Consensus 169 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~-- 238 (327)
T 3aln_A 169 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q-- 238 (327)
T ss_dssp CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------
T ss_pred cCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H--
Confidence 999997653322 12234689999999998 456789999999999999999999999975322100 0
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
.........+.+........+..+.+|+.+||+.||++||++.+++++--
T Consensus 239 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 239 -----LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp ------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred -----HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 00000001111111112234568999999999999999999999998743
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=330.69 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=196.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 5689999999999999999997654 789999999975432 22467889999999999999999999998
Q ss_pred eCCce------EEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 EDDHR------LLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
..+.. ++||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCC
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCC
Confidence 77655 99999995 68877763 34899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
++|+|||++...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ +....
T Consensus 183 ~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~ 255 (371)
T 4exu_A 183 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQIL 255 (371)
T ss_dssp EEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH
T ss_pred EEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH
Confidence 999999999764322 234578999999999977 7889999999999999999999999975421110 00000
Q ss_pred hhhhhcccc------------ccccccccccC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTSKRR------------IFRVLDPRLEG---QFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~~~~------------~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......... ........... ......+.++.+||.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 256 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000 00000000000 0011235789999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=327.82 Aligned_cols=256 Identities=24% Similarity=0.293 Sum_probs=175.7
Q ss_pred hcCCCCC-ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPD-SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++. ++||+|+||+||+|.+.. ++..||+|++.... ....+....++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 4578885 479999999999997764 78999999986431 222223334566789999999999876
Q ss_pred ----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC---CCC
Q 015909 150 ----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NYN 222 (398)
Q Consensus 150 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~---~~~ 222 (398)
....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCce
Confidence 4458999999999999999987643 46899999999999999999999998 999999999999975 455
Q ss_pred EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
++|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........... ..
T Consensus 170 ~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~ 242 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MK 242 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HH
Confidence 9999999997643221 2345789999999999888999999999999999999999999965432211000 00
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
..+ ...............+.++.+||.+||+.||.+|||+.+++++-.
T Consensus 243 ------~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 243 ------RRI-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred ------Hhh-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 000 000000111111234678999999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.71 Aligned_cols=267 Identities=25% Similarity=0.354 Sum_probs=201.4
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCC---CCCccccee
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQL---HHPNLVKLV 144 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~I~~~~ 144 (398)
..++|++.+.||+|+||.||+|.+.. .++..||+|.+..... .....+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 45789999999999999999997632 2578999999864322 2233566777777766 899999999
Q ss_pred eEEE-----eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC
Q 015909 145 GYCL-----EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219 (398)
Q Consensus 145 ~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~ 219 (398)
+++. .....++||||++ ++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~ 155 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTS 155 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcC
Confidence 9987 4567899999996 699999987543 45899999999999999999999998 999999999999999
Q ss_pred CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
++.++|+|||++...... .......||..|+|||++.+..++.++||||||+++|+|++|+.||....... ...
T Consensus 156 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~ 229 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLG 229 (326)
T ss_dssp TCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH
T ss_pred CCCEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH
Confidence 999999999999764322 12334678999999999999999999999999999999999999997543211 100
Q ss_pred hhhhhhhc--cccc----------cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPYLTS--KRRI----------FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~--~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........ .... ................+..+.+||.+||+.||++||++.+++++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 0000 00000000011222346788999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=326.71 Aligned_cols=246 Identities=24% Similarity=0.424 Sum_probs=192.7
Q ss_pred HHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc------chHHHHHHHHHHcCC----C
Q 015909 67 LRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ------GHKEWLTEINYLGQL----H 136 (398)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~ 136 (398)
.....++|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.+++.+ +
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 96 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCC
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCC
Confidence 34456789999999999999999996654 6889999999754321 223345788888888 8
Q ss_pred CCcccceeeEEEeCCceEEEEee-cCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 137 HPNLVKLVGYCLEDDHRLLVYEF-MPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 137 h~~I~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
||||+++++++...+..++|||+ +.+++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 97 h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni 170 (312)
T 2iwi_A 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENI 170 (312)
T ss_dssp CSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGE
T ss_pred CCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhE
Confidence 99999999999999999999999 78899999998764 4899999999999999999999998 99999999999
Q ss_pred EEc-CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 015909 216 LLD-SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLT-AKSDIYSFGVVLLEILSGRRAIDKNRPTG 293 (398)
Q Consensus 216 lv~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~p~~~~~~~~ 293 (398)
+++ .++.++|+|||++....... .....||..|+|||++.+..+. .++||||||+++|+|++|+.||....
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--- 243 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--- 243 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred EEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---
Confidence 999 88999999999998754322 2345689999999999877664 58999999999999999999996321
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ...++...+..+.++|.+||+.||++|||+.+++++
T Consensus 244 ---------~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ---------EILEA------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---------HHHHT------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------HHhhh------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 011222345678999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=330.11 Aligned_cols=204 Identities=24% Similarity=0.323 Sum_probs=171.7
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CC-----ccc
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HP-----NLV 141 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~I~ 141 (398)
....++|++.+.||+|+||+||+|.+.. ++..||+|++.... .....+..|+.+++.++ |+ +|+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 3446789999999999999999997654 78899999997532 22455677888887774 44 599
Q ss_pred ceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc--C
Q 015909 142 KLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD--S 219 (398)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~--~ 219 (398)
++++++...+..++||||++ ++|.+++..... ..+++..+..++.||+.||.|||++..+|+||||||+|||++ .
T Consensus 120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred EeeeeeccCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence 99999999999999999995 599999987542 458999999999999999999996433499999999999995 5
Q ss_pred CCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 015909 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289 (398)
Q Consensus 220 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~ 289 (398)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 197 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 788999999999875332 23457899999999999999999999999999999999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=328.49 Aligned_cols=247 Identities=21% Similarity=0.378 Sum_probs=200.8
Q ss_pred HHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc------chHHHHHHHHHHcCCC--C
Q 015909 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ------GHKEWLTEINYLGQLH--H 137 (398)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h 137 (398)
+.....++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.+. |
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 107 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSS
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCC
Confidence 334456789999999999999999997654 7899999998654322 2244668999999996 5
Q ss_pred CcccceeeEEEeCCceEEEEeecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 138 PNLVKLVGYCLEDDHRLLVYEFMPR-GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 138 ~~I~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
+||+++++++...+..++|||++.+ ++|.+++...+ .+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 108 ~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIl 181 (320)
T 3a99_A 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENIL 181 (320)
T ss_dssp CSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEE
T ss_pred CCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEE
Confidence 9999999999999999999999975 89999998754 5899999999999999999999998 999999999999
Q ss_pred Ec-CCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 015909 217 LD-SNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGE 294 (398)
Q Consensus 217 v~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~ 294 (398)
++ .++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....
T Consensus 182 l~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---- 253 (320)
T 3a99_A 182 IDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253 (320)
T ss_dssp EETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred EeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence 99 78999999999998754322 234568999999999987766 678999999999999999999996321
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... ...+...+.++.+||.+||+.||++|||+.+++++
T Consensus 254 --------~~~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 --------EIIRGQ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --------HHHHCC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------hhhccc------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00112235678999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=326.14 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=196.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|.+.+.||+|+||.||+|.+.. +|..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 4679999999999999999997654 789999999975432 22456789999999999999999999998
Q ss_pred eCCc------eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 EDDH------RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
.... .++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~ 164 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCE 164 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCC
T ss_pred cccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCc
Confidence 7654 499999996 58877653 24899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
++|+|||++...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+..... .....
T Consensus 165 ~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i 236 (353)
T 3coi_A 165 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQI 236 (353)
T ss_dssp EEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHH
T ss_pred EEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence 999999999764322 233578999999999877 678999999999999999999999997543211 00000
Q ss_pred hhhhhc-c----------------ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTS-K----------------RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~-~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... . ..+.......+ .......+.++.+||.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 0 00000000000 11122446789999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=324.56 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=200.7
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCc------ccce
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN------LVKL 143 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~------I~~~ 143 (398)
..++|++.+.||+|+||+||+|.+.. ..+..||+|++.... ...+.+.+|+.+++.++|++ ++.+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHA--------RGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecC--------CCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 35789999999999999999997654 124789999997532 33456778999999887655 8999
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEE------
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILL------ 217 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv------ 217 (398)
++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEE
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccc
Confidence 99999999999999999 6677777766532 46899999999999999999999998 9999999999999
Q ss_pred -------------cCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCC
Q 015909 218 -------------DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284 (398)
Q Consensus 218 -------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~ 284 (398)
+.++.++|+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 56789999999999764322 233578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhhhc--------ccc--c------------------cccccc-cccCCCCHHHHHHHHHHH
Q 015909 285 AIDKNRPTGEHNLVEWAKPYLTS--------KRR--I------------------FRVLDP-RLEGQFSLPQAQKAASLA 335 (398)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~--------~~~--~------------------~~~~~~-~~~~~~~~~~~~~l~~li 335 (398)
||....... ........... ... . .....+ ..........+.++.+||
T Consensus 238 pf~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 238 LFQTHENRE---HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp SCCCSSHHH---HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCHHH---HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence 997533211 11000000000 000 0 000000 000112234467899999
Q ss_pred HHhccCCCCCCCCHHHHHHH
Q 015909 336 LQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 336 ~~~l~~dP~~Rps~~ell~~ 355 (398)
.+||+.||.+|||+.+++++
T Consensus 315 ~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 315 RRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHTCSSTTTSCCHHHHTTS
T ss_pred HHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999865
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=330.81 Aligned_cols=255 Identities=25% Similarity=0.323 Sum_probs=187.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~ 150 (398)
+.|.+.++||+|+||+||.+... +|..||||.+... ..+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 45666789999999999865321 5889999998653 235678899999876 899999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCC---CHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC-------
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPL---SWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN------- 220 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l---~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~------- 220 (398)
+..++||||++ ++|.+++.......... .+..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccc
Confidence 99999999995 69999998654321111 23345779999999999999998 9999999999999654
Q ss_pred ------CCEEEeeccCCcCCCCCCCcc--ccccccccccccccccccc-------CCCCCchhHHHHHHHHHHHHh-CCC
Q 015909 221 ------YNAKLSDFGLARDGPTGDKSH--VSTRVMGTYGYAAPEYLAT-------GHLTAKSDIYSFGVVLLEILS-GRR 284 (398)
Q Consensus 221 ------~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~ 284 (398)
+.++|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 489999999998764432211 1234579999999999975 678999999999999999999 999
Q ss_pred CCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 285 AIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
||....... .. ....... .+..........+.++.+||.+||+.||.+|||+.+++++
T Consensus 239 Pf~~~~~~~----~~----i~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 239 PFGDKYSRE----SN----IIRGIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTCSTTTHH----HH----HHHTCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCchhhH----HH----HhcCCCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 996432110 00 0000000 0111122345677899999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.18 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=182.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-c-hHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-G-HKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+...... . ...+.++..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 3578899999999999999997754 6889999999754332 1 233445556788889999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceecCCCCCCEEEcCCCCEEEee
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-EPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
..+..++||||+ ++.+..+..... ..+++..++.++.||+.||.|||+. + |+|+||||+||+++.++.++|+|
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~d 168 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCD 168 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECC
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEE
Confidence 999999999999 666666665433 4689999999999999999999985 8 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
||++....... ......||+.|+|||++. +..++.++||||||+++|+|++|+.||...... .....
T Consensus 169 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~ 240 (318)
T 2dyl_A 169 FGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLT 240 (318)
T ss_dssp CTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH
T ss_pred CCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHH
Confidence 99987653322 123356899999999994 567889999999999999999999999653211 11111
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... .+... .....+.++.+++.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~-------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 241 KVLQEE-------PPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHSC-------CCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHhccC-------CCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111110 00000 111235678999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=327.71 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=185.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC-CCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~ 150 (398)
.+|.+.++||+|+||+||.... .++..||||++...... .+.+|+.+|+.+ +||||+++++++.+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~----------~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM----------FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE----------SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEecCCeeecCcCEEEEEEEE----------eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 4688889999999999653321 15789999999754332 346899999998 799999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-----CCCEEE
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-----NYNAKL 225 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-----~~~~kl 225 (398)
...++||||++ ++|.+++..... .+....++.++.||+.||.|||+++ |+||||||+|||++. ...++|
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred CEEEEEEECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEE
Confidence 99999999995 699999986543 2344456789999999999999999 999999999999953 346889
Q ss_pred eeccCCcCCCCCCCc-ccccccccccccccccccc---cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhh
Q 015909 226 SDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLA---TGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~ 300 (398)
+|||+++........ .......||+.|+|||++. ...++.++|||||||++|+|++ |..||.......
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------- 237 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------- 237 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------
Confidence 999999875433211 1233467999999999997 4567889999999999999999 999995422110
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ..... . ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus 238 ~~~-~~~~~------~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 238 ANI-LLGAC------S-LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHH-HTTCC------C-CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHH-HhccC------C-ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 000 00000 0 00111223456678999999999999999999999953
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=308.25 Aligned_cols=233 Identities=13% Similarity=0.098 Sum_probs=184.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc---hHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||.||+|++.. ++..||+|++....... .+.+.+|+.++..++||||+++++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 4679999999999999999997754 68999999997654322 36788999999999999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
...+..|+||||+++++|.+++... .....+..++.||+.||.|||+++ |+||||||+|||++.++.++|++
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~ 172 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAY 172 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECS
T ss_pred EECCcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEe
Confidence 9999999999999999999998532 355678889999999999999999 99999999999999999999985
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
++ |++ .++.++|||||||++|+|++|+.||............
T Consensus 173 ~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------- 214 (286)
T 3uqc_A 173 PA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------- 214 (286)
T ss_dssp CC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------
T ss_pred cc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------
Confidence 43 333 3688999999999999999999999764332110000
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
......... .........+.++.++|.+||+.||++| |+.++++.|+++..
T Consensus 215 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 215 ERDTAGQPI--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CBCTTSCBC--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHhccCCC--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000000000 0000112235679999999999999999 99999999987754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=337.51 Aligned_cols=263 Identities=25% Similarity=0.346 Sum_probs=198.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-ccchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-FQGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~---------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~ 83 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTT---------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence 3689999999999999999986543 78899999987542 2335668899999999999999999998755
Q ss_pred ------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC-
Q 015909 150 ------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN- 222 (398)
Q Consensus 150 ------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~- 222 (398)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp TCCCCTTSSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSS
T ss_pred cccccCCCeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCc
Confidence 6678999999999999999986542 235888999999999999999999998 999999999999987665
Q ss_pred --EEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 223 --AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 223 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...|
T Consensus 161 ~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~ 232 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQW 232 (676)
T ss_dssp CEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHS
T ss_pred eeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhh
Confidence 9999999998754432 22346799999999999999999999999999999999999999964311 1111
Q ss_pred hhhhhhccc---ccccc------c--cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 015909 301 AKPYLTSKR---RIFRV------L--DPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVV 353 (398)
Q Consensus 301 ~~~~~~~~~---~~~~~------~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 353 (398)
......... ..... + ............+..+.++|.+||..||++|||+.+++
T Consensus 233 ~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp STTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 100000000 00000 0 00112234455788999999999999999999999844
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.39 Aligned_cols=251 Identities=19% Similarity=0.172 Sum_probs=187.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCC-Ccc-------
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHH-PNL------- 140 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~~I------- 140 (398)
+.|+..++||+|+||+||+|.+.. ++..||||++..... ...+.+.+|+.+++.+.| +|.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 457788999999999999997654 788999999874322 335778999999999976 221
Q ss_pred --cceeeE------------EEe-----CCceEEEEeecCCCCHHHHHhhc---CCCCCCCCHHHHHHHHHHHHHHHHHH
Q 015909 141 --VKLVGY------------CLE-----DDHRLLVYEFMPRGSMENHLFRR---GSYFQPLSWSLRMKIALGAANGLAFL 198 (398)
Q Consensus 141 --~~~~~~------------~~~-----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~l~~~~~~~i~~qi~~al~~L 198 (398)
+...+. +.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 111111 111 22456778876 78999988532 22224577889999999999999999
Q ss_pred HcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccccccccccccccccccc----------ccCCCCCchh
Q 015909 199 HSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYL----------ATGHLTAKSD 268 (398)
Q Consensus 199 H~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D 268 (398)
|+++ |+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|
T Consensus 228 H~~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 228 HHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp HHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred HhCC--cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 9999 999999999999999999999999998764322 334567 999999999 5556888999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 015909 269 IYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD 348 (398)
Q Consensus 269 vwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 348 (398)
||||||++|+|++|+.||.......... ..+... . ..+.++.+||.+||+.||++||+
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRSC--K----NIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhhc--c----cCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999996532211100 011100 0 12467999999999999999999
Q ss_pred HHHHHHH--HHHHHHH
Q 015909 349 MDEVVKE--LEQLQEL 362 (398)
Q Consensus 349 ~~ell~~--L~~l~~~ 362 (398)
+.+++++ ++.+++.
T Consensus 358 ~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 358 PLQAMETPEYEQLRTE 373 (413)
T ss_dssp HHHHTTSHHHHHHHHH
T ss_pred HHHHHhCHHHHHHHHH
Confidence 9999876 5555443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=305.54 Aligned_cols=230 Identities=23% Similarity=0.311 Sum_probs=181.3
Q ss_pred hcCCCCC-ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHH-cCCCCCcccceeeEEE
Q 015909 71 TRNFRPD-SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL-GQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~~I~~~~~~~~ 148 (398)
.++|.+. ++||+|+||.||+|.+.. ++..||+|.+... ..+.+|+.++ +.++||||+++++++.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~ 81 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 81 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence 3457666 789999999999997654 7889999998642 5677888888 5568999999999988
Q ss_pred e----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC---CC
Q 015909 149 E----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NY 221 (398)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~---~~ 221 (398)
. ....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||+++. ++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp EEETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTC
T ss_pred hhcCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCC
Confidence 7 6778999999999999999987643 46899999999999999999999999 999999999999997 78
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
.++|+|||++.... +..++.++||||||+++|+|++|+.||...........
T Consensus 158 ~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---- 209 (299)
T 3m2w_A 158 ILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---- 209 (299)
T ss_dssp CEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC----
T ss_pred cEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH----
Confidence 99999999986421 24567889999999999999999999965322110000
Q ss_pred hhhhhccccccccccccccCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLEGQFS----LPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 356 (398)
....... .....+ ...+.++.+|+.+||+.||.+|||+.+++++-
T Consensus 210 --------~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 210 --------MKTRIRM--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp --------SCCSSCT--TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------HHHHHhh--ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 0000000 001111 12367899999999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=337.01 Aligned_cols=243 Identities=22% Similarity=0.362 Sum_probs=194.4
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..++|++.+.||+|+||+||+|++.. .++..||||.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGG--------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcC--------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 34789999999999999999997643 1578999999865432 33456789999999999999999999998
Q ss_pred eCCc-----eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 149 EDDH-----RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 149 ~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
..+. .|+||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~ 220 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QL 220 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cE
Confidence 8766 7999999999999887643 4899999999999999999999999 9999999999999875 89
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
||+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.......
T Consensus 221 kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------- 283 (681)
T 2pzi_A 221 KLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------- 283 (681)
T ss_dssp EECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------
T ss_pred EEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------
Confidence 99999999875432 3357999999999997654 889999999999999999999886421100
Q ss_pred hhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 015909 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-DMDEVVKELEQLQ 360 (398)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~l~ 360 (398)
. .........+..+.++|.+||+.||++|| +++++...|..+.
T Consensus 284 ----------~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 ----------L----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----------C----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------c----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 00001122346789999999999999999 5666766666553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.17 Aligned_cols=242 Identities=18% Similarity=0.190 Sum_probs=182.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--------cchHHHHHHHHHHcCCC------
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--------QGHKEWLTEINYLGQLH------ 136 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------ 136 (398)
.++|++.+.||+|+||+||+|++ ++..||+|++..... ...+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 46789999999999999999975 478999999975432 23467889999988885
Q ss_pred ---CCcccceeeEEE-----------------e-------------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHH
Q 015909 137 ---HPNLVKLVGYCL-----------------E-------------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSL 183 (398)
Q Consensus 137 ---h~~I~~~~~~~~-----------------~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~ 183 (398)
||||+++.+++. . .+..++||||+++|++.+.+.+ ..+++..
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~ 162 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLAT 162 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHH
Confidence 666666666543 2 6789999999999976666533 3489999
Q ss_pred HHHHHHHHHHHHHHHH-cCCCCceecCCCCCCEEEcCCC--------------------CEEEeeccCCcCCCCCCCccc
Q 015909 184 RMKIALGAANGLAFLH-SAEPKVIYRDFKASNILLDSNY--------------------NAKLSDFGLARDGPTGDKSHV 242 (398)
Q Consensus 184 ~~~i~~qi~~al~~LH-~~~~~ivH~Dlkp~Nilv~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~ 242 (398)
++.++.||+.||.||| +++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 163 ~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------ 234 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------ 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------
T ss_pred HHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------
Confidence 9999999999999999 898 99999999999999877 899999999986432
Q ss_pred ccccccccccccccccccCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccc-c-cccccc
Q 015909 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVV-LLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF-R-VLDPRL 319 (398)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~-l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~ 319 (398)
....||+.|+|||++.+.. +.++|||||+++ .++++.|..||... .|...... .+. . ......
T Consensus 235 -~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~---~~~~~~~~~~~~ 300 (336)
T 2vuw_A 235 -GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTD---KMLKQMTFKTKC 300 (336)
T ss_dssp -TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHH---HHHHTCCCSSCC
T ss_pred -CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHH---hhhhhhccCccc
Confidence 1347999999999998766 889999998777 77788899988420 01000000 000 0 000111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH-HH
Q 015909 320 EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVV-KE 355 (398)
Q Consensus 320 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell-~~ 355 (398)
........+.++.+||.+||+.| |+++++ +|
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 11123356889999999999976 999998 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=274.49 Aligned_cols=170 Identities=18% Similarity=0.123 Sum_probs=127.7
Q ss_pred CCcEEEEEEcccCCc----------cchHHHHHHHHHHcCC-CCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcC
Q 015909 105 TGMLIAVKRLNQEGF----------QGHKEWLTEINYLGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG 173 (398)
Q Consensus 105 ~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 173 (398)
.|+.|++|.+..... ...+++.+|+++|+++ .|+||+++++++.+++..||||||++|++|.+++...+
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~ 337 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE 337 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC
Confidence 578899999965422 1235688999999999 69999999999999999999999999999999998764
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccc
Q 015909 174 SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253 (398)
Q Consensus 174 ~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 253 (398)
+++.. .|+.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+...... ......+||+.||
T Consensus 338 ----~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~Ym 406 (569)
T 4azs_A 338 ----EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVF 406 (569)
T ss_dssp ----CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHH
T ss_pred ----CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhc
Confidence 46654 47899999999999999 9999999999999999999999999998754332 2234568999999
Q ss_pred cccccccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 015909 254 APEYLATGHLTAKSDIYSFGVVLLEILSGRRAI 286 (398)
Q Consensus 254 aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~ 286 (398)
|||++.+ .+..++|+||+|+++++|.++..++
T Consensus 407 APE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 407 VNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHC------------------CCCCTTHHHH
T ss_pred cHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 9999976 4677899999999988876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-29 Score=249.13 Aligned_cols=185 Identities=16% Similarity=0.238 Sum_probs=144.3
Q ss_pred CCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--------chHHHHHHHHHHcCCCCCcccceeeE
Q 015909 75 RPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--------GHKEWLTEINYLGQLHHPNLVKLVGY 146 (398)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~I~~~~~~ 146 (398)
...++||+|+||+||+|.. .+..+++|........ ..+.+.+|+.+|++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 4467899999999999944 4677888886443221 13457899999999999999976666
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+...+..++||||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~ 471 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYII 471 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEEC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEE
Confidence 6678888999999999999999865 4568999999999999999 999999999999998 99999
Q ss_pred eccCCcCCCCCCCcc-----ccccccccccccccccccc--CCCCCchhHHHHHHHHHHHHhCCCCC
Q 015909 227 DFGLARDGPTGDKSH-----VSTRVMGTYGYAAPEYLAT--GHLTAKSDIYSFGVVLLEILSGRRAI 286 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~p~ 286 (398)
|||+++......... ......||+.|||||++.+ ..|+...|+|+..+-..+.+.++.+|
T Consensus 472 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 472 DFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999998764422111 1235689999999999977 66788899999999998888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-25 Score=201.36 Aligned_cols=149 Identities=13% Similarity=0.053 Sum_probs=117.8
Q ss_pred HHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc------------------cchHHHHHHH
Q 015909 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF------------------QGHKEWLTEI 129 (398)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~ 129 (398)
......|.+.+.||+|+||.||+|.+ . +|..||+|.++.... .....+.+|+
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~ 155 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 155 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHH
T ss_pred HhCCeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHH
Confidence 33445677779999999999999976 3 688999999964321 1235678999
Q ss_pred HHHcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecC
Q 015909 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRD 209 (398)
Q Consensus 130 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~D 209 (398)
.+|+.++ | +++.+++. .+..++||||+++++|.+ +.. .....++.||+.||.|||+++ |+|||
T Consensus 156 ~~l~~l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g--iiHrD 218 (282)
T 1zar_A 156 RALQKLQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG--IVHGD 218 (282)
T ss_dssp HHHHHTT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred HHHHhcc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC--CEeCC
Confidence 9999998 4 66666543 356799999999999987 311 123468999999999999999 99999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccc
Q 015909 210 FKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLA 259 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 259 (398)
|||+|||++ ++.++|+|||+++. +..++|||.+.
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999999999 99999999999863 34478898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.8e-21 Score=172.99 Aligned_cols=137 Identities=19% Similarity=0.085 Sum_probs=104.6
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcE--EEEEEcccCCcc------------------------chHHHHH
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGML--IAVKRLNQEGFQ------------------------GHKEWLT 127 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~ 127 (398)
|.+.+.||+|+||.||+|.+.. +|.. ||||+++..... ....+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 6678999999999999997632 5778 999987543111 0125788
Q ss_pred HHHHHcCCCCCcc--cceeeEEEeCCceEEEEeecCC-C----CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-
Q 015909 128 EINYLGQLHHPNL--VKLVGYCLEDDHRLLVYEFMPR-G----SMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH- 199 (398)
Q Consensus 128 E~~~l~~l~h~~I--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH- 199 (398)
|+.+|..+.|++| ..+++. +..++||||+.+ | +|.++... .++..+..++.|++.+|.|||
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHH
Confidence 9999999988764 333332 367899999942 3 67665432 123456789999999999999
Q ss_pred cCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 200 SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 200 ~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
+.+ |+||||||+|||++. .++|+|||+|...
T Consensus 189 ~~g--ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 EAE--LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSC--EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HCC--EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 888 999999999999988 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=8.4e-18 Score=157.44 Aligned_cols=136 Identities=13% Similarity=0.083 Sum_probs=97.1
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-----c---------chH--------HHHHHHHH
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-----Q---------GHK--------EWLTEINY 131 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~---------~~~--------~~~~E~~~ 131 (398)
|++...||+|+||.||+|... +|..||||+++.... . ... ...+|...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 889999999999999999653 588999998753210 0 001 12356677
Q ss_pred HcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCC
Q 015909 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFK 211 (398)
Q Consensus 132 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlk 211 (398)
|.++.+.++.-.. .+.. ...+|||||++|++|..+.. . .....++.||+.+|.+||++| |||||||
T Consensus 167 L~rL~~~gv~vp~-p~~~-~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g--IVHrDLK 232 (397)
T 4gyi_A 167 MKALYEEGFPVPE-PIAQ-SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG--LIHGDFN 232 (397)
T ss_dssp HHHHHHTTCSCCC-EEEE-ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred HHHHHhcCCCCCe-eeec-cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC--CcCCCCC
Confidence 7777544432221 1111 23479999999888754321 1 123567899999999999998 9999999
Q ss_pred CCCEEEcCCC----------CEEEeeccCCcC
Q 015909 212 ASNILLDSNY----------NAKLSDFGLARD 233 (398)
Q Consensus 212 p~Nilv~~~~----------~~kl~Dfg~a~~ 233 (398)
|.||||++++ .+.|+||+-+..
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 9999998766 389999998765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=4.6e-13 Score=120.25 Aligned_cols=144 Identities=14% Similarity=0.005 Sum_probs=110.0
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYC 147 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~ 147 (398)
.....|++...++.|+.+.||++.. .+..+++|............+.+|+.+++.+. +..+.++++++
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~ 79 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3445788888899999999999742 35789999987532223345788999999884 67788899998
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE------------------------- 202 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------- 202 (398)
...+..|+|||+++|.+|.+.... ......++.+++.+|..||+..
T Consensus 80 ~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 80 RHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred ecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 888899999999999998765211 1123357788999999999810
Q ss_pred --------------------------------CCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 203 --------------------------------PKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 203 --------------------------------~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
..++|+|++|.||+++++..+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 238999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=2.5e-11 Score=108.51 Aligned_cols=135 Identities=16% Similarity=0.051 Sum_probs=94.8
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCc--ccceeeEEEeCC
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN--LVKLVGYCLEDD 151 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~--I~~~~~~~~~~~ 151 (398)
|.+..+.+.|..+.||++... +|..+++|..... ....+..|+.+++.+.+.+ +.+++++....+
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~ 88 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG 88 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CceEecccCCCCceEEEEecC----------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence 343333345667999997432 4667999987654 2245678999988885444 556888888777
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE----------------------------- 202 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------------------------- 202 (398)
..++||||++|.+|. .. .... ..++.+++..|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~-------~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SS-------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD 156 (264)
T ss_dssp CEEEEEECCSSEETT--TS-------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred CCEEEEEecCCcccC--cC-------cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence 889999999998874 11 1121 245667777777887642
Q ss_pred ---------------------------CCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 203 ---------------------------PKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 203 ---------------------------~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
..++|+|++|.||++++++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1289999999999998766667999998743
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=1e-10 Score=109.95 Aligned_cols=141 Identities=13% Similarity=0.199 Sum_probs=102.5
Q ss_pred CCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcc--cCC-ccchHHHHHHHHHHcCCC--CCcccceeeEEEeC
Q 015909 76 PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN--QEG-FQGHKEWLTEINYLGQLH--HPNLVKLVGYCLED 150 (398)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~~I~~~~~~~~~~ 150 (398)
..+.|+.|.++.||+... .+..+++|+.. ... ......+.+|+.+++.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~-----------~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT-----------PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEEC-----------SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEE-----------CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 356789999999999754 24578888775 322 123356778999999886 44577888877665
Q ss_pred ---CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------
Q 015909 151 ---DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA-------------------------- 201 (398)
Q Consensus 151 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------------------------- 201 (398)
+..|+|||+++|..+.+. ....++......++.+++..|..||+.
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTK 184 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHH
Confidence 347999999998776431 113467788888999999999999972
Q ss_pred ------------------------------CCCceecCCCCCCEEEcCCCC--EEEeeccCCcC
Q 015909 202 ------------------------------EPKVIYRDFKASNILLDSNYN--AKLSDFGLARD 233 (398)
Q Consensus 202 ------------------------------~~~ivH~Dlkp~Nilv~~~~~--~kl~Dfg~a~~ 233 (398)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 185 QYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134899999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=5.1e-11 Score=109.31 Aligned_cols=182 Identities=19% Similarity=0.221 Sum_probs=118.5
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCc--ccceeeEEEeCC--
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPN--LVKLVGYCLEDD-- 151 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~--I~~~~~~~~~~~-- 151 (398)
.+.++.|....||+. +..+++|+.... .....+.+|+.+|+.+. +.. +.+++.......
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 456899999999985 245888886533 33466789999998873 333 334444333322
Q ss_pred -ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------
Q 015909 152 -HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE---------------------------- 202 (398)
Q Consensus 152 -~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------- 202 (398)
..|+||++++|.+|...... .++......++.+++..+..||+..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS 162 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEcccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence 34789999999888754332 2566777778888888888888511
Q ss_pred ----------------------------CCceecCCCCCCEEEcC--CCCEEEeeccCCcCCCCCCCccccccccccccc
Q 015909 203 ----------------------------PKVIYRDFKASNILLDS--NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252 (398)
Q Consensus 203 ----------------------------~~ivH~Dlkp~Nilv~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 252 (398)
..++|+|++|.||+++. ...+.|+||+.+........ ......+
T Consensus 163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~ 236 (304)
T 3sg8_A 163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMED 236 (304)
T ss_dssp TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCT
T ss_pred ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhh
Confidence 23799999999999987 55678999998865322110 0000011
Q ss_pred ---cccccccc-----C---------CCCCchhHHHHHHHHHHHHhCCCCC
Q 015909 253 ---AAPEYLAT-----G---------HLTAKSDIYSFGVVLLEILSGRRAI 286 (398)
Q Consensus 253 ---~aPE~~~~-----~---------~~~~~~DvwslG~~l~ell~g~~p~ 286 (398)
..|+.... + ......+.|+++.++|.+.+|..+|
T Consensus 237 ~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 237 DEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred ccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12221110 0 0112268999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=3.3e-07 Score=82.16 Aligned_cols=135 Identities=18% Similarity=0.093 Sum_probs=95.1
Q ss_pred eecccCCc-eEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEeCCceEEE
Q 015909 79 VLGEGGFG-SVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 79 ~lg~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 156 (398)
.+..|..| .||+..... .+..+++|.-... ....+.+|+.+|+.|. +--+.+++.++.+.+..++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 34556555 689864322 4567888876532 3456778999988874 33367788888888999999
Q ss_pred EeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---------------------------------
Q 015909 157 YEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEP--------------------------------- 203 (398)
Q Consensus 157 ~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--------------------------------- 203 (398)
||+++|.++.+...... .....+..++...|..||+...
T Consensus 99 me~l~G~~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE 170 (272)
T ss_dssp EECCCSEEHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred EEeeCCccccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence 99999988877654321 1223456667777777775320
Q ss_pred -----------------------CceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 204 -----------------------KVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 204 -----------------------~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 178999999999999877777999988753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=4.1e-07 Score=83.25 Aligned_cols=135 Identities=21% Similarity=0.145 Sum_probs=89.7
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCC---cccceeeEEE-eCCc
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP---NLVKLVGYCL-EDDH 152 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---~I~~~~~~~~-~~~~ 152 (398)
.+.++.|....||+. +..+++|+.... .....+.+|+.+|+.|.+. .+.+++.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 356888888899985 345788875321 2345688999999998642 3556666654 3455
Q ss_pred eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------
Q 015909 153 RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE------------------------------ 202 (398)
Q Consensus 153 ~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------ 202 (398)
.++||++++|.+|...... .++......++.++...|..||+..
T Consensus 88 ~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~ 161 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVF 161 (306)
T ss_dssp EEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTG
T ss_pred eEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcc
Confidence 7899999999888763211 1233344444444444444444321
Q ss_pred ----------------------------CCceecCCCCCCEEEcC---CCCE-EEeeccCCcC
Q 015909 203 ----------------------------PKVIYRDFKASNILLDS---NYNA-KLSDFGLARD 233 (398)
Q Consensus 203 ----------------------------~~ivH~Dlkp~Nilv~~---~~~~-kl~Dfg~a~~ 233 (398)
..++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 162 ~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 162 PLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 23699999999999987 4554 8999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3.4e-06 Score=80.01 Aligned_cols=76 Identities=14% Similarity=0.115 Sum_probs=48.6
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC-------ccchHHHHHHHHHHcCCCC--Cc-ccceeeE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG-------FQGHKEWLTEINYLGQLHH--PN-LVKLVGY 146 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h--~~-I~~~~~~ 146 (398)
.+.||.|.++.||++.... .+..+++|...... ......+..|+++|+.+.. +. +.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4579999999999985432 45789999764321 1123456778888887632 33 4455543
Q ss_pred EEeCCceEEEEeecCCC
Q 015909 147 CLEDDHRLLVYEFMPRG 163 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~ 163 (398)
+.+..++|||++++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455678999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=2.5e-06 Score=79.62 Aligned_cols=85 Identities=2% Similarity=-0.120 Sum_probs=52.9
Q ss_pred cee-cccCCceEEEEEecCCcccccCCC-CCcEEEEEEcccCC---ccchHHHHHHHHHHcCCC-C--CcccceeeEEEe
Q 015909 78 SVL-GEGGFGSVFKGWVDEHSLASTRPG-TGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLH-H--PNLVKLVGYCLE 149 (398)
Q Consensus 78 ~~l-g~G~~g~Vy~~~~~~~~~~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~~I~~~~~~~~~ 149 (398)
+.| +.|....+|+...... .... .+..+++|...... ......+.+|+.+++.|. + -.+.+++.+..+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~----~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQ----QDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEE----ETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EECCCCCccceEEEEEEecc----cCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 567 7888899998754200 0000 15678888875432 112245678888888874 2 346677777655
Q ss_pred C---CceEEEEeecCCCCHH
Q 015909 150 D---DHRLLVYEFMPRGSME 166 (398)
Q Consensus 150 ~---~~~~lv~e~~~~~~L~ 166 (398)
. +..++|||+++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3468999999886643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.12 E-value=4.3e-05 Score=70.53 Aligned_cols=30 Identities=20% Similarity=0.229 Sum_probs=26.7
Q ss_pred CceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 204 KVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 204 ~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
.++|+|+++.||+++.++.+.|+||+.+..
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 499999999999998788999999987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00012 Score=66.79 Aligned_cols=75 Identities=16% Similarity=0.115 Sum_probs=57.6
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC---CCcccceeeEEEeCCce
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH---HPNLVKLVGYCLEDDHR 153 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~~I~~~~~~~~~~~~~ 153 (398)
.+.|+.|....+|+... .+..+++|..... ....+..|+..|+.|. ...+.+++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 35689999999999743 3567888987543 2456788999888884 35678888888777889
Q ss_pred EEEEeecCCCCH
Q 015909 154 LLVYEFMPRGSM 165 (398)
Q Consensus 154 ~lv~e~~~~~~L 165 (398)
++|||++++..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999988754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00015 Score=65.28 Aligned_cols=80 Identities=18% Similarity=0.178 Sum_probs=55.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCC---cccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHP---NLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---~I~~~~~~~ 147 (398)
+....-.+.+|.|..+.||+.... +|..|++|+...........+..|+..|+.|.-. -+.+++++
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~- 82 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW- 82 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE-
T ss_pred CCCeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec-
Confidence 344555677999999999998653 5789999987654444445678899988887421 24445543
Q ss_pred EeCCceEEEEeecCCCC
Q 015909 148 LEDDHRLLVYEFMPRGS 164 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~ 164 (398)
+..++|||+++++.
T Consensus 83 ---~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 83 ---DDRTLAMEWVDERP 96 (288)
T ss_dssp ---ETTEEEEECCCCCC
T ss_pred ---cCceEEEEeecccC
Confidence 23478999997654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00016 Score=68.97 Aligned_cols=76 Identities=17% Similarity=0.206 Sum_probs=45.3
Q ss_pred CceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCccccccccc--ccccccccccccCC---CCCchhHHHHHHHHHH
Q 015909 204 KVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG--TYGYAAPEYLATGH---LTAKSDIYSFGVVLLE 278 (398)
Q Consensus 204 ~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwslG~~l~e 278 (398)
.++|+|++|.|||++.++ +.|+||+.+........ . ..... ...|++|+...... -....++..+...+|+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--l-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--I-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--H-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--H-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 399999999999998776 99999998875322110 0 00011 13456665443111 1122455577777777
Q ss_pred HHhCC
Q 015909 279 ILSGR 283 (398)
Q Consensus 279 ll~g~ 283 (398)
.+.+.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00039 Score=58.96 Aligned_cols=101 Identities=16% Similarity=0.055 Sum_probs=67.8
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcc
Q 015909 163 GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLH-SAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSH 241 (398)
Q Consensus 163 ~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~ 241 (398)
-+|.+++...+ .+++++++|.++.|.+.+|.-+- ... -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 37999998887 68999999999999999887762 111 12333457899999999998764 1110
Q ss_pred cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCC
Q 015909 242 VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR 284 (398)
Q Consensus 242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~ 284 (398)
.....+.+||... ...+.+.=|||||+++|..+.-..
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123467888763 345677899999999999987433
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00029 Score=63.82 Aligned_cols=71 Identities=8% Similarity=0.035 Sum_probs=43.2
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-cceeeEEEeCCceEE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-VKLVGYCLEDDHRLL 155 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-~~~~~~~~~~~~~~l 155 (398)
.+.|+.|....+|+. ..+++|+....... ......|+.+++.+...++ .+++. .+.+..++
T Consensus 23 i~~l~gG~tN~~~~~---------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~--~~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLH--VDPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE---------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEE--ECTTTCCE
T ss_pred eeEcCCcccccccee---------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEE--EECCCCEE
Confidence 577888999999986 23788877643211 1122467777776643233 34443 34455689
Q ss_pred EEeec-CCCCH
Q 015909 156 VYEFM-PRGSM 165 (398)
Q Consensus 156 v~e~~-~~~~L 165 (398)
++||+ ++.++
T Consensus 85 v~e~i~~g~~l 95 (301)
T 3dxq_A 85 VTRYIAGAQTM 95 (301)
T ss_dssp EEECCTTCEEC
T ss_pred EEeecCCCccC
Confidence 99999 66554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0009 Score=61.09 Aligned_cols=159 Identities=14% Similarity=0.158 Sum_probs=83.2
Q ss_pred CCCHHHHHHHhcCCCCC-----ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC
Q 015909 61 NFSYSDLRTATRNFRPD-----SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL 135 (398)
Q Consensus 61 ~~~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l 135 (398)
.++.+++.....+|.+. +.|+.|....+|+.... +..+++|..... .....+..|+.+++.|
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-----------~g~~vlk~~~~~--~~~~~l~~e~~~l~~L 72 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-----------KDPLILTLYEKR--VEKNDLPFFLGLMQHL 72 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-----------SCCEEEEEECC-----CCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-----------CccEEEEEeCCC--CCHHHHHHHHHHHHHH
Confidence 34556666666667653 34666888899987542 235889988653 1223455677776665
Q ss_pred C-----CCccccee-e--EEEeCCceEEEEeecCCCCHHH----H----------HhhcC-CCCCC----CC---HHHHH
Q 015909 136 H-----HPNLVKLV-G--YCLEDDHRLLVYEFMPRGSMEN----H----------LFRRG-SYFQP----LS---WSLRM 185 (398)
Q Consensus 136 ~-----h~~I~~~~-~--~~~~~~~~~lv~e~~~~~~L~~----~----------~~~~~-~~~~~----l~---~~~~~ 185 (398)
. -|.++... + +....+..++++++++|..+.. . +.... ....+ .. +....
T Consensus 73 ~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~ 152 (322)
T 2ppq_A 73 AAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLW 152 (322)
T ss_dssp HHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHH
T ss_pred HHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHH
Confidence 3 23333211 1 1123456789999998754310 0 11111 11011 11 11100
Q ss_pred H------------HHHHHHHHHHHHHcC-----CCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 186 K------------IALGAANGLAFLHSA-----EPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 186 ~------------i~~qi~~al~~LH~~-----~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
. +...+...+..+... ...++|+|+.+.||++++++.+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 153 DKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0 001133344444421 1238999999999999877656899998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00047 Score=64.59 Aligned_cols=148 Identities=15% Similarity=0.132 Sum_probs=80.5
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 156 (398)
+.|..|-...+|++...... ......+..|++|+.... ........+|..+++.|. +.-..++++.+.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~--~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHL--PSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTS--CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCc--cccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45767888899998653210 001123578999986432 234566778999998875 3223556655432 399
Q ss_pred EeecCCCCHHH-----------H---Hh---hcC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 015909 157 YEFMPRGSMEN-----------H---LF---RRG-SYFQPLS--WSLRMKIALGAAN-------------------GLAF 197 (398)
Q Consensus 157 ~e~~~~~~L~~-----------~---~~---~~~-~~~~~l~--~~~~~~i~~qi~~-------------------al~~ 197 (398)
|||++|.+|.. + +. ... ...+... +..+..+..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998755421 1 11 110 1111222 3344444433321 1222
Q ss_pred ----HHcC--CCCceecCCCCCCEEEcCC----CCEEEeeccCCc
Q 015909 198 ----LHSA--EPKVIYRDFKASNILLDSN----YNAKLSDFGLAR 232 (398)
Q Consensus 198 ----LH~~--~~~ivH~Dlkp~Nilv~~~----~~~kl~Dfg~a~ 232 (398)
|... ...++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2222 1248999999999999876 789999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0051 Score=56.15 Aligned_cols=142 Identities=15% Similarity=0.119 Sum_probs=76.9
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCc--ccceeeE-----EEeC
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN--LVKLVGY-----CLED 150 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~--I~~~~~~-----~~~~ 150 (398)
..|+ |....||+.... +|..+++|...... .....+..|..+++.|.... +.+++.. ....
T Consensus 32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 3566 888899986321 35578999986432 23456667888777764212 3333332 1224
Q ss_pred CceEEEEeecCCCCHH-----HH---------HhhcC---CC--CCCCCHHHH----------------------HHHHH
Q 015909 151 DHRLLVYEFMPRGSME-----NH---------LFRRG---SY--FQPLSWSLR----------------------MKIAL 189 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~-----~~---------~~~~~---~~--~~~l~~~~~----------------------~~i~~ 189 (398)
+..+++|++++|..+. .+ +.... .. ....+.... ...+.
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 5567899999874431 11 11100 00 011221111 11122
Q ss_pred HHHHHHHHHHc--CCCCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 190 GAANGLAFLHS--AEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 190 qi~~al~~LH~--~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
.++..+.-+-. ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22222222211 122389999999999998 4 899999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00037 Score=66.56 Aligned_cols=80 Identities=15% Similarity=0.085 Sum_probs=48.7
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-cceeeEEEeCCceEE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-VKLVGYCLEDDHRLL 155 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-~~~~~~~~~~~~~~l 155 (398)
.+.|+.|....||++....... .....+..+++|+.... .....+.+|+.+++.|...++ .++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 3467788889999986542100 00113568899988432 112456689998888753333 55665543 2 38
Q ss_pred EEeecCCCC
Q 015909 156 VYEFMPRGS 164 (398)
Q Consensus 156 v~e~~~~~~ 164 (398)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999997643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0011 Score=63.67 Aligned_cols=74 Identities=12% Similarity=0.024 Sum_probs=44.4
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-cceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-VKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-~~~~~~~~~~~~~~lv 156 (398)
+.|+.|-...+|++.... .+..+++|+..... ...-...+|+.+++.|...++ .++++.+. + .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETT---------TTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEE
T ss_pred EEcCCCeEeEEEEEEECC---------CCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEE
Confidence 457778889999986532 24678899875432 111112478888888864444 46666552 2 359
Q ss_pred EeecCCCCH
Q 015909 157 YEFMPRGSM 165 (398)
Q Consensus 157 ~e~~~~~~L 165 (398)
|||++|.+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0042 Score=56.95 Aligned_cols=31 Identities=32% Similarity=0.405 Sum_probs=26.8
Q ss_pred CceecCCCCCCEEEcCC----CCEEEeeccCCcCC
Q 015909 204 KVIYRDFKASNILLDSN----YNAKLSDFGLARDG 234 (398)
Q Consensus 204 ~ivH~Dlkp~Nilv~~~----~~~kl~Dfg~a~~~ 234 (398)
.++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 49999999999999864 68999999988653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00092 Score=62.43 Aligned_cols=81 Identities=7% Similarity=0.033 Sum_probs=42.6
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCc-ccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPN-LVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~-I~~~~~~~~~~~~~~lv 156 (398)
+.|+.|....+|+........ ...+..+..+++|+..... ........|..+++.|...+ +.++++.. .-++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 457778888999986432000 0001123678888875432 11112356778777774333 34566543 23789
Q ss_pred EeecCCCC
Q 015909 157 YEFMPRGS 164 (398)
Q Consensus 157 ~e~~~~~~ 164 (398)
|+|++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.012 Score=54.09 Aligned_cols=30 Identities=17% Similarity=0.189 Sum_probs=26.7
Q ss_pred CceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 204 KVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 204 ~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 489999999999999888899999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.49 E-value=0.014 Score=55.27 Aligned_cols=81 Identities=10% Similarity=0.007 Sum_probs=46.3
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 156 (398)
+.|..|-...+|+........ .....+..|++|+..... ...-...+|..+++.|. +.-..++++.+ . -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 456668888999986542100 001125789999875432 11122357888887774 22234555432 2 3789
Q ss_pred EeecCCCCH
Q 015909 157 YEFMPRGSM 165 (398)
Q Consensus 157 ~e~~~~~~L 165 (398)
++|++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999988653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.72 E-value=0.71 Score=38.91 Aligned_cols=123 Identities=10% Similarity=0.089 Sum_probs=81.3
Q ss_pred HHHHHcCCCCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCcee
Q 015909 128 EINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIY 207 (398)
Q Consensus 128 E~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH 207 (398)
|+.+|.. .||+++.. .+-..++.+.+.++.-+ ....+-.- +.++....+.++.+|+....++++ =+|
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~----r~t 102 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT----RYT 102 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS----SEE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC----ceE
Confidence 4444432 58888876 45566676666666433 22222221 236788899999999887755543 567
Q ss_pred cCCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015909 208 RDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287 (398)
Q Consensus 208 ~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~ 287 (398)
--|.|+|++++.++.+++.--|+-... +|. .++...=+-.+=+++..+++++..|+
T Consensus 103 f~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 103 FVLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCCSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 789999999999999999877764321 221 12223335577889999999988874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.73 E-value=1.4 Score=37.20 Aligned_cols=115 Identities=10% Similarity=0.096 Sum_probs=77.2
Q ss_pred CCCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCceecCCCCCC
Q 015909 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLA-FLHSAEPKVIYRDFKASN 214 (398)
Q Consensus 136 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~ivH~Dlkp~N 214 (398)
.||++ -..+-.+++.+.+.++.-+++.=...+. .++....+.++.+|+.... +++ . -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCce
Confidence 57887 3444466777777777643333333332 2678889999999887655 443 3 6778899999
Q ss_pred EEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015909 215 ILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID 287 (398)
Q Consensus 215 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~ 287 (398)
|+++.++.++|.-.|+-.. ++|.. ++...=+-.+=|++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987776432 22321 1222234567788889999887774
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.83 E-value=0.42 Score=44.79 Aligned_cols=29 Identities=28% Similarity=0.322 Sum_probs=24.4
Q ss_pred ceecCCCCCCEEE------cCCCCEEEeeccCCcC
Q 015909 205 VIYRDFKASNILL------DSNYNAKLSDFGLARD 233 (398)
Q Consensus 205 ivH~Dlkp~Nilv------~~~~~~kl~Dfg~a~~ 233 (398)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999988753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.26 E-value=0.17 Score=48.57 Aligned_cols=62 Identities=10% Similarity=0.123 Sum_probs=17.1
Q ss_pred CCceecccCCceEEEEEecCCcccccCCCCCcEEEE------EEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 76 PDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAV------KRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
+.+.|| ||.||+|.+.. ...+||+ |....... +....+.+|..+++.++|||+++.+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~---------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYK---------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccc---------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 456676 99999997753 2345666 65543222 2334678889999999999999988876
Q ss_pred Ee
Q 015909 148 LE 149 (398)
Q Consensus 148 ~~ 149 (398)
..
T Consensus 214 ~~ 215 (463)
T 3cxl_A 214 VH 215 (463)
T ss_dssp EE
T ss_pred Ee
Confidence 43
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 398 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-74 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-68 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-67 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-67 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-66 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-65 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-64 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-61 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-60 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-60 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 3e-74
Identities = 62/292 (21%), Positives = 117/292 (40%), Gaps = 31/292 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+G G FG+V+KG + + + + + Q + + E+ L
Sbjct: 9 QITVGQRIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+ H N++ +GY +V ++ S+ +HL + + IA A
Sbjct: 59 RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTA 114
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+ +LH +I+RD K++NI L + K+ DFGLA SH ++ G+ +
Sbjct: 115 QGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 253 AAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
APE + + +SD+Y+FG+VL E+++G+ P N + + R
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMV--GR 224
Query: 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
++ + L +CL + RP +++ +E L
Sbjct: 225 GYLSPDLSKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 217 bits (553), Expect = 7e-69
Identities = 71/310 (22%), Positives = 131/310 (42%), Gaps = 31/310 (10%)
Query: 63 SYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH 122
+Y + LG G +G V++G + +AVK L ++ +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV- 57
Query: 123 KEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWS 182
+E+L E + ++ HPNLV+L+G C + ++ EFM G++ ++L Q +S
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAV 115
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
+ + +A ++ + +L I+RD A N L+ N+ K++DFGL+R GD
Sbjct: 116 VLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 172
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302
+ APE LA + KSD+++FGV+L EI + + +
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------- 224
Query: 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362
++ +L+ + +K L C P RP E+ + E + +
Sbjct: 225 --------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
Query: 363 RNMHKRPQKE 372
++ +KE
Sbjct: 277 SSISDEVEKE 286
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-68
Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 33/289 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+G G FG V G+ +A+K + EG ++++ E +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIR-EGAMSEEDFIEEAEVM 54
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+L HP LV+L G CLE LV+EFM G + ++L + + + + L
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVC 111
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+A+L E VI+RD A N L+ N K+SDFG+ R D+ ST +
Sbjct: 112 EGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKW 168
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312
A+PE + ++KSD++SFGV++ E+ S + +NR E +VE F
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI-------STGF 219
Query: 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
R+ PRL + + C P+ RP ++++L ++ E
Sbjct: 220 RLYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-68
Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 39/290 (13%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
+ + +G+G FG V G G +AVK + + + +L E +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53
Query: 132 LGQLHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
+ QL H NLV+L+G +E+ L +V E+M +GS+ ++L RG L +K +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLD 111
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
+ +L ++RD A N+L+ + AK+SDFGL ++ S
Sbjct: 112 VCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPV 164
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
+ APE L + KSD++SFG++L EI S R P L + R
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV-------PR 212
Query: 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
+ + + C ++ +RP ++ ++LE ++
Sbjct: 213 VEKGYKMDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (551), Expect = 2e-68
Identities = 77/319 (24%), Positives = 133/319 (41%), Gaps = 40/319 (12%)
Query: 62 FSYSDLRTATRNF---------RPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK 112
F++ D A R F + + V+G G FG V G + + +A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 113 RLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFR 171
L + +++L+E + +GQ HPN++ L G + +++ EFM GS+++ L +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 172 RGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
+ + + G A G+ +L + ++RD A NIL++SN K+SDFGL+
Sbjct: 121 N---DGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 232 RDGPTGDKSHVSTRV---MGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDK 288
R T + APE + T+ SD++S+G+V+ E++S
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---- 231
Query: 289 NRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD 348
RP + + D RL P A L L C + RP
Sbjct: 232 -RPYWDMTNQDVINAIEQ---------DYRLPPPMDCPSA--LHQLMLDCWQKDRNHRPK 279
Query: 349 MDEVVKELEQLQELRNMHK 367
++V L+++ N K
Sbjct: 280 FGQIVNTLDKMIRNPNSLK 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (549), Expect = 4e-68
Identities = 73/322 (22%), Positives = 122/322 (37%), Gaps = 43/322 (13%)
Query: 61 NFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ 120
N L N +GEG FG VF+ + ++AVK L +E
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQA----RAPGLLPYEPFTMVAVKMLKEEASA 57
Query: 121 G-HKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF--- 176
++ E + + +PN+VKL+G C L++E+M G + L +
Sbjct: 58 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 117
Query: 177 -----------------QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS 219
PLS + ++ IA A G+A+L K ++RD N L+
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGE 175
Query: 220 NYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEI 279
N K++DFGL+R+ + D + PE + T +SD++++GVVL EI
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235
Query: 280 LSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCL 339
S + + I+ V D + + +L C
Sbjct: 236 FSYGLQPYYG---------------MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCW 279
Query: 340 SVEPKLRPDMDEVVKELEQLQE 361
S P RP + + L+++ E
Sbjct: 280 SKLPADRPSFCSIHRILQRMCE 301
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 1e-67
Identities = 71/315 (22%), Positives = 123/315 (39%), Gaps = 45/315 (14%)
Query: 67 LRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEW 125
+ +F S LG G G VFK + +G+++A K ++ E +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 126 LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
+ E+ L + + P +V G D + E M GS++ L + G + +
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILG 107
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
K+++ GL +L + K+++RD K SNIL++S KL DFG++ ++
Sbjct: 108 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS 162
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAID------------------ 287
+GT Y +PE L H + +SDI+S G+ L+E+ GR I
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
Query: 288 ----KNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQK----AASLALQCL 339
RP + IF +LD + + +CL
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
Query: 340 SVEPKLRPDMDEVVK 354
P R D+ +++
Sbjct: 283 IKNPAERADLKQLMV 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-67
Identities = 63/288 (21%), Positives = 110/288 (38%), Gaps = 33/288 (11%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
++ LG G FG V G + +A+K + EG E++ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKV 52
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
+ L H LV+L G C + ++ E+M G + N+L +++
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDV 109
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
+ +L + ++RD A N L++ K+SDFGL+R D+ S
Sbjct: 110 CEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVR 166
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311
++ PE L ++KSDI++FGV++ EI S + P E A I
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETA-------EHI 214
Query: 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359
+ L S +K ++ C + RP ++ + +
Sbjct: 215 AQGLRLYRPHLAS----EKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 4e-67
Identities = 73/285 (25%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+ LG G FG V+ G+ + +AVK L Q G +L E N +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQ-GSMSPDAFLAEANLM 62
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
QL H LV+L + ++ E+M GS+ + L L+ + + +A A
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIA 119
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+AF+ I+RD +A+NIL+ + K++DFGLAR ++ +
Sbjct: 120 EGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 176
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312
APE + G T KSD++SFG++L EI++ R P E + +
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQ-------NLE 224
Query: 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357
R ++ L C P+ RP D + LE
Sbjct: 225 RGYRMVRPDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 4e-67
Identities = 78/312 (25%), Positives = 131/312 (41%), Gaps = 31/312 (9%)
Query: 54 LQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKR 113
L ++ + + ++ + V+G G FG V+ G + ++ G + AVK
Sbjct: 9 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKS 62
Query: 114 LNQEGFQGH-KEWLTEINYLGQLHHPNLVKLVGYCLEDD-HRLLVYEFMPRGSMENHLFR 171
LN+ G ++LTE + HPN++ L+G CL + L+V +M G + N +
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122
Query: 172 RGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
+ + L A G+ FL K ++RD A N +LD + K++DFGLA
Sbjct: 123 ET---HNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 232 RD--GPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN 289
RD D H T + A E L T T KSD++SFGV+L E+++
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA----- 232
Query: 290 RPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDM 349
P + N + L +R + P + L+C + ++RP
Sbjct: 233 PPYPDVNTFDITVYLLQGRRLLQPEYCP-----------DPLYEVMLKCWHPKAEMRPSF 281
Query: 350 DEVVKELEQLQE 361
E+V + +
Sbjct: 282 SELVSRISAIFS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-66
Identities = 73/309 (23%), Positives = 115/309 (37%), Gaps = 38/309 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINY 131
LG G FG V + + + M +AVK L +E ++E+
Sbjct: 24 RLSFGKTLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 132 LGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF-------------- 176
L L +H N+V L+G C L++ E+ G + N L R+ F
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 177 QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPT 236
L + + A G+AFL S I+RD A NILL K+ DFGLARD
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296
V + APE + T +SD++S+G+ L E+ S + P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256
Query: 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
++++ + + C +P RP ++V+ +
Sbjct: 257 --------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 357 E-QLQELRN 364
E Q+ E N
Sbjct: 303 EKQISESTN 311
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-66
Identities = 69/306 (22%), Positives = 118/306 (38%), Gaps = 42/306 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINY 131
N VLG G FG V + ++ G + +AVK L ++ +E ++E+
Sbjct: 38 NLEFGKVLGSGAFGKVMNA----TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 132 LGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYF-------------- 176
+ QL H N+V L+G C L++E+ G + N+L + F
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 177 -----QPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231
L++ + A A G+ FL ++RD A N+L+ K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291
RD + V + APE L G T KSD++S+G++L EI S P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 292 TGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDE 351
+ ++++ + ++ + C + + + RP
Sbjct: 272 VDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 352 VVKELE 357
+ L
Sbjct: 317 LTSFLG 322
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 9e-66
Identities = 73/317 (23%), Positives = 122/317 (38%), Gaps = 41/317 (12%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINY 131
R +G+G FG V++G G +AVK + + EI
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50
Query: 132 LGQLHHPNLVKLVGYCLEDD----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
L H N++ + +D+ LV ++ GS+ ++L R ++ +K+
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKL 105
Query: 188 ALGAANGLAFLHS------AEPKVIYRDFKASNILLDSNYNAKLSDFGLAR--DGPTGDK 239
AL A+GLA LH +P + +RD K+ NIL+ N ++D GLA D T
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165
Query: 240 SHVSTRVMGTYGYAAPEYLAT------GHLTAKSDIYSFGVVLLEILSGRR----AIDKN 289
+GT Y APE L ++DIY+ G+V EI D
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
Query: 290 RPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQA-QKAASLALQCLSVEPKLRPD 348
P + + + + K + L P + ++ +A + A + +C R
Sbjct: 226 LPYYDLVPSDPSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 349 MDEVVKELEQLQELRNM 365
+ K L QL + +
Sbjct: 285 ALRIKKTLSQLSQQEGI 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-65
Identities = 66/292 (22%), Positives = 127/292 (43%), Gaps = 28/292 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINY 131
V+G G FG V+KG L ++ + +A+K L + + ++L E
Sbjct: 8 CVTRQKVIGAGEFGEVYKGM-----LKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
+GQ H N+++L G + +++ E+M G+++ L + F S + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF---SVLQLVGMLRGI 119
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPTGDKSHVSTRVMGTY 250
A G+ +L + ++RD A NIL++SN K+SDFGL+R + ++ ++
Sbjct: 120 AAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
+ APE ++ T+ SD++SFG+V+ E+++ E
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------- 221
Query: 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362
+ + ++ + L +QC E RP ++V L++L
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-64
Identities = 78/308 (25%), Positives = 126/308 (40%), Gaps = 42/308 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINY 131
+ + V+GEG FG V K + + G M A+KR+ + H+++ E+
Sbjct: 11 DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 132 LGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRR------------GSYFQP 178
L +L HHPN++ L+G C + L E+ P G++ + L + S
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 179 LSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD 238
LS + A A G+ +L + I+RD A NIL+ NY AK++DFGL+R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 239 KSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298
K T + A E L T SD++S+GV+L EI+S P
Sbjct: 182 K---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCA 233
Query: 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358
E ++ + + L QC +P RP +++ L +
Sbjct: 234 ELY-------EKLPQGYRLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 359 LQELRNMH 366
+ E R +
Sbjct: 283 MLEERKTY 290
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-64
Identities = 60/290 (20%), Positives = 103/290 (35%), Gaps = 40/290 (13%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEI 129
R + D +G G F +V+KG T + +A L + + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 130 NYLGQLHHPNLVKLVGYCLE----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
L L HPN+V+ +LV E M G+++ +L R + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLR 115
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLSDFGLARDGPTGDKSHVST 244
GL FLH+ P +I+RD K NI + + K+ D GLA ++ +
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 171
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
V+GT + APE D+Y+FG+ +LE+ + N + +
Sbjct: 172 AVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYS-----ECQNAAQIYR-- 223
Query: 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
RV F + + C+ R + +++
Sbjct: 224 --------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 9e-64
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 32/284 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINY 131
++ LGEG +G V T +AVK ++ + + EI
Sbjct: 6 DWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
L+H N+VK G+ E + + L E+ G + + + + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQL 112
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 113 MAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 252 YAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
Y APE L D++S G+VL +L+G D+ + +
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------------YS 217
Query: 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
++ L + A +L + L P R + ++ K
Sbjct: 218 DWKEKKTYLNPWKKIDSA--PLALLHKILVENPSARITIPDIKK 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-63
Identities = 66/300 (22%), Positives = 123/300 (41%), Gaps = 33/300 (11%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLTEINYLGQL 135
D LG G FGSV +G + +A+K L Q + +E + E + QL
Sbjct: 14 DIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 136 HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGL 195
+P +V+L+G C + + +LV E G + L + + + S ++ + G+
Sbjct: 67 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGM 122
Query: 196 AFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPTGDKSHVSTRVMGTYGYAA 254
+L E ++RD A N+LL + + AK+SDFGL++ G + + A
Sbjct: 123 KYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 255 PEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFRV 314
PE + +++SD++S+GV + E LS + +P + E I +
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVM-------AFIEQG 228
Query: 315 LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQKEHQ 374
+ + +L C + + RPD V + + ++ + + H
Sbjct: 229 KRMECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY--SLASKVEGHHH 282
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-63
Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 31/293 (10%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTE 128
++ R LG+G FG V +G D S G + +AVK L + + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
+N + L H NL++L G L ++ V E P GS+ + L + + A
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTLSRYA 117
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV-STRVM 247
+ A G+ +L S + I+RD A N+LL + K+ DFGL R P D +V
Sbjct: 118 VQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 248 GTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
+ + APE L T + SD + FGV L E+ + + P N +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKE 230
Query: 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
R+ R D Q ++ +QC + +P+ RP + L + Q
Sbjct: 231 GERLPRPED----------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-63
Identities = 62/289 (21%), Positives = 117/289 (40%), Gaps = 35/289 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEIN 130
++ +G G +G K R G ++ K L+ + ++E+N
Sbjct: 5 DYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 131 YLGQLHHPNLVKLVGYCLE--DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
L +L HPN+V+ ++ + +V E+ G + + + + Q L +++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 189 LGAANGLAFLHS---AEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
L H V++RD K +N+ LD N KL DFGLAR + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
+GT Y +PE + KSDI+S G +L E+ + P + E A
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAG--- 224
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+I R+ ++S + + + L+++ RP ++E+++
Sbjct: 225 ----KIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 1e-62
Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 36/287 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+ LG+G FG V+K T +L A K ++ + + ++++ EI+ L
Sbjct: 13 FWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
HPN+VKL+ +++ ++ EF G+++ + +PL+ S +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTL 120
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
+ L +LH K+I+RD KA NIL + + KL+DFG++ + +GT +
Sbjct: 121 DALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYW 176
Query: 253 AAPEYLAT-----GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
APE + K+D++S G+ L+E+ P E N +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVL------ 224
Query: 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+I + P L +CL R ++++
Sbjct: 225 -LKIAKSEPPTLAQPSRWSSN--FKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-62
Identities = 65/324 (20%), Positives = 132/324 (40%), Gaps = 39/324 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYL 132
F+ VLG G FG+V+KG + +A+K L + + +KE L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKGL-----WIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+ +P++ +L+G CL +L + + MP G + +++ + + A
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIA 121
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
G+ +L + ++++RD A N+L+ + + K++DFGLA+ +K + + +
Sbjct: 122 KGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312
A E + T +SD++S+GV + E+++ P E I
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------IS 223
Query: 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQKE 372
+L+ + ++C ++ RP E++ E ++ + PQ+
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA------RDPQRY 277
Query: 373 HQAKGHVHFKGRATTYPRPSASPL 396
+G P P+ S
Sbjct: 278 LVIQGD-----ERMHLPSPTDSNF 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-62
Identities = 67/285 (23%), Positives = 114/285 (40%), Gaps = 33/285 (11%)
Query: 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEINYLGQ 134
D LG G FG+V KG+ +AVK L E E L E N + Q
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 135 LHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANG 194
L +P +V+++G C E + +LV E G + +L + + +++ + G
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMG 119
Query: 195 LAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTG-DKSHVSTRVMGTYGYA 253
+ +L E ++RD A N+LL + + AK+SDFGL++ + T +
Sbjct: 120 MKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 254 APEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313
APE + ++KSD++SFGV++ E S + +P E + +
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTA-------MLEK 225
Query: 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358
++ L C + + + RP V L
Sbjct: 226 GERMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-62
Identities = 68/300 (22%), Positives = 119/300 (39%), Gaps = 33/300 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+ R + LG+G FG V+ G + +A+K L G + +L E +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLK-PGTMSPEAFLQEAQVM 66
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
+L H LV+L ++ +V E+M +GS+ + L + + +A A
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIA 123
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGY 252
+G+A++ ++RD +A+NIL+ N K++DFGLAR ++ +
Sbjct: 124 SGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 180
Query: 253 AAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312
APE G T KSD++SFG++L E+ + R E +
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VL 224
Query: 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNMHKRPQKE 372
++ + L QC EP+ RP + + LE +P +
Sbjct: 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (508), Expect = 8e-62
Identities = 74/327 (22%), Positives = 126/327 (38%), Gaps = 62/327 (18%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LT 127
+ F +G G FG+V+ ++A+K+++ G Q +++W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
E+ +L +L HPN ++ G L + LV E+ + + + PL +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAV 120
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
GA GLA+LHS +I+RD KA NILL KL DFG A + +
Sbjct: 121 THGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFV 172
Query: 248 GTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304
GT + APE + G K D++S G+ +E+ + P N +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSAL--- 223
Query: 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK---------- 354
I + P L+ + + CL P+ RP + ++K
Sbjct: 224 ----YHIAQNESPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 355 ---------ELEQLQELRNMHKRPQKE 372
+ ++EL N+ R K+
Sbjct: 277 TVIMDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 5e-61
Identities = 68/287 (23%), Positives = 112/287 (39%), Gaps = 44/287 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEI 129
+F LG+G FG+V+ + ++A+K L + + E+
Sbjct: 7 DFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L HPN+++L GY + L+ E+ P G++ L +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYIT 113
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
AN L++ HS +VI+RD K N+LL S K++DFG + P S T + GT
Sbjct: 114 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 167
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
Y PE + K D++S GV+ E L G+ + N + +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------- 216
Query: 310 RIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEVVK 354
+F+ P + A L + L P RP + EV++
Sbjct: 217 ---------SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-60
Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 30/290 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINY 131
+GEG FG V +G + +A+K +E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
+ Q HP++VKL+G ++ ++ E G + + L R L + + A
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQL 117
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
+ LA+L + ++RD A N+L+ SN KL DFGL+R + +++
Sbjct: 118 STALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIK 174
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311
+ APE + T+ SD++ FGV + EIL +P + RI
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIG-------RI 222
Query: 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
+ SL +C + +P RP E+ +L + E
Sbjct: 223 ENGERLPMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 4e-60
Identities = 68/296 (22%), Positives = 129/296 (43%), Gaps = 29/296 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHK-EWLTEINY 131
LG+G FG V++G + +A+K +N+ + E+L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAK----GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG------SYFQPLSWSLRM 185
+ + + ++V+L+G + L++ E M RG ++++L P S S +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTR 245
++A A+G+A+L++ K ++RD A N ++ ++ K+ DFG+ RD D +
Sbjct: 137 QMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
+ + +PE L G T SD++SFGVVL EI + L
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGL 239
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361
++++ + V++ L L C PK+RP E++ +++ E
Sbjct: 240 SNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-59
Identities = 80/304 (26%), Positives = 118/304 (38%), Gaps = 36/304 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG-HKEWLTEINY 131
+ LG G FG V + + + T +AVK L + H+ ++E+
Sbjct: 14 RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 132 LGQ-LHHPNLVKLVGYCLEDDHRL-LVYEFMPRGSMENHLFRRGSYFQP----------- 178
L HH N+V L+G C + L ++ EF G++ +L + + F P
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 179 -LSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTG 237
L+ + + A G+ FL S K I+RD A NILL K+ DFGLARD
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 238 DKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297
+ APE + T +SD++SFGV+L EI S P +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKI 242
Query: 298 VEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357
E L R R + + L C EP RP E+V+ L
Sbjct: 243 DEEFCRRLKEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 358 QLQE 361
L +
Sbjct: 293 NLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-59
Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 34/304 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLTEINY 131
LGEG FG V L +P +AVK L + + + ++E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 132 LGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRG------------SYFQP 178
+ + H N++ L+G C +D ++ E+ +G++ +L R + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 179 LSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGD 238
LS + A A G+ +L S K I+RD A N+L+ + K++DFGLARD D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 239 KSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV 298
+T + APE L T +SD++SFGV+L EI + + P E
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 299 EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358
+F++L + + C P RP ++V++L++
Sbjct: 246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 359 LQEL 362
+ L
Sbjct: 294 IVAL 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-58
Identities = 66/306 (21%), Positives = 122/306 (39%), Gaps = 37/306 (12%)
Query: 49 SEGEILQSSNIKNFSYSDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGML 108
S+ EIL+ S D + + + +G+G G+V+ TG
Sbjct: 1 SDEEILEKLR-SIVSVGDPK---KKYTRFEKIGQGASGTVYTA---------MDVATGQE 47
Query: 109 IAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENH 168
+A++++N + + + EI + + +PN+V + L D +V E++ GS+ +
Sbjct: 48 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 169 LFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228
+ + L FLHS +VI+RD K+ NILL + + KL+DF
Sbjct: 108 VTETCM-----DEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDF 160
Query: 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDK 288
G + + ++GT + APE + K DI+S G++ +E++ G
Sbjct: 161 GFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE----- 213
Query: 289 NRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD 348
P N + I P L+ L +CL ++ + R
Sbjct: 214 -PPYLNENPLRALY-------LIATNGTPELQNPEKLSAI--FRDFLNRCLDMDVEKRGS 263
Query: 349 MDEVVK 354
E+++
Sbjct: 264 AKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-56
Identities = 55/293 (18%), Positives = 108/293 (36%), Gaps = 40/293 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEI 129
+F+ +LGEG F +V T A+K L + E
Sbjct: 9 DFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
+ + +L HP VKL +D+ + G + ++ + G +
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTA 115
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
+ L +LH +I+RD K NILL+ + + +++DFG A+ K + +GT
Sbjct: 116 EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
Y +PE L SD+++ G ++ ++++G P+
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP------------------PFRAGNE 215
Query: 310 RIFRVLDPRLEGQFSLPQA--QKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360
+ + ++ ++ P+ KA L + L ++ R +E+
Sbjct: 216 --YLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (449), Expect = 1e-52
Identities = 60/284 (21%), Positives = 101/284 (35%), Gaps = 33/284 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
++ LG G FG V + T TG A K + + EI +
Sbjct: 27 HYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
L HP LV L +D+ +++YEFM G + + +S ++
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVC 134
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYN--AKLSDFGLARDGPTGDKSHVSTRVMGTY 250
GL +H ++ D K NI+ + + KL DFGL V GT
Sbjct: 135 KGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTA 189
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
+AAPE + +D++S GV+ +LSG P G N E + +
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWN 243
Query: 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ + ++ + L +P R + + ++
Sbjct: 244 MDDSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 173 bits (440), Expect = 3e-52
Identities = 62/296 (20%), Positives = 116/296 (39%), Gaps = 38/296 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTEIN 130
+ +LG GG V +AVK L + + + + E
Sbjct: 9 YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRL----LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186
L+HP +V + + +V E++ ++ + + G P++ ++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIE 115
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPTGDKSHVSTR 245
+ A L F H +I+RD K +NI++ + K+ DFG+AR +G+ +
Sbjct: 116 VIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 246 VMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
V+GT Y +PE + A+SD+YS G VL E+L+G P + V A ++
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHV 227
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-DMDEVVKELEQLQ 360
L + ++ L+ L+ P+ R E+ +L ++
Sbjct: 228 REDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (437), Expect = 5e-51
Identities = 56/284 (19%), Positives = 102/284 (35%), Gaps = 33/284 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+ LG G FG V + TG + K +N EI+ +
Sbjct: 30 YYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
QLHHP L+ L + +L+ EF+ G + + + +S + + A
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQAC 137
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNA--KLSDFGLARDGPTGDKSHVSTRVMGTY 250
GL +H +++ D K NI+ ++ + K+ DFGLA + T
Sbjct: 138 EGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATA 192
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
+AAPE + + +D+++ GV+ +LSG P + +E +
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWE 246
Query: 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ +A L EP+ R + + ++
Sbjct: 247 FDEDAFSSVS--------PEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 1e-49
Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 41/282 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTE- 128
+F ++G GGFG V+ + TG + A+K L+++ QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 129 --INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMK 186
++ + P +V + D + + M G + HL + G + + +
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115
Query: 187 IALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRV 246
I L GL +H+ V+YRD K +NILLD + + ++SD GLA D
Sbjct: 116 IIL----GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHAS 165
Query: 247 MGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
+GT+GY APE L G + +D +S G +L ++L G +++ +H +
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------- 218
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347
R+ + L FS + SL L + R
Sbjct: 219 ----RMTLTMAVELPDSFS----PELRSLLEGLLQRDVNRRL 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (421), Expect = 2e-49
Identities = 64/298 (21%), Positives = 113/298 (37%), Gaps = 48/298 (16%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLN---------QEGFQGHK 123
N+ P +LG G V + T AVK ++ +E + +
Sbjct: 4 NYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 124 EWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWS 182
L E++ L ++ HPN+++L + LV++ M +G + ++L + LS
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEK 110
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
KI + LH +++RD K NILLD + N KL+DFG + D
Sbjct: 111 ETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEK 165
Query: 243 STRVMGTYGYAAPEYLATGHL------TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296
V GT Y APE + + D++S GV++ +L+G P
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRK 219
Query: 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ + ++ + + L + L V+P+ R +E +
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-49
Identities = 68/287 (23%), Positives = 105/287 (36%), Gaps = 39/287 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
+F +LG+G FG VF T A+K L ++ + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 130 NYLG-QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
L HP L + ++ V E++ G + H+ S A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYA 109
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
GL FLH ++YRD K NILLD + + K++DFG+ ++ GD G
Sbjct: 110 AEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCG 165
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308
T Y APE L D +SFGV+L E+L G+ P + E
Sbjct: 166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDN 219
Query: 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355
R L+ A L ++ EP+ R + +++
Sbjct: 220 PFYPRWLEKE------------AKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 5e-49
Identities = 59/285 (20%), Positives = 111/285 (38%), Gaps = 36/285 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-WLTEINYL 132
+ VLG G F V T L+A+K + ++ +G + EI L
Sbjct: 11 YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
++ HPN+V L H L+ + + G + + + +G + ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117
Query: 193 NGLAFLHSAEPKVIYRDFKASNILL---DSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
+ + +LH + +++RD K N+L D + +SDFGL++ D V + GT
Sbjct: 118 DAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGT 172
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
GY APE LA + D +S GV+ +L G P + N + + L ++
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEY 226
Query: 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ + A + +P+ R ++ ++
Sbjct: 227 EFDSPYWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 1e-48
Identities = 53/345 (15%), Positives = 112/345 (32%), Gaps = 51/345 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+ LG G FG V + + K + +G EI+ L
Sbjct: 6 KYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
H N++ L + ++++EF+ + + L+ +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVC 112
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYNA--KLSDFGLARDGPTGDKSHVSTRVMGTY 250
L FLHS + + D + NI+ + ++ K+ +FG AR GD + +
Sbjct: 113 EALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAP 167
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
Y APE ++ +D++S G ++ +LSG P + + + ++
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYT 221
Query: 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV-----------------V 353
+ + +A + L E K R E +
Sbjct: 222 FDEEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
Query: 354 KELEQLQELRNMHKRPQKEHQAKGHVHFKGRATTYPRPSASPLRI 398
+ L+ + + K+ + + G + S + +++
Sbjct: 274 RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKV 318
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-48
Identities = 72/322 (22%), Positives = 122/322 (37%), Gaps = 29/322 (9%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGH-KEWLTEI 129
+ S +GEG +G V + + +A+K+++ Q + + L EI
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L + H N++ + + ++ M L++ Q LS
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL-LKTQHLSNDHICYFLY 116
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD-GPTGDKSHVSTRVMG 248
GL ++HSA V++RD K SN+LL++ + K+ DFGLAR P D + T +
Sbjct: 117 QILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 249 TYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307
T Y APE + T DI+S G +L E+LS R + N + +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 308 KRRIFRVLDPRLEGQFSLPQAQK-------------AASLALQCLSVEPKLRPDMDEVVK 354
+ + SLP K A L + L+ P R ++++
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ-AL 293
Query: 355 ELEQLQELRNMHKRPQKEHQAK 376
L++ + P E K
Sbjct: 294 AHPYLEQYYDPSDEPIAEAPFK 315
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 9e-48
Identities = 67/292 (22%), Positives = 107/292 (36%), Gaps = 33/292 (11%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE-----WLTEINYLG 133
LGEG F +V+K T ++A+K++ K+ L EI L
Sbjct: 5 FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
+L HPN++ L+ + LV++FM +E + L+ S L
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNS---LVLTPSHIKAYMLMTLQ 111
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYA 253
GL +LH +++RD K +N+LLD N KL+DFGLA+ G + T + T Y
Sbjct: 112 GLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYR 167
Query: 254 APEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRP----------TGEHNLVEWAK 302
APE L + D+++ G +L E+L + + G +W
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227
Query: 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
F+ L P R + +K
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 1e-46
Identities = 65/313 (20%), Positives = 112/313 (35%), Gaps = 34/313 (10%)
Query: 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---- 125
A + + + +GEG +G VFK G +A+KR+ + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKAR--------DLKNGGRFVALKRVRVQTGEEGMPLSTIR 56
Query: 126 -LTEINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMEN--HLFRRGSYFQPLSWS 182
+ + +L HPN+V+L C + ++ + +
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
+ GL FLHS +V++RD K NIL+ S+ KL+DFGLAR
Sbjct: 117 TIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMA 171
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302
T V+ T Y APE L D++S G + E+ + + + +
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
Query: 303 PYLTSK---------RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEV- 352
+ R+ F + +F + L L+CL+ P R
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
Query: 353 ----VKELEQLQE 361
++LE+ +E
Sbjct: 292 SHPYFQDLERCKE 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-46
Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 28/295 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEIN 130
NF+ +GEG +G V+K TG ++A+K++ + + EI+
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
L +L+HPN+VKL+ ++ LV+EF+ + F S + L
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQ 110
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
GLAF HS +V++RD K N+L+++ KL+DFGLAR + + V+ +
Sbjct: 111 LLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLW 167
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKN----------RPTGEHNLVEW 300
A L + + DI+S G + E+++ R + R G + V W
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 301 AKPY-LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ + F + + P + SL Q L +P R +
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 2e-46
Identities = 54/303 (17%), Positives = 98/303 (32%), Gaps = 37/303 (12%)
Query: 66 DLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW 125
+LR R +R +G G FG ++ G T G +A+K + H +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQL 49
Query: 126 LTEINYLGQLHHPNLVKLVGYCLED-DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLR 184
E + + + +C + D+ ++V E + + F S
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTV 105
Query: 185 MKIALGAANGLAFLHSAEPKVIYRDFKASNIL---LDSNYNAKLSDFGLAR-----DGPT 236
+ +A + + ++HS I+RD K N L + DFGLA+
Sbjct: 106 LLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163
Query: 237 GDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHN 296
+ + GT YA+ + + D+ S G VL+ G + +
Sbjct: 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223
Query: 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKEL 356
E ++ P P A+ C S+ +PD + +
Sbjct: 224 KYERISEK--------KMSTPIEVLCKGYPSE--FATYLNFCRSLRFDDKPDYSYLRQLF 273
Query: 357 EQL 359
L
Sbjct: 274 RNL 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (395), Expect = 4e-45
Identities = 63/279 (22%), Positives = 108/279 (38%), Gaps = 41/279 (14%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE---WLTE 128
++F+ LG G FG V G A+K L +E K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
L + HP ++++ G + ++ +++ LF Q + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYA 110
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
L +LH +IYRD K NILLD N + K++DFG A+ P V+ + G
Sbjct: 111 AEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCG 163
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308
T Y APE ++T D +SFG+++ E+L+G P + N ++ + L ++
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAE 217
Query: 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347
R + L + ++ + R
Sbjct: 218 LRFPPFFNE------------DVKDLLSRLITRDLSQRL 244
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-45
Identities = 58/291 (19%), Positives = 106/291 (36%), Gaps = 42/291 (14%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW------LT 127
+ LG G F V K TG+ A K + + + +
Sbjct: 12 YDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 128 EINYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
E++ L ++ HPN++ L +L+ E + G + + L + L+ +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEF 118
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSN----YNAKLSDFGLARDGPTGDKSHVS 243
NG+ +LHS ++ + D K NI+L K+ DFGLA G++
Sbjct: 119 LKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 173
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303
+ GT + APE + L ++D++S GV+ +LSG + + L +
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSAV 231
Query: 304 YLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ F A + L +PK R + + ++
Sbjct: 232 NYEFEDEYFSNTSAL------------AKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (392), Expect = 4e-45
Identities = 49/304 (16%), Positives = 92/304 (30%), Gaps = 36/304 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+++ +GEG FG +F+G T +A+K + + E
Sbjct: 6 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54
Query: 133 GQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAA 192
L + V Y ++ ++ + S+E+ L G + S A
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQML 111
Query: 193 NGLAFLHSAEPKVIYRDFKASNILLDSNYN-----AKLSDFGLAR---DGPTGDKS--HV 242
+ +H ++YRD K N L+ + + DFG+ + D T
Sbjct: 112 ARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302
+ GT Y + + + D+ + G V + L G + E
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362
+ P E P+ ++ PD D + ++ E
Sbjct: 230 EK--------KQSTPLRELCAGFPEE--FYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
Query: 363 RNMH 366
N
Sbjct: 280 LNTT 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (389), Expect = 9e-45
Identities = 57/295 (19%), Positives = 111/295 (37%), Gaps = 30/295 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEIN 130
+ +GEG +G V+K + G A+K++ E + EI+
Sbjct: 3 KYHGLEKIGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
L +L H N+VKL +LV+E + + + G L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQ 108
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
NG+A+ H +V++RD K N+L++ K++DFGLAR + + ++ +
Sbjct: 109 LLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLW 165
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
A + + + DI+S G + E+++G + + SK
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 311 IFRVLDPRLEGQFSLPQA-----------QKAASLALQCLSVEPKLRPDMDEVVK 354
P+ + F++ + + L + L ++P R + ++
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-44
Identities = 68/347 (19%), Positives = 124/347 (35%), Gaps = 37/347 (10%)
Query: 68 RTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLT 127
R ++ V+G G FG V++ +G L+A+K++ Q+ +
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQD----KRFKNR 62
Query: 128 EINYLGQLHHPNLVKLVGYCLEDD------HRLLVYEFMPRGSMENHLFRRGSYFQPLSW 181
E+ + +L H N+V+L + + LV +++P ++ Q L
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPV 121
Query: 182 SLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-YNAKLSDFGLARDGPTGDKS 240
LA++HS + +RD K N+LLD + KL DFG A+ G+ +
Sbjct: 122 IYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT-------- 292
+ + Y A T+ D++S G VL E+L G+ +
Sbjct: 180 V--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 293 --GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQA-QKAASLALQCLSVEPKLRPDM 349
G + + F + + P+ +A +L + L P R
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 350 DEVVKELEQLQELRNMHKRPQKEHQAKGHVHFKGRATTYPRPSASPL 396
E ELR+ + + +F + + P A+ L
Sbjct: 298 LEACAH-SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATIL 343
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-43
Identities = 59/284 (20%), Positives = 99/284 (34%), Gaps = 39/284 (13%)
Query: 79 VLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL-HH 137
VLG G G V + T A+K L + E+ +
Sbjct: 19 VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64
Query: 138 PNLVKLVGYC----LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAAN 193
P++V++V L+V E + G + + + RG Q + +I
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGE 122
Query: 194 GLAFLHSAEPKVIYRDFKASNILLDSNYN---AKLSDFGLARDGPTGDKSHVSTRVMGTY 250
+ +LHS + +RD K N+L S KL+DFG A++ + + T
Sbjct: 123 AIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTP 177
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310
Y APE L D++S GV++ +L G P ++ + + T R
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRM 231
Query: 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVK 354
+ S ++ L L EP R + E +
Sbjct: 232 GQYEFPNPEWSEVS----EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-43
Identities = 62/310 (20%), Positives = 111/310 (35%), Gaps = 61/310 (19%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKE------WLT 127
++ +LG GGFGSV+ G R + +A+K + ++ E
Sbjct: 6 YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 128 EINYLGQLH--HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRM 185
E+ L ++ +++L+ + D +L+ E L L
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELAR 113
Query: 186 KIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-YNAKLSDFGLARDGPTGDKSHVST 244
+ H V++RD K NIL+D N KL DFG K V T
Sbjct: 114 SFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 167
Query: 245 RVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303
GT Y+ PE++ + + ++S G++L +++ G
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------------ 209
Query: 304 YLTSKRRIFRVLDPRLEGQFSLPQ--AQKAASLALQCLSVEPKLRPDMDEV-----VKEL 356
F + + GQ Q + + L CL++ P RP +E+ ++++
Sbjct: 210 --------FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 357 EQLQELRNMH 366
QE +H
Sbjct: 262 LLPQETAEIH 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-42
Identities = 72/278 (25%), Positives = 104/278 (37%), Gaps = 38/278 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
+F +LG+G FG V TG A+K L +E E +TE
Sbjct: 6 DFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L HP L L D V E+ G + HL R + +
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGA 112
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
+ L +LH V+YRD K N++LD + + K++DFGL ++G + + GT
Sbjct: 113 EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
Y APE L D + GVV+ E++ GR P + + L +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEI 222
Query: 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347
R R L P +A SL L +PK R
Sbjct: 223 RFPRTLSP------------EAKSLLAGLLKKDPKQRL 248
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 6e-42
Identities = 66/309 (21%), Positives = 114/309 (36%), Gaps = 42/309 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG--HKEWLTEIN 130
+ + +G+G FG VFK TG +A+K++ E + L EI
Sbjct: 11 KYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 131 YLGQLHHPNLVKLVGYCLE--------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWS 182
L L H N+V L+ C LV++F + S
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLS 117
Query: 183 LRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHV 242
++ NGL ++H K+++RD KA+N+L+ + KL+DFGLAR S
Sbjct: 118 EIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 243 S--TRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV- 298
+ T + T Y PE L D++ G ++ E+ + + N + L+
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
Query: 299 ------------EWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAA-SLALQCLSVEPKL 345
L K + + +++ + A L + L ++P
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295
Query: 346 RPDMDEVVK 354
R D D+ +
Sbjct: 296 RIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-41
Identities = 59/296 (19%), Positives = 102/296 (34%), Gaps = 30/296 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEIN 130
+ +GEG +G+VFK T ++A+KR+ + L EI
Sbjct: 3 KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 131 YLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALG 190
L +L H N+V+L D LV+EF + + G +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQ 109
Query: 191 AANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTY 250
GL F H V++RD K N+L++ N KL++FGLAR + + S V+ +
Sbjct: 110 LLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLW 166
Query: 251 GYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT-----------GEHNLVE 299
+ D++S G + E+ + R + G +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAA-SLALQCLSVEPKLRPDMDEVVK 354
W + + + +P+ L L P R +E ++
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-40
Identities = 57/315 (18%), Positives = 111/315 (35%), Gaps = 31/315 (9%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINY 131
+R +G G +G+V TG +A+K+L + K E+
Sbjct: 20 YRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 132 LGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGA 191
L + H N++ L+ D+ +F + + L +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 192 ANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYG 251
GL ++H+ +I+RD K N+ ++ + K+ DFGLAR S ++ V+ +
Sbjct: 131 LKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWY 184
Query: 252 YAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311
A L T DI+S G ++ E+++G+ + + + ++
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 312 FRVLDPRLEGQFSLPQAQK-------------AASLALQCLSVEPKLRPDMDEVVKELEQ 358
D LP+ +K A +L + L ++ + R E
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE-ALAHPY 303
Query: 359 LQELRNMHKRPQKEH 373
+ L + PQ +
Sbjct: 304 FESLHDTEDEPQVQK 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (334), Expect = 5e-36
Identities = 62/278 (22%), Positives = 101/278 (36%), Gaps = 41/278 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEW---LTEI 129
F LG G FG V +G A+K L+++ K+ L E
Sbjct: 42 QFDRIKTLGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 130 NYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L ++ P LVKL ++ + +V E++ G M +HL R G S A
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAA 148
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGT 249
+LHS +IYRD K N+L+D +++DFG A+ + + GT
Sbjct: 149 QIVLTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGT 201
Query: 250 YGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309
APE + + D ++ GV++ E+ +G P ++ + ++ K
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKV 255
Query: 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347
R L L V+ R
Sbjct: 256 RFPSHFSS------------DLKDLLRNLLQVDLTKRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 5e-35
Identities = 70/282 (24%), Positives = 114/282 (40%), Gaps = 34/282 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----QGHKEWLTE 128
NF VLG G +G VF + TG L A+K L + + + TE
Sbjct: 25 NFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78
Query: 129 INYLGQL-HHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKI 187
L + P LV L + L+ +++ G + HL +R + +
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIY 134
Query: 188 ALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVM 247
L LH + +IYRD K NILLDSN + L+DFGL+++ D++ +
Sbjct: 135 VGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFC 191
Query: 248 GTYGYAAPEYLATGH--LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305
GT Y AP+ + G D +S GV++ E+L+G + +++ E ++ L
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE--KNSQAEISRRIL 249
Query: 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP 347
S+ + + A L + L +PK R
Sbjct: 250 KSEPPYPQEMSA------------LAKDLIQRLLMKDPKKRL 279
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 1e-34
Identities = 52/307 (16%), Positives = 99/307 (32%), Gaps = 49/307 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYL 132
+++ LG G + VF+ + VK L K+ EI L
Sbjct: 36 DYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKIL 83
Query: 133 GQL-HHPNLVKLVGYCLEDDHRL--LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIAL 189
L PN++ L + R LV+E + + Q L+
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMY 136
Query: 190 GAANGLAFLHSAEPKVIYRDFKASNILLDS-NYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
L + HS +++RD K N+++D + +L D+GLA G + +
Sbjct: 137 EILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVA 191
Query: 249 TYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPT-----------GEHN 296
+ + PE L D++S G +L ++ + G +
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251
Query: 297 LVEWAKPYLTSKRRIFRVLDPR---------LEGQFSLPQAQKAASLALQCLSVEPKLRP 347
L ++ Y F + R + + + +A + L + + R
Sbjct: 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311
Query: 348 DMDEVVK 354
E ++
Sbjct: 312 TAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-33
Identities = 58/299 (19%), Positives = 105/299 (35%), Gaps = 30/299 (10%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTE 128
++ S +G G +GSV + TG+ +AVK+L++ K E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 129 INYLGQLHHPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIA 188
+ L + H N++ L+ + + Q L+ +
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 189 LGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMG 248
GL ++HS +I+RD K SN+ ++ + K+ DFGLAR ++ V
Sbjct: 128 YQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVAT 181
Query: 249 TYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR------------RAIDKNRPTGEHN 296
+ A L H DI+S G ++ E+L+GR + I + T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 297 LVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAA-SLALQCLSVEPKLRPDMDEVVK 354
L++ P++ A A L + L ++ R + +
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-32
Identities = 62/315 (19%), Positives = 113/315 (35%), Gaps = 53/315 (16%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEI 129
+ ++ +G G G V + +A+K+L++ K E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 130 NYLGQLHHPNLVKLVGYCL------EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSL 183
+ ++H N++ L+ E LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHER 120
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVS 243
+ G+ LHS +I+RD K SNI++ S+ K+ DFGLAR T S +
Sbjct: 121 MSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR----------------RAID 287
T + T Y APE + DI+S G ++ E++ + +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 288 KNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQ--------AQKAASLALQCL 339
P L + Y+ ++ + + P+L P A +A L + L
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295
Query: 340 SVEPKLRPDMDEVVK 354
++P R +D+ ++
Sbjct: 296 VIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 8e-28
Identities = 46/324 (14%), Positives = 102/324 (31%), Gaps = 54/324 (16%)
Query: 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLG 133
+ LG G F +V+ +A+K + + + EI L
Sbjct: 15 YILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQ 64
Query: 134 QLHHPNLVKLVGYCLEDDHRLLVYE------------FMPRGSMENHLFRRGSYFQPLSW 181
+++ + K +LL + + + +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 182 SLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN-YNAKLSDFGLARDGPTGDKS 240
+I+ GL ++H +I+ D K N+L++ L +A G
Sbjct: 125 IYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRR---------------- 284
T + T Y +PE L +DI+S ++ E+++G
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 285 -----AIDKNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRL---------EGQFSLPQAQK 330
+ P+ ++ + + S+ + + + + +FS +A++
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 331 AASLALQCLSVEPKLRPDMDEVVK 354
+ L ++P+ R D +V
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.0 bits (173), Expect = 4e-15
Identities = 20/170 (11%), Positives = 45/170 (26%), Gaps = 38/170 (22%)
Query: 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVK--RLNQEGFQ--------GHKEWLT 127
++GEG +VF VK ++ F+ G +
Sbjct: 6 KLMGEGKESAVFNC----------YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV 55
Query: 128 EINYLGQLHHPNLVKLVGYC----LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSL 183
+ L KL G + ++ E + +
Sbjct: 56 LAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVEN 104
Query: 184 RMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARD 233
++ +A + +++ D N+L+ + DF + +
Sbjct: 105 PDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 398 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.77 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.99 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.71 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-57 Score=409.76 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=210.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||+|+||+||+|.+.. +|..||+|++........+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 479999999999999999997654 78999999997665566778999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..|+|||||++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a 163 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 163 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhh
Confidence 999999999999999988653 4899999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
+....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.... ..........
T Consensus 164 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~--- 232 (293)
T d1yhwa1 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNG--- 232 (293)
T ss_dssp EECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHC---
T ss_pred eeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCC---
Confidence 87543322 234567999999999999999999999999999999999999999653211 0011000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......+...+.++.+||.+||+.||++|||+.|+++|
T Consensus 233 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 233 ------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ------SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00112233456789999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=411.47 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=206.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|.+.. +|..||+|++..... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 3579999999999999999997764 789999999975432 334568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++..|+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG 148 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFG 148 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCT
T ss_pred CceeEEEEeccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccch
Confidence 99999999999999999998654 35899999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+|+..............+||+.|||||++.+..+ +.++|||||||++|+|++|+.||........ .... ...
T Consensus 149 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~----~~~-- 221 (271)
T d1nvra_ 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD----WKE-- 221 (271)
T ss_dssp TCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHH----HHT--
T ss_pred hheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHH----Hhc--
Confidence 9987654443334456789999999999988776 5779999999999999999999975432211 0000 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...........+.++.+||.+||+.||++|||++|++++
T Consensus 222 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 222 --------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000011112345788999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-56 Score=402.08 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=204.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC--ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG--FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||+||+|.++ ..||||+++... ....+.+.+|+.+|++++||||+++++++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence 467999999999999999999642 359999997543 234577899999999999999999999864
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
....++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 75 -~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 75 -APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp -SSSCEEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCC
T ss_pred -ccEEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccc
Confidence 567899999999999999997654 45899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|+|+...............||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+...... +.. ..
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~----~~ 222 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIF----MV 222 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHH----HH
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHH----HH
Confidence 99987655444444556789999999999864 3578999999999999999999999975432110 000 00
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
... ...+ .....+...+.++.+|+.+||+.||++|||+++++++|+.+++
T Consensus 223 ~~~-----~~~p-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 223 GRG-----YLSP-DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHT-----SCCC-CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcC-----CCCC-cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 000 0001 1112233446789999999999999999999999999988764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=401.76 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=208.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.+.. ++..||+|++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 468999999999999999997754 78999999986432 234567889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+++..++|||||++|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeeccc
Confidence 9999999999999999999998764 4899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|....... .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+.... ........
T Consensus 151 G~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~-- 218 (263)
T d2j4za1 151 GWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISR-- 218 (263)
T ss_dssp CSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT--
T ss_pred ceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHc--
Confidence 9998754332 33467999999999999999999999999999999999999999653211 11111000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ...++...+.++.+||.+||+.||++|||++|+++|
T Consensus 219 --------~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 219 --------V--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --------T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --------C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0 111233356789999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-57 Score=405.68 Aligned_cols=256 Identities=22% Similarity=0.346 Sum_probs=197.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc--chHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ--GHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||+||+|++.. +|+.||+|.+...... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 579999999999999999997764 7899999999765432 34568899999999999999999999865
Q ss_pred --CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---CCceecCCCCCCEEEcCCCCEE
Q 015909 150 --DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE---PKVIYRDFKASNILLDSNYNAK 224 (398)
Q Consensus 150 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---~~ivH~Dlkp~Nilv~~~~~~k 224 (398)
.+.+|+|||||++|+|.+++.........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 45689999999999999999765444467999999999999999999999854 3499999999999999999999
Q ss_pred EeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 225 LSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|+|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+ ....
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~---~~~i 226 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL---AGKI 226 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHHH
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HH---HHHH
Confidence 999999987543221 234468999999999999999999999999999999999999999653211 11 1111
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. .. ....+...+.++.+||.+||+.||.+|||++|++++
T Consensus 227 ~~----------~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 RE----------GK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HH----------TC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Hc----------CC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 00 011233456789999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-56 Score=408.15 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=213.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.+.. ++..||||+++... ...+.+.+|+.+|++++||||+++++++.+.
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 4578889999999999999998765 68899999997653 4467899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++|+|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred CeeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccc
Confidence 999999999999999999976543 56899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
|+....... .......||+.|+|||++.+..|+.++|||||||++|||++|..||...... ....
T Consensus 162 a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-----~~~~--------- 226 (287)
T d1opja_ 162 SRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVY--------- 226 (287)
T ss_dssp TTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHH---------
T ss_pred eeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-----HHHH---------
Confidence 987544322 2233356899999999999999999999999999999999977666432111 1100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
+.+........+...+.++.+|+.+||+.||++|||++++++.|+.+.
T Consensus 227 --~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 227 --ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111111122233445678999999999999999999999999887653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-56 Score=404.65 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=209.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+.|++.+.||+|+||+||+|.+.. ++..||+|++........+.+.+|+.+|++++||||+++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999997765 78999999998766666788999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a 157 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVS 157 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhh
Confidence 9999999999999999987654 46899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccccccccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
...... ........||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+..... . ......
T Consensus 158 ~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~---~~~i~~ 229 (288)
T d2jfla1 158 AKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V---LLKIAK 229 (288)
T ss_dssp EECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHHH
T ss_pred hccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H---HHHHHc
Confidence 753221 11233467999999999984 4568899999999999999999999997543211 1 011111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. ......+...+.++.+||.+||+.||++|||++|+++|
T Consensus 230 ~~---------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 230 SE---------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SC---------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CC---------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00111223456789999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=396.26 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=201.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 46888999999999999999764 36689999997654 44578999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred ceEEEEEecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchh
Confidence 9999999999999999987654 45889999999999999999999998 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG-RRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......||+.|+|||++.+..++.++|||||||++|||+++ .+||..... ......... .
T Consensus 149 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~-~-- 218 (263)
T d1sm2a_ 149 RFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDIST-G-- 218 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHHHHH-T--
T ss_pred eeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHHHHHh-c--
Confidence 875443222 22345789999999999999999999999999999999995 555543211 111111100 0
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.....+...+.++.+|+.+||+.||++|||+++++++|+++.+
T Consensus 219 --------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 219 --------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1111223345789999999999999999999999999998865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-55 Score=401.88 Aligned_cols=264 Identities=24% Similarity=0.419 Sum_probs=203.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+|++.++||+|+||+||+|++... ......||||.+..... ...+.+.+|+.+|++++||||+++++++...
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCC------CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 5678889999999999999987531 11345789999865433 3456789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCccc
Confidence 99999999999999999887654 46899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCccc---ccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 231 ARDGPTGDKSHV---STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 231 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
++.......... .....||+.|||||.+.+..++.++|||||||++|||++ |+.||.+.... .+.... .
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i----~ 247 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAI----E 247 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----H
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHH----H
Confidence 987544322211 122457999999999999999999999999999999998 89999753211 111110 0
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELR 363 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 363 (398)
.......+...+.++.+|+.+||+.||++|||+.++++.|+++.+..
T Consensus 248 ----------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 248 ----------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp ----------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 01111233445678999999999999999999999999998875543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=396.25 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=199.7
Q ss_pred CCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe--
Q 015909 74 FRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE-- 149 (398)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~-- 149 (398)
|++.+.||+|+||+||+|.+.. ++..||+|.+..... ...+.+.+|+++|++++||||+++++++..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 4677889999999999997754 788999999865432 334678899999999999999999999865
Q ss_pred --CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc-CCCCEEEe
Q 015909 150 --DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD-SNYNAKLS 226 (398)
Q Consensus 150 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~-~~~~~kl~ 226 (398)
...+++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++.+|+||||||+|||++ .++.+||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 345799999999999999998764 58999999999999999999999877799999999999996 57899999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|||+|+..... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||...... .........
T Consensus 158 DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~i~~ 227 (270)
T d1t4ha_ 158 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTS 227 (270)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTT
T ss_pred ecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHHHHc
Confidence 99999864322 2345689999999999865 6999999999999999999999999643211 111111000
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ...++...+.++.+||.+||+.||++|||++|+++|
T Consensus 228 -------~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 228 -------GVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -------TCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CCC---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 000 011112234578999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=404.77 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=207.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.+.. ++..||||++.... ....+.+.+|+.+|++++||||+++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 469999999999999999997754 78999999986432 234567899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+++..|+|||||++|+|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEeccc
Confidence 9999999999999999999988775 4899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|+..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~-- 224 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKIIK-- 224 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHT--
T ss_pred ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHHc--
Confidence 9998765544444445578999999999999999999999999999999999999999753211 11111111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ...++...+.++.+||.+||+.||++|||++|++++
T Consensus 225 --------~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 225 --------L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --------T--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --------C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 0 112233446789999999999999999999998765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-56 Score=410.83 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=206.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|++.. +|..||+|+++.... .....+.+|+.+|+.++||||+++++++.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 5689999999999999999997754 789999999975432 334678999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.+..++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeC
Confidence 999999999999999999998764 48999999999999999999997 47 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc-
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS- 307 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~- 307 (398)
|+|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......... +.......
T Consensus 150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~--~~~~~~~~~ 223 (322)
T d1s9ja_ 150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDA 223 (322)
T ss_dssp CCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH--C--------
T ss_pred CCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHHhcCCc
Confidence 999864221 22346899999999999999999999999999999999999999976432210000 00000000
Q ss_pred -----------------------cccccc----cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 -----------------------KRRIFR----VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 -----------------------~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.....+ ..............+.++.+||.+||+.||.+|||++|+++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000 000000000011235678999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-55 Score=401.08 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=193.9
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..+.|++.++||+|+||+||+|++.. +++.||+|++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34679999999999999999997654 789999999975433 23356789999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc---CCCCEEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD---SNYNAKL 225 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~---~~~~~kl 225 (398)
+++..|+|||||++|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||+. .++.+||
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl 151 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMI 151 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred ECCEEEEEEeccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEE
Confidence 9999999999999999999997653 5999999999999999999999998 99999999999995 5789999
Q ss_pred eeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
+|||+|+...... .....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.... .......
T Consensus 152 ~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~ 222 (307)
T d1a06a_ 152 SDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQIL 222 (307)
T ss_dssp CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH
T ss_pred eccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHh
Confidence 9999998654332 234467999999999999999999999999999999999999999653211 1111111
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
... ...........+.++.+||.+||+.||++|||++|++++
T Consensus 223 ~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 223 KAE--------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTC--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccC--------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 100 011112223456789999999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-55 Score=405.35 Aligned_cols=265 Identities=26% Similarity=0.408 Sum_probs=211.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++.++||+|+||+||+|++... ........||+|.+... .......+.+|+.+|.++ +||||+++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCC----CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 36789999999999999999987541 12234557999998653 223456788999999998 8999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecC
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS-------------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRD 209 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~D 209 (398)
+.+..++|||||++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+|||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRD 189 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRD 189 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 99999999999999999999976532 1235899999999999999999999998 99999
Q ss_pred CCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 015909 210 FKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDK 288 (398)
Q Consensus 210 lkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~ 288 (398)
|||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++ |++||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987554444334445678999999999999999999999999999999998 8999975
Q ss_pred CCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 015909 289 NRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELE 357 (398)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 357 (398)
..... .+.. .+........+...+.++.+||.+||+.||++|||++||+++|.
T Consensus 270 ~~~~~--~~~~--------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDA--NFYK--------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSH--HHHH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHH--HHHH--------------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 43221 1111 11111112233445678999999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-54 Score=405.39 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=210.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|++.. +|..||+|++........+.+.+|+.+|++|+||||+++++++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3589999999999999999997754 7899999999876666667889999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc--CCCCEEEeec
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD--SNYNAKLSDF 228 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~--~~~~~kl~Df 228 (398)
+.+|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCC
T ss_pred CEEEEEEEcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeec
Confidence 99999999999999999986543 35899999999999999999999999 99999999999996 4678999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+++...... ......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.... ..........
T Consensus 171 G~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~ 241 (350)
T d1koaa2 171 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD 241 (350)
T ss_dssp TTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC
T ss_pred chheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC
Confidence 9998764432 234468999999999999999999999999999999999999999653211 1111111110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. .........+.++.+||.+||+.||++|||++|+++|
T Consensus 242 ~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 WN--------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CC--------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CC--------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0111112345789999999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-54 Score=404.66 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=210.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||+|+||+||+|.+.. +|..||+|++..........+.+|+.+|++|+||||+++++++.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 469999999999999999997654 78999999998765555677889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc--CCCCEEEeecc
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD--SNYNAKLSDFG 229 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~--~~~~~kl~Dfg 229 (398)
.+|+|||||++|+|.+++...+ ..+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEEEEcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecc
Confidence 9999999999999998876543 46899999999999999999999998 99999999999997 67899999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
+|....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... .........
T Consensus 175 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~-- 243 (352)
T d1koba_ 175 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRC-- 243 (352)
T ss_dssp TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHC--
T ss_pred cceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC--
Confidence 998765432 234467999999999999999999999999999999999999999653211 111111110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
............+.++.+||.+||+.||.+|||+.|+++|
T Consensus 244 ------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 ------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111122223456789999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=386.00 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=210.9
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||+|+||+||+|+++ ++..||||.++.... ..+.+.+|+.++++++||||+++++++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 57899999999999999999864 477899999986543 4578999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
.+++||||+++|+|..++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLS 147 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred ceEEEEEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhh
Confidence 9999999999999999977654 45889999999999999999999998 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
+........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .... . +..
T Consensus 148 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~---~-i~~--- 216 (258)
T d1k2pa_ 148 RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE---H-IAQ--- 216 (258)
T ss_dssp CBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH---H-HHT---
T ss_pred eeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHH---H-HHh---
Confidence 865443322 2334678999999999999999999999999999999998 89999754211 1111 0 111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQ 358 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 358 (398)
......+...+.++.+|+.+||+.||++|||+++++++|.+
T Consensus 217 -------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 217 -------GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -------CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01112233445789999999999999999999999999854
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-54 Score=398.19 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=202.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..|+..+.||+|+||+||+|++.. ++..||||++...... ..+.+.+|+.+|++++||||+++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 358999999999999999997654 7899999999765432 2356889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+++..|+|||||++|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DF 159 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDF 159 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCC
T ss_pred ECCEEEEEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeec
Confidence 999999999999999887766554 35899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCccccccccccccccccccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhh
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYL 305 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (398)
|+|..... .....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.... .......
T Consensus 160 G~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~ 227 (309)
T d1u5ra_ 160 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA 227 (309)
T ss_dssp TTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH
T ss_pred ccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH
Confidence 99986433 234579999999999864 45899999999999999999999999653211 0000000
Q ss_pred hccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 306 TSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. .......+...+.++.+||.+||+.||++|||++++++|
T Consensus 228 ~----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 228 Q----------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp H----------SCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred h----------CCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 0 000111122345789999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=391.57 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=208.8
Q ss_pred cCCCCCce-ecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSV-LGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~-lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|.+.+. ||+|+||+||+|.+.. ..++..||||.++.... ...+.+.+|+.+|++++||||+++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEec-------CCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45666674 9999999999997643 12566899999975432 345678999999999999999999998864
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCT
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccch
Confidence 56899999999999999986543 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCc-ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 230 LARDGPTGDKS-HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... ++... +..
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----i~~ 227 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQ 227 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHT
T ss_pred hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHc
Confidence 99876543322 12234568999999999999999999999999999999998 99999754221 11111 111
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
. .....+...+.++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 228 ~----------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 228 G----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp T----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 1112334456789999999999999999999999999987654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=390.49 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=206.5
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+.+|++++||||+++++++. +
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~ 79 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence 467899999999999999999864 46789999997653 44577999999999999999999999775 5
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccc
Confidence 677999999999999998765432 35899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRR 310 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (398)
|+....... .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... .... .. +.
T Consensus 156 a~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~---~~-i~---- 224 (272)
T d1qpca_ 156 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVI---QN-LE---- 224 (272)
T ss_dssp CEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH---HH-HH----
T ss_pred eEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHH---HH-HH----
Confidence 987644322 2233457899999999999999999999999999999999965554322110 0111 10 00
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 311 IFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
.. .....+...+.++.+|+.+||+.||++|||++++++.|+.+-
T Consensus 225 --~~----~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 225 --RG----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --TT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --hc----CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 01 111123345678999999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=388.42 Aligned_cols=264 Identities=25% Similarity=0.411 Sum_probs=203.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
..|++.++||+|+||+||+|.++.. .......||||.+..... .....+.+|+.+|++++||||+++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCC-----CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4678889999999999999987641 112345799999865433 2345688999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++||||+.++++.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999887654 46899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCC-cccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDK-SHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++....... ........||+.|+|||++.+..++.++|||||||++|||++|..|+...... ..+. ..
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~---~~------ 225 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM---KA------ 225 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH---HH------
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH---HH------
Confidence 987544322 12223356899999999999999999999999999999999966555332111 1111 10
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
+........+...+.++.+|+.+||+.||++|||+.++++.|+.+.+
T Consensus 226 -----i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 226 -----INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11111222333456789999999999999999999999999987765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=396.13 Aligned_cols=249 Identities=29% Similarity=0.378 Sum_probs=210.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++++.||+|+||+||+|++.. +|..||+|++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 579999999999999999997654 79999999997532 234577889999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+.+|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+||
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCC
T ss_pred cccccccceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeec
Confidence 9999999999999999999998875 4899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.. .........
T Consensus 150 G~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~~~- 220 (337)
T d1o6la_ 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILME- 220 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-
T ss_pred ccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHhcC-
Confidence 99986543222 234578999999999999999999999999999999999999999754311 111111110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
...++...+.++.+||.+||+.||.+|++ ++++++|
T Consensus 221 -----------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 -----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11223345678999999999999999995 8888875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=386.93 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=200.8
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEeCCceEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLEDDHRLL 155 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~~~~l 155 (398)
+.||+|+||+||+|.+.. ..++..||||+++.... ...+.+.+|+.+|++++||||+++++++.. +..++
T Consensus 13 k~iG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEcc-------CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 469999999999997643 22567899999965432 234678999999999999999999999854 56789
Q ss_pred EEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCCC
Q 015909 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDGP 235 (398)
Q Consensus 156 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~~ 235 (398)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 vmE~~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcc
Confidence 999999999999998753 5899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcc-cccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccccccc
Q 015909 236 TGDKSH-VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKRRIFR 313 (398)
Q Consensus 236 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... .+.. .+..
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~----~i~~------ 225 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEK------ 225 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHT------
T ss_pred ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH----HHHc------
Confidence 433222 2234578999999999999999999999999999999998 89999753211 1111 0111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 314 VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
......+...+.++.+|+.+||+.||++|||++++++.|+..
T Consensus 226 ----~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 226 ----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 011122334567899999999999999999999999988765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=391.32 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=207.2
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc------cchHHHHHHHHHHcCCCCCccccee
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF------QGHKEWLTEINYLGQLHHPNLVKLV 144 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~I~~~~ 144 (398)
.++|++.+.||+|+||+||+|++.. +|..||||++..... ...+.+.+|+.+|++++||||++++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 4679999999999999999997754 789999999864322 2356789999999999999999999
Q ss_pred eEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC---
Q 015909 145 GYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY--- 221 (398)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~--- 221 (398)
+++.+.+..|+|||||++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSS
T ss_pred EEEEECCEEEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcc
Confidence 99999999999999999999999998764 5899999999999999999999999 99999999999998766
Q ss_pred -CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 222 -NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 222 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..
T Consensus 154 ~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~ 224 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ET 224 (293)
T ss_dssp CCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH
T ss_pred cceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HH
Confidence 59999999998764332 233457899999999999999999999999999999999999999753211 11
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......... ......+...+.++.+||.+||+.||.+|||+++++++
T Consensus 225 ~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 225 LANVSAVNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHTTCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcCC--------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111000000 00000011235678999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=385.19 Aligned_cols=265 Identities=24% Similarity=0.365 Sum_probs=203.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|++.. ....+..||+|.+..... ...+.+.+|+.+|++++||||+++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEec------CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4579999999999999999998753 122456899999865433 33567899999999999999999999985
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
++..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCeEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccch
Confidence 567899999999999999877654 46899999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...... .+.... ...
T Consensus 154 ~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i----~~~ 225 (273)
T d1mp8a_ 154 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----ENG 225 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----HTT
T ss_pred hheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcC
Confidence 9987543322 22334568999999999999999999999999999999998 89999754321 111100 000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
.....+...+.++.+||.+||+.||++|||+.+|+++|+.+.+.++.
T Consensus 226 ----------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~ 272 (273)
T d1mp8a_ 226 ----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272 (273)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhC
Confidence 01123334567899999999999999999999999999988766543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=390.26 Aligned_cols=272 Identities=27% Similarity=0.367 Sum_probs=206.2
Q ss_pred HHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeE
Q 015909 69 TATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGY 146 (398)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~ 146 (398)
...++|++.+.||+|+||+||+|.+.. ..+..+++.||+|.+..... ...+.+.+|..++.++ +|+||+.++++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEES----TTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcC----CCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344689999999999999999998754 22334678999999975433 3345677888888777 68999999998
Q ss_pred EEeC-CceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCC
Q 015909 147 CLED-DHRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKAS 213 (398)
Q Consensus 147 ~~~~-~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~ 213 (398)
+... ...++|||||++|+|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~ 163 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 163 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcc
Confidence 7664 468999999999999999976432 1235889999999999999999999998 999999999
Q ss_pred CEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCC
Q 015909 214 NILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSG-RRAIDKNRPT 292 (398)
Q Consensus 214 Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~p~~~~~~~ 292 (398)
||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876554444444556899999999999999999999999999999999986 5677543221
Q ss_pred CCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 293 GEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
. .+.. .+... .....+...+.++.+|+.+||+.||++|||+++++++|+++.+.
T Consensus 244 ~--~~~~----~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 244 E--EFCR----RLKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp H--HHHH----HHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H--HHHH----HHhcC----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1 1111 11110 11122333456899999999999999999999999999988654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-53 Score=389.20 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=207.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|++.. +|..||||++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 569999999999999999997654 78999999986432 244577899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+.+..|+||||+++|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+||
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCeeeeEeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecC
Confidence 9999999999999999999988764 4788999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|+..... ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+... ..........
T Consensus 149 G~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~- 216 (316)
T d1fota_ 149 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA- 216 (316)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC-
T ss_pred ccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcC-
Confidence 999875432 2346899999999999999999999999999999999999999975321 1111111111
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
...++...+.++.+++.+||+.||.+|+ |++++++|
T Consensus 217 -----------~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 -----------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----------CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1122334467899999999999999996 89999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-53 Score=389.91 Aligned_cols=262 Identities=22% Similarity=0.391 Sum_probs=206.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.+|++.++||+|+||+||+|.+..+ .......||+|.+... .....+.+.+|+.+|++++||||+++++++.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~- 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT- 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCC-----CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4699999999999999999987541 1112347999988643 33456789999999999999999999999876
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+..++++|++.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred CCeeEEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeecccc
Confidence 45678889999999999887764 46899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.... .+... +..
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~----i~~-- 228 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEK-- 228 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHH----HHH--
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHc--
Confidence 987655444444445678999999999999999999999999999999998 88888653221 11111 111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
......+...+.++.+|+.+||+.||.+|||+.+++++|..+..
T Consensus 229 --------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 --------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 01112233456789999999999999999999999999987754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=378.95 Aligned_cols=252 Identities=27% Similarity=0.451 Sum_probs=200.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEe-C
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE-D 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~-~ 150 (398)
++|++.+.||+|+||.||+|.+ +|..||||+++.+ ...+.+.+|++++++++||||+++++++.+ .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-----------~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred HHeEEeEEEecCCCeEEEEEEE-----------CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 5688899999999999999976 3678999999765 345778999999999999999999999865 4
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccC
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGL 230 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~ 230 (398)
+.+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CcEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeeccccc
Confidence 568999999999999999976532 34899999999999999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhhccc
Q 015909 231 ARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLTSKR 309 (398)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
++..... .....+|..|+|||++.+..++.++|||||||++|||++ |++||...... +.....
T Consensus 150 s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i-------- 213 (262)
T d1byga_ 150 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV-------- 213 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH--------
T ss_pred ceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH--------
Confidence 9864332 223467899999999999999999999999999999998 78887643211 111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 310 RIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
........+...+.++.+||.+||+.||.+|||+.+++++|++++.-
T Consensus 214 ------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 214 ------EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ------TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 01111223334557899999999999999999999999999988653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.1e-52 Score=375.46 Aligned_cols=261 Identities=23% Similarity=0.343 Sum_probs=203.9
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccc---hHHHHHHHHHHcCCCCCcccceeeEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQG---HKEWLTEINYLGQLHHPNLVKLVGYC 147 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~I~~~~~~~ 147 (398)
.++|++.+.||+|+||+||+|.+.. +++.||+|++....... ...+.+|+.+|+.++||||+++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 4679999999999999999997654 78999999997654332 45688999999999999999999998
Q ss_pred EeCCc----eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 148 LEDDH----RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 148 ~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
...+. .|+||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccc
Confidence 87543 789999999999999988764 5899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCC-cccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDK-SHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+|+|||.+........ ........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.... ....
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~ 224 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAY 224 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHH
Confidence 9999999875433222 22234467999999999999999999999999999999999999999753211 1111
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-DMDEVVKELEQLQ 360 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~l~ 360 (398)
........ .........+.++.+||.+||+.||++|| |++++++.|.+++
T Consensus 225 ~~~~~~~~--------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 225 QHVREDPI--------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHCCCC--------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHhcCCC--------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11111100 01111223457899999999999999998 8999998888764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-52 Score=391.75 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=202.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHH---HHHHHHHcCCCCCcccceee
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEW---LTEINYLGQLHHPNLVKLVG 145 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~~I~~~~~ 145 (398)
++|++.++||+|+||+||+|++.. +|..||+|++..... .....+ ..|+.+++.++||||+++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 579999999999999999997754 789999999864321 122223 34577888899999999999
Q ss_pred EEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 146 YCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
++.+.+..|+|||||++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEE
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEE
Confidence 9999999999999999999999998764 4789999999999999999999999 999999999999999999999
Q ss_pred eeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
+|||+|+...... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||........ ......
T Consensus 149 ~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~- 220 (364)
T d1omwa3 149 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRM- 220 (364)
T ss_dssp CCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHH-
T ss_pred eeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh-
Confidence 9999998754332 234579999999999864 5689999999999999999999999976432211 110000
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
... .....+...+.++.+||.+||+.||++||| ++++++|
T Consensus 221 ---------~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 221 ---------TLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---------SSS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---------ccc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 000 011222334678999999999999999999 7898876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-53 Score=387.83 Aligned_cols=268 Identities=25% Similarity=0.346 Sum_probs=213.6
Q ss_pred HhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-chHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 70 ATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-GHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
..++|++.+.||+|+||+||+|++.. .....++..||||++...... ..+.+.+|+.+|++++||||+++++++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPG----LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEET----SSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECC----CccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 45689999999999999999998753 123346789999999765433 3567899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS--------------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYR 208 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~ 208 (398)
..+..++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+++ |+||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHr 164 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 164 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEee
Confidence 99999999999999999999975431 1234889999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCC-CCCC
Q 015909 209 DFKASNILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR-RAID 287 (398)
Q Consensus 209 Dlkp~Nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~p~~ 287 (398)
||||+||||+.++.+||+|||+|+...............||+.|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999997654443333344567899999999999999999999999999999999985 5675
Q ss_pred CCCCCCCcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 015909 288 KNRPTGEHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQ 360 (398)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 360 (398)
..... .... . +.... ....+...+.++.+|+.+||+.||++|||+.++++.|+++.
T Consensus 245 ~~~~~---e~~~---~-v~~~~----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHE---EVIY---Y-VRDGN----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHH---HHHH---H-HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHH---HHHH---H-HHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 43211 1111 1 11000 11123344568999999999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-52 Score=391.70 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=207.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++++.||+|+||+||+|.+.. +|..||||++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 479999999999999999997754 78999999986432 234567899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
.....++||||+.+|+|..++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred cccccccccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeec
Confidence 9999999999999999999998774 4899999999999999999999999 999999999999999999999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|+|+..... .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+... ..........
T Consensus 186 G~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~- 253 (350)
T d1rdqe_ 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSG- 253 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-
T ss_pred eeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcC-
Confidence 999875432 2346799999999999999999999999999999999999999965321 1111111110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRP-----DMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 355 (398)
....+...+.++.+||.+||+.||.+|+ |++++++|
T Consensus 254 -----------~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 254 -----------KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----------CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0112234567899999999999999994 89999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=386.81 Aligned_cols=252 Identities=24% Similarity=0.305 Sum_probs=200.9
Q ss_pred hcCCCCC-ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcC-CCCCcccceeeEEE
Q 015909 71 TRNFRPD-SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQ-LHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~~I~~~~~~~~ 148 (398)
.++|++. ++||+|+||+||+|++.. +++.||||+++.. ..+.+|+.++.+ ++||||++++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3578876 469999999999997654 7899999998643 567789998655 58999999999987
Q ss_pred e----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC---CC
Q 015909 149 E----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS---NY 221 (398)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~---~~ 221 (398)
+ ...+|+|||||+||+|.+++...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTC
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccc
Confidence 5 4668999999999999999986543 46999999999999999999999999 999999999999975 56
Q ss_pred CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 222 NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 222 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
.+||+|||+|+....... .....||+.|+|||++.+..|+.++|||||||++|+|++|++||.+..........
T Consensus 152 ~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--- 225 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--- 225 (335)
T ss_dssp CEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred cccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---
Confidence 799999999987544332 33467999999999999999999999999999999999999999754322111000
Q ss_pred hhhhhcccccccccccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 302 KPYLTSKRRIFRVLDPRLE--GQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...+...... .......+.++.+||.+||+.||++|||+.|+++|
T Consensus 226 ---------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 ---------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---------HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000001111 11112346789999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-53 Score=380.41 Aligned_cols=260 Identities=27% Similarity=0.392 Sum_probs=199.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc---cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF---QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
++|++.+.||+|+||+||+|.+.. ..+....||||++..... ...+.+.+|+.+|++++||||+++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~------~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEEC------CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 568999999999999999998653 122455799999875432 33467899999999999999999999996
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeec
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDF 228 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Df 228 (398)
+ ...++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred e-cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccc
Confidence 5 57789999999999999887654 45899999999999999999999998 999999999999999999999999
Q ss_pred cCCcCCCCCCCccc-ccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCcchhhhhhhhhh
Q 015909 229 GLARDGPTGDKSHV-STRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEHNLVEWAKPYLT 306 (398)
Q Consensus 229 g~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (398)
|+++.......... .....|+..|+|||++.+..++.++||||||+++|||++ |+.||.+.... ........
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~ 229 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDK 229 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHT
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHh
Confidence 99987654433222 233467889999999999999999999999999999998 89999643211 11111111
Q ss_pred ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 307 SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.......+...+.++.+|+.+||+.||++|||+++|++.|.+.
T Consensus 230 ----------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 ----------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111122334457899999999999999999999999988865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=386.30 Aligned_cols=253 Identities=19% Similarity=0.239 Sum_probs=207.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED 150 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~ 150 (398)
.++|++.+.||+|+||+||+|.+.. ++..||+|.++.... ....+.+|+.+|+.++||||+++++++.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 4679999999999999999997765 789999999976543 235678999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC--CCCEEEeec
Q 015909 151 DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS--NYNAKLSDF 228 (398)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~--~~~~kl~Df 228 (398)
+.+|+|||||++++|.+++...+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.++|+||
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEccc
Confidence 99999999999999999997654 35899999999999999999999998 999999999999984 458999999
Q ss_pred cCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 229 GLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
|++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...... ..........
T Consensus 149 G~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~ 219 (321)
T d1tkia_ 149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAE 219 (321)
T ss_dssp TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC
T ss_pred chhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC
Confidence 9998754332 234467899999999999999999999999999999999999999753211 1111111100
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. +........+.++.+||.+||..||.+|||++|+++|
T Consensus 220 ~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 YT--------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CC--------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC--------CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000001235678999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=379.72 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=200.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
++|++.+.||+|+||+||+|+++. +..||||++.... ...+.+.+|+.+|++++||||+++++++. ++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~ 84 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 84 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence 579999999999999999998753 4579999997554 44578999999999999999999999985 56
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+++|+|..++..... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CeEEEEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchh
Confidence 68999999999999998875432 45899999999999999999999998 999999999999999999999999999
Q ss_pred cCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhccccc
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRI 311 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (398)
+....... .......||+.|+|||++....++.++|||||||++|||++|..|+...... ....... .
T Consensus 161 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i----~----- 228 (285)
T d1fmka3 161 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV----E----- 228 (285)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH----H-----
T ss_pred hhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH----H-----
Confidence 87543332 2233457899999999999999999999999999999999966655432111 1111110 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 312 FRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.....+.+..++.++.+||.+||+.||++||+++++++.|+.+
T Consensus 229 -----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 229 -----RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp -----TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred -----hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 0111123334567899999999999999999999999887753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.3e-52 Score=374.46 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=206.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc---------chHHHHHHHHHHcCCC-CCcc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ---------GHKEWLTEINYLGQLH-HPNL 140 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~~I 140 (398)
.++|++.+.||+|+||+||+|++.. +++.||||++...... ..+.+.+|+.+|++++ ||||
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI 72 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred cccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence 3689999999999999999997654 7899999998654321 1235789999999997 9999
Q ss_pred cceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 141 VKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
+++++++.+++..|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||||+.+
T Consensus 73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~ 146 (277)
T d1phka_ 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD 146 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred EEEEeecccCcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC
Confidence 999999999999999999999999999998764 5899999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCccccccccccccccccccccc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT------GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGE 294 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~ 294 (398)
+.+||+|||+++....... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+....
T Consensus 147 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-- 221 (277)
T d1phka_ 147 MNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-- 221 (277)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred CCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--
Confidence 9999999999987644322 334679999999999853 34688999999999999999999999754211
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
........... ..........++++++|+.+||+.||.+|||++|++++
T Consensus 222 ----~~~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 222 ----LMLRMIMSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ----HHHHHHHHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----HHHHHHHhCCC--------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00111111100 11112223456789999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=379.39 Aligned_cols=271 Identities=26% Similarity=0.381 Sum_probs=212.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||.||+|++.... .....++..||||++..... .....+.+|...+.++ +||||+++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~--~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCC--cccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 467899999999999999999865411 11223456899999976543 3346788899999888 7999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
+++..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiL 167 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL 167 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccccee
Confidence 99999999999999999999976542 1245899999999999999999999999 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTGEH 295 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~~~ 295 (398)
++.++.+||+|||+++...............||+.|+|||.+.++.|+.++||||||+++|||++ |.+||.+....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 99999999999999987655444444555678999999999999999999999999999999998 78888643221
Q ss_pred chhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 015909 296 NLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQEL 362 (398)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 362 (398)
.... .+.. ......+...+.++.+||.+||+.||++|||+.|+++.|+++-.+
T Consensus 245 ~~~~----~i~~----------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 ELFK----LLKE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHH----HHHT----------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HHHc----------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1111 1111 111122334467899999999999999999999999999887543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=384.45 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=204.7
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCC---ccchHHHHHHHHHHc-CCCCCcccceeeEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEG---FQGHKEWLTEINYLG-QLHHPNLVKLVGYC 147 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~~I~~~~~~~ 147 (398)
++|++.+.||+|+||+||+|++.. +++.||||++.... ....+.+..|..++. .++||||+++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 579999999999999999997654 79999999996432 233456677777665 68999999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEee
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSD 227 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~D 227 (398)
.+++..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred ccCCceeEEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccc
Confidence 99999999999999999999998765 4899999999999999999999999 99999999999999999999999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS 307 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
||+++....... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.... .........
T Consensus 147 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~ 218 (320)
T d1xjda_ 147 FGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMD 218 (320)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC
T ss_pred cchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHcC
Confidence 999986543322 234468999999999999999999999999999999999999999753211 111111100
Q ss_pred cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 015909 308 KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMD-EVVK 354 (398)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 354 (398)
...++...+.++.+||.+||+.||.+||++. ++++
T Consensus 219 ------------~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 ------------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------------CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1122333467899999999999999999995 7765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=379.70 Aligned_cols=267 Identities=25% Similarity=0.376 Sum_probs=216.0
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCC-CCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQL-HHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~I~~~~~~~~ 148 (398)
.++|++.++||+|+||.||+|.+.. ..+..++..||||+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~----~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYG----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCeEEEEEEEec----cccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 4678999999999999999998753 12335788999999975433 3455788999999999 6999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCC
Q 015909 149 EDDHRLLVYEFMPRGSMENHLFRRGS--------------YFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASN 214 (398)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~N 214 (398)
+.+..++|||||++|+|.+++..... ....+++..+..++.||+.||+|||+++ ++||||||+|
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~N 175 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARN 175 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccc
Confidence 99999999999999999999976542 2235899999999999999999999999 9999999999
Q ss_pred EEEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 015909 215 ILLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILS-GRRAIDKNRPTG 293 (398)
Q Consensus 215 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~p~~~~~~~~ 293 (398)
|+++.++.++|+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |.+||.......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999997665554444555789999999999999999999999999999999999 555554432211
Q ss_pred CcchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 294 EHNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
.+.. ... .......+...+.++.+||.+||+.||++|||++++++.|++.
T Consensus 256 --~~~~----~i~----------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 --KFYK----MIK----------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp --HHHH----HHH----------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHH----HHh----------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 0111 111 1111122333467899999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=377.98 Aligned_cols=259 Identities=30% Similarity=0.458 Sum_probs=205.6
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCc--EEEEEEcccC-CccchHHHHHHHHHHcCC-CCCcccceeeEE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGM--LIAVKRLNQE-GFQGHKEWLTEINYLGQL-HHPNLVKLVGYC 147 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~I~~~~~~~ 147 (398)
++|++.++||+|+||+||+|.+.. ++. .||||.+... .....+.+.+|+++|.++ +||||+++++++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---------CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 578889999999999999998754 343 5778887543 223456789999999999 799999999999
Q ss_pred EeCCceEEEEeecCCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCE
Q 015909 148 LEDDHRLLVYEFMPRGSMENHLFRRG------------SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNI 215 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Ni 215 (398)
.+.+..++||||+++|+|.+++.... .....+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NI 158 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 158 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceE
Confidence 99999999999999999999997541 22356899999999999999999999998 99999999999
Q ss_pred EEcCCCCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCCCCC
Q 015909 216 LLDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR-RAIDKNRPTGE 294 (398)
Q Consensus 216 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~~~~ 294 (398)
|++.++.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+....
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-- 233 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-- 233 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred EEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--
Confidence 999999999999999976433221 22346899999999999999999999999999999999965 566542211
Q ss_pred cchhhhhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 295 HNLVEWAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
.+.. . +. .......+...+.++.+||.+||+.||++|||+++++++|+++.+
T Consensus 234 -~~~~---~-i~----------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 234 -ELYE---K-LP----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -HHHH---H-GG----------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHH---H-HH----------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 0 00 011122333456789999999999999999999999999998865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=380.92 Aligned_cols=259 Identities=24% Similarity=0.272 Sum_probs=193.6
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc-----chHHHHHHHHHHcCCCCCcccceeeEEEeCC
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ-----GHKEWLTEINYLGQLHHPNLVKLVGYCLEDD 151 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~~ 151 (398)
+++||+|+||+||+|++.. +|+.||||+++..... ..+.+.+|+.+|++++||||+++++++.+++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 5789999999999997654 7899999999654322 1346889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCC
Q 015909 152 HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLA 231 (398)
Q Consensus 152 ~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a 231 (398)
..++||||+.++++..+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~ivmE~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceeehhhhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccc
Confidence 999999999877666554333 45888999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc--c
Q 015909 232 RDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS--K 308 (398)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 308 (398)
+....... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+..... ........+.. .
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTE 222 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCT
T ss_pred cccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCCh
Confidence 87544322 2334679999999999865 467999999999999999999999997543211 11000000000 0
Q ss_pred ------ccccccccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 ------RRIFRVLDPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ------~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...............+ ...+.++.+||.+||+.||++|||++|+|+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000000000111 1235689999999999999999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=375.56 Aligned_cols=266 Identities=26% Similarity=0.393 Sum_probs=199.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 579999999999999999997754 789999999965432 235678999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..|+||||+.+ .+..++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ccceeEEEeecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCC
Confidence 9999999999955 55555544322 56999999999999999999999999 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcc
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH-LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSK 308 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
+|+...... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.... +...........
T Consensus 148 ~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~ 223 (298)
T d1gz8a_ 148 LARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPD 223 (298)
T ss_dssp HHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred cceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCc
Confidence 997653322 2234467999999999876655 57899999999999999999999975421110 000000000000
Q ss_pred c----cccccc--ccccc--CCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 309 R----RIFRVL--DPRLE--GQF-----SLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 309 ~----~~~~~~--~~~~~--~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
. ...... ..... ... ....+.++.+|+.+||..||++|||++|+++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 000000 00000 000 11235688999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=370.79 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=203.9
Q ss_pred CceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccC-CccchHHHHHHHHHHcCCCCCcccceeeEEEe-CCceE
Q 015909 77 DSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQE-GFQGHKEWLTEINYLGQLHHPNLVKLVGYCLE-DDHRL 154 (398)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~-~~~~~ 154 (398)
.++||+|+||+||+|.+..+ .++...||||.++.. .....+.+.+|+++|++++||||+++++++.. +...+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECC------CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 57899999999999987541 123457999999743 33445779999999999999999999999876 45789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeeccCCcCC
Q 015909 155 LVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFGLARDG 234 (398)
Q Consensus 155 lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~~ 234 (398)
+|||||++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 106 lv~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EEEEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhc
Confidence 9999999999999987654 45788889999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCcc--cccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhcccccc
Q 015909 235 PTGDKSH--VSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTSKRRIF 312 (398)
Q Consensus 235 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|..||....... +...+ ... ..
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~---i~~-g~--- 251 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY---LLQ-GR--- 251 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HHT-TC---
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH---HHc-CC---
Confidence 4433221 2233578999999999999999999999999999999999888875432111 11111 111 00
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 015909 313 RVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQE 361 (398)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 361 (398)
....+...+.++.+|+.+||+.||++||++.|++++|+.+.+
T Consensus 252 -------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011222345789999999999999999999999999998854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=374.02 Aligned_cols=242 Identities=22% Similarity=0.390 Sum_probs=198.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCcc------chHHHHHHHHHHcCCC--CCcccc
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQ------GHKEWLTEINYLGQLH--HPNLVK 142 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~~I~~ 142 (398)
.++|++.++||+|+||+||+|++.. ++..||||++...... ....+.+|+.+|++++ ||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 4689999999999999999997754 7899999998654221 1234568999999986 899999
Q ss_pred eeeEEEeCCceEEEEeecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-C
Q 015909 143 LVGYCLEDDHRLLVYEFMPR-GSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-N 220 (398)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-~ 220 (398)
+++++.+.+..++||||+.+ +++.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++. +
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNR 147 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTT
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCC
Confidence 99999999999999999975 57888887654 5899999999999999999999999 999999999999984 5
Q ss_pred CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHL-TAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
+.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....
T Consensus 148 ~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------- 214 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------- 214 (273)
T ss_dssp TEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred CeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------
Confidence 79999999999864332 2345679999999999987765 567899999999999999999996421
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... ..++...+.++.+||.+||+.||++|||++|++++
T Consensus 215 ---~i~~~~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 ---EIIRGQ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---HHHHCC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHhhcc------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000000 01122245789999999999999999999999885
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=371.20 Aligned_cols=276 Identities=26% Similarity=0.355 Sum_probs=202.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHH--HHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWL--TEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|.+.+.||+|+||.||+|++ +|..||||++.... ...+. .|+..+..++||||+++++++.
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~ 67 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN 67 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEE
Confidence 46788899999999999999975 47899999986542 23333 4555556789999999999998
Q ss_pred eCC----ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCceecCCCCCCEEEc
Q 015909 149 EDD----HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSA------EPKVIYRDFKASNILLD 218 (398)
Q Consensus 149 ~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~ivH~Dlkp~Nilv~ 218 (398)
+.+ ..++||||+++|+|.+++.+. .+++..++.++.|++.||.|||+. .++|+||||||+||||+
T Consensus 68 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~ 142 (303)
T d1vjya_ 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 142 (303)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred eCCCcceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc
Confidence 754 578999999999999999864 489999999999999999999974 12399999999999999
Q ss_pred CCCCEEEeeccCCcCCCCCCCcc--cccccccccccccccccccCC------CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015909 219 SNYNAKLSDFGLARDGPTGDKSH--VSTRVMGTYGYAAPEYLATGH------LTAKSDIYSFGVVLLEILSGRRAIDKNR 290 (398)
Q Consensus 219 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~ell~g~~p~~~~~ 290 (398)
.++.+||+|||+++......... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||....
T Consensus 143 ~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 99999999999998654433221 233467999999999987643 5678999999999999999998885432
Q ss_pred CCCCcchhh-hhhhhhh--ccccccccccccccCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 291 PTGEHNLVE-WAKPYLT--SKRRIFRVLDPRLEGQ-FSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 291 ~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
......... ...+... ........+.+.+... .+......+.+|+.+||+.||++|||+.|+++.|+++.+.+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred ccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 221100000 0000000 0000011111111111 1233556799999999999999999999999999999877654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=373.35 Aligned_cols=266 Identities=24% Similarity=0.380 Sum_probs=212.6
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
.++|++.+.||+|+||+||+|.++. .....++..||||+++.... .....+.+|+.++++++||||+++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEE----EETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC----cccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4678899999999999999998753 12223467899999975432 334568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRG------SYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
.+..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceE
Confidence 999999999999999999986432 22345789999999999999999999998 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGR-RAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~p~~~~~~~~~~~~~~~~~ 302 (398)
||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++|. +||.+... .....
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~ 246 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLR 246 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence 999999998754444444445567899999999999999999999999999999999984 67754211 11111
Q ss_pred hhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 015909 303 PYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQL 359 (398)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 359 (398)
... ... ....+...+..+.+++.+||+.||++|||++++++.|++.
T Consensus 247 ~i~-~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 247 FVM-EGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHH-TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHH-hCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111 100 1112233457899999999999999999999999988644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=370.64 Aligned_cols=266 Identities=25% Similarity=0.350 Sum_probs=198.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCC---CCCcccceee
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQL---HHPNLVKLVG 145 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~I~~~~~ 145 (398)
.++|++++.||+|+||+||+|++.. .+++.||||++..... .....+.+|+.+|+.| +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEEC--------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 4689999999999999999997643 1367899999864322 2234566777777665 7999999999
Q ss_pred EEEe-----CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 146 YCLE-----DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 146 ~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
++.. ....+++||+++++.+........ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS 152 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC
Confidence 9863 346789999997766654444332 56899999999999999999999999 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhh
Q 015909 221 YNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEW 300 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~ 300 (398)
+.+||+|||++...... .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+...... +...
T Consensus 153 ~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i 227 (305)
T d1blxa_ 153 GQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKI 227 (305)
T ss_dssp CCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH
T ss_pred CCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHH
Confidence 99999999998764322 234457899999999999999999999999999999999999999975432110 0000
Q ss_pred hhhhhhc--------c----ccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 301 AKPYLTS--------K----RRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 301 ~~~~~~~--------~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.. .... . ..............+....+..+.+||.+||+.||++|||++|+++|
T Consensus 228 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 228 LD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HH-HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH-hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000 0 00000000000111222345788999999999999999999999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.4e-50 Score=365.58 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=198.4
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++.++||+|+||+||+|.++ +++.||||++..... ...+.+.+|+.+|++++||||+++++++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 58999999999999999999763 578999999975432 235778999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
.+..+++||++.++.+..+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG 145 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFG 145 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCceeEEEEeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccc
Confidence 99999999999766555555433 46999999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh----
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY---- 304 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---- 304 (398)
++........ ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+...... +.......
T Consensus 146 ~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~ 221 (286)
T d1ob3a_ 146 LARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPN 221 (286)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCC
T ss_pred cceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCC
Confidence 9876433221 2234568999999999865 4568999999999999999999999975422110 00000000
Q ss_pred ---hhccccccc------cccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 305 ---LTSKRRIFR------VLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 305 ---~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
......... ..............+.++.+||.+||+.||++|||++|+++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 000000011122335788999999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-48 Score=356.37 Aligned_cols=268 Identities=18% Similarity=0.187 Sum_probs=211.1
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCC-CcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH-PNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~I~~~~~~~~~ 149 (398)
+++|++.+.||+|+||+||+|++.. +|+.||+|++.... ....+.+|+++++.|.| +||+.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 5789999999999999999997654 78999999986542 23456788999999875 899999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcC-----CCCEE
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDS-----NYNAK 224 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~-----~~~~k 224 (398)
....++||||+ +++|.+++...+ ..++...+..++.|++.||+|||+++ |+||||||+|||++. .+.++
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CCccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceE
Confidence 99999999999 789999987665 45899999999999999999999999 999999999999964 57899
Q ss_pred EeeccCCcCCCCCCCc-----ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh
Q 015909 225 LSDFGLARDGPTGDKS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE 299 (398)
Q Consensus 225 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~ 299 (398)
|+|||+|+........ .......||+.|||||++.+..++.++||||||+++|||++|+.||.+...........
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 9999999875433211 12334679999999999999999999999999999999999999997644332221111
Q ss_pred hhhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 300 WAKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
.... .... .....+. ...+.++.+++..|+..+|++||+++.+.+.|+++.+..+.
T Consensus 227 ~i~~---~~~~---~~~~~l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 227 RIGE---KKQS---TPLRELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHHH---HHHH---SCHHHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHh---ccCC---CChHHhc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 1110 0000 0000011 12346789999999999999999999999999887654443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=358.59 Aligned_cols=267 Identities=19% Similarity=0.212 Sum_probs=203.4
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccc-eeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVK-LVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~-~~~~~~~ 149 (398)
+++|++.+.||+|+||+||+|++.. +|+.||||++..... ...+..|+++++.++|++++. +.+++.+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 4689999999999999999997754 788999999875432 245788999999998776555 4555677
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEc---CCCCEEEe
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLD---SNYNAKLS 226 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~---~~~~~kl~ 226 (398)
.+..++||||+ +++|...+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..++|+
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEEEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeee
Confidence 78889999999 667777666544 46899999999999999999999999 99999999999986 35579999
Q ss_pred eccCCcCCCCCCCc-----ccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhh-h
Q 015909 227 DFGLARDGPTGDKS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVE-W 300 (398)
Q Consensus 227 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~-~ 300 (398)
|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||............. .
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 99999876443321 12334679999999999999999999999999999999999999997644332221111 1
Q ss_pred hhhhhhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhhc
Q 015909 301 AKPYLTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKELEQLQELRNM 365 (398)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 365 (398)
....... ..+.. ....+.++.+++.+||+.||++||+++++.+.|+.+....+.
T Consensus 229 ~~~~~~~-------~~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 229 SEKKMST-------PIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp HHHHHHS-------CHHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hcccCCC-------ChhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 1100000 00000 112346789999999999999999999999998887654443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=365.90 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=194.2
Q ss_pred CCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcccceeeEEEeC--
Q 015909 73 NFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNLVKLVGYCLED-- 150 (398)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~~-- 150 (398)
+|+..++||+|+||+||+|++.. +|+.||||++...... ..+|+.+|++++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 57888999999999999998765 7899999999754322 23799999999999999999998643
Q ss_pred ----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-CEEE
Q 015909 151 ----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKL 225 (398)
Q Consensus 151 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-~~kl 225 (398)
..+++||||++++ +...+.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeE
Confidence 3468999999665 44444322222356999999999999999999999998 99999999999999765 8999
Q ss_pred eeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh--
Q 015909 226 SDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK-- 302 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~-- 302 (398)
+|||++........ .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ +....+
T Consensus 165 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~ 239 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVL 239 (350)
T ss_dssp CCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHH
T ss_pred ecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHh
Confidence 99999987644332 334679999999998765 5789999999999999999999999965432110 000000
Q ss_pred ---------hhhhc--cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 ---------PYLTS--KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ---------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
..... ....................+.++.+||.+||..||++|||+.|+++|
T Consensus 240 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000000000001111122346789999999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=365.30 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=196.7
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++++.||+|+||+||+|.+.. +|+.||||++..... ...+.+.+|+.+|+.++||||++++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4689999999999999999997754 789999999975432 23457889999999999999999999997
Q ss_pred eCC------ceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCC
Q 015909 149 EDD------HRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYN 222 (398)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~ 222 (398)
..+ .+|+||||+ +.+|..++... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccc
Confidence 654 469999999 66787776543 4899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCCcCCCCCCCccccccccccccccccccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhh
Q 015909 223 AKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWA 301 (398)
Q Consensus 223 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~ 301 (398)
++|+|||+|+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.............
T Consensus 160 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~ 234 (346)
T d1cm8a_ 160 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234 (346)
T ss_dssp EEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence 999999999875332 234679999999999876 45789999999999999999999999754321100000000
Q ss_pred h-----hhhh---------ccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 015909 302 K-----PYLT---------SKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE--LEQL 359 (398)
Q Consensus 302 ~-----~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~l 359 (398)
. .... ....+.......+ .......+.++.+||.+||..||.+|||++|+|+| |+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cCCCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0 0000 0000000000000 01112335678899999999999999999999986 5443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=365.09 Aligned_cols=269 Identities=23% Similarity=0.298 Sum_probs=196.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
+.+|++++.||+|+||+||+|++.. +|..||||++..... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 4579999999999999999997654 789999999975432 334578899999999999999999999876
Q ss_pred CCc----eEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEE
Q 015909 150 DDH----RLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKL 225 (398)
Q Consensus 150 ~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl 225 (398)
... .+++++++.+++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEE
T ss_pred ccccccceEEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEE
Confidence 532 34455566699999999754 4899999999999999999999998 999999999999999999999
Q ss_pred eeccCCcCCCCCCCc-ccccccccccccccccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhh
Q 015909 226 SDFGLARDGPTGDKS-HVSTRVMGTYGYAAPEYLA-TGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKP 303 (398)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (398)
+|||++......... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.................
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence 999999865443222 1234467999999999984 45678999999999999999999999975432111000000000
Q ss_pred hhhccc-------cc-cccccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 304 YLTSKR-------RI-FRVLDPRLEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 304 ~~~~~~-------~~-~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
...... .. ............+ ...+.++.+|+.+||+.||.+|||++++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00 0000000000111 1224578999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=356.59 Aligned_cols=267 Identities=24% Similarity=0.321 Sum_probs=194.8
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++++.||+|+||+||+|++.. +|+.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~ 79 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence 3689999999999999999998754 789999999865432 33567889999999999999999999885
Q ss_pred e--------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCC
Q 015909 149 E--------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSN 220 (398)
Q Consensus 149 ~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~ 220 (398)
. .+..++||||+.++.+....... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~ 153 (318)
T d3blha1 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD 153 (318)
T ss_dssp C----------CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT
T ss_pred cccccccccCceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC
Confidence 5 34679999999766554433222 46899999999999999999999998 9999999999999999
Q ss_pred CCEEEeeccCCcCCCCCCCc--ccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcch
Q 015909 221 YNAKLSDFGLARDGPTGDKS--HVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNL 297 (398)
Q Consensus 221 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~ 297 (398)
+.+||+|||++......... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......
T Consensus 154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~--- 230 (318)
T d3blha1 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--- 230 (318)
T ss_dssp SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---
T ss_pred CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---
Confidence 99999999999765433221 122335799999999998765 689999999999999999999999975322111
Q ss_pred hhhhhhhhhc-cc---------cccccccccccCCCCH-------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 298 VEWAKPYLTS-KR---------RIFRVLDPRLEGQFSL-------PQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 298 ~~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......... .. ................ ..+.++.+||.+||+.||++|||++|+++|
T Consensus 231 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 231 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1000000000 00 0000000000000111 114567899999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=349.88 Aligned_cols=265 Identities=23% Similarity=0.284 Sum_probs=204.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|++++.||+|+||+||+|++.. ++..||||+++.... .....+.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 579999999999999999997754 789999999865432 335678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEeecc
Q 015909 150 DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLSDFG 229 (398)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg 229 (398)
....++|++++.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred ccceeEEeeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecc
Confidence 99999999999888888877655 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCcCCCCCCCcccccccccccccccccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhhhhc-
Q 015909 230 LARDGPTGDKSHVSTRVMGTYGYAAPEYLATGH-LTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPYLTS- 307 (398)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~- 307 (398)
.++....... ......++..|+|||++.+.. ++.++|||||||++|||++|+.||...... .+...........
T Consensus 147 ~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~ 222 (292)
T d1unla_ 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTP 222 (292)
T ss_dssp TCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred hhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCC
Confidence 9987544332 223345788999999987654 689999999999999999999997532211 1111100000000
Q ss_pred -------------cccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 308 -------------KRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 308 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
....................+..+.+||.+||+.||.+|||++|+|+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000001111223345688999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.3e-48 Score=358.71 Aligned_cols=260 Identities=18% Similarity=0.256 Sum_probs=198.1
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEeC
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLED 150 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~ 150 (398)
++|++++.||+|+||+||+|++.. ++..||+|+++.. ..+.+.+|+.+|+.++ ||||+++++++...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 579999999999999999997654 7899999998753 3467889999999995 99999999998753
Q ss_pred --CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCC-CEEEee
Q 015909 151 --DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNY-NAKLSD 227 (398)
Q Consensus 151 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~-~~kl~D 227 (398)
...++||||+++++|..+. +.+++..+..++.||+.||.|||+++ |+||||||+||||+.++ .++|+|
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecc
Confidence 5689999999999986542 35899999999999999999999999 99999999999998655 699999
Q ss_pred ccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh--------
Q 015909 228 FGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV-------- 298 (398)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~-------- 298 (398)
||+|+....... .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............
T Consensus 174 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 174 WGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp GGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred cccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 999987544332 3346789999999998765 5799999999999999999999999754322110000
Q ss_pred ---hhhhhh-hhcccccccc--------ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 299 ---EWAKPY-LTSKRRIFRV--------LDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 299 ---~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+.... .......... .............+.++.+||.+||..||++|||++|+|+|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0000000000 00001111122346789999999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=357.27 Aligned_cols=257 Identities=28% Similarity=0.370 Sum_probs=205.3
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc----cchHHHHHHHHHHcCCCC-CcccceeeE
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF----QGHKEWLTEINYLGQLHH-PNLVKLVGY 146 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~~I~~~~~~ 146 (398)
++|++++.||+|+||+||+|+... ...+|..||+|.++.... ...+.+.+|+.+|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECc------cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 569999999999999999997632 234789999999865322 234567899999999976 899999999
Q ss_pred EEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCEEEe
Q 015909 147 CLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNAKLS 226 (398)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~kl~ 226 (398)
+.+....+++|||+.+++|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEES
T ss_pred eccCCceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEe
Confidence 999999999999999999999998875 3788999999999999999999998 9999999999999999999999
Q ss_pred eccCCcCCCCCCCcccccccccccccccccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhhhh
Q 015909 227 DFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG--HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAKPY 304 (398)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (398)
|||+++....... .......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||........... .....
T Consensus 172 DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~ 248 (322)
T d1vzoa_ 172 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRI 248 (322)
T ss_dssp CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHH
T ss_pred eccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhc
Confidence 9999986543322 223446799999999999764 467899999999999999999999976543322111 11110
Q ss_pred hhccccccccccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 015909 305 LTSKRRIFRVLDPRLEGQFSLPQAQKAASLALQCLSVEPKLRPD-----MDEVVKE 355 (398)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 355 (398)
... ....+...+.++.+||.+||+.||++||| ++|+++|
T Consensus 249 ~~~------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 249 LKS------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccC------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 000 11223345678999999999999999994 7888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=357.06 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=191.0
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEEe
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCLE 149 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~~ 149 (398)
++|+++++||+|+||+||+|++.. +|..||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 679999999999999999997764 799999999975433 234568899999999999999999999964
Q ss_pred ------CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 150 ------DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 150 ------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
....|+|||||.+ ++...+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCE
T ss_pred ccccccCceeEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccce
Confidence 3678999999965 4444443 34899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchh-----
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLV----- 298 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~----- 298 (398)
+++|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..........
T Consensus 159 kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp EECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 999999987654332 234467899999999999999999999999999999999999999654211000000
Q ss_pred ----hh-------hhhhhhccc-----cccccccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 299 ----EW-------AKPYLTSKR-----RIFRVLDPRL---EGQFSLPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 299 ----~~-------~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.+ ......... .......... ........+.++.+||.+||..||++|||++|+|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000000000 0000000000 011123357789999999999999999999999977
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=355.50 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=195.3
Q ss_pred hcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc--cchHHHHHHHHHHcCCCCCcccceeeEEE
Q 015909 71 TRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF--QGHKEWLTEINYLGQLHHPNLVKLVGYCL 148 (398)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~I~~~~~~~~ 148 (398)
.++|++.+.||+|+||+||+|++.. +|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4689999999999999999997654 799999999975433 33456889999999999999999999986
Q ss_pred eC-----CceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEEEcCCCCE
Q 015909 149 ED-----DHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNILLDSNYNA 223 (398)
Q Consensus 149 ~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nilv~~~~~~ 223 (398)
.. ...+++|+++.+++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred eccccccCceEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccc
Confidence 43 3346667778899999998543 4899999999999999999999999 9999999999999999999
Q ss_pred EEeeccCCcCCCCCCCcccccccccccccccccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCCCCcchhhhhh
Q 015909 224 KLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATG-HLTAKSDIYSFGVVLLEILSGRRAIDKNRPTGEHNLVEWAK 302 (398)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (398)
+++|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+........ ..
T Consensus 161 kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i--~~ 233 (348)
T d2gfsa1 161 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI--LR 233 (348)
T ss_dssp EECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HH
T ss_pred cccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--HH
Confidence 9999999876422 23346789999999987665 4688999999999999999999999754321110000 00
Q ss_pred hhhhcccccc---------cccccc-ccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 015909 303 PYLTSKRRIF---------RVLDPR-LEGQFS-----LPQAQKAASLALQCLSVEPKLRPDMDEVVKE 355 (398)
Q Consensus 303 ~~~~~~~~~~---------~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 355 (398)
.......... ...... ...... ...+.++.+||.+||..||.+|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000 000000 000001 1235678999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-42 Score=323.80 Aligned_cols=266 Identities=19% Similarity=0.236 Sum_probs=190.8
Q ss_pred cCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-----------CCcc
Q 015909 72 RNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-----------HPNL 140 (398)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~I 140 (398)
.+|+++++||+|+||+||+|++.. +|+.||||+++.... ..+.+.+|+.+++.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 369999999999999999997754 789999999976532 2356678888888775 5789
Q ss_pred cceeeEEEe--CCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceecCCCCCCEEE
Q 015909 141 VKLVGYCLE--DDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHS-AEPKVIYRDFKASNILL 217 (398)
Q Consensus 141 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~ivH~Dlkp~Nilv 217 (398)
+++++++.. ....+++|+++..+.......... ....+++..+..++.||+.||.|||+ .+ |+||||||+|||+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll 159 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLM 159 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeee
Confidence 999988764 345667777665544333333222 23568999999999999999999997 77 9999999999999
Q ss_pred cCCC------CEEEeeccCCcCCCCCCCcccccccccccccccccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q 015909 218 DSNY------NAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAPEYLATGHLTAKSDIYSFGVVLLEILSGRRAIDKNRP 291 (398)
Q Consensus 218 ~~~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p~~~~~~ 291 (398)
+.++ .++|+|||.+...... .....||+.|+|||++.+..++.++|+|||||++++|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 7654 3999999998764322 2346799999999999999999999999999999999999999976433
Q ss_pred CCCcchhhhhhh---hhhc-----------------cccccccccc----------cccCCCCHHHHHHHHHHHHHhccC
Q 015909 292 TGEHNLVEWAKP---YLTS-----------------KRRIFRVLDP----------RLEGQFSLPQAQKAASLALQCLSV 341 (398)
Q Consensus 292 ~~~~~~~~~~~~---~~~~-----------------~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~ 341 (398)
............ .+.. .......... ..........+.++.+||.+||..
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 221111110000 0000 0000000000 011234456788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 015909 342 EPKLRPDMDEVVKE 355 (398)
Q Consensus 342 dP~~Rps~~ell~~ 355 (398)
||.+|||++|+|+|
T Consensus 315 dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 315 DPRKRADAGGLVNH 328 (362)
T ss_dssp STTTCBCHHHHHTC
T ss_pred ChhHCcCHHHHhcC
Confidence 99999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.5e-25 Score=186.94 Aligned_cols=163 Identities=13% Similarity=0.097 Sum_probs=116.9
Q ss_pred CCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCc-----c-------------chHHHHHHHHHHcCCC
Q 015909 75 RPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGF-----Q-------------GHKEWLTEINYLGQLH 136 (398)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~-------------~~~~~~~E~~~l~~l~ 136 (398)
.++++||+|+||+||+|.+. +|..||||+++.... . .......|+..+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 45789999999999999753 578999998753211 0 0122356888999999
Q ss_pred CCcccceeeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceecCCCCCCEE
Q 015909 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEPKVIYRDFKASNIL 216 (398)
Q Consensus 137 h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ivH~Dlkp~Nil 216 (398)
|.+++..+++. ..+++|||+++..+.. ++......++.|++.+|.|||+++ |+||||||+|||
T Consensus 73 ~~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NIL 135 (191)
T d1zara2 73 GLAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVL 135 (191)
T ss_dssp TSSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEE
T ss_pred CCCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhhee
Confidence 99998887653 2379999998755432 333445678999999999999999 999999999999
Q ss_pred EcCCCCEEEeeccCCcCCCCCCCcccccccccccccccc------cccccCCCCCchhHHHHHHHH
Q 015909 217 LDSNYNAKLSDFGLARDGPTGDKSHVSTRVMGTYGYAAP------EYLATGHLTAKSDIYSFGVVL 276 (398)
Q Consensus 217 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslG~~l 276 (398)
++++ .++|+|||+|......... .|... +.+ ...|+.++|+||+.--+
T Consensus 136 v~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred eeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9865 5899999999764322211 11110 111 35678889999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.77 E-value=4.1e-08 Score=85.45 Aligned_cols=149 Identities=15% Similarity=0.041 Sum_probs=101.3
Q ss_pred HHHHHHhcCCCCCceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccce
Q 015909 65 SDLRTATRNFRPDSVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKL 143 (398)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~ 143 (398)
.++......|++.+..+-++.+.||+... .+..+++|............+.+|...+..|. +--+.++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~v 75 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKV 75 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcE
Confidence 35566667787777655555678998642 45667888876554444455678888877664 3335677
Q ss_pred eeEEEeCCceEEEEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--------------------
Q 015909 144 VGYCLEDDHRLLVYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAEP-------------------- 203 (398)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-------------------- 203 (398)
+.+...++..++||++++|.++.+..... .. ...++.++...+..||+...
T Consensus 76 l~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T d1j7la_ 76 LHFERHDGWSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEEEEETTEEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEEecCCceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence 88888888899999999988876543211 11 22245555666666664310
Q ss_pred -------------------------------------CceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 204 -------------------------------------KVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 204 -------------------------------------~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 178999999999998776667999987643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=6.7e-06 Score=70.54 Aligned_cols=130 Identities=17% Similarity=0.087 Sum_probs=81.5
Q ss_pred eecccCC-ceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCC--CcccceeeEEEeCCceEE
Q 015909 79 VLGEGGF-GSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHH--PNLVKLVGYCLEDDHRLL 155 (398)
Q Consensus 79 ~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~~I~~~~~~~~~~~~~~l 155 (398)
.+..|.. +.||+.... .+..+++|....... ..+..|+..|+.|.. -.+.+++.+..+.+..++
T Consensus 17 ~~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECT----------TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred EcCCcccCCeEEEEEeC----------CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 3444543 678987542 466688888755432 335677777776642 235667887788888899
Q ss_pred EEeecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------
Q 015909 156 VYEFMPRGSMENHLFRRGSYFQPLSWSLRMKIALGAANGLAFLHSAE--------------------------------- 202 (398)
Q Consensus 156 v~e~~~~~~L~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------------- 202 (398)
||++++|.++.+. ...... ++.++...|.-||+..
T Consensus 84 v~~~i~G~~~~~~---------~~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (255)
T d1nd4a_ 84 LLGEVPGQDLLSS---------HLAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 151 (255)
T ss_dssp EEECCSSEETTTS---------CCCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred EEEeeeccccccc---------cccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccc
Confidence 9999987654321 011111 1223333444444311
Q ss_pred -----------------------CCceecCCCCCCEEEcCCCCEEEeeccCCcC
Q 015909 203 -----------------------PKVIYRDFKASNILLDSNYNAKLSDFGLARD 233 (398)
Q Consensus 203 -----------------------~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~~ 233 (398)
..++|+|+.|.||+++++..+-|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 152 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 0179999999999998876678999987643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=4.1e-05 Score=70.08 Aligned_cols=76 Identities=16% Similarity=0.124 Sum_probs=47.2
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEccc------CC-ccchHHHHHHHHHHcCCC-C--CcccceeeEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQ------EG-FQGHKEWLTEINYLGQLH-H--PNLVKLVGYC 147 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~-h--~~I~~~~~~~ 147 (398)
+.||.|....||+..... ++..+++|.-.. +. .........|++.|+.+. + ..+.+++.
T Consensus 32 ~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~-- 100 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-- 100 (392)
T ss_dssp EECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--
T ss_pred EEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--
Confidence 468999999999985432 467888886431 11 122344567888777652 2 34555554
Q ss_pred EeCCceEEEEeecCCCC
Q 015909 148 LEDDHRLLVYEFMPRGS 164 (398)
Q Consensus 148 ~~~~~~~lv~e~~~~~~ 164 (398)
.+.+..++|||++++..
T Consensus 101 ~d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 101 SDTEMAVTVMEDLSHLK 117 (392)
T ss_dssp EETTTTEEEECCCTTSE
T ss_pred EcCCCCEEEEeccCCcc
Confidence 35667789999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.99 E-value=0.00079 Score=61.30 Aligned_cols=80 Identities=14% Similarity=0.057 Sum_probs=51.0
Q ss_pred ceecccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCC-CCcccceeeEEEeCCceEEE
Q 015909 78 SVLGEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLH-HPNLVKLVGYCLEDDHRLLV 156 (398)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 156 (398)
+.|+-|-.-.+|++...+... ........|++++.... .......+|..+++.+. +.-..++++++.+ .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 567778889999987765321 11124566888877632 23345568888888885 3334566766532 688
Q ss_pred EeecCCCCH
Q 015909 157 YEFMPRGSM 165 (398)
Q Consensus 157 ~e~~~~~~L 165 (398)
+||++|.+|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999976443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.78 E-value=0.0064 Score=53.02 Aligned_cols=159 Identities=13% Similarity=0.044 Sum_probs=80.6
Q ss_pred CCCHHHHHHHhcCCCCCcee-----cccCCceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCC
Q 015909 61 NFSYSDLRTATRNFRPDSVL-----GEGGFGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQL 135 (398)
Q Consensus 61 ~~~~~~~~~~~~~y~~~~~l-----g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l 135 (398)
..+.+++.....+|-++++. ..|---+.|+.... +..+++|+.... ...+.+..|+.++..|
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-----------~g~yVLri~~~~--~~~~~l~~~~~~l~~L 68 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-----------KDPLILTLYEKR--VEKNDLPFFLGLMQHL 68 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-----------SCCEEEEEECC-----CCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-----------CCcEEEEEcCCC--CCHHHHHHHHHHHHhh
Confidence 35677888888889886554 35556778887542 345889988643 1224455566666665
Q ss_pred C-----CCcccceee---EEEeCCceEEEEeecCCCCHH-----H---------HHhhcCCCC-----CC----------
Q 015909 136 H-----HPNLVKLVG---YCLEDDHRLLVYEFMPRGSME-----N---------HLFRRGSYF-----QP---------- 178 (398)
Q Consensus 136 ~-----h~~I~~~~~---~~~~~~~~~lv~e~~~~~~L~-----~---------~~~~~~~~~-----~~---------- 178 (398)
. .|..+...+ +.........++.++.+.... . .+....... ..
T Consensus 69 ~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (316)
T d2ppqa1 69 AAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLW 148 (316)
T ss_dssp HHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHH
T ss_pred hhccccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhh
Confidence 3 222222110 112234445556555442211 0 000000000 00
Q ss_pred --------CCHHHHHHHHHHHHHHHHHHHcC--CCCceecCCCCCCEEEcCCCCEEEeeccCCc
Q 015909 179 --------LSWSLRMKIALGAANGLAFLHSA--EPKVIYRDFKASNILLDSNYNAKLSDFGLAR 232 (398)
Q Consensus 179 --------l~~~~~~~i~~qi~~al~~LH~~--~~~ivH~Dlkp~Nilv~~~~~~kl~Dfg~a~ 232 (398)
.........+..+...+.-.+.. ..++||+|+.++||+++++...-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 149 DKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00001112222233333333321 1249999999999999988777899998874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.71 E-value=0.0048 Score=54.24 Aligned_cols=67 Identities=15% Similarity=0.048 Sum_probs=41.5
Q ss_pred CceEEEEEecCCcccccCCCCCcEEEEEEcccCCccchHHHHHHHHHHcCCCCCcc-----ccee--eEEEeCCceEEEE
Q 015909 85 FGSVFKGWVDEHSLASTRPGTGMLIAVKRLNQEGFQGHKEWLTEINYLGQLHHPNL-----VKLV--GYCLEDDHRLLVY 157 (398)
Q Consensus 85 ~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~I-----~~~~--~~~~~~~~~~lv~ 157 (398)
--.||++... +|..|++|+.+.. ....+++..|...+..|....| +..- ..+......+.++
T Consensus 35 EN~vy~v~~~----------dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 35 ENRVYQFQDE----------DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp SSEEEEECCT----------TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred cceeEEEEcC----------CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 4579987542 5788999987654 2345667788888777642221 1111 1223456678889
Q ss_pred eecCC
Q 015909 158 EFMPR 162 (398)
Q Consensus 158 e~~~~ 162 (398)
++++|
T Consensus 104 ~~~~G 108 (325)
T d1zyla1 104 PSVGG 108 (325)
T ss_dssp ECCCC
T ss_pred eecCC
Confidence 98865
|